accession,name,description,Study Disease/Focus,Study Design,Study Markerset,Parent study,Study Molecular Data Type,Study Content,Ancestry (computed),NIH Institute,Study Consent,Release Date,Embargo Release Date,Related Terms
"phs000001.v3.p1","NEI Age-Related Eye Disease Study (AREDS)","The Age-Related Eye Disease Study (AREDS) was initially designed as a long-term multi-center, prospective study of the clinical course of age-related macular degeneration (AMD) and age-related cataract. In addition  to collecting natural history data, AREDS included a clinical trial of high-dose vitamin and mineral supplements for AMD and a clinical trial of high","Cataract","Case-Control","Illumina100K, Affymetrix_100K, HumanOmni2.5-4v1_D","Not Applicable","Not Provided","16 phenotype datasets, 635 variables, 48 documents, 3 analyses, 3 molecular datasets, 4757 subjects, 6962 samples, 1 sub-studies","European (575), African American (11), Hispanic1 (2), South Asian (2), Other (3)","NEI","EDO --- Eye disease research only , GRU --- General research purposes","2012-04-05","2016-02-11","Cataract, Membranous; Cataracts, Membranous; Membranous Cataract; Membranous Cataracts; Pseudoaphakias"
"phs000007.v30.p11","Framingham Cohort","Startup of Framingham Heart Study. Cardiovascular disease (CVD) is the leading cause of death and serious illness in the United States. In 1948, the Framingham Heart Study (FHS) --  under the direction of the National Heart Institute (now known as the National Heart, Lung, and Blood Institute, NHLBI) -- embarked on a novel and","Cardiovascular Diseases","Prospective Longitudinal Cohort","HuEx-1_0-st, custom_probe_set, Affymetrix_50K, Affymetrix_100K, Genome-Wide_Human_SNP_Array_5.0, LegacySet, HapMap_phaseII, CVDSNP55v1_A, exome_vcf_grc37, HumanOmni5-4v1_B, target_markerset_grc36, SNP-PCR, HumanMethylation450, WES_markerset_grc36, WGS_markerset_grc36, FHSOmni_Axiom_PLINK_Markerset, HumanExome-12v1_CHARGE-ExomeChip-v6, 1000G_ref_panel, exome_vcf_ESP6800, WGS_markerset_grc37, WES_markerset_grc37, HRC1_ref_panel","Not Applicable","Not Provided","434 phenotype datasets, 61988 variables, 1293 documents, 3029 analyses, 27 molecular datasets, 15154 subjects, 51800 samples, 8 sub-studies","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000178.v10.p8","The Cancer Genome Atlas (TCGA)","The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including  large-scale genome sequencing. TCGA is a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI","Neoplasms","Tumor vs. Matched-Normal","WGS_markerset_grc37","Not Applicable","Not Provided","3 phenotype datasets, 8 variables, 1 molecular datasets, 11429 subjects, 11429 samples, 1 sub-studies","","NCI","GRU --- General research use","2018-08-17","2018-08-17","Adenocarcinoma of lung; Carcinoma, squamous cell of head and neck; Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant"
"phs000179.v6.p2","Genetic Epidemiology of COPD (COPDGene)","Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States and the only leading cause of death that is steadily increasing in frequency.  This project will establish a racially diverse cohort that is sufficiently large and appropriately designed for genome-wide association analysis of","Pulmonary Disease, Chronic Obstructive","Case-Control","HumanOmni1-Quad_v1-0_B, WES_markerset_grc37, custom_array","Not Applicable","Not Provided","4 phenotype datasets, 341 variables, 16 documents, 4 analyses, 5 molecular datasets,  SRA, 10371 subjects, 11951 samples, 2 sub-studies","European (978), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (2)","NHLBI","HMB --- Health/medical/biomedical , DS-CS --- Disease-specific (copd and smoking)","2019-05-03","2015-09-19","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD"
"phs000200.v11.p3","Women's Health Initiative","The Women's Health Initiative (WHI) is a long-term national health study that has focused on strategies for preventing heart disease, breast and colorectal cancer, and osteoporotic fractures in postmenopausal  women. The original WHI study included 161,808 postmenopausal women enrolled between 1993 and 1998. The Fred Hutchinson Cancer Research Center in","Women's Health","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, HumanOmni1-Quad_v1-0_B, exome_vcf_grc37, Cardio-Metabo_Chip, custom_PCR_marker_set, HumanOmniExpressExome-8v1_B, 1000G_ref_panel, exome_vcf_ESP6800, MEGA_Consortium_15063755_B2, target_markerset_grc37, HumanMethylation450","Not Applicable","Not Provided","86 phenotype datasets, 6208 variables, 72 documents, 14 molecular datasets, 143213 subjects, 104158 samples, 9 sub-studies","European (588), African (302), East Asian (2), African American (7967), Hispanic1 (526), Hispanic2 (2407), Other Asian or Pacific Islander (19), Other (196)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Adrenal Gland Tumor; Adrenal Neoplasm; Adrenal Neoplasms; Adrenal Tumor; Adrenal neoplasia; Neoplasm of Adrenal Gland"
"phs000209.v13.p3","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort","MESA The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and  the risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers","Cardiovascular Diseases","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, CVDSNP55v1_A, exome_vcf_grc37, HumanExome-12v1-1, exome_vcf_ESP6800","Not Applicable","Not Provided","93 phenotype datasets, 22147 variables, 182 documents, 5 molecular datasets, 9780 subjects, 23922 samples, 3 sub-studies","","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Atherogenesis"
"phs000218.v22.p8","NCI TARGET: Therapeutically Applicable Research to Generate Effective    Treatments","The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy,  through identification of genomic changes associated with the following childhood cancers: Acute Lymphoblastic Leukemia (ALL) - A fast-growing type","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 10 variables,  SRA, 5968 subjects, 11941 samples, 9 sub-studies","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000235.v13.p2","NCI Cancer Genome Characterization Initiative (CGCI)","The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging  sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 6 variables,  SRA, 601 subjects, 723 samples, 6 sub-studies","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000280.v5.p1","Atherosclerosis Risk in Communities (ARIC) Cohort","The Atherosclerosis Risk in Communities (ARIC) Study, sponsored by the National Heart, Lung and Blood Institute (NHLBI), is a prospective epidemiologic study conducted in four U.S. communities. The four  communities are Forsyth County, NC; Jackson, MS; the northwest suburbs of Minneapolis, MN; and Washington County, MD. ARIC is designed to investigate","Cardiovascular Diseases","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, CVDSNP55v1_A, HapMap_Phase3, exome_vcf_grc37, Cardio-Metabo_Chip, 1000G_ref_panel, exome_vcf_ESP6800, WES_markerset_grc37, targeted_region_sequencing, WGS_markerset_grc37, LegacySet, target_markerset_grc37, ExomeChip","Not Applicable","Not Provided","289 phenotype datasets, 18704 variables, 357 documents, 15 molecular datasets, 15678 subjects, 43640 samples, 6 sub-studies","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","Atherogenesis; Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System"
"phs000285.v3.p2","CARDIA Cohort","CARDIA is a study examining the etiology and natural history of cardiovascular disease beginning in young adulthood. In 1985-1986, a cohort of 5115 healthy black and white men and  women aged 18-30 years were selected to have approximately the same number of people in subgroups of age (18-24 and 25-30), sex, race, and education","Cardiovascular Diseases","Prospective Longitudinal Cohort","iSELECT_HG18, Genome-Wide_Human_SNP_Array_6.0, 1000G_ref_panel, exome_vcf_grc37, custom_PCR_marker_set, exome_vcf_ESP6800","Not Applicable","Not Provided","322 phenotype datasets, 9364 variables, 115 documents, 7 molecular datasets,  SRA, 3622 subjects, 13539 samples, 4 sub-studies","European (148), African (9), African American (555), Hispanic1 (6), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (4)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Atherogenesis; Caloric Intake; Energy intake; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High"
"phs000286.v6.p2","The Jackson Heart Study (JHS)","The Jackson Heart Study (JHS) is a large, community-based, observational study whose participants were recruited from urban and rural areas of the three counties (Hinds, Madison and Rankin) that  make up the Jackson, MS metropolitan statistical area (MSA). Participants were enrolled from each of 4 recruitment pools: random, 17%; volunteer, 30","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55v1_A, Genome-Wide_Human_SNP_Array_6.0, Human1Mv1_C, exome_vcf_grc37, exome_vcf_ESP6800, HumanExome-12-v1-0-B","Not Applicable","Not Provided","110 phenotype datasets, 4690 variables, 2 documents, 9 molecular datasets, 3889 subjects, 12729 samples, 6 sub-studies","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","Arrhythmia; Arrhythmia, Cardiac; Arrhythmias, Cardiac; Arrythmia; Cardiac Arrhythmias; Cardiac Dysrhythmia"
"phs000287.v6.p1","Cardiovascular Health Study (CHS) Cohort","Objectives The Cardiovascular Health Study (CHS) is a study of risk factors for development and progression of CHD and stroke in people aged 65 years and older. The objectives  of the Cardiovascular Health Study are to: 1) quantify associations of conventional and hypothesized risk factors with CHD and stroke; 2) assess the","Cardiovascular Diseases","Prospective Longitudinal Cohort","CVDSNP55v1_A, HumanCNV370-Duo_v1, exome_vcf_grc37, custom_PCR_marker_set, HumanOmni1-Quad_v1-0_B, exome_vcf_ESP6800, targeted_region_sequencing, WGS_markerset_grc37, WES_markerset_grc37, Cardio-Metabo_Chip, HumanExome-12v1","Not Applicable","Not Provided","56 phenotype datasets, 14718 variables, 22 documents, 11 molecular datasets, 5609 subjects, 16192 samples, 5 sub-studies","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Aging, Biological; Biological Aging; AP - Angina pectoris; Angina; Anginal syndrome; Angor Pectoris"
"phs000631.v1.p1","ARDSnet and the iSPAAR Consortium: Genetic Studies","Acute Respiratory Distress Syndrome (ARDS)/ Acute Lung Injury (ALI) is a syndrome defined by the presence of acute hypoxemic respiratory failure, bilateral pulmonary infiltrates on chest radiograph, a known  clinical risk factor (e.g. sepsis, pneumonia, trauma, gastric fluid aspiration, pancreatitis, massive transfusion), and the absence of physiologic or","Respiration Disorders","Clinical Trial","Human660W-Quad_v1_A, exome_vcf_grc37, LUNG_GO_Exome, exome_vcf_ESP6800","Not Applicable","Not Provided","3 phenotype datasets, 22 variables, 4 molecular datasets, 3033 subjects, 3772 samples, 2 sub-studies","","NHLBI","HMB --- Health/medical/biomedical","2014-01-15","2015-01-15","Pyaemia; Pyaemias; Pyemia; Pyemias; Pyohemia; Pyohemias"
"phs000640.v7.p1","HeLa Cell Genome Sequencing Studies","This study contains all authorized whole genome sequence data of the HeLa cell line from datasets currently in dbGaP. These data have been approved for health, medical, and/or biomedical  research purposes. Access to these data can be granted for one year. Accessible data will include the studies listed on this page and any additional","Uterine Cervical Neoplasms","Case Set","whole_genome_vcf_grc37","Not Applicable","Not Provided","2 phenotype datasets, 11 variables, 2 molecular datasets,  SRA, 1 subjects, 137 samples, 11 sub-studies","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs000653.v3.p1","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes","The Epi4K project began in 2011 as an international, multi-center study that seeks to identify and characterize the genetic bases of complex epilepsies. The Center without Walls Epi4K project  includes three cores and four scientific projects, as well as a steering committee comprised of the primary study investigators and representatives","Epilepsy","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","Not Provided","4 phenotype datasets, 24 variables, 2 molecular datasets,  SRA, 2186 subjects, 2186 samples, 3 sub-studies","","NINDS","GRU --- General research use , DS-ESD-GSO --- Disease-specific (epilepsy and seizure disorders, gso)","2018-09-19","2018-09-19","EP - Epilepsy; Epilepsies; Epileptic; Epileptic disorder; Seizure Disorder; Seizure Disorders"
"phs000684.v1.p1","Age related Macular Degeneration - MMAP Cohort: Association and    Sequencing Studies","Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves  interaction of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis","Macular Degeneration","Case-Control","HumanCNV370-Duo_v1, HumanMethylation450","Not Applicable","Not Provided","2 phenotype datasets, 13 variables, 2 analyses, 2 molecular datasets, 5653 subjects, 7229 samples, 4 sub-studies","","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2014-05-08","2015-05-08",""
"phs000700.v1.p1","RoadmapEpigenomics_Broad","For the NIH Roadmap Epigenomics project, we applied ChlP-Seq, HTBS and WGBS pipelines to generate comprehensive high-resolution maps of chromatin state and DNA methylation for 100 diverse cell types.  Cell types were selected for their biological and medical importance, and for their potential to maximize the comprehensiveness of acquired","Nervous System Diseases","Cross-Sectional","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 10 variables,  SRA, 3 subjects, 19 samples, 1 sub-studies","","NIDA","AARC --- Alzheimer's and age related conditions","2014-07-23","2015-04-23","Disease, Nervous System; Diseases, Nervous System; Disorder, Nervous System; Disorder, Neurologic; Disorder, Neurological; Disorders, Nervous System"
"phs000703.v1.p1","CATHeterization GENetics (CATHGEN)","The CATHGEN biorepository consists of biological samples collected on 9334 sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review  Board informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the","Coronary Disease","Cross-Sectional","HumanHT-12_v3, HumanOmni1-Quad_v1-0_C","Not Applicable","Not Provided","2 phenotype datasets, 7 variables, 3 molecular datasets, 3304 subjects, 3306 samples, 2 sub-studies","","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2014-07-30","2014-07-30","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000725.v1.p1","Rare Cancer Tumors Project","A large proportion of common cancers affecting patients around the world have been selected for comprehensive cancer genome studies. Further efforts will be needed to tackle the remaining tumor  types, including the rare forms of cancers. Although rare, these cancers tend to be more aggressive and fast growing with an early recurrence","Neoplasms","Prospective Longitudinal Cohort","exome_vcf_grc37","Not Applicable","Not Provided","2 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 99 subjects, 248 samples, 3 sub-studies","","NHGRI","GRU --- General research use","2016-01-20","2016-01-20","BT - Brain tumor; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain"
"phs000743.v1.p1","METSIM (METabolic Syndrome In Men) Study","The METSIM Study includes 10,197 men, aged from 45 to 73 years, randomly selected from the population register of the town of Kuopio, Eastern Finland, and examined in 2005-2010.  The aim of the study is to investigate genetic and non-genetic factors associated with the risk of type 2 diabetes (T2D), cardiovascular disease (CVD","Metabolic Syndrome X","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","Not Provided","3 phenotype datasets, 36 variables, 1 molecular datasets, 982 subjects, 982 samples, 1 sub-studies","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-08","2017-01-19","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000755.v2.p1","BrainSpan Atlas of the Human Brain","The NIH-funded BrainSpan (www.brainspan.org) and PsychENCODE (www.psychencode.org). Consortia sought to generate and analyze multi-dimensional genomics data from the developing and adult human brain in healthy and disease states. One  of the main goals has been to perform large-scale and integrated analysis of the genome, transcriptome, and epigenome of the human brain to broaden","Brain Diseases","Control Set","HumanOmni2.5-4v1_B, HumanMethylation450","Not Applicable","Not Provided","3 phenotype datasets, 12 variables, 2 molecular datasets, 61 subjects, 1279 samples, 2 sub-studies","","NIMH","GRU --- General research use","2019-01-08","2018-05-23","Aging, Biological; Biological Aging; Brain Disease; Brain Disorders; CNS Disorder, Intracranial; CNS Disorders, Intracranial"
"phs000761.v1.p1","Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA)","The OPPERA project has two sub-studies investigating effects of genetic, physiological, psychological and clinical factors on the risk of developing painful temporomandibular disorder (TMD). 1. OPPERA I baseline case-control  study of chronic TMJD (dbGaP study accession phs000762). This sub-study uses a case-control study design to investigate characteristics associated","Temporomandibular Joint Disorders","Case-Control","targeted_region_sequencing","Not Applicable","Not Provided","3 phenotype datasets, 21 variables, 1 documents, 2 molecular datasets, 3446 subjects, 3035 samples, 2 sub-studies","","NIDCR","DS-TMJD-RD --- Disease-specific (temporomandibular joint disorder, rd)","2015-03-27","2015-03-27","Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Pains, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Pains, Widespread Chronic"
"phs000788.v2.p3","Research Program on Genes, Environment and Health (RPGEH)","The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) is a resource developed to facilitate research on genetic and environmental factors on common diseases and healthy aging.  The RPGEH resource links biospecimens, health surveys, and comprehensive electronic medical records on broadly consented adult members of Kaiser","Aging","Prospective Longitudinal Cohort","Axiom_KP_UCSF_EUR, Axiom_KP_UCSF_AFR, Axiom_KP_UCSF_EAS, Axiom_KP_UCSF_LAT, WGS_markerset_grc37, Axiom_KP_UCSF_EUR, Axiom_KP_UCSF_AFR, Axiom_KP_UCSF_EAS, Axiom_KP_UCSF_LAT","Not Applicable","Not Provided","3 phenotype datasets, 12 variables, 3 molecular datasets, 78423 subjects, 78423 samples, 2 sub-studies","","NIA","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2018-05-15","2018-05-15","Aging, Biological; Biological Aging; Anxiety State, Neurotic; Anxiety States, Neurotic; Neurotic Anxiety State; Neurotic Anxiety States"
"phs000801.v2.p1","NCI Non-Hodgkin Lymphoma GWAS","Within the framework of the International Lymphoma Epidemiology Consortium (InterLymph) Consortium and NCI-sponsored Cohort Consortium, investigators from 22 studies came together to conduct a genome-wide association study (GWAS) of  non-Hodgkin lymphoma (NHL). The goal of the study was to identify common genetic variants associated with the risk of NHL. As described previously","Lymphoma, Non-Hodgkin","Prospective Longitudinal Cohort","HumanOmniExpressExome-8v1_A, HumanOmniExpress, HumanOmniExpress-12v1_A","Not Applicable","Not Provided","2 phenotype datasets, 7 variables, 5 molecular datasets, 10491 subjects, 10791 samples, 5 sub-studies","","NCI","DS-CA-IRB-NPU-GSO --- Disease-specific (cancer, irb, npu, gso) , DS-NHL-NPU-GSO --- Disease-specific (non-hodgkin lymphoma, npu, gso) , GRU-NPU-MDS --- General research use (npu, mds)","2016-09-22","2016-09-22","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000810.v1.p1","Hispanic Community Health Study /Study of Latinos (HCHS/SOL)","The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) is a multi-center epidemiologic study in Hispanic/Latino populations to determine the role of acculturation in the prevalence and development  of disease, and to identify risk factors playing a protective or harmful role in Hispanics/Latinos. The study is sponsored by the National Heart","Cardiovascular Diseases","Prospective Longitudinal Cohort","Cardio-Metabo_Chip, SoL_HCHS_Custom_15041502_B3_RefStrand","Not Applicable","Not Provided","3 phenotype datasets, 282 variables, 2 molecular datasets, 12895 subjects, 25746 samples, 2 sub-studies","","NHLBI","HMB-NPU --- Health/medical/biomedical (npu) , HMB --- Health/medical/biomedical","2015-12-07","2016-12-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000833.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T)","This initiative is part of the Single Cell Analysis Program (SCAP) and is funded through the NIH Common Fund (See http://nihroadmap.nih.gov/), which supports cross-cutting programs that are expected to  have exceptionally high impact. Common Fund initiatives address key roadblocks in biomedical research that impede basic scientific discovery and its","Not Provided","Case Set","RNAseq_probe_set_grc38","Not Applicable","Not Provided","3 phenotype datasets, 22 variables, 1 documents, 16 molecular datasets, 215 subjects, 9269 samples, 3 sub-studies","","NIMH","GRU --- General research use , GRU-NPU --- General research use (npu)","2017-11-27","2017-11-27",""
"phs000842.v2.p1","PediGFR","The Pediatric Investigation for Genetic Factors Associated with Renal Progression (PediGFR) (RO1-DK082394) is an international collaborative study among three large prospective cohort studies of children with chronic kidney disease.  The participating parent cohort studies are the Chronic Kidney Disease in Children (CKiD), the Effect of Strict Blood Pressure Control and ACE","Kidney Diseases","Prospective Longitudinal Cohort","HumanOmni2.5-8v1_A, HumanOmni2.5-8v1_C, HumanOmni2_5-4v1_H","Not Applicable","Not Provided","2 phenotype datasets, 8 variables, 4 molecular datasets, 1828 subjects, 1580 samples, 3 sub-studies","","NIDDK","DS-CKD-COMP-IRB --- Disease-specific (chronic kidney disease and related complications, irb)","2019-03-29","2019-03-29","Failure, Kidney; Failures, Kidney; Failures, Renal; Kidney Failures; RF - Renal failure; Renal Failure"
"phs000847.v2.p1","T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)","The Type 2 Diabetes (T2D) Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Consortium is a collaborative international effort to identify genes influencing susceptibility to type 2 diabetes  in multiple ethnic groups using next generation sequencing. To fulfill this objective, T2D-GENES Consortium undertook two large sequencing studies","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","Sentrix_Human-6_Expression_BeadChip, WGS_markerset_grc37, WES_markerset_grc37","Not Applicable","Not Provided","3 phenotype datasets, 14 variables, 3 molecular datasets, 1539 subjects, 2142 samples, 2 sub-studies","","NIDDK","DS-DIAB-IRB-RD --- Disease-specific (diabetes, irb, rd)","2016-12-13","2016-12-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000867.v1.p1","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study","The Finland-United States Investigation of NIDDM Genetics (FUSION) study is a long-term effort to identify genetic variants that predispose to type 2 diabetes (T2D) or that impact the variability  of T2D-related quantitative traits. The initial effort involved linkage analysis of affected-sibling-pair (ASP) families based on over 5,000","Diabetes Mellitus, Type 2","Case-Control","HumanHap300v1-1_C","Not Applicable","Not Provided","3 phenotype datasets, 28 variables, 1 molecular datasets,  SRA, 1850 subjects, 3928 samples, 2 sub-studies","","NIDDK","GRU-IRB --- General research use (irb)","2015-04-24","2015-04-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000876.v1.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL)","The study was conducted under the auspices of the Transdisciplinary Research In Cancer of the Lung (TRICL) Research Team, which is a part of the Genetic Associations and MEchanisms  in ONcology (GAME-ON) consortium, and associated with the International Lung Cancer Consortium (ILCCO). Ethics All participants provided written","Lung Neoplasms","Case-Control","WES_markerset_grc37","Not Applicable","Not Provided","2 phenotype datasets, 11 variables, 1 molecular datasets, 1942 subjects, 2030 samples, 2 sub-studies","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-CA --- Disease-specific (cancer) , HMB-MDS --- Health/medical/biomedical (mds) , LCRF --- Lung cancer risk factors , DS-LCS-RD --- Disease-specific (lung cancer or smoking, rd)","2017-02-07","2017-02-07","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000991.v1.p1","VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment","The Vanderbilt Electronic Systems for Pharmacogenomic Assessment (VESPA) Project is a large electronic medical record (EMR)- and biobank-based initiative for translational pharmacogenomics discoveries. Key research resources utilized in this  effort include the BioVU DNA databank and associated Synthetic Derivative database of clinical information, and software tools developed to identify","Dose-Response Relationship, Drug","Cross-Sectional","HumanOmni1-Quad_v1-0_H, HumanOmni5-4v1_B","Not Applicable","Not Provided","2 phenotype datasets, 7 variables, 2 molecular datasets, 2252 subjects, 2252 samples, 2 sub-studies","","NIGMS","HMB --- Health/medical/biomedical","2016-10-26","2017-10-26","Dose Response Relationship, Drug; Dose-Response Relationships, Drug; Drug Dose-Response Relationship; Drug Dose-Response Relationships; Relationship, Drug Dose-Response; Relationships, Drug Dose-Response"
"phs001001.v1.p1","MGH Atrial Fibrillation Study","The Massachusetts General Hospital (MGH) Atrial Fibrillation Study was initiated in 2001. The study has enrolled serial probands, unaffected and affected family members with atrial fibrillation. At enrollment participants  undergo a structured interview to systematically capture their past medical history, AF treatments, and family history. An electrocardiogram is","Atrial Fibrillation","Case Set","WES_markerset_grc37, target_markerset_grc37","Not Applicable","Not Provided","4 phenotype datasets, 35 variables, 3 molecular datasets,  SRA, 1025 subjects, 949 samples, 3 sub-studies","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-AF-IRB-RD --- Disease-specific (atrial fibrillation, irb, rd)","2018-03-06","2018-03-06","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001022.v1.p1","PsychENCODE: Autism Transcriptional and Epigenetic Profiling","Our current understanding of autism spectrum disorders (ASD) delineates a highly heritable, yet etiologically heterogeneous disease. Forward genetic approaches to find disease associated mutations or common variation have been  successful and continue to offer considerable power. Yet, given the accumulating evidence for very significant heterogeneity and environmental","Autistic Disorder","Case-Control","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 18 variables,  SRA, 123 subjects, 499 samples, 4 sub-studies","","NIMH","GRU --- General research use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs001030.v1.p1","Viral Respiratory Pathogens Genetics","The overall purpose of this study is to investigate the host genetic factors in response to influenza virus infection, with the focus on influenza vaccination in the first substudy  ""Adult Influenza Vaccine Genetics"" and with the focus on influenza natural infection and other acute respiratory infections (ARIs) in the second","Influenza, Human","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 9 variables, 388 subjects, 518 samples, 2 sub-studies","","NIAID","GRU-IRB --- General research use (irb)","2017-06-02","2017-06-02","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas"
"phs001078.v1.p1","Common Variant GWAS, GECCO","Genetics Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort which aims to accelerate the discovery of colorectal cancer-related variants by discovering, replicating and fine-mapping Genome Wide Association  Study (GWAS) findings, conducting a meta-analysis of GWAS data, and investigating how genetic variants are modified by environmental risk factors","Colorectal Neoplasms","Case-Control","HumanCytoSNP-12v2, HumanOmniExpress-12v1_A, HumanOmniExpress_NCI_GECCO","Not Applicable","Not Provided","2 phenotype datasets, 9 variables, 12 molecular datasets, 17766 subjects, 18509 samples, 12 sub-studies","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001120.v1.p1","ELLIPSE Prostate Cancer Meta-Analysis and Genotyping","The Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium is an international effort to discover risk loci for prostate cancer. It includes the meta-analysis of existing GWAS data  as well as novel GWAS, exome, and iCOGS genotyping. The GWAS meta-analysis includes the following cases and controls from studies of European","Prostatic Neoplasms","Case-Control","Cancer_BeadChip, HumanExome, HumanOmni2.5-8v1_A","Not Applicable","Not Provided","2 phenotype datasets, 7 variables, 3 molecular datasets, 12947 subjects, 12947 samples, 2 sub-studies","","NCI","DS-PC-MDS --- Disease-specific (prostate cancer, mds) , DS-CA --- Disease-specific (cancer) , GRU-MDS --- General research use (mds) , DS-PC --- Disease-specific (prostate cancer)","2017-03-31","2017-03-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001166.v1.p1","Type 2 Diabetes Starr County GWAS and Exome Sequencing","The T2D Seq GWAS Starr County Cohort is utilized in the following dbGaP sub-studies. To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click  on the following sub-studies below or in the ""Sub-studies"" box located on the right hand side of this top-level study page phs001166 T2D Seq GWAS","Diabetes Mellitus, Type 2","Case-Control","Genome-Wide_Human_SNP_Array_6.0, exome_vcf_grc37","Not Applicable","Not Provided","2 phenotype datasets, 11 variables, 2 molecular datasets, 1997 subjects, 2121 samples, 2 sub-studies","","NIDDK","GRU-IRB --- General research use (irb)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001167.v1.p1","Type 2 Diabetes in African Americans, GWAS and Exome Sequencing","The T2D Seq GWAS AA Cohort is utilized in the following dbGaP sub-studies. To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on  the following sub-studies below or in the ""Sub-studies"" box located on the right hand side of this top-level study page phs001167 T2D Seq GWAS AA","Diabetes Mellitus, Type 2","Case-Control","Genome-Wide_Human_SNP_Array_6.0, exome_vcf_grc37","Not Applicable","Not Provided","2 phenotype datasets, 13 variables, 2 molecular datasets, 3054 subjects, 3192 samples, 2 sub-studies","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001172.v1.p2","NINDS Parkinson's Disease","This study utilized the well characterized collection of North American Caucasians with Parkinson's disease, and neurologically normal controls from the sample population which are banked in the National Institute  of Neurological Disorders and Stroke (NINDS Repository) collection. Two sub-studies are included, in sub-study ""NINDS-Genome-Wide Genotyping in","Parkinson Disease","Case-Control","WES_markerset_grc37","Not Applicable","Not Provided","2 phenotype datasets, 9 variables, 2 molecular datasets,  SRA, 2116 subjects, 3582 samples, 2 sub-studies","","NINDS","GRU --- General research use","2016-12-22","2016-12-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs001175.v2.p2","CTSP: Clinical Trial Sequencing Project","For the Clinical Trials Sequencing Project (CTSP), National Cancer Institute (NCI) will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify  recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures that would be important to the","Breast","Collection","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 6 variables,  SRA, 366 subjects, 366 samples, 1 sub-studies","","NCI","GRU --- General research use","2019-01-29","2018-04-11","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs001180.v1.p1","Genes-Environments and Admixture in Latino Asthmatics (GALA II) Study","A case-control pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. Each participant had two spirometry measurements using the KoKo PFT System. With the first  spirometry test, participant was administered with 4 puffs of HFA Albuterol. The second albuterol measurement was based on age, for participants","Lung Diseases","Case-Control","Axiom_GW_LAT_1_na34","Not Applicable","Not Provided","4 phenotype datasets, 27 variables, 1 molecular datasets, 4458 subjects, 4427 samples, 1 sub-studies","","NHLBI","DS-LD-RD --- Disease-specific (lung disease, rd)","2017-12-20","2017-12-20","Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders; Lung disorder"
"phs001194.v2.p2","Pediatric Cardiac Genomics Consortium (PCGC) Study","Multi-center, prospective observational cohort study of individuals with congenital heart defects (CHD). Phenotypic data and source DNA derived from 10,000 probands, parents, and families of interest are being collected  to investigate relationships between genetic factors and phenotypic and clinical outcomes in patients with CHD. The PCGC Cohort is utilized in the","Heart Defects, Congenital","Prospective Longitudinal Cohort","HumanOmni1-Quad_v1-0_B, HumanOmni25-8v1, HumanOmni2.5-8v1_A, HumanOmni2.5-8v1.1","Not Applicable","Not Provided","20 phenotype datasets, 435 variables, 2 molecular datasets, 9463 subjects, 11829 samples, 1 sub-studies","","NHLBI","HMB --- Health/medical/biomedical , DS-CHD --- Disease-specific (congenital heart disease)","2018-09-14","2017-11-09","Abnormalities, Heart; Abnormality, Heart; Cardiac abnormalities; Cardiac anomaly; Congenital Heart Defect; Congenital anomaly of heart"
"phs001238.v2.p1","Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of four networks in the NHLBI Family-Blood Pressure Program (FBPP). GENOA's long-term objective is to elucidate the genetics of target  organ complications of hypertension, including both atherosclerotic and arteriolosclerotic complications involving the heart, brain, kidneys, and","Hypertension","Prospective Longitudinal Cohort","Human1M-Duov3_H, Genome-Wide_Human_SNP_Array_6_0, Human660W-Quad_v1_H, Human1M-Duov3_H, Genome-Wide_Human_SNP_Array_6_0","Not Applicable","Not Provided","39 phenotype datasets, 1118 variables, 1 documents, 1 molecular datasets, 3462 subjects, 3039 samples, 1 sub-studies","","NHLBI","DS-ASC-RF-NPU --- Disease-specific (arteriosclerosis and its risk factors, npu)","2018-08-08","2017-09-08","Aging, Biological; Biological Aging; Arterial Pressure, Mean; Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure"
"phs001300.v1.p1","NABEC: North American Brain Expression Consortium","This study utilized neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). This top-level study, phs001300, makes available all phenotype data of the NABEC study participants.  In addition, molecular data of six sub-studies are available through dbGaP: 1. NABEC Genome-Wide Genotyping - phs000249 2. NABEC Exome Sequencing","Gene Expression Profiling","Control Set","HumanHap550_v3, Human610-Quadv1_B, Human660W-Quad_v1_A, WES_markerset_grc37, Neuro_Consortium_20013217_A2","Not Applicable","Not Provided","3 phenotype datasets, 14 variables, 6 molecular datasets,  SRA, 432 subjects, 2246 samples, 6 sub-studies","","NIA","GRU --- General research use","2018-03-21","2018-03-21","Analyses, Transcript Expression; Analyses, Transcriptome; Analysis, Transcript Expression; Analysis, Transcriptome; Gene Expression Monitoring; Gene Expression Monitorings"
"phs001304.v1.p1","NCI Biospecimen Pre-analytical Variables (BPV) Analysis","The Biospecimen Pre-analytical Variables (BPV) Program is a National Cancer Institute-sponsored study to systematically assess the effects of pre-analytical factors on the molecular profile of biospecimens. A robust biospecimen  collection infrastructure was established to prospectively collect biospecimens using rigorous standard operating procedures to control for most","Carcinoma, Renal Cell","Case Set","SNP-PCR, Cytogenetic_Arrays, custom_markerset","Not Applicable","Not Provided","3 phenotype datasets, 466 variables, 6 molecular datasets,  SRA, 153 subjects, 1554 samples, 7 sub-studies","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001442.v1.p1","The Environmental Determinants of Diabetes in the Young Study (TEDDY)    Project","The Environmental Determinants of Diabetes in the Young (TEDDY) Study investigates genetic and genetic-environmental interactions, including gestational events, childhood infections, dietary exposures, and other environmental factors after birth, in  relation to the development of islet autoimmunity and type 1 diabetes (T1D). A consortium of six clinical centers assembled to participate in the","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","HumanHT-12_v4, Custom_TEDDY_ImmunoArray_176K","Not Applicable","Not Provided","4 phenotype datasets, 18 variables, 2 molecular datasets, 8325 subjects, 22071 samples, 3 sub-studies","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2018-08-31","2018-08-31","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs001475.v1.p1","Genes Influencing Susceptibility to Infection and Malnutrition","NIH birth cohort study Amebiasis is a common cause of diarrhea and is associated with malnutrition in grade-school aged children in an urban slum of Dhaka, Bangladesh. Field Studies  of Human Immunity to Amebiasis in Bangladesh was designed to determine the contribution of amebiasis to illness in the first 2 years of life when","Sprue, Tropical","Prospective Longitudinal Cohort","Human1M-Duov3_B, HumanOmni2.5-8v1_C, HumanOmni1-Quad_v1-0_B, MEGA_Consortium_v2_15070954_A2","Not Applicable","Not Provided","2 phenotype datasets, 6 variables, 2 molecular datasets, 1093 subjects, 1093 samples, 3 sub-studies","","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-specific (tropical enteropathy, irb, pub, npu, mds, gso, rd)","2018-11-13","2018-11-13","Child Development; Development, Child; Communicable Disease; Disease due to infection; Disease, Communicable; Disease, Infectious"
"phs001683.v1.p1","CSER: Incorporation of Genomic Sequencing into Pediatric Cancer Care","This project includes data derived from subjects enrolled in the BASIC3 (Baylor College of Medicine Advancing Sequencing in Childhood Cancer Care) study. BASIC3 is a National Genome Human Research  Institute (NHGRI) and National Cancer Institute-funded Clinical Sequencing Exploratory Research (CSER) consortium project that focused on prospective","Genes, Neoplasm","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 17 variables,  SRA, 626 subjects, 482 samples, 2 sub-studies","","NCI","GRU-PUB --- General research use (pub)","2019-08-20","2019-08-20","Bone Cancer; Cancer of Bone; Cancer of the Bone; Malignant Bone Tumor; Malignant Neoplasm of Bone; Malignant Neoplasm of the Bone"
"phs000016.v2.p2","International Multi-Center ADHD Genetics Project","The goal of the project is to complete a 600,000 tag SNP genome-wide association scan of 958 parent-child trios from the International Multisite ADHD Genetics (IMAGE) project, in order to  assess the association of SNP markers with ADHD, analyze quantitative ADHD phenotypes, complete copy number analyses, assess parent of origin effects","Attention Deficit Disorder with Hyperactivity","Family/Twin/Trios","Perlegen500K","Not Applicable","SNP Genotypes (Array)","9 phenotype datasets, 442 variables, 14 documents, 1 analyses, 1 molecular datasets, 2758 subjects, 2758 samples","European (2683), Hispanic1 (38), Hispanic2 (3), South Asian (5), Other (13)","NIMH","ADHD --- Adhd","2009-12-02","2008-03-26","ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder; Attention Deficit Hyperactivity Disorders"
"phs000017.v3.p1","Whole Genome Association Study of Bipolar Disorder","The goal of the project is to identify genes that make individuals more susceptible to bipolar disorder (manic depressive illness) and to better understand the brain pathways involved in  the disease. Dataset versioning Version 1: European-American (EA) ancestry only Version 2: Version 1 plus African-American (AA) ancestry Version 3","Bipolar Disorder","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","17 phenotype datasets, 8678 variables, 89 documents, 2 analyses, 2 molecular datasets, 3261 subjects, 3261 samples","European (2058), African (24), African American (1033), Hispanic1 (15)","NIMH","GRU --- General research use , BARD --- Bipolar and related disorders , BDO --- Bipolar disorder only","2008-11-24","2008-12-01","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar disorder"
"phs000018.v2.p1","Search for Susceptibility Genes for Diabetic Nephropathy in Type 1    Diabetes (GoKinD study participants), GAIN","Genetics of Kidneys in Diabetes (GoKinD) study is an initiative aimed at identifying susceptibility genes for diabetic nephropathy in type 1 diabetes. A large number of individuals with type  1 diabetes were screened to identify two subsets, one with clear-cut kidney disease and another with normal renal status despite long-term diabetes","Diabetic Nephropathies","Case-Control","Affymetrix_500K","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 68 variables, 28 documents, 3 analyses, 1 molecular datasets, 3046 subjects, 1829 samples","European (1697), African (1), East Asian (3), African American (46), Hispanic1 (24), Hispanic2 (21), Other Asian or Pacific Islander (4), South Asian (3), Other (8)","NIDDK","DS-T1DCR-IRB --- Disease-specific (type 1 diabetes, complications, and related traits, irb)","2014-12-18","2008-07-09",""
"phs000019.v1.p1","Collaborative Association Study of Psoriasis","The goal of this collaborative study is to combine the resources and expertise of three groups with long-standing studies of psoriasis genetics in order to identify new genetic susceptibility  factors for psoriasis, a common inflammatory skin disease that affects over 4 million Americans. Consent groups and participant set General research","Psoriasis","Case-Control","Perlegen500K","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 35 variables, 5 documents, 1 analyses, 2 molecular datasets, 2875 subjects, 2875 samples","European (2707), African (1), East Asian (1), African American (5), Hispanic1 (7), Hispanic2 (21), Other Asian or Pacific Islander (3), South Asian (1)","NIAMS","GRU --- General research use , ADO --- Autoimmune disease only","2007-11-13","2008-08-13","Acropustulosis; Chronic palmoplantar pustular psoriasis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis"
"phs000020.v2.p1","Major Depression: Stage 1 Genomewide Association in Population-Based    Samples","Identification of genomic regions that confer susceptibility to or protection from major depressive disorder (MDD) via genomewide association. Consent groups and participant set Psychiatric and Related Somatic Conditions (PRSC):  3741 (1821 cases, 1822 controls, 98 others)","Depressive Disorder, Major","Case-Control","Perlegen500K","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 232 variables, 5 documents, 1 analyses, 1 molecular datasets, 3741 subjects, 3741 samples","European (3612), Hispanic1 (5), Hispanic2 (1), Other Asian or Pacific Islander (5), South Asian (3), Other (25)","NIMH","PRSC --- Psychiatric and related somatic conditions","2008-10-27","2008-07-09","Depression, Involutional; Involutional Melancholia; Melancholia, Involutional"
"phs000021.v3.p2","Genome-Wide Association Study of Schizophrenia","The goal of the study is to find susceptibility genes for schizophrenia. Dataset versioning Version 1: European-American (EA) ancestry only Version 2: Version 1 plus African-American (AA) ancestry Consent  groups and participant set General research use (GRU): 4591 cases and controls (1217 EA cases, 1442 EA controls, 953 AA cases, 979 AA controls) This","Schizophrenia","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","8 phenotype datasets, 824 variables, 29 documents, 2 analyses, 2 molecular datasets, 5064 subjects, 5064 samples","European (2718), African (44), African American (2072), Hispanic1 (20), Hispanic2 (5), Other (4)","NIMH","GRU --- General research use , SARC --- Schizophrenia and related conditions","2010-10-28","2008-12-03","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000048.v1.p1","Mayo-Perlegen LEAPS (Linked Efforts to Accelerate Parkinson's Solutions)    Collaboration","We performed a two-tiered, whole-genome association study of Parkinson disease (PD). For tier 1, we individually genotyped 198,345 uniformly spaced and informative single-nucleotide polymorphisms (SNPs) in 443 sibling pairs  discordant for PD. For tier 2a, we individually genotyped 1,793 PD-associated SNPs (P .01 in tier 1) and 300 genomic control SNPs in 332 matched case","Parkinson Disease","Case-Control","Perlegen85K","Not Applicable","SNP Genotypes (Array)","2 phenotype datasets, 12 variables, 6 documents, 3 analyses, 1 molecular datasets, 1550 subjects, 1550 samples","European (885), Other (1)","NHGRI","HR --- Health research (hr)","2008-03-03","2008-03-03","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000049.v1.p1","Genotyping the 270 HapMap samples for GAIN by Broad","The Broad Institute Center for Genotyping and Analysis is an NCRR-funded fee-for-service SNP genotyping facility based at MIT (www.broad.mit.edu/genotyping). For the GAIN studies, Broad uses the Affymetrix GeneChip genotyping platform.  The first set of studies is being analyzed on the soon-to-be-publicly-released ""Human Mapping 500K Array 2.0"", which detects 500,000 SNPs, as well as","Normalcy","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","","European (87), African (89), East Asian (84), Other Asian or Pacific Islander (2)","NHGRI","","","",""
"phs000050.v1.p1","Genotyping the 270 HapMap samples for GAIN by Perlegen","For the GAIN studies, Perlegen Sciences uses a high-density oligonucleotide array-based platform to analyze 600,000 SNPs in large numbers of individuals. The SNP set was selected on the basis of  linkage disequilibrium analysis of the HapMap data, and includes tag SNPs for all CEU bins. The arrays consist of DNA probes (short segments of DNA","Normalcy","Family/Twin/Trios","Not Provided","Not Applicable","SNP Genotypes (Array)","270 samples","European (90), African (87), East Asian (85), African American (3), Other Asian or Pacific Islander (5)","NHGRI","","","",""
"phs000086.v3.p1","DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes","The Diabetes Control and Complications Trial (DCCT, 1982-93) and the Epidemiology of Diabetes Interventions and Complications follow-up study (EDIC, 1994-2016) have been ongoing for more than twenty years. After  a mean follow-up of approximately 16 years, the DCCT-EDIC cohort of 1,441 Type 1 diabetics had remained remarkably complete with more than 90% of the","Insulin-Dependent Diabetes Mellitus","Clinical Trial","HumanHap550_v3, Human1Mv1_C","Not Applicable","SNP Genotypes (Array)","119 phenotype datasets, 13191 variables, 151 documents, 5 analyses, 2 molecular datasets, 1516 subjects, 1447 samples","European (1343), East Asian (3), African American (30), Hispanic1 (5), Hispanic2 (11), Other Asian or Pacific Islander (4), South Asian (1), Other (4)","NIDDK","DS-T1D-IRB --- Disease-specific (type 1 diabetes, irb) , DS-DRC-IRB --- Disease-specific (diabetes and related complications, irb)","2014-11-05","2014-11-05","Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic Nephropathies; Diabetic nephropathy; Diabetic renal disease; Disorder of kidney co-occurrent and due to diabetes mellitus"
"phs000088.v1.p1","Search for Susceptibility Genes for Diabetic Nephropathy in Type 1    Diabetes (GoKinD study participants and parents), NIDDK","Genetics of Kidneys in Diabetes (GoKinD) study is an initiative aimed at identifying susceptibility genes for diabetic nephropathy in type 1 diabetes. A large number of individuals with type 1  diabetes were screened to identify two subsets, one with clear-cut kidney disease and another with normal renal status despite long-term diabetes","Diabetic Nephropathies","Case-Control","Affymetrix_500K","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 64 variables, 26 documents, 1 analyses, 1 molecular datasets, 1206 subjects, 1220 samples","European (1132), East Asian (2), African American (7), Hispanic1 (11), Hispanic2 (12), Other Asian or Pacific Islander (3), South Asian (4), Other (2)","NIDDK","T1DC --- T1 diabetes and complications (t1dc)","2008-11-20","2008-11-20","Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy; Diabetic renal disease; Disorder of kidney co-occurrent and due to diabetes mellitus; Kidney Disease, Diabetic"
"phs000091.v2.p1","GENEVA Diabetes Study (NHS/HPFS)","Type 2 diabetes mellitus (T2D) affects approximately 21 million individuals in the U.S., or almost 10% of the U.S. adult population. Because diabetes is determined by both genetic and  environmental factors, a better understanding of the etiology of diabetes requires a careful investigation of gene-environment interactions. The","Diabetes Mellitus, Type 2","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 37 variables, 24 documents, 3 molecular datasets, 6033 subjects, 6088 samples","European (5822), African (2), East Asian (34), African American (48), Hispanic1 (12), Hispanic2 (29), Other Asian or Pacific Islander (6), South Asian (4), Other (4)","NHGRI","NPU --- Non-profit use only","2009-07-31","2010-07-31","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000092.v1.p1","Study of Addiction: Genetics and Environment (SAGE)","This study is part of the Gene Environment Association Studies initiative (GENEVA) funded by the National Human Genome Research Institute. The overarching goal is to identify novel genetic factors  that contribute to addiction through a large-scale genome-wide association study of DSM-IV alcohol dependent (and frequently illicit drug dependent","Alcoholism","Case-Control","Human1Mv1_C, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 140 variables, 108 documents, 3 analyses, 2 molecular datasets, 4121 subjects, 8485 samples","European (2671), African (9), East Asian (1), African American (1324), Hispanic1 (39), Hispanic2 (57), Other Asian or Pacific Islander (3), Other (17)","NHGRI","HR --- Health research , ARC --- Alcoholism and related conditions","2008-09-23","2009-09-23","Alcohol Use Disorder; Alcohol Use Disorders; Use Disorder, Alcohol; Use Disorders, Alcohol; Disorder, Drug Use; Drug Use Disorder"
"phs000093.v2.p2","A Genome Wide Scan of Lung Cancer and Smoking","The majority of cases of lung cancer are the culmination of a dynamic process that begins with smoking initiation, proceeds through dependency and smoking persistence, continues with lung cancer  development and ends with progression to disseminated disease or response to therapy and survival. We are conducting a whole genome study of lung","Lung Neoplasms","Case-Control","HumanHap550_v3, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 34 variables, 33 documents, 3 molecular datasets, 5566 subjects, 11337 samples","European (5561), Hispanic1 (2), Hispanic2 (2), Other (1)","NCI","CADM --- Research related to adult diseases and methods , SLD --- Research related to smoking or lung disease","2009-10-22","2010-01-08","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000094.v1.p1","International Consortium to Identify Genes and Interactions Controlling    Oral Clefts","Oral clefts represent the most common group of craniofacial birth defects in humans, and include cleft lip with or without cleft palate (CL/P) and cleft palate (CP). Oral clefts  have a complex and heterogeneous etiology, with strong evidence for both genetic and environmental causal factors. Candidate gene studies and genome","Cleft Palate","Family/Twin/Trios","Human610-Quadv1_B, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 39 variables, 29 documents, 2 molecular datasets, 7507 subjects, 7567 samples","European (3094), African (3), East Asian (3395), African American (46), Hispanic1 (11), Hispanic2 (101), Other Asian or Pacific Islander (366), South Asian (30), Other (43)","NIDCR","CFA --- Craniofacial anomalies","2010-04-22","2011-04-22","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lip; Cleft Lips; Cleft of upper lip"
"phs000095.v3.p1","Dental Caries GWAS","Dental caries (also known as tooth decay) remains the most common chronic disease of childhood, five times more common than asthma and seven times more common than environmental allergies,  with more than 40% of children exhibiting caries when they enter kindergarten. In 2005, it was estimated that dental health care costs were","Dental Caries","Family/Twin/Trios","Human610-Quadv1_B, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 180 variables, 76 documents, 3 molecular datasets, 5618 subjects, 4412 samples","European (3609), African (1), East Asian (9), African American (342), Hispanic1 (62), Hispanic2 (41), Other Asian or Pacific Islander (12), South Asian (21), Other (19)","NIDCR","DS-OH-GSO --- Disease-specific (oral health, gso)","2014-12-18","2015-12-18","Caries; Caries, Dental; Cariosity of teeth; Carious lesion; Decay, Dental; Dental Decay"
"phs000096.v4.p1","HAPO Maternal Glycemia and Birthweight GEI Study","Low and high birth weight are not only major causes of neonatal morbidity and mortality, but epidemiological data have established an association between birth weight and later life risk  of adult metabolic diseases. Fetal growth is determined by complex interactions between fetal genes and the maternal uterine environment. Subtle or","Pregnancy Complications","Prospective Longitudinal Cohort","Human1M-Duov3_B, Human610-Quadv1_B, HapMap_Phase3, HumanOmni1-Quad_v1-0_B, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","9 phenotype datasets, 270 variables, 44 documents, 11 molecular datasets, 9987 subjects, 9339 samples","European (2751), African (158), East Asian (165), African American (2073), Hispanic1 (26), Hispanic2 (1427), Other Asian or Pacific Islander (2277), South Asian (17), Other (123)","NHGRI","T2DMBIRTHWT --- Gwa mapping: maternal metabolism-birth weight interactions","2012-05-16","2012-12-02","Gestation; Pregnancy, function"
"phs000101.v5.p1","Genome-Wide Association Study of Amyotrophic Lateral Sclerosis","Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder clinically characterized by rapidly progressive paralysis and death due to respiratory failure, typically within two to three years of symptom onset.  The number of ALS cases across the globe will increase to nearly 400,000 in 2040, predominantly due to aging of the population. Unraveling the","Amyotrophic Lateral Sclerosis","Case-Control","HumanHap550_v1, HumanHap550_v3, ALS_iSelect, HumanHap550_v1, HumanHap550_v3, HumanHap317kv1, HumanHap240S_A, ALS_iSelect, Human660W-Quad_v1_B, exome_vcf_grc37, HumanOmniExpress-24v1-1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","10 phenotype datasets, 181 variables, 5 documents, 1 analyses, 5 molecular datasets, 15480 subjects, 15480 samples","European (11990), African (17), East Asian (28), African American (66), Hispanic1 (63), Hispanic2 (53), Other Asian or Pacific Islander (14), South Asian (62), Other (26)","NINDS","GRU --- General research use","2018-09-11","2018-09-11","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs000102.v1.p1","Ischemic Stroke Genetics Study (ISGS)","The third leading cause of death in the United States, stroke is an acute neurological event leading to death of neural tissues. Although the majority of strokes are ischemic  strokes, meaning there is oxygen deprivation to the brain, almost 20% of strokes are hemorrhagic, resulting from bleeding into the brain. Stroke is a","Cerebrovascular Disorders","Case-Control","Illumina100K","Not Applicable","SNP Genotypes (Array)","2 phenotype datasets, 74 variables, 5 documents, 1 analyses, 1 molecular datasets, 485 subjects, 485 samples","European (481), African American (1), Hispanic1 (2), Hispanic2 (1)","NINDS","GRU --- General research use , SARD --- Stroke and related disorders","2008-06-26","2008-06-26","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Brain Vascular Disorder"
"phs000103.v1.p1","GENEVA Study of Preterm Delivery (DNBC/Iowa)","Preterm labor resulting in the delivery of a premature child is a complex problem with an enormous impact on individuals, families and society. An estimated 500,000 children are born  prematurely in the U.S. each year, and 5 million worldwide die annually of prematurity and its complications. Prematurity is also the single largest","Premature Birth","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 63 variables, 10 documents, 2 molecular datasets, 4136 subjects, 3945 samples","European (3830), Hispanic1 (1), Hispanic2 (2), Other Asian or Pacific Islander (3), Other (2)","NHGRI","GRU --- General research use","2010-10-08","2011-10-08","Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births; Premature birth"
"phs000122.v1.p1","Whole Genome Association Study of Systemic Lupus Erythematosus","The goal of this collaborative study was to identify new genetic risk factors for Systemic Lupus Erythematosus (SLE). To do this we conducted a genome-wide scan by combining the  resources and expertise from a number of SLE researchers to establish a large sample set comprising 1311 SLE cases and 3340 controls. The SLE case","Lupus Erythematosus, Systemic","Case-Control","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 19 variables, 1 analyses, 4651 subjects","","NIAMS","GRU --- General research use","2010-03-25","2010-03-25","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs000124.v3.p1","Neuroblastoma Genome-Wide Association Study (NBL-GWAS)","Neuroblastoma is a malignancy of the developing sympathetic nervous system that most commonly affects young children and is often lethal. The etiology of this embryonal cancer is not fully  understood. We therefore initiated a genome-wide association study (GWAS) in 2007 focused on neuroblastoma patients identified through the Children's","Neuroblastoma","Case-Control","Not Provided","Not Applicable","Not Provided","","European (1635), Hispanic1 (7), Hispanic2 (9), Other (11)","NCI","","","","Not Provided"
"phs000125.v1.p1","CIDR: Collaborative Study on the Genetics of Alcoholism (COGA)","This is a case-control study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study  that includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Alcoholism","Case-Control","Human1Mv1_C","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 428 variables, 49 documents, 3 analyses, 1 molecular datasets, 1945 subjects, 1957 samples","European (1295), African (13), East Asian (4), African American (473), Hispanic1 (39), Hispanic2 (63), Other Asian or Pacific Islander (8), South Asian (4), Other (14)","NIAAA","HR --- Health research , ARC --- Alcoholism and related conditions","2008-10-06","2009-10-06","Alcohol Use Disorder; Alcohol Use Disorders; Use Disorder, Alcohol; Use Disorders, Alcohol"
"phs000126.v2.p1","CIDR: Genome Wide Association Study in Familial Parkinson Disease (PD)","This proposal brings together the two largest NIH funded genetic studies focused on the identification of novel genes that influence the risk of PD. These two studies, PROGENI (PI:  Tatiana Foroud; R01NS037167) and GenePD (PI: Richard Myers; R01NS036711) have been evaluating and recruiting families with two or more PD affected","Parkinson Disease","Case-Control","HumanCNV370-Duo_v1","Not Applicable","SNP Genotypes (Array)","6 phenotype datasets, 165 variables, 11 documents, 1 analyses, 1 molecular datasets, 1991 subjects, 2082 samples","","NINDS","GRU --- General research use , DS-PDRD-NPU --- Disease-specific (parkinson's disease and related disorders, npu)","2016-09-29","2017-09-29","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000127.v2.p1","Study of Irish Amyotrophic Lateral Sclerosis (SIALS)","Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by loss of motor neurons. Epidemiological studies indicate that 2-5% of cases are familial, usually with an autosomal dominant  pattern of inheritance. For a portion of these, causative genes have been identified. The remaining 95% of ALS cases are described as sporadic, and","Amyotrophic Lateral Sclerosis","Case-Control","HumanHap550_v3","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 17 variables, 1 analyses, 1 molecular datasets,  SRA, 432 subjects, 432 samples","European (432)","NINDS","NPU --- Non-profit_use","2010-09-07","2008-10-06","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs000128.v3.p3","GAW16 Framingham and Simulated Data","Important links to apply for individual-level data 1. Genetic Analysis Workshop 2. Instructions to Request Authorized Access 3. Data Use Certification Requirements (DUC) 4. Apply here for controlled access  to individual level data 5. Research Use Statement Questions regarding GAW16 should be directed to Vanessa Olmo at vanessa@business-endeavors.com","Coronary Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","207 phenotype datasets, 6582 variables, 6 documents, 2 molecular datasets, 14275 subjects, 7096 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds)","2010-07-28","2008-10-19","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000130.v1.p1","NIDDK IBDGC Crohn's Disease Genome-Wide Association Study","This dataset contains data from a genome-wide association study performed with 968 Inflammatory Bowel Disease (IBD) affected cases and 995 unrelated controls using the Illumina HumanHap300 Genotyping BeadChip. Cases  were selected to have Crohn's disease with ileal involvement, and controls were matched to cases based on sex and year of birth. Subjects were drawn","Crohn Disease","Case-Control","HumanHap300v1-1_C","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 82 variables, 2 documents, 1 analyses, 1 molecular datasets, 1963 subjects, 1963 samples","European (1740), East Asian (1), African American (2), Hispanic1 (10), Other Asian or Pacific Islander (1), Other (6)","NIDDK","GRU --- General research use , IBDO --- Inflammatory bowel disease only","2008-11-06","2008-11-06","Colitis Gravis; Colitis ulcerosa; Colitis, Ulcerative; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis"
"phs000138.v2.p1","GWAS for Genetic Determinants of Bone Fragility","Osteoporotic fractures are largely due to an increased propensity to fall with aging and a reduction in bone strength. Although skeletal architecture contributes to fracture risk, bone mineral density  (BMD) is the most important determinant of bone strength and fracture risk. Between 60 and 80% of the variance of BMD of adult Caucasian women is due","Osteoporosis","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 52 variables, 2 molecular datasets, 1493 subjects, 1590 samples","European (1480), Hispanic1 (2), Hispanic2 (3), Other (2)","NIA","GRU --- General research use","2010-07-01","2010-08-04","Bone Densities; Bone Mineral Densities; Bone Mineral Density; Density, Bone; Density, Bone Mineral; Age Related Osteoporosis"
"phs000139.v1.p1","IMSGC Genome Wide Association Study of Multiple Sclerosis","The goal of this study is to perform a comprehensive allelic and genotypic association analysis of the entire human genome in multiple sclerosis. The recent definitive linkage genome screen  demonstrated that there is no other MS risk gene with an effect size anywhere near that of the MHC. However, linkage analysis is significantly","Multiple Sclerosis","Family/Twin/Trios","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 34 variables, 2 documents, 1 analyses, 1 molecular datasets, 3002 subjects, 3002 samples","European (2947), East Asian (1), Hispanic1 (11), Hispanic2 (40), Other Asian or Pacific Islander (1), Other (2)","NINDS","MSRD --- Multiple sclerosis and related disorders , MS --- Multiple sclerosis , NPU --- Non-profit use only","2008-11-06","2008-11-06","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple"
"phs000142.v1.p1","Whole Genome Association Twin Study of Myopia and Glaucoma Risk Factors","Myopia and glaucoma are highly prevalent ophthalmic disorders worldwide and contribute significantly to ocular morbidity. There is substantial evidence that genetic factors play a significant role in the development  of non-syndromic myopia and glaucoma. We propose to perform mapping studies for well-characterized twin populations in the United Kingdom and","Eye Diseases","Family/Twin/Trios","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 49 variables, 10 documents, 1 molecular datasets, 2928 subjects, 3124 samples","European (2870), African (4), East Asian (10), African American (14), Hispanic1 (2), Hispanic2 (1), Other Asian or Pacific Islander (12), South Asian (6), Other (9)","NEI","GRU --- General research use","2009-08-27","2009-10-27","Disease of eyeball; Disease, Eye; Diseases, Eye; Disorder of eye proper; Disorder of eyeball; Disorder of globe"
"phs000144.v1.p1","NHGRI Tumor Sequencing Project (Lung Adenocarcinoma)","The Tumor Sequencing Project (TSP) Consortium is a collaboration among participants at the Baylor College of Medicine Human Genome Sequencing Center, the Broad Institute Genome Sequencing Platform, the Dana  Farber Cancer Institute, the Memorial Sloan-Kettering Cancer Center, the Genome Sequencing Center and Siteman Cancer Center at Washington University","Neoplasms","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","7 phenotype datasets, 48 variables, 1 molecular datasets, 384 subjects, 768 samples","","NHGRI","GRU --- General research use","2009-02-27","2009-02-27","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000145.v4.p2","POPRES: Population Reference Sample","POPRES version 1 and 2 Technological and scientific advances, stemming in large part from the Human Genome and HapMap projects, have made large-scale, genome-wide investigations feasible and cost-effective. These  advances have the potential to dramatically impact drug discovery and development by identifying genetic factors that contribute to variation in","Normalcy","Case-Control","Affymetrix_500K, Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS)","6 phenotype datasets, 47 variables, 2 molecular datasets, 8012 subjects, 8012 samples","European (3175), African (8), East Asian (73), African American (321), Hispanic1 (11), Hispanic2 (114), South Asian (360), Other (15)","NHGRI","GRU --- General research use","2013-04-18","2012-10-22","Normalcies; Normalities"
"phs000147.v3.p1","CGEMS Breast Cancer GWAS","The initial stage of the Cancer Genetic Markers of Susceptibility (CGEMS) breast cancer genome-wide association study (GWAS) included genotyping 528,173 SNPs (Illumina HumanHap550) in 1,145 postmenopausal women of European  ancestry with invasive breast cancer and 1,142 controls from the Nurses' Health Study (NHS). Subsequently, incident invasive breast cancer cases from","Breast Neoplasms","Case-Control","HumanHap550_v1, HumanHap550_v3, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed), WXS","4 phenotype datasets, 16 variables, 1 documents, 1 analyses, 3 molecular datasets,  SRA, 2576 subjects, 2723 samples","European (2573), Hispanic2 (3)","NCI","GRU --- General research use","2015-06-11","2014-02-13","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000153.v9.p8","Framingham SHARe Social Network","Note: Data Use Restrictions: The data must only be used for genetic research projects solely in the area of health-related social-network research. This study compiles detailed information on family  and social ties linked to participants in the offspring cohort of the Framingham Heart Study. The investigators took computerized information from","Social Behavior","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 49 variables, 4 documents, 15172 subjects","","NHLBI","DS-SN-IRB-MDS --- Disease-specific (social network, irb, mds) , DS-SN-IRB-NPU-MDS --- Disease-specific (social network, irb, npu, mds)","2016-03-02","2010-06-26","Depression; Behavior, Social; Behaviors, Social; Social Behaviors"
"phs000159.v8.p4","Whole-Genome Sequencing of Acute Myeloid Leukemia","We used massively parallel sequencing technology to sequence the genomic DNA of tumor cells (leukemic bone marrow) and normal cells (skin biopsy) obtained from patients with Acute Myeloid Leukemia  (AML). Patients had either de novo AML (AML with no prior diagnosis of a hematologic disease or exposure to chemotherapy), secondary AML (occurring","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","custom_PCR_marker_set, whole_genome_vcf_grc36, Genome-Wide_Human_SNP_Array_6.0, whole_genome_vcf_grc37, target_vcf_grc37, WGS_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), SNP Genotypes (NGS)","5 phenotype datasets, 179 variables, 1 documents, 6 molecular datasets,  SRA, 170 subjects, 663 samples","European (17), African American (1), Other (1)","NHGRI","GRU --- General research use , DS-HEM --- Disease-specific (hematologic disease)","2016-08-01","2016-08-01","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs000160.v1.p1","Genetics Consortium for Late Onset of Alzheimer's Disease (LOAD CIDR    Project)","Multiplex Family Study The purpose of the NIA Genetics Initiative: Multiplex Family Study is to identify families with multiple members diagnosed with late-onset Alzheimer's Disease. Families will be characterized  clinically and blood samples will be collected to establish cell lines. If a blood sample is not available, autopsy samples will be collected for DNA","Alzheimer Disease","Prospective Longitudinal Cohort","Linkage_IVB_panel","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 25 variables, 1 documents, 1 molecular datasets, 2398 subjects, 2512 samples","","NIA","GRU --- General research use , NPU --- Non-profit use , ALZ --- Alzheimer disease only , ALZ_NPU --- Alzheimer disease and non-profit use only","2009-04-14","2009-04-14","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000166.v2.p1","SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)","SNP Health Association Resource (SHARe) Asthma Resource project (SHARP) is conducting a genome-wide analysis in adults and children who have participated in National Heart, Lung, and Blood Institute's clinical  research trials on asthma. This includes 1041 children with asthma who participated in the Childhood Asthma Management Program (CAMP), 994 children","Asthma","Cross-Sectional","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","9 phenotype datasets, 348 variables, 39 documents, 1 molecular datasets, 4046 subjects, 4046 samples","","NHLBI","ARR --- Asthma-related research","2009-09-09","2009-12-11",""
"phs000167.v1.p1","Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)","This study is part of the Molecular Genetics of Schizophrenia (MGS) genome wide association study (GWAS) of 3,972 cases (2,686 EA and 1,286 AA) and 3,629 controls (2,656 EA  and 973 AA) (analyzed sample remaining after quality control exclusions), comprised of European ancestry (EA) and African American (AA) samples. We","Schizophrenia","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","6 phenotype datasets, 432 variables, 27 documents, 1 molecular datasets, 3029 subjects, 3061 samples","European (2816), African (3), African American (113), Hispanic1 (13), Hispanic2 (11), Other Asian or Pacific Islander (1), South Asian (1), Other (11)","NIMH","GRU --- General research use , SARC --- Schizophrenia and related conditions","2009-05-13","2010-02-13","Brief Reactive Psychoses; Brief psychotic disorder; Psychoses, Brief Reactive; Psychosis, Brief Reactive; Reactive Psychoses, Brief; Reactive Psychosis, Brief"
"phs000168.v2.p2","NIA - Late Onset Alzheimer's Disease and National Cell Repository for    Alzheimer's Disease Family Study: Genome-Wide Association Study for    Susceptibility Loci","Alzheimer disease is the most common neurodegenerative disorder of the elderly affecting an estimated five million Americans. Genetic factors contribute to the risk for disease with heritability estimates ranging  from 57% to 79%. More than a decade ago, the 4 variant of APOE was identified and remains the most consistently replicated genetic variant","Alzheimer Disease","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 80 variables, 1 documents, 1 molecular datasets, 5220 subjects, 5572 samples","European (4445), African (4), East Asian (8), African American (310), Hispanic1 (403), Hispanic2 (39), Other Asian or Pacific Islander (1), Other (10)","NIA","GRU --- General research use , NPU --- Non profit use , DS-ALZ --- Disease-specific (alzheimer disease) , DS-ALZ-NPU --- Disease-specific (alzheimer disease, npu)","2015-04-28","2010-09-21","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000169.v1.p1","Whole Genome Association Study of Visceral Adiposity in the HABC Study","The Health Aging and Body Composition (Health ABC) Study is a NIA-sponsored cohort study of the factors that contribute to incident disability and the decline in function of healthier  older persons, with a particular emphasis on changes in body composition in old age. Between 4/15/97 and 6/5/98 the Health ABC study has recruited","Obesity","Prospective Longitudinal Cohort","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets, 2802 subjects, 2991 samples","European (1654), African (40), East Asian (1), African American (1080), Hispanic1 (22), Hispanic2 (2), Other (3)","NIA","GRU --- General research use","2010-01-15","2011-01-15","Adipose Tissue, Retroperitoneal; Fat, Retroperitoneal; Fats, Retroperitoneal; Retroperitoneal Adipose Tissue; Retroperitoneal Fat; Retroperitoneal Fats"
"phs000170.v2.p1","GWAS on Cataract and HDL in the PMRP","The primary goals of this project are to develop and validate electronic phenotyping algorithms, to accurately identify cases and controls while maintaining a positive predictive value (PPV) of 95%,  and to conduct a genome wide association study that advances understanding of two specific yet interrelated disease states, while simultaneously","Cataract","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","7 phenotype datasets, 551 variables, 5 documents, 1 molecular datasets, 11059 subjects, 4048 samples","European (3919), East Asian (8), African American (2), Hispanic1 (2), Hispanic2 (10), Other Asian or Pacific Islander (4), South Asian (1), Other (1)","NHGRI","HMB-GSO --- Health/medical/biomedical (gso)","2015-03-09","2016-03-09","Cataract, Membranous; Cataracts, Membranous; Membranous Cataract; Membranous Cataracts; Pseudoaphakias; Cholesterol, HDL2"
"phs000171.v1.p1","Genetic Multiple Sclerosis Associations - GeneMSA","This is a multi-centre, case-controlled study to develop a dataset containing 1000 MS cases and 1000 matched controls and to associate DNA sequence (allelic) variations with MS phenotypes. Study  subjects were enrolled through a prospective effort initiated in 2003. Three MS clinical centres were involved in subject recruitment and biological","Multiple Sclerosis","Case-Control","HumanHap550_v1","Not Applicable","SNP Genotypes (Array)","40 phenotype datasets, 740 variables, 4 documents, 1 analyses, 1 molecular datasets, 1920 subjects, 2054 samples","European (1818), African American (1), Hispanic1 (9), Hispanic2 (44), Other Asian or Pacific Islander (2), Other (17)","NINDS","MSG --- Multiple sclerosis genetics research","2009-05-12","2009-05-12","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple"
"phs000180.v3.p2","T1DGC: Genome-Wide Association Study in Type 1 Diabetes, 2008","Cases with Type 1 Diabetes (T1D) in the UK, were part of the Wellcome Trust Case Control Consortium (WTCCC) - http://www.wtccc.org.uk - that first reported in 2007: Wellcome Trust  Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678","Diabetes Mellitus, Type 1","Case Set","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 28 variables, 14 documents, 1 analyses, 1 molecular datasets, 4069 subjects, 4129 samples","European (4023), African (1), Hispanic1 (9), Other Asian or Pacific Islander (1), South Asian (2), Other (7)","NIDDK","DS-T1DR-IRB --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb)","2015-05-27","2012-08-03","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs000181.v1.p1","Alcohol Research using Australian twins and their families (OZ-ALC)","The Australian twin-family study of alcohol use disorder (OZALC study) derives from telephone diagnostic interview studies of two general population volunteer cohorts of Australian twins (cohort 1, mostly born  1940-1964; cohort 2, born 1964-71) and the spouses of the former cohort - a total of over 11,000 families. Three coordinated studies, using a shared","Alcohol-Related Disorders","Family/Twin/Trios","HumanCNV370-Duo_v1, HumanCNV370-Quad_v3_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 44 variables, 2 documents, 1 molecular datasets, 6775 subjects, 7084 samples","European (6629), East Asian (2), Hispanic1 (2), Other Asian or Pacific Islander (22), South Asian (10), Other (29)","NIAAA","RATRP --- Research on alcohol and tobacco related phenotypes","2009-11-10","2010-05-10","Alcohol Related Disorders; Alcohol-Related Disorder; Disorder, Alcohol-Related; Disorders, Alcohol-Related; Depression; Depressive Disorder"
"phs000185.v6.p1","Genetic Studies in the Hutterites","We have conducted genetic studies of disease-associated quantitative phenotypes, including microbiome and gene expression studies, by genotyping and/or sequencing in the Hutterites, a founder population of European descent. The  Hutterites who have participated in our studies live on communal farms in South Dakota and are related to each other through multiple lines of","Prospective","Prospective Longitudinal Cohort","WGS_markerset_grc37, RNAseq_probe_set_grc37","Not Applicable","AMPLICON, RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq expression levels, WGS","12 phenotype datasets, 63 variables, 335 analyses, 3 molecular datasets,  SRA, 365 subjects, 1581 samples","European (98)","NHLBI","GRU-NPU --- General research use (npu)","2018-11-30","2018-11-30","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000187.v1.p1","High Density SNP Association Analysis of Melanoma","This research builds upon an extensive resource of melanoma cases and hospital based controls collected over several years at the U.T. M.D. Anderson Cancer Center. The goal of this  research is to identify novel susceptibility and outcome-related genes for melanoma using a systematic genome-wide association-based approach. Our","Melanoma","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 38 variables, 7 documents, 3 molecular datasets, 3115 subjects, 3311 samples","European (3009), Hispanic1 (3), Hispanic2 (18), Other (3)","NCI","GRU --- General research use","2010-05-18","2011-05-18","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000188.v1.p1","Vanderbilt Genome-Electronic Records (VGER) Project: QRS Duration","An important potential enabling resource for Personalized Medicine is the combination of a DNA repository with Electronic Medical Record (EMR) systems sufficiently robust to provide excellence in clinical care  and to serve as resources for analysis of disease susceptibility and therapeutic outcomes across patient populations. The Vanderbilt EMR is a state","Heart Conduction System","Case Set","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 36 variables, 1 molecular datasets, 3021 subjects, 3203 samples","European (2501), African (8), East Asian (4), African American (469), Hispanic1 (12), Hispanic2 (9), Other Asian or Pacific Islander (7), South Asian (4), Other (7)","NHGRI","HR_VU --- Health research - vanderbilt u , HR_NWU --- Health research - northwestern u","2010-10-08","2011-10-08",""
"phs000196.v3.p1","CIDR: NGRC Parkinson's Disease Study","This is a gene-environment study of Parkinson's disease. PD is a common, progressive, age-related, movement disorder that affects 1-2% of the people over the age of 65. The NeuroGenetics  Research Consortium (NGRC) is the infrastructure of the study. Protocols and methods are standardized across NGRC clinics and labs as much as","Parkinson Disease","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 124 variables, 1 documents, 1 molecular datasets, 4011 subjects, 4271 samples","European (3976), African American (1), Hispanic1 (1), Hispanic2 (4), Other Asian or Pacific Islander (1), Other (3)","NINDS","GRU-IRB --- General research use (irb)","2015-06-30","2016-06-30","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000198.v1.p1","Sporadic Amyotrophic Lateral Sclerosis Study","Genomewide association study of risk for sporadic amyotrophic lateral sclerosis (ALS) and ALS patient phenotype. Genotypes were analyzed for 288,357 markers in 1,821 sporadic ALS patients and 2,258 controls.  DNA from study participants were obtained from one of three centres in the US (Boston, Atlanta, National Institute of Neurological Disorders and","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","Not Applicable","Not Provided","","","NINDS","","","","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs000199.v1.p1","CHOP Control CNV Study","We present a database of copy number variations (CNVs) detected in 2,026 disease-free individuals, using high-density, SNP-based oligonucleotide microarrays. This large cohort analyzed for CNVs in a single study  using a uniform array platform and computational tools, comprises mainly of Caucasians (65.2%) and African-Americans (34.2%), We have catalogued and","Normalcy","Case-Control","HumanHap550_v1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 2026 subjects, 2026 samples","","NIGMS","GRU --- General research use","2009-10-27","2009-10-27","Normalcies; Normalities"
"phs000201.v2.p1","Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes","We performed genome-wide copy number analysis with paired normal and tumor DNA obtained from 86 adult patients with de novo AML using the Affymetrix Genome-Wide Human SNP array 6.0  containing 1.85 million features. Acquired copy number alterations (CNA) were confirmed using an independent, higher resolution, custom array","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 47 variables, 1 molecular datasets, 86 subjects, 172 samples","","NCI","DS-HEM-MDS-GSO --- Disease-specific (hematologic disease, mds, gso)","2014-04-17","2010-01-12","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs000202.v1.p1","OMRF SLEGEN GWAS Data from European-American Women with Lupus","""Systemic lupus erythematosus (SLE) is a common systemic autoimmune disease with complex etiology but strong clustering in families (lambda(S) approximately 30). We performed a genome-wide association scan using 317,501  SNPs in 720 women of European ancestry with SLE and in 2,337 controls, and we genotyped consistently associated SNPs in two additional independent","Lupus Erythematosus, Systemic","Case-Control","HumanHap300v1-1_C","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 analyses, 1 molecular datasets, 297 subjects, 297 samples","European (294), Hispanic2 (3)","NIAMS","LRR --- Lupus related research","2010-03-24","2011-03-24","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs000203.v1.p1","A Genome-Wide Association Study of Peripheral Arterial Disease","The Electronic Medical Record Phenotypes and Community-engaged Genomic Association Study aims to identify genetic variants mediating susceptibility to peripheral arterial disease (PAD). The study leverages a biorepository of blood  samples of 1688 PAD cases and 1649 controls, and the electronic medical record (EMR) to annotate the biorepository. PAD cases were identified from","Peripheral Vascular Diseases","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 44 variables, 3 documents, 1 molecular datasets, 3337 subjects, 3432 samples","European (3298), African (2), East Asian (2), African American (14), Hispanic1 (1), Hispanic2 (13), South Asian (6), Other (1)","NHGRI","HR_MYO --- Health research - mayo clinic","2010-11-05","2011-11-05","Angiopathies, Peripheral; Angiopathy, Peripheral; Diseases, Peripheral Vascular; PVD-peripheral vascular disease; Peripheral Angiopathies; Peripheral Angiopathy"
"phs000204.v1.p1","Genetic Analysis of Limb Malformation Disorders: Freeman Sheldon Syndrome    Exome Sequencing Study (LMD-FSS)","The overall goal of this project is to investigate the etiology and pathogenesis of malformations (i.e., birth defects) of the limb, concentrating on abnormalities of limb patterning such as  limb deficiency/duplications and multiple congenital contractures. The exome sequences of four unrelated individuals were obtained by massively","Freeman-Sheldon Syndrome","Mendelian","Not Provided","Not Applicable","WXS","2 phenotype datasets, 9 variables,  SRA, 3 subjects, 3 samples","","NHLBI","GRU --- Freeman sheldon syndrome exome - general research use","2010-08-19","2010-08-19","AMC; AMC - Arthrogryposis multiplex congenita; Amyoplasia Congenita; Arthrogryposes; Arthrogryposes, Congenital Multiple; Arthrogryposis"
"phs000205.v6.p2","International Standards for Cytogenomic Arrays","The International Standards for Cytogenomic Arrays (ISCA) Consortium is a rapidly growing group of clinical cytogenetics and molecular genetics laboratories committed to improving quality of patient care related to  clinical genetic testing using new molecular cytogenetic technologies including array comparative genomic hybridization (aCGH) and quantitative SNP","Developmental Disabilities","Case Set","Cytogenetic_Arrays","Not Applicable","CNV Genotypes","4 phenotype datasets, 18 variables, 4 molecular datasets, 53936 subjects, 49013 samples","","NICHD","GRU --- General research use","2016-06-20","2017-06-20","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000206.v5.p3","Pancreatic Cancer Cohort and Case-Control Consortium (PanScan)","Within the framework of the NCI-sponsored Cohort Consortium, investigators from 12 prospective epidemiologic cohorts formed the Pancreatic Cancer Cohort Consortium in 2006. This study, also known as ""PanScan"", is  funded by the National Cancer Institute (NCI) and involves conducting a genome-wide association study (GWAS) of common genetic variants to identify","Pancreatic Neoplasms","Case-Control","Human610-Quadv1_B, HumanHap550_v3, HumanOmniExpress-12v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 documents, 2 analyses, 2 molecular datasets, 9437 subjects, 9702 samples","European (8770), African (5), East Asian (320), African American (161), Hispanic1 (33), Hispanic2 (92), Other Asian or Pacific Islander (31), South Asian (14), Other (11)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods , DS-PACA-GSO --- Disease-specific (pancreatic cancer, gso) , O-DS-PACA-IRB-COL-GSO --- Disease-specific (pancreatic cancer, irb, col, gso) , GRU --- General research use , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso)","2015-09-25","2015-09-25","Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic; Neoplasms, Pancreas; Neoplasms, Pancreatic"
"phs000207.v1.p1","CGEMS Prostate Cancer GWAS - Stage 1 - PLCO","The Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer genome-wide association study (GWAS) included genotyping approximately 550,000 SNPs (Phase 1A with HumanHap300 and Phase 1B HumanHap240, both from Illumina,  San Diego, CA) in 1,172 prostate cancer patients and 1,157 controls of European ancestry from the Prostate, Lung, Colon and Ovarian (PLCO, http","Prostatic Neoplasms","Case-Control","HumanHap240S_A","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 2 analyses, 1 molecular datasets, 2252 subjects, 2300 samples","European (2251), Hispanic1 (1)","NCI","CADM --- Research related to adult diseases and methods","2009-12-22","2009-12-22","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000210.v1.p1","PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events    Study","Source of Patients The source of the patients for this genome-wide case control study was MA.27, which was conducted as a multi-cooperative group effort under the auspices of the  NCI Breast Cancer Intergroup of North America. The NCIC Clinical Trials Group (CTG) serves as the coordinating group, with participation by the NCI","Breast Neoplasms","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 documents, 1 molecular datasets, 879 subjects, 878 samples","","NIGMS","HR --- Health research","2009-10-14","2010-10-14","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000211.v1.p1","Genotyping 400 Samples from the NIGMS Human Variation Panels","The Human Genetic Cell Repository is sponsored by the National Institute of General Medical Sciences (NIGMS) with the mission of supplying scientists with the materials for accelerating disease gene  discovery and functional studies. The resources available include highly-characterized, contaminant-free cell cultures and high quality, well","Normalcy","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 11 variables, 1 molecular datasets, 400 subjects, 400 samples","African American (387), Hispanic1 (12), Other (1)","NIGMS","GRU --- General research use","2009-11-10","2009-11-10","Normalcies; Normalities"
"phs000215.v2.p1","Genome-Wide Association Analysis of Biomarkers in the InCHIANTI and BLSA","Version 1 The aim of this study was to identify gene(s) associated with serum iron concentrations. This dataset contains the results from a meta-analysis of 1919 subjects from the  InCHIANTI and Baltimore Longitudinal Study of Aging (BLSA). Both studies are population based prospective studies that evaluate the contributors of","Nutritional and Metabolic Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 23 variables, 94 analyses","","NIA","GRU --- General research use","2013-09-27","2010-02-05",""
"phs000216.v1.p1","International Consortium on the Genetics of Systemic Lupus Erythematosus    (SLEGEN)","The genetic makeup of an individual strongly influences the risk of developing systemic lupus erythematosus (SLE). The identification of genes that predispose an individual to SLE will lead to  earlier and better diagnosis, better treatments, and possibly prevention. To this end, the International Consortium on the Genetics of Systemic Lupus","Lupus Erythematosus, Systemic","Case-Control","Not Provided","Not Applicable","Not Provided","1 analyses","","NIAMS","GRU --- General research use","2010-03-25","2010-03-25",""
"phs000217.v2.p1","Genome-Wide Association Study of Leprosy and Dapsone Hypersensitivity    Syndrome (DHS)","Leprosy GWAS Leprosy is a chronic infectious disease caused by Mycobacterium leprae (M. leprae). Due to M. leprae's narrow host range and an inability to be cultured in vitro,  the biological investigation of this disease has been difficult. Host genetic factors have been suggested to play an important role in disease","Leprosy","Case-Control","Not Provided","Not Applicable","Not Provided","2 analyses, 1220 subjects","","NIAID","LSO --- Leprosy studies only","2013-11-05","","4,4' Diaminophenyl Sulfone; 4,4'-Diaminophenyl Sulfone; 4,4'-Sulfonylbisbenzamine; 4,4'-Sulfonyldianiline; Bis(4-aminophenyl)sulfone; Croysulfone"
"phs000219.v1.p1","GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)","GenADA is a multi-site collaborative study, involving GlaxoSmithKline Inc and nine medical centres in Canada, to develop a dataset containing 1000 Alzheimer's disease patients and 1000 ethnically-matched controls in  order to associate DNA sequence (allelic) variations in candidate genes with Alzheimer's disease phenotypes. The study consists of both retrospective","Alzheimer Disease","Case-Control","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","59 phenotype datasets, 1558 variables, 10 documents, 1 analyses, 1 molecular datasets, 1718 subjects, 1588 samples","European (1586), Hispanic2 (2)","NIMH","GBA --- Genetic basis of alzheimer's","2010-01-21","2010-07-21","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000220.v2.p2","PAGE: Multiethnic Cohort (MEC)","The Multiethnic Cohort (MEC) has established a large biorepository of blood and urine (N 67,000) and cryopreserved lymphocytes (N 15,000) linked to extensive, prospectively collected risk factors (e.g., diet,  smoking, physical activity), biomarkers and clinical data for five racial/ethnic groups. This cohort study of over 215,000 men and women in Hawaii","Neoplasms","Case-Control","Cardio-Metabo_Chip, MEGA_Consortium_15063755_B2","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 68 variables, 1 analyses, 4 molecular datasets, 27995 subjects, 37714 samples","European (105), African (129), East Asian (3648), African American (4958), Hispanic1 (200), Hispanic2 (55), Other Asian or Pacific Islander (2973), South Asian (1), Other (709)","NHGRI","DS-CRM-PUB-MDS --- Disease-specific (cancer research and methods, pub, mds) , GRU --- General research use","2018-06-27","2018-06-27","Cholesterol, HDL2; HDL cholesterol 2; HDL(2) Cholesterol; HDL2 Cholesterol; High density lipoprotein cholesterol subfraction 2; High density lipoprotein cholesterol, sub-fraction II"
"phs000221.v1.p1","NHLBI Family Heart Study (FamHS)","The Family Heart Study (FamHS) was funded by the National Heart, Lung, and Blood Institute (NHLBI). It was begun in 1992 with the ascertainment of 1,200 families, half randomly  sampled, and half selected because of an excess of coronary heart disease (CHD) or risk factor abnormalities as compared with age- and sex-specific","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","99 analyses","","NHLBI","GRU --- General research use","2011-06-21","","Atherogenesis; CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases"
"phs000222.v5.p2","PREDICT-HD Huntington Disease Study","The purpose of this project is to make clinical measurements from the PREDICT-HD consortium available through the dbGaP mechanism. The phenotype data will first be converted into a community  open standard and subsequently exported to dbGaP for archival and open access distribution of the results of the studies. This will permit members of","Huntington Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","15 phenotype datasets, 787 variables, 8 documents, 1476 subjects","","NINDS","GRU --- General research use","2017-09-25","2017-11-16","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea"
"phs000224.v3.p2","VitGene Generalized Vitiligo Genetics Study","Generalized vitiligo is an autoimmune disease in which melanocyte loss results in patchy depigmentation of skin and hair. For this third GWAS of generalized vitiligo, SNPs were genotyped in  1,059 generalized vitiligo cases of European-derived white (EUR) ancestry using the Illumina Human OmniExpress BeadChip array. The data were combined","Vitiligo","Case-Control","Not Provided","Not Applicable","SNP Genotypes (Array)","2857 subjects, 2938 samples","European (1769), Hispanic1 (1), Hispanic2 (2), South Asian (1), Other (3)","NIAMS","","","","Not Provided"
"phs000225.v1.p1","Expression QTL (eQTL) Analysis in Human Primary Cells","The common genetic variants associated with complex traits typically lie in non-coding DNA and may alter gene regulation in a cell type-specific manner. Consequently, the choice of tissue or  cell model in the dissection of disease associations is important. We carried out an expression quantitative trait loci (eQTL) study of primary human","Osteoporosis","Case-Control","Not Provided","Not Applicable","Not Provided","","","NIAMS","GRU --- General research use","2010-10-01","2010-10-01","Bone Densities; Bone Mineral Densities; Bone Mineral Density; Density, Bone; Density, Bone Mineral; Age Related Osteoporosis"
"phs000228.v4.p1","HMP Core Microbiome Sampling Protocol A (HMP-A)","This first clinical study of the Human Microbiome Project (HMP) addresses whether individuals share a core human microbiome. It involves broad determination of the microbiota found in five anatomical  sites: the oral cavity, skin, nasal cavity, gastrointestinal tract and vagina. This study will enroll approximately 300 healthy male and female","Metagenomics","Control Set","target_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","7 phenotype datasets, 269 variables, 35 documents, 1 molecular datasets,  SRA, 300 subjects, 55762 samples","European (214), East Asian (14), African American (20), Hispanic1 (5), Hispanic2 (26), Other Asian or Pacific Islander (5), South Asian (13), Other (1)","NHGRI","HMP --- Human microbiome research","2018-02-08","2018-02-08","Community Genomic; Community Genomics; Environmental Genomic; Environmental Genomics; Genomic, Community; Genomic, Environmental"
"phs000233.v1.p1","Genome Wide Association Study of Asthma","This data forms part of an ongoing genome wide association study into the genetic variants that predispose to pediatric asthma at the Children's Hospital of Philadelphia (CHOP). All cases  and controls were recruited at CHOP and genotyped at the Center for Applied Genomics (CAG). The data set includes 793 cases and 1988 controls. The","Asthma","Case-Control","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","DS-AS-AT --- Disease-specific (asthma and atopy)","2019-09-12","2019-09-12","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000234.v2.p2","Group Health/UW Aging and Dementia eMERGE Study","The ""Development and Use of Network Infrastructure for High-Throughput GWA Studies"" project is collaboration between Group Health Cooperative (GH), the University of Washington (UW), and the Fred Hutchinson Cancer  Research Center (FHCRC). It is one of 5 sites participating in The Electronic Medical Records and Genomics (eMERGE) Network funded by the National","Dementia","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 43 variables, 12 documents, 1 molecular datasets, 3756 subjects, 3746 samples","European (3498), African (5), East Asian (68), African American (128), Hispanic1 (10), Hispanic2 (18), Other Asian or Pacific Islander (13), South Asian (2), Other (4)","NHGRI","HR_MC --- Health research - marshfield clinic , HR_VU --- Health research - vanderbilt u , HR_GHS --- Health research - group health seattle , AGING_GHS --- Dementia or aging - group health seattle , HR_MYO --- Health research - mayo clinic","2018-05-30","2018-05-30","Age Factor; Age Factors; Factor, Age; Factors, Age; Advanced age; Aged"
"phs000237.v1.p1","Northwestern NUgene Project: Type 2 Diabetes","The ability to correlate genetic variation with disease susceptibility and response to drug therapy depends on genotype or sequence analysis of large numbers of richly characterized DNA samples. Eight  years agoWe are a part of NHGRI's electronic Medical Records and Genomics (eMERGE) Network, whose goal is to conduct genome-wide association studies","Diabetes Mellitus, Type 2","Case-Control","Human660W-Quad_v1_A, Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 41 variables, 3 documents, 2 molecular datasets, 3563 subjects, 3539 samples","European (1738), African (35), East Asian (3), African American (1586), Hispanic1 (25), Hispanic2 (27), Other Asian or Pacific Islander (8), South Asian (1), Other (14)","NHGRI","HR_VU --- Health research - vanderbilt u , HR_NWU --- Health research - northwestern u","2011-04-22","2012-04-22","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000238.v1.p1","NEIGHBOR Consortium Glaucoma GWAS","This is a case-control study of primary open angle glaucoma (POAG). POAG is an intraocular pressure (IOP) related progressive optic neuropathy that ultimately leads to blindness. For this study  we have formed a collaborative consortium contributing 2170 POAG cases and 2347 controls with a unified definition of POAG (the NEIGHBOR consortium","Glaucoma","Case-Control","Human660W-Quad_v1_C","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 46 variables, 1 molecular datasets, 5073 subjects, 5416 samples","European (4591), African (10), East Asian (4), African American (72), Hispanic1 (46), Hispanic2 (304), Other Asian or Pacific Islander (4), South Asian (9), Other (33)","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2013-11-20","2014-08-20",""
"phs000239.v2.p1","Genome, Epigenome and RNA Sequences of MZ Twins Discordant for MS","Monozygotic (MZ) twins have been widely employed for dissection of the relative contributions of genetics and environment in disease. In multiple sclerosis (MS), an autoimmune demyelinating disease that commonly  causes neurodegeneration and disability in young adults, disease discordance in MZ twins has been interpreted to indicate environmental importance in","Multiple Sclerosis","Family/Twin/Trios","Not Provided","Not Applicable","Bisulfite-Seq, FL-cDNA, WGS","5 phenotype datasets, 17 variables,  SRA, 6 subjects, 16 samples","","NINDS","GRU --- General research use","2010-07-27","2011-05-19","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000240.v1.p1","NEI Ocular Hypertension Treatment Study (OHTS)","The Ocular Hypertension Treatment Study (OHTS) is an National Eye Institute-sponsored multi-center, randomized, prospective treatment trial designed to determine whether lowering intraocular pressure (IOP) in individuals with ocular hypertension  delays or prevents the development of primary open angle glaucoma (POAG). A total of 1,636 individuals with ocular hypertension between 40 and 80","Glaucoma, Open-Angle","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 20 variables, 4 documents, 1 molecular datasets, 1063 subjects, 1131 samples","European (756), African (9), East Asian (7), African American (242), Hispanic1 (14), Hispanic2 (17), Other Asian or Pacific Islander (2), South Asian (2), Other (8)","NEI","GRC --- Glaucoma and related conditions","2011-08-03","2012-08-03","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle"
"phs000244.v1.p1","Genetic Analysis of Limb Malformation Disorders: Miller Syndrome    Sequencing Study (LMD-MS)","The overall goal of this project is to investigate the etiology and pathogenesis of malformations (i.e., birth defects) of the limb, concentrating on abnormalities of limb patterning such as  limb deficiency/duplications and multiple congenital contractures. The exome sequences of two siblings and two unrelated individuals were obtained by","Genee-Wiedemann Syndrome","Mendelian","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 14 variables,  SRA, 6 subjects, 8 samples","","NHLBI","GRU --- Miller syndrome exome - general research use","2010-08-19","2010-08-19","Ciliary Dyskinesia; Ciliary Dyskinesias; Ciliary Motility Disorder; Disorder, Ciliary Motility; Dyskinesia, Ciliary; Dysmotile cilia syndrome"
"phs000245.v1.p1","Whole Genome Sequencing of Triple Negative Breast Cancer","Breast Cancer Subject Participant ID 700064 (Source Sample names: 6888 and 206). We used massively parallel DNA sequencing technologies to screen entire genomes, in an unbiased manner, for genetic  changes associated with tumor growth and metastasis. We describe the complete genome sequence analysis of four DNA samples from a 44-year old African","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WGS","4 phenotype datasets, 21 variables,  SRA, 1 subjects, 4 samples","","NHGRI","CR --- Cancer research","2010-10-08","2010-10-08","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000247.v5.p3","The Neonatal Microbiome and NEC","The Neonatal Microbiome and Necrotizing enterocolitis (NEC) study is a multi-centered case control study testing the hypothesis that NEC is a direct or indirect consequence of the enteric biomass,  its products, or both. Very low birth weight infants (VLBW; birth weight 1500 grams) admitted to the neonatal intensive care unit are prospectively","Enterocolitis, Necrotizing","Case-Control","Not Provided","Not Applicable","AMPLICON, WGS","7 phenotype datasets, 67 variables, 3 documents,  SRA, 1962 subjects, 3882 samples","","NIAID","HMP --- Human microbiome research","2017-08-01","2015-04-25","Disorder, Functional Gastrointestinal; Disorders, Functional Gastrointestinal; Functional Gastrointestinal Disorder; Functional Gastrointestinal Disorders; Gastrointestinal Disorder, Functional; Gastrointestinal Disorders, Functional"
"phs000248.v1.p1","Genetic Determinants of Viral Clearance in HCV-Infected Populations","The World Health Organization estimates there are 170 million persons with HCV infection worldwide, and an estimated 4 million persons are infected in the United States. Persistent HCV infection  can cause cirrhosis and hepatocellular cancer. Long term disease consequences do not occur in persons who spontaneously recover. It is not known why","Hepatitis C","Case-Control","HumanOmni1-Quad_v1-0_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 3434 subjects, 3636 samples","European (2544), African (16), East Asian (12), African American (542), Hispanic1 (124), Hispanic2 (136), Other Asian or Pacific Islander (9), South Asian (17), Other (34)","NIDA","GRU-IRB --- General research use (irb)","2014-02-13","2015-02-13","HCV Infection; Hepatitis C Virus Infection; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; PT-NANBH; Parenterally Transmitted Non A, Non B Hepatitis; Parenterally-Transmitted Non-A, Non-B Hepatitis"
"phs000250.v1.p1","CALGB 80303: Genome-Wide Association Study of Advanced Pancreatic Cancer    Patients","CALGB 80303 was a randomized, phase III study in advanced pancreatic cancer patients treated with Gemcitabine plus either Bevacizumab or placebo. No difference in overall survival (OS) was observed  between the two arms. We prospectively collected germline DNA and conducted a genome-wide association study (GWAS).","Pancreatic Neoplasms","Case-Control","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 32 variables, 1 molecular datasets, 351 subjects, 351 samples","European (307), African (1), East Asian (4), African American (27), Hispanic1 (3), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (1), Other (1)","NIGMS","APTC --- For use in future research to learn about, prevent or treat cancer","2011-07-08","2012-07-08","Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic; Neoplasms, Pancreas; Neoplasms, Pancreatic"
"phs000251.v2.p2","Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)","Psoriasis, a highly prevalent disease of humans of unknown cause, is a chronic inflammatory disorder primarily involving skin, with distinctive clinical characteristics. With the newly developed tools that facilitate  microbiome research, it now is possible to assess whether the cutaneous microbiome plays a role in the pathogenesis of this disorder. Preliminary","Psoriasis","Metagenomics","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 27 variables,  SRA, 93 subjects, 236 samples","","NIAMS","HMP --- Human microbiome research","2014-03-04","2011-06-16","Acropustulosis; Chronic palmoplantar pustular psoriasis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis"
"phs000254.v2.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis)","The major goal of this project is to apply second generation resequencing technology to identify disease causing variants influencing pediatric and adult lung diseases in a collection of two  longitudinal population cohorts of cystic fibrosis patients that have been well characterized for a comprehensive set of clinical traits. In Phase I","Cystic Fibrosis","Prospective Longitudinal Cohort","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 28 variables, 3 molecular datasets,  SRA, 431 subjects, 431 samples","","NHLBI","DS --- Disease specific (cystic fibrosis and genetic variation discovery research related to cystic fibrosis) , GRU --- General research use","2012-10-24","2014-12-26","CF; CF - Cystic fibrosis; Fibrocystic disease; Fibrosis, Cystic; MUCOVISCIDOSIS"
"phs000255.v1.p1","Effect of Crohn's Disease Risk Alleles on Enteric Microbiota","This UH2/UH3 demonstration project entitled ""Effects of Crohn's disease risk alleles on enteric microbiota"" is focused on characterizing intestinal associated microbiota in patients with ileal Crohn's disease (ileal CD),  ulcerative colitis (UC) and control patients without inflammatory bowel diseases (non-IBD). We hypothesize that genetic factors that affect Paneth","Crohn Disease","Metagenomics","Not Provided","Not Applicable","AMPLICON","6 phenotype datasets, 23 variables,  SRA, 228 subjects, 293 samples","","NIDDK","HMP --- Human microbiome research , BSDO --- Bacterial sequence data only","2010-06-08","2011-06-08","Colitis Gravis; Colitis ulcerosa; Colitis, Ulcerative; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis"
"phs000256.v3.p2","The Vaginal Microbiome: Disease, Genetics and the Environment","The vagina is an interactive interface with the environment, and as such is covered by a protective epithelial surface. This surface is colonized by bacteria and other microorganisms which,  through a variety of mechanisms serve to further protect the host from invasion by pathogens. Alterations in the normal vaginal microflora","Microbiomes, Human","Metagenomics","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 98 variables,  SRA, 3474 subjects, 28230 samples","","NIAID","HMP --- Human microbiome research","2013-08-01","2012-07-08","Metagenome; Metagenomes"
"phs000257.v3.p1","Human Gut Microbiome in Crohn's Disease","Inflammatory bowel diseases (IBD), such as Crohn's disease, are chronic, immunologically mediated disorders that have severe medical consequences. The current hypothesis is that these diseases are due to an  overly aggressive immune response to a subset of commensal enteric bacteria. Studies to date on IBD have suggested that the disorder may be caused by","Crohn Disease","Family/Twin/Trios","Not Provided","Not Applicable","AMPLICON, WGS","5 phenotype datasets, 30 variables, 4 documents,  SRA, 69 subjects, 168 samples","","NIDDK","HMP --- Microbiome","2018-09-25","2018-09-25","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's regional enteritis; Crohns Disease"
"phs000258.v2.p1","Human Gut Microbiome in Amish Obesity","Emerging evidence that the gut microbiota may contribute in important ways to human health and disease has led us and others to hypothesize that both symbiotic and pathological relationships  between gut microbes and their host may be key contributors to obesity and the metabolic complications of obesity. Our ""Thrifty Microbiome Hypothesis","Obesity","Metagenomics","Not Provided","Not Applicable","AMPLICON","3 phenotype datasets, 21 variables, 20 documents,  SRA, 404 subjects, 599 samples","","NIDDK","HMP --- Human microbiome research","2011-04-15","2011-06-23","Morbid Obesities; Morbid Obesity; OBESITY, SEVERE; Obesities, Morbid; Obesities, Severe; Obesity, Morbid"
"phs000259.v2.p1","Urethral Microbiome of Adolescent Males","Urethral microbiome of adolescent males is designed to characterize the microbial communities resident in the urethra of young men, to identify differences in these communities as a function of  race/ethnicity, circumcision status, sexual exposures, and uro-genital symptoms. We collect detailed sexual behavior and symptoms data using cellular","Urethritis","Metagenomics","Not Provided","Not Applicable","AMPLICON, WGS","6 phenotype datasets, 46 variables,  SRA, 55 subjects, 144 samples","","NIAID","HMP --- Human microbiome research","2011-03-10","2010-06-07","Genital Organs, Male; Genital, Male; Genitalia, Male; Genitals, Male; Male Genital; Male Genital Organ"
"phs000260.v4.p2","Foregut Microbiome in Development of Esophageal Adenocarcinoma","The distal esophagus is an important anatomical area where gastric acid reflux can cause reflux esophagitis (RE), Barrett's esophagus (BE) (intestinal metaplasia), and esophageal adenocarcinoma (EA). The incidence of  EA has increased 6-fold in the U.S. since the 1970s, parallel to a significant increase in the prevalence of gastroesophageal reflux diseases (GERD","Esophageal Adenocarcinoma","Case-Control","Not Provided","Not Applicable","AMPLICON, WGS","4 phenotype datasets, 20 variables, 5 documents,  SRA, 110 subjects, 575 samples","","NCI","HMP --- Human microbiome research","2017-10-13","2011-07-01","BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome; Barrett esophagus"
"phs000261.v1.p1","The Microbial Ecology of Bacterial Vaginosis","Archived self-collected vaginal swabs were utilized from a pilot study of vaginal douching cessation (NIH/NIAID R03-AI061131). Thirty-nine non-pregnant, reproductive-age women who reported the use of vaginal douche products in  the two months prior to screening were enrolled. Thirty-three of these successfully completed the 16-week longitudinal study. Participants self","Vaginosis, Bacterial","Metagenomics","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 27 variables, 6 documents,  SRA, 34 subjects, 998 samples","","NIAID","HMP --- Human microbiome research","2010-06-28","2011-06-28","BV; BV - Bacterial vaginosis; Bacterial Vaginitides; Bacterial Vaginitis; Bacterial Vaginoses; Nonspecific Vaginitis"
"phs000262.v3.p2","The Role of the Gut Microbiota in Ulcerative Colitis","The aims of the multi-center Ulcerative Colitis Human Microbiome Project (UCHMP) are to examine the role of the enteric microbiome in causing human ulcerative colitis, specifically the development of  pouchitis. Pouchitis is an inflammatory condition of the surgically-created ileoanal pouch that serves as a pseudo-rectum in patients with ulcerative","Pouchitis","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 26 variables, 6 documents,  SRA, 50 subjects, 612 samples","","NIDDK","HMP --- Human microbiome research","2017-09-08","2017-09-08","Colitis Gravis; Colitis ulcerosa; Colitis, Ulcerative; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis"
"phs000263.v1.p1","Metagenomic Study of the Human Skin Microbiome Associated with Acne","Acne vulgaris affects 17 million Americans, more than 80% of the people of age 12-24. The goal of this study is to investigate the relationship between acne pathogenesis and  the skin microbiota residing in the microcomedones. This study will enroll approximately 100 healthy individuals and acne patients, both male and","Acne Vulgaris","Metagenomics","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 25 variables,  SRA, 94 subjects, 165 samples","","NIAMS","HMP --- Human microbiome research","2010-06-22","2011-06-22","Not Provided"
"phs000265.v3.p1","The Human Gut Microbiome and Recurrent Abdominal Pain in Children","This project explores the nature of the human intestinal microbiome in healthy children and children with recurrent abdominal pain. The overall goal is to obtain a robust knowledge-base of  the intestinal microbiome in children without evidence of pain or gastrointestinal disease, children with functional abdominal pain, and children","Irritable Bowel Syndrome","Metagenomics","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 43 variables, 5 documents,  SRA, 69 subjects, 127 samples","","NIDDK","HMP --- Microbiome","2011-10-17","2011-06-07","Digestive System Disease; Digestive System Diseases; Disease, Digestive System; Diseases, Digestive System; Gastrointestinal and digestive disorder; System Disease, Digestive"
"phs000266.v4.p1","Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency","The NIH Intramural Skin Microbiome Consortium (NISMC) is a collaboration of investigators with primary expertise in genomics, bioinformatics, large-scale DNA sequencing, dermatology, immunology, allergy, infectious disease, and clinical microbiology.  Atopic dermatitis (AD, ""eczema"") is a chronic relapsing skin disorder that affects 15% of U.S. children and is associated with $1 billion of medical","Dermatitis, Atopic","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","5 phenotype datasets, 29 variables,  SRA, 114 subjects, 3211 samples","","NIAMS","HMP --- Human microbiome research","2013-10-25","2012-09-13","AD - Atopic dermatitis; ATOD; Allergic dermatitis; Allergic eczema; Atopic Dermatitides; Atopic Eczema"
"phs000267.v5.p2","Autism Genome Project (AGP) Consortium - GWAS - Stage I and II","Autism spectrum disorders (ASDs) are highly heritable ( 90%), yet the underlying genetic determinants are largely unknown. To understand the genetic and phenotypic heterogeneity in ASDs, we analyzed 2,611  strictly defined ASD families with over 1,000,000 single nucleotide polymorphisms (SNPs), and applied multiple analytical strategies to examine these","Autistic Disorder","Family/Twin/Trios","Human1Mv1_C, Human1M-Duov3_B, Human1Mv1_C, Human_1M, Human1M-Duov3","Not Applicable","CNV Genotypes, SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 documents, 126 analyses, 4 molecular datasets, 7880 subjects, 7880 samples","European (6911), African (38), East Asian (77), African American (115), Hispanic1 (109), Hispanic2 (390), Other Asian or Pacific Islander (53), South Asian (74), Other (80)","NIMH","DS-ASD --- Disease-specific (autism spectrum disorder)","2017-01-09","2014-04-24","Child Development Disorders, Pervasive; Pervasive Child Development Disorders; AUTISTIC DISORDER; AUTS; Autism; Autism (209850)"
"phs000268.v1.p1","Genotyping NIGMS CEPH Samples from the United States, Venezuela, and    France","The Human Genetic Cell Repository (HGCR) is sponsored by the National Institute of General Medical Sciences (NIGMS) with the mission of supplying scientists with the materials for accelerating disease  gene discovery and functional studies. The resources available include highly-characterized, contaminant-free fibroblast cell lines, transformed","Cell Line","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 181 subjects, 184 samples","European (153), Hispanic2 (28)","NIGMS","GRU --- General research use","2011-02-25","2011-02-25","Normalcies; Normalcy; Normalities"
"phs000269.v1.p1","Genotyping NIGMS Chromosomal Aberration and Inherited Disorder Samples","As part of an effort to correlate molecular copy number variation determinations with state of the art karyotype analyses, 716 samples derived from 697 individuals from the Chromosomal Aberrations  and Inherited Disorders collections of the NIGMS Human Genetic Cell Repository were genotyped and analyzed for CNV determination by the Microarray","Chromosome Disorders","Cross-Sectional","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 1 molecular datasets, 697 subjects, 716 samples","European (527), African (8), East Asian (7), African American (67), Hispanic1 (25), Hispanic2 (37), Other Asian or Pacific Islander (7), South Asian (10), Other (9)","NIGMS","GRU --- General research use","2010-08-10","2010-08-11","Anomaly of chromosome; Chromosomal Disorder; Chromosomal Disorders; Chromosomal abnormality syndrome; Chromosomal anomaly; Chromosomal hereditary disorder"
"phs000272.v1.p1","Genome-Wide Association Study of Beh et's Disease (Turkish)","Introduction Behet's disease (BD) is a genetically complex multisystem disease of unknown etiology, characterized by recurrent inflammatory attacks affecting orogenital mucosa, eyes, skin, joints, blood vessels, and less frequently,  the central nervous system and gastrointestinal tract. Family studies suggest a genetically complex contribution to BD. With the exception of HLA-B51","Behcet Syndrome","Case-Control","HumanCNV370-Duo_v1","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 7 variables, 1 analyses, 1 molecular datasets, 2493 subjects, 2493 samples","European (1283), Hispanic1 (26), Other (1184)","NIAMS","GRU --- General research use","2010-09-27","2011-09-27","Adamantiades Behcet Disease; Adamantiades-Behcet Disease; Adamantiades-Behcet Diseases; BD; BEHCET DISEASE; Behcet Triple Symptom Complex"
"phs000273.v1.p1","High-Throughput Retrotransposon Discovery in Humans","The aim of this study is to discover LINE-1 (L1) insertion sites present in humans that are absent from the reference genome sequence. We use the distinguishing nucleotide characteristics  of human-specific L1 elements to resequence the L1 3' flanking regions thus locating the L1 insertion sites whether or not they are present in the","Normalcy","Cross-Sectional","Not Provided","Not Applicable","AMPLICON, CLONE","3 phenotype datasets, 14 variables, 1 documents,  SRA, 25 subjects, 25 samples","","NIGMS","GRU --- General research use","2011-07-12","","Normalcies; Normalities"
"phs000274.v1.p1","Genome-Wide Association Study of Celiac Disease","Celiac disease (gluten-sensitive enteropathy, celiac sprue) is a common disease with significant morbidity and mortality. It is caused by sensitivity to the dietary protein gluten, resulting in a chronic  enteropathy in the small intestine. Celiac disease is now recognized to be a common disease, with reports that the disease frequency is 1:133 in the","Celiac Disease","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 molecular datasets, 2300 subjects, 2394 samples","European (2203), African (2), East Asian (1), African American (2), Hispanic1 (7), Hispanic2 (21), Other Asian or Pacific Islander (2), South Asian (5), Other (3)","NIDDK","GRU --- General research use","2011-11-30","2012-11-30","CD - Celiac disease; CELIAC SPRUE, SUSCEPTIBILITY TO, 1; CELIAC1; CS - Celiac sprue; Celiac Sprue; Celiac disease"
"phs000275.v1.p1","BWH MS Genetic Collection","The main objective of this GWA study is to identify Multiple Sclerosis (MS) susceptibility loci. Whole-genome association analysis was performed on 924 individuals genotyped on the Affymetrix 6.0 Genechip.  The cohort consisted of 860 clinically diagnosed MS patients and 64 control subjects.","Multiple Sclerosis","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 1 molecular datasets, 924 subjects, 924 samples","European (919), Hispanic1 (2), Hispanic2 (2), Other (1)","NINDS","MSRD --- Ms and related disorders","2012-10-02","2013-10-02","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple"
"phs000276.v2.p1","STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)","The Northern Finland Birth Cohorts program (NFBC) was initiated in the 1960s in the two northernmost provinces of Finland to study risk factors involved in pre-term birth and intrauterine  growth retardation, and the consequences of these early adverse events on subsequent morbidity and mortality. The uniqueness of NBFCs is that the","Metabolic Syndrome X","Prospective Longitudinal Cohort","HumanCNV370-Duo_v1","Not Applicable","SNP Genotypes (Array), WXS","4 phenotype datasets, 34 variables, 9 analyses, 1 molecular datasets,  SRA, 5415 subjects, 10931 samples","European (5353), Hispanic2 (2), Other (47)","NHLBI","GRU --- General research use","2014-01-24","2014-01-24","Cholesterol Level, High; Cholesterol Levels, High; Cholesterol, Elevated; Cholesterols, Elevated; Elevated Cholesterol; Elevated Cholesterols"
"phs000277.v1.p1","International Consortium on the Genetics of Heroin Dependence","This collaboration of Australian and American investigators aims to identify genes associated with liability for heroin dependence. The project uses a case-control design in which cases met lifetime DSM-IV  criteria for heroin dependence. Controls included assessed individuals who did not meet DSM-IV heroin dependence criteria and unassessed general","Heroin Dependence","Case-Control","HumanCNV370-Quadv3_C, Human660W-Quad_v1_C, HumanCNV370v1_C, Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 103 variables, 1 molecular datasets, 6487 subjects, 6732 samples","European (6069), East Asian (69), African American (6), Hispanic1 (47), Hispanic2 (33), Other Asian or Pacific Islander (68), South Asian (21), Other (172)","NIDA","SUD --- Substance use dependence only , RATRP --- Research on alcohol and tobacco related phenotypes , SUDCT --- Substance dependence, childhood trauma and related disorders , ARC --- Alcohol related conditions","2013-08-14","2014-08-14","Addiction, Heroin; Dependence, Heroin; Heroin Addiction"
"phs000279.v2.p1","NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Myocardial Infarction","Prospective Longitudinal Cohort","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 30 variables, 2 molecular datasets,  SRA, 736 subjects, 727 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2013-10-25","2016-04-12","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000284.v2.p1","NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource    (CARe)","The Cleveland Family Study is the largest family-based study of sleep apnea world-wide, consisting of 2284 individuals (46% African American) from 361 families studied on up to 4 occasions  over a period of 16 years. The study was begun in 1990 with the initial aims of quantifying the familial aggregation of sleep apnea. NIH renewals","Sleep Apnea Syndromes","Prospective Longitudinal Cohort","Not Provided","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 2339 variables, 9 documents, 1473 subjects, 1538 samples","African (4), African American (647), Hispanic1 (10), Other (1)","NHLBI","DS-HLBS-IRB-NPU --- Disease-specific (heart, lung, blood, and sleep disorders, irb, npu)","2018-12-03","2011-02-08","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs000288.v2.p2","Ciliopathies Exome Sequencing Initiative","The study is aimed at identifying new genes involved in pediatric brain disorders from inbred families originating predominantly in the Middle East. Each patient analyzed to date has a  specific and highly unique neurodevelopmental disorder that is likely to be recessive in nature. Many patients have one of the diseases along the","Congenital Abnormalities","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 4 documents, 1 molecular datasets,  SRA, 2569 subjects, 2569 samples","","NHGRI","GRU --- General research use","2017-11-15","2017-11-15","BBS; Bardet Biedl Syndrome; Biedl-Bardet syndrome; LMBB - Laurence-Moon-Bardet-Biedl syndrome; Laurence Moon Bardet Biedl Syndrome; Laurence-Moon-Bardet-Biedl Syndrome"
"phs000289.v2.p1","NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of    VTE)","Overview: Our overall long-term goal is to determine risk factors for the complex (multifactorial) disease, venous thromboembolism (VTE), that will allow physicians to stratify individual patient risk and target  VTE prophylaxis to those who would benefit most. In this genome-wide association case-control study (1300 cases and 1300 controls) we hope to","Venous Thrombosis","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 53 variables, 4 documents, 2 molecular datasets, 2597 subjects, 2760 samples","European (2555), East Asian (1), African American (1), Hispanic1 (11), Hispanic2 (22), Other Asian or Pacific Islander (1), South Asian (1), Other (2)","NHGRI","GRU --- General research use","2011-06-28","2011-09-20","Phlebothromboses; Phlebothrombosis; Thromboses, Venous; Thrombosis, Venous; VENOUS THROMBOSIS; Venous Thromboses"
"phs000290.v1.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Pulmonary Arterial    Hypertension)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Hypertension, Pulmonary","Case-Control","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 2 molecular datasets,  SRA, 96 subjects, 94 samples","","NHLBI","GRU --- General research use","2011-09-06","2011-12-06","Diffuse Scleroderma; Diffuse Sclerosis; SS - Systemic sclerosis; Scleroderma syndrome; Scleroderma, Diffuse; Scleroderma, Systemic"
"phs000291.v2.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of    Chronic Obstructive Pulmonary Disease)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Pulmonary Disease, Chronic Obstructive","Prospective Longitudinal Cohort","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 44 variables, 2 molecular datasets,  SRA, 337 subjects, 337 samples","","NHLBI","GRU --- General research use","2012-05-21","2012-08-21","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease"
"phs000292.v1.p1","GENEVA Genetics of Early Onset Stroke (GEOS) Study","The Genetics of Early Onset Stroke (GEOS) Study is a population-based case-control study designed to identify genes associated with early-onset ischemic stroke and to characterize interactions of identified stroke  genes and/or SNPs with environmental risk factors such as smoking and oral contraceptive use. The GEOS study consists of 921 ischemic stroke cases","Stroke","Case-Control","HumanOmni1-Quad_v1-0_B, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 33 variables, 4 documents, 3 molecular datasets, 1862 subjects, 1949 samples","European (990), African (34), East Asian (9), African American (723), Hispanic1 (10), Hispanic2 (13), Other Asian or Pacific Islander (6), South Asian (16), Other (16)","NHGRI","STROKE --- Genetic studies of stroke , MEDCOND --- Studies of genes for medical conditions","2010-08-06","2011-08-06","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA (Cerebrovascular Accident)"
"phs000293.v1.p1","The Familial Intracranial Aneurysm Linkage Study (FIA)","Our long-term objective is to identify susceptibility genes that are related to the formation of intracranial aneurysms (IA). Rupture of IAs occurs in 16,000 to 17,000 persons in the  U.S. annually and nearly half of affected persons are dead within the first 30 days. An additional 6,000 to 7,000 persons with unruptured IAs are","Intracranial Aneurysm","Family/Twin/Trios","HumanLinkage-12","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 28 variables, 16 documents, 1 molecular datasets, 2507 subjects, 2073 samples","","NINDS","GRU --- General research use","2013-07-26","2014-07-26","Aneurysm, Middle Cerebral Artery; Middle Cerebral Artery Aneurysm"
"phs000294.v1.p1","STAMPEED: Myocardial Infarction Genetics Consortium (MIGen)","Myocardial infarction (MI) is a common complex disease and the leading cause of death and disability worldwide. The genetic basis of this disease is largely unknown. It has been  thought that early-onset MI events would have a substantially greater heritability, thus making DNA collections with younger individuals desirable","Myocardial Infarction","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 1 molecular datasets, 6042 subjects, 6042 samples","European (5943), African (3), African American (35), Hispanic1 (9), Hispanic2 (20), Other Asian or Pacific Islander (3), South Asian (9), Other (20)","NHLBI","GRU --- General research use","2010-08-24","2010-08-24","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000295.v2.p1","Next Generation Mendelian Genetics: Kabuki Syndrome","The ultimate purpose of this research is to identify genes causing hereditary disorders. We are scaling a new approach to identify the candidate genes and gene mutations that underlie  rare human Mendelian (a set of primary tenets relating to the transmission of hereditary characteristics from parent to child) diseases by using","Kabuki syndrome","Mendelian","Not Provided","Not Applicable","WGS","4 phenotype datasets, 28 variables,  SRA, 10 subjects, 10 samples","","NHGRI","GRU --- General research use","2017-12-22","2017-12-22","KABUK1; KABUKI MAKE-UP SYNDROME; KABUKI SYNDROME; KMS; Kabuki Makeup Syndrome; Kabuki make up syndrome"
"phs000297.v1.p1","eMERGE Network Study of Resistant Hypertension","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of five participating sites (Group Health Seattle, Marshfield Clinic, Mayo Clinic, Northwestern University, and Vanderbilt University) funded by  the NHGRI to investigate the use of electronic medical record systems for genomic research. The goal of eMERGE is to conduct genome-wide association","Hypertension","Case-Control","Human1M-Duov3_B, Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 1 molecular datasets, 5281 subjects, 5491 samples","European (4097), African (26), East Asian (19), African American (1057), Hispanic1 (25), Hispanic2 (24), Other Asian or Pacific Islander (9), South Asian (8), Other (7)","NHGRI","HR_GHS --- Health research - group health seattle , AGING_GHS --- Dementia or aging - group health seattle , HR_MC --- Health research - marshfield clinic , HR_VU --- Health research - vanderbilt u , HR_MYO --- Health research - mayo clinic , HR_NWU --- Health research - northwestern u","2012-09-26","2013-09-26","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs000298.v4.p3","Autism Sequencing Consortium (ASC)","The ARRA Autism Sequencing Collaboration was created in 2010 bringing together expert large-scale sequencing center (at the Baylor College of Medicine, PI Richard Gibbs and the Board Institute of  MIT and Harvard, PI Mark J. Daly) and a collaborative network of research labs focused on the genetics of autism (brought together by the Autism","Autistic Disorder","Case-Control","WES_markerset_grc36, WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 29 variables, 2 molecular datasets,  SRA, 12772 subjects, 12772 samples","","NIMH","DS-ASD --- Disease-specific (autism spectrum disorder) , GRU --- General research use , DS-AOND-MDS --- Disease-specific (autism or other neurodevelopment conditions, mds) , HMB-MDS --- Health/medical/biomedical (mds)","2018-07-12","2018-07-12",""
"phs000299.v2.p1","Genentech Lung Cancer Sequencing","Version 1 Whole genome sequencing was applied to tumor and adjacent normal lung tissue in an individual non-small-cell lung cancer patient. We present an analysis of somatic changes identified  throughout the tumor genome, including single-nucleotide variants, copy number variants, and large-scale chromosomal rearrangements. Over 50,000 high","Lung Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq, WGS","5 phenotype datasets, 24 variables,  SRA, 21 subjects, 25 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2014-02-28","2010-08-18","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell"
"phs000302.v1.p1","Genetic Study on Nephropathy in Type-2 Diabetes","A collection of patients with type-2 diabetes was collected at the Joslin Diabetes Center. Patients were categorized to a group of cases with diabetic nephropathy, and a group of  controls with normoalbuminuria. From these groups, 173 cases and 177 controls were randomly selected for a genome-wide association study.","Diabetic Nephropathies","Case-Control","HumanCNV370-Duo_v1","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 15 variables, 3 documents, 1 molecular datasets, 350 subjects, 350 samples","European (326), African (1), East Asian (2), African American (11), Hispanic1 (6), Hispanic2 (3), South Asian (1)","NIDDK","DIABCOMP --- Diabetes and complications","2011-08-19","2012-08-19","Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic nephropathy; Diabetic renal disease; Disorder of kidney co-occurrent and due to diabetes mellitus; Kidney Disease, Diabetic"
"phs000303.v1.p1","Genetic Epidemiology of Refractive Error in the KORA Study","KORA (""Kooperative Gesundheitsforschung in der Region Augsburg"" which translates as ""Cooperative Health Research in the Region of Augsburg"") is a population based study of adults randomly selected from 430,000  inhabitants living in Augsburg and 16 surrounding counties in Germany. The collection was done in 4 separate groups from 1984-2001 (S1-S4). One of","Population Control","Prospective Longitudinal Cohort","HumanOmni2.5-4v1_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 24 variables, 4 documents, 1 molecular datasets, 1980 subjects, 1956 samples","European (1868), Other (1)","NEI","GRU --- General research use","2011-10-28","2012-07-28","Abnormal curving of the cornea or lens of the eye; Astigmatism; Farsightedness; Hypermetropia; Hypermetropia (farsightedness); Hyperopia"
"phs000304.v3.p1","Genes and Blood Clotting Study (GABC)","Objectives: Use genome-wide approaches to identify genetic variants that influence common thrombosis and hemostasis factors, as well as selected common human traits. Design/Methods: The GABC study was a prospective  sibling cohort design. Siblings were recruited by targeted email to the undergraduate and graduate student email lists at the University of Michigan","von Willebrand Disease","Family/Twin/Trios","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 105 variables, 1 documents, 2 molecular datasets, 1179 subjects, 1218 samples","European (953), African (5), East Asian (78), African American (34), Hispanic1 (8), Hispanic2 (27), Other Asian or Pacific Islander (18), South Asian (35), Other (8)","NHLBI","HMB-NPU --- Health/medical/biomedical (npu)","2018-05-11","2016-05-28","Caries; Caries, Dental; Cariosity of teeth; Carious lesion; Decay, Dental; Dental Caries"
"phs000305.v1.p1","PGRN-RIKEN NSABP Prevention Study","The primary aim of this study is to identify genes related to the occurrence of breast events, defined as occurrence of invasive breast cancer or ductal carcinoma in situ  (DCIS), in women at high risk of developing breast cancer who have received a Selective Estrogen Receptor Modulator (SERM - tamoxifen or raloxifene","Breast Neoplasms","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 55 variables, 2 documents, 1 molecular datasets, 1763 subjects, 1763 samples","European (1756), Hispanic2 (4), Other Asian or Pacific Islander (1), Other (2)","NIGMS","APTC --- For use in the future research to learn about, prevent or treat cancer","2010-11-16","2011-11-16","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000306.v4.p1","A Multiethnic GWAS of Prostate Cancer","Multiple GWA studies of prostate cancer conducted in European White populations are ongoing. These studies will continue to have a dramatic impact on our understanding of the contribution of  common genetic variation on inter-individual susceptibility to this common cancer. Important questions that will remain unanswered, however, are","Prostatic Neoplasms","Case-Control","Human660W-Quad_v1_A, Human1M-Duov3_B, HapMap_Phase3, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","7 phenotype datasets, 67 variables, 2 documents, 6 molecular datasets,  SRA, 9457 subjects, 11325 samples","European (115), African (185), East Asian (2157), African American (4425), Hispanic1 (112), Hispanic2 (1997), Other Asian or Pacific Islander (56), South Asian (1), Other (81)","NCI","DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds) , GRU-MDS --- General research use (mds) , DS-PC --- Disease-specific (prostate cancer) , CHDSADM --- Cancer, heart disease, stroke, alzheimer disease, and diabetes research and methods , HMB-PUB-MDS --- Health/medical/biomedical (pub, mds)","2014-04-17","2013-02-01","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000308.v1.p1","The Glaucoma Genes and Environment (GLAUGEN) Study","Background Information: Primary open-angle glaucoma (POAG) is an age-related, intraocular pressure (IOP)-dependent progressive optic neuropathy that ultimately leads to irreversible blindness. Vision loss from POAG is a condition of  public health significance. Current evidence suggests that POAG is a polygenetic disease modified by environmental influences. Despite the fact that","Glaucoma, Open-Angle","Case-Control","Human660W-Quad_v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 59 variables, 21 documents, 2 molecular datasets, 2289 subjects, 2243 samples","European (2148), African (1), African American (2), Hispanic1 (18), Hispanic2 (12), Other Asian or Pacific Islander (2), Other (2)","NEI","MEEI --- Massachusetts eye and ear infirmary , GRU --- General research use","2010-12-21","2011-12-21","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle"
"phs000310.v1.p1","Discovery of Non-ETS Gene Fusions using RNA Sequencing","Half of prostate cancers harbor gene fusions between TMPRSS2 and members of the ETS transcription factor family. To date little is known about the presence of non-ETS fusion events  in prostate cancer. We employed next-generation transcriptome sequencing (RNA-Seq) in order to explore the whole transcriptome of 25 human prostate","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 30 variables,  SRA, 28 subjects, 28 samples","","NHGRI","PPC --- For general medical research, for non-profit only","2011-05-02","2011-05-02","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000311.v1.p1","FusionSeq: Finding Fusions with Paired-End RNA-Seq","We have developed FusionSeq to identify fusion transcripts from paired-end RNA-sequencing. FusionSeq includes filters to remove spurious candidate fusions with artifacts such as misalignments or random pairing of transcript  fragments and it ranks candidates according to several statistics. It also has a module to identify exact sequences at breakpoint junctions","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 27 variables,  SRA, 8 subjects, 8 samples","","NHGRI","PPC --- For general medical research, for non-profit only","2011-05-03","2011-05-03","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000313.v4.p2","SardiNIA Medical Sequencing Discovery Project","The SardiNIA Medical Sequencing Discovery Project studies the genetics of blood lipid levels and personality in a Sardinian population cohort. The project has generated draft genome sequences for approximately  2,000 individuals using whole genome shotgun sequencing. The draft sequences will allow investigators to evaluate the contribution of common and rare","Cardiovascular Diseases","Family/Twin/Trios","Not Provided","Not Applicable","WGS","5 phenotype datasets, 24 variables,  SRA, 2105 subjects, 2077 samples","","NIA","GRU-IRB --- General research use (irb)","2017-12-05","2011-10-20","Behavior and Behavior Mechanisms"
"phs000314.v1.p1","Genetic Associations in Idiopathic Talipes Equinovarus (GAIT)","Isolated clubfoot or idiopathic talipes equinovarus (ITEV) is one of the five most common birth defects, affecting approximately 4,000 newborns each year in the US. While the orthopedic care  of these children has improved, long-term problems persist and the health care costs are significant. Studies suggest that clubfoot is a complex","Clubfoot","Family/Twin/Trios","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 50 variables, 2 documents, 1 molecular datasets, 1903 subjects, 1832 samples","European (885), East Asian (1), African American (1), Hispanic1 (4), Hispanic2 (802), Other Asian or Pacific Islander (2), Other (21)","NICHD","GRU --- General research use","2012-07-17","2013-07-17","CCF; CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; Club feet; Club foot; Clubbed Foot; Clubfeet"
"phs000327.v1.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (SWISS)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Stroke","Family/Twin/Trios","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 44 variables, 2 molecular datasets,  SRA, 94 subjects, 94 samples","","NHLBI","DS-STK-IRB-RD --- Disease specific (stroke and related disorders)","2013-03-25","2013-06-25","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA (Cerebrovascular Accident)"
"phs000328.v2.p1","Genome-wide Analysis of Lymphoma","Version 1. Diffuse Large B-cell Lymphoma (DLBCL) represents the most common form of B-cell non-Hodgkin Lymphoma (B-NHL), accounting for 30% of the de novo diagnoses and also arising as  a frequent clinical evolution of Follicular Lymphoma (FL). The molecular pathogenesis of DLBCL is associated with multiple genetic lesions that in","Lymphoma, Large B-Cell, Diffuse","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WXS","3 phenotype datasets, 10 variables, 2 molecular datasets,  SRA, 119 subjects, 146 samples","European (35), Hispanic1 (3), Other (1)","NCI","DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds)","2013-12-30","2013-12-30","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma"
"phs000329.v1.p1","Evolution of Human BCR-ABL1 Lymphoblastic Leukemia-Initiating Cells","Many tumour types are composed of genetically diverse cells, however little is known of how diversity evolves or the impact diversity has on functional properties. Here, using xenografting and  DNA copy number alteration (CNA) profiling of human BCR-ABL1 lymphoblastic leukaemia, we demonstrate that genetic diversity occurs in functionally","Acute Lymphoblastic Leukemia","Xenograft","Not Provided","Not Applicable","Not Provided","","","NCI","","","","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000330.v1.p1","The Genomic Complexity of Primary Human Prostate Cancer","Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic  alterations that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WGS","4 phenotype datasets, 34 variables, 1 documents,  SRA, 7 subjects, 14 samples","","NHGRI","HMB-NPU --- Health/medical/biomedical (npu)","2011-02-10","2011-02-10","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000331.v1.p1","PGRN-RIKEN: Genome-Wide Association Study of Drug-Induced Long-QT    Syndrome","The goal of this study was to identify genetic risk factors for drug-induced prolongation of the QT interval (diLQT) and the ventricular arrhythmia torsades de pointes (TdP). We conducted  a genome-wide association study (GWAS) focusing on subjects with a history of long QT and/or TdP after taking medication. Controls for this study","Long QT Syndrome","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 831 subjects, 831 samples","European (687), East Asian (14), African American (102), Hispanic1 (5), Hispanic2 (4), Other Asian or Pacific Islander (2), South Asian (6), Other (3)","NHLBI","GRU --- Health/medical/biomedical (gso)","2012-03-30","2013-03-30","Not Provided"
"phs000332.v3.p2","GWAS of Preterm Birth","Preterm birth (PTB, born before 37 weeks of gestation) is a leading cause of neonatal mortality and post-natal morbidity. PTB affects one in nine all live births in the  U.S. Notably, the highest rate of PTB occurs among African Americans (one in six). PTB is a complex trait, likely determined by multiple","Infant, Premature","Case-Control","1000G_ref_panel, HumanOmni25-8v1, HumanOmni2.5-4v1_D","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 47 variables, 2 molecular datasets, 1779 subjects, 1917 samples","European (2), African (297), African American (1467), Hispanic1 (6), Hispanic2 (4), Other Asian or Pacific Islander (1), Other (14)","NICHD","DS-PTB-RD --- Disease-specific (preterm birth, rd)","2016-02-02","2016-07-28","Age, Fetal; Age, Gestational; Ages, Fetal; Ages, Gestational; Chronologic Fetal Maturity; Fetal Age"
"phs000333.v1.p1","Family Investigation of Nephropathy and Diabetes (FIND) Study","The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic kidney disease. Study subjects were recruited from eleven centers and  in many ethnic groups throughout the United States. A genome-wide association study (GWAS) was conducted with the Affymetrix 6.0 chip. Subjects","Diabetes Mellitus","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 56 variables, 6 documents, 1 molecular datasets, 2622 subjects, 2622 samples","European (753), African (43), African American (818), Hispanic1 (13), Hispanic2 (979), Other Asian or Pacific Islander (1), Other (15)","NIDDK","DNAR --- Diabetes, kidney disease, retinopathy and/or related diseases","2011-10-25","2011-10-25","Diabetic Kidney Disease; Diabetic Kidney Diseases; Diabetic Nephropathies; Diabetic nephropathy; Diabetic renal disease; Disorder of kidney co-occurrent and due to diabetes mellitus"
"phs000335.v3.p2","Genome-Wide associations of Lung Health Study (LHS)","The 'Genome-Wide Associations Environmental Interactions in the Lung Health Study' at Johns Hopkins University aims to test for association between lung function decline as a primary outcome associated with  chronic obstructive pulmonary disease (COPD) using banked DNA and phenotype data on 4,287 European Americans from the longitudinal, multicenter Lung","COPD","Prospective Longitudinal Cohort","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 357 variables, 26 documents, 2 molecular datasets, 4391 subjects, 4361 samples","European (4113), African American (5), Hispanic1 (4), Hispanic2 (19), Other Asian or Pacific Islander (1), South Asian (1), Other (2)","NHLBI","DS-HLB --- Disease-specific (heart, lung, and blood diseases)","2015-06-24","2016-06-24","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease"
"phs000336.v1.p1","DCEG Lung Cancer Study","Three genetic loci for lung cancer risk have been identified by genome-wide association studies (GWAS), but inherited susceptibility to specific histologic types of lung cancer is not well established.  We conducted a GWAS of lung cancer and its major histologic types genotyping 515,922 single nucleotide polymorphisms (SNPs) in 5,739 incident lung","Lung Neoplasms","Prospective Longitudinal Cohort","Human1M-Duov3_B, Human610-Quadv1_B, HumanHap240S_A, HumanHap300v1-1_C, HumanHap550-2v3_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 documents, 1 molecular datasets, 11517 subjects, 13073 samples","European (11511), Hispanic1 (3), Hispanic2 (1), Other (2)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods , SLD --- Research related to lung disease or smoking","2011-05-27","2011-05-27","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000337.v1.p1","Genetic Basis of Developmental Disabilities","Developmental disabilities are birth defects that cause lifelong problems with how a body part or system works. Developmental disabilities include nervous system insults affecting how the brain, spinal cord  and nervous system function; they cause intellectual disability, including Down syndrome and fragile X syndrome; and they also cause learning and","Intellectual Disability","Family/Twin/Trios","HumanExome-12v1-2_A, HumanOmni1-Quad_v1-0_H, Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WGS, WXS","5 phenotype datasets, 37 variables, 1 molecular datasets,  SRA, 94 subjects, 184 samples","European (9), Hispanic1 (1)","NICHD","GRU-GSO --- General research use (gso) , DS-DD-GSO-RD --- Disease-specific (developmental disabilities, gso, rd)","2016-07-29","2017-07-29","Child Development Disorders, Pervasive; Pervasive Child Development Disorders; Idiocy; Mental retardation (profound); Profound intellectual development disorder; Profound mental handicap"
"phs000338.v1.p1","National Institute on Aging (NIA) SardiNIA Study","Sardinia is the second largest island in the Mediterranean and constitutes a genetically isolated founder population. This population has aided in the identification of genes involved in several Mendelian  disorders and is attractive for genetic studies due to its organization in long-established settlements that developed from an initial group of","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","98 analyses","","NIA","GRU --- General research use","2011-04-26","","Acceptance Process; Acceptance Processes; Process, Acceptance; Processes, Acceptance; Circulating Lipoproteins; Lipoprotein"
"phs000339.v2.p1","MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH)","Human disorders of mitochondrial oxidative phosphorylation (OXPHOS) represent a devastating collection of inherited diseases. These disorders impact at least 1:5000 live births, and are characterized by multi-organ system involvement.  They are characterized by remarkable locus heterogeneity, with mutations in the mtDNA as well as in over 77 nuclear genes identified to date. It is","Mitochondrial Diseases","Case-Control","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 134 subjects, 134 samples","","NHGRI","GRU --- General research use","2013-03-28","2012-08-31","Disease, Mitochondrial; Disorder, Mitochondrial; Disorders, Mitochondrial; Mitochondrial Disease; Mitochondrial Disorder; Mitochondrial Disorders"
"phs000340.v3.p1","Sequencing of ETP T-ALL","CREST The accurate identification of structural variations using whole-genome DNA sequencing data generated by next-generation sequencing technology is extremely difficult. To address this challenge, we have developed CREST, an  algorithm that uses sequencing reads with partial alignments to the reference human genome (so-called soft-clipped reads) to directly map the","Leukemia, T-cell","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS, WXS","5 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 106 subjects, 196 samples","European (68), African American (11), Hispanic1 (2), Hispanic2 (8), Other Asian or Pacific Islander (2)","NCI","GRU-MDS --- General research use (mds)","2014-04-16","2012-01-12","Leukemia, Lymphocytic, T Cell; Leukemia, Lymphocytic, T-Cell; Leukemia, T Cell; Leukemia, T Lymphocytic; Leukemia, T-Cell Lymphocytic; Leukemia, T-Lymphocytic"
"phs000341.v2.p1","The Genetic Basis of Hypodiploid ALL","The genetic basis of hypodiploid acute lymphoblastic leukemia (ALL), a subtype of ALL characterized by aneuploidy and poor outcome, is unknown. Genomic profiling of 124 hypodiploid ALL cases, including  whole-genome and exome sequencing of 40 cases, identified two subtypes that differ in the severity of aneuploidy, transcriptional profiles and","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0, Mapping250K_Nsp","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS, WXS","5 phenotype datasets, 33 variables, 2 molecular datasets,  SRA, 241 subjects, 379 samples","European (78), African American (15), Hispanic1 (4), Hispanic2 (16), Other Asian or Pacific Islander (4), South Asian (1), Other (7)","NCI","GRU --- General research use","2013-06-11","2013-06-11","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000343.v3.p1","The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention    Stroke Prevention (VISP) trial","The VISP trial (PI Jim Toole, M.D., Wake Forest University School of Medicine) was a multi-center, double-blind, randomized, controlled clinical trial that enrolled patients aged 35 or older with  Hcy levels above the 25th percentile at screening and a non-disabling cerebral infarction (NDCI) within 120 days of randomization [Toole, 2002]. The","Stroke","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","39 phenotype datasets, 1918 variables, 50 documents, 2 molecular datasets, 2164 subjects, 2177 samples","European (1720), African (16), East Asian (18), African American (246), Hispanic1 (12), Hispanic2 (54), Other Asian or Pacific Islander (7), South Asian (16), Other (11)","NHGRI","SR --- Stroke research","2013-06-11","2014-06-11","CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary"
"phs000344.v1.p1","Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland","The genetic etiology of amyotrophic lateral sclerosis (ALS) is not well understood. Finland has one of the highest incidence of ALS in the world, making it an ideal population  for study. To identify genetic risk factors for this fatal neurodegenerative disease, we undertook a genome-wide association study of 405 Finnish","Amyotrophic Lateral Sclerosis","Case-Control","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 18 variables, 1 molecular datasets, 896 subjects, 896 samples","European (895), Other (1)","NINDS","GRU --- General research use","2011-06-30","2011-06-30","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs000345.v1.p1","NIDDK IBD Genetics Consortium Ulcerative Colitis Genome-Wide Association    Study","This dataset contains data for 1,028 white, non-Hispanic, European ancestry individuals with ulcerative colitis who were included in a genome-wide association study published by Silverberg et al. (2009). These  individuals were ascertained in North America and selected to have either left-sided or extensive disease (i.e., individuals with proctitis only were","Colitis, Ulcerative","Case-Control","HumanHap550_v3, HumanHap300_v2","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 67 variables, 2 documents, 1 molecular datasets, 1028 subjects, 1028 samples","European (1021), African (1), Hispanic1 (1), Hispanic2 (2), South Asian (1), Other (2)","NIDDK","GRU --- General research use , IBDO --- Inflammatory bowel disease only","2012-05-02","2012-05-02","Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis; ULCERATIVE COLITIS"
"phs000346.v2.p2","Cancer Genetic Markers of Susceptibility for Bladder Cancer (CGEMS    Bladder)","This study funded by the National Cancer Institute (NCI) involves conducting a genome-wide association study of common genetic variants to identify markers of susceptibility to bladder cancer. This bladder  GWAS has led to the discovery of three novel regions in the genome associated with bladder cancer risk. Cases were defined as individuals having","Urinary Bladder Neoplasms","Case-Control","HumanHap240S_A, HumanHap300v1-1_C, HumanHap550_v3, Human610-Quadv1_B, Human1M-Duov3_B, Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 documents, 2 molecular datasets, 11424 subjects, 13060 samples","European (11410), Hispanic1 (6), Hispanic2 (4), Other (5)","NCI","CADM --- Cancer in all age groups, adult diseases, and methods","2015-06-12","2015-06-12","Carcinoma, no subtype; Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant"
"phs000347.v1.p1","NHLBI GO-ESP: Family Studies (Aortic Disease)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Aortic Diseases","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 29 subjects, 29 samples","","NHLBI","GRU-IRB --- General research use (irb)","2013-07-10","2013-10-10",""
"phs000348.v2.p1","Towards a Genomic Understanding of Myeloma","This project was designed to describe genetic abnormalities in primary samples from patients with multiple myeloma by next generation sequencing. We generated sequence data from multiple myeloma (MM) patients  analyzing DNA both from tumor cells (purified from bone marrow using CD138 selection as a marker of plasma cells) and from normal peripheral blood","Multiple Myeloma","Tumor vs. Matched-Normal","WGS_markerset_grc37, maf_grc36","Not Applicable","SNV Aggregate (.MAF), WGS, WXS","4 phenotype datasets, 32 variables, 2 molecular datasets,  SRA, 204 subjects, 409 samples","","NCI","GRU-MDS --- General research use (mds) , DS-CCRD-MDS --- Disease-specific (cancer and cancer-related disorders, mds)","2014-12-22","2014-12-22","Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease; Kahler's disease"
"phs000349.v1.p1","SNPs and Extent of Atherosclerosis (SEA) Study","The SEA study is a genome-wide association study to identify genetic variants associated with premature atherosclerosis in subjects included in the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) repository  - a unique NHLBI resource including data, DNA and arterial specimens from over 3000 multi-ethnic subjects 15-34 years of age who died of non","Atherosclerosis","Case-Control","Perlegen_2.4M","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 21 variables, 1 documents, 1 molecular datasets, 1068 subjects, 1068 samples","","NHLBI","GRU --- NULL","2011-05-05","2011-05-05","Atherogenesis"
"phs000350.v1.p1","FHCRC - Whole-Exome Sequencing of Hereditary Prostate Cancer Families","The specific aim of this study is to identify hereditary prostate cancer (HPC) susceptibility genes using a novel study design, whereby whole-exome sequencing will be undertaken on multiple affected  relatives from 19 HPC families, in which 3 affected relatives were diagnosed with clinically aggressive and/or early onset prostate cancer (PC","Prostatic Neoplasms","Family/Twin/Trios","Not Provided","Not Applicable","WXS","5 phenotype datasets, 26 variables, 1 documents,  SRA, 94 subjects, 96 samples","","NCI","GRU-MDS --- General research use (mds)","2014-04-01","2014-04-01","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000351.v1.p1","NCI Genome-Wide Association Study of Renal Cell Carcinoma","The National Cancer Institute (NCI) genome-wide association study (GWAS) of renal cell carcinoma (RCC) was conducted to investigate common genetic variants associated with RCC risk. The GWAS includes 1,453  RCC cases and 3,531 controls of European background from 4 studies (3 cohort, 1 case-control), scanned using the Illumina InfiniumHumanHap 550, 610","Carcinoma, Renal Cell","Case-Control","HumanHap550_v3, Human610-Quadv1_B, Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 9 variables, 1 documents, 1 molecular datasets, 4735 subjects, 4909 samples","European (4729), Hispanic1 (1), Hispanic2 (2), Other (3)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods","2011-05-17","2011-05-17","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs000352.v1.p1","Sequencing of Retinoblastoma","Retinoblastoma is a pediatric cancer of the developing retina. All retinoblastomas are believed to initiate with biallelic inactivation of the RB1 gene. To identify subsequent genetic lesions in retinoblastoma,  we performed whole genome sequencing of tumor and normal DNA of 4 children with retinoblastoma and one matched orthotopic xenograft. Both alleles of","Retinoblastoma","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS","5 phenotype datasets, 34 variables, 1 molecular datasets,  SRA, 46 subjects, 93 samples","European (22), African American (13), Hispanic1 (1), Hispanic2 (7), South Asian (1), Other (1)","NCI","GRU --- General research use","2012-01-19","2012-01-19","Cancer, Retinoblastoma Eye; Cancers, Retinoblastoma Eye; Eye Cancer, Retinoblastoma; Eye Cancers, Retinoblastoma; Glioblastoma, Retinal; Glioblastomas, Retinal"
"phs000353.v1.p1","GENEVA Study of Preterm Delivery (African-American)","Preterm delivery resulting in the birth of a premature infant is a complex problem with a devastating impact on individuals, families and society. The prevalence of preterm birth has  increased steadily in developed countries over the last 20 years and more than three million children die of preterm birth worldwide each year","Premature Birth","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","10 phenotype datasets, 290 variables, 52 documents, 2 molecular datasets, 3478 subjects, 2203 samples","European (200), African (25), East Asian (2), African American (1676), Hispanic1 (38), Hispanic2 (160), Other Asian or Pacific Islander (6), South Asian (7), Other (27)","NHGRI","PTB --- Preterm birth and its complications","2011-08-16","2012-08-16","Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births; Premature birth"
"phs000354.v1.p1","NHLBI GO-ESP Family Studies: Pulmonary Arterial Hypertension","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Hypertension, Pulmonary","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NHLBI","GRU --- General research use","2013-09-27","2013-12-27","Not Provided"
"phs000355.v1.p1","Genome Wide Association for Asthma and Lung Function","The SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic (STAMPEED) asthma project includes subjects with asthma and controls from the Chicago Asthma Genetics Study (CAG), NHLBI multicenter  Severe Asthma Research Program (SARP) and NHLBI Collaborative Studies on the Genetics of Asthma CSGA (Wake Forest). All studies included European","Asthma","Case-Control","Not Provided","Not Applicable","Not Provided","2 analyses","","NHLBI","GRU --- General research use","2011-10-28","","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000356.v2.p1","Population Architecture using Genomics and Epidemiology (PAGE)","PAGE II (2013-2019) seeks to expand understanding gained during PAGE I and similar studies of how ancestry-specific differences in allele frequencies and LD may explain differences in risks of  common traits and conditions. Recent studies have identified rare genetic variants that are likely to contribute to common diseases and traits and","Population Genetics","Cross-Sectional","Not Provided","Not Applicable","Not Provided","20 analyses","","NHGRI","GRU --- General research use","2017-05-31","2017-05-31","Electrocardiography; AI - Alcohol intake; Alcohol Consumption; Alcohol Drinking; Alcoholic drink intake; Consumption, Alcohol"
"phs000357.v2.p1","Genome-Wide Association Study in Systemic Sclerosis","The Scleroderma Family Registry and DNA Repository (Registry) was initially developed as a registry and bio-specimen repository of patients with systemic sclerosis (scleroderma), family members and unaffected healthy controls.  A case-control design was later adopted due to the lack of availability of many parents in this adult-onset disease, which precluded a linkage","Systemic Sclerosis","Case-Control","Human610-Quadv1_B, Immuno_BeadChip_1_0","Not Applicable","SNP Genotypes (Array)","7 phenotype datasets, 102 variables, 2 molecular datasets, 833 subjects, 833 samples","","NIAMS","DS-SSCAA --- Disease-specific (systemic sclerosis (scleroderma) and other autoimmune diseases)","2018-09-28","2018-09-28","Diffuse Scleroderma; Diffuse Sclerosis; SS - Systemic sclerosis; Scleroderma syndrome; Scleroderma, Diffuse; Scleroderma, Systemic"
"phs000358.v1.p1","PGC: the PUWMa GWAS of ADHD","The PUWMa GWAS of ADHD is a multi-site collaboration initiated to conduct a family-based association study from existing research samples. The source sample of ADHD families was ascertained at  Massachusetts General Hospital (MGH, N 309 trios), Washington University at St. Louis (WASH-U, N 272 trios), and University of California at Los","Attention Deficit Hyperactivity Disorder","Family/Twin/Trios","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 38 variables, 1 documents, 1 molecular datasets, 1383 subjects, 1383 samples","European (1284), African (3), East Asian (5), African American (23), Hispanic1 (13), Hispanic2 (47), Other Asian or Pacific Islander (2), Other (6)","NIMH","ADHD_RD --- Adhd and related disorders","2011-09-15","2011-12-15","ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorder with Hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorders"
"phs000359.v1.p1","KIF1A Hereditary Spastic Paraparesis","The study involves a single consanguineous Palestinian family with Hereditary Spastic Paraparesis (HSP). The affected individuals suffer from spasticity of the lower limbs and abnormal gait. Using exome sequencing  and homozygosity mapping, our analysis implicated the causative mutation in the motor domain of KIF1A, a gene that functions in anterograde axonal","Hereditary Spastic Paraplegias","Case-Control","Mapping250K_Nsp","Not Applicable","SNP Genotypes (Array), CLONEEND, WXS","3 phenotype datasets, 8 variables, 1 molecular datasets,  SRA, 4 subjects, 5 samples","Hispanic1 (2)","NINDS","MDNS --- Diseases of muscle and the nervous system","2012-08-31","2012-10-01","Familial spastic paraparesis; Familial spastic paraplegia; Familial spastic paraplegia syndrome; HSP; HSP - Hereditary spastic paraplegia; Hereditary Spastic Paraplegia"
"phs000360.v3.p1","eMERGE Network Combined Dataset","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of five participating sites (Group Health Seattle, Marshfield Clinic, Mayo Clinic, Northwestern University, and Vanderbilt University) funded by  the NHGRI to investigate the use of electronic medical record systems for genomic research. The goal of eMERGE is to conduct genome-wide association","Electronic Health Records","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","6 phenotype datasets, 94 variables, 9 documents, 4 analyses, 1 molecular datasets, 18663 subjects, 18663 samples","European (15595), African (65), East Asian (86), African American (2702), Hispanic1 (60), Hispanic2 (79), Other Asian or Pacific Islander (35), South Asian (14), Other (27)","NHGRI","HMB --- Health/medical/biomedical , DS-DEM --- Disease-specific (dementia) , HM-B-GSO-NIC --- Health/medical/biomedical (gso) , HMB-GSO --- Health/medical/biomedical (gso)","2016-08-11","2017-08-11","Anthropometry; Chronic Disease; Chronic Diseases; Chronic Illness; Chronic Illnesses; Chronic disorder"
"phs000361.v1.p1","Genome-Wide Association Studies in Upper Gastrointestinal Cancers (Asian)","This project aims to conduct genome-wide association studies (GWAS) in two anatomically different upper gastrointestinal (UGI) cancer sites in two populations with distinctly different disease rates and genetic profiles.  One population has very high rates for both esophageal squamous cell carcinomas (ESCCs) and gastric cancers (GCs) and is comprised of Asians (the","Intestinal Neoplasms","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 1 documents, 2 analyses, 1 molecular datasets, 5623 subjects, 5754 samples","East Asian (5459), Other Asian or Pacific Islander (164)","NCI","CODA --- Cancer and other important diseases in adults , EGA --- Esophageal and gastric cancer in adults","2011-06-21","2011-06-21","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophagus Neoplasm; Esophagus Neoplasms; Esophagus Tumor"
"phs000362.v1.p1","NHLBI GO-ESP: Family Studies: (Familial Atrial Fibrillation)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Atrial Fibrillation","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NHLBI","HMB --- Health/medical/biomedical","2013-08-28","2013-11-28","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs000364.v2.p1","Genome-Wide Analysis of Chronic Lymphocytic Leukemia","Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation The pathogenesis of chronic lymphocytic leukemia (CLL), the most common leukemia in adults, is still largely  unknown since the full spectrum of genetic lesions that are present in the CLL genome, and therefore the number and identity of dysregulated cellular","Chronic Lymphocytic Leukemia","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WXS","4 phenotype datasets, 13 variables, 2 molecular datasets,  SRA, 43 subjects, 61 samples","European (31)","NCI","DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds)","2013-11-15","2013-11-15","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000365.v1.p1","Genetic Basis of XMEN Disease","The etiologies of primary immunodeficiencies often yield novel insights about the immune system. Although a genetic etiology has been suspected for patients with abnormally low CD4+ T cells in  the absence of HIV infection or any known causes of lymphopenia, no genetic mutation has been described to date for any case of primary CD4","Immune System Diseases","Case-Control","Not Provided","Not Applicable","WXS","5 phenotype datasets, 27 variables,  SRA, 3 subjects, 6 samples","","NIAID","DIS --- Diseases of the immune system","2011-08-16","2012-05-16","Disease, Immune; Disease, Immune System; Disease, Immunologic; Disease, Immunological; Diseases of Immune System; Diseases, Immune"
"phs000366.v1.p1","NHLBI: Cooperative Study of Sickle Cell Disease (CSSCD)","Phenotypic heterogeneity is characteristic of sickle cell anemia, a Mendelian disorder caused by homozygosity for the sickle HBB gene (glu6val). Patients have different rates of hemolysis/vasculopathy and viscosity/vasoocclusion-related complications.  These complications account for a substantial reduction in life expectancy. In 1994, the median life expectancy for men and women with sickle cell","Sickle Cell Anemia","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","GRU --- General research use","2011-08-02","","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S"
"phs000367.v1.p1","Genome Wide Association Study in Familial Crohn's Disease","The National Institute of Diabetes and Digestive and Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK - IBDGC) conducted a genome wide association study (GWAS) using the Human Omni2.5-Quad  beadchip from Illumina to identify disease variants associated with familial Crohn's disease. This study includes a subset of individuals from an","Crohn Disease","Family/Twin/Trios","HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 molecular datasets, 704 subjects, 730 samples","European (684), African American (8), Hispanic1 (4), South Asian (1), Other (2)","NIDDK","DS-IBD-IRB --- Disease-specific (inflammatory bowel disease, irb)","2013-08-12","2013-08-12","Colitis Gravis; Colitis ulcerosa; Colitis, Ulcerative; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis"
"phs000368.v1.p1","POLYGEN","PCOS is a complex genetic disease reflecting the interplay of susceptibility genes and environmental factors. The cardinal reproductive feature of the syndrome, hyperandrogenemia, appears to play a direct role  in the pathogenesis of the associated metabolic abnormalities. Male as well as female first-degree relatives have reproductive and metabolic","Polycystic Ovary Syndrome","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 28 variables, 11 documents, 1 molecular datasets, 4151 subjects, 8286 samples","European (4052), African American (13), Hispanic1 (15), Hispanic2 (11), Other Asian or Pacific Islander (2), South Asian (1), Other (5)","NICHD","PCOS --- Genetic analysis of polycystic ovary syndrome , NUGENE --- Nugene biorepository","2011-11-30","2012-11-30","HYPERANDROGENEMIA; Multicystic ovaries; Ovarian Degeneration, Sclerocystic; Ovarian Syndrome, Polycystic; Ovary Syndrome, Polycystic; PCO"
"phs000369.v1.p1","Sequence Analysis of Mutations and Translocations Across Breast Cancer    Subtypes","This study combined whole exome (103 samples) and whole genome (22 samples) sequencing over a total of 108 breast tumors and matched normal DNA to identify novel mutations and  translocations. Samples were subjected to paired-end Illumina sequencing with goal of 30x coverage of tumor/normal for whole genomes and 100x tumor","Carcinoma, Ductal, Breast","Tumor vs. Matched-Normal","HuEx-1_0-st, Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), mRNA Expression (Array), WGS, WXS","4 phenotype datasets, 23 variables, 2 molecular datasets,  SRA, 108 subjects, 216 samples","","NCI","GRU --- General research use , CRGM --- Cancer research and general methods","2012-04-19","2012-04-19","BREAST CANCER, INVASIVE DUCTAL; Carcinoma, Infiltrating Duct; Carcinoma, Invasive Ductal, Breast; Carcinomas, Infiltrating Duct; Infiltrating Ductal Adenocarcinoma; Infiltrating Ductal Breast Carcinoma"
"phs000370.v2.p1","The Mutational Landscape of Head and Neck Squamous Cell Carcinoma","This study was the first-known large-scale effort to uncover the mutational spectrum of head and neck cancers. We analyzed whole-exome sequence from 92 tumor-normal pairs and retained 74 of  them for significance analysis. The majority exhibited a mutational profile consistent with tobacco exposure; human papilloma virus sequence was","Head and Neck Neoplasms","Case Set","Somatic_Mutations_TCGA","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 92 subjects, 184 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2014-04-17","2014-04-17","Head Neoplasms; Neoplasms, Head"
"phs000371.v2.p1","Genetic Modifiers of Huntington's Disease","Huntington's disease (HD) is a neurodegenerative disorder typically diagnosed in mid-life that is caused by expansion of an otherwise polymorphic CAG trinucleotide repeat. The mutation causes a gain-of-function of  the huntingtin protein to trigger a pathogenic process that produces detectable phenotypic differences many years before the traditional diagnosis","Huntington Disease","Prospective Longitudinal Cohort","HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets, 2802 subjects, 3211 samples","European (2679), African (3), East Asian (2), African American (48), Hispanic1 (4), Hispanic2 (43), Other Asian or Pacific Islander (6), South Asian (6), Other (11)","NINDS","GRU --- General research use , HDR --- Huntington's disease research","2016-11-21","2014-06-12","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea"
"phs000372.v1.p1","ADGC Genome Wide Association Study","The National Institute on Aging (NIA) Alzheimer's Disease Centers (ADCs) cohort includes subjects ascertained and evaluated by the clinical and neuropathology cores of the 29 NIA-funded ADCs. Data collection  is coordinated by the National Alzheimer's Coordinating Center (NACC). NACC coordinates collection of phenotype data from the 29 ADCs, cleans all","Alzheimer Disease","Case-Control","Human660W-Quad_v1_A, HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 1 molecular datasets, 6065 subjects, 6065 samples","European (5376), African (15), East Asian (21), African American (434), Hispanic1 (58), Hispanic2 (142), Other Asian or Pacific Islander (2), South Asian (1), Other (16)","NIA","ADR --- Alzheimer's disease genetics consortium","2014-02-19","2015-02-19","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000373.v1.p1","Osteoporotic Fractures in Men (MrOS)","The Osteoporotic Fractures in Men Study (MrOS) is a multi-center prospective, longitudinal, observational study of risk factors for vertebral and all non-vertebral fractures in older men, and of the  sequelae of fractures in men. The original specific aims of the study include: (1) to define the skeletal determinants of fracture risk in older men","Osteoporosis","Prospective Longitudinal Cohort","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 134 variables, 4 documents, 1 molecular datasets, 5130 subjects, 5274 samples","European (4655), African (4), East Asian (143), African American (178), Hispanic1 (17), Hispanic2 (99), Other Asian or Pacific Islander (18), South Asian (10), Other (6)","NIAMS","DS-AGR1-RD --- Disease-specific (aging related 1, rd) , DS-AGR2-RD --- Disease-specific (aging related 2, rd) , DS-AGR3-RD --- Disease-specific (aging related 3, rd)","2017-12-01","2017-12-01","Arthritides, Degenerative; Arthritis, Degenerative; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy; Degenerative joint disease"
"phs000374.v1.p1","Genomic Sequencing of Colorectal Adenocarcinomas","This study was the first-known effort to complete the complete genome sequencing of primary colorectal adenocarcinomas and the matched germline genome. Nine colorectal adenocarcinomas selected on the basis of  having chromosomal instability were subjected to 'shotgun' Illumina sequencing with 101-bp paired end reads to an approximate goal of 30x coverage of","Colonic Neoplasms","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 25 variables, 1 molecular datasets,  SRA, 9 subjects, 18 samples","","NHGRI","GRU --- General research use","2011-11-08","2011-11-08","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000375.v1.p1","Genome-Wide Association of Platelet Phenotypes","The goal of this study was to identify genetic variants in a genome-wide association study (GWAS) that are associated with previously obtained platelet function phenotypes measured in each individual  under baseline conditions and following 2 weeks of low dose aspirin (ASA). During this study we performed a high density 1 million-SNP genome scan on","Platelet Aggregation","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","1 documents, 410 analyses","","NHLBI","NPU --- Non profit research use","2012-02-07","","Blood Physiological Concept; Blood Physiological Concepts; Blood Physiological Phenomena; Blood Physiological Phenomenas; Blood Physiological Phenomenon; Blood Physiology"
"phs000376.v1.p1","Whole Exome Sequencing in Familial Parkinson Disease","We have an ongoing study that has recruited families having at least a sibling pair with Parkinson disease (PD). Families have been screened for mutations in known PD causative  genes (LRRK2, parkin, etc). Following review of families without a causative mutation, we selected families for whole exome sequencing that had the","Parkinson Disease","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 46 variables, 1 molecular datasets,  SRA, 77 subjects, 44 samples","","NINDS","DS-PDND --- Disease-specific (parkinson's disease or other neurodegenerative disorders)","2014-10-20","2015-10-20","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000378.v1.p1","Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of    Dementia","In 1991 collaboration between researchers at Indiana University School of Medicine and the University of Ibadan, Ibadan, Nigeria established the Indianapolis-Ibadan Dementia Project. It is a longitudinal, prospective population-based  comparative epidemiological study of the prevalence and incidence rates and risk factors of Alzheimer's disease and other age associated dementias","Alzheimer Disease","Prospective Longitudinal Cohort","HumanOmni2.5-8v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 43 variables, 24 documents, 2 molecular datasets, 1251 subjects, 1302 samples","African (1221), African American (30)","NIA","GRU-IRB --- General research use (irb)","2014-05-06","2015-05-06","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000379.v1.p1","Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA): GENOA is one of four research networks that form the NHLBI Family Blood Pressure Program (FBPP). From its inception in 1995, GENOA's  long-term objective was to elucidate the genetics of hypertension and its arteriosclerotic target-organ damage, including both atherosclerotic","Peripheral Arterial Disease","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","1 documents, 19 analyses","","NHLBI","GRU --- General research use","2011-10-05","","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000380.v1.p1","eMERGE Genome-Wide Association Studies of Obesity (Metabochip)","The Geisinger eMERGE Genome Wide Association Studies of Obesity (Metabochip) Project is a genetic study of a cohort of primarily Caucasian patients with extreme obesity who have undergone bariatric  surgery. Roux-en-Y gastric bypass (RYGB) surgery, in which intestinal anatomy is altered, dramatically ameliorates and/or eliminates Type 2 diabetes","Obesity","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 36 variables, 1 molecular datasets, 982 subjects, 982 samples","","NHGRI","HR_GC_NASH --- Health research - geisinger clinic -nash","2012-01-17","2013-01-17","Gastric stapling; Stapling, Stomach; Stomach Stapling; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2"
"phs000381.v1.p1","Geisinger eMERGE - MyCode Project","A research cohort of adult Geisinger Clinic patients was enrolled from community-based primary care clinics of the Geisinger Health System. Patients were eligible for enrollment if they were a  primary care patient of a Geisinger Clinic physician and were scheduled for a non-emergent clinic visit. All participants provided written informed","Normalcy","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 29 variables, 2 documents, 1 molecular datasets, 1231 subjects, 1264 samples","European (1222), African American (5), Hispanic1 (2), Hispanic2 (2)","NHGRI","HR_GC_MYCODE --- Health research - geisinger clinic - mycode","2011-12-19","2012-12-19",""
"phs000382.v3.p1","CIDR Whole Exome Sequencing in Joubert Syndrome","The purpose of this study is to identify new genetic causes of neurodevelopmental diseases (NDDs) in the Joubert syndrome (JS) spectrum. Joubert syndrome is a recessive disease characterized by  cerebellar vermis hypoplasia. Our currently funded NINDS award entitled ""Molecular characterization of Joubert syndrome"" seeks to identify new","Joubert syndrome 1","Prospective Longitudinal Cohort","whole_exome_seq, WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 17 variables, 4 documents, 3 molecular datasets,  SRA, 106 subjects, 106 samples","","NINDS","ARU --- Academic research use","2018-06-06","2018-06-06","CC2D2A; CEREBELLAR VERMIS HYPO/APLASIA, OLIGOPHRENIA, CONGENITAL ATAXIA, OCULAR COLOBOMA, AND HEPATIC FIBROSIS; COACH (cerebellar vermis hypoplasia, oligophrenia, congenital ataxia, coloboma, hepatic fibrosis) syndrome; COACH syndrome; Cerebellar Vermis Hypo-Aplasia, Oligophrenia, Congenital Ataxia, Ocular Coloboma, And Hepatic Fibrosis; Cerebellar vermis hypo-aplasia, Oligophrenia, Ataxia congenital, Coloboma, and Hepatic fibrosis"
"phs000383.v1.p1","GWAS of Breast Cancer in the African Diaspora","The paucity of data on the genetic epidemiology of breast cancer for racial/ethnic groups other than those of European ancestry hinders the development of innovative interventions to reduce health  disparities. Women in the African Diaspora experience a disproportionate burden of pre-menopausal breast cancer in comparison to all other races for","Breast Neoplasms","Case-Control","HumanOmni2.5-8v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 34 variables, 2 molecular datasets, 3766 subjects, 4001 samples","European (20), African (1481), African American (2234), Hispanic1 (21), Other Asian or Pacific Islander (1), South Asian (2), Other (7)","NCI","HRGM --- Health research and general methods","2012-12-14","2013-12-14","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000384.v1.p1","Genentech Whole Genome Sequencing of Four Hepatocellular Carcinoma    Patients","Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). In this study we sequenced the whole genome ( 80X) and transcriptome of tumor and  non-tumor samples from four HCC patients and identified over two hundred HBV integration sites. We found significant clonal expansion of HBV","Hepatocellular Carcinomas","Case-Control","Not Provided","Not Applicable","RNA-Seq, WGS","4 phenotype datasets, 20 variables,  SRA, 4 subjects, 18 samples","","NCI","GRU --- General research use","2012-07-30","2012-07-30","Hepatitis B Virus Infection; Hepatitis B infection; SH - Serum hepatitis; Serum hepatitis; Viral Hepatitis B; Viral hepatitis type B"
"phs000385.v1.p1","Epigenetic Profiling of Human Colorectal Cancer","DNA methylation, together with chromatin modifications, constitute the epigenome that functions to regulate gene expression and genome integrity. DNA methylation alterations are ubiquitous in human cancers, as many genes  acquire DNA methylation in a cancer-specific manner. DNA methylation at these sites in the genome of cancer cells not only serves as a marker for","Colorectal Neoplasms","Case-Control","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array), Bisulfite-Seq","5 phenotype datasets, 42 variables, 1 documents, 1 molecular datasets,  SRA, 100 subjects, 104 samples","","NCI","GRU --- General research use","2011-11-29","2011-11-29","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000387.v1.p1","Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)","A large research cohort of Geisinger Abdominal Aortic Aneurysm (AAA) patients was created by enrolling and consenting patients of the Geisinger Department of Vascular Surgery. Consented patients provide blood,  serum and DNA samples for research and authorize use of data in their medical record for research. They also complete a data questionnaire that asks","Abdominal Aortic Aneurysms","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 28 variables, 1 molecular datasets, 910 subjects, 943 samples","European (908), Hispanic2 (1)","NHGRI","HR_GC_AAA --- Health research - geisinger clinic - aaa","2011-12-19","2012-12-19","Not Provided"
"phs000388.v1.p1","IPM BioBank GWAS","The Institute for Personalized Medicine (IPM) Biobank Project is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over  70,000 inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86","Metabolic Syndrome X","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 13 variables, 6 documents, 1 molecular datasets, 2867 subjects, 2867 samples","European (700), African (102), East Asian (1), African American (1038), Hispanic1 (704), Hispanic2 (152), Other Asian or Pacific Islander (2), South Asian (21), Other (147)","NHGRI","HR_MSSM --- Health research - mssm","2011-09-21","2012-09-21","CRF - Chronic Renal Failure; Chronic Kidney Failure; Chronic Renal Disease; Chronic renal failure syndrome; Disease, End-Stage Kidney; Disease, End-Stage Renal"
"phs000389.v1.p1","GENIE UK-ROI Diabetic Nephropathy GWAS","Diabetic kidney disease, or diabetic nephropathy (DN), is one of the leading causes of end-stage renal disease in the United States and worldwide. DN is a common complication of  long-standing type 1 and type 2 diabetes. The clinical course is characterized by development of proteinuria and gradual loss of kidney function","Diabetes Mellitus, Type 1","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 22 variables, 1 molecular datasets, 1801 subjects, 1822 samples","European (1726)","NIDDK","GRU --- General research use","2011-11-04","2011-11-04","Diabetes Complications; Diabetes Mellitus Complication; Diabetes Mellitus Complications; Diabetes Related Complications; Diabetes-Related Complication; Diabetes-Related Complications"
"phs000390.v1.p1","Genomic Wide Scans for Female Osteoporosis Genes","Osteoporosis is a condition of excessive skeletal fragility which results in high risk to low trauma fractures. It is the most prevalent metabolic bone disease and is a major  public health problem which may result in devastating morbidity and mortality. The most powerful, measurable determinant of fracture risk is bone","Osteoporosis","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 28 variables, 2 documents, 1 molecular datasets, 1617 subjects, 1617 samples","European (1598), African American (3), Hispanic1 (4), Hispanic2 (6), Other Asian or Pacific Islander (2), Other (4)","NIAMS","OSTEO --- Osteoporosis","2012-04-26","2013-04-26","Age Related Osteoporosis; Age-Related Bone Loss; Age-Related Bone Losses; Age-Related Osteoporoses; Age-Related Osteoporosis; Bone Loss, Age Related"
"phs000391.v1.p1","Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study","CHD is the leading cause of death in the United States. One of the most common ways to prevent CHD is to take an anti-platelet agent, which lessens platelet  aggregation. Two of the most common anti-platelet agents are aspirin and clopidogrel. However, up to 25% to 30% of people do not respond to these","Platelets","Interventional","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 36 variables, 19 documents, 15 analyses, 666 subjects, 666 samples","","NHLBI","GRU --- General research use","2012-12-11","2013-12-11","Blood Platelet; PLT - Platelet; PLT - Platelets; Platelet, Blood; Platelets, Blood; Reticuloendothelial System, Platelets"
"phs000392.v1.p1","Exome Sequencing of arPEO","Progressive external ophthalmoplegia (PEO) is an inherited mitochondrial disease that follows either autosomal dominant or recessive forms of inheritance (adPEO or arPEO). AdPEO is a genetically heterogeneous disease and  several genes including POLG1 and C10orf2/Twinkle have been identified as responsible genes. On the other hand, POLG1 was the only established gene","Ophthalmoplegia, Chronic Progressive External","Case-Control","Not Provided","Not Applicable","WXS","4 phenotype datasets, 13 variables,  SRA, 1 subjects, 1 samples","","NHGRI","GRU --- General research use","2011-10-20","2011-10-20","CPEO; CPEO - chronic progressive external ophthalmoplegia; Chronic Progressive External Ophthalmoplegia; Chronic progressive ophthalmoplegia; Disease, Graefe; Dystrophy, Ocular Muscular"
"phs000393.v1.p1","Genes Contributing to Nicotine Dependence in Humans","A genome-wide association study on smoking behavior and nicotine dependence in Icelandic smokers, assessed by the number of cigarettes smoked per day, smoking initiation and degree of dependence on  nicotine. The number of cigarettes smoked per day was ascertained through questionnaires given to individuals participating in multiple disease","Tobacco Use Disorder","Case-Control","Not Provided","Not Applicable","Not Provided","1 phenotype datasets, 5 variables, 3 analyses","","NIDA","GRU --- General research use","2012-01-18","","Dependence, Nicotine; Nicotine Addiction; Nicotine Dependence"
"phs000394.v1.p1","Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)","The APDGC was formed to conduct a genome-wide association study in individuals with neuropathologically confirmed Parkinson Disease (PD) and neuropathologically normal controls. The rationale for the study is that  including only cases and controls with neuropathologically confirmed disease status will reduce diagnostic misclassification and increase power to","Parkinson Disease","Case-Control","HumanOmni1-Quad_v1-0_H, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 19 variables, 2 molecular datasets, 977 subjects, 1044 samples","European (932), African (2), East Asian (7), African American (24), Hispanic1 (5), Hispanic2 (7)","NINDS","ARU --- Academic research use","2012-06-22","2013-06-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000395.v1.p1","CPMCRI Breast Health Cohort","Description of Cohort: The California Pacific Medical Center (CPMC) Breast Health Cohort is a cohort study based at CPMC and is linked to the San Francisco Mammography Registry, one  of the sites of the NCI-funded Breast Cancer Screening Consortium (U01CA063740). CPMC is a community hospital in San Francisco, which has one of the","Breast Neoplasms","Case-Control","HumanOmni1-Quad_v1-0_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 30 variables, 1 documents, 1 molecular datasets, 982 subjects, 1014 samples","European (942), Hispanic1 (3), Hispanic2 (2), Other (3)","NCI","GRU --- General research use","2012-07-20","2012-07-20","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000396.v1.p1","DCEG Imputation Reference Dataset","We have built a new resource for imputation of SNPs for existing and future genome-wide association studies (GWAS), known as the Division of Cancer Epidemiology and Genetics (DCEG) Reference  Set. The first build of the data set includes 728 cancer-free individuals of European descent from three large prospectively sampled studies, 98","Not Provided","Clinical Trial","DCEG_ReferenceSet_2.8M","Not Applicable","SNP Genotypes (imputed)","2 phenotype datasets, 4 variables, 1 molecular datasets, 1249 subjects, 1249 samples","","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods , EGC --- Esophageal and stomach cancer","2011-05-07","2011-05-07",""
"phs000397.v1.p1","NIA Long Life Family Study (LLFS)","The Long Life Family Study (LLFS) is an international collaborative study of the genetics and familial components of exceptional survival, longevity, and healthy aging. Families were recruited through elderly  probands (generally in their 90s) who self-reported on the survival history of their parents and siblings, and on the basis of this information","Longevity","Family/Twin/Trios","HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 104 variables, 11 documents, 1 molecular datasets, 4835 subjects, 5015 samples","European (4673), East Asian (4), African American (16), Hispanic1 (7), Hispanic2 (2), Other Asian or Pacific Islander (1), South Asian (1), Other (3)","NIA","GRU-IRB --- General research use (irb) , GRU-IRB-NPU --- General research use (irb, npu) , DS-LARHC-IRB-NPU --- Disease-specific (longevity, age-related health conditions, irb, npu)","2013-12-12","2014-12-12","Aging, Biological; Biological Aging; AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia"
"phs000404.v1.p1","The Genetic Architecture of Smoking and Smoking Cessation","This study includes samples from two projects: Collaborative Genetic Study of Nicotine Dependence (COGEND; PI: Laura Bierut) and University of Wisconsin Transdisciplinary Tobacco Use Research Center (UW-TTURC; PI: Timothy  Baker). Data are available for an additional 1420 COGEND subjects through the Study of Addiction: Genetics and Environment (SAGE), dbGaP study","Smoking Cessation","Case-Control","HumanOmni2.5-4v1_D, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 189 variables, 15 documents, 2 molecular datasets, 3499 subjects, 3564 samples","European (2545), African (4), East Asian (8), African American (751), Hispanic1 (25), Hispanic2 (45), Other Asian or Pacific Islander (12), South Asian (6), Other (17)","NIDA","GRU --- General research use , NAR --- Nicotine addiction research","2011-12-14","2012-12-14","Behavior, Smoking; Behaviors, Smoking; Smoking Behaviors; Smoking, Tobacco and Cancer-Behavior; Dependence, Nicotine; Nicotine Addiction"
"phs000405.v1.p1","Next Generation Mendelian Genetics: Malignant Hyperthermia","Malignant hyperthermia (MH) is a genetic disorder that causes a profound metabolic derangement following exposure to certain anesthetics. While approximately half of all cases are associated with ryanodine receptor-1  gene (RYR1) mutations, many cases have an unknown genetic cause. We sought to identify rare variants in novel MH candidate genes by sequencing the","Malignant Hyperthermia","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 13 subjects, 13 samples","","NHGRI","GRU --- General research use","2012-11-20","2012-11-20","Anesthesia Hyperthermia; Anesthesia Hyperthermias; Anesthesia Related Hyperthermia; Anesthesia Related Hyperthermias; Hyperpyrexia, Malignant; Hyperpyrexias, Malignant"
"phs000407.v1.p1","IMAGE II Genome-Wide Association","This sample represents a collection of cases across a range of sites. All of these samples were ascertained for ADHD with most meeting criteria for combined type ADHD. The  collection sites span Europe and America. Further details on the source and inclusion and exclusion information can be found in Neale et al. ""Case","Attention Deficit Disorder with Hyperactivity","Case-Control","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 923 subjects, 923 samples","European (880), African American (18), Hispanic1 (19), Hispanic2 (2), Other (4)","NIMH","ADHD --- Attention deficit hyperactivity disorder","2012-05-02","2012-05-02","ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder; Attention Deficit Hyperactivity Disorders"
"phs000408.v1.p1","eMERGE Genome-Wide Association Studies of Obesity","The Geisinger eMERGE Genome-Wide Association Studies of Obesity Project is a genetic study of a cohort of primarily Caucasian patients with extreme obesity who have undergone bariatric surgery. Roux-en-Y  gastric bypass (RYGB) surgery, in which intestinal anatomy is altered, dramatically ameliorates and/or eliminates Type 2 diabetes mellitus (T2D) in","Obesity","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 molecular datasets, 962 subjects, 1006 samples","European (959), African American (1), Hispanic2 (2)","NHGRI","HR_GC_NASH --- Health research - geisinger clinic -nash","2011-12-06","2012-12-06","Gastric stapling; Stapling, Stomach; Stomach Stapling; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2"
"phs000409.v1.p1","Sequencing of Medulloblastoma","Medulloblastoma is a heterogenous disease made up of at least four distinct subtypes of disease which appear to exploit and disrupt naturally occurring developmental pathways of cellular growth and  hindbrain development. To better understand the driver mutations of this disease, we performed whole genome sequencing of 37 medulloblastomas and the","Medulloblastoma","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS","5 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 93 subjects, 306 samples","European (45), East Asian (2), African American (6), Hispanic1 (3), Hispanic2 (8), Other Asian or Pacific Islander (4), South Asian (3), Other (5)","NCI","GRU --- General research use","2012-05-30","2012-05-30","Arachnoidal Cerebellar Sarcoma, Circumscribed; Circumscribed arachnoidal cerebellar sarcoma; Desmoplastic Medulloblastomas; Desmoplastic Nodular Medulloblastoma; MEDULLOBLASTOMA, DESMOPLASTIC; Medulloblastoma, desmoplastic, somatic"
"phs000410.v1.p1","Whole Exome Sequencing for Colorectal Cancer","This project was designed to use next generation sequencing technology to screen the protein coding regions of the genome for low frequency variants in a panel of high-risk colorectal  adenocarcinoma cases. Blood and cell-line DNA for colorectal cancer patients and a subset of quality control samples that had existing whole exome","Colorectal Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 21 variables,  SRA, 165 subjects, 174 samples","","NCI","GRU-MDS --- General research use (mds) , GRU-NPU-MDS --- General research use (npu, mds)","2014-03-14","2014-03-14","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000413.v2.p1","Transcriptome Sequencing of Pediatric AML FAB-M7","High resolution analysis of DNA copy number abnormalities and loss-of-heterozygosity on acute myeloblastic leukemia samples utilizing SNP arrays has demonstrated that in contrast to pediatric ALL, de novo AML  is characterized by a very low burden of genomic alterations (Radtke, et al., PNAS, 2009). Samples for this study represented a cross-section of the","Acute Megakaryoblastic Leukemia","Case Set","Not Provided","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS, WXS","5 phenotype datasets, 32 variables, 1 molecular datasets,  SRA, 15 subjects, 85 samples","European (8), African American (2), Hispanic2 (2), Other Asian or Pacific Islander (2)","NCI","GRU --- General research use","2012-11-20","2013-08-20","AMKL; AML M7; Acute M7 Myeloid Leukemia; Acute Megakaryoblastic Leukemia (FAB Type M7); Acute Megakaryoblastic Leukemias; Acute Megakaryocytic Leukemia"
"phs000414.v1.p1","Whole Genome Sequencing of CBF-Leukemia","Pediatric de novo acute myeloid leukemia (AML) is a heterogeneous disease that can be divided into clinically distinct subtypes based on the presence of specific chromosomal abnormalities or gene  alterations. One of the best characterized subtypes of AML involves leukemias with alterations of the core-binding factor (CBF)-complex, which","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WGS","3 phenotype datasets, 16 variables,  SRA, 17 subjects, 34 samples","","NCI","GRU --- General research use","2012-05-30","2013-03-02","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs000415.v1.p1","Whole Exome and Targeted Sequencing in Tourette Syndrome Multiplex    Families","This study consists of 771 individuals from 15 extended, multi-generational Tourette Syndrome (TS) pedigrees collected by the Tourette Syndrome Association International Consortium for Genetics (TSAICG), 213 of whom are  affected either with TS or its broader, genetically related phenotype, chronic tic disorder (CT). Prior microsatellite linkage analysis, including","Tourette Syndrome","Family/Twin/Trios","HumanOmniExpress-12v1_H","Not Applicable","SNP Genotypes (Array), Targeted-Capture, WXS","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 256 subjects, 302 samples","European (169)","NINDS","DS-TS-NPU --- Disease-specific (tourette syndrome, npu) , GRU --- General research use","2015-08-14","2016-08-14","Chorea, Habit; Choreas, Habit; Habit Chorea; Habit Choreas; Habit Spasm; Habit Spasms"
"phs000416.v2.p1","Genetics of Cerebral Hemorrhage with Anticoagulation (GOCHA)","This is a prospective, longitudinal cohort study of spontaneous ICH. Subjects were recruited from among consecutive patients 55 years old who presented with primary hemorrhage to the Massachusetts General  Hospital or one of our off-site collaborators from 1999 to 2010. Potential subjects were identified by screening lists of all admissions to the","Intracranial Hemorrhage","Case-Control","HumanHap550_v3","Not Applicable","SNP Genotypes (Array), Targeted-Capture","4 phenotype datasets, 48 variables, 5 documents, 1 molecular datasets,  SRA, 3569 subjects, 3590 samples","European (1667), African (7), East Asian (4), African American (27), Hispanic1 (13), Hispanic2 (7), Other Asian or Pacific Islander (1), South Asian (1), Other (14)","NINDS","DS-STK --- Disease-specific (stroke)","2019-06-27","2019-06-27","Amyloid Angiopathy, Cerebral; Amyloid angiopathy; Angiopathy, Cerebral Amyloid; Angiopathy, Congophilic; CAA; CAA - Cerebral amyloid angiopathy"
"phs000417.v2.p1","BrainCloud: Data from Human Postmortem Brain Across the Lifespan","This study explores the temporal dynamics and genetic control of transcription and DNA methylation in the human dorsolateral prefrontal cortex in postmortem tissue. This study examines 269 subjects for  gene expression (version 1) and 108 subjects for DNA methylation (version 2). The subjects are normal controls without neuropathological and","Aging","Case-Control","Human1M-Duov3_B, HumanHap650Yv3, Human1M-Duov3","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 21 variables, 2 molecular datasets, 270 subjects, 270 samples","European (110), East Asian (3), African American (148), Hispanic1 (1), Hispanic2 (5), Other Asian or Pacific Islander (1), South Asian (2)","NIMH","GRU --- General research use","2012-02-02","2012-02-02","Aging, Biological; Biological Aging"
"phs000418.v2.p1","Temporal Dissection of Tumorigenesis in Primary Cancers","The earliest genetic abnormalities in cancer represent a unique opportunity for timely clinical diagnosis. Classic deep sequencing of tumors identifies many aberrations acquired later in cancer progression. In this  study, data regarding simple mutation and chromosomal aberration were integrated to trace the evolution of cutaneous squamous cell carcinomas and","Carcinoma, Squamous Cell","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WXS","4 phenotype datasets, 27 variables,  SRA, 8 subjects, 16 samples","","NCI","DS-CA-IRB-MDS --- Disease-specific (cancer, irb, mds)","2014-04-16","2012-05-15","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular; Carcinomas, Squamous"
"phs000419.v1.p1","A Novel Recurrent Mutation in MITF Predisposes to Familial and Sporadic    Melanoma","We conducted whole-genome sequencing of probands from several melanoma families, identifying one individual carrying a novel germline variant (c.G1075A, NM_000248.3; p.E318K, NP_000239.1; rs149617956) in the melanoma lineage-specific oncogene MITF.  While the variant cosegregated with melanoma in some, but not all cases in the family, linkage analysis of 31 families subsequently identified to","Melanoma","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 15 variables,  SRA, 1 subjects, 1 samples","","NCI","CRO --- Cancer research only","2012-02-03","2012-02-03","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000421.v1.p1","A Genome-Wide Association Study of Fuchs' Endothelial Corneal Dystrophy    (FECD)","Fuchs' Endothelial Corneal Dystrophy (FECD) is a common disease that results in loss of vision associated with progressive corneal edema and loss of corneal transparency. In the initial stages  of the disease, excrescences on Descemet's membrane with the appearance of an abnormal posterior collagenous layer, result in the clinical and","Fuchs' Endothelial Dystrophy","Case-Control","HumanOmni2.5-4v1_H, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 89 variables, 2 molecular datasets, 4592 subjects, 4782 samples","European (4576), African American (9), Hispanic2 (5), Other Asian or Pacific Islander (1), Other (1)","NEI","FECD --- Fecd studies only , GRU --- General research use , EDO --- Eye disease research only","2013-05-31","2014-03-03","Dystrophy, Fuch's Endothelial; Dystrophy, Fuchs' Endothelial; Endothelial Dystrophy, Fuch's; Endothelial Dystrophy, Fuchs'; Fuch Endothelial Dystrophy; Fuch's Endothelial Dystrophy"
"phs000422.v1.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Asthma","Case Set","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 2 molecular datasets,  SRA, 191 subjects, 191 samples","","NHLBI","GRU --- General research use","2013-05-16","2013-08-16","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000423.v1.p1","GWAS for Early Onset Coronary Disease (ADVANCE)","ADVANCE (Atherosclerotic Disease, VAscular functioN, and genetiC Epidemiology) is a large epidemiological study of genetic and non-genetic determinants of coronary artery disease (CAD) that started in 2000 as a  collaborative effort between researchers at Stanford University and Kaiser Permanente of Northern California. The overarching goal of the study is to","Coronary Disease","Case-Control","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","NPU --- Non profit research use","2012-03-09","","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000424.v8.p2","Genotype-Tissue Expression (GTEx)","Lay Description The aim of the Genotype-Tissue Expression (GTEx) Project is to increase our understanding of how changes in our genes affect human health and disease with the ultimate  goal of improving health care for future generations. GTEx will create a database that researchers can use to study how inherited changes in genes","Reference Values","Cross-Sectional","RNAseq_probe_set_grc37, HuGene-1_1-st-v1, 1000G_ref_panel, RNAseq_probe_set_grc38, HumanOmni5-4v1_B, HumanExome-12v1-1, exome_vcf_grc37, HumanOmni25-8v1, whole_genome_vcf_grc37, WES_markerset_grc37, WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","Allele-Specific Expression, Allele-Specific Expression, SNP Genotypes (Array), mRNA Expression (Array), SNP Genotypes (imputed), RNA-Seq, CNV Genotypes, SNP/CNV Genotypes (NGS), RNA Seq expression levels, WGS, WXS","4 phenotype datasets, 269 variables, 1 documents, 11 molecular datasets,  SRA, 980 subjects, 22951 samples","European (153), East Asian (2), African American (25), Hispanic1 (3), Hispanic2 (2)","NHGRI","GRU --- General research use","2019-07-18","2019-07-18","Normal Value; Normal Values; Range, Normal; Range, Reference; Ranges, Normal; Ranges, Reference"
"phs000425.v1.p1","Alcohol Dependence GWAS in European- and African Americans","This study includes SSADDA (Semi Structured Assessment for Drug Dependence and Alcoholism) assessed subjects (mostly unrelated, but including some affected sibling pairs) recruited in the course of several substance  dependence genetics projects. The sample includes 1889 African-American (AA) subjects and 1020 European-American (EA) subjects. Among the AAs, 1397","Alcoholism","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 45 variables, 1 molecular datasets, 2909 subjects, 3050 samples","European (831), African (100), African American (1802), Hispanic1 (139), Hispanic2 (16), Other (21)","NIAAA","ARC --- Alcohol related conditions","2012-03-09","2013-03-09","Alcohol Use Disorder; Alcohol Use Disorders; Use Disorder, Alcohol; Use Disorders, Alcohol; Abuse, Cocaine; Cocaine Abuse"
"phs000426.v1.p1","SLCO1B1 Variants and Methotrexate Clearance","Methotrexate plasma concentration is related to its clinical effects. To identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL),  we performed a genome-wide analysis (GWAS) of 500,568 germline single-nucleotide polymorphisms (SNPs) in 434 children with ALL who received 3,014","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 673 subjects, 673 samples","European (459), African (2), East Asian (7), African American (111), Hispanic1 (12), Hispanic2 (70), Other Asian or Pacific Islander (2), South Asian (4), Other (6)","NIGMS","BRU --- Biomedical research use","2011-12-13","2011-12-13","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000428.v2.p2","Health and Retirement Study (HRS)","Introduction to V2: This data release comprises data from the V1 release combined with approximately 3,000 additional samples, collected during the HRS 2010 field period. The 2010 data include  samples from a random half of the new cohort enrolled in 2010 along with a significant expansion of the minority sample. Description: The University","Aging","Prospective Longitudinal Cohort","HumanOmni2.5-4v1_D, 1000G_ref_panel, HumanOmni2.5-8v1_C, HumanOmni2.5-4v1_D, HumanOmni2.5-8v1_C","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 25 variables, 4 molecular datasets, 15620 subjects, 16508 samples","European (11124), African (145), East Asian (94), African American (2425), Hispanic1 (216), Hispanic2 (1394), Other Asian or Pacific Islander (58), South Asian (58), Other (106)","NIA","NPR --- Non-profit research use only","2017-02-02","2017-02-02","Aging, Biological; Biological Aging; AI - Alcohol intake; Alcohol Consumption; Alcohol Drinking; Alcoholic drink intake"
"phs000430.v1.p1","Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)","Reprinted from http://www.haltctrial.org/ Purpose The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial is a randomized controlled trial designed to evaluate the safety and efficacy of long-term use  of pegylated interferon for the treatment of chronic hepatitis C in patients who failed to respond to previous interferon therapy. The HALT-C Trial","Hepatitis C","Clinical Trial","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 47 variables, 1 molecular datasets, 966 subjects, 966 samples","European (710), African (3), East Asian (14), African American (137), Hispanic1 (19), Hispanic2 (70), Other Asian or Pacific Islander (2), South Asian (6), Other (5)","NIMH","GRU --- General research use","2013-02-12","2014-02-12","HCV Infection; Hepatitis C Virus Infection; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; PT-NANBH; Parenterally Transmitted Non A, Non B Hepatitis; Parenterally-Transmitted Non-A, Non-B Hepatitis"
"phs000431.v2.p1","IgA Nephropathy GWAS (IGANGWAS)","In this second study version, we report a genome-wide association study of IgA nephropathy performed in individuals of European ancestry (US and Italian cohorts), followed by a meta-analysis with  the existing GWAS cohorts (Han Chinese [study version 1] and French cohorts). Genomic DNA was extracted from whole blood and genotyped with the","Glomerulonephritis, IGA","Case-Control","Human610-Quadv1_B, HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 16 variables, 2 molecular datasets, 3615 subjects, 3615 samples","European (1514), East Asian (2006), Hispanic1 (4), Other Asian or Pacific Islander (90), Other (1)","NIDDK","GRU-IRB --- General research use (irb)","2015-02-23","2015-02-23",""
"phs000433.v1.p1","The Sea Islands Genetic Network (SIGNET)","Recent genome-wide association studies (GWAS) have successfully identified genetic variants that influence diabetes risk in European populations, however most do not have a major impact on diabetes risk in  populations of African descent. The African American (AA) population from the Sea Islands of coastal South Carolina and Georgia has high rates of","Type 2 Diabetes Mellitus","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 74 variables, 1 molecular datasets, 4291 subjects, 4358 samples","European (18), African (1028), African American (3215), Hispanic1 (29), Other (1)","NIDDK","GRU --- General research use , LGRU --- General research use except hiv/aids , SR --- Stroke and risk factors for stroke","2012-08-17","2012-08-17","Dyslipidemia; Dyslipidemias; High blood cholesterol/triglycerides; Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2"
"phs000434.v1.p1","Next Generation Mendelian Genetics: Atypical Werner Syndrome","Werner syndrome (WS) is an adult-onset progeroid syndrome characterized by accelerated aging. The International Registry of Werner Syndrome in the Department of Pathology, University of Washington, collects WS cases  from all over the world. Classical WS is caused by WRN mutations. Those who do not carry WRN are categorized as ""atypical Werner syndrome."" A small","Werner Syndrome","Case-Control","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 8 subjects, 8 samples","","NHGRI","AAS --- Accelerated aging syndromes","2012-09-12","2012-09-12","Adult Premature Aging Syndrome; Adult Progeria; Pangeria; Progeria of the adult; Progeria, Adult; Syndrome, Werner"
"phs000435.v3.p1","Whole Exome Sequencing of Chronic Lymphocytic Leukemia","The somatic genetic basis of chronic lymphocytic leukemia (CLL), a common and clinically heterogenous adult leukemia, remains poorly understood. Massively parallel sequencing technology now provides a method for systematic  discovery of genetic alterations that underlie disease, and for uncovering new therapeutic targets and biomarkers. In study version 2 we presented a","Chronic Lymphocytic Leukemia","Case Set","maf_grc36, Genome-Wide_Human_SNP_Array_6.0, whole_exome_seq","Not Applicable","SNP Genotypes (Array), Bisulfite-Seq, RNA-Seq, SNV (.MAF), SNV Aggregate (.MAF), WGS, WXS","4 phenotype datasets, 24 variables, 2 molecular datasets,  SRA, 186 subjects, 959 samples","","NHGRI","GRU --- General research use","2017-04-05","2013-06-03","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000436.v1.p1","University of Miami Study on Genetics of Autism and Related Disorders    (AutismDisorders)","Autism spectrum disorders (ASD) are neurodevelopmental in origin and characterized by impairments in reciprocal social interaction and communication accompanied by restricted and repetitive patterns of interest or behavior. With  improved surveillance and a broadening of the diagnostic criteria, the most recent prevalence studies suggest that ASD may affect as many as 1/166","Autistic Disorder","Family/Twin/Trios","Human1Mv1_C","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 26 variables, 1 molecular datasets, 1205 subjects, 1205 samples","European (1181), African (1), African American (2), Hispanic1 (8), Hispanic2 (6), South Asian (3), Other (1)","NIMH","DS-ASD-RD --- Disease-specific (autism spectrum disorder, rd)","2014-03-05","2014-03-05","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000437.v1.p1","Next Generation Mendelian Genetics: Auriculocondylar Syndrome (ACS)","This project is part of an ongoing project to identify the molecular genetic basis of rare craniofacial disorders. This specific project involved the collection of DNA samples from four  probands with severe manifestations of auriculocondylar syndrome and their parents. Detailed clinical phenotypic data is available on each proband","Auriculo-condylar syndrome","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NHGRI","DS-CFD --- Disease-specific (craniofacial disorders)","2014-05-01","2016-02-01","ARCND1; Ears prominent and constricted; QUESTION MARK EARS SYNDROME; Question mark ear; Question-Mark Ear Syndrome"
"phs000438.v1.p1","PGRN-RIKEN: Identification of Genetic Predictors of ACE    Inhibitor-Associated Angioedema","The purpose of this study is to identify genetic predictors of ACE inhibitor-associated angioedema. In addition to preventing the formation of the pressor angiotensin II, ACE inhibitors prevent the  carboxyl-terminal degradation of the vasoactive substances bradykinin and substance P. Angioedema is hypothesized to result from defective amino","Angioedema","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 721 subjects, 722 samples","European (437), African (4), African American (217), Hispanic1 (1), Hispanic2 (2), Other (1)","NHLBI","HMB --- Health/medical/biomedical","2014-09-30","2015-09-30","Angioedema-urticaria; Angioneurotic Edema; Angioneurotic Edemas; Angioneurotic oedema; Angiooedema; Bradykinine-induced angioedema"
"phs000439.v1.p1","PGRN-RIKEN: Rate Control Therapy in Patients with Atrial Fibrillation","The goal of this study was to identify genetic predictors of response to rate control therapy in patients with AF. We conducted a genome-wide association study (GWAS) focusing on  subjects with a history of atrial fibrillation. Rate control therapy for AF uses a range of drugs (beta-adrenergic receptor blockers, calcium channel","Atrial Fibrillation","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 17 variables, 1 molecular datasets, 1888 subjects, 1888 samples","European (1743), African (5), East Asian (3), African American (110), Hispanic1 (10), Hispanic2 (9), Other Asian or Pacific Islander (3), South Asian (3), Other (2)","NHLBI","HMB --- Health/medical/biomedical","2012-09-05","2013-09-05","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs000440.v1.p1","CCDG: Dental Caries and CL/P in Guatemala","This study provides an opportunity to investigate the genetics of both dental caries and orofacial clefts (OFCs) in one set of families ascertained in Guatemala. This study is part  of the Gene Environment Association Studies initiative (GENEVA, http://www.genevastudy.org), which was developed through the trans-NIH Genes","Dental Caries","Case-Control","Human610-Quadv1_B, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 119 variables, 21 documents, 2 molecular datasets, 1304 subjects, 968 samples","African American (1), Hispanic2 (884), Other (55)","NIDCR","OH --- Oral health","2012-03-20","2013-03-20","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lip; Cleft Lips; Cleft of upper lip"
"phs000442.v1.p1","Drug Resistant Hypertension in African Americans' Exome","Resistant hypertension is defined as blood pressure that remains above goal in spite of the concurrent use of 3 antihypertensive agents of different classes or the concurrent use of  4 or more antihypertensive agents regardless of control. Its diagnosis is important for the identification of patients who are at high risk of having","Hypertension","Case-Control","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 1 molecular datasets,  SRA, 91 subjects, 91 samples","","NHLBI","GRU --- General research use","2012-04-12","2013-04-12","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs000443.v1.p1","Molecular Profiling of Cancer","Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor biology.  Here we discover 121 unannotated prostate cancer-associated ncRNA transcripts (PCATs) by ab initio assembly of high-throughput sequencing of polyA","Prostatic Neoplasms","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 22 variables,  SRA, 72 subjects, 144 samples","","NCI","CRGM --- Cancer research and general methods","2012-05-08","2012-05-08","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000444.v1.p1","Italian PBC Study","A Genome-wide association study of primary biliary cirrhosis (PBC) with an Italian cohort and loci meeting suggestive criteria were confirmed using a replication dataset from a previous Canadian study.  The results confirmed associations for IL12A, IL12RB2, and HLA (peak between DQA1 and DQB1) and identified novel associations with IKZF3/ORMDL3 on","Liver Cirrhosis, Biliary","Case-Control","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 18 variables, 1 documents, 1 analyses, 1 molecular datasets, 1389 subjects, 1389 samples","European (1389)","NIDDK","PBCRC --- Primary biliary cirrhosis and related conditions","2012-04-20","2012-04-20","Biliary Cirrhosis, Primary; Billiary Cholangitis, Primary; Cholangitis, Chronic Nonsuppurative Destructive; Cholangitis, Primary Billiary; Chronic Non-Suppurative Destructive Cholangitis; Chronic nonsuppurative destructive cholangitis"
"phs000445.v1.p1","HIV-Resistant People with Hemophilia","Rare individuals are highly resistant to infection with human immunodeficiency virus (HIV). Studies of candidate genes resulted in the discovery of a 32bp deletion in the CC-chemokine receptor 5  gene (CCR532), which rendered this critical co-receptor for primary HIV infection to be non-functional. Pharmacologic and vaccine-induced blockade","HIV","Case-Control","Not Provided","Not Applicable","OTHER, WGS","4 phenotype datasets, 14 variables,  SRA, 20 subjects, 21 samples","","NCI","HVI --- Hemophilia and viral infections","2012-10-16","2012-10-16","AIDS Virus; AIDS Viruses; Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; HIV - Human immunodeficiency virus; HTLV-III"
"phs000447.v1.p1","Prostate Cancer Genome Sequencing Project","Prostate cancer is a prevalent cause of cancer morbidity and mortality in men. In order to characterize the full range of somatic mutations in protein-coding genes that may drive  the growth of prostate cancer, we sequenced the exonic regions of genomic and tumor DNA from over 100 patients with high-risk primary prostate cancer","Prostatic Neoplasms","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WGS, WXS","4 phenotype datasets, 27 variables, 1 molecular datasets,  SRA, 149 subjects, 624 samples","","NHGRI","GRU --- General research use , CRO --- Cancer research only","2012-04-26","2012-04-26","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000448.v1.p1","Genetics of Schizophrenia in an Ashkenazi Jewish Case-Control Cohort","Schizophrenia is characterized by high heritability ( 80%), yet the identification of susceptibility genes has proven extremely challenging. The Ashkenazi Jewish population, derived from a limited number of founders,  may be enriched for a subset of susceptibility alleles, which may also have higher odds ratios than those detected by previous studies. GWAS was","Schizophrenia","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 documents, 1 molecular datasets, 3096 subjects, 3096 samples","European (3063), Hispanic1 (4), Hispanic2 (10), South Asian (1), Other (18)","NIMH","GRU --- General research use","2012-09-04","2013-09-04","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000449.v2.p1","Genetic Variation and Signatures of Natural Selection in Diverse Africans","Our study identified candidate regions of genome involved in adaptation and identified regions associated with selected phenotypes.","Population Control","Case-Control","Human1M-Duov3_B, Human1M-Duov3","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 2 molecular datasets, 172 subjects, 172 samples","African (123), African American (49)","NIEHS","NPU --- Non-profit use","2012-08-08","2012-08-08","Demographic Effectiveness; Effectiveness, Demographic"
"phs000450.v3.p1","Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma","Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is a clinically and genetically heterogenous disease that is further classified into transcriptionally defined activated B-cell (ABC)  and germinal center B-cell (GCB) subtypes. Here, we describe a comprehensive genetic analysis of DLBCLs that identifies low-frequency alterations","Lymphoma, Large B-Cell, Diffuse","Case Set","whole_genome_vcf","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 306 subjects, 442 samples","","NCI","GRU-NPU-MDS --- General research use (npu, mds) , DS-BLD-MDS --- Disease-specific (blood and lymph disorders, mds) , DS-CA-MDS --- Disease-specific (cancer, mds)","2018-10-11","2013-03-02","DLBCL; Diffuse Histiocytic Lymphoma; Diffuse Histiocytic Lymphomas; Diffuse Large Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse Large-Cell Lymphomas"
"phs000451.v1.p1","NHLBI and NIA The New England Centenarian Study (NECS)","Supercentenarians (age 110+ years old) generally delay or escape age-related diseases and disability well beyond the age one hundred and this exceptional survival is likely to be influenced by  a genetic predisposition that includes both common and rare genetic variants. In this report, we describe the complete genomic sequences of male and","Centenarian","Case-Control","whole_genome_vcf","Not Applicable","CNV Genotypes, SNP Genotypes (NGS), WGS","3 phenotype datasets, 12 variables, 1 molecular datasets,  SRA, 2 subjects, 2 samples","","NIA","GRU --- General research use","2012-09-13","2012-09-13","Aging, Biological; Biological Aging; Aged, 80 and over; Oldest Old; Length of Life; Lifespan"
"phs000452.v2.p1","Melanoma Genome Sequencing Project","Melanoma is the most prevalent cause of skin cancer morbidity and mortality. In order to characterize the full range of somatic mutations that may drive the growth of melanoma,  we are sequencing tumor and normal DNA from a set of roughly 150 melanomas. For the majority of samples (approximately 90% of the cases) mutations in","Melanoma","Case Set","maf_grc37, Genome-Wide_Human_SNP_Array_6.0, Genome-Wide_Human_SNP_Array_6_0, maf_grc37","Not Applicable","SNP Genotypes (Array), RNA-Seq, SNV Aggregate (.MAF), WGS, WXS","4 phenotype datasets, 30 variables, 2 molecular datasets,  SRA, 234 subjects, 737 samples","","NHGRI","GRU --- General research use , DS-M --- Disease-specific (melanoma)","2016-01-08","2016-01-08","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000454.v1.p1","HIV-1 Host Genetics Among Injection Drug Users","The overarching goal of this project is to identify and characterize genetic determinants of HIV 1 susceptibility and resistance in samples of African American (AA) and European American (EA)  injection drug users (IDUs) by conducting (1) a case/control genome-wide association (GWA) study of HIV 1 infection (positive/negative); (2) a case","HIV","Case-Control","HumanOmni1-Quad_v1-0_H, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 42 variables, 2 molecular datasets, 3227 subjects, 3884 samples","European (1082), African (36), African American (1997), Hispanic1 (34), Hispanic2 (43), Other Asian or Pacific Islander (6), Other (29)","NIDA","HRNC --- Health research (non-commercial)","2013-06-25","2014-06-25","AIDS Virus; AIDS Viruses; Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; HIV - Human immunodeficiency virus; HTLV-III"
"phs000455.v1.p1","Dobyns DBD","Study 1 2R01-NS050375 (PI: DOBYNS, William B.) The genetic basis of mid-hindbrain malformations Our general goal for this project is to advance our understanding of human developmental disorders that  involve the brainstem and cerebellum - brain structures derived from the embryonic midbrain and hindbrain - that affect a minimum of 2.4 per 1000","Brain Diseases","Case-Control","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 29 variables, 1 molecular datasets,  SRA, 10 subjects, 10 samples","","NINDS","GRU --- General research use","2012-06-22","2012-07-22","ACC; ACC - Agenesis of corpus callosum; Absence of Corpus Callosum; Absence of the corpus callosum; Absent corpus callosum; Ageneses, Corpus Callosum"
"phs000456.v1.p1","Risk Assessment of Cerebrovascular Events (RACE) Study","This study includes 1,220 cases with young onset stroke (stroke before age 60 years) who are participants of the larger RACE study. Risk Assessment of Cerebrovascular Events (RACE) is  an on-going existing case-control study of stroke now involving over 5000 imaging confirmed cases of stroke and 5000 controls, recruited from seven","Stroke","Case-Control","Human660W-Quad_v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 39 variables, 3 documents, 2 molecular datasets, 2627 subjects, 2632 samples","European (4), African American (4), Hispanic1 (14), Other Asian or Pacific Islander (2), South Asian (2427), Other (42)","NHGRI","GRU --- General research use","2012-05-08","2013-05-08","Anterior Cerebral Circulation Infarction; Infarction, Anterior Cerebral Circulation; Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents"
"phs000458.v1.p1","NEIGHBOR-Methylation in POAG","This is a case-control study of Primary Open Angle Glaucoma (POAG). POAG is a progressive optic neuropathy that eventually leads to blindness. More than 30 million people worldwide have  Primary Open Angle Glaucoma (POAG), of which greater than 3 million are blind. Gene expression changes in the retina have been observed for POAG","Glaucoma, Open-Angle","Case-Control","HumanMethylation450","Not Applicable","Methylation (CpG)","3 phenotype datasets, 9 variables, 1 molecular datasets, 122 subjects, 122 samples","","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2013-12-17","2014-09-17","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle"
"phs000459.v1.p1","Genome-wide Association Study of 24 Hour Urine Composition in the Nurses'    Health Study, Nurses' Health Study II, and the Health Professionals    Follow-Up Study","Building upon our previous linkage and association studies, we will use whole exome sequencing studies of second and third degree affected relatives drawn from multiplex families. Our specific aims  are: 1) To conduct whole exome sequencing on affected members (2 and 3 relatives) drawn from multiplex cleft families from a consortium to identify","Cleft Lip","Family/Twin/Trios","Not Provided","Not Applicable","WXS","4 phenotype datasets, 17 variables,  SRA, 115 subjects, 121 samples","","NIDCR","OC-IRB-COL-GSO-BEATY --- Oral clefts, irb, col, gso, beatyt , DS-CFD-GSO --- Disease-specific (craniofacial disorders, gso) , OC-IRB-COL-GSO-BAILEYWILSON --- Oral clefts, irb, col, gso, bailey-wilsonj , OC-IRB-COL-GSO-MANGOLD-NOTHEN --- Oral clefts, irb, col, gso, mangolde-nothenm , DS-OFC --- Disease-specific (orofacial cleft)","2016-01-13","2016-01-13","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip; Congenital fissure of lip"
"phs000460.v1.p1","Genome wide association study of 24 hour urine composition in the Nurses'    Health Study, Nurses' Health Study II, and the Health Professionals    Follow-Up Study","Genetic and environmental factors play an important role in the etiology of nephrolithiasis. This project will build on and extend our previous efforts (examining environmental risk factors for stone  formation) by allowing us to study the risk of stone formation associated with specific genes and gene-environment interactions. We will take","Nephrolithiasis","Prospective Longitudinal Cohort","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 2 documents, 1 molecular datasets, 1682 subjects, 1682 samples","European (1677), Hispanic1 (2), Hispanic2 (1), Other (2)","NIDDK","GRU-IRB --- General research use (irb)","2014-05-23","2014-05-23","Elevated urine calcium levels; Hypercalcinuria; Hypercalciuria; Hypercalcuria; High urine oxalate levels; Hyperoxaluria"
"phs000461.v1.p1","GLAUGEN-Methylation in POAG","This is a case-control study of Primary Open Angle Glaucoma (POAG). POAG is a progressive optic neuropathy that eventually leads to blindness. More than 30 million people worldwide have  Primary Open Angle Glaucoma (POAG), of which greater than 3 million are blind. Gene expression changes in the retina have been observed for POAG","Glaucoma, Open-Angle","Case-Control","HumanMethylation450","Not Applicable","Methylation (CpG)","3 phenotype datasets, 9 variables, 1 molecular datasets, 70 subjects, 70 samples","","NEI","GRU --- General research use","2014-02-19","2015-02-19","Compensated Glaucoma; Compensative Glaucoma; Glaucoma Simplex; Glaucoma, Compensated; Glaucoma, Compensative; Glaucoma, Open Angle"
"phs000472.v2.p1","Estrogen Receptor Positive Breast Cancer: Aromatase Inhibitor Response    Study","Highly variable outcomes are observed in patients with estrogen receptor positive (ER+) breast cancer who undergo preoperative estrogen deprivation therapy with aromatase inhibitors (AI). In this study, 46 baseline  tumor and normal genomes and 31 baseline tumor/normal exomes of participants selected from two clinical trials of neoadjuvant AI therapy on ER","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","5 phenotype datasets, 73 variables,  SRA, 115 subjects, 473 samples","","NHGRI","DS-CA --- Disease-specific (cancer)","2017-09-13","2017-09-13",""
"phs000473.v2.p2","Sweden-Schizophrenia Population-Based Case-Control Exome Sequencing","Current findings of the genetic risk of schizophrenia and bipolar disorder emerging from genome wide association studies (GWAS) support a highly polygenic model displaying the full spectrum of causal  alleles that includes the extremes of rare, penetrant alleles as well as common alleles of small effect. Lower frequency polymorphism, rare variants","Schizophrenia","Case-Control","exome_vcf_grc37, WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 19 variables, 2 molecular datasets,  SRA, 12380 subjects, 12380 samples","","NIMH","GRU --- General research use","2016-10-26","2016-10-26","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000474.v3.p2","Biology and Molecular Analysis of Human Hematopoiesis Genetics","In this study we have performed exome sequencing using the hybrid capture method that has previously been described (Gnirke et al., Nature Biotechnology, 2009) on genomic DNA samples from  patients with the congenital bone marrow failure syndrome that affects the erythroid lineage, specifically, Diamond-Blackfan anemia. This disease is","Anemia, Dyserythropoietic, Congenital","Mendelian","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 3 molecular datasets,  SRA, 556 subjects, 556 samples","","NHGRI","DS-BMF --- Disease-specific (bone marrow failure conditions)","2016-04-28","2016-04-28","ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND; Aase syndrome; Aase-Smith II syndrome; Aase-Smith syndrome II; Anemia congenital erythroid hypoplastic; Anemia, Blackfan Diamond"
"phs000475.v1.p1","The Molecular Basis of Inherited Reproductive Disorders","The purpose of this study is to discover genetic mutations in patients who have GnRH deficient states. This includes individuals with variant forms of hypogonadotropic hypogonadism, including individuals who  have somatic anomalies involving mid-line facial defects, renal agenesis, synkinesia, and ataxia, amongst others.","Hypogonadism","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 1 subjects, 1 samples","","NHGRI","GRU --- General research use","2012-06-08","2012-06-08","5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (human or pig); FSH Releasing Hormone; FSH-Releasing Hormone; Follicle Stimulating Hormone-Releasing Factor; GN-RH; GRF"
"phs000476.v1.p1","Molecular Defects in Pseudohypoparathyroidism or Related Disorders","Maintaining calcium levels within a narrow normal range is of critical importance for numerous different cellular functions. One of the most important regulators of blood calcium levels is parathyroid  hormone (PTH), which mediates its actions through the PTH/PTHrP receptor, a Gs-coupled receptor. Few inherited disorders are characterized by","Pseudohypoparathyroidism","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 20 subjects, 20 samples","","NHGRI","PHPH --- Pseudohypoparathyroidism or related disorders","2012-07-17","2012-07-17","PHD Ib; PHD Ibs; PHD1b; PHP IB; PHP1B; Pseudohypoparathyroidism Ib (PHP-Ib)"
"phs000477.v1.p1","Genetic Defects in Familial Renal Disorders","1. Several different genes cause, when mutated, increased urinary phosphate excretion and hypophosphatemia leading to rickets/osteomalacia; however, the majority of phosphate-wasting disorders has not yet been defined at the  molecular level. Identification of phosphate-regulating genes has provided important novel insights into the mechanism contributing to phosphate","Hypophosphatemia, Familial","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 21 subjects, 31 samples","","NHGRI","FRD --- Genetic defects in familial renal disorders","2012-06-06","2012-06-06","ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE; ARTHRODENTOOSTEODYSPLASIA; Acrodentoosteodysplasia; Arthro-dento-osteo dysplasia; Arthrodentoosteodysplasias; CHENEY SYNDROME"
"phs000478.v1.p1","Strabismus, CCDD and Other Anomalies","Strabismus is one of the most common ophthalmological diseases affecting our population. It has many detrimental effects for affected individuals, including functional visual loss from amblyopia, secondary psychosocial difficulties,  and limited employment opportunities. Strabismus also imposes a significant economical burden on society from the cost of screening programs","Strabismus","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 13 subjects, 13 samples","","NHGRI","CCDD --- Strabismus, cranial nerve abnormalities and associated disorders","2012-05-07","2012-05-07","Blepharoptoses; Blepharoptosis; Drooping eyelid; Drooping upper eyelid; Droopy eyelid; Droopy eyelids"
"phs000479.v1.p1","NHLBI Exome Sequencing in SCID","Analysis of the molecular etiologies of severe combined immunodeficiency (SCID) has led to important insights into the control of immune cell development. Most cases of SCID result from either  X-linked or autosomal recessive inheritance of mutations in a known causative gene. However, in some cases, the molecular etiology remains unclear","Severe Combined Immunodeficiency","Family/Twin/Trios","Not Provided","Not Applicable","WXS","6 phenotype datasets, 36 variables, 1 documents,  SRA, 3 subjects, 3 samples","","NHLBI","GRU --- General research use","2013-04-25","2014-04-25","Bubble boy disease; Combined Immunodeficiencies, Severe; Combined Immunodeficiency, Severe; Combined T-cell and B-cell immunodeficiency; Immunodeficiencies, Severe Combined; Immunodeficiency Syndrome, Severe Combined"
"phs000481.v2.p1","Cholesterol and Pharmacogenetics (CAP) Study","The Cholesterol and Pharmacogenetics Study was a 6-week open label, non-randomized study of 40mg/day simvastatin treatment in 335 African-American and 609 Caucasian (944 total) men and women. Plasma lipids  and lipoproteins were measured on two occasions prior to treatment and at 4 and 6 weeks of treatment. The study was designed to test for genetic","Hypercholesterolemia","Clinical Trial","HumanHap300v1-1_C, Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array), RNA-Seq","5 phenotype datasets, 31 variables, 2 molecular datasets, 650 subjects, 911 samples","European (545), African American (3), Hispanic1 (7), Hispanic2 (17), Other Asian or Pacific Islander (3), South Asian (1), Other (10)","NHLBI","GRU --- General research use","2016-01-07","2013-02-07","HMG CoA Reductase Inhibitors; HMG-CoA Reductase Inhibitors; HMG-CoA Statins; Hydroxymethylglutaryl CoA Reductase Inhibitors; Hydroxymethylglutaryl CoenzymeA Reductase Inhibitors; Hydroxymethylglutaryl-CoA Inhibitors"
"phs000482.v1.p1","Sporadic Autism Exomes Reveal a Highly Interconnected Protein Network of    De Novo Mutations","It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70% of cases, the underlying genetic cause is unknown. Under the  hypothesis that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or","Autistic Disorder","Family/Twin/Trios","Not Provided","Not Applicable","WXS","4 phenotype datasets, 19 variables,  SRA, 617 subjects, 617 samples","","NIMH","DS-ASD-RD --- Disease-specific (autism spectrum disorder, rd)","2012-09-07","2012-09-07","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000483.v1.p1","Massachusetts General Hospital/Eisai NIMH AD Genetics Initiative Study","This study cohort was collected as part of the National Institute of Mental Health (NIMH) Alzheimer's disease Genetics Initiative Study. Recruitment of families, predominantly sibling, for the cohort was  focused on local memory disorder clinics, nursing homes, and the surrounding community. Clinical evaluation was performed at the University of","Alzheimer Disease","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 23 variables, 1504 subjects, 1504 samples","","NIMH","","","","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000484.v1.p1","Molecular Genetic Analysis of Inherited Kidney Dysfunction","Samples were chosen for sequencing from a set of probands from pedigrees with apparently inherited forms of focal segmental glomerulosclerosis (FSGS). Several genes have been identified which when mutated  cause FSGS under both recessive and dominant inheritance patterns. These known genes are estimated to explain less than 50% of inherited FSGS. We","Glomerulosclerosis, Focal Segmental","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 7 subjects, 7 samples","","NHGRI","IKD --- Kidney diseases","2012-06-06","2012-06-06","FGS - Focal glomerulosclerosis; FSGS; FSGS - Focal Segmental Glomerulosclerosis; Focal Glomerulosclerosis; Focal Sclerosing Glomerulonephritides; Focal Sclerosing Glomerulonephritis"
"phs000485.v1.p1","Gene Mutation and Rescue in Congenital Diaphragmatic Hernia","Congenital Diaphragmatic Hernia (CDH) is a common and life-threatening malformation. The most common phenotype is left-sided posterolateral (Bochdalek-type) hernia accompanied by pulmonary hypoplasia. Due to the high mortality, most  of the cases have no family history for CDH. The rare presumed Mendelian instances of CDH have the potential to be extremely informative about the","Congenital diaphragmatic hernia","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 4 subjects, 4 samples","","NHGRI","CDH --- Congenital diaphragmatic hernia and related disorders","2012-06-08","2012-06-08","Not Provided"
"phs000486.v1.p1","Integration of Genomics and Transcriptomics in unselected Twins and in    Major Depression","Our goals are to develop a comprehensive understanding of the genomics of transcription in a population based unselected sample and to discover DNA and RNA biomarkers for major depressive  disorder (MDD). This work is essential to developing a more complete understanding of the biological basis of MDD, a common complex trait associated","Depressive Disorder, Major","Prospective Longitudinal Cohort","Affymetrix_Human_Genome_U219_Array, Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), mRNA Expression (Array)","5 phenotype datasets, 44 variables, 2 molecular datasets, 8257 subjects, 10490 samples","European (4926), African American (3), Hispanic1 (17), Hispanic2 (3), Other Asian or Pacific Islander (27), South Asian (7), Other (78)","NIMH","DS-PD-RSC --- Disease-specific (psychiatric disorders and related somatic conditions)","2014-12-18","2015-12-18","Depression, Involutional; Involutional Melancholia; Melancholia, Involutional"
"phs000487.v2.p1","Functionally Active Copy Number Variants Associated with Prostate Cancer    Risk","Prostate cancer is a leading cause of cancer death in males throughout the world and has the largest estimated effect of heritability among the most common tumor types. Copy  Number Variants (CNVs) are a recently recognized class of human germline polymorphisms (Iafrate AJ, et al. (2004) Nat Genet 36, 949-951; Sebat J, et","Prostatic Neoplasms","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","CNV Genotypes","4 phenotype datasets, 22 variables, 2 analyses, 1 molecular datasets, 1903 subjects, 1903 samples","","NCI","DS-PC-NPU-MDS-GSO --- Disease-specific (prostate cancer, npu, mds, gso)","2014-04-15","2014-01-04","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000488.v2.p1","Genomic Sequencing of Lung Adenocarcinoma","Lung carcinoma is the leading cause of cancer death in the United States and world-wide; lung adenocarcinoma is the most common cause of lung cancer. Pilot studies of lung  adenocarcinoma with hybrid-capture based whole exome sequencing will enable us to identify new targets for therapy and improve diagnosis. We will","Carcinoma, Non-Small-Cell Lung","Case Set","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WGS, WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 208 subjects, 430 samples","","NHGRI","GRU --- General research use , DS-CA --- Disease-specific (cancer) , DS-LC --- Disease-specific (lung cancer) , DS-CA-MDS --- Disease-specific (cancer, mds)","2016-12-08","2012-10-18","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER"
"phs000490.v1.p1","A Study of the Genetic Causes of Complex Pediatric Disorders","The Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia (CHOP) is a high-throughput, highly automated genotyping and sequencing facility equipped with state-of-the-art genotyping and sequencing platforms.  Children who are treated at the Children's Hospital Healthcare Network and their parents may be eligible to take part in a major initiative to","Non-Neoplastic Pediatric Disorder","Case-Control","HumanHap550_v3, Human610-Quadv1_B, BDCHP-1X10-HUMANHAP550","Not Applicable","SNP Genotypes (Array)","9 phenotype datasets, 174 variables, 1 molecular datasets, 7431 subjects, 7430 samples","European (3322), African (47), East Asian (93), African American (2862), Hispanic1 (198), Hispanic2 (68), Other Asian or Pacific Islander (63), South Asian (45), Other (94)","NHGRI","GRU --- General research use","2012-10-02","2013-10-02","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000491.v1.p1","Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma","Study to evaluate the molecular genetics of ccRCC through integrative analyses of tumors and tumorgrafts using multiple platforms in clinically annotated samples. Genome and exome data for patients giving  consent to have the information available on a public, secure, database is being submitted.","Carcinoma, Renal Cell","Case-Control","Not Provided","Not Applicable","WXS","5 phenotype datasets, 30 variables,  SRA, 3 subjects, 7 samples","","NCI","GRU --- General research use","2012-10-05","2013-01-05","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs000492.v2.p1","Genetics of Human Developmental Brain Disorders","Developmental brain malformations are at the core of significant neurological diseases affecting many families in the United States and around the world. It is known that epilepsy, specific learning  deficits and intellectual disability, cerebral palsy, and abnormalities of brain volume can be attributed in many cases to pathological malformations","Microcephaly","Cross-Sectional","exome_vcf_grc37, WGS_markerset_grc37, HumanOmni2.5-8v1_C, Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array), RNA-Seq, SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), Targeted-Capture, WXS","6 phenotype datasets, 22 variables, 2 molecular datasets,  SRA, 96 subjects, 146 samples","","NHGRI","DS-EAC-PUB-GSO --- Disease-specific (epilepsy and cognition, pub, gso) , DS-MMS-PUB-GSO --- Disease-specific (microcephaly-micromelia syndrome, pub, gso) , DS-PM-PUB-GSO --- Disease-specific (polymicrogyria, pub, gso) , GRU-PUB --- General research use (pub) , GRU-IRB-NPU --- General research use (irb, npu)","2017-07-26","2017-07-26","Abnormalities, Congenital, Nervous System; Abnormalities, Nervous System; Abnormality of the nervous system; Abnormality, Nervous System; Anomalies, Nervous System; Anomaly, Nervous System"
"phs000493.v1.p1","Genetic Association Studies in the Solomon Islanders","The goal of this study was to determine the genetics underlying blond hair in the Solomon Islands, which has the highest prevalence of blondism outside of Europe. Participants in  the study were of self-reported Solomon Islands ancestry and were 6-36 years of age at enrollment. Individuals with blond (N 43) and dark hair (N 42","Hair","Case-Control","Not Provided","Not Applicable","Not Provided","1 analyses","","NHGRI","NPR --- Non-profit research","2013-02-22","","Fetal Hair; Fetal Hairs; Hair, Fetal; Hairs, Fetal"
"phs000494.v1.p1","CCHMC - eMERGE Data","This submission includes genotyping data from 6 separate cohorts (named A-E here), each is described in separate paragraphs below. Cohort A) Autism is a neurodevelopmental disorder that affects 1.5  million people in the United States, at an estimated lifetime cost of $4 million. It is part of Pervasive Developmental Disorder characterized by","Child Health","Prospective Longitudinal Cohort","Human610-Quadv1_B, Human660W-Quad_v1_A, HumanOmni5-4v1_B, Genome-Wide_Human_SNP_Array_6.0, HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 4562 subjects, 4562 samples","European (3786), African (7), East Asian (21), African American (473), Hispanic1 (111), Hispanic2 (77), Other Asian or Pacific Islander (23), South Asian (26), Other (37)","NHGRI","HR_CCHMC --- Health research - cincinnati children's hospital medical center","2012-07-23","2013-07-23","Arthritis, Juvenile Systemic; Juvenile Onset Still Disease; Juvenile Onset Stills Disease; Juvenile Systemic Arthritis; Juvenile onset Still's disease; Juvenile-Onset Still's Disease"
"phs000495.v1.p1","The Gene Partnership (TGP) - eMERGE Data","The Gene Partnership (TGP) is a prospective longitudinal registry at Boston Children's Hospital (BCH) to study the genetic and environmental contributions to childhood health and disease, collect genetic information  on a large number of children who have been phenotyped, and implement the Informed Cohort and the Informed Cohort Oversight Board (ICOB). The term","Non-Neoplastic Pediatric Disorder","Prospective Longitudinal Cohort","Axiom_GW_EUR_1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 55 variables, 1 molecular datasets, 1024 subjects, 1077 samples","European (738), East Asian (17), African American (128), Hispanic1 (73), Hispanic2 (15), Other Asian or Pacific Islander (20), South Asian (7), Other (26)","NHGRI","HR_CHB --- Health research - children's hospital boston","2012-08-30","2013-08-30","Arrhythmia; Arrhythmia, Cardiac; Arrhythmias, Cardiac; Arrythmia; Cardiac Arrhythmias; Cardiac Dysrhythmia"
"phs000496.v1.p1","Columbia University Study of Caribbean Hispanics and Late Onset    Alzheimer's disease","Compared to Caucasians residing in the same community the incidence rate of Alzheimer's disease is approximately twice as high in Caribbean Hispanics. Moreover, Caribbean Hispanics represent a homogenous population  with only a few founders. Replication of genetic associations in other ethnic groups provides supporting evidence that a putative gene is involved in","Alzheimer Disease","Case-Control","HumanOmni1-Quad_v1-0_H, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 53 variables, 2 molecular datasets, 4002 subjects, 3208 samples","European (131), African (7), African American (1029), Hispanic1 (1780), Hispanic2 (110), Other (82)","NIA","GRU-IRB --- General research use (irb)","2014-07-09","2015-07-09","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000497.v3.p2","Genetic Analysis of Hirschsprung Disease","Hirschsprung disease (HSCR) is a birth defect resulting from the absence of nerve (ganglion) cells in the gastrointestinal tract. Hirschsprung disease has a population incidence of 1/5,000 live births  and most often occurs as an isolated condition. However, approximately 30% of HSCR cases are associated with other birth defects such as Down","Disease, Hirschsprung","Mendelian","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 2 molecular datasets,  SRA, 416 subjects, 421 samples","","NHGRI","DS-HD --- Disease-specific (hirschsprung disease)","2016-10-13","2013-12-03","Aganglionic Megacolon; Aganglionosis; Congenital Megacolon; Congenital aganglionic megacolon; Congenital intestinal aganglionosis; Disease, Hirschsprung's"
"phs000500.v1.p1","Non-Invasive Whole Genome Sequencing of a Human Fetus","The overall purpose of this study was to demonstrate the feasibility of producing haplotype-phased whole genome sequence data from a fetus using free fetal DNA isolated from maternal plasma  collected during the first half of gestation.","Prenatal Care","Family/Twin/Trios","Not Provided","Not Applicable","POOLCLONE, WGS","4 phenotype datasets, 19 variables,  SRA, 6 subjects, 8 samples","","NHGRI","GRU --- General research use","2013-01-30","2013-01-30","Antenatal Care; Antepartum care of mother; Care, Antenatal; Care, Prenatal; Pregnancy care"
"phs000502.v1.p1","Genome-Wide Analysis of Splenic Marginal Zone Lymphoma","Splenic Marginal Zone Lymphoma (SMZL) is a B-cell malignancy of unknown pathogenesis and thus orphan of targeted therapies. By integrating whole-exome sequencing and copy-number analysis of 8 paired tumor-normal  DNAs from patients with SMZL, we show that the typical SMZL exome carries 30 genetic alterations. Targeted resequencing of selected candidates in an","Lymphoma, Non-Hodgkin","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WXS","3 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 8 subjects, 16 samples","European (8)","NCI","CRGM_PUB --- Cancer research and general methods with publication statement","2012-08-02","2013-08-02","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma; Reticulum-Cell Sarcomas"
"phs000504.v2.p2","Medulloblastoma exome sequence analysis","Medulloblastomas are the most common malignant brain tumors in children. Identifying and understanding the genetic events that drive these tumors is critical for the development of more effective diagnostic,  prognostic and therapeutic strategies. Recently, our group and others described distinct molecular subtypes of medulloblastoma based on","Medulloblastoma","Case-Control","Not Provided","Not Applicable","WXS","4 phenotype datasets, 16 variables,  SRA, 92 subjects, 184 samples","","NHGRI","DS-CA --- Disease-specific (cancer)","2013-12-04","2012-07-31",""
"phs000505.v2.p1","Gene Fusion Discovery through RNA Sequencing of Human Glioblastoma Stem    Cell Lines","We used massively parallel, paired-end sequencing of expressed transcripts (RNA-seq) to detect novel gene fusions in short-term cultures of glioma stem-like cells freshly isolated from nine patients carrying primary  glioblastoma multiforme (GBM). The culture of primary GBM tumors under serum-free conditions selects cells that retain phenotypes and genotypes","Glioblastoma","Case Set","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 10 variables,  SRA, 24 subjects, 24 samples","","NCI","GRU-MDS --- General research use (mds)","2013-07-31","2012-10-31","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (Glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme"
"phs000506.v1.p1","NIAID Multicenter AIDS Cohort Study (MACS)","The Multicenter AIDS Cohort Study (MACS) is an ongoing prospective study of the natural and treated histories of HIV-1 infection in homosexual and bisexual men conducted by sites located  in Baltimore, Chicago, Pittsburgh and Los Angeles. A total of 6,972 men have been enrolled. From April 1984 through March 1985, 4954 men were","Acquired Immunodeficiency Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","","","NIAID","","","","AIDS Related Opportunistic Infections; AIDS, Opportunistic Infection; AIDS-Related Opportunistic Infection; AIDS-Related Opportunistic Infections; HIV Related Opportunistic Infections; HIV-Related Opportunistic Infection"
"phs000507.v2.p2","Benign Ethnic Neutropenia/Leukopenia (BEN) in African-Americans","Benign ethnic neutropenia (BEN) is a clinical condition more commonly observed in African-Americans. It is characterized by a relative reduction in neutrophil count by about 1000 cells per microliter,  leading to a decrease in total leukocyte count by similar decrement. Previous reports of this condition showed that there was neither higher","Neutropenia","Case-Control","HumanOmniExpress-12v1_H, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 34 variables, 4 documents, 2 molecular datasets, 1200 subjects, 1273 samples","European (5), African (48), African American (1119), Hispanic1 (15), Other (1)","NHLBI","HMB --- Health/medical/biomedical","2019-07-10","2019-07-10","Not Provided"
"phs000508.v2.p1","Genomic Sequencing of Pediatric Rhabdoid Cancers","In this study, we sequenced the exomes of 35 rhabdoid tumors, highly aggressive cancers of early childhood. This study is part of a larger effort to characterize pediatric cancers  as part of the Slim Initiative for Genomic Medicine (SIGMA) project.","Rhabdoid Tumor","Case-Control","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 35 subjects, 70 samples","","NCI","PCR --- Pediatric cancer research , DS-CA-MDS --- Disease-specific (cancer, mds)","2014-04-15","2014-04-15","Not Provided"
"phs000509.v1.p1","Genome Sequencing of Hepatocellular Carcinoma","Hepatocellular carcinoma (HCC) accounts for 85-90% of primary liver cancers. We have focused on three major HCC etiologies:hepatitis C virus (HCV), hepatitis B virus (HBV), and nonviral causes. The  onset and progression of cancer is driven by extensive rearrangement and mutation of the genome. We combined our capability to capture and enrich","Carcinoma, Hepatocellular","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 22 variables, 1 molecular datasets,  SRA, 100 subjects, 178 samples","","NHGRI","GRU --- General research use","2015-06-23","2015-12-23","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs000511.v1.p1","Treatment of Genetic Screening of Hypertriglyceridemia type I, III, and V    - HTG Amsterdam","This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.","Hypertriglyceridemia","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 48 subjects, 48 samples","","NHGRI","HTG --- Hypertriglyceridemia type i, iii, and v","2012-10-01","2012-10-01","Not Provided"
"phs000512.v1.p1","Genetics of High HDL Cholesterol","We have assembled what we believe to be the largest cohort in the world ascertained specifically based on the phenotypes of extremely low or high HDL-Cholesterol (HDL-C). Several years  ago, we initiated a protocol at the University of Pennsylvania to recruit subjects with extremely low or high levels of HDL-C with the primary goal","Lipoproteins, HDL","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 97 subjects, 97 samples","","NHGRI","CD --- Cardiovascular disease","2012-10-19","2012-10-19","HLD - Hyperlipidemia; Hyperlipemia; Hyperlipemias; Hyperlipidemias; Lipidemia; HDL Cholesterol, Low Serum"
"phs000513.v1.p1","MAST Kinase and Notch Gene Families in Breast Cancer","Paired-end transcriptome sequencing was performed on a panel of breast cancer cell lines and tissues and a set of benign cell line and tissue controls. Analyses of the paired  end sequences were performed and chimeric transcripts derived from gene rearrangement events were identified. Sequencing was performed on Illumina","Breast Neoplasms","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 19 variables,  SRA, 89 subjects, 89 samples","","NCI","CRGM --- Cancer research and general methods","2012-09-14","2012-09-14","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000514.v1.p1","Identification of Genes Involved in Familial Coronary Artery Disease","Studying families with multiple cases of coronary artery disease (CAD) or with early onset CAD in order to identify new genes involved in CAD in an autosomal dominant manner.  After identifying these genes in families that pass on CAD in Mendelian inheritance, we want to pursue their role in the pathogenesis of CAD and","Coronary Artery Disease","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 19 subjects, 19 samples","","NHGRI","GRU --- General research use","2012-10-25","2012-10-25","Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery"
"phs000516.v2.p1","Genome Sequencing of Pancreatic Ductal Adenocarcinoma","Pancreatic ductal adenocarcinomas (PDAC) is the 11th most common cancer in the USA but the 4th in fatalities. The onset and progression of cancer is driven by extensive rearrangement  and mutation of the genome. We combined our capability to capture and enrich exome DNA with the next generation sequencing capacity to allow us to","Carcinoma, Pancreatic Ductal","Case Set","Not Provided","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 37 variables,  SRA, 59 subjects, 118 samples","","NHGRI","GRU --- General research use","2017-04-13","2013-12-13","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas"
"phs000517.v3.p1","Multiethnic Cohort (MEC) Breast Cancer Genetics","The Multiethnic Cohort Study is a population-based prospective cohort study (n 215,251) that was initiated between 1993 and 1996 and includes subjects from various ethnic groups - African Americans  and Latinos primarily from Californian (great Los Angeles area) and Native Hawaiians, Japanese-Americans, and European Americans primarily from","Breast Neoplasms","Case-Control","Human660W-Quad_v1_A, Human1M-Duov3_H, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 19 variables, 1 documents, 2 molecular datasets, 3708 subjects, 3790 samples","European (34), African (21), East Asian (1650), African American (869), Hispanic1 (45), Hispanic2 (992), Other Asian or Pacific Islander (58), Other (39)","NCI","DS-CA --- Disease-specific (cancer) , GRU-MDS --- General research use (mds) , HMB-MDS --- Health/medical/biomedical (mds)","2015-06-11","2014-01-25","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000518.v1.p1","NHLBI GO-ESP Family Studies: Idiopathic Bronchiectasis","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Bronchiectasis","Prospective Longitudinal Cohort","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 24 subjects, 24 samples","","NHLBI","GRU --- General research use","2012-10-12","2013-01-12","Bronchiectases; Permanent enlargement of the airways of the lungs"
"phs000519.v1.p1","Study of Melanoma Risk in Australia and the United Kingdom","The results from a small number of melanoma GWAS have been published. Initial studies identified several pigmentation- and nevus-associated loci that mediate an effect on melanoma risk, however, these  studies were somewhat limited in that sample number (hence power) was low, they used first-generation low density SNP arrays, or used pools of DNA","Melanoma","Case Set","HumanOmniExpressExome-8v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 353 variables, 1 molecular datasets, 3912 subjects, 4079 samples","European (3907), African American (1), Hispanic1 (1), Other (3)","NCI","GRU-MDS --- General research use (mds) , DS-M-MDS --- Disease-specific (melanoma, mds)","2014-03-12","2015-03-12","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000521.v1.p1","Episodic Ataxia Syndrome","Individuals with episodic ataxia experience recurrent attacks of dizziness and incoordination; between attacks patients are typically normal. The majority of cases are likely caused by an inherited genetic mutation.  However, in some patients we are unable to identify the mutation. So far, 2 genes have been identified which cause different types of episodic ataxia","Ataxia","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","15 phenotype datasets, 1872 variables, 10 documents, 131 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-10-26","2017-10-26","Ataxia (loss of muscle coordination); Ataxias; Ataxy; Coordination Impairment; Coordination Impairments; Dyssynergia"
"phs000522.v1.p1","Hyperdiploid Acute Lymphoblastic Leukemia RNA-Seq","Few genetic drivers of children with hyperdiploid precursor B-cell acute lymphoblastic leukemia (ALL) have been identified to date. In an effort to detect novel genomic rearrangements that could be  promoting leukemogenesis in this subset of patients, we sequenced ribosomal RNA-depleted transcriptomes isolated from 5 hyperdiploid acute","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Case Set","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 10 variables,  SRA, 5 subjects, 5 samples","","NCI","PCRGM --- Pediatric cancer research and general methods","2013-01-16","2014-01-16","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL"
"phs000523.v1.p1","Cebu Longitudinal Health and Nutrition Survey (CLHNS)","Conducted by a team of researchers from the United States and the Philippines, the Cebu Longitudinal Health and Nutrition Survey is part of an ongoing study of a cohort  of Filipino women who gave birth between May 1, 1983, and April 30, 1984. The cohort of children born during that period, their mothers, other","Maternal Nutritional Physiological Phenomena","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 29 variables, 1 molecular datasets, 1799 subjects, 1799 samples","East Asian (199), Other Asian or Pacific Islander (1600)","NIDDK","GRU --- General research use","2012-09-17","2012-09-17",""
"phs000524.v1.p1","Chronic Renal Insufficiency Cohort Study (CRIC)","The Chronic Renal Insufficiency Cohort (CRIC study) was established in 2001 by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to improve the understanding of the relationship  between chronic kidney disease and cardiovascular disease. The goals of the CRIC Study are to examine risk factors for progression of chronic kidney","Chronic Renal Insufficiency","Case Set","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 129 variables, 119 documents, 1 molecular datasets, 3598 subjects, 3598 samples","European (1600), African (45), East Asian (43), African American (1458), Hispanic1 (72), Hispanic2 (309), Other Asian or Pacific Islander (24), South Asian (25), Other (22)","NIDDK","AHC --- All health conditions , KHB --- Research on disease of kidney, heart and blood vessels","2013-01-04","2013-01-04","Chronic Kidney Insufficiencies; Chronic Renal Insufficiencies; Chronic renal impairment; Kidney Insufficiencies, Chronic; Kidney Insufficiency, Chronic; Renal Insufficiencies, Chronic"
"phs000525.v1.p1","Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers","In this study, we describe a systematic analysis of pseudogene 'transcription' from an RNA-Seq resource of 293 samples, from 13 cancer and normal tissue types. We observed a highly  prevalent, genome-wide expression of pseudogenes that could be categorized as universally expressed or lineage- and/or cancer-specific. We also","Neoplasms","Cross-Sectional","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 15 variables,  SRA, 293 subjects, 293 samples","","NCI","CRGM --- Cancer research and general methods","2013-03-29","2013-03-29","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000535.v1.p1","Genome and Targeted Sequencing of Bladder Cancer","One primary bladder cancer and paired peripheral blood sample were subjected to whole genome sequencing on an Illumina HiSeq 2000 platform. This technology was utilized to investigate the genetic  basis of a durable remission of metastatic bladder cancer in a patient treated with everolimus, a drug that inhibits the mTOR (mammalian target of","Urinary Bladder Neoplasms","Clinical Trial","Not Provided","Not Applicable","OTHER, WGS","4 phenotype datasets, 18 variables,  SRA, 14 subjects, 16 samples","","NCI","GRU --- General research use","2012-11-02","2012-11-02","Bladder Cancer; Bladder Cancers; CA - Bladder cancer; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder"
"phs000536.v2.p1","Retrotransposition in Colorectal Cancer","The purpose of this study is to ascertain the locations of somatic LINE-1 retrotransposition events in human colon tumor samples by pooling multiple tumor samples from different patients and  performing a targeted resequencing assay (Ewing and Kazazian, Genome Research 2010) to sequence the 3' flanking regions of all insertions in the","Colonic Neoplasms","Case-Control","Not Provided","Not Applicable","AMPLICON","5 phenotype datasets, 29 variables,  SRA, 92 subjects, 17 samples","","NIGMS","GRU --- General research use","2016-02-25","2012-11-27","CA - Cancer of colon; COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic"
"phs000537.v1.p1","Next Generation Mendelian Genetics: Familial Hemophagocytic    Lymphohistiocytosis","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Familial hemophagocytic lymphohistiocytosis (fHLH) is a serious immune disorder that results from  defective cytotoxic lymphocyte function. Autosomal recessive mutations in PFP1, UNC13D, STX11, STBP2, or RAB27, and hemizygous mutations in SH2D1A or","Lymphohistiocytosis, Hemophagocytic","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 4 subjects, 4 samples","","NHGRI","GRU --- General research use","2012-11-26","2012-11-26","Acquired hemophagocytic lymphohistiocytosis; Hemophagocytic Syndrome, Infection Associated; Hemophagocytic Syndrome, Infection-Associated; Hemophagocytic Syndrome, Reactive; Hemophagocytic syndrome due to infection; IAHS"
"phs000538.v1.p1","Next Generation Mendelian Genetics: Familial Combined Hyperlipidemia","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. The research study procedures included the collection of a fasting blood sample,  2 medical history/life style questionnaires and a measurement of subjects' waist circumference that were completed many years ago. Blood samples were","Hyperlipidemia, Familial Combined","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 6 subjects, 6 samples","","NHGRI","HD --- Heart disease","2012-11-28","2012-11-28","COMBINED HYPERLIPIDEMIA, FAMILIAL; Combined Hyperlipidemias, Familial; FAMILIAL COMBINED HYPERLIPIDEMIA; FCHL; FCHL3; Familial Combined Hyperlipidemias"
"phs000539.v1.p1","Next Generation Mendelian Genetics: Congenital Hyperinsulinism","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Congenital Hyperinsulinism (CHI) is the most common cause of hypoglycemia in the  newborn and it is due to mutations in 8 different genes (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, HNF4A and UCP2). It is a heterogeneous disease","Hyperinsulinism, Congenital","Mendelian","target_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets,  SRA, 8 subjects, 8 samples","","NHGRI","GRU --- General research use","2012-12-04","2012-12-04","ABCC8-Related Hyperinsulinism; Autosomal recessive hyperinsulinemic hypoglycemia due to SUR1 deficiency; Familial Hyperinsulinemic Hypoglycemia 1; HHF1; HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA; HYPERINSULINISM, CONGENITAL"
"phs000540.v1.p1","Next Generation Mendelian Genetics: Ehlers-Danlos Syndrome Type VIII","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Ehlers-Danlos syndrome Type VIII is a dominantly inherited connective tissue disorder that  is distinguished from other forms of EDS by significant early-onset periodontal disease. Although the clinical phenotype is well delineated, the","Ehlers-Danlos Syndrome","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 8 subjects, 8 samples","","NHGRI","DCT --- Disorders of connective tissues","2012-11-30","2012-11-30","Cutis Elastica; Cutis hyperelastica; Cutis hyperelastica dermatorrhexis; Danlos Disease, Ehlers; Danlos disease; Disease, Ehlers Danlos"
"phs000541.v1.p1","Next Generation Mendelian Genetics: Muscle Hypertrophy","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Samples were collected from a single, multi-generational family with the same phenotype  of exaggerated muscular development (muscular hypertrophy) and strength characterized by reduced fat pad thickness under the skin. All family members","Hypertrophy","Mendelian","exome_vcf_grc37, targeted_region_sequencing","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 7 subjects, 7 samples","European (3)","NHGRI","MDD --- Muscle development disorders","2013-03-28","2013-03-28","Not Provided"
"phs000542.v1.p1","Next Generation Mendelian Genetics: Neonatal Diabetes","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. Neonatal diabetes mellitus (ND) is a rare form of monogenic diabetes (90,000-260,000  live births) that is diagnosed in the first 6 months of life. The disease has been classified as transient or permanent and although it can be","Pancreatic beta cell agenesis with neonatal diabetes mellitus","Mendelian","target_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 4 subjects, 4 samples","","NHGRI","GRU --- General research use","2012-11-28","2012-11-28","Congenital absence of insulin-producing beta cells with diabetes mellitus"
"phs000543.v1.p1","Exome Sequencing of Pleuropulmonary Blastoma","Pleuropulmonary blastoma (PPB) is a rare, aggressive pediatric cancer arising from the lung or pleural cavity. In this study, we sequenced and analyzed the exomes of 15 PPB matched  tumor and normal pairs. This study is part of a larger effort to characterize pediatric cancers as part of the Slim Initiative for Genomic Medicine","Pleuropulmonary Blastoma","Case Set","Somatic_Mutations_TCGA","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 14 variables, 1 analyses, 1 molecular datasets,  SRA, 15 subjects, 30 samples","","NCI","GRU-MDS --- General research use (mds)","2014-11-06","2014-11-06","Not Provided"
"phs000545.v1.p1","Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical    Factors","We hypothesized that genetic variability in the enzymes/proteins involved in drug metabolism, inflammation, and immune function is a major underlying contributor to mucositis incidence and progression and that, based  on this variability we can identify variants that influence risk, and develop a mucositis progression prediction model that improves on existing","Multiple Myeloma","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 molecular datasets, 764 subjects, 764 samples","European (699), African (1), East Asian (2), African American (41), Hispanic1 (5), Hispanic2 (11), South Asian (3), Other (2)","NINR","DS-CIM --- Disease-specific (chemotherapy induced mucositis)","2015-06-12","2016-06-12","Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease; Kahler's disease"
"phs000546.v1.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Stroke","Case-Control","exome_vcf_grc37, exome_vcf_ESP6800","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 36 variables, 2 molecular datasets, 75 subjects, 75 samples","","NHLBI","DS-STK-IRB-RD --- Disease-specific (stroke, irb, rd)","2013-07-10","2013-10-10","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Apoplexy"
"phs000547.v1.p1","A Genome-Wide Association Study in Breast Cancer Patients from the    SUCCESS Trial","The SUCCESS-A Study (http://www.success-studie.de) is a randomized Phase III study of response to treatment of early primary breast cancer with adjuvant therapy after surgical resection. The primary outcome is  disease-free survival and secondary outcomes are overall survival and toxicity. The study design includes comparison of two pairs of treatment","Breast Neoplasms","Interventional","HumanOmniExpress-12v1_G_FFPE, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 41 variables, 4 documents, 2 molecular datasets, 3596 subjects, 3440 samples","European (3274), East Asian (5), African American (2), Hispanic1 (11), Hispanic2 (4), Other Asian or Pacific Islander (3), South Asian (1), Other (22)","NHGRI","BCETC --- Breast cancer, study drug efficacy and toxicity, and covariates","2012-12-19","2013-12-19","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000548.v1.p1","Aspirin Pharmacogenomics","The study protocol for both cohorts has been previously described (Journal of Thrombosis and Thrombolysis 2012:1-12). HV1 cohort: Briefly 50 healthy volunteers were exposed to two weeks of 325mg/day  aspirin after which whole blood RNA was collected in PAXgene tubes and profiled by microarray before and after aspirin exposure. The pre-aspirin","Aspirin","Interventional","Affy_expression_Human_Genome_U133_Plus2_0","Not Applicable","mRNA Expression (Array)","5 phenotype datasets, 14 variables, 1 molecular datasets, 104 subjects, 201 samples","","NIGMS","ASP --- Aspirin-related research","2013-07-10","2014-07-10",""
"phs000549.v1.p1","Clonal Evolution of Pre-Leukemic HSC Precedes Human AML","Acute myeloid leukemia is an aggressive clonal malignancy of the bone marrow that is the direct result of sequential acquisition of mutations in a single lineage of cells. In  this study, we investigate a model in which this mutational acquisition occurs serially in long-lived self-renewing hematopoietic stem cells","Leukemia, Myeloid, Acute","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 16 variables,  SRA, 6 subjects, 12 samples","","NHLBI","DS-BD-MDS --- Disease-specific (blood disorders, mds)","2013-06-13","2013-06-13","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs000550.v1.p1","Characterization of Pancreatic Adenocarcinoma Patients Using NGS","In this study, we whole genome sequenced tumor/normal pairs from three pancreatic adenocarcinoma patients to separately characterize each patient with respect to somatic alterations. For 2 patients for whom  tumor RNA was available, we also performed RNA sequencing to evaluate gene expression changes. While additional sequencing is needed to improve our","Pancreatic Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS","4 phenotype datasets, 19 variables,  SRA, 4 subjects, 9 samples","","NCI","GRU --- General research use","2013-01-29","2013-01-29","Carcinoma, no subtype; Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant"
"phs000551.v1.p1","Gene expression in CAD","Case control cohort: The details have been previously published: American Heart Journal. 2010;160:371-379 e372. Briefly, a nested case:control cohort of CATHGEN participants who had experienced death or MI (n  250) after their index catheterization and age-, sex-, and race-matched controls (n 250) who were free of death/MI 2 years after cardiac","Cardiovascular Diseases","Case-Control","Affy_expression_Human_Genome_U133_Plus2_0","Not Applicable","mRNA Expression (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 594 subjects, 638 samples","","NIGMS","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2012-11-19","2013-05-19","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000552.v2.p1","Genomic Characterization of Meningiomas","Meningiomas are the most common primary brain tumor in the US. Although the tumor suppressor gene NF2 is disrupted in approximately half of meningiomas, the complete spectrum of genetic  changes in meningiomas remains poorly understood, particularly in the large subset of tumors without NF2 alterations. Therefore we performed whole","Meningioma","Case Set","exome_vcf_grc37","Not Applicable","AMPLICON, SNP/CNV Genotypes (NGS), WGS, WXS","4 phenotype datasets, 15 variables, 1 analyses, 2 molecular datasets,  SRA, 65 subjects, 130 samples","","NCI","DS-BDBC-NPU-MDS --- Disease-specific (brain disorders and brain cancer, npu, mds)","2014-04-15","2013-01-17","Diffuse meningiomatosis; Meningioma, Multiple; Meningiomas, Multiple; Meningiomatoses; Meningiomatosis; Multiple Meningioma"
"phs000553.v1.p1","Familial Exome Sequencing in Rare Pediatric Phenotypes","To discover novel candidate genes associated with rare Mendelian phenotypes, we will conduct individual genomic and phenotypic characterization using genome-wide array, pedigree exome sequencing, candidate genotyping, and pertinent clinical  testing to define phenotype. Pedigrees included in this submission will have a variety of clinical pathological phenotypes.","Mendelian","Family/Twin/Trios","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WXS","5 phenotype datasets, 30 variables, 2 documents, 1 molecular datasets,  SRA, 6 subjects, 7 samples","European (5)","NHLBI","GRU-MDS --- General research use (mds)","2013-06-27","2014-06-27","Isolated Non-compaction of the Ventricular Myocardium; Isolated Noncompaction of the Ventricular Myocardium; Microlissencephalies; Microlissencephaly; Microlissencephaly II; Microlissencephaly III"
"phs000554.v1.p1","Mutational Landscape of Lethal Castrate Resistant Prostate Cancer","Exome sequencing of matched pairs of tumor / normal genomic DNA was performed from high risk localized prostate cancer or lethal, metastatic, castrate resistant prostate cancer (CRPC). Exome libraries  were prepared using Illumina Paired_End Genome DNA Sample Prep Kit and captured using Agilent SureSelect Capture Library or Roche EZ Exome capture","Prostatic Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WXS","5 phenotype datasets, 30 variables,  SRA, 59 subjects, 120 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2017-10-17","2017-10-17","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000556.v1.p1","NHLBI GO-ESP: Family Studies (Atypical Cystic Fibrosis)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Cystic Fibrosis","Case-Control","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 25 variables, 1 molecular datasets,  SRA, 12 subjects, 6 samples","","NHLBI","DS-CF --- Disease-specific (cystic fibrosis)","2013-07-10","2013-10-10","CF; CF - Cystic fibrosis; Fibrocystic disease; Fibrosis, Cystic; MUCOVISCIDOSIS"
"phs000558.v1.p1","Glaucoma Exome Sequencing","This is a study of primary open angle glaucoma (POAG) conducted through exome sequencing of cases and comparison of variant frequencies with general population frequencies available in dbGAP and  controlled for sequencing platform artifact to minimize false positives. POAG is an intraocular pressure (IOP) related progressive optic neuropathy","Glaucoma","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 21 variables,  SRA, 175 subjects, 175 samples","","NEI","GRU-IRB --- General research use (irb)","2017-04-07","2017-10-07","Not Provided"
"phs000559.v1.p1","PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE)    - BioVU Cancer Project","As part of Population Architecture using Genomics and Epidemiology PAGE study (Phase I), the Epidemiologic Architecture using Genomics and Epidemiology (EAGLE I) project accessed both epidemiologic- and clinic-based collections.  The epidemiologic-based collection of EAGLE I included the National Health and Nutritional Examination Surveys (NHANES), ascertained between 1991","Neoplasms","Case-Control","custom_probe_set","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 68 variables, 1 molecular datasets, 15256 subjects, 15256 samples","","NHGRI","GRU --- General research use","2014-01-15","2015-01-15","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000560.v1.p1","The Detroit Neighborhood Health Study (DNHS)","The Detroit Neighborhood Health Study (DNHS) is a prospective, representative longitudinal cohort study of predominantly African American adults living in Detroit, Michigan. The overall goal of the DNHS is  to identify how genetic variation, lifetime experience of stressful and traumatic events, and features of the neighborhood environment predict","Stress Disorders, Post-Traumatic","Prospective Longitudinal Cohort","HumanOmniExpress-12v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 91 variables, 1 molecular datasets, 845 subjects, 507 samples","European (70), African (9), African American (415), Hispanic1 (3), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (1), Other (2)","NIDA","GRU-NPU --- General research use (npu)","2014-07-25","2015-07-25","Combat Neurosis; Neuroses, Post Traumatic; Neuroses, Post-Traumatic; Neuroses, Posttraumatic; PTSD; PTSD - Post-traumatic stress disorder"
"phs000561.v1.p1","Metabolism and Genetics of Hypobetalipoproteinemia","Hypobetalipoproteinemia is characterized by extremely low levels of low-density lipoprotein cholesterol. Familial hypobetalipoproteinemia (FHBL) is a monogenic form of hypobetalipoproteinemia caused by mutations in the APOB gene. There are  cases of hypobetalipoproteinemia not caused by mutations in APOB, however. The purpose of this study is to identify novel genetic causes of","Hypobetalipoproteinemias","Mendelian","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 11 subjects, 11 samples","","NHGRI","HPBLM --- Metabolism and genetics of hypobetalipoproteinemia: population screen","2012-11-14","2012-11-14","Familial Hypobetalipoproteinemia; Hypo beta Lipoproteinemia; Hypo beta Lipoproteinemias; Hypobetalipoproteinemia"
"phs000562.v1.p1","The Genetic Landscape of Mutations in Burkitt Lymphoma","Burkitt lymphoma (BL) is characterized by deregulation of MYC, but the contribution of other genetic mutations to the disease is largely unknown. We sequenced exomes of 59 BL tumors,  14 of which had paired normal tissue. Our work elucidates commonly occurring gene-coding mutations in Burkitt lymphoma and implicates ID3 as a novel","Burkitt Lymphoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WXS","4 phenotype datasets, 14 variables,  SRA, 59 subjects, 72 samples","","NCI","GRU --- General research use","2013-01-29","2013-01-29","BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt tumor [obs]; Burkitt's Lymphoma; Burkitt's Tumor"
"phs000563.v1.p1","Pilocytic Astrocytoma in NF1","Neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome is one of the most common autosomal dominant tumor predisposition syndromes in which affected individuals develop brain tumors. These low-grade glial  neoplasms (pilocytic astrocytomas) typically arise in children younger than 7 years of age and are hypothesized to result from a combination of","Pilocytic Astrocytoma","Case Set","HumanMethylation450","Not Applicable","Methylation (CpG), WGS","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 4 subjects, 10 samples","","NCI","DS-BST --- Disease-specific (brain and spinal tumors)","2013-07-01","2013-07-01","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Glioma; Neoplasm of Neuroglia"
"phs000564.v2.p1","Rapid Whole Genome Sequencing for Genetic Disease Diagnosis in the NICU","Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3,500 monogenic diseases have been characterized, but clinical testing  is available for only some of them and many feature clinical and genetic heterogeneity. As such, an immense unmet need exists for improved molecular","Congenital, Hereditary, and Neonatal Diseases and Abnormalities","Family/Twin/Trios","whole_genome_vcf_grc37","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 19 variables, 2 molecular datasets, 279 subjects, 278 samples","","NICHD","GRU-IRB-PUB-COL-NPU-MDS-GSO --- General research use (irb, pub, col, npu, mds, gso)","2015-07-14","2015-07-14","Ataxia; Ataxia, Cerebellar; Ataxias, Cerebellar; Cerebellar Ataxias; Cerebellar Incoordination; Cerebellar Incoordinations"
"phs000565.v1.p1","Copy Number Variation in Congenital Kidney Malformations","We report a study of large rare, copy number variants (CNVs) in 192 patients with renal hypodysplasia (RHD). Congenital malformations of the kidney and urinary tract are present in  3 to 7 per 1,000 births, accounting for 16% of birth defects. These malformations account for 40-50% of pediatric and 7% of adult end-stage renal","Congenital Abnormalities","Case Set","Human660W-Quad_v1_A, Human610-Quadv1_B","Not Applicable","CNV Genotypes","4 phenotype datasets, 12 variables, 1 molecular datasets, 192 subjects, 192 samples","","NIDDK","GRU --- General research use","2012-12-14","2012-12-14","Anomaly of chromosome; Chromosomal Disorder; Chromosomal Disorders; Chromosomal abnormality syndrome; Chromosomal anomaly; Chromosomal hereditary disorder"
"phs000567.v1.p1","NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative    Sequencing","Transcriptome sequencing of solitary fibrous tumors / hemangiopericytomas from a variety of anatomic sites revealed recurrent gene fusions between two genes, NAB2 and STAT6. All SFTs examined exhibited an  in-frame fusion transcript encoding a fusion protein containing the EGR1 interaction domain of NAB2 with the transcriptional activation domain of","Solitary Fibrous Tumors","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 20 variables,  SRA, 26 subjects, 26 samples","","NCI","CRM --- Cancer research and methods","2013-01-11","2014-01-11","Not Provided"
"phs000568.v1.p1","Genomic Sequencing of Solitary Fibrous Tumors","Solitary fibrous tumors (SFTs) are rare mesenchymal tumors that can be benign or malignant. In this study, we sequenced and analyzed the exomes of 17 SFT matched tumor and  normal pairs. This study appertains to a large endeavor to characterize cancers as part of the Slim Initiative for Genomic Medicine in the Americas","Sarcoma","Case Set","whole_exome_seq","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 17 subjects, 34 samples","","NCI","GRU --- General research use","2013-01-10","2013-01-10","Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas"
"phs000572.v7.p4","Alzheimer's Disease Sequencing Project (ADSP)","The overarching goals of the Alzheimer's Disease Sequencing Project (ADSP) are to: (1) identify new genomic variants contributing to increased risk of developing Alzheimer's Disease (AD), (2) identify new  genomic variants contributing to protection against developing AD, and (3) provide insight as to why individuals with known risk factor variants","Alzheimer Disease","Case-Control","WGS_markerset_grc37, WES_markerset_grc37","Not Applicable","CNV Genotypes, SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","8 phenotype datasets, 72 variables, 6 molecular datasets,  SRA, 15630 subjects, 11529 samples","European (233), African American (78), Hispanic1 (256), Hispanic2 (7), Other (4)","NHGRI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-ALZ-IRB --- Disease-specific (alzheimer disease, irb) , DS-ALZ-IRB-NPU --- Disease-specific (alzheimer disease, irb, npu) , DS-ND-IRB --- Disease-specific (neurodegenerative disease, irb) , DS-ND-IRB-NPU --- Disease-specific (neurodegenerative disease, irb, npu)","2016-04-12","2017-05-15","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000573.v1.p1","Genetic Heterogeneity of Diffuse Large B Cell Lymphoma","We sequenced exomes of 94 DLBCL tumors and cell lines. 34 of the tumors had paired normal tissue. Our work elucidates commonly occurring gene-coding mutations in DLBCL.","Lymphoma, Large B-Cell, Diffuse","Case-Control","target_vcf_grc36","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 94 subjects, 128 samples","","NCI","GRU --- General research use","2013-04-02","2013-04-02","DLBCL; Diffuse Histiocytic Lymphoma; Diffuse Histiocytic Lymphomas; Diffuse Large Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse Large-Cell Lymphomas"
"phs000574.v1.p1","Rett Syndrome Natural History Protocol","This observational study will involve the comprehensive assessment of the clinical features of Rett syndrome with this Rare Diseases Clinical Research Network. A clinical database of 1350 individuals with  Rett syndrome including MECP2 mutation status for the purpose of elaborating phenotype-genotype correlations will be established. Eligible","Rett Syndrome","Case Set","Not Provided","Not Applicable","Not Provided","21 phenotype datasets, 2728 variables, 13 documents, 1020 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-03-13","2017-03-13","MeCP-2 Protein; MeCP2; MeCP2 Protein; Methyl CpG Binding Protein 2; AUTISM, DEMENTIA, ATAXIA, AND LOSS OF PURPOSEFUL HAND USE; Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome"
"phs000575.v1.p1","PWS Natural History Protocol","This observational study will involve the comprehensive assessment of the medical, behavioral and nutritional history and the clinical features of individuals with Prader-Willi syndrome and individuals with features of  PWS-like/EMO. A blood sample will be obtained from the participants in order to create a DNA and RNA repository. In those PWS participants with a","Prader-Willi Syndrome","Case Set","Not Provided","Not Applicable","Not Provided","19 phenotype datasets, 3052 variables, 15 documents, 200 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-02-23","2017-02-23","Morbid Obesities; Morbid Obesity; OBESITY, SEVERE; Obesities, Morbid; Obesities, Severe; Obesity, Morbid"
"phs000576.v1.p1","Angelman Syndrome Natural History Protocol","This study is a longitudinal multidisciplinary investigation on the natural history, morbidity and mortality of Angelman Syndrome (AS). We will collect detailed longitudinal data on a cohort of AS  individuals to gain a better understanding of the disease progression, and to follow the natural history of the clinical features of this cohort","Angelman Syndrome","Clinical Trial","Not Provided","Not Applicable","Not Provided","20 phenotype datasets, 3306 variables, 23 documents, 245 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-03-20","2017-03-20","AS; Angelman syndrome-like; Angelman's syndrome; Children, Puppet; HAPPY PUPPET SYNDROME; HAPPY PUPPET SYNDROME, FORMERLY"
"phs000577.v1.p1","UCDC Longitudinal Study","Individuals with Urea Cycle Disorders (UCD) cannot remove ammonia, a waste product, from the blood. The purpose of this study is to conduct a longitudinal investigation of the natural  history, morbidity, and mortality in people with UCD. This study will look at how people with a UCD grow and develop over time and how often they get","Urea Cycle Disorders, Inborn","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","30 phenotype datasets, 12964 variables, 41 documents, 542 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-01-31","2018-01-31","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder"
"phs000578.v1.p1","Nondystrophic Myotonias","NMD are rare ion channel disorders. The optimal management and treatment of these disorders are not known. This multi-center proposal will allow the prospective collection of standardized data from  a critical number of patients to help better define the clinical features of NDM. The data will also be used to establish clinically relevant","Nondystrophic myotonia","Clinical Trial","Not Provided","Not Applicable","Not Provided","23 phenotype datasets, 2896 variables, 18 documents, 95 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-10-24","2017-10-24",""
"phs000579.v1.p1","Small Intestine Neuroendocrine Tumors (Carcinoid Tumors)","The diagnosed incidence of small bowel neuroendocrine tumors (NETs) is increasing. While patients with localized disease can be treated surgically, those with metastatic disease currently have few treatment options.  The success of biologically targeted therapies in other malignancies has led to interest in the molecular alterations underlying the pathogenesis of","Intestinal Neoplasms","Case Set","Somatic_Mutations_TCGA","Not Applicable","SNV (.MAF), WGS, WXS","4 phenotype datasets, 20 variables, 1 analyses, 1 molecular datasets,  SRA, 51 subjects, 105 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-GI-MDS --- Disease-specific (gastrointestinal illness, mds) , GRU-MDS --- General research use (mds)","2013-11-06","2013-11-22","Intestinal Tumor; Intestinal Tumors; Intestines Neoplasm; Intestines Neoplasms; Neoplasm of Intestines; Neoplasm of intestine"
"phs000580.v1.p1","PAGE: CALiCo: Strong Heart Study (SHS)","The SHS is a study of cardiovascular disease and its risk factors among American Indian men and women. Using standardized methodology, it was designed to estimate cardiovascular disease mortality  and morbidity and the prevalence of known and suspected cardiovascular disease risk factors and to assess the significance of these risk factors in a","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 analyses","","NHGRI","HMB --- Health/medical/biomedical","2013-06-12","","C Reactive Protein; C-Reactive Protein; CRP - C-reactive protein; Protein, C-Reactive; Proteins, specific or class, C-reactive; Cholesterol, HDL2"
"phs000581.v1.p1","NHLBI GO-ESP: Family Studies (Dilated Cardiomyopathy)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Cardiomyopathy, Dilated","Case Set","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 49 subjects, 48 samples","","NHLBI","DS-FDC --- Disease specific (familial dilated cardiomyopathy)","2013-06-11","2013-09-11","1As, Dilated cardiomyopathy; CARDIOMYOPATHY, CONGESTIVE; CARDIOMYOPATHY, DILATED, WITH CONDUCTION DEFECT 1; CARDIOMYOPATHY, FAMILIAL IDIOPATHIC; CARDIOMYOPATHY, IDIOPATHIC DILATED; CDCD1"
"phs000582.v1.p1","NHLBI GO-ESP: Family Studies (Familial Interstitial Pneumonia)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Idiopathic Pulmonary Fibrosis","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NHLBI","DS-LD --- Disease specific (lung diseases)","2013-05-16","2013-08-16","Acute interstitial pneumonitis; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; Dysplasias, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA"
"phs000583.v1.p1","Asian Indian Diabetic Heart Study (AIDHS)","The Punjabi Sikh population is a well-defined, carefully collected homogeneous sample from northern India and the US. It has unique characteristics, which are ideal for genetic studies. Sikhs are  strictly a non-smoking population and about 50% of participants are life-long vegetarians. All subjects included in the genome-wide association","Metabolic Syndrome X","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 molecular datasets, 1616 subjects, 1616 samples","South Asian (1611), Other (5)","NIDDK","T2DMS --- Type 2 diabetes and metabolic syndrome","2014-03-24","2014-03-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000585.v2.p1","International Consortium for Blood Pressure (ICBP)","The ICBP consortium is an international effort to investigate blood-pressure genetics. The consortium was formed by two parent consortia, the CHARGE-BP consortium (Cohorts for Heart and Aging Research in  Genomic Epidemiology - blood pressure) and the GBPGEN consortium (Global Blood Pressure Genetics Consortium). In 2011 we performed genome-wide","Hypertension","Metagenomics","Not Provided","Not Applicable","Not Provided","6 analyses","","NHLBI","GRU-IRB --- General research use (irb)","2016-10-26","2016-10-26","DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure; Diastolic arterial pressure; Pressure, Diastolic; BP - High blood pressure"
"phs000586.v1.p1","Genome Wide Association Studies in Alopecia Areata","1054 unrelated alopecia areata patients were genotyped with the Illumina HumanHap550v3.0 genotyping chip. Allele frequencies were compared to publically available data from three population cohorts of controls.","Alopecia Areata","Case Set","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 1054 subjects, 1054 samples","European (1039), African American (1), Hispanic1 (3), Hispanic2 (4), South Asian (2), Other (5)","NIAMS","DS-AA-MDS-RD --- Disease-specific (alopecia areata, mds, rd)","2017-04-10","2017-04-10","AA - Alopecia areata; Alopecia Circumscripta; Circumscribed alopecia; Patchy loss of hair"
"phs000587.v1.p1","NHLBI GO-ESP: Family Studies (Mendelian Lipid Disorders)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Hyperlipoproteinemia Type II","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 29 subjects, 29 samples","","NHLBI","DS-CLA --- Disease-specific (cardiovascular disease, lipoprotein metabolism disorders/atherosclerosis)","2014-04-28","2014-07-28","Density Lipoproteinemia, Hyper-Low; Density Lipoproteinemias, Hyper-Low; Essential Hypercholesterolemia; Essential Hypercholesterolemias; Essential familial hypercholesterolemia; FH"
"phs000588.v1.p1","VCRC5502: Longitudinal Protocol for Giant Cell Arteritis","The development and validation of accurate biological markers and predictors of disease activity and outcome for Giant Cell Arteritis, a form of idiopathic vasculitis, would have a major positive  impact on the clinical care of patients with this rare disease, be an important insight into the design of clinical trials and feasibility of new","Giant Cell Arteritis","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","32 phenotype datasets, 3390 variables, 30 documents, 194 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-08-14","2019-08-14","Arterial Inflammation; Arteritides; Arteritis; Inflammation of artery; Inflammation, Arterial; Arteritides, Giant Cell"
"phs000589.v1.p1","VCRC5503: Longitudinal Protocol for Takayasu's Arteritis","The development and validation of accurate biological markers and predictors of disease activity and outcome for Takayasu's arteritis, a form of idiopathic vasculitis, would have a major positive impact  on the clinical care of patients with this rare disease, be an important advance in the design of clinical trials and feasibility of new drug","Takayasu Arteritis","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","33 phenotype datasets, 3409 variables, 30 documents, 138 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-07-30","2019-07-30","Arterial Inflammation; Arteritides; Arteritis; Inflammation of artery; Inflammation, Arterial; Aortitis Syndrome"
"phs000590.v1.p1","VCRC5504: Longitudinal Protocol for Polyarteritis Nodosa","The development and validation of accurate biological markers and predictors of disease activity and outcome in Polyarteritis Nodosa (PAN), a form a idiopathic vasculitis, would have a major positive  impact on the clinical care of patients with this rare disease, be an important advance in the design of clinical trials and feasibility of new drug","Polyarteritis Nodosa","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","28 phenotype datasets, 3245 variables, 28 documents, 71 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-09-06","2018-09-06","Arterial Inflammation; Arteritides; Arteritis; Inflammation of artery; Inflammation, Arterial; Classical Polyarteritis Nodosa"
"phs000592.v1.p1","Screening Protocol and Longitudinal Study of Bone Marrow Failure    Syndromes and Cytopenias","The purpose of this study is to characterize patients with Bone Marrow Failure Syndromes (BMFS) and to track the clinical course of patients with these diseases over time. An  exact and comprehensive diagnosis at presentation is essential. Due to the sporadic nature of BMFS (aplastic anemia, myelodysplastic syndrome","Anemia, Aplastic","Clinical Trial","Not Provided","Not Applicable","Not Provided","22 phenotype datasets, 2534 variables, 22 documents, 341 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-07-27","2017-07-27","Hemoglobinuria, Nocturnal Paroxysmal; Hemoglobinuria, Paroxysmal Nocturnal; Marchiafava Micheli Syndrome; Marchiafava-Micheli Syndrome; Marchiafava-Micheli disease; Nocturnal Paroxysmal Hemoglobinuria"
"phs000594.v1.p1","A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia","LGL leukemia can be divided into three subsets including the following:  or T-LGL and NK-LGL leukemia. All three subtypes will be enrolled using a two-stage design. The primary  endpoint of the study is assessment of overall clinical response. Correlative laboratory studies will be performed aimed at determining the mechanism","Leukemia, Large Granular Lymphocytic","Clinical Trial","Not Provided","Not Applicable","Not Provided","21 phenotype datasets, 2605 variables, 16 documents, 9 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-06-21","2017-06-21","Aggressive NK Cell Leukemia; Aggressive Natural Killer Cell Leukemia; LGL Leukemia; LGL Leukemias; LGLL - Large granular lymphocytic leukemia; Large Granular Lymphocyte Leukemia"
"phs000595.v1.p1","PCD Cross-Sectional","We have established a consortium of 7 geographically-dispersed clinical research sites that are designed to study rare diseases of the airways, which involve defects in clearance of mucus secretions  from the airways (defective ""mucociliary clearance""). These sites will collaborate in diagnostic, genetic, and other studies in patients with","Primary ciliary dyskinesia","Clinical Genetic Testing","Not Provided","Not Applicable","Not Provided","16 phenotype datasets, 2059 variables, 14 documents, 617 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-08-18","2017-08-18","Bronchiectasis, chronic sinusitis AND dextrocardia syndrome; DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS; KARTAGENER SYNDROME; Kartagener Triad; Kartagener's Syndrome; Kartagener's Triad"
"phs000596.v1.p1","Longitudinal Study of PCD: 5-18 Years of Age","The purpose of this longitudinal study protocol is to define age-related prevalence of phenotypic characteristics and the progression of key features of lung disease in participants with one of  these disorders, Primary Ciliary Dyskinesia (PCD). In PCD, the abnormal structure and function of cilia results in impaired clearance of secretions","Primary ciliary dyskinesia","Clinical Genetic Testing","Not Provided","Not Applicable","Not Provided","15 phenotype datasets, 1532 variables, 16 documents, 124 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-08-18","2017-08-18","Bronchiectasis, chronic sinusitis AND dextrocardia syndrome; DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS; KARTAGENER SYNDROME; Kartagener Triad; Kartagener's Syndrome; Kartagener's Triad"
"phs000597.v1.p1","DNA Methylation Analysis of Prostate Cancer","Aberrant DNA methylation changes are known to occur during prostate cancer progression beginning with precursor lesions. Utilizing fifty nanograms of genomic DNA in Methylplex-Next Generation Sequencing (M-NGS) we mapped  the global DNA methylation patterns in prostate tissues (n 17) and cells (n 2). Peaks were located from mapped reads obtained in each sequencing run","Prostatic Neoplasms","Case-Control","Not Provided","Not Applicable","OTHER","4 phenotype datasets, 23 variables,  SRA, 17 subjects, 19 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2013-11-26","2013-11-26","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000598.v2.p2","Exome Sequencing of Esophageal Adenocarcinoma","The incidence of esophageal adenocarcinoma (EAC) has risen 600% over the last 30 years. When coupled to the five-year survival rate of only 15% for this disease, identification of  new therapeutic targets for EAC is of great importance. Here, we analyze the mutational spectra identified from the whole genome sequencing of 16","Esophageal Neoplasms","Tumor vs. Matched-Normal","whole_exome_seq","Not Applicable","SNV (.MAF), WGS, WXS","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 150 subjects, 300 samples","","NHGRI","DS-HEC --- Disease-specific (human esophageal cancer) , DS-CA --- Disease-specific (cancer) , DS-CA-MDS --- Disease-specific (cancer, mds)","2013-11-22","2013-11-22","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophagus Neoplasm; Esophagus Neoplasms; Esophagus Tumor"
"phs000600.v1.p1","Genomic Sequencing of Cervical Cancers","Cervical cancer is responsible for 10-15% of cancer related deaths in women worldwide. The etiological role of infection with high-risk human papilloma viruses (HPV) in carcinomas of the cervix  is well established. In general, the development of cervical carcinomas follows a progression from persistent HPV infection through precancerous","Uterine Cervical Neoplasms","Case-Control","Somatic_Mutations_TCGA","Not Applicable","RNA-Seq, SNV (.MAF), WGS, WXS","4 phenotype datasets, 24 variables, 2 analyses, 1 molecular datasets,  SRA, 115 subjects, 230 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2014-03-19","2014-03-19","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs000601.v1.p1","Identifying the Genetic Explanation for Heritable Breast Cancer","The project developed a suite of new methods (FAVR) designed to assist the shortlisting of genetic variants under a rare variant-phenotype/disease model. The methods were designed to work with  commonly used massively parallel sequencing analysis pipelines, such as the GATK or ANNOVAR, and have been made publically available as a suite of","Breast Neoplasms","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 20 subjects, 20 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2013-10-29","2013-10-29","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000602.v2.p1","Identification of Targetable FGFR Gene Fusions in Diverse Cancers","In this study, patients with advanced cancer across all histologies were enrolled in our IRB approved clinical sequencing program, called MI-ONCOSEQ, to go through an integrative sequencing which includes  whole exome sequencing of the tumor and matched normal, and transcriptome sequencing. Four index cases were identified which harbor gene","Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 16 variables,  SRA, 7 subjects, 7 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2014-04-16","2013-05-21","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000603.v1.p1","AME Natural History Protocol","The objective of this project is to observe the natural history of apparent mineralocorticoid excess (AME). AME is a rare monogenic hypertensive disease first described by the Principal Investigator,  Dr. Maria I. New, in 1977 [1], for which the first mutation in the causative HSD11B2 gene was reported by her group in 1995. [2] Little is known","Apparent mineralocorticoid excess","Case Set","Not Provided","Not Applicable","Not Provided","10 phenotype datasets, 506 variables, 9 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-03-14","2018-03-14","11-beta-hydroxysteroid dehydrogenase deficiency type 2; AME; AME - apparent mineralocorticoid excess; AME 1; AME1; Apparent Mineralocorticoid Excess Syndrome"
"phs000604.v1.p1","Mapping Genes for Mammographic Density","We recruited 1,521 women from the Old Order Amish (OOA) population of Lancaster County, Pennsylvania, with the primary goal of identifying genetic factors that influence mammographic density. All women  were between the ages of 40 and 88 years, with a mean of 54 years. Additional study design details, including eligibility criteria, are described","Neoplasms","Collection","Not Provided","Not Applicable","Not Provided","3 analyses","","NCI","GRU-MDS --- General research use (mds)","2013-08-22","","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000605.v1.p1","Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus    Trial (The MILES Trial)","Lymphangioleiomyomatosis (LAM) is an uncommon, progressive, cystic lung disease that predominantly affects young women. It is believed to be caused by defects within cellular pathways that regulate nutrient uptake,  cell size, cell migration, and cell proliferation. The disease is caused by mutations in tuberous sclerosis complex (TSC) genes. Individuals with","Lymphangioleiomyomatosis","Clinical Trial","Not Provided","Not Applicable","Not Provided","20 phenotype datasets, 3727 variables, 37 documents, 111 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-03-30","2018-03-30","LAM; LYMPHANGIOMYOMATOSIS; Lymphangioleiomyomatoses; Lymphangioleiomyomatosis, somatic; Lymphangiomyomatoses; TSC1-Related Lymphangioleiomyomatosis"
"phs000606.v1.p1","HIT after Cardiac Bypass","The purpose of this study is to determine how often heart surgery patients who receive heparin develop an immune response (heparin-induced thrombocytopenia) that leads to clots forming in different  parts of the body. These clots usually occur in the legs (deep venous thrombosis or DVT) or lungs (pulmonary embolism or PE) or cause heart attacks","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","11 phenotype datasets, 626 variables, 14 documents, 1051 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-03-16","2018-03-16","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000607.v3.p2","Neurodevelopmental Genomics: Trajectories of Complex Phenotypes","This study is a collaboration between the Center for Applied Genomics (CAG) at Children's Hospital of Philadelphia (CHOP) and the Brain Behavior Laboratory at the University of Pennsylvania (Penn).  The cohort consists of youths aged 8-21 years who consulted the CHOP network and volunteered to participate in genomic studies of complex pediatric","Mental Processes","Prospective Longitudinal Cohort","Human610-Quadv1_B, Genome-Wide_Human_SNP_Array_6.0, HumanHap550_v3, Axiom, HumanOmniExpress, HumanHap550_v1, BDCHP-1X10-HUMANHAP550, Human1M-Duov3_B, HumanOmniExpress-12v1_A, HumanOmniExpress-12v1_B, HumanOmniExpressExome-8v1_A","Not Applicable","SNP Genotypes (Array)","7 phenotype datasets, 936 variables, 3 documents, 2 molecular datasets, 9496 subjects, 9267 samples","European (5285), African (55), East Asian (72), African American (3257), Hispanic1 (300), Hispanic2 (85), Other Asian or Pacific Islander (55), South Asian (44), Other (121)","NIMH","GRU-NPU --- General research use (npu)","2018-05-17","2018-05-17","Form of thinking, function; Form of thought; Human Information Processing; Information Processing, Human"
"phs000608.v1.p1","Whole Genome Profiling to Detect Schizophrenia Methylation Markers","Schizophrenia (SCZ) is a devastating psychiatric disorder. The aim of this study was to detect DNA methylation (5meC) profiles in whole blood associated with SCZ. The sample consisted of  schizophrenia cases and controls selected from national population registers in Sweden. We employed MBD protein-based enrichment of the methylated","Schizophrenia","Case-Control","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 31 variables, 2 documents, 1 molecular datasets, 1459 subjects, 1459 samples","","NIMH","GRU --- General research use","2013-12-13","2014-12-13","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000609.v1.p1","RNA-Seq studies of Gene Expression in Cells and Networks in FI and ACC in    Autism","RNA-Seq studies of Gene Expression in Cells and Networks in FI (fronto-insular) and AC (anterior cingulate) cortex in Autism. We seek to understand the cellular bases of autism by  using a new technology, RNA-Seq, to determine differences in gene expression in autopsy brains of subjects with well described autism versus age and","Autism","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 18 variables,  SRA, 27 subjects, 43 samples","","NIMH","GRU --- General research use","2013-06-20","2013-06-20","AUTISTIC DISORDER; AUTS; Autism (209850); Autism disorder; Autism, Early Infantile; Autism, Infantile"
"phs000611.v1.p1","Whole Genome Comparisons of Breast Cancers and their Xenotransplants","Early passage breast cancer xenografts have been proposed as alternatives to cell lines as model systems for studying the basic biology of tumors and for advancing therapy development. This  study explores the relatedness of primary disease genomes to their matched xenotransplants. Using paired-end massively parallel sequencing 17 matched","Breast Neoplasms","Xenograft","whole_genome_vcf_grc36","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 16 subjects, 67 samples","","NHGRI","DS-CA --- Disease-specific (cancer) , DS-CROTx --- Cancer treatment research only","2014-01-15","2014-03-15","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000612.v1.p1","The mutational characterization of adenoid cystic carcinoma","Adenoid cystic carcinoma (ACC) typically emanate from the major and minor salivary glands of the head and neck. ACCs have high rates of perineural invasion, locoregional recurrence, and distant  metastasis. Here we report sequencing of 60 tumor/normal pairs and find substantial mutational diversity. On pathway analysis, a significant","Cancer","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","CNV Genotypes, WXS","4 phenotype datasets, 34 variables, 1 molecular datasets,  SRA, 60 subjects, 127 samples","","NIDCR","DS-CA --- Disease-specific (cancer)","2014-06-04","2014-06-04","CA; CA - Cancer; Malignancies; Malignancy; Malignant Tumor; Malignant neoplasm"
"phs000614.v1.p1","Genomic Analysis of Pediatric Low Grade Gliomas","Pediatric low-grade gliomas (PLGGs) are among the most common solid tumors in children but, apart from mutations or duplications in the BRAF kinase in specific subclasses, few genetic driver  events are known. Diffuse PLGGs compose a set of uncommon subtypes that exhibit invasive growth and are therefore especially challenging clinically","Astrocytoma","Tumor vs. Matched-Normal","whole_genome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WGS","5 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 1 subjects, 2 samples","","NCI","DS-PBDPBC-NPU-MDS --- Disease-specific (pediatric brain disorders and pediatric brain cancer, npu, mds)","2013-07-22","2013-07-22","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytic tumor; Astrocytoma, no ICD-O subtype"
"phs000615.v1.p1","NINDS Stroke Genetics Network (SiGN)","The NINDS Stroke Genetics Network (SiGN) is a large international collaboration designed to detect genetic variants that predispose to subtypes of ischemic stroke. The study implements a genome wide  association study (GWAS) methodology with all stroke cases undergoing phenotypic and stroke-subtype classification using the same web-based Causative","Cerebral infarction","Case-Control","HumanOmni5Exome-4v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 molecular datasets, 11187 subjects, 11579 samples","European (9187), African (80), East Asian (2), African American (1057), Hispanic1 (176), Hispanic2 (453), Other Asian or Pacific Islander (4), South Asian (7), Other (118)","NINDS","DS-STK-NPU --- Disease-specific (stroke, npu) , GRU-NPU --- General research use (npu)","2014-09-29","2015-09-29","Cerebral Infarction, Left Hemisphere; Cerebral, Left Hemisphere, Infarction; Infarction, Cerebral, Left Hemisphere; Infarction, Left Hemisphere, Cerebral; Left Hemisphere, Cerebral Infarction; Left Hemisphere, Infarction, Cerebral"
"phs000616.v2.p2","CIP: Obesity-Diabetes Familial Risk","The VIVA LA FAMILIA Study was designed to identify genetic variants influencing childhood obesity and its comorbidities in the Hispanic population. Family recruitment and phenotyping were conducted in 2000-2005  in Houston, TX. All enrolled children (n 1030) and parents gave written informed consent or assent. The protocol was approved by the Institutional","Obesity","Prospective Longitudinal Cohort","HumanOmni1-Quad_v1-0_B, HumanOmni2.5-4v1_B","Not Applicable","SNP Genotypes (Array), WXS","5 phenotype datasets, 36 variables, 1 molecular datasets, 935 subjects, 957 samples","African American (3), Hispanic2 (828), Other (27)","NIDDK","DS-OBS-IRB-RD --- Disease-specific (obesity, irb, rd)","2015-07-17","2013-11-12","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000617.v1.p1","KCNE1Polymorphism as Possible Modulator of Drug-Induced TdP","The goal of this study was to search for genetic variants that could be responsible for modifying the risk of drug-induced long QT syndrome (diLQTS). diLQTS is a relatively  common adverse drug event and has been a leading cause for drug relabeling and withdrawal from the market. Our hypothesis, that variants in genes","Long QT Syndrome","Case-Control","GoldenGate_Custom","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 molecular datasets, 290 subjects, 290 samples","","NHLBI","HMB --- Health/medical/biomedical","2016-06-16","2017-06-16","Not Provided"
"phs000618.v1.p1","Hypertriglyceridemia Study in Mexicans","Coronary artery disease (CAD) is the number one cause of death and mortality world-wide. High levels of serum triglycerides (TGs) and low levels of serum high-density lipoprotein cholesterol (HDL-C)  are major risk factors for CAD. Previous epidemiological studies have shown that these two lipid disturbances are highly common dyslipidemias in","Hypertriglyceridemia","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 4 analyses, 1 molecular datasets, 4350 subjects, 4350 samples","European (26), Hispanic1 (1), Hispanic2 (2188), Other Asian or Pacific Islander (1), Other (13)","NHLBI","DS-HTG-MDS-RD --- Disease-specific (hypertriglyceridemia, mds, rd)","2013-10-25","2013-10-25","Not Provided"
"phs000619.v1.p1","Epigenetic Marks as Peripheral Biomarkers of Autism","Autism is a common disorder whose causes are poorly understood. Both genetic and environmental influences are thought to act together causing autism. Epigenetics is an area that bridges genetic  and environmental influencing and commonly is studied by examining dynamic methylation changes to the DNA. We have screened a total of 78 autistic","Autistic Disorder","Case-Control","HumanMethylation450","Not Applicable","Methylation (CpG)","5 phenotype datasets, 21 variables, 1 molecular datasets, 820 subjects, 820 samples","","NIMH","GRU --- General research use","2013-09-05","2013-09-05","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000620.v1.p1","Minnesota Center for Twin and Family Research (MCTFR)","This is an epidemiological study of substance abuse and related psychopathology in which the subjects have been drawn from the Minnesota Center for Twin and Family Research (MCTFR). The  MCTFR is a large, ongoing, family-based study. It is in part a longitudinal study of two cohorts of adolescent twins and their parents. It","Substance-Related Disorders","Prospective Longitudinal Cohort","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array), WGS","6 phenotype datasets, 29 variables, 1 molecular datasets,  SRA, 7377 subjects, 6097 samples","European (5960)","NIDA","GRU --- General research use","2015-06-24","2016-06-24","Disorders, Impulse Control; ICD; Impulse Control Disorder; Impulse Control Disorders; Impulse-Control Disorders; Disorder, Drug Use"
"phs000621.v1.p1","Genome Wide Association Studies in ECOG 2997 Trial","The ECOG 2997 trial was a randomized controlled trial for patients with previously untreated CLL comparing fludarabine monotherapy to the combination of fludarabine and cyclophosphamide. The initial clinical findings  of this study were published in the Journal of Clinical Oncology in 2007 (JCO 25:793-8). Additional laboratory studies have also published (JCO 25","Leukemia, Lymphoid","Clinical Trial","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 215 subjects, 215 samples","European (177), African (2), East Asian (1), African American (31), Hispanic1 (1), Hispanic2 (1), South Asian (2)","NCI","HMB-PUB-MDS --- Health/medical/biomedical (pub, mds)","2013-06-26","2013-06-26","Aleukemic lymphatic leukemia [obs]; Aleukemic lymphocytic leukemia [obs]; Aleukemic lymphoid leukemia [obs]; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid"
"phs000622.v1.p1","FaceBase Study of Facial Shape in Tanzania: CIDR","The goals of this project are to identify loci that underlie major genetic determinants of orofacial shape, by means of a GWAS in a cohort of normal African children  (from Tanzania) from whom we have collected 3D digitized facial morphometric scans, and a subsequent replication study of normal children from the","Congenital, Hereditary, and Neonatal Diseases and Abnormalities","Clinical Trial","HumanOmni2.5-8v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","6 phenotype datasets, 84 variables, 2 molecular datasets, 3623 subjects, 3739 samples","African (1372), African American (2185)","NIDCR","DS-CFR --- Disease-specific (craniofacial research)","2014-12-23","2014-12-23",""
"phs000623.v1.p1","Rare Mendelian Disease in Old Order Amish and Mennonite Patients","The Clinic for Special Children (CSC) has integrated biochemical and molecular methods into a rural pediatric practice serving Old Order Amish and Mennonite (Plain) children. Among the Plain people,  we have used single nucleotide polymorphism (SNP) microarrays to genetically map recessive disorders to large autozygous haplotype blocks (mean 4.4","Developmental Disabilities","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 106 subjects, 106 samples","","NHGRI","GRU --- General research use","2013-08-22","2013-08-22","Child Development Disorder; Child Development Disorders; Development Disorder, Child; Development Disorders, Child; Developmental Disability; Disabilities, Developmental"
"phs000625.v1.p1","Targeted Sequencing of GWAS Loci in Cleft Lip and Palate","Nonsyndromic cleft lip and palate (NSCL/P) is a complex disorder caused by both genetic and environmental factors and has been the focus of an extensive effort to identify genetic  risk factors. A number of candidate gene studies have been performed but have not been widely replicated. To date, four independent genome wide","Orofacial Cleft, Nonsyndromic","Family/Twin/Trios","Not Provided","Not Applicable","WXS","5 phenotype datasets, 31 variables,  SRA, 6123 subjects, 5512 samples","","NHGRI","DS-CFD --- Disease-specific (craniofacial disorders) , DS-OFC --- Disease-specific (orofacial cleft) , DS-OC-GSO --- Disease-specific (oral clefts, gso)","2014-07-03","2015-01-03","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lip; Cleft Lips; Cleft of upper lip"
"phs000626.v1.p1","CD4+ cell transcriptional profiling by RNA sequencing","We use next generation sequencing to investigate the different transcriptomes of closely related CD4+ T-cells from healthy human donors to elucidate the genetic programs that underlie their specialized immune  functions. Six cell types were included: Regulatory T-cells (CD25hiCD127low/neg with 95% FOXP3+ purity), regulatory T-cells activated using PMA","Immune System Processes","Control Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 15 variables,  SRA, 2 subjects, 12 samples","","NIAID","GRU --- General research use","2015-08-25","2015-08-25","Not Provided"
"phs000627.v1.p1","UNC Hepatocellular Carcinoma Study by Exome Sequencing (HCCSES)","Genetic alterations in specific driver genes lead to disruption of cellular pathways and are critical events in the instigation and progression of hepatocellular carcinoma. As a prerequisite for individualized  cancer treatment, we sought to characterize the landscape of recurrent somatic mutations in hepatocellular carcinoma. We performed whole exome","Carcinoma, Hepatocellular","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","3 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 87 subjects, 174 samples","","NCI","GRU-MDS --- General research use (mds)","2014-03-14","2014-03-14","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs000628.v1.p1","Characterization of a Metastatic Cervical Cancer Using NGS","In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect  and analyze HPV infection in the same sample.","Uterine Cervical Neoplasms","Case Set","exome_vcf_grc37","Not Applicable","RNA-Seq, SNP Genotypes (NGS), WGS, WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 3 subjects, 7 samples","","NCI","GRU-MDS --- General research use (mds)","2014-12-16","2014-12-16","Carcinoma, no subtype; Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant"
"phs000629.v1.p1","GWAS of Familial Lung Cancer","Familial lung cancer cases were collected by the Genetic Epidemiology of Lung Cancer Consortium (GELCC) recruitment sites: University of Cincinnati, Karmanos Cancer Institute at Wayne State University, Louisiana State  University Health Sciences Center-New Orleans, Mayo Clinic, and Medical College of Ohio. Familial cases for this study came from three sources: 1","Lung Neoplasms","Case-Control","HumanOmniExpressExome-8v1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 22 variables, 2 molecular datasets, 1553 subjects, 1620 samples","European (1531), East Asian (4), African American (9), Hispanic1 (3), Hispanic2 (4), Other Asian or Pacific Islander (1), South Asian (1)","NCI","DS-LC-IRB-COL-MDS --- Disease-specific (lung cancer, irb, col, mds)","2014-10-16","2014-10-16","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000630.v1.p1","Exome Chip Study of NIMH Controls","Here, we report exome chip genotyping results of 1052 samples from the NIMH control set, a collection of healthy controls for general research use. The samples are all unrelated.","Normalcy","Control Set","HumanExome-12v1-1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 1051 subjects, 1051 samples","","NIMH","GRU --- General research use","2014-05-02","2014-05-02","Normalcies; Normalities"
"phs000632.v1.p1","NHLBI GO-ESP: Family Studies (Hematological Cancers)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Hemic and Lymphatic Diseases","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 10 subjects, 19 samples","","NHLBI","HMB-NPU --- Health/medical/biomedical (npu)","2014-01-30","2014-04-30",""
"phs000633.v1.p1","Enrichment of Lung Microbiome Associated with Pulmonary Inflammation","Background: The lung microbiome of healthy individuals frequently harbors oral organisms. Despite evidence that micro-aspiration is commonly associated with smoking-related lung diseases, the effects of lung microbiome enrichment with  upper airway taxa on inflammation has not been studied. We hypothesize that the presence of oral microorganisms in the lung microbiome is associated","Pneumonia","Cross-Sectional","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 17 variables,  SRA, 29 subjects, 103 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb)","2014-03-21","2014-03-21","Inflammation, Lung; Inflammation, Pulmonary; Inflammations, Lung; Inflammations, Pulmonary; Lung Inflammation; Lung Inflammations"
"phs000634.v1.p1","NCI GWAS of Lung Cancer in Never Smokers","A genomewide study of lung cancer in never smokers Abstract and specific aims In the United States, lung cancer incidence and mortality rates have been steadily declining over the  past decade, following decline in the prevalence of tobacco smoking. However, lung cancer remains the leading cause of cancer death, killing more","Lung Neoplasms","Case-Control","HumanOmniExpress-12v1_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 4 analyses, 1 molecular datasets, 2320 subjects, 2320 samples","European (2318), Hispanic1 (1), Other (1)","NCI","GRU-MDS --- General research use (mds) , DS-CA --- Disease-specific (cancer)","2015-06-29","2015-06-29","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000636.v1.p1","Whole Exome Sequencing for Familial Intracranial Aneurysm (FIA I-II)    Study","The goal of this study is to identify the genes underlying the risk of intracranial aneurysm (IA). The FIA Study initially recruited families appropriate for linkage analysis. Therefore, the  recruitment focus was not only on probands with a family history of IA but also required that biological samples be obtained for at least two","Intracranial Aneurysm","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 32 variables, 1 molecular datasets,  SRA, 45 subjects, 45 samples","","NINDS","GRU --- General research use","2013-08-22","2014-01-22","Aneurysm, Middle Cerebral Artery; Middle Cerebral Artery Aneurysm; Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents"
"phs000637.v1.p1","Methotrexate Clearance GWAS","We estimated the plasma clearance of methotrexate from 1279 acute lymphoblastic leukemia (ALL) patients treated on the Children Oncology Group 9904 and 9905 trials (http://clinicaltrials.gov/show/NCT00005585 and http://clinicaltrials.gov/show/NCT00005596). Patients received  either a 24-hour infusion of a 1 g/m2 dose or 4-hour infusion of a 2 g/m2 dose). Methotrexate clearance was lower in older children (p 7 x 10-7","Precursor B-Cell Lymphoblastic Leukemia-Lymphoma","Clinical Trial","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 1267 subjects, 1267 samples","European (823), African (3), East Asian (18), African American (90), Hispanic1 (38), Hispanic2 (225), Other Asian or Pacific Islander (24), South Asian (17), Other (29)","NIGMS","HMB --- Health/medical/biomedical","2013-10-29","2013-10-29","Leukemia, Pre B Cell; Leukemia, Pre-B-Cell; Leukemias, Pre-B-Cell; Pre B ALL; Pre B Cell Leukemia; Pre B-ALL"
"phs000638.v1.p1","Genome-Wide Association Study of Relapse of Childhood Acute Lymphoblastic    Leukemia","Using risk-directed therapy for childhood acute lymphoblastic leukemia (ALL), outcome has improved dramatically in the last 40 years. However, a substantial portion of patients experience relapse, many of whom  have no known risk factors. Taking a genome-wide approach, we sought to evaluate the relationships between germline SNP genotypes and the risk of","Precursor Cell Lymphoblastic Leukemia-Lymphoma","Interventional","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 2487 subjects, 2487 samples","European (1631), African (5), East Asian (33), African American (243), Hispanic1 (61), Hispanic2 (396), Other Asian or Pacific Islander (41), South Asian (30), Other (47)","NIGMS","HMB --- Health/medical/biomedical","2014-02-21","2014-02-21","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000639.v1.p1","Human Autism Genetics and Activity Dependent Gene Activation","The goal of this proposal is to bring together the power of 1) whole exome sequencing, 2) homozygosity mapping in consanguineous families, 3) genome-wide maps of neuronal transcription in  response to neuronal activity, and 4) genome-wide maps of the binding sites of factors that regulate this transcription to generate and annotate a","Autism Spectrum Disorder","Family/Twin/Trios","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 767 subjects, 767 samples","","NIMH","DS-ASD --- Disease-specific (autism spectrum disorder)","2015-11-05","2015-11-05","Child Development Disorders, Pervasive; Pervasive Child Development Disorders"
"phs000641.v1.p1","TTC7A Mutations for Combined Immunodeficiency with Intestinal Atresia","Combined Immunodeficiency with Multiple Intestinal Atresias (CID-MIA) is a rare genetic disorder with the cause previously unknown. Symptoms of CID-MIA include atresias in the small and/or large intestine, as  well as immunodeficiency. In this study, we sequenced the whole exome of 5 unrelated CID-MIA patients as well as their healthy family members, and","Immunological Deficiency Syndrome","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 15 subjects, 15 samples","","NIAID","GRU-IRB --- General research use (irb)","2013-12-04","2014-12-04","Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndromes, Antibody; Syndrome, Antibody Deficiency; Syndromes, Antibody Deficiency"
"phs000644.v1.p1","The Effect of the Menstrual Cycle on the Normal Human Breast","The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center [www.komentissuebank.iu.edu] (KTB) was established expressly for the prospective collection of normal, healthy breast tissue  from volunteer donors. Blood is also obtained from donors at the time of donation and is processed for serum, plasma and peripheral blood leukocyte","Menstrual Cycle","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 44 variables,  SRA, 20 subjects, 20 samples","","NCI","DS-BRCA-PUB-MDS --- Disease-specific (breast cancer, pub, mds)","2013-09-10","2013-09-10","Cycle, Endometrial; Cycles, Endometrial; Endometrial Cycle; Endometrial Cycles"
"phs000645.v5.p1","Location and Function of Cytosine-5 Methylation in RNA","Mutations in the cytosine-5 RNA methyltransferase NSun2 can cause neurodevelopmental disorders and symptoms commonly found in patients with Dubowitz-like syndrome. Some tRNAs are known to be methylated NSun2, however  the occurrence of cytosine-5 methylation (m5C) in other RNA biotypes is still under debate. Location in RNA and function of m5C has not been studied","Dubowitz Syndrome","Case-Control","Not Provided","Not Applicable","Bisulfite-Seq, OTHER, RNA-Seq, ncRNA-Seq","4 phenotype datasets, 23 variables,  SRA, 4 subjects, 309 samples","","NICHD","GRU --- General research use","2019-04-11","2016-05-22","Dubowitz syndrome; Dwarfism-eczema-peculiar facies syndrome; Intrauterine growth retardation, short stature, microcephaly, mild mental retardation with behavior problems, eczema, and unusual and distinctive faci"
"phs000646.v1.p1","Breakpoint Detection Using Long Insert Whole Genome Sequencing","In this study, we hypothesize that shallow long insert whole genome sequencing (LI-WGS) increases our power for detecting breakpoints compared to shallow short insert WGS. We performed a priori  analyses to demonstrate the benefits of LI-WGS, developed a long insert library preparation protocol based off Illumina's protocol, and compared LI","Chromosome Breakpoints","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 16 variables, 3 subjects, 6 samples","","NCI","GRU-MDS --- General research use (mds)","2013-09-10","2013-09-10","Breakpoint, Chromosome; Breakpoints, Chromosome; Chromosome Breakpoint; CA; CA - Cancer; Cancer"
"phs000647.v1.p1","Study of Adaptation to Hypoxia in Ethiopian Highlanders","Although it has long been proposed that genetic factors contribute to adaptation to high altitude, such factors remain largely unverified. Recent advances in high-throughput sequencing have made it feasible  to analyze genome-wide patterns of genetic variation in human populations. Since traditionally such studies surveyed only a small fraction of the","Cell Hypoxia","Cross-Sectional","whole_genome_vcf_grc37","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets, 13 subjects, 13 samples","African American (7)","NHLBI","GRU --- General research use","2013-12-20","2013-12-20","Anoxia, Cell; Anoxia, Cellular; Anoxias, Cell; Anoxias, Cellular; Cell Anoxia; Cell Anoxias"
"phs000648.v1.p1","Pancreatic Cancer Case-Control Association Study","Pancreatic cancer is the 4th leading cause of cancer death in the United States. This is in large part due to the rapidly fatal course of this disease, as  the vast majority of patients die within months of diagnosis and the five-year survival rate is less than 5. We have brought together over 8000","Pancreatic Neoplasms","Case-Control","HumanOmniExpressExome-8v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 8021 subjects, 8377 samples","European (7589), African (5), East Asian (91), African American (123), Hispanic1 (31), Hispanic2 (73), Other Asian or Pacific Islander (30), South Asian (39), Other (40)","NCI","DS-PACA --- Disease-specific (pancreatic cancer)","2015-06-22","2015-06-22","Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic; Neoplasms, Pancreas; Neoplasms, Pancreatic"
"phs000649.v1.p1","Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)","This is a prospective, multicenter, randomized, open-label, parallel-group study to evaluate pharmacogenomic responses to antihypertensives. The primary aim of this study is to identify the genetic determinants of antihypertensive  and adverse metabolic responses focused on two preferred and pharmacodynamically contrasting drugs, a beta-blocker (atenolol) and a thiazide diuretic","Hypertension","Prospective Longitudinal Cohort","HapMap_Phase3","Not Applicable","SNP Genotypes (imputed)","4 phenotype datasets, 81 variables, 2 analyses, 1 molecular datasets, 230 subjects, 228 samples","European (219), East Asian (2), Hispanic2 (4), Other Asian or Pacific Islander (2), South Asian (1)","NIGMS","PEAR --- All pear patients","2016-04-01","2016-04-01","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs000652.v1.p1","Cohort-Based Genome-Wide Association Study of Glioma (GliomaScan)","We conducted a new independent GWAS of adult glioma using 1,856 cases and 4,955 controls from 14 cohort studies belonging to the Cohort Consortium, 3 case-control studies, and 1  population-based case only study. Cases were newly diagnosed glioma [ICDO-3 codes 9380-9480 or equivalent], and controls were cancer-free at the time","Glioma","Case-Control","HumanHap550_v3, Human610-Quadv1_B, Human660W-Quad_v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 analyses, 3 molecular datasets, 6811 subjects, 7072 samples","European (6780), Hispanic1 (2), Hispanic2 (3), Other (26)","NCI","DS-GAO-GSO --- Disease-specific (glioma in adults only, gso) , CADM --- Cancer in all age groups, other diseases in adults only, and methods","2013-12-17","2014-12-17","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia"
"phs000655.v3.p1","Genetics of Inherited Muscle Disease","The samples are drawn from a collection of patients with a heterogeneous set of neuromuscular disorders, including congenital muscular dystrophy, congenital myopathy, limb-girdle muscular dystrophy, Emery-Dreifuss muscular dystrophy, and  arthrogryposis, along with unaffected parents and siblings in some cases. The samples were collected by the following clinicians affiliated with the","Muscular Dystrophies","Collection","whole_exome_seq, exome_vcf_grc37, whole_genome_vcf_grc37, WGS_markerset_grc37, WES_markerset_grc37","Not Applicable","RNA-Seq, SNP Genotypes (NGS), WGS, WXS","4 phenotype datasets, 11 variables, 3 molecular datasets,  SRA, 708 subjects, 744 samples","European (94), African American (2), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (1), South Asian (2), Other (1)","NHGRI","GRU --- General research use , DS-NMD --- Disease-specific (neuromuscular disease) , HMB --- Health/medical/biomedical","2017-01-19","2017-01-19","AMC; AMC - Arthrogryposis multiplex congenita; Amyoplasia Congenita; Arthrogryposes; Arthrogryposes, Congenital Multiple; Arthrogryposis"
"phs000656.v1.p1","Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire    Sequencing","We developed an improved high throughput sequencing approach to measure the quantities and sequences of the repertoire of antibody heavy chain RNA in a blood sample. Using this approach  we analyzed the antibody repertoire in response to yearly vaccinations with influenza vaccines TIV and LAIV in healthy adults in two subsequent years","Influenza Vaccines","Interventional","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 15 variables,  SRA, 28 subjects, 105 samples","","NIAID","IRU --- Immunology research use","2013-09-26","2013-09-26","B Cell; B Cells; B Lymphocytes; B-Cell; B-Cells; Bursa Dependent Lymphocytes"
"phs000657.v1.p1","NGS in Advanced Cancers","In this study, we used NGS to identify somatic events in advanced stage cancer patients to demonstrate the feasibility for using this approach to improve patient treatment.","Carcinoma","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 17 variables,  SRA, 15 subjects, 31 samples","","NCI","GRU-MDS --- General research use (mds)","2013-11-20","2013-11-20","Carcinoma, no subtype; Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant"
"phs000658.v1.p1","MDD2000AFFY","Sub-study QI: 941 cases of Major Depressive Disorder (MDD) from the Queensland Institute of Medical Research (QIMR), Australia Sub-study VU: 127 MDD cases from The Netherlands Study of Anxiety  and Depression (NESDA) (http://www.nesda.nl) and The Netherlands Twin Registry (NTR) (http://www.tweelingenregister.org) based at the VU Amsterdam","Depressive Disorder, Major","Case Set","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 50 variables, 2 documents, 1 molecular datasets, 1441 subjects, 1441 samples","European (1440), Other (1)","NIMH","NR --- No data use restrictions","2014-01-30","2014-01-30","Depression, Involutional; Involutional Melancholia; Melancholia, Involutional"
"phs000659.v1.p1","Mount Sinai Hospital (MSH, Toronto, CANADA) pelvic pouch microbiome study","This study involved evaluation of the tissue associated microbiome of the ileal pouch following surgery for ulcerative colitis (UC) or familial adenomatous polyposis (FAP). Individuals were recruited, with biopsies  taken from the ileal pouch and the pre-pouch ileum, microbial DNA was extracted and sequenced using 454 pyrosequencing. Total bacterial community","Inflammatory Bowel Diseases","Case-Control","Not Provided","Not Applicable","POOLCLONE","4 phenotype datasets, 16 variables,  SRA, 80 subjects, 158 samples","","NIDDK","GRU --- General research use","2013-11-01","2013-11-01","ADENOMATOUS POLYPOSIS OF THE COLON; APC; APC - Adenomatous Polyposis Coli; Adenomatous Polyposes, Familial; Adenomatous Polyposis Coli, Familial; Adenomatous Polyposis Colus"
"phs000660.v1.p1","Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study","AHC is a rare and severe neurological disorder, and characterized by episodic hemiplegia or quadriplegia attacks, accompanied by other paroxysmal symptoms of oculomotor abnormalities, dystonia, seizures and autonomic disturbances;  the age of onset usually occurrs before 18 months of life. Sodium-potassium ATPase alpha3 subunit (ATP1A3) has recently been identified as a causal","Alternating hemiplegia of childhood","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","East Asian (9), Other Asian or Pacific Islander (3)","NINDS","GRU --- General research use","2014-06-06","2015-06-06","AHC; AHC1; Alternating hemiplegia; Alternating hemiplegia syndrome"
"phs000661.v1.p1","Germline Sequencing for Aggressive Prostate Carcinoma","This study aims to elucidate the genetic determinants of susceptibility to aggressive prostate carcinoma. To this end, germ line whole exome sequence has been generated from patients with aggressive  prostate cancer. Whole genome sequence for a representative subset of tumors from patients whose cancer was resistant to primary therapy is included","Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 13 variables,  SRA, 5 subjects, 10 samples","","NHGRI","DS-PC --- Disease-specific (prostate cancer)","2013-12-18","2013-12-18","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000662.v1.p1","National Children's Study Vanguard Study Formative Research Study (NCS)","The National Children's Study (NCS) is a multi-year prospective epidemiological study tasked with identifying a nationally representative sample of 100,000 children and following them from pregnancy through age 21  to study environmental impacts on growth, development, and health. Determination of NCS enrollee ancestry is important for assessing the diversity of","Population Groups","Prospective Longitudinal Cohort","HumanExome-12v1-1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets,  SRA, 641 subjects, 641 samples","","NICHD","HBM --- Health/biomedical/medical-irb","2013-12-20","2014-12-20","Tribes"
"phs000663.v2.p2","NIDDK Drug-Induced Liver Injury Network (DILIN)","The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has established the Drug-Induced Liver Injury Network (DILIN) to collect and analyze cases of severe liver injury caused  by prescription drugs, over-the-counter drugs, and alternative medicines, such as herbal products and supplements.","Drug-Induced Liver Injury","Case Set","Human1M-Duov3_B, ExomeChip","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 2 molecular datasets, 743 subjects, 743 samples","European (592), African (2), East Asian (17), African American (63), Hispanic1 (12), Hispanic2 (38), Other Asian or Pacific Islander (8), South Asian (6), Other (5)","NIDDK","DS-DILI-IRB --- Disease-specific (drug-induced liver injury, irb)","2018-09-10","2018-09-10","Hepatitides, Toxic; Hepatitis, Toxic; Toxic Hepatitides; Toxic Hepatitis; Toxin-associated hepatitis"
"phs000664.v1.p1","Genome Variations Among the Aboriginals in Malaysia","Copy number variation (CNV) has been recognized as a major contributor to human genome diversity. It plays an important role in determining phenotypes and has been associated with a  number of common and complex diseases. However the CNV data from diverse populations is rather limited. Here we report the first investigation of","Population Groups","Cross-Sectional","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 34 subjects, 34 samples","","NHGRI","GRU --- General research use","2013-11-15","2014-02-15","Tribes"
"phs000666.v1.p1","B and T Cell Determinants of Influenza Vaccine Responses in the Elderly","The study sequenced antibody heavy chain gene rearrangements from human subjects receiving influenza vaccination.","Influenza Vaccines","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 15 variables, 27 subjects, 2554 samples","","NIAID","DS-IR-IRB --- Disease-specific (immunological research, irb)","2014-02-05","2015-02-05","Advanced age; Aged; Aged 65 and Over; Elderly; Elderly (Over 65); Senior Citizen"
"phs000669.v1.p1","AMBER Consortium","The AMBER Consortium Study was formed to pool interview data, questionnaire data, and biological samples from epidemiological studies of breast cancer in African-American women to discover the potential causes  of early-onset and aggressive breast cancer in African-American women. AMBER is funded through a Program Project grant from the National Cancer","Breast Neoplasms","Case-Control","1000G_ref_panel, HumanExome-12v1-1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 23 variables, 2 molecular datasets, 6830 subjects, 7127 samples","European (5), African (151), African American (3782), Hispanic1 (42), Other (19)","NCI","DS-BRCA-COL-MDS-GSO --- Disease-specific (breast cancer, col, mds, gso)","2016-10-21","2016-10-21","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000670.v1.p1","PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)","This pharmacogenomic study focused on the response of patients with MDD to an 8-week course of treatment with citalopram or escitalopram. Briefly, clinical assessments and research assessments were performed  at each study visit as summarized in Table 1. Many patients continued on antidepressant medication after the 8 week study. Table 1: Study timeline","Depressive Disorder, Major","Prospective Longitudinal Cohort","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 52 variables, 7 documents, 4 analyses, 1 molecular datasets, 529 subjects, 529 samples","European (500), African (1), East Asian (2), African American (9), Hispanic1 (2), Hispanic2 (7), Other Asian or Pacific Islander (4), South Asian (2), Other (2)","NIGMS","HMB --- Health/medical/biomedical","2014-01-22","2015-01-22","Depression, Involutional; Involutional Melancholia; Melancholia, Involutional"
"phs000671.v1.p1","Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia","To understand the genetic mechanisms driving variant and IGHV4-34 expressing hairy-cell leukemia, we performed whole exome sequencing of tumor/normal pairs from ten patients.","Leukemia, Hairy Cell","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets,  SRA, 10 subjects, 20 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2013-11-14","2013-11-14","HCL; HCL - Hairy cell leukemia; HCL-C; Hairy Cell Leukemias; LRE - Leukemic reticuloendotheliosis; Leukemias, Hairy Cell"
"phs000672.v1.p1","NIDCR Sj gren's International Collaborative Clinical Alliance (SICCA)","The Sj gren's International Collaborative Clinical Alliance (SICCA) is a multisite observational cohort study that recruited a large cohort of geographically diverse participants. Enrollment of participants began in late  2004 at five (one domestic and four international) sites, in which all groups used the same protocol-directed methods to provide uniform evaluations","Sjogren's Syndrome","Collection","HumanOmni2.5-4v1_H, HumanOmni25-8v1, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 118 variables, 2 molecular datasets, 3932 subjects, 4225 samples","European (2439), African (5), East Asian (834), African American (104), Hispanic1 (20), Hispanic2 (305), Other Asian or Pacific Islander (29), South Asian (170), Other (26)","NIDCR","DS-ADO --- Disease-specific (autoimmune diseases)","2015-09-14","2015-09-14","Absent salivary secretion; Aptyalia; Aptyalism; Asialia; Asialias; Clinical xerostomia"
"phs000673.v3.p1","University of Michigan Clinical Sequencing Exploratory Research (CSER)","Overview. The personalization of therapy for cancer will require molecular characterization of unique and shared genetic aberrations. In particular, patients who have a sarcoma or other rare cancers and  are candidates for clinical trials could potentially benefit by identifying eligibility for ""targeted"" drugs based on the ""actionable"" genes in their","Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 23 variables,  SRA, 621 subjects, 2278 samples","","NCI","GRU --- General research use","2018-12-20","2014-11-13","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000676.v2.p2","Sequence-Based Analysis of Human Breast Tumors","The goal of this study is to study gene expression patterns in tumors, normal tissues, and cell lines.","Breast Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq, WXS","5 phenotype datasets, 37 variables,  SRA, 28 subjects, 232 samples","","NCI","GRU-MDS --- General research use (mds) , DS-CA-MDS --- Disease-specific (cancer, mds)","2018-02-28","2014-10-29","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000677.v1.p1","An APOBEC Cytidine Deaminase Mutagenesis in Human Cancers","Reprinted from Roberts et al. ""An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers"", Nature Genetics, 45:970-976, 2013, with permission of Nature Publishing Group: Recent studies indicate  that a subclass of APOBEC cytidine deaminases, which convert cytosine to uracil during RNA editing and retrovirus or retrotransposon restriction, may","Neoplasms","Cross-Sectional","whole_exome_seq","Not Applicable","SNV (.MAF)","3 phenotype datasets, 12 variables, 1 molecular datasets,  SRA, 5427 subjects, 5427 samples","","NCI","GRU --- General research use","2013-12-20","2013-12-20","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000678.v1.p1","A Family-Based Study of Genes and Environment in Young-Onset Breast    Cancer","To study environmental and genetic causes of young onset breast cancer, we recruited women who had been young when recently diagnosed (under age 50 and within 4 years of  enrollment), and had been identified as potentially eligible by a sister who was already participating in the ongoing Sister Study. The unaffected","Breast Neoplasms","Case-Control","HumanOmniExpressExome-8, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 30 variables, 2 molecular datasets, 5957 subjects, 3492 samples","European (3055), African (5), East Asian (16), African American (144), Hispanic1 (19), Hispanic2 (85), Other Asian or Pacific Islander (10), South Asian (4), Other (4)","NIEHS","GRU --- General research use","2015-02-25","2016-02-25","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000679.v1.p1","Genome-Wide Association Study of Anorexia Nervosa","Twin studies are consistent with substantial heritability in anorexia nervosa (AN), although detecting and confirming individual risk alleles has been difficult, due to small effects of single alleles and  limited samples in prior studies. Methods: 1105 AN DNA samples obtained in a multisite study and 3733 pediatric patients of normal body weight were","Anorexia Nervosa","Case-Control","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 203 variables, 1 molecular datasets, 1001 subjects, 1001 samples","European (995), Hispanic1 (1), Hispanic2 (4), Other (1)","NIMH","GRU --- General research use","2014-04-09","2014-04-09","AN - Anorexia nervosa; Anorexia Nervosas; Nervosa, Anorexia; Nervosas, Anorexia"
"phs000681.v1.p1","Diabetes Prevention Program Genetics (DPPG)","The Diabetes Prevention Program (DPP) was a multicenter controlled clinical trial examining the efficacy of an intensive lifestyle intervention or metformin to prevent or delay the development of diabetes  in a population selected to be at high risk due to the presence of impaired glucose tolerance (IGT) and obesity. Development of diabetes, defined by","Diabetes Mellitus, Type 2","Clinical Trial","iPLEX_gold, Illumina_array, iPLEX_gold","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 2535 subjects, 2535 samples","European (1312), African (16), East Asian (43), African American (438), Hispanic1 (40), Hispanic2 (296), Other Asian or Pacific Islander (32), South Asian (31), Other (36)","NIDDK","DS-DHD-IRB --- Disease-specific (diabetes and heart disease, irb)","2014-11-20","2014-11-20","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000682.v1.p1","Genetics of Neuropsychiatric and Neurodevelopmental Disorders","Although schizophrenia is a highly heritable disease, relatively little progress had been made in securely identifying the genetic causes of this disorder, and most instances of schizophrenia in the  general population remain unexplained. One avenue of explanation for the genetic basis of schizophrenia, however, has been effectively closed by","Psychiatry and Psychology Category","Family/Twin/Trios","whole_genome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WGS","5 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 162 subjects, 162 samples","European (84), African (1), East Asian (1), African American (66), Hispanic1 (8), Hispanic2 (2)","NIMH","GRU --- General research use","2014-04-11","2015-04-11","Hypervigilance; Ataxia (loss of muscle coordination); Ataxias; Ataxy; Coordination Impairment; Coordination Impairments"
"phs000683.v1.p1","SIGMA Type 2 Diabetes Consortium","Diabetes in Mexico Study (DMS): Individuals were enrolled in the study, recruited from two tertiary level institutions (IMSS and ISSSTE) located in Mexico City. The diagnosis of T2D was  made based on ADA criteria. 811 unrelated healthy subjects older than 45 years and with fasting glucose levels below 100 mg/dL were classified as","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Not Applicable","Not Provided","","","NIDDK","","","","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000687.v1.p1","Bulgarian Schizophrenia Trio Sequencing Study","The primary aim of this study is to whole exome sequence complete Bulgarian trios to identify de novo mutations in schizophrenic probands. We are investigating the rate of de  novo mutations in probands as well as looking for enrichment among previously implicated genes and synaptic gene sets.","Schizophrenia","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 1826 subjects, 1826 samples","","NIMH","GRU-NPU --- General research use (npu)","2015-03-26","2015-09-26","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000689.v1.p1","Genomic Analysis of Peripheral T-Cell Lymphomas","Peripheral T-cell lymphomas (PTCLs) are a heterogeneous and poorly understood group of non Hodgkin lymphomas. We aim to identify new genetic alterations in PTCL transformation by using a combination  of whole exome sequencing of tumor-normal DNA pairs, RNAseq analysis and targeted deep sequencing of candidate genes. Our data identified highly","Lymphoma, T-Cell, Peripheral","Case-Control","Not Provided","Not Applicable","RNA-Seq, WXS","3 phenotype datasets, 18 variables,  SRA, 59 subjects, 59 samples","","NCI","DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds)","2014-11-18","2014-11-18","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma; Reticulum-Cell Sarcomas"
"phs000690.v1.p1","Whole-genome sequencing in multiplex epilepsy families","Epilepsy is one of the most common neurologic disorders, affecting approximately 4% of individuals at some time in their lives. More than 30% of people with epilepsy continue to  have seizures despite treatment, and improved approaches to treatment and prevention are sorely needed. In the search for new strategies to reduce","Idiopathic generalized epilepsy","Family/Twin/Trios","Not Provided","Not Applicable","WGS, WXS","5 phenotype datasets, 22 variables, 60 subjects, 60 samples","","NINDS","GRU --- General research use , DS-ESD-GSO --- Disease-specific (epilepsy and seizure disorders, gso)","2014-01-30","2015-01-30","GEFS+; Generalized Epilepsy with Febrile Seizures Plus"
"phs000691.v2.p1","CIP: Differential Response to Hydroxyurea and Incidence of Stroke in    Sickle Cell Disease","Sickle cell disease (SCD) is a severe debilitating hematological disorder associated with a high degree of morbidity and mortality. There are approximately 200,000 babies born with sickle cell disease  each year, with the disease predominately affecting individuals in Africa. The overall global burden of the disease is tremendous, with more than","Anemia, Sickle Cell","Case-Control","Not Provided","Not Applicable","WGS, WXS","4 phenotype datasets, 20 variables, 1 documents,  SRA, 651 subjects, 651 samples","","NHGRI","GRU --- General research use","2015-04-01","2014-07-10","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S"
"phs000692.v1.p1","A Pharmcogenetic Study of Bipolar Disorder in a Taiwanese Han Chinese    Population (TWBP)","Objective: To identify genetic variants associated with response to lithium prophylaxis treatment. Materials: 294 bipolar I (BPI) patients receiving lithium treatment, a subset of 1761 bipolar I (BPI) patients  recruited by the Taiwan Bipolar Consortium. Lithium response was assessed based on the Alda Scale. Methods: Responders to lithium treatment were","Bipolar Disorder","Case Set","Not Provided","Not Applicable","Not Provided","4 analyses","","NIMH","DS-BPD-RD --- Disease-specific (bipolar disorder, rd)","2014-02-27","2014-02-27","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar disorder"
"phs000693.v5.p1","University of Washington Center for Mendelian Genomics (UW-CMG)","The Centers for Mendelian Genomics project uses next-generation sequencing and computational approaches to discover the genes and variants that underlie Mendelian conditions. By discovering genes that cause Mendelian conditions,  we will expand our understanding of their biology to facilitate diagnosis and new treatments.","Rare Diseases","Mendelian","exome_vcf_grc37, WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 5 molecular datasets,  SRA, 1439 subjects, 1439 samples","","NHGRI","GRU --- General research use","2017-01-25","2017-01-25","AFD, NAGER TYPE; AFD1; Acrofacial Dysostosis 1, Nager Type; Acrofacial dysostosis, Nager type; MANDIBULOFACIAL DYSOSTOSIS, TREACHER COLLINS TYPE, WITH LIMB ANOMALIES; Mandibulofacial dysostosis with preaxial limb anomalies"
"phs000694.v3.p2","Clinical Cancer Sequencing","Translating whole exome sequencing (WES) for prospective clinical use may impact the care of cancer patients; however, multiple innovations are necessary for clinical implementation. These include: (1) rapid and  robust WES from formalin-fixed paraffin embedded (FFPE) tumor tissue, (2) analytical output similar to data from frozen samples, and (3) clinical","Neoplasms","Case Set","Somatic_Mutations","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 15 subjects, 39 samples","","NHGRI","DS-CA-MDS --- Disease-specific (cancer, mds)","2017-09-07","2014-05-16","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000695.v1.p1","A Phase I/II Trial of Sirolimus (Rapamune ) and Cyclosporine in Patients    with Refractory Aplastic Anemia","The most successful treatment for aplastic anemia is bone marrow transplantation. However, few patients are eligible for this procedure. For others, treatment usually consists of immunosuppressive agents, such as  antithymocyte globulin (ATG) and cyclosporine. Unfortunately, even with immunosuppressive therapy, relapse is common. New combinations of medications","Aplastic Anemia","Clinical Trial","Not Provided","Not Applicable","Not Provided","16 phenotype datasets, 707 variables, 9 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-04-06","2018-04-06","Not Provided"
"phs000696.v1.p1","Exome Sequencing of Craniopharyngiomas","Craniopharyngiomas are epithelial tumors of the brain that form in the suprasellar region. Patients experience a broad range of sequelae from growth of the tumors and from therapeutic interventions.  We used whole exome sequencing to investigate the genetic aberrations in both adamantinomatous and papillary craniopharyngiomas. We found mutations","Craniopharyngioma","Case Set","Not Provided","Not Applicable","Not Provided","","","NCI","","","","Adamantinoma; Adamantinomatous tumor; Craniopharyngeal duct tumor; Craniopharyngioma (WHO Grade I); Craniopharyngiomas; Dysodontogenic epithelial tumor"
"phs000697.v1.p1","Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome","In people with MDS, the bone marrow stops making healthy blood cells and instead produces poorly functioning, malformed, and immature blood cells. This can lead to anemia resulting from  too few healthy red blood cells, infection resulting from too few healthy white blood cells, and bleeding resulting from too few healthy platelets","Myelodysplastic Syndromes","Clinical Trial","Not Provided","Not Applicable","Not Provided","16 phenotype datasets, 2379 variables, 9 documents, 39 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-04-18","2018-04-18","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic"
"phs000698.v1.p1","The Use of High Resolution Chest Computed Tomography in Alpha-1    Antitrypsin Deficiency (QUANTUM-1)","AAT deficiency is a genetic disorder associated with emphysema. Spirometry, the lung function test that measures how well the lungs exhale air, is used to diagnose and track the  progression of emphysema. Some studies have suggested that forced expiratory volume in 1 second (FEV1) measurements, a type of spirometry test, may","alpha 1-Antitrypsin Deficiency","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","22 phenotype datasets, 1170 variables, 19 documents, 51 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-03-30","2018-03-30","Not Provided"
"phs000699.v1.p1","Osteosarcoma Genomics","In this study we attempt to elucidate the genomic characteristics of osteosarcoma. Clinical characteristics 58 tumor / normal pairs from 58 patients were included in the study. Median age  at diagnosis was 12 years. 49% of the patients were male and 47% had metastases at diagnosis. 5 year overall survival was 49% for the entire","Osteosarcoma","Case Set","Somatic_Mutations_TCGA","Not Applicable","RNA-Seq, SNV (.MAF), WGS, WXS","4 phenotype datasets, 14 variables, 1 analyses, 1 molecular datasets,  SRA, 58 subjects, 116 samples","","NCI","DS-CA-NPU-MDS --- Disease-specific (cancer, npu, mds)","2015-01-07","2015-01-07","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteochondrosarcoma; Osteogenic Sarcoma; Osteogenic Sarcomas"
"phs000701.v1.p1","Dietary Supplements for the Treatment of Angelman Syndrome","This study has been designed to evaluate the possible therapeutic benefits of L-5-methyltetrahydrofolate (Metafolin), vitamin B12, creatine and betaine in children with Angelman Syndrome (AS). This study is based  on the hypotheses 1) that dietary manipulation may increase global DNA methylation; 2) that increased methylation of the paternal chromosome in AS","Angelman Syndrome","Interventional","Not Provided","Not Applicable","Not Provided","20 phenotype datasets, 2419 variables, 16 documents, 91 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2016-07-28","2016-07-28","AS; Angelman syndrome-like; Angelman's syndrome; Children, Puppet; HAPPY PUPPET SYNDROME; HAPPY PUPPET SYNDROME, FORMERLY"
"phs000706.v1.p1","RAD50 Hypomorphism as Basis for Response to Chemotherapy","Outlier analyses represent a versatile method to identify predictive biomarkers of response to both targeted agents and chemotherapy. We performed whole genome sequencing (WGS) of tumor and germline blood  from a patient with metastatic small cell carcinoma of the ureter who experienced a durable complete response to a combination of irinotecan plus","Ureteral Neoplasms","Case Set","Not Provided","Not Applicable","OTHER, WGS","4 phenotype datasets, 20 variables, 1 subjects, 5 samples","","NCI","GRU-MDS --- General research use (mds)","2014-06-19","2014-06-19","Neoplasia of the ureters; Neoplasm of Ureter; Neoplasm of the Ureter; Neoplasm, Ureteral; Neoplasms of Ureter; Neoplasms of the Ureter"
"phs000707.v2.p1","Next Generation Mendelian Genetics: Hereditary Neurological Disorders","The NHGRI Next Generation Mendelian Genetics project uses exome resequencing to identify variants in unsolved Mendelian diseases. This dataset was obtained from exome analyses of people with hereditary neurologic  disorders of unknown cause.","Nervous System Diseases","Case Set","exome_vcf_grc37, WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 17 variables, 2 molecular datasets,  SRA, 18 subjects, 18 samples","","NHGRI","DS-HND-NPU --- Disease-specific (hereditary neurological disorders, npu)","2017-04-20","2017-04-20","Ataxia (loss of muscle coordination); Ataxias; Ataxy; Coordination Impairment; Coordination Impairments; Dyssynergia"
"phs000708.v1.p1","Warfarin Pharmacogenetics: Pharmacogenetic Optimization of Anticoagulant    Response (POAT) and Genetic and Environmental Determinants of Warfarin    Response (GEDWR)","Although the efficacy of warfarin in the treatment and prevention of thromboembolic disorders is proven, it is vastly underutilized with difficulties in management and risk of complications being the  main deterrents. Recognition of genetic regulation of warfarin response has fueled efforts to quantify this influence, but the focus has been","Thromboembolism","Interventional","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 analyses, 1 molecular datasets, 200 subjects, 199 samples","African (5), African American (194)","NHLBI","DS-TH --- Disease-specific (thromboembolic disorders and hemorrhage)","2015-10-01","2015-10-01","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs000709.v1.p1","The Genome and Transcriptome of Fibrolamellar Hepatocellular Carcinoma","Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare liver tumor primarily affecting adolescents and young adults. Little is known of the molecular pathogenesis. To characterize the disease we performed RNA  sequencing and whole genome sequencing on FL-HCC tumors and adjacent normal tissue. The results demonstrate few consistent differences on the","Fibrolamellar hepatocellular carcinoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 12 variables,  SRA, 11 subjects, 29 samples","","NCI","DS-CA-IRB-MDS --- Disease-specific (cancer, irb, mds)","2014-05-09","2014-05-09","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs000710.v1.p1","1000 Genomes Used for Cloud Testing","This study provides public access to a demonstration subset of 1000 genomes sequence data in dbGaP. It is intended to be used by software developers who design, implement and  validate pipelines for dbGaP data. While this project distributes only public data, it uses dbGaP security mechanisms which include a project","Test study for cloud access","Cross-Sectional","Not Provided","Not Applicable","RNA-Seq, WGS","5 phenotype datasets, 17 variables,  SRA, 108 subjects, 108 samples","","NLM","","","","Not Provided"
"phs000712.v1.p1","UIC ACE Exome Sequencing Analysis","Autism spectrum disorder (ASD) is highly heritable with recent sibling recurrence risk estimates of 19% overall and 26% in males. The heritable phenotype of hyperserotonemia, or elevated levels of  platelet serotonin (5HT), in 35% of people with ASD is a well-established biomarker. The efficacy of drugs like risperidone and potent serotonin","Autistic Disorder","Family/Twin/Trios","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 194 variables, 1 molecular datasets,  SRA, 589 subjects, 533 samples","","NICHD","DS-ASD-RD --- Disease-specific (autism spectrum disorder, rd)","2015-11-03","2016-08-03","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000713.v1.p1","GDNF and Anxiety","GDNF gene variants were studied as possible risk factors of depression or anxiety on a young sample. The association study involved eight (rs1981844, rs3812047, rs3096140, rs2973041, rs2910702, rs1549250, rs2973050  and rs11111) GDNF single nucleotide polymorphisms and anxiety and depression scores measured by the Hospital Anxiety and Depression Scale (HADS) on","Anxiety","Cross-Sectional","SNP-PCR","Not Applicable","SNP Genotypes (PCR)","4 phenotype datasets, 42 variables, 1 molecular datasets, 708 subjects, 708 samples","","NIMH","GRU --- General research use","2014-10-21","2014-10-21","Hypervigilance; Depression"
"phs000714.v1.p1","NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)","We performed genome-wide association studies (GWAS) to study the Spontaneous Preterm birth (SPTB). Maternal and neonatal DNA from 743 SPTB (20 to and less than 34 weeks), and 752  controls (39 to and less than 42 weeks) who fully consented for public research usage were collected from participants in several clinical centers in","Premature Birth","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 332 variables, 1 molecular datasets, 2928 subjects, 2852 samples","European (1389), African (10), East Asian (10), African American (703), Hispanic1 (93), Hispanic2 (491), Other Asian or Pacific Islander (65), South Asian (14), Other (77)","NICHD","DS-PREG-COM-RD --- Disease-specific (pregnancy complications, rd)","2014-07-22","2015-04-22","Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm; Premature Births; Premature birth"
"phs000715.v1.p1","NINDS MS and ADEM Deep Sequencing Studies","Deep sequencing allows for a rapid, accurate characterization of microbial DNA and RNA sequences in many types of samples. Deep sequencing (also called next generation sequencing or NGS) is  being developed to assist with the diagnosis of a wide variety of infectious diseases. In this study, seven frozen brain samples (n 7) from deceased","Multiple Sclerosis, Chronic Progressive","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 23 variables, 35 subjects, 35 samples","","NINDS","GRU --- General research use","2014-06-25","2014-07-25","Acute Necrotizing Encephalitis, Herpetic; Herpetic Acute Necrotizing Encephalitis; Chronic Progressive Multiple Sclerosis; Multiple sclerosis (MS) chronic/progressive; Dawson's encephalitis; Dawson's inclusion body encephalitis"
"phs000716.v1.p1","GWAS of Lung Cancer Susceptibility in Never-Smoking Women in Asia","To learn about the etiology of lung cancer among never-smoking women in Asia, we formed the Female Lung Cancer Consortium in Asia (FLCCA), which includes studies of lung cancer  in Eastern Asia and conducted a GWAS. We analyzed a total of 5510 lung cancer cases and 4544 controls and identified 3 novel loci (Lan et al., 2012","Lung Neoplasms","Case-Control","Human610-Quadv1_B, Human660W-Quad_v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 3 analyses, 2 molecular datasets, 8881 subjects, 9178 samples","East Asian (8808), Other Asian or Pacific Islander (73)","NCI","DS-LC-MDS --- Disease specific (lc, mds)","2014-06-04","2014-06-04","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000717.v1.p1","Genomics of Circulating Tumor Cells","Comprehensive analyses of cancer genomes in clinical settings promise to inform prognoses and guide the deployment of precise cancer treatments. A major barrier, however, is the inaccessibility of adequate  metastatic tissue for accurate genomic analysis in prostate and other cancers. A potential solution is to characterize circulating tumor cells (CTCs","Prostatic Neoplasms","Case Set","maf_grc37","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 2 subjects, 48 samples","","NCI","DS-PC-MDS --- Disease-specific (prostate cancer, mds)","2014-10-17","2014-10-17","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000718.v1.p1","Trisomy 21 Nondisjunction (T21NDJ)","The overall goal of the project is to identify genetic risk factors associated with chromosome 21 nondisjunction in the oocyte. The dataset derives from multi-site collection of live birth  probands with Down syndrome due to standard trisomy 21 (T21) and their biological parents. The type of nondisjunction error (NDJ)(maternal or","Nondisjunction, Genetic","Family/Twin/Trios","HumanOmniExpressExome-8, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 31 variables, 2 documents, 2 molecular datasets, 2230 subjects, 2289 samples","European (1961), African (3), East Asian (2), African American (48), Hispanic1 (10), Hispanic2 (130), Other Asian or Pacific Islander (9), South Asian (3), Other (20)","NICHD","DS-DS-IRB-RD --- Disease-specific (down syndrome, irb, rd)","2015-06-23","2016-06-23","47,XX,+21; 47,XY,+21; DS; Down syndrome; Down's Syndrome; Downs syndrome"
"phs000719.v1.p1","Genetic Basis of Pulmonary Non-tuberculous Mycobacterial Infections","This project aims at characterizing the human host susceptibility to pulmonary non-tuberculous mycobacterial (PNTM) infections. PNTM infections occur in patients with chronic lung disease, but also in a distinct  group of elderly women without lung defects but who share a common body morphology: tall and lean with scoliosis, pectus excavatum, and mitral valve","Mycobacterium avium-intracellulare Infection","Family/Twin/Trios","whole_genome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","6 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 102 subjects, 102 samples","","NIAID","DS-PNTM-IRB --- Disease-specific (pulmonary non-tuberculous mycobacterial infection, irb)","2014-08-19","2015-08-19","Infection caused by Mycobacterium intracellulare; Infection, Mycobacterium avium intracellulare; Infection, Mycobacterium avium-intracellulare; Infection, Mycobacterium intracellulare; Infections, Mycobacterium avium-intracellulare; Infections, Mycobacterium intracellulare"
"phs000720.v2.p1","Genomic Sequencing of Pediatric Rhabdomyosarcoma","Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood accounting for approximately 350 newly diagnosed cases yearly in the United States. With the development of multimodal chemotherapy  regimens, relapse-free survival rates have improved to 70-80% in patients with localized disease albeit with significant toxicity. Unfortunately","Rhabdomyosarcoma","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 15 variables,  SRA, 147 subjects, 294 samples","","NCI","GRU-PUB-MDS --- General research use (pub, mds) , DS-CA-MDS --- Disease-specific (cancer, mds)","2017-04-13","2015-06-10","Alveolar Rhabdomyosarcomas; Monomorphous Round Cell Rhabdomyosarcoma; RHABDOMYOSARCOMA 2; RHABDOMYOSARCOMA, ALVEOLAR; RMS2; RMSA"
"phs000722.v2.p2","DFCI Colorectal Cancer Cohorts","Colorectal cancer is a molecularly heterogeneous disease. Whole Exome Sequencing from patients diagnosed with colorectal cancer in the NHS and HPFS cohorts will extend our understanding of the genetic  changes occurring in specific clinical contexts in the disease. This effort has the potential to discover novel recurrently mutated genes and","Colorectal Neoplasms","Tumor vs. Matched-Normal","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 10 variables, 2 molecular datasets,  SRA, 676 subjects, 1369 samples","","NHGRI","GRU --- General research use , DS-MH --- Disease-specific (men's health)","2017-05-04","2017-05-04","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000726.v1.p1","Genome-wide Association Study of Myasthenia Gravis","The purpose of this project was to conduct a genome-wide associate study to search for the genetic factors that predispose to myasthenia gravis. The rationale for this study lies  in the fact that, although the immunological and physiological processes affecting the neuromuscular junctions of myasthenia gravis patients are well","Myasthenia gravis","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 972 subjects, 972 samples","European (972)","NIA","GRU-IRB --- General research use (irb)","2015-03-17","2015-03-17","Generalized Myasthenia Gravis; Myasthenia Gravis, Generalized"
"phs000727.v1.p1","miRNA profiles in serum and CSF of Parkinson's and Alzheimer's patients","We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing) from postmortem patients diagnosed with Alzheimer's or Parkinson's disease, and neurologically normal controls. All biofluids  were cell-free and patient matched, there was one cerebrospinal fluid and one serum sample from each of 70 patients with Alzheimer's disease, 67","Alzheimer Disease","Case-Control","Not Provided","Not Applicable","miRNA-Seq","4 phenotype datasets, 36 variables,  SRA, 211 subjects, 395 samples","","NINDS","GRU --- General research use","2014-11-05","2014-11-05","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000728.v1.p1","Lung Cancer Susceptibility in Smokers","Over 85% of all patients diagnosed with lung cancer report a history of tobacco use, though only 10% of tobacco smokers eventually develop lung cancer. Epidemiologic studies have shown  that family members of patients with lung cancer have a higher risk of developing lung cancer than controls. In an effort to identify variants","Lung Neoplasms","Family/Twin/Trios","Not Provided","Not Applicable","WXS","3 phenotype datasets, 9 variables,  SRA, 204 subjects, 204 samples","","NHGRI","GRU --- General research use , DS-LC --- Disease-specific (lung cancer)","2018-01-30","2018-01-30","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000729.v1.p1","Follicular Lymphoma 2013 - Malek","A cohort of follicular lymphoma cases had tumor cells purified from tissue samples after informed consent using flow cytometry. DNA was extracted from the cells, and samples were subjected  to solution-based exome capture using the Illumina TruSeq Exome Enrichment Kit and the Illumina HiSeq 2000 platform.","Lymphoma, Follicular","Case Set","exome_vcf","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets, 9 subjects, 18 samples","","NCI","DS-LYM-MDS --- Disease-specific (lymphoma, mds)","2014-06-24","2014-06-24","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma"
"phs000730.v1.p1","Genomics of Brain Metastases","Brain metastases are the most frequently occurring intracranial tumors in adults. Median survival after the diagnosis of a brain metastasis is in the order of a few months. Despite  its large burden of disease and devastating clinical sequelae, we continue to have a limited understanding of the molecular mechanisms driving brain","Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 24 variables,  SRA, 86 subjects, 292 samples","","NHGRI","GRU --- General research use , DS-CRM --- Disease-specific (cancer research and methods) , GRU-NPU --- General research use (npu)","2015-11-16","2015-11-16","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000732.v1.p1","L1-seq and genome-wide SNP genotyping in a multiethnic Asian population","Insertions of the human-specific subfamily of LINE-1 (L1) retrotransposon are highly polymorphic across individuals and can critically influence the human transcriptome. We hypothesized that L1 insertions could represent genetic  variants determining important human phenotypic traits, and performed an integrated analysis of L1 elements and single nucleotide polymorphisms (SNPs","Molecular Structure","Prospective Longitudinal Cohort","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array), Tn-Seq","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 20 subjects, 20 samples","East Asian (9), Other Asian or Pacific Islander (8)","NHGRI","GRU --- General research use","2014-04-24","2014-04-24","Molecular Structures; Structure, Molecular; Structures, Molecular"
"phs000733.v1.p1","ICPCG Genome Wide Association Study of Familial Prostate Cancer","Initially, the ICPCG focused largely on high-risk prostate cancer pedigrees using linkage analysis. However, association studies have also been informative to find prostate cancer susceptibility variants in the genome.  We hypothesize that genome-wide (GW) association studies of familial cases of prostate cancer will have the power to identify rarer and perhaps less","Prostate cancer, familial","Case-Control","HumanOmni5Exome-4v1-1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 21 variables, 2 molecular datasets, 4036 subjects, 4181 samples","European (3930), African (6), East Asian (2), African American (26), Hispanic1 (10), Hispanic2 (5), Other Asian or Pacific Islander (3), South Asian (4), Other (4)","NCI","DS-PC --- Disease-specific (prostate cancer)","2015-03-10","2015-03-10","Familial malignant neoplasm of prostate; Hereditary prostate cancer"
"phs000734.v1.p1","Osteosarcoma Genome-wide Association Study","This is a genome-wide association study (GWAS) of osteosarcoma, the most common primary bone malignancy. Osteosarcoma typically occurs in adolescents and young adults. It occurs at increased frequency in  several inherited cancer predisposition syndromes but the genetic contribution to sporadic osteosarcoma is largely unexplored. The objective of this","Osteosarcoma","Case Set","HumanOmniExpress-12v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 694 subjects, 717 samples","European (676), Hispanic1 (7), Hispanic2 (9), Other (2)","NCI","GRU --- General research use","2014-06-10","2014-06-10","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteochondrosarcoma; Osteogenic Sarcoma; Osteogenic Sarcomas"
"phs000735.v1.p1","The Placenta Harbors a Unique Microbiome","This study is to investigate placental microbiome through 16S rDNA-based and whole genome shotgun metagenomic sequencing. Identified taxa and their gene carriage patterns were compared to other human body  sites niches. The placental microbiome profiles were most akin to the human oral microbiome.","Bacterial Infections","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 15 variables,  SRA, 48 subjects, 48 samples","","NICHD","GRU --- General research use","2014-05-23","2014-05-23","Not Provided"
"phs000737.v1.p1","NIDDK Genetics of Metabolic Syndrome in an Island Population","The major objective of this study was to conduct a systematic genetic study of metabolic traits involved in metabolic syndrome through collection and analysis of epidemiological, demographic, environmental, and  relevant biological and clinical data from a relatively isolated island population of the eastern Adriatic coast of Croatia. The population was","Metabolic Syndrome X","Cross-Sectional","GenomeWideSNP_5","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 74 variables, 1 molecular datasets, 2089 subjects, 1315 samples","European (1315)","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2015-02-05","2015-02-05","CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary"
"phs000738.v1.p1","Exome Sequencing in Schizophrenia Families","Schizophrenia is a complex neuropsychiatric disorder characterized by marked genetic heterogeneity. Much of the genetic architecture of the disorder has yet to be explained, but de novo mutations appear  to play an important role. We used exome sequencing of parent-offspring quads and trios to detect de novo mutations in persons with schizophrenia","Schizophrenia","Family/Twin/Trios","Not Provided","Not Applicable","WXS","5 phenotype datasets, 23 variables,  SRA, 216 subjects, 216 samples","","NIMH","DS-PD-RSC --- Disease-specific (psychiatric disorders and related somatic conditions)","2014-05-12","2014-05-12","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000739.v1.p1","Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas","RNA-seq data from two cases of ameloblastoma was analyzed for candidate gene fusions and point mutations. Recurrent point mutations identified in the RNA-seq data, as well as mutations identified  with limited panel targeted deep sequencing, were validated as somatic. Expanding to a larger cohort of 28, one of two activating mutations was found","Ameloblastoma","Case Set","exome_vcf_grc37","Not Applicable","AMPLICON, RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 7 subjects, 9 samples","","NCI","GRU-MDS --- General research use (mds)","2014-05-05","2014-05-05","94 kDa B-raf Protein; B-RAF Serine/Threonine Protein Kinase; B-Raf protein, human; BRAF; BRAF Protein; BRAF1 Protein"
"phs000740.v1.p1","Whole Genome Sequencing of Waldenstrom's Macroglobulinemia","Whole genome sequencing was conducted on 10 tumor/germline paired samples along with 20 additional unpaired tumor samples from patients with Waldesntrom's macroglobulinemia. Tumor lymphoplasmacytic lymphoma cells were obtained from  CD19+ selected bone marrow mononuclear cells. Germline tissue was obtained from CD19 depleted peripheral blood mononuclear cells. High molecular","Waldenstrom Macroglobulinemia","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 19 variables,  SRA, 30 subjects, 40 samples","","NCI","GRU-MDS --- General research use (mds)","2019-07-11","2019-07-11","Lymphoma, Lymphocytic, Plasmacytoid; Lymphoma, Lymphoplasmacytoid; Lymphomas, Lymphoplasmacytoid; Lymphoplasmacytoid Lymphoma; Lymphoplasmacytoid Lymphomas; Macroglobulinaemia, Waldenstrom's"
"phs000741.v2.p1","Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics    Study","The GOLDN study was initiated to assess how genetic factors interact with environmental (diet and drug) interventions to influence blood levels of triglycerides and other atherogenic lipid species and  inflammation markers (registered at clinicaltrails.gov, number NCT00083369). The study recruited Caucasian participants primarily from three","Metabolomics","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, HumanMethylation450","Not Applicable","Methylation (CpG), SNP Genotypes (Array)","5 phenotype datasets, 123 variables, 3 molecular datasets, 968 subjects, 968 samples","European (689), Hispanic1 (3), Hispanic2 (2), Other Asian or Pacific Islander (1), Other (1)","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2016-11-29","2016-11-29","Metabolic Profiling; Metabolomic"
"phs000742.v1.p1","The Epilepsy Phenome/Genome Project","The Epilepsy Phenome/Genome Project (EPGP) is a large-scale, international, multi-institutional, collaborative research project, sponsored by the National Institute of Neurological Disorders and Stroke, designed to understand the genes that  cause common and rare epilepsies. The overall goal of EPGP is to collect detailed, high quality phenotypic (i.e., characteristics of individuals","Epilepsy","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","19 phenotype datasets, 1866 variables, 5538 subjects","","NINDS","DS-EP --- Disease-specific (epilepsy)","2018-07-25","2018-07-25","Attack, Lightning; Attacks, Lightning; EIEE1; Infantile Spasm; Infantile Spasms; Intellectual disability-hypsarrhythmia syndrome"
"phs000744.v4.p2","Yale Center for Mendelian Genomics (Y CMG)","Yale University is home to one of three national centers created by the NIH to study the genetics of rare inherited diseases. Researchers at Yale, the University of Washington,  and a center operated jointly by Baylor and Johns Hopkins University will analyze the genomes of thousands of patients who suffer from more than","Familial Idiopathic Pulmonary Fibrosis","Mendelian","whole_exome_seq, HumanCNV370v1_C, HumanOmni1-Quad_v1-0_B, exome_vcf_grc37, WES_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","5 phenotype datasets, 19 variables, 4 molecular datasets,  SRA, 1896 subjects, 1960 samples","","NHGRI","GRU --- General research use","2016-08-09","2016-08-09","Aorta Coarctation; Aorta Coarctations; Aortic Coarctation; Aortic Coarctations; Coaractation of the aorta; Coarctation"
"phs000745.v1.p1","RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease","In this study, RNA sequencing was performed on astrocytes microdissected from the posterior cingulate cortex of Alzheimer's disease subjects and healthy elderly controls.","Alzheimer Disease","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 21 variables,  SRA, 20 subjects, 20 samples","","NIA","GRU --- General research use","2014-08-15","2015-08-15","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs000747.v2.p1","Whole Exome and Transcriptome Sequencing in Sporadic ALS","Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal and devastating neurodegenerative disorder that causes the progressive death of upper and lower motor neurons. Although  many efforts have been done to elucidate molecular factors involved in the onset and progression of the disorder, the causes of ALS are yet unknown","Amyotrophic Lateral Sclerosis","Case-Control","exome_vcf_grc37","Not Applicable","RNA-Seq, SNP Genotypes (NGS), WXS, miRNA-Seq","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 17 subjects, 40 samples","","NINDS","GRU --- General research use","2017-11-30","2015-08-20","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs000748.v7.p4","Multiple Myeloma CoMMpass Study","The Multiple Myeloma Research Foundation (MMRF) CoMMpass (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile) trial (NCT01454297) is a longitudinal observation study of 1000 newly diagnosed  myeloma patients receiving various standard approved treatments that aim at collecting tissue samples, genetic information, Quality of Life (QoL) and","Multiple Myeloma","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 29 variables,  SRA, 1014 subjects, 5118 samples","","NCI","GRU-MDS --- General research use (mds) , DS-MCRD-MDS --- Disease-specific (myeloma and other cancer-related disorders, mds)","2019-03-20","2014-10-07","Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease; Kahler's disease"
"phs000750.v1.p1","Genomic Origins and Admixture in Latinos (GOAL)","The GOAL Study was designed to comprehensively evaluate the genomic architecture of diverse Hispanic/Latino individuals with origins from the Caribbean, Central and South America, and to understand the impact  of this diversity on genetic disease studies. Population structure and admixture are key confounders in genome-wide association and medical","Population Groups","Family/Twin/Trios","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 20 variables, 4 documents, 1 molecular datasets, 271 subjects, 250 samples","European (40), African American (34), Hispanic1 (62), Hispanic2 (83), Other (31)","NIGMS","GRU --- General research use","2014-09-04","2014-09-04","Tribes"
"phs000751.v1.p1","GWAS in Fibrosing Interstitial Lung Disease","This study was a case-control genome-wide association study of 1616 non-Hispanic white cases and 4683 controls. Under an additive model for the minor allele at each SNP, we identified  19 SNPs, representing 7 chromosomal locations (5p15, 6p24, 7q22, 11p15, 15q14-15, 17q21, and 19p13), with genome-wide significant (P 5x10-8","Lung Diseases, Interstitial","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 analyses, 1 molecular datasets, 1616 subjects, 1616 samples","European (1605), Hispanic1 (1), Hispanic2 (8), Other (2)","NHLBI","DS-LD-IRB-PUB --- Disease-specific (lung disease, irb, pub)","2014-06-25","2014-06-25","Acute interstitial pneumonitis; Cryptogenic Fibrosing Alveolitides; Cryptogenic Fibrosing Alveolitis; Dysplasia, Fibrocystic Pulmonary; Dysplasias, Fibrocystic Pulmonary; FIBROCYSTIC PULMONARY DYSPLASIA"
"phs000753.v1.p1","High Density SNP Association Analysis of Lung Cancer","This research builds upon an extensive resource of a case-control study that has been ongoing at the UT MD Anderson Cancer Center since 1991. To identify risk variants for  lung cancer, we conducted a genome-wide association study. Cases are newly diagnosed, histologically-confirmed patients presenting at MD Anderson","Lung Neoplasms","Case-Control","HumanHap300v1-1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 2290 subjects, 2290 samples","European (2284), African American (1), Hispanic1 (1), Hispanic2 (2), Other (2)","NCI","GRU-MDS --- General research use (mds)","2014-09-30","2014-09-30","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000756.v1.p1","Exome Sequence of Finnish Sub-Isolate Samples from the FINRISK Cohort","We propose to undertake, at the McDonnell Genome Institute of Washington University, a collaborative exome sequencing project of 10,000 samples from a large Finnish population cohort, FINRISK, a participating  component of the Sequencing Initiative Suomi (SISu) consortium. Together these sequenced samples will provide a unique resource for identification of","Not Provided","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 27 variables,  SRA, 9335 subjects, 9335 samples","","NHGRI","DS-CBCDAA --- Disease-specific (cardio-brain-cancer-diabetes-asthma-allergy)","2019-03-04","2019-03-04",""
"phs000757.v1.p1","Ataxia Gene Identification by Integrated Genomic Analysis","Ataxias are a group of diseases that result in a lack of coordinated muscle movement. Hereditary ataxias are genetically heterogeneous and it is reported that 40% of suspected genetic  ataxias currently have an unknown cause. We used exome sequencing to detect mutations responsible for ataxia. We sequenced, when available, multiple","Ataxia","Family/Twin/Trios","Not Provided","Not Applicable","WXS","5 phenotype datasets, 17 variables, 127 subjects, 54 samples","","NINDS","DS-NDR-IRB --- Disease-specific (neurological disorders research, irb)","2015-04-01","2015-04-01","Ataxia (loss of muscle coordination); Ataxias; Ataxy; Coordination Impairment; Coordination Impairments; Dyssynergia"
"phs000758.v1.p1","Family Genomics of Congenital Heart Defects","The study identified the causal mutation in a five-generation pedigree harboring a cardiac septal defect. The inheritance pattern is consistent with an autosomal dominant mutation with high penetrance. We  performed whole-genome sequencing (Complete Genomics) on 21 individuals in the pedigree, of which 11 individuals are affected. We identified a single","Heart Septal Defects","Family/Twin/Trios","Mastervar_tsv","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 28 subjects, 21 samples","","NHLBI","HMB --- Health/medical/biomedical","2014-10-07","2015-10-07","Abnormality of the cardiac septa; Cardiac Septal Defects; Congenital cardiac septal defect; Congenital heart defects, septal; Congenital septal defects; Defect, Heart Septal"
"phs000759.v1.p1","Spectrum of Mutations in Myeloid Neoplasms","Patients with myeloid malignancies bearing high-risk cytogenetic abnormalities lack effective therapies and have a poor overall survival. -7/del(7q) is identified in half of high-risk myeloid neoplasms. We recently identified  CUX1 to be a haploinsufficient myeloid tumor suppressor gene located within the commonly deleted segment of 7q22. Here we identify the spectrum of","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 21 variables,  SRA, 18 subjects, 25 samples","","NCI","GRU-MDS --- General research use (mds)","2014-10-08","2014-10-08","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs000760.v1.p1","Human Responses to Influenza Vaccination","The data consist of the DNA sequences of antibody gene rearrangements from peripheral blood human B cells of subjects vaccinated with trivalent seasonal influenza or monovalent pandemic H1N1 vaccine.  Multiple replicate libraries of immunoglobulin heavy chain gene rearrangements were prepared from each subject for each time point.","Influenza Vaccines","Case-Control","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 16 variables,  SRA, 15 subjects, 586 samples","","NIAID","HMB-IRB --- Health/medical/biomedical (irb)","2015-02-20","2015-02-20","FLU - Influenza vaccine; Flu Vaccines; Influenza Vaccine; Influenza Virus Vaccine; Influenza Virus Vaccines; Influenzavirus Vaccines"
"phs000763.v1.p1","The Collaborative Study on the Genetics of Alcoholism (COGA)","COGA is a family study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study  that includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Alcoholism","Family/Twin/Trios","HumanOmniExpress-12v1_C, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 60 variables, 1 documents, 1 analyses, 2 molecular datasets, 3557 subjects, 2058 samples","European (2014), African American (7), Hispanic1 (18), Hispanic2 (15), Other Asian or Pacific Islander (1), Other (3)","NIAAA","DS-ALC-IRB-RD --- Disease-specific (alcoholism, irb, rd)","2015-01-22","2016-01-22","Alcohol Use Disorder; Alcohol Use Disorders; Use Disorder, Alcohol; Use Disorders, Alcohol"
"phs000766.v1.p1","GEI Studies - Psoriasis","The GEI Studies Project was started as an NIH consortium involving 5 disease groups with funding provided through the Genes, Environment, and Health Initiative (GEI). The objective of the  project was to optimize strategies for identifying rare variants as a follow up to genome-wide association studies (GWAS) using next-generation","Psoriasis","Case-Control","Not Provided","Not Applicable","WXS","4 phenotype datasets, 15 variables,  SRA, 4844 subjects, 4844 samples","","NHGRI","GRU --- General research use","2015-03-31","2015-10-01","Arthritic Psoriasis; Arthritis, Psoriatic; Arthropathies, Psoriatic; Arthropathy, Psoriatic; PA (Psoriatic arthritis); PsA (Psoriatic arthritis)"
"phs000767.v1.p1","The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study","The UC San Diego Chronic Lymphocytic Leukemia Study is designed to identify genetic, epigenetic, and transcriptional changes important for CLL. This data release consists of samples collected to 1)  identify genomic changes associated with CLL progression using serially collected tumor samples; 2) characterize the transcriptional consequences of","Chronic Lymphocytic Leukemia","Tumor vs. Matched-Normal","Not Provided","Not Applicable","AMPLICON, RNA-Seq","4 phenotype datasets, 27 variables,  SRA, 49 subjects, 177 samples","","NCI","DS-CLL --- Disease-specific (chronic lymphocytic leukemia)","2014-07-11","2014-07-11","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000768.v2.p1","Genomic sequencing of Ewing's Sarcoma","The Ewing sarcoma family of tumors (EFT) is a group of malignant small round blue cell tumors that arise in bone or soft tissue. Ewing sarcoma (ES) is the  second most common type of primary bone tumor to affect children and adolescents and accounts for 2.9% of all childhood cancers. This data set","Sarcoma, Ewing","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS","4 phenotype datasets, 21 variables,  SRA, 93 subjects, 99 samples","","NCI","GRU --- General research use","2017-06-29","2016-07-28","(pPNET) Peripheral Primitive Neuroectodermal Tumors; ESFT; Ewing family of tumors; Ewing sarcoma / PNET; Ewing's family of tumors; Ewing's tumor of bone (type)"
"phs000769.v1.p1","NHLBI Lung HIV Microbiome Project (LHMP)","Humans interact with countless microorganisms in multiple environments. The Lung HIV Microbiome Project (LHMP) characterized the microbiome of the lung and respiratory tract. This effort provided initial data to  develop further hypotheses addressing differences between HIV-infected and HIV-uninfected individuals. The project involved multiple studies, either","HIV","Metagenomics","Not Provided","Not Applicable","AMPLICON","5 phenotype datasets, 37 variables,  SRA, 141 subjects, 642 samples","","NHLBI","GRU --- General research use , DS-HIV --- Disease-specific (human immunodeficiency virus)","2015-11-20","2016-11-20","AIDS Virus; AIDS Viruses; Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; HIV - Human immunodeficiency virus; HTLV-III"
"phs000770.v1.p1","Somatic Mutation Profile by Next Generation Sequencing in HER2+ Breast    Cancer","The HER pathway is the driving force behind 30% of human breast cancers. It is important to understand how targeted therapies block different cellular pathways, and mechanisms of escape  from this blockage. Therapies directed at HER2 establish a successful treatment paradigm, but de novo and acquired resistance exist. The HER","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 13 variables, 14 subjects, 29 samples","","NHGRI","GRU --- General research use","2016-09-02","2016-09-02","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000771.v2.p1","Bladder Cancer Clinical Cohorts","Cisplatin-based chemotherapy is the standard of care for patients with muscle invasive urothelial carcinoma. Pathologic downstaging to pT0/pTis after neoadjuvant cisplatin-based chemotherapy is associated with improved survival, and some  patients with metastatic disease achieve complete responses to these therapies. However, the molecular determinants of cisplatin response are","Urinary Bladder Neoplasms","Case-Control","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 101 subjects, 232 samples","","NHGRI","DS-BLADDERCA --- Disease-specific (bladder cancer) , DS-GEN-URI-CA --- Disease-specific (genitourinary cancer) , HMB-MDS --- Health/medical/biomedical (mds)","2019-02-28","2014-09-25","Bladder Cancer; Bladder Cancers; CA - Bladder cancer; Cancer of Bladder; Cancer of the Bladder; Cancer, Bladder"
"phs000772.v1.p1","Genetic Predictors of Adverse Radiotherapy Effects (Gene-PARE)","The goal of this study was to identify SNPs and CNPs that are associated with development of normal tissue toxicities resulting from radiotherapy for prostate cancer. The study population  includes approximately 1,400 men treated with brachytherapy, external beam radiation therapy, or a combination of the two treatments, and assessed","Prostatic Neoplasms","Prospective Longitudinal Cohort","custom_markerset","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 39 variables, 1 molecular datasets, 787 subjects, 848 samples","","NCI","GRU-MDS --- General research use (mds)","2014-10-17","2014-10-17","Dysfunction, Erectile; Erectile Dysfunction; Failure of erection; Impotence; Impotence, Male; Impotence, Male Sexual"
"phs000773.v1.p1","CTLA4:CD28 in Sezary Syndrome","We sequenced two tumor and one normal whole genome libraries for a Sezary syndrome patient and also sequenced RNA libraries for each tumor. We identified a novel, highly expressed  CTLA4:CD28 gene fusion that is predicted to results in a leading to stimulatory T-cell signaling in the presence of an inhibitory signal.","Sezary Syndrome","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 15 variables, 1 molecular datasets, 3 subjects, 7 samples","","NCI","GRU-MDS --- General research use (mds)","2017-06-12","2017-06-12","Analysis using pyrosequencing technique; Pyrosequencing; Erythroderma, Sezary; Lymphoma, Sezary's; SEZARY SYNDROME, SOMATIC; Sezary Erythroderma"
"phs000774.v2.p1","CCDG: Genetics of Orofacial Clefts and Related Phenotypes","The purpose of this study is to investigate the genetics of orofacial clefts (OFCs) in a large study population, and importantly, to incorporate subclinical phenotypic features into these studies.  Orofacial clefts (OFCs) comprise a significant fraction of human birth defects (about 1/700 live births (Rahimov et al. 2012) and represent a major","Cleft Lip","Family/Twin/Trios","HumanCoreExomePlusCustom_Marazita, OFC_WGHum-CoreExomePlusCustom_020813_1","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 76 variables, 9 documents, 2 molecular datasets, 11925 subjects, 12248 samples","European (3972), African (222), East Asian (1056), African American (302), Hispanic1 (444), Hispanic2 (3210), Other Asian or Pacific Islander (773), South Asian (346), Other (1402)","NIDCR","DS-CFR --- Disease-specific (craniofacial research)","2018-02-16","2015-11-02","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip; Congenital fissure of lip"
"phs000775.v1.p1","Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset","Schizophrenia is a common and severe psychotic disorder. While some common SNPs and rare copy number variants have been identified as being significantly associated with disease risk, the biological  mechanisms remain undefined. To identify gene expression abnormalities in schizophrenia, we generated whole-genome gene expression profiles using","Schizophrenia","Case-Control","HumanHT-12_v4","Not Applicable","mRNA Expression (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 859 subjects, 859 samples","","NIMH","GRU --- General research use , DS-PD-RSC --- Disease-specific (psychiatric disorders and related somatic conditions)","2014-07-25","2014-07-25","Dementia Praecox; Disorder, Schizophrenic; Disorders, Schizophrenic; SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER; SCZD; Schizophrenias"
"phs000776.v1.p1","Consanguinity and Rare Mutations Outside of MCCC Genes Underlie    Non-Specific Phenotypes of MCC Deficiency","3-Methylcrotonyl-CoA Carboxylase Deficiency (MCCD) is an autosomal recessive disorder of leucine catabolism, which has a highly variable clinical phenotype, ranging from acute metabolic acidosis to non-specific symptoms such as  developmental delay, failure to thrive, hemiparesis, muscular hypotonia, and multiple sclerosis. Implementation of newborn screening for MCCD has","Urea Cycle Disorders, Inborn","Case-Control","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 33 subjects, 33 samples","","NICHD","DS-MCCD-IRB-NPU --- Disease-specific (3-methylcrotonyl-coa carboxylase deficiency, irb, npu)","2014-10-27","2015-10-27","ALDH7A1 protein, human; ATQ1 protein, human; Antiquitin-1 protein, human; aldehyde dehydrogenase 7 family, member A1 protein, human; antiquitin protein, human; ABCC7 protein, human"
"phs000777.v1.p1","NIDDK Gene discovery in FSGS","Focal segmental glomerulosclerosis (FSGS) is a frequent cause of end-stage renal disease. The pathogenesis of FSGS has not been precisely defined and there are no consistently effective treatments. Recent  studies identifying causal genes in rare, inherited FSGS, including our own study, have associated mutations in at least six genes with familial FSGS","Glomerulosclerosis, Focal Segmental","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 3 documents, 1 molecular datasets, 10 subjects, 10 samples","","NIDDK","GRU-IRB --- General research use (irb)","2014-09-04","2014-09-04","FGS - Focal glomerulosclerosis; FSGS; FSGS - Focal Segmental Glomerulosclerosis; Focal Glomerulosclerosis; Focal Sclerosing Glomerulonephritides; Focal Sclerosing Glomerulonephritis"
"phs000778.v1.p1","NIDDK Gene discovery in VUR","Primary vesicoureteric reflux (PVUR), or non-syndromic VUR, is the most common type of congenital anomaly of the kidney and the urinary tract (CAKUT). PVUR is the single most important  risk factor for pyelonephritis and renal parenchymal scarring in the pediatric age group. Renal parenchymal scarring due to PVUR is referred to as","Vesico-Ureteral Reflux","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets, 5 subjects, 5 samples","","NIDDK","GRU-IRB --- General research use (irb)","2014-11-05","2014-11-05","Necrotizing Pyelonephritis; Pyelonephritis, Acute Necrotizing; Familial vesicoureteral reflux; Reflux, Vesico-Ureteral; Reflux, Vesicoureteral; Ureteral reflux"
"phs000779.v1.p1","OFCCR SNP-CpG","We profiled the methylation landscape of 2100 DNA samples ( 1100 cases of colorectal cancer and 1000 controls) from the Ontario Familial Colon Cancer Registry (OFCCR) using the HumanMethylation450  array from Illumina. DNA was extracted from lymphocyte pellets, except for 99 samples for which DNA was extracted from lymphoblastoid cell lines","Colorectal Neoplasms","Case-Control","Affymetrix_100K, Affymetrix_500K, HumanMethylation450","Not Applicable","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 2402 subjects, 2902 samples","European (2281), African (1), East Asian (40), African American (10), Hispanic1 (7), Hispanic2 (13), Other Asian or Pacific Islander (5), South Asian (21), Other (19)","NHGRI","DS-CA-IRB --- Disease-specific (cancer, irb)","2014-10-17","2014-10-17","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000780.v1.p1","Exome Sequencing of Childhood Wilms Tumor","Wilms tumor is the most common kidney cancer of children. To define the mutation spectrum of Wilms tumor, we performed whole-exome sequencing on matched tumor-normal pairs. A further set  of tumor samples underwent whole exome sequencing without accompanying normal tissue. Exome data for patients giving consent to have the information","Wilms Tumor","Case Set","Not Provided","Not Applicable","Not Provided","5 subjects, 8 samples","","NIDDK","","","","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000781.v1.p1","Children's Hospital of Philadelphia: GWAS of Left-Sided Cardiac Defects","This is a family-based genome-wide association study of congenital left-sided cardiac lesions (LSLs). Cases with LSLs and their parents were recruited from the Cardiac Center at The Children's Hospital  of Philadelphia between 1997 and 2010. The discovery dataset included 405 LSL case-parent triads. DNA was extracted from blood or saliva samples from","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","","","NHLBI","","","","Abnormalities, Heart; Abnormality, Heart; Cardiac abnormalities; Cardiac anomaly; Congenital Heart Defect; Congenital anomaly of heart"
"phs000782.v1.p1","Post-Liver Transplant Recurrent Human Hepatocellular Carcinoma Study    (RHCCS)","The whole exome sequencing showed that HERC5 deletion and under-expression associates with shorter: time to tumor recurrence, progression-free, and overall survival in hepatocellular carcinoma (HCC) in two independent studies  (p1 0.004, HR1 1.80; p2 0.018, HR2 3.31) totaling 286 HCC patients. Matched primary and recurrent tumors indicated a clonal selection advantage in","Carcinoma, Hepatocellular","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 16 subjects, 46 samples","","NCI","GRU-PUB-MDS --- General research use (pub, mds)","2017-10-06","2017-10-06","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs000783.v2.p1","Gene Mutation and Rescue in Human Congenital Diaphragmatic Hernia (CDH)","Congenital diaphragmatic hernia (CDH) is a common and severe birth defect characterized by structural defects of the diaphragm and by pulmonary hypoplasia. Congenital diaphragmatic hernia patient may present either  as an isolated phenotype or together with other congenital anomalies in a complex phenotype. Despite the clinical significance of CDH, the underlying","Hernias, Diaphragmatic, Congenital","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 27 variables, 2 molecular datasets,  SRA, 469 subjects, 471 samples","","NICHD","DS-CDH-IRB-COL --- Disease-specific (congenital diaphragmatic hernia, irb, col)","2018-04-18","2018-04-18","Abnormalities, Multiple; MCA; Multiple Abnormalities; Multiple congenital malformations; ARP-1; ApoAI Regulatory Protein 1"
"phs000784.v2.p1","Genetic Epidemiology Network of Salt Sensitivity (GenSalt)","The GenSalt study is aimed at identifying novel genes which interact with the effect of dietary sodium and potassium intake or cold pressor on blood pressure.","Arterial Pressure, Mean","Interventional","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 1675 subjects, 1000 samples","East Asian (977), Other Asian or Pacific Islander (23)","NHLBI","GRU-IRB --- General research use (irb)","2016-12-12","2014-11-05","Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure; Mean Arterial Pressure; Mean Arterial Pressures; Pressure, Mean Arterial"
"phs000785.v1.p1","Sequencing Analysis of Cutaneous Squamous Cell Carcinoma","The Exome Sequencing Analysis of Cutaneous Squamous Cell Carcinoma (SCC) study is a single-center cohort study. To identify recurrent genomic aberrations that might underlie the development of this malignancy,  we performed whole exome sequencing on a series of SCC-normal pairs to distill a list of 336 candidate genes that were subsequently re-sequenced in","Carcinoma, Squamous Cell","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","210 subjects, 210 samples","","NIAMS","","","","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinomas, Epidermoid; Carcinomas, Planocellular; Carcinomas, Squamous"
"phs000787.v1.p1","Immunosenescence: Immunity in the Young and Aged","The study sequenced TCRB gene rearrangements from young versus elderly human subjects.","Aging","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 14 variables, 9 subjects, 210 samples","","NIAID","HMB-IRB --- Health/medical/biomedical (irb)","2015-05-08","2016-01-08","Aging, Biological; Biological Aging"
"phs000789.v1.p1","Collaborative Study of Genes, Nutrients and Metabolites (CSGNM)","While many genetic and metabolic studies focus on understanding disease states, this genome wide association study (GWAS) was designed to understand the influence of genetic variants on circulating metabolites  and factors in normal, healthy individuals. Over 2500 healthy, ethnically Irish college students attending Trinity College Dublin completed a health","Not Provided","Control Set","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 76 variables, 1 molecular datasets, 2408 subjects, 2527 samples","European (2408)","NHGRI","HMB --- Health/medical/biomedical","2015-10-29","2016-10-29","3 Hydroxyanthranilic Acid; 3-Hydroxyanthranilic Acid; Acid, 3-Hydroxyanthranilic; Benzoic acid, 2-amino-3-hydroxy-; 3-(3-Hydroxyanthraniloyl)alanine; 3-Hydroxy-DL-kynurenine"
"phs000790.v1.p1","Comparative Analysis of Primary and Metastatic Colorectal Cancer","Molecular profiling for somatic mutations that predict response to anti-EGFR therapy in colorectal cancer (CRC) has become standard practice. However, abundant tissue from metastatic lesions is not always available  from patients with metastatic CRC. Concerns involving genetic heterogeneity between primary and metastatic lesions have called into question the","Colorectal Neoplasms","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","SNV (.MAF), WGS","3 phenotype datasets, 17 variables, 1 molecular datasets, 4 subjects, 12 samples","","NCI","GRU-MDS --- General research use (mds)","2015-01-29","2015-01-29","CA - Cancer of colon; COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic"
"phs000791.v1.p1","Integrated Epigenetic Maps of Human Embryonic, Extraembryonic and Adult    Cells","Working cooperatively with other Mapping Centers and the Data Coordination Center (EDACC) funded by this Roadmap mechanism we have comprehensively mapped the epigenomes of select human cells with significant  relevance to complex human disease. Our effort has been focused on cells relevant to human health and complex disease including cells from the blood","Neoplasms","Control Set","Not Provided","Not Applicable","Bisulfite-Seq, ChIP-Seq, MRE-Seq, MeDIP-Seq, RNA-Seq, WGS, miRNA-Seq","5 phenotype datasets, 31 variables,  SRA, 50 subjects, 258 samples","","NIDA","HMB --- Health/medical/biomedical","2016-03-24","2016-12-24","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000792.v1.p1","Oncogenomics of Malignant Peripheral Nerve Sheath Tumors","Malignant peripheral nerve sheath tumors (MPNSTs) are a group of highly aggressive soft tissue sarcomas that may occur sporadically, in association with neurofibromatosis type I (NF1-associated), or after radiotherapy  (RT-associated). We utilized comprehensive genomic approaches and identified recurrent loss-of-function somatic alterations in the Polycomb","Neurilemmoma","Case Set","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), RNA-Seq, WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 18 subjects, 46 samples","","NCI","GRU-PUB-MDS --- General research use (pub, mds)","2014-11-24","2014-11-24","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000793.v1.p1","Paired AML Epigenetics Study on Clonality","We describe methclone, a novel method to identify epigenetic loci that harbor large changes in the clonality of their epialleles (epigenetic alleles). Methclone efficiently analyzes genome-wide DNA methylation sequencing  data. We quantify the changes using a composition entropy difference calculation and also introduce a new measure of global clonality shift, loci","Leukemia, Myeloid, Acute","Collection","Not Provided","Not Applicable","Bisulfite-Seq","4 phenotype datasets, 25 variables,  SRA, 18 subjects, 18 samples","","NINDS","GRU --- General research use","2014-09-12","2014-09-12","Acute Biphenotypic Leukemia; Acute Biphenotypic Leukemias; Acute Leukemia, Biphenotypic; Acute Leukemia, Hybrid; Acute Leukemia, Mixed-Lineage; Acute Leukemias, Biphenotypic"
"phs000794.v1.p1","Longitudinal Genome-Wide Analysis of Patients with Chronic Lymphocytic    Leukemia","Samples from two-center prospective phase 2 clinical trail conducted at Ohio State University (Columbus, OH) and Mayo Clinic (Rochester, MN) were analyzed in 12 cases. All patients had progressive  CLL as defined by National Cancer Institute (NCI) Working Group criteria. Patients provided written informed consent for correlative studies","Chronic Lymphocytic Leukemia","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 20 variables,  SRA, 12 subjects, 42 samples","","NCI","GRU-MDS --- General research use (mds)","2015-04-15","2015-04-15","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000795.v1.p1","Gastric Cancer Genetic Analysis of Metastasis","To identify candidate drivers involved in oncogenesis and tumor evolution, we conducted an extensive genome sequencing analysis of metastatic progression in diffuse gastric cancer. This involved a comparison between  a primary tumor from a Hereditary Diffuse Gastric Cancer Syndrome proband and its subsequent recurrence as an ovarian metastasis.","Stomach Neoplasms","Case-Control","Not Provided","Not Applicable","WGS, WXS","5 phenotype datasets, 23 variables, 17 subjects, 6 samples","","NCI","HMB-PUB-MDS --- Health/medical/biomedical (pub, mds)","2017-04-11","2017-04-11","Cancer metastatic to ovary; Carcinoma, Krukenberg; Krukenberg Carcinoma; Krukenberg Neoplasm; Krukenberg's Tumor; Krukenbergs Tumor"
"phs000796.v1.p1","Genome Wide Association Study of Chronic TMD: Discovery Phase","The OPPERA project is investigating effects of genetic, physiological, psychological and clinical factors on the risk of developing painful temporomandibular disorder (TMD). This case-control study is a discovery-phase genome  wide association study that aims to identify commonly-occurring genetic variants associated with chronic TMD. It represents the first step in a","Temporomandibular Joint Disorders","Case-Control","1000G_ref_panel, HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 1184 variables, 21 documents, 2 molecular datasets, 3104 subjects, 3239 samples","European (1935), African (25), East Asian (84), African American (725), Hispanic1 (63), Hispanic2 (72), Other Asian or Pacific Islander (41), South Asian (117), Other (42)","NIDCR","DS-TMJD-RD --- Disease-specific (temporomandibular joint disorder, rd)","2016-05-19","2016-05-19","Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Pains, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Pains, Widespread Chronic"
"phs000797.v1.p1","CTLA4 haploinsufficiency and immune dysregulation","We identified germline heterozygous mutations in CTLA4 in members of four families with severe immune dysregulation. Human CTLA4 haploinsufficiency caused dysregulation of FoxP3+ regulatory T (Treg) cells and lymphocytic  infiltration of target organs, mimicking Ctla4 homozygous mice. Patients also exhibited a B cell phenotype, with progressive loss of B cells and","Autoimmune enteropathy","Case Set","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 27 variables, 1 molecular datasets, 5 subjects, 5 samples","","NIAID","DS-ADO-IRB-PUB --- Disease-specific (autoimmune diseases, irb, pub)","2014-10-24","2015-10-24","Anemia, Hemolytic, Idiopathic Acquired; AITP; Autoimmune Thrombocytopenia; Autoimmune Thrombocytopenias; Autoimmune Thrombocytopenic Purpura; Autoimmune Thrombocytopenic Purpuras"
"phs000798.v1.p1","Performance Characteristics of Selective Targeted Enrichment in Genetic    Diagnostic Testing","The Nex-StoCT and ACMG recommend that validation of an NGS-based diagnostic test include performance test characteristics for assay accuracy, analytical sensitivity and specificity, reproducibility and repeatability. To measure these  parameters for the GEDi capture and sequencing test, 4 samples (three randomly selected patient samples and the NA12878 HapMap sample) were prepared","Genetic Testing","Control Set","HumanOmni2.5-8v1_C","Not Applicable","SNP Genotypes (Array), WXS","3 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 4 subjects, 44 samples","European (4)","NEI","GRU-NPU --- General research use (npu)","2014-11-26","2015-05-26","Genetic Predictive Testing; Genetic Predisposition Testing; Genetic Testing, Predictive; Predictive Genetic Testing; Predictive Testing, Genetic; Predisposition Testing, Genetic"
"phs000799.v1.p1","Shanghai Breast Cancer Genetics Study (SBCGS)","The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast  Cancer Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only","Breast Neoplasms","Case-Control","1000G_ref_panel, Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (imputed), SNP Genotypes (NGS)","4 phenotype datasets, 17 variables, 2 molecular datasets, 5152 subjects, 5152 samples","East Asian (5106), Other Asian or Pacific Islander (46)","NCI","GRU-PUB-NPU --- General research use (pub, npu)","2015-06-11","2018-08-28","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000803.v2.p1","Gastorointestinal Cancer Clinical Cohorts","Comprehensive genomic profiling of colon adenocarcinomas has revealed multiple recurrent alterations that may inform new treatment strategies. Clinical trials of these agents are ongoing, although the mechanisms of response  and resistance to these agents are not well characterized. The goal of this study is to perform comprehensive profiling of pre-treatment and post","Colonic Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","RNA-Seq, SNV Aggregate (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 6 subjects, 22 samples","","NHGRI","DS-MULT --- Disease-specific (multiple) , DS-CA --- Disease-specific (cancer)","2017-09-20","2015-05-13","Bile Duct Cancer; Bile Duct Cancers; Cancer of Bile Duct; Cancer of the Bile Duct; Cancer, Bile Duct; Cancers, Bile Duct"
"phs000804.v1.p1","Genomic Sequencing of Ewing Sarcoma","Pediatric Ewing sarcoma is a pediatric cancer that primarily arises from the bone. It is characterized by chimeric fusions of the EWS gene and an ETS family transcription factor.  In this study, we performed massively parallel sequencing of a larger collection of Ewing sarcoma tumors to define the genomic landscape of this","Sarcoma, Ewing","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS, WXS","4 phenotype datasets, 18 variables, 1 molecular datasets, 102 subjects, 132 samples","","NCI","GRU --- General research use , DS-CA-MDS --- Disease-specific (cancer, mds)","2016-12-13","2016-12-13","ES; Ewing Sarcoma; Ewing Tumor; Ewing's Sarcoma; Ewing's Tumor; Ewings Sarcoma"
"phs000806.v1.p1","MIGen_ExS: Ottawa Heart Study","The Ottawa Heart Study is a cross-sectional case-control study designed to identify genes that predispose to angiographically defined coronary artery disease. All exome sequencing was performed at the Broad  Institute of Harvard and MIT; samples sequence capture was performed using Agilent SureSelect Human All Exon Kit v2 and sequencing was performed on","Not Provided","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 1968 subjects, 1968 samples","","NHLBI","GRU --- General research use","2016-03-24","2016-03-24",""
"phs000807.v1.p1","Breast Cancer Study","The Cancer and Leukemia Group B (CALGB) 40101 trial compared four and six cycles of AC or single-agent paclitaxel in early breast cancer. The study was a 2X2 factorial  design trial that also examined the effects of AC vs singleagent paclitaxel.","Breast Neoplasms","Prospective Longitudinal Cohort","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 molecular datasets, 1914 subjects, 1914 samples","European (1612), African (7), East Asian (16), African American (169), Hispanic1 (21), Hispanic2 (58), Other Asian or Pacific Islander (11), South Asian (5), Other (15)","NIGMS","APTC --- For the use in future research to learn about, prevent or treat cancer","2015-02-03","2016-02-03","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000809.v1.p1","Autosomal recessive PGM3 mutations cause a new Congenital Disorder of    Glycosylation","To define a genetic syndrome of severe atopy, elevated serum IgE, immune deficiency, autoimmunity, and motor and neurocognitive impairment, eight patients from two families who had similar syndromic features  were studied. Whole exome sequencing was performed to identify disease-causing mutations. A disease segregated with a novel autosomal recessive","Congenital Disorders of Glycosylation","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 26 variables, 1 molecular datasets, 8 subjects, 8 samples","","NIAID","GRU --- General research use (irb)","2014-11-25","2014-11-25","CDG; CDG - Carbohydrate-deficient glycoprotein syndrome; Carbohydrate Deficient Glycoprotein Syndrome; Carbohydrate deficiency glycoprotein syndrome; Carbohydrate-Deficient Glycoprotein Syndrome; Carbohydrate-Deficient Glycoprotein Syndromes"
"phs000811.v1.p1","Comparison of custom capture for targeted next generation DNA sequencing","Targeted, capture-based DNA sequencing is an economical way to sequence a customized region of the genome. Several targeted sequencing kits are available, but the efficacies of these kits have  not been compared. We appraised four targeted DNA technologies for next generation sequencing, considering on-target sequencing, uniformity, and","Neoplasms","Tumor vs. Matched-Normal","target_vcf","Not Applicable","OTHER, SNP Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 10 subjects, 16 samples","","NHGRI","GRU --- General research use","2015-01-09","2015-01-09","DNA - Deoxyribonucleic acid; Deoxyribonucleic Acid; Deoxyribonucleic acids; CA; CA - Cancer; Cancer"
"phs000812.v1.p1","The Breast and Prostate Cancer Cohort Consortium (BPC3)","The Breast and Prostate Cancer Cohort Consortium (BPC3) was established in 2003 to pool data and biospecimens from nine large prospective cohorts to conduct research on gene-environment interactions in  cancer etiology. The BPC3 initially focused on the association of 70 candidate genes in the Steroid Hormone Metabolism and IGF pathways with risk of","Prostatic Neoplasms","Case-Control","1000G_ref_panel, Human610-Quadv1_B, HumanHap550_v1, Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 46 variables, 2 analyses, 4 molecular datasets, 12501 subjects, 12501 samples","European (12484), Hispanic1 (4), Hispanic2 (6), South Asian (1), Other (6)","NCI","GRU-MDS --- General research use (mds) , HMB-PUB-MDS --- Health/medical/biomedical (pub, mds) , DS-BOED-MDS --- Disease-specific (breast, ovarian, or endometrial disease, mds) , CADM --- Cancer in all age groups, other disease in adults only and methods","2015-06-11","2015-06-11","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000813.v1.p1","Sequencing of Targeted Genomic Regions Associated with Smoking","This study includes samples from two projects: Collaborative Genetic Study of Nicotine Dependence (COGEND; PI: Laura Bierut) and Genetic Study of Nicotine Dependence in African Americans (AAND; PI: Laura  Bierut and Eric Johnson). The majority of the COGEND subjects included in the current study overlap with the two datasets already available on dbGaP","Tobacco Use Disorder","Case-Control","target_vcf_grc37, HumanExome-12v1-1_A, CIDR_Barcode_markerset","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","4 phenotype datasets, 131 variables, 27 documents, 1 molecular datasets,  SRA, 2969 subjects, 3098 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2015-10-23","2016-10-23","Behavior, Smoking; Behaviors, Smoking; Smoking Behaviors; Smoking, Tobacco and Cancer-Behavior; Cessation, Smoking; Giving Up Smoking"
"phs000814.v1.p1","MIGen_ExS: Italian Atherosclerosis Thrombosis and Vascular Biology","Italian Atherosclerosis Thrombosis and Vascular Biology study is a prospective, nationwide, case-control study involving 125 coronary care units in Italy. The cases were patients who were hospitalised for a  first MI before the age of 45 years and underwent coronary angiography. Acute MI was defined as resting chest pain lasting more than 30 minutes","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 3592 subjects, 3592 samples","","NHLBI","GRU --- General research use","2016-01-21","2016-01-21","Atherogenesis; Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery"
"phs000815.v1.p1","Gene Expression and Regulatory Networks in Human Leukocytes","Profiling of gene expression with microarrays holds great potential for human health, for illuminating disease pathways or providing biomarkers to monitor disease or its resolution. Using high-throughput approaches for  genotyping, immunophenotyping and gene expression analysis, the project will examine the basis for the control of gene expression in human immune","Not Provided","Control Set","HumanOmniExpressExome-8","Not Applicable","SNP Genotypes (Array), OTHER, RNA-Seq","6 phenotype datasets, 25 variables, 1 molecular datasets, 688 subjects, 1383 samples","European (359), African (20), East Asian (139), African American (135), Hispanic1 (10), Hispanic2 (4), Other Asian or Pacific Islander (15), Other (5)","NIGMS","DS-IR --- Disease-specific (immunological research)","2018-10-12","2018-10-12",""
"phs000816.v2.p1","Characterization of X Chromosome Inactivation by high-throughput    sequencing","This study of DNA and RNA sequencing of 5 parent-offspring trios is a single center study. The goal of this study is to characterize X chromosome inactivation (XCI) ratio  in females using phased genomic variations obtained through whole genome or exome sequencing in trios, followed by allele-specific expression","X Chromosome Inactivation","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","RNA-Seq, SNP Genotypes (NGS), WGA, WXS","5 phenotype datasets, 63 variables, 1 molecular datasets,  SRA, 424 subjects, 511 samples","European (4), Hispanic2 (1), Other (1)","NHGRI","GRU --- General research use","2017-04-20","2015-06-18","AIC; AIC - Aicardi syndrome; Agenesis of Corpus Callosum with Chorioretinal Abnormality; Agenesis of Corpus Callosum with Infantile Spasms and Ocular Abnormalities; Aicardi Syndrome; Aicardi's Syndrome"
"phs000817.v1.p1","Responses to Varicella Zoster Virus Vaccination","The study sequenced antibody heavy chain gene rearrangements from 4 identical twin pairs undergoing vaccination with Varicella Zoster viral vaccine.","Varicella Vaccine","Family/Twin/Trios","Not Provided","Not Applicable","AMPLICON","5 phenotype datasets, 18 variables, 16 subjects, 256 samples","","NIAID","GRU --- General research use","2015-02-10","2016-02-10","Oka Varicella Vaccine; Vaccine, Chickenpox; Vaccine, Oka Varicella; Vaccine, Varicella; Varicella Vaccine, Oka"
"phs000819.v1.p1","Normal Human Tissue Sequencing Project","The Normal Human Tissue Sequencing Project provides RNA expression and DNA methylation data from normal (non-diseased) human tissues. This data set from a variety of source tissue is a  valuable resource for human disease studies.","Not Provided","Control Set","HumanMethylation450","Not Applicable","Methylation (CpG), RNA-Seq","4 phenotype datasets, 17 variables, 1 molecular datasets, 27 subjects, 54 samples","","NHGRI","HMB --- Health/medical/biomedical , DS-HEM --- Disease-specific (hematologic disease)","2018-02-09","2018-02-09",""
"phs000820.v1.p1","CCF AFIB GWAS study","Blood samples were taken from patients who have lone atrial fibrillation. DNA samples were processed with Illumina Hap550 and Hap 610 chips.","Atrial Fibrillation","Case Set","HumanHap550-2v3_B, Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 543 subjects, 543 samples","European (529), East Asian (2), African American (7), Hispanic1 (1), Hispanic2 (4)","NHLBI","GRU --- General research use","2015-11-17","2015-11-17","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs000821.v1.p1","DNA Methylation age and mortality in the Lothian Birth Cohorts","The study examined the association between DNA methylation age and mortality. Methylation age was estimated in 4 cohorts (including the Lothian Birth Cohorts of 1921 and 1936) and related  to subsequent time-to-death. Across all four cohorts there was a strong correlation between predicted methylation age and chronological age. For","Mortality","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 19 variables, 1366 subjects","","NHLBI","HMB --- Health/medical/biomedical","2014-11-12","2015-11-12","mortality"
"phs000822.v1.p1","Genome-Wide Discovery of Novel Breast Cancer Predisposing Mutations","Cancer risk shows clear heritability, but the inherited genetic factors remain largely unknown. This project will seek to identify new genes in which mutations confer hereditary risk for early  onset breast cancer, with important implications for both biological understanding and clinical prediction and prevention. Identifying cancer","Breast Neoplasms","Case Set","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 12 variables, 1 molecular datasets, 466 subjects, 466 samples","","NHGRI","DS-GLCS-GSO --- Disease-specific (cancer - germline genetic susceptibility, gso)","2016-03-31","2017-03-31","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000823.v1.p1","Discovery of Novel Melanoma Predisposing Mutations by Exome Sequencing","Melanoma risk shows clear heritability, but the inherited genetic factors remain largely unknown. Rare high risk mutations in CDKN2A, CDK4, BAP1 and TERT have been described but these variants,  in aggregate, account for less than 50% of the kindreds reporting a family history of melanoma. This project will seek to identify new genes which","Melanoma","Case Set","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 12 variables, 1 molecular datasets, 387 subjects, 387 samples","","NHGRI","DS-CA --- Disease-specific (cancer) , GRU --- General research use , DS-UM-NPU --- Disease-specific (uveal melanoma, npu)","2016-06-21","2017-06-21","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000824.v1.p1","Genome-Wide Discovery of Novel Colon Cancer Predisposing Mutations","Cancer risk shows clear heritability, but the inherited genetic factors remain largely unknown. This project will seek to identify new genes in which mutations confer hereditary risk for early  onset colorectal cancer, with important implications for both biological understanding and clinical prediction and prevention. Identifying cancer","Colorectal Neoplasms","Case Set","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 12 variables, 1 molecular datasets, 100 subjects, 100 samples","","NHGRI","DS-GLCS-GSO --- Disease-specific (cancer - germline genetic susceptibility, gso)","2016-01-20","2017-01-20","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000825.v1.p1","Whole Genome Sequencing of HUES63 and HUES64","In this study we used next generation deep sequencing technologies to analyze the genomes of Harvard University Stem Cell lines 63 and 64. We performed 101-bp paired-end whole genome  sequencing of the two cell lines using Illumina HiSeq platforms. The sequence reads obtained were analyzed for copy number and used for replication","Growth and Development","Control Set","Not Provided","Not Applicable","WGS","3 phenotype datasets, 12 variables,  SRA, 2 subjects, 2 samples","","NIMH","GRU --- General research use","2014-11-20","2014-11-20","Not Provided"
"phs000826.v1.p1","Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31","Background National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31 suggested the efficacy of adjuvant trastuzumab, even in HER2-negative breast cancer. This finding prompted us to develop a  predictive model for degree of benefit from trastuzumab using archived tumor blocks from B-31. Methods Case subjects with tumor blocks were randomly","Breast Neoplasms","Clinical Trial","nCounter_GeneExpressionAssay","Not Applicable","miRNA Expression (Array)","4 phenotype datasets, 25 variables, 1 molecular datasets, 1579 subjects, 1579 samples","","NCI","DS-CA-IRB-MDS --- Disease-specific (cancer, irb, mds)","2015-05-12","2015-05-12","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000827.v3.p1","N.C. Clinical Genomic Evaluation by NextGen Exome Sequencing (NCGENES)","North Carolina Clinical Genomic Evaluation by Next-generation Exome Sequencing This study is part of a larger consortium project investigating the validity and best use of next-generation sequencing (in particular,  whole exome sequencing, or WES) in clinical care. Participants are patients who were either seen in the UNC Cancer and Adult Genetics Clinic or","Genetic Diseases, Inborn","Case Set","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 24 variables, 3 molecular datasets, 592 subjects, 592 samples","","NHGRI","GRU --- General research use","2016-11-22","2016-11-22","ADENOMATOUS POLYPOSIS OF THE COLON; APC; APC - Adenomatous Polyposis Coli; Adenomatous Polyposes, Familial; Adenomatous Polyposis Coli, Familial; Adenomatous Polyposis Colus"
"phs000830.v1.p1","XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study","Base mutations occur at higher frequencies within heterochromatin and late-replicating DNA. In this study, we show that regional differences in mutation frequency are absent in portions of the genome  that are not transcribed within cutaneous squamous cell carcinomas (cSCCs) with an XPC-\- genetic background. The XPC-\- genetic background","Xeroderma Pigmentosum, Complementation Group C","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WGS","4 phenotype datasets, 20 variables,  SRA, 13 subjects, 26 samples","","NCI","DS-SKCA-MDS --- Disease-specific (skin cancer, mds) , DS-CA-MDS --- Disease-specific (cancer, mds)","2015-09-16","2015-09-16","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid; Carcinomas, Planocellular"
"phs000831.v1.p1","Sporadic Amyotrophic Lateral Sclerosis (ALS): Sequencing Study","Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the nerves in the brain and spinal cord, leading to muscle weakening and eventual paralysis and death. Ten percent  of ALS cases are thought to be familial while the majority of cases are sporadic and the causative factors unknown. Dr. Roger Pamphlett of the","Amyotrophic Lateral Sclerosis","Family/Twin/Trios","Not Provided","Not Applicable","WGS, WXS","5 phenotype datasets, 17 variables,  SRA, 157 subjects, 157 samples","","NHGRI","DS-ALS --- Disease-specific (amyotrophic lateral sclerosis)","2015-08-21","2015-08-21","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs000832.v1.p1","Sensitivity to the subjective effects of amphetamine","The goal of this study was to identify SNPs associated with subjective, physiological, and behavioral responses to d-amphetamine. The study was double-blind and placebo-controlled. 381 healthy volunteers aged 18-35  years old received oral doses of d-amphetamine (10 and 20 mg) and placebo over the course of three different phenotyping sessions. A subset of","Dextroamphetamine","Prospective Longitudinal Cohort","Genome-Wide_Human_SNP_Array_6.0, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 770 variables, 2 analyses, 2 molecular datasets, 381 subjects, 381 samples","European (337), African (4), East Asian (9), African American (14), Hispanic2 (12), South Asian (2), Other (3)","NIDA","GRU --- General research use","2015-04-02","2015-04-02","1-phenylpropan-2-amine; Amfetamine; Amfetamine-containing product; Benzeneethanamine, alpha-methyl-, (+-)-; Desoxynorephedrin; Phenamine"
"phs000837.v1.p1","Whole Genome Sequencing of Two 22q11DS Trios","Two subjects with 22q11.2 deletion syndromes (22q11DS) and their parents were recruited for a whole genome sequencing study to identify candidate genetic modifiers of the various phenotypes seen in  22q11DS. Both probands had a typical 3 megabase deletion on chromosome 22q11.2 but discordant phenotypes.","Tetralogy of Fallot","Family/Twin/Trios","whole_genome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WGS","5 phenotype datasets, 27 variables, 1 molecular datasets, 6 subjects, 6 samples","European (6)","NHGRI","GRU-IRB --- General research use (irb)","2015-09-01","2015-09-01","Arthritis, Juvenile Systemic; Juvenile Onset Still Disease; Juvenile Onset Stills Disease; Juvenile Systemic Arthritis; Juvenile onset Still's disease; Juvenile-Onset Still's Disease"
"phs000838.v1.p1","Ghana Prostate Study","Participants were recruited through the Ghana Prostate Study-a population-based component, and a clinical component. The population-based component was a probability sample designed using the 2000 Ghana Population and Housing  Census data in an attempt to recruit approximately 1,000 men aged 50-74 years in the Greater Accra region ( 3 million people), which successfully","Prostatic Neoplasms","Case-Control","HumanOmni5-4v1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 932 subjects, 932 samples","African (920), African American (12)","NCI","DS-UC-MDS --- Disease-specific (urinary conditions, mds)","2015-07-10","2015-07-10","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000839.v1.p1","Bitter Blockers (BB)","The goal of this project is to determine variation in human bitter perception and the effectiveness of bitter blockers in individuals of different genotypes. The project is based on  the parent project titled ""Efficacy of bitter taste blockers on flavor acceptance in pediatric population"", which addresses how bitter taste","Taste Perception","Control Set","HumanOmni25-8v1, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 114 variables, 1 analyses, 2 molecular datasets, 139 subjects, 145 samples","European (28), African (1), African American (97), Hispanic1 (5), Hispanic2 (3), Other Asian or Pacific Islander (3), South Asian (1), Other (1)","NIDCD","GRU-PUB --- General research use (pub)","2016-07-18","2017-05-18","Feeling - sensation; Function, Sensory; Functions, Sensory; Observation of sensation; Organoleptic; Sensation"
"phs000840.v1.p1","GoT2D","The Genetics of Type 2 Diabetes Consortium (GoT2D) is a collaboration between the University of Michigan, the Broad Institute and the Wellcome Trust Centre for Human Genetics. The overall  aim is to extend upon recent efforts, such as genome-wide association studies (GWAS) and large scale meta-analyses. While they have proved successful","Type 2 Diabetes Mellitus","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS, WXS","4 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 2348 subjects, 6965 samples","European (2348)","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-08-10","2016-08-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000841.v1.p1","Tyrosine Kinase Mutations in Endometrial Cancer","The purpose of the original study was to search for somatic mutations in the tyrosine kinome of serous and clear cell endometrial carcinomas (human). The study was conducted in  two phases. Phase 1: A mutation discovery screen, in which 577 exons encoding the catalytic domains of 86 tyrosine kinases were PCR-amplified and","Endometrial Carcinomas","Case Set","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 24 variables,  SRA, 112 subjects, 180 samples","","NHGRI","DS-EC --- Disease-specific (endometrial carcinoma)","2015-02-13","2016-02-13","Endometrial Neoplasms; Endometrial Tumor; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium"
"phs000846.v1.p1","Whole Genome Bisulfite Sequencing of ccf DNA and its Cellular    Contributors","Background: Circulating cell free (ccf) fetal DNA has enabled non-invasive prenatal fetal aneuploidy testing without direct discrimination of the genetically distinct maternal and fetal DNA. Current testing may be  improved by specifically enriching the sample material for fetal DNA. DNA methylation may allow for such a separation of DNA and thus support","DNA Methylation","Cross-Sectional","Not Provided","Not Applicable","Bisulfite-Seq","4 phenotype datasets, 17 variables,  SRA, 27 subjects, 27 samples","","NHGRI","GRU-IRB --- General research use (irb)","2015-03-26","2015-03-26","Biology, Developmental; Developmental Biology; Epigenetic; Epigenetics; Antenatal Diagnoses; Antenatal Diagnosis"
"phs000848.v1.p1","Autosomal recessive TPP2 mutations cause a new human immunodeficiency","To define a genetic syndrome of combined immunodeficiency, severe autoimmunity, and developmental delay, 4 patients from two families who had similar syndromic features were studied. To identify disease-causing mutations,  we performed whole exome sequencing for one patient and her healthy parent from Family 1 and also for one patient from Family 2. Disease segregated","Immunologic Deficiency Syndromes","Case-Control","exome_vcf","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 24 variables, 1 molecular datasets, 3 subjects, 3 samples","","NIAID","GRU --- General research use (irb)","2014-12-16","2015-12-16","Autoimmune Response; Autoimmune Responses; Child Development Disorder; Child Development Disorders; Development Disorder, Child; Development Disorders, Child"
"phs000851.v1.p1","African American Breast Cancer GWAS","The GWAS includes African American participants from 9 epidemiological studies of breast cancer, comprising a total of 3,153 cases and 2,831 controls (cases/controls: The Multiethnic Cohort Study (MEC), 734/1,003;  The Los Angeles component of The Women's Contraceptive and Reproductive Experiences (CARE) Study, 380/224; The Women's Circle of Health Study (WCHS","Breast Neoplasms","Case-Control","1000G_ref_panel, Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 18 variables, 2 molecular datasets, 5367 subjects, 5367 samples","European (4), African (185), African American (5024), Hispanic1 (116), Hispanic2 (4), South Asian (4), Other (30)","NCI","CHALLENGE --- Up for a challenge (publication required) , CHALLENGE-NPU --- Up for a challenge (not for profit use only, publication required)","2015-06-11","2015-09-03","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000852.v1.p1","GEDI: A Developmental Model of Gene-Environment Interplay in SUDs","1. Great Smoky Mountains Study (GSMS; Costello et al. 1996, 1997) Three cohorts of boys and girls, aged 9, 11, and 13 years at intake in 1993, were selected  from a rural population of some 20,000 children using a household equal probability design. A two-phase procedure was used for White and African","Substance-Related Disorders","Family/Twin/Trios","1000G_ref_panel","Not Applicable","SNP Genotypes (imputed)","4 phenotype datasets, 16 variables, 1 molecular datasets, 784 subjects, 784 samples","","NIDA","DS-ADMH-IRB-GSO-RD --- Disease-specific (addiction and mental health, irb, gso, rd)","2017-08-01","2017-08-01","Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs000853.v1.p1","Normative Aging Study (NAS)","The Normative Aging Study (NAS) is a longitudinal study established by the United States Department of Veterans Affairs in 1963. Participants were male residents and free of chronic disease  at the time of recruitment. Participants were invited to undergo an in-person examination every 3-5 years. Participants provided information on","Mortality","Prospective Longitudinal Cohort","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 26 variables, 1 molecular datasets, 657 subjects, 657 samples","","NIEHS","GRU --- General research use","2015-02-06","2015-02-06","mortality"
"phs000855.v1.p1","Resistance studies in Lung Cancer","The purpose of the study was to compare gene expression profiles from a cohort of crizotinib-resistant ALK-rearranged lung tumors and a cohort of treatment-naive ALK-rearranged lung tumors. Expression profiles  were generated by RNA-seq. In parallel, gene expression profiles were obtained from ALK-rearranged lung cancer cell lines in the presence or absence","Carcinoma","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 10 variables,  SRA, 15 subjects, 48 samples","","NHGRI","DS-LCTC-MDS --- Disease-specific (lung cancer and thoracic malignancies, mds)","2015-04-07","2015-04-07","Carcinoma, no subtype; Epithelial Carcinoma; Epithelial Neoplasm, Malignant; Epithelial Neoplasms, Malignant; Epithelial Tumor, Malignant; Epithelial Tumors, Malignant"
"phs000856.v1.p1","Chromothripsis in Patient WHIM-09","We are studying the natural history, pathogenesis and treatment of patients with WHIM syndrome, an immunodeficiency disorder characterized by warts, hypogammaglobulinemia, recurrent infections and neutropenia usually due to autosomal  dominant gain-of-function mutations in chemokine receptor CXCR4. We have identified a patient born with WHIM syndrome and the WHIM mutation","WHIM syndrome","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 23 variables,  SRA, 1 subjects, 2 samples","","NIAID","GRU-IRB --- General research use (irb)","2015-02-05","2015-05-05","Agammaglobulinaemia; Agammaglobulinemia; Agammaglobulinemias; Autosomal dominant or sporadic congenital neutropenia; Congenital Agranulocytosis; Congenital Neutropenia"
"phs000857.v1.p1","Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole","These are tumor biopsies and corresponding normal samples from patients with early stage ER+/HER2- breast cancer who had received the aromatase inhibitor letrozole for 10-21 days prior to surgery.","Breast Neoplasms","Clinical Trial","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 10 variables,  SRA, 50 subjects, 50 samples","","NHGRI","HMB-PUB-NPU --- Health/medical/biomedical (pub, npu)","2015-04-29","2015-04-29","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000858.v1.p1","Whole Genome Sequencing and Haplotyping of Blastocyst Biopsies","Current methods available for pre-implantation genetic diagnosis (PGD) of in vitro fertilized (IVF) embryos do not detect de novo. Detection of these types of mutations requires whole genome sequencing  (WGS). In this study advanced massively parallel WGS was performed on three 5-10 cell biopsies from two blastocyst-stage embryos. Overall, greater","Fertilization in Vitro","Family/Twin/Trios","whole_genome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 17 variables, 1 molecular datasets, 6 subjects, 7 samples","","NHGRI","HMB-IRB --- Health/medical/biomedical (irb)","2017-08-07","2017-08-07","Artificial Fertilization; Fertilization, Test-Tube; Fertilizations in Vitro; Fertilizations, Test-Tube; IVF; In Vitro Fertilization"
"phs000862.v1.p1","Immune Response to IT ERT in Mucopolysaccharidosis I Patient","In this study we characterized the immune response to intrathecal (IT) recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis I (MPS I) subjects with spinal cord compression who had been previously  treated with intravenous rhIDU. Concentrations of specific antibodies and cytokines were measured in serum and cerebrospinal fluid (CSF) collected","Mucopolysaccharidosis I","Clinical Trial","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 40 variables, 8 documents, 5 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-31","2018-05-31","Disease, Lysosomal Storage; Diseases, Lysosomal Storage; Disorder, Lysosomal Enzyme; Disorders, Lysosomal Enzyme; Enzyme Disorder, Lysosomal; Enzyme Disorders, Lysosomal"
"phs000863.v1.p1","NCI GWAS of Renal Cell Carcinoma in African Americans","The NCI GWAS of renal cell carcinoma (RCC) in African Americans was undertaken to provide insight into genetic loci affecting susceptibility to this malignancy in a racial group known  to be at elevated risk. We genotyped 1,136,723 single-nucleotide polymorphisms (SNPs) among 255 cases and 375 controls of African ancestry from the","Carcinoma, Renal Cell","Case-Control","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 630 subjects, 650 samples","African (15), African American (607), Hispanic1 (8)","NCI","DS-RCC-NPU-MDS --- Disease-specific (kidney cancer, npu, mds)","2015-06-24","2015-06-24","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs000864.v1.p1","Genomic Predictors of Combat Stress Vulnerability and Resilience","The Genomic Predictors of Combat Stress Vulnerability and Resilience Study was designed to probe the likely hereditary basis for risk or resilience to develop PTSD and other trauma spectrum  disorders. The overall guiding hypothesis was that genomic variation gives rise to risk/susceptibility traits that, when actuated by traumatic","Stress Disorders, Post-Traumatic","Prospective Longitudinal Cohort","HumanOmniExpressExome-8v1_A, HumanOmniExpressExome-8v1_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 analyses, 1 molecular datasets, 3992 subjects, 3992 samples","European (2662), African (10), East Asian (55), African American (198), Hispanic1 (102), Hispanic2 (766), Other Asian or Pacific Islander (122), South Asian (5), Other (72)","NIMH","GRU --- General research use","2015-07-15","2015-07-15","Combat Neurosis; Neuroses, Post Traumatic; Neuroses, Post-Traumatic; Neuroses, Posttraumatic; PTSD; PTSD - Post-traumatic stress disorder"
"phs000866.v1.p1","Family Genomics of Bipolar Disorder","This study examined the segregation of variants with phenotype in pedigrees harboring bipolar disorder.","Bipolar Disorder","Case-Control","whole_genome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 87 subjects, 87 samples","","NIMH","DS-PD-RSC-RD --- Disease-specific (psychiatric disorders and related somatic conditions, rd)","2016-10-20","2016-10-20","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar disorder"
"phs000868.v1.p1","Transcriptome Sequencing of Pediatric Neuroblastoma","Neuroblastoma is the most common extra-cranial solid tumor in children. It represents 8% to 10% of all childhood cancers. Stage 4 Neuroblastoma is characterized by its clinical heterogeneous outcome.  The special category, stage 4S tumors (2-5% of all NB) are chemo-sensitive, and the patients show spontaneous regression. On the other hand, MYCN","Neuroblastoma","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 14 variables,  SRA, 29 subjects, 29 samples","","NCI","GRU --- General research use","2015-06-05","2015-06-05","Not Provided"
"phs000869.v1.p1","Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study    (BEAGESS)","BEAGESS is a genome-wide association study (GWAS) which takes advantage of the extensive data collected by investigators in the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON, http://beacon.tlvnet.net), representing many of  the high-quality population-based and other epidemiologic studies of BE and EA in the world. The overall goal of our research is to evaluate the","Esophageal Neoplasms","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 6923 subjects, 6929 samples","European (6907), Hispanic1 (1), Hispanic2 (5), Other (10)","NCI","GRU-MDS --- General research use (mds)","2015-06-19","2015-06-19","BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome; Barrett esophagus"
"phs000870.v1.p1","Characterization of Human Transcriptome by Computational and HTS    Approaches","We have deeply sequenced total RNA and whole exome of six different post-mortem human snap-frozen tissues (brain, liver, lung, striated muscle, kidney, heart) from three unrelated healthy Caucasian individuals  (males, aged 47-54) with the aim to characterize post-transcriptional events due to alternative splicing and RNA editing. In addition, to facilitate","Not Provided","Control Set","whole_genome_vcf_grc37, exome_vcf_grc37","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), WGS, WXS, miRNA-Seq","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 3 subjects, 57 samples","","NHGRI","GRU --- General research use","2015-10-19","2016-10-19",""
"phs000871.v1.p1","Whole Exome Sequencing of Pancreatic Neuroendocrine Tumors","Pancreatic neuroendocrine tumors (PNETs), often referred to as ""islet cell tumors"", are neuroendocrine neoplasms that arise from cells of the endocrine and nervous system within the pancreas. These rare  tumors which originate from the pancreatic islet are divided into many categories and are often classified by the hormone most strongly secreted","Carcinoma, Neuroendocrine","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 35 variables, 1 molecular datasets, 33 subjects, 66 samples","","NHGRI","GRU --- General research use","2017-05-09","2017-05-09","Neuroendocrine Tumors; Neuroendocrine neoplasia; Tumor, Neuroendocrine; Tumors, Neuroendocrine; Islet of Langerhans tumor; Pancreatic islet cell tumors"
"phs000873.v1.p1","Exome sequencing of a family with thrombocytopenia and leukemia","A family with a history of bleeding, variable thrombocytopenia, red cell macrocytosis and two cases of pre B-cell acute lymphoblastic leukemia was studied in a single visit. The family  was assessed for bleeding history using a bleeding questionnaire. Additionally, complete blood counts were measured and whole blood was collected","Thrombocytopenia","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 3 documents, 1 molecular datasets,  SRA, 8 subjects, 11 samples","","NHLBI","GRU --- General research use","2015-04-15","2015-04-15","Abnormal Erythrocyte; Abnormal Erythrocytes; Erythrocyte, Abnormal; Erythrocytes, Abnormal; B Cell Leukemia; B Lymphocytic Leukemia"
"phs000874.v1.p1","Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS)","GERFHS is a population-based, case-control study of hemorrhagic stroke in the Greater Cincinnati/Northern Kentucky region. Cases are recruited from within 50 miles of the University of Cincinnati and population-based  controls are matched to cases by age (+/- 5 years), race and gender from the same population as cases. All study participants are of self-reported","Intracerebral Hemorrhage","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 950 subjects, 950 samples","European (950)","NINDS","GRU-PUB --- NULL","2015-05-22","2015-05-22","Bleeding in brain; Brain Hemorrhage, Cerebral; Brain Hemorrhages, Cerebral; Cerebral Brain Hemorrhage; Cerebral Brain Hemorrhages; Cerebral Hemorrhages"
"phs000879.v1.p1","DFCI Brown Lab CLL Sequencing Study","Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+CD19+ B cells in peripheral lymphoid organs, bone marrow and blood. In this study we analyze matched  whole genome sequencing and RNA-seq data from CLL patients to characterize the mutational processes operative throughout tumor evolution. Source of","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WGS","4 phenotype datasets, 10 variables,  SRA, 30 subjects, 60 samples","","NHGRI","GRU --- General research use","2015-11-04","2015-11-04","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000881.v1.p1","Children's Hospital of Philadelphia GWAS of Conotruncal Cardiac Defects","This is a family-based genome-wide association study of conotruncal and related cardiac malformations (CTDs). Cases with CTDs and their parents were recruited from the Cardiac Center at The Children's  Hospital of Philadelphia between 1992 and 2010. The discovery dataset included 750 CTD case-parent triads. DNA was extracted from blood or saliva","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","","","","Double Outlet Right Ventricle, Noncommitted VSD; Abnormalities, Heart; Abnormality, Heart; Cardiac abnormalities; Cardiac anomaly; Congenital Heart Defect"
"phs000882.v1.p1","Prostate Cancer Genome-Wide Association Study for Uncommon Susceptibility    Loci (PEGASUS)","This genome-wide association study was funded by the National Cancer Institute (NCI) to identify uncommon susceptibility loci for prostate cancer. A total of 4,600 prostate cancer cases and 2,840  controls of European ancestry from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial were genotyped using the Illumina","Prostatic Neoplasms","Case-Control","HumanOmni2.5-4v1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 7440 subjects, 7639 samples","European (7436), Hispanic1 (3), Other (1)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods","2017-01-24","2017-01-24","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000883.v1.p1","MIGen_ExS: PROCARDIS","The Precocious Coronary Artery Disease (PROCARDIS) study is an international, multicenter case-control study aimed at discovering the genetic contributors to premature coronary artery disease. All exome sequencing was performed  at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Agilent SureSelect Human All Exon Kit v2 and sequencing was","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 2054 subjects, 2054 samples","","NHLBI","DS-HTD --- Disease-specific (heart disease)","2016-01-29","2016-01-29","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000884.v1.p1","Gut Microbiome Profiles and Risk of Colorectal Cancer","Findings from recent studies suggest that the community of microbes residing in the human body is important in disease etiology; however, it remains unclear whether personal factors modulate human  microbial composition. Studies based on animal models indicate that differences in composition might be attributed to sex-mediated effects. We","Human Microbiome","Case-Control","Not Provided","Not Applicable","POOLCLONE","4 phenotype datasets, 35 variables, 1 documents,  SRA, 240 subjects, 240 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2015-09-21","2015-09-21","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000885.v1.p1","Strong Activation of Retroviral LTRs in HCC","The ncRNA transcriptome of human hepatocellular carcinoma (HCC) is largely unexplored. We used CAGE to characterize transcription start sites across different etiologies of human HCCs with emphasis on ncRNAs.  Here we report that retroviral LTR promoters, expressed in healthy tissues such as testis and placenta but not liver, are widely activated in HCC","Carcinoma, Hepatocellular","Case-Control","CAGE_RNA_seq_markerset","Not Applicable","RNA-Seq, Expression ncRNA (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 55 subjects, 105 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2015-09-17","2015-09-17","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs000886.v1.p1","An Omics View of Asthma through Monozygotic Twins","The etiology of asthma involves both genetic and non-genetic factors. We performed whole transcriptome sequencing on monozygotic twins discordant or concordant for asthma (with concordant healthy twins as controls),  and identified multiple potential transcriptomic profiles associated with the asthma phenotype.","Asthma","Case-Control","Not Provided","Not Applicable","RNA-Seq","5 phenotype datasets, 27 variables, 1 documents,  SRA, 74 subjects, 74 samples","","NHLBI","GRU --- General research use","2016-06-08","2016-06-08","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000888.v1.p1","eMERGE Network Imputed GWAS for 41 phenotypes","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of ten participating sites (Cincinnati Children's Hospital Medical Center/Boston Children's Hospital, Children's Hospital of Philadelphia, Essentia Institute of  Rural Health, Marshfield Clinic Research Foundation and Pennsylvania State University, Geisinger Clinic, Group Health Cooperative/University of","Not Provided","Case-Control","Not Provided","Not Applicable","SNP Genotypes (imputed)","46 phenotype datasets, 394 variables, 39 documents, 2 molecular datasets, 55029 subjects, 55029 samples","European (40624), African (532), East Asian (267), African American (11129), Hispanic1 (1229), Hispanic2 (518), Other Asian or Pacific Islander (190), South Asian (136), Other (404)","NHGRI","HMB --- Health/medical/biomedical , DS-DEM --- Disease-specific (dementia) , HM-B-GSO-NIC --- Health/medical/biomedical - genetic studies only-no insurance companies , HMB-GSO --- Health/medical/biomedical (gso) , GRU --- General research use , DS-CHILDD --- Disease-specific (childhood diseases)","2016-08-11","2017-05-10","ACE Inhibitors; Angiotensin Converting Enzyme Antagonists; Angiotensin Converting Enzyme Inhibitors; Angiotensin I Converting Enzyme Inhibitors; Angiotensin I-Converting Enzyme Inhibitors; Angiotensin-Converting Enzyme Antagonists"
"phs000892.v6.p1","CPTAC Proteogenomic Confirmatory Study","Recently, significant progress has been made in characterizing and sequencing the genomic alterations in statistically robust numbers of samples from several types of cancer. For example, The Cancer Genome  Atlas (TCGA), International Cancer Genome Consortium (ICGC) and other similar efforts are identifying genomic alterations associated with specific","Neoplasms","Case Set","HumanOmni5-4v1_B, WES_markerset_grc37, HumanOmni5-4v1-1_A","Not Applicable","SNP Genotypes (Array), RNA-Seq, SNP Genotypes (NGS), WXS, miRNA-Seq","6 phenotype datasets, 284 variables, 3 molecular datasets,  SRA, 334 subjects, 987 samples","European (94), East Asian (24), African American (9), Hispanic1 (3), Hispanic2 (6), Other Asian or Pacific Islander (1), Other (1)","NHGRI","GRU --- General research use","2017-02-14","2017-11-09","Adenocarcinoma of lung; BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor"
"phs000893.v1.p1","Genome-Wide Association Study of Endometrial Cancer in E2C2","Endometrial cancer, the most common gynecological malignancy in the United States, has both an environmental and genetic component. To this end, we conducted a genome-wide association study to identify  genes involved in endometrial cancer using studies from the NCI-supported Epidemiology of Endometrial Cancer Consortium (E2C2). For the discovery","Carcinoma, Endometrioid","Case-Control","divers_arrays, HumanExome-12v1-1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 8622 subjects, 8622 samples","European (5642), Hispanic1 (4), Hispanic2 (3), Other (3)","NCI","GRU-MDS --- General research use (mds) , GRU-COL-MDS --- General research use (col, mds) , DS-CA --- Disease-specific (cancer) , DS-EC-MDS --- Disease-specific (endometrial carcinoma, mds) , DS-ENDOMETRIAL-MDS --- Disease-specific (endometrial diseases, mds) , DS-BOED-MDS --- Disease-specific (breast, ovarian, or endometrial disease, mds) , DS-CHRONIC --- Disease-specific (chronic diseases) , CADM --- Cancer in all age groups, other disease in adults only and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso)","2016-10-27","2016-10-27","Endometrial Neoplasms; Endometrial Tumor; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium"
"phs000895.v1.p1","Integrated Genomic Analysis of Periampullary Tumors","Adenocarcinomas arising in the complex environment of the ampulla of Vater constitute a histopathological heterogenous group, presumably originating from the different epithelial cellular constituents present at the site: pancreas,  bile duct, and intestinal duodenum. These tumors have been described in many different ways: intra-ampullary, periampullary, intra-ampullary","Not Provided","Prospective Longitudinal Cohort","Not Provided","Not Applicable","OTHER, WXS","4 phenotype datasets, 19 variables,  SRA, 160 subjects, 320 samples","","NHGRI","GRU --- General research use","2016-06-10","2016-06-10",""
"phs000896.v1.p1","Functional Dynamics of the Elderly Gut Microbiome During Probiotic    Consumption","A mechanistic understanding of the health benefits conferred by consumption of probiotic bacteria has been limited by our knowledge of the resident gut microbiota and its interaction with the  host. We used fecal samples from a study of twelve healthy individuals aged 65-80 to characterize the structure and functional dynamics of the gut","Human Microbiome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON, RNA-Seq","5 phenotype datasets, 22 variables,  SRA, 12 subjects, 72 samples","","NCCIH","GRU --- General research use","2017-01-11","2017-01-11","Human Microbiomes; Microbiome, Human"
"phs000898.v1.p1","Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes","We experimentally determined Mb-scale haplotypes from germline and cancer genome sequencing. Using a microfluidic process that partitions long DNA fragments into hundreds of thousands of barcoded reactions, we determined  haplotype blocks from matched colorectal cancer samples in the delineation of haplotypes of allelic imbalances and other genomic instability events.","Colorectal Neoplasms","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 15 variables,  SRA, 1 subjects, 2 samples","","NHGRI","HMB-PUB-COL-MDS --- Health/medical/biomedical (pub, col, mds)","2015-07-28","2016-07-28","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000899.v1.p1","NIMH Amish Mennonite Bipolar Genetics Study (AmBiGen)","Bipolar affective disorder is a severe, heritable condition affecting about one percent of the population. The mode of inheritance is poorly understood and probably involves multiple loci of small  to moderate effect. In this project, we use genetic mapping and sequencing methods to identify genetic markers and variations that contribute to the","Bipolar Disorder","Prospective Longitudinal Cohort","HumanOmniExpress, WES_markerset_grc37, WGS_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS)","5 phenotype datasets, 24 variables, 3 molecular datasets, 166 subjects, 166 samples","European (165), African American (1)","NIMH","GRU --- General research use , DS-BPD --- Disease-specific (bipolar disorder)","2019-05-01","2019-05-01","Affective Psychosis, Bipolar; BIPOLAR AFFECTIVE DISORDER; BPAD; Bipolar Affective Psychosis; Bipolar Disorders; Bipolar disorder"
"phs000900.v1.p1","Functionally-defined Therapeutic Targets in DIPG","Diffuse Intrinsic Pontine Glioma (DIPG) is a universally fatal childhood cancer. Here, we performed a chemical screen in patient-derived DIPG cell cultures along with RNAseq expression analysis and integrated  computational modeling to identify potentially effective therapeutic strategies. Panobinostat, among the more promising agents identified","Glioma","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WXS","3 phenotype datasets, 13 variables,  SRA, 22 subjects, 75 samples","","NCI","GRU --- General research use","2015-05-01","2015-05-01","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia"
"phs000901.v1.p1","University of Washington CSF biomarker study for Parkinson disease","There is a clear need to develop biomarkers for Parkinson disease (PD) diagnosis and monitoring disease progression. In this study we evaluated cerebrospinal fluid (CSF) proteins, which are known  to be critically involved in PD or identified in our preliminary profiling studies, aptamers, and RNAs as potential PD biomarkers. Access to subjects","Parkinson Disease","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 17 variables,  SRA, 57 subjects, 57 samples","","NINDS","GRU --- General research use","2015-07-01","2016-07-01","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000902.v1.p1","MIGen_ExS: Regicor","The Registre Gironi del Cor (REGICOR) study developed a nested case-control cohort from the Girona province in Spain in order to study genetic factors associated with the development of  coronary heart disease. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 784 subjects, 784 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2016-01-21","2016-01-21","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000903.v1.p1","OCD Collaborative Genetic Association Study (OCGAS)","The OCD Collaborative Genetics Association Study Group (OCGAS) was funded by NIMH to conduct a genome-wide association study to identify disease susceptibility loci of early-onset obsessive-compulsive disorder (OCD). Collaborators  at Johns Hopkins, Brown, Columbia, MGH, UCLA, and NIMH evaluated 2,000 individuals with OCD and collected DNA from these individuals and both their","Obsessive-Compulsive Disorder","Family/Twin/Trios","HumanOmniExpress-12v1_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 analyses, 1 molecular datasets, 2614 subjects, 2613 samples","European (2504), East Asian (10), African American (5), Hispanic1 (14), Hispanic2 (48), Other Asian or Pacific Islander (7), South Asian (11), Other (14)","NIMH","DS-OCD-OPC --- Disease-specific (obsessive compulsive disorder and other psychiatric conditions)","2015-10-26","2016-02-01","Anancastic neurosis; Anankastic Personalities; Anankastic Personality; Anankastic neurosis; Disorder, Obsessive-Compulsive; Disorders, Obsessive-Compulsive"
"phs000904.v1.p1","APC Promoter Deletion in Classic Familial Adenomatous Polyposis","The 80% of individuals with classic familial adenomatous polyposis (FAP) have detectable mutations in the coding sequence of the adenomatous polyposis coli (APC) gene. To investigate the 20% of  families without detectable causative mutations, we used exome sequencing and second-generation sequencing of the APC locus including non-coding","Familial Adenomatous Polyposis","Mendelian","Not Provided","Not Applicable","WXS","5 phenotype datasets, 26 variables,  SRA, 8 subjects, 8 samples","","NIDDK","HMB-IRB --- Health/medical/biomedical (irb)","2018-02-02","2018-02-02","CA - Cancer of colon; COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon; Cancer, Colonic"
"phs000906.v1.p1","eMERGE Network PGx Cohort","eMERGE-PGx is a multi-site test of the concept that sequence information can be coupled to electronic medical records (EMRs) for use in healthcare. The promise of personalized medicine -  health care guided by each individual's biological characteristics - is being fostered by increasingly powerful and economical methods to acquire","Pharmacogenetics","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","OTHER, SNP Genotypes (NGS)","7 phenotype datasets, 44 variables, 1 molecular datasets,  SRA, 9010 subjects, 9473 samples","","NHGRI","HMB --- Health/medical/biomedical , DS-DEM --- Disease-specific (dementia) , GRU --- General research use","2017-12-06","2017-12-06","Atomoxetine; Tomoxetine; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation"
"phs000907.v1.p1","Brain Metastases in Squamous Cell Lung Cancers","Putative oncogenic pathways in squamous cell lung cancer have been recently characterized, although their biologic repercussions in patients is largely unknown. This study sought to discover potential clinical manifestations  of major pathways in squamous cell lung cancer, particularly the PI3K pathway. Two key findings emerged: patients with stage IV squamous cell lung","Squamous Cell Carcinoma","Case Set","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 28 variables, 1 molecular datasets,  SRA, 5 subjects, 13 samples","","NCI","DS-CA --- Disease-specific (cancer)","2016-12-22","2016-12-22","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell"
"phs000908.v1.p1","Identification of Rare Variants in PD through Whole Exome Sequencing","The focus of this study is to identify a new level of genetic variation, i.e. rare genetic variants with a population frequency less than 5%, usually less than 1%,  which are believed to provide a stronger risk per variant than those studied to date in the large genome wide association studies (GWAS). To do this","Not Provided","Case-Control","target_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 22 variables, 1 molecular datasets,  SRA, 200 subjects, 200 samples","","NINDS","GRU-IRB --- General research use (irb) , DS-PD-IRB --- Disease-specific (parkinson's disease, irb)","2016-01-25","2017-01-25",""
"phs000909.v1.p1","Neuroendocrine Prostate Cancer (Trento/Cornell/Broad 2015)","A subset of advanced prostate cancers can progress from an androgen receptor (AR)-driven state to AR independence, often associated with low or absent AR expression and extensive neuroendocrine differentiation.  Once neuroendocrine prostate cancer (NEPC) develops, patients typically demonstrate an aggressive clinical course and poor overall survival. Early","Adenocarcinoma","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Bisulfite-Seq, RNA-Seq, WXS","4 phenotype datasets, 14 variables,  SRA, 94 subjects, 300 samples","","NHGRI","GRU --- General research use","2016-02-19","2016-02-19","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000910.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): Copy Number Variant (CNV)    Study","Type 1 Diabetes Genetics Consortium (T1DGC) was formed to address issues of limited sample size and consistency of phenotyping that had limited genetic investigations on risk of type 1  diabetes (T1D). The T1DGC first collected affected sib pair (ASP) families from four geographic networks (Asia-Pacific, Europe, North America, United","Diabetes Mellitus, Type 1","Family/Twin/Trios","target_markerset_grc36","Not Applicable","CNV Genotypes","5 phenotype datasets, 36 variables, 1 molecular datasets, 8005 subjects, 8005 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2015-08-24","2015-08-24","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs000911.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): ImmunoChip Study","The Type 1 Diabetes Genetics Consortium (T1DGC) was formed to address issues of limited sample size and consistency of phenotyping that had limited genetic investigations on risk of type  1 diabetes (T1D). The T1DGC first collected affected sib pair (ASP) families from four geographic networks (Asia-Pacific, Europe, North America","Diabetes Mellitus, Type 1","Case-Control","custom_array","Not Applicable","SNP Genotypes (Array)","6 phenotype datasets, 31 variables, 1 molecular datasets, 17460 subjects, 17460 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2016-06-09","2016-06-09","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs000912.v1.p1","San Francisco Bay Area Latina Breast Cancer Study","The genome-wide association study (GWAS) includes participants enrolled into two different studies. The first study, the San Francisco Bay Area Cancer Study (SFBCS) is a population-based case-control study of  breast cancer conducted in the San Francisco Bay Area and included women ages 35-79 years from three racial/ethnic groups: Non-Hispanic whites","Breast Neoplasms","Case-Control","1000G_ref_panel, Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 23 variables, 2 molecular datasets, 1165 subjects, 1165 samples","European (94), African American (8), Hispanic1 (34), Hispanic2 (977), Other Asian or Pacific Islander (2), South Asian (1), Other (49)","NCI","DS-CABNHD-MDS --- Disease-specific (cancer, benign neoplasms, or hematopoietic diseases related to cancer, mds) , GRU-COL --- General research use (col)","2015-06-11","2018-10-25","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000913.v1.p1","Genomic Analysis of Mycosis Fungoides and S zary Syndrome","Mycosis Fungoides (MF) and S zary Syndrome (Sz) comprise the majority of Cutaneous T-Cell Lymphoma (CTCL) cases and are characterized by clinical heterogeneity. This array of symptoms includes skin  patches, plaques and tumors as well as blood involvement and erythroderma. Because the genetic basis of CTCL is still poorly understood, we performed","Mycosis Fungoides","Tumor vs. Matched-Normal","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 93 subjects, 170 samples","European (4), East Asian (1)","NCI","HMB --- Health/medical/biomedical","2015-08-10","2015-08-10","Erythroderma, Sezary; Lymphoma, Sezary's; SEZARY SYNDROME, SOMATIC; Sezary Erythroderma; Sezary Lymphoma; Sezary's Disease"
"phs000914.v1.p1","Genome-wide Association Study of Adiposity in Samoans","The research goal of this study is to identify genetic variation that increases susceptibility to obesity and cardiometabolic phenotypes among adult Samoans using genome-wide association (GWAS) methods. DNA from  peripheral blood and phenotypic information were collected from 3,119 adult Samoans, 23 to 70 years of age. The participants reside throughout the","Obesity","Cross-Sectional","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 182 variables, 8 documents, 1 molecular datasets, 3501 subjects, 3293 samples","Other Asian or Pacific Islander (3113), Other (6)","NHLBI","GRU-IRB-PUB-COL-NPU-GSO --- General research use (irb, pub, col, npu, gso)","2016-06-06","2017-06-06","DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure; Diastolic arterial pressure; Pressure, Diastolic"
"phs000915.v2.p2","Integrative Clinical Sequencing Analysis of Metastatic Castration    Resistant Prostate Cancer Reveals a High Frequency of Clinical    Actionability","Most prostate cancer deaths are caused by metastatic, castration resistant disease (mCRPC). To develop a precision medicine framework for mCRPC, we established a multi-institutional, international clinical sequencing infrastructure to  enroll and carry out prospective whole exome and transcriptome sequencing of tumors from a cohort of mCRPC patients. We obtained high quality DNA and","Prostatic Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, SNV (.MAF), WXS","4 phenotype datasets, 10 variables,  SRA, 274 subjects, 763 samples","","NCI","DS-PC-MDS --- Disease-specific (prostate cancer, mds) , DS-CA-MDS --- Disease-specific (cancer, mds) , GRU --- General research use , HMB-PUB-NPU --- Health/medical/biomedical (pub, npu)","2019-02-08","2016-01-15","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs000916.v1.p1","MIGen_ExS: Munich-MI","The Munich-MI study is a case-control cohort study recruited at the German Heart Center in Munich, Germany. It is focused on understanding the genetic contributors to early myocardial-infarction (MI)  in the German population. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 799 subjects, 799 samples","","NHLBI","DS-CVD-NPU --- Disease-specific (cardiovascular disease, npu)","2016-07-28","2016-07-28","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000917.v1.p1","MIGen_ExS: PROMIS","The Pakistan Risk of Myocardial Infarction (PROMIS) study is a retrospective multicenter case-control cohort study of individuals with and without coronary heart disease from Pakistan. Multiple biological samples have  been collected from the participants including DNA, plasma, serum, and whole blood. The goal of the study is to recruit 20,000 cases and 20,000","Coronary Artery Disease","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 7298 subjects, 7298 samples","","NHLBI","GRU --- General research use","2016-01-26","2016-01-26","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs000918.v1.p1","International Parkinson's Disease Genomics Consortium (IPDGC), NeuroX    Dataset","Expanded replication set based on Nalls et al. 2014.","Parkinson Disease","Case-Control","NeuroX_15036164_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 11402 subjects, 11402 samples","","NINDS","GRU --- General research use","2015-06-15","2015-06-15","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000920.v3.p2","NHLBI TOPMed: Genes-environments and Admixture in Latino Asthmatics (GALA    II) Study","This is a case-only pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. Each participant had two spirometry measurements using the KoKo PFT System. With  the first spirometry test, participant was administered with 4 puffs of HFA Albuterol. The second albuterol measurement was based on age, for","Lung Diseases","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 3 molecular datasets,  SRA, 4707 subjects, 4763 samples","European (5), African American (34), Hispanic1 (360), Hispanic2 (475), Other (39)","NHLBI","DS-LD-IRB-COL --- Disease-specific (lung diseases, irb, col)","2019-06-05","2019-06-05","Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders; Lung disorder"
"phs000921.v3.p1","NHLBI TOPMed: Study of African Americans, Asthma, Genes and Environment    (SAGE) Study","This is a parallel case-control pharmacogenetic study of bronchodilator drug response among African American children with and without asthma. Each participant had spirometry measured using the KoKo PFT System.  Asthmatic participants were administered with 4 puffs of HFA Albuterol. Healthy participants were given a baseline spirometry test. The overall goal","Lung Diseases","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 28 variables, 2 documents, 3 molecular datasets,  SRA, 2106 subjects, 2105 samples","African (6), African American (470), Hispanic1 (8), Other (15)","NHLBI","DS-LD --- Disease-specific (lung disease)","2018-06-19","2018-06-19","Disease, Lung; Disease, Pulmonary; Diseases, Lung; Diseases, Pulmonary; Lung Disorders; Lung disorder"
"phs000922.v1.p1","Genetic Aberrations and Subclonal Structure Impact Chronic Lymphocytic    Leukemia","Large-scale whole-exome sequencing (WES) of primary tumor samples enables the unbiased discovery of recurrent putative driver events and patterns of clonal evolution. We report the identification of 44 recurrently  mutated genes and 11 recurrent CNVs through the WES of 538 chronic lymphocytic leukemia (CLL) and matched germline DNAs. These include previously","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","maf_grc37","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 280 subjects, 619 samples","","NHGRI","DS-CRM-MDS --- Disease-specific (cancer research and methods, mds)","2015-10-20","2016-10-20","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000923.v1.p1","Molecular Characterization of Germ Cell Tumors","We performed comprehensive molecular profiling of germ cell tumors, including whole exome sequencing and transcriptome sequencing, derived from patient samples. This project additionally explores mechanisms of chemosensivity in these  patients, as well as mechanisms of tumor evolution in the context of treatment.","Male Germ Cell Tumor","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","RNA-Seq, SNV Aggregate (.MAF), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 55 subjects, 141 samples","","NHGRI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-GCT-MDS --- Disease-specific (germ cell tumors, mds)","2016-09-28","2016-09-28","Not Provided"
"phs000924.v3.p1","NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research)    Resource","The iPSCORE Resource of human induced pluripotent stem cells (hiPSCs) was created as part of the Next-Gen Consortium funded by the NHLBI. The overarching purpose of the iPSCORE Resource  is to provide a large collection of hiPSCs for use in studying the impact of genetic variation on molecular and physiological phenotypes. This","Heart Diseases","Family/Twin/Trios","RNAseq_probe_set_grc37, RNAseq_gene_transcripts, HumanCoreExome-12v1-1_A, HumanCoreExome-24v1-0_A, HumanMethylation450, MEGA_Consortium_v2_15070954_A2","Not Applicable","ATAC-seq, Methylation (CpG), SNP Genotypes (Array), ChIP-Seq, Hi-C, RNA-Seq, RNA Seq expression levels","5 phenotype datasets, 65 variables, 1 documents, 5 molecular datasets,  SRA, 277 subjects, 1678 samples","European (145), East Asian (21), African American (4), Hispanic1 (3), Hispanic2 (10), Other Asian or Pacific Islander (20), South Asian (6), Other (15)","NHLBI","GRU --- General research use , DS-CMP-MDS --- Disease-specific (cardiomyopathy, mds) , DS-CMP-MD-MDS --- Disease-specific (cardiomyopathy and mitochondrial disease, mds)","2019-06-27","2019-03-06","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Cardiac Disease; Cardiac Diseases"
"phs000925.v1.p1","PAGE: IPM BioMe Biobank","The Institute for Personalized Medicine (IPM) BioMe Biobank is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over  70,000 inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86","Cardiovascular Diseases","Prospective Longitudinal Cohort","MEGA_Consortium_15063755_B2","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 21 variables, 1 molecular datasets, 13067 subjects, 13883 samples","European (308), African (509), East Asian (615), African American (5928), Hispanic1 (2720), Hispanic2 (1044), Other Asian or Pacific Islander (245), South Asian (695), Other (690)","NHGRI","GRU --- General research use","2017-03-29","2017-03-29","Cholesterol, HDL2; HDL cholesterol 2; HDL(2) Cholesterol; HDL2 Cholesterol; High density lipoprotein cholesterol subfraction 2; High density lipoprotein cholesterol, sub-fraction II"
"phs000926.v1.p1","Rare disease susceptibility alleles in children with Crohn disease","The overall goal of this proposed project is to identify rare genetic variants contributing to childhood onset-Crohn disease. Crohn disease is a chronic inflammatory disorder of the gastrointestinal tract  of unclear etiology and no known cure. Affected children suffer from diarrhea, abdominal pain, growth disturbances, and an impaired quality of life","Crohn Disease","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 18 variables, 1 molecular datasets, 4 subjects, 4 samples","European (4)","NIDDK","DS-IBD-IRB-RD --- Disease-specific (inflammatory bowel disease, irb, rd)","2015-08-07","2015-08-07","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's regional enteritis; Crohns Disease"
"phs000927.v1.p1","CSER: Clinical Implementation of Carrier Testing Using NGS (NextGen)","We will investigate the clinical implementation of genome sequencing (GS) for carrier screening to aid reproductive decision-making in adults. The study is organized into three inter-related Projects. The study  population will include women and their partners who receive pre-conception testing. In Project 1, we will conduct a Randomized Clinical Trial to","Not Provided","Clinical Genetic Testing","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 202 subjects, 202 samples","European (162), East Asian (7), African American (3), Hispanic1 (3), Hispanic2 (11), Other Asian or Pacific Islander (8), South Asian (4), Other (4)","NHGRI","GRU --- General research use","2017-06-12","2017-06-12",""
"phs000928.v1.p1","Effect of LGG Probiotic on Human Whole Blood Transcriptome","Open label study to evaluate the safety of Lactobacillus rhamnosus GG ATCC 53103 (LGG) in elderly subjects. Fifteen healthy elderly volunteers, ages 65-80 were enrolled in a study in  which they received LGG capsules containing 1 x 1010 CFU, twice daily for 28 days and were followed through day 56. The study subjects completed a","Volunteers, Human","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 20 variables, 2 documents,  SRA, 11 subjects, 32 samples","","NCCIH","HMB --- Health/medical/biomedical","2016-01-14","2016-01-14","Advanced age; Aged; Aged 65 and Over; Elderly; Elderly (Over 65); Senior Citizen"
"phs000930.v6.p1","CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology)","GWAS have successfully identified genetic loci associated with a variety of conditions such as type 2 diabetes and coronary disease. The large number of statistical tests required in GWAS  has posed a special challenge because few studies that have DNA and high-quality phenotype data are sufficiently large to provide adequate","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","144 analyses, 1 molecular datasets","","NHLBI","GRU --- General research use","2018-04-03","2017-03-17","Brain Vascular Disorder; Brain Vascular Disorders; CVD - Cerebrovascular disease; Cerebrovascular Disease; Cerebrovascular Diseases; Cerebrovascular lesion"
"phs000932.v1.p1","Somatic Reference Standard for Cancer Sequencing","In this study, we separately performed PCR-free whole genome sequencing on the paired tumor/normal melanoma COLO-829 and lymphoblastoid COLO-829BL cell lines across three separate institutions (TGen, Illumina, Genome Sciences  Centre at the British Columbia Cancer Agency). We performed a meta-analysis of all data, in combination with the originally reported analysis of","Melanoma","Tumor vs. Matched-Normal","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WGA","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 1 subjects, 8 samples","","NCI","GRU --- General research use","2016-06-15","2016-06-15","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000933.v2.p1","Melanoma Exome Sequencing","This study reports on the whole-exome sequencing (WES) of 213 patient-derived melanoma samples, including matched normal DNA for 133 of the tumors. The goal is the elucidation of the  genetic basis of sun-exposed melanoma. Specimens were collected by the Tissue Resource Core of the Yale SPORE in Skin Cancer with participants","Melanoma","Case Set","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 14 variables, 2 molecular datasets,  SRA, 290 subjects, 505 samples","","NCI","DS-M-MDS-GSO --- Disease-specific (melanoma, mds, gso)","2018-11-19","2018-11-19","Analysis using pyrosequencing technique; Pyrosequencing; Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas"
"phs000934.v1.p1","Antibody Repertoires in CVID","The data consist of the DNA sequences of antibody gene rearrangements from peripheral blood human B cells of subjects with Common Variable Immune Deficiency (CVID) and healthy controls subjects.","Common Variable Immunodeficiency","Case-Control","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 11 variables,  SRA, 198 subjects, 1291 samples","","NIAID","DS-IR-IRB --- Disease-specific (immunological research, irb)","2016-03-11","2017-03-11","CVAG; CVI - Common variable immunodeficiency; CVID; CVID - Common variable immunodeficiency; Common Variable Hypogammaglobulinemia; Common Variable Hypogammaglobulinemias"
"phs000935.v1.p1","Applying Genomic Sequencing in Pediatrics (PediSeq)","The purpose of this research study is to learn more about newer types of genetic testing called whole exome sequencing and whole genome sequencing. Current genetic testing usually examines  one gene or a few genes at a time. Exome and genome sequencing allow us to test most of a person's genes at one time with a single test. This testing","Genetic Testing","Cross-Sectional","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 22 variables, 1 molecular datasets,  SRA, 159 subjects, 159 samples","Other (2)","NHGRI","GRU --- General research use","2016-11-23","2016-11-23","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000936.v1.p1","NHLBI GO-ESP: Early-Onset Myocardial Infarction Exome Chip (Broad EOMI)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Not Provided","Case-Control","HumanExome-12v1-1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 5870 subjects, 5870 samples","","NHLBI","GRU --- General research use , DS-MI --- Disease-specific (myocardial infarction) , DS-CVD --- Disease-specific (cardiovascular disease)","2016-02-01","2016-02-01",""
"phs000937.v1.p1","The Landscape of Antisense Gene Expression in Human Cancers","High throughput RNA Sequencing has revealed that the human genome is widely transcribed. However, the extent of natural antisense transcription, the molecular mechanisms by which natural antisense transcripts (NATs)  might affect their cognate sense genes, and the role of NATs in cancer are less well understood. Here, we use strand-specific paired-end RNA","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 19 variables, 376 subjects, 376 samples","","NCI","DS-CA-NPU-MDS --- Disease-specific (cancer, npu, mds) , DS-LC-MDS --- Disease-specific (lung cancer, mds)","2016-08-24","2016-08-24","Adenocarcinoma of lung; Adrenal Cortex Adenocarcinoma; Adrenal Cortex Cancer; Adrenal Cortical Adenocarcinoma; Adrenal Cortical Carcinoma; Adrenal Cortical Carcinomas"
"phs000938.v1.p1","Appraisal of Whole Exome Sequencing Methods","Next generation sequencing has aided characterization of genomic variation. While whole genome sequencing may capture all possible mutations, whole exome sequencing is more cost-effective and captures most phenotype-altering mutations.  Initial strategies for exome enrichment utilized a hybridization-based capture approach. Recently, amplicon-based methods were designed to simplify","Not Provided","Cross-Sectional","target_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 3 subjects, 4 samples","","NHGRI","GRU-PUB --- General research use (pub)","2015-07-24","2015-07-24",""
"phs000939.v2.p1","Epigenetic and Genetic Profiling in Lymphoma","Lymphomas are a prevalent and heterogeneous family of cancers arising in cells of the immune system. Drivers of lymphomagenesis include genomic rearrangements that juxtapose active regulatory elements with specific  oncogene targets, as well as mutations affecting specific transcription factors and chromatin regulatory proteins. This study seeks to combine genome","Lymphoma, B-Cell","Case Set","Not Provided","Not Applicable","ChIP-Seq","4 phenotype datasets, 20 variables,  SRA, 20 subjects, 20 samples","","NHGRI","GRU --- General research use","2017-09-01","2015-08-12","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000941.v1.p1","Phylogenetic Analyses Reveal Complex Patterns of Melanoma Metastasis","Subpopulations of cells in a primary melanoma can disseminate and establish metastases. Still, the precise ancestral relationship between primary tumors and their metastases is not well understood. Using whole-exome  sequencing (for discovery) and targeted sequencing (for validation), we analyzed mutation patterns of primary melanomas and two or more metastases in","Melanoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WXS","3 phenotype datasets, 11 variables,  SRA, 8 subjects, 39 samples","","NCI","GRU --- General research use , DS-M-MDS --- Disease-specific (melanoma, mds)","2015-09-18","2015-09-18","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000942.v1.p1","Use of WGS for Diagnosis and Discovery in the Cancer Genetics Clinic","Despite the potential of whole-genome sequencing (WGS) to improve patient diagnosis and care, the empirical value of WGS in the cancer genetics clinic is unknown. We performed WGS on  members of two cohorts of cancer genetics patients: those with BRCA1/2 mutations (n 176) and those without (n 82). Initial analysis of potentially","Neoplasms","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 31 variables, 1 molecular datasets,  SRA, 258 subjects, 258 samples","European (214), African American (14), Hispanic1 (3), Hispanic2 (17), Other Asian or Pacific Islander (1), South Asian (4), Other (4)","NCI","GRU-PUB-MDS --- General research use (pub, mds)","2016-03-03","2016-03-03","ADENOMATOUS POLYPOSIS OF THE COLON; APC; APC - Adenomatous Polyposis Coli; Adenomatous Polyposes, Familial; Adenomatous Polyposis Coli, Familial; Adenomatous Polyposis Colus"
"phs000944.v1.p1","eMERGE Clinical Center at Partners HealthCare","The Partners HealthCare Biobank is a large research data and sample repository working within the framework of Partners Personalized Medicine. It provides researchers access to high quality, consented samples  to help foster research, advance understanding of the causes of common diseases, and advance the practice of medicine. The Partners Biobank provides","Hypercholesterolemia","Cross-Sectional","MEGA_Consortium","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 2 documents, 1 molecular datasets, 4929 subjects, 4929 samples","European (4210), African (21), East Asian (43), African American (292), Hispanic1 (186), Hispanic2 (73), Other Asian or Pacific Islander (20), South Asian (33), Other (51)","NHGRI","HMB-MDS --- Health/medical/biomedical (mds)","2016-03-07","2016-03-07","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000946.v3.p1","NHLBI TOPMed: Boston Early-Onset COPD Study in the TOPMed Program","Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States and the only leading cause of death that is steadily increasing in frequency.  This project collected a set of extended pedigrees ascertained through subjects with severe, early-onset COPD. This study has enrolled subjects with","Chronic Obstructive Pulmonary Disease","Family/Twin/Trios","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 29 variables, 2 documents, 3 molecular datasets,  SRA, 80 subjects, 74 samples","European (73), Hispanic1 (1)","NHLBI","DS-CS-RD --- Disease-specific (copd and smoking, rd)","2018-05-18","2018-05-18","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease"
"phs000947.v1.p1","DNA methylation in SLE-Related Autoantibodies","Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can have debilitating effects on multiple organ systems. In SLE, the pivotal immunologic disturbance is the formation of autoantibodies  directed against nuclear and cellular antigens. These autoantibodies are associated with specific organ manifestations. Our previous work has shown","Systemic Lupus Erythematosus","Case Set","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 14 variables, 1 molecular datasets, 325 subjects, 325 samples","","NCATS","DS-ADO-IRB --- Disease-specific (autoimmune diseases, irb)","2015-10-06","2015-10-06","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs000948.v1.p1","Genetic Discovery and Application in a Clinical Setting: Continuing a    Partnership (eMERGE Phase II)","The electronic Medical Records and Genomics (eMERGE) Network is a consortium of ten participating sites funded by the NHGRI to investigate the use of electronic medical record systems for  genomic research. The goal of eMERGE is to conduct genome-wide association studies in approximately 19,000 individuals using EMR-derived phenotypes","Not Provided","Control Set","HumanExome-12v1-1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 1968 subjects, 1968 samples","","NHGRI","HMB --- Health/medical/biomedical","2015-08-28","2015-08-28",""
"phs000949.v1.p1","Genetic Analysis of Normal Human Facial Variation","The purpose of this project is to identify genes associated with normal human quantitative facial variation. The motivation for this project stems from the fact that very little is  known about how variation in specific genes relates to the diversity of facial forms commonly observed in humans. Viable candidates for these","Anthropometry","Control Set","OmniExpressExomeCustom_121313, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 88 variables, 2 molecular datasets, 3186 subjects, 3328 samples","European (2967), African (11), East Asian (1), African American (18), Hispanic1 (9), Hispanic2 (164), South Asian (1), Other (15)","NIDCR","DS-CFR --- Disease-specific (craniofacial research)","2016-02-09","2016-02-09","Craniometry; 3D Imaging, Computer-Generated; 3D Imagings, Computer-Generated; Computer Assisted Three Dimensional Imaging; Computer Generated 3D Imaging; Computer-Assisted Three-Dimensional Imaging"
"phs000950.v1.p1","NCI SEER Formalin Fixed Paraffin Embedded (FFPE) Tissue Feasibility Study","Next Generation Sequencing (NGS) technologies are being used for detection of somatic mutations in tumors and studies of germline variation. However, most NGS studies used DNA isolated either from  whole blood or fresh frozen tissue specimens. Meanwhile, the tissue specimens available from most National Cancer Institute (NCI) funded cohorts and","Neoplasms","Case Set","WES_markerset_grc37","Not Applicable","RNA-Seq, SNP Genotypes (NGS), WXS","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 59 subjects, 129 samples","","NCI","GRU --- General research use , HMB-MDS --- Health/medical/biomedical (mds)","2018-01-04","2018-01-04","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000951.v3.p3","NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene) in the TOPMed    Program","This study contains whole genome sequence data and harmonized phenotype variables produced as part of NHLBI's Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing (WGS) project. The National Heart,  Lung and Blood Institute (NHLBI) Trans-Omics for Precision Medicine (TOPMed) program is designed to generate scientific resources to enhance","Pulmonary Disease, Chronic Obstructive","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 3 molecular datasets,  SRA, 10618 subjects, 10776 samples","European (5801), African (83), African American (2730), Hispanic1 (31), Hispanic2 (15), Other Asian or Pacific Islander (1), Other (15)","NHLBI","HMB-MDS --- Health/medical/biomedical (mds) , DS-CS-MDS-RD --- Disease-specific (copd and smoking, mds, rd)","2018-12-18","2018-12-18","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD"
"phs000952.v1.p1","Substance Dependence GWAS in European- and African - Americans","This study includes SSADDA (Semi Structured Assessment for Drug Dependence and Alcoholism) assessed subjects (mostly unrelated, but including some affected sibling pairs) recruited in the course of several substance  dependence genetics projects. The sample includes 1,531 self-reported African-American (AA) subjects, 1,339 self-reported European-American (EA","Substance-Related Disorders","Case-Control","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 51 variables, 1 molecular datasets, 2872 subjects, 2872 samples","European (1139), African (56), African American (1434), Hispanic1 (187), Hispanic2 (26), Other (29)","NIDA","DS-ADX-IRB-RD --- Disease-specific (addictive disorders, irb, rd)","2016-03-15","2017-03-15","Alcohol Related Disorders; Alcohol-Related Disorder; Alcohol-Related Disorders; Disorder, Alcohol-Related; Disorders, Alcohol-Related; Abuse, Cocaine"
"phs000953.v1.p1","Microdissected Pancreatic Cancer Whole Exome Sequencing","109 micro-dissected pancreatic cancer cases and normal control tissue were subjected to whole-exome sequencing. Microdissection enriches tumor cellularity and enhances mutation calling.","Pancreatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","3 phenotype datasets, 11 variables,  SRA, 109 subjects, 218 samples","","NCI","DS-PACA-IRB-NPU-MDS --- Disease-specific (pancreatic cancer, irb, npu, mds)","2015-11-30","2015-11-30","Neoplasm of Pancreas; Neoplasm of the Pancreas; Neoplasm, Pancreas; Neoplasm, Pancreatic; Neoplasms, Pancreas; Neoplasms, Pancreatic"
"phs000954.v2.p1","NHLBI TOPMed: The Cleveland Family Study (WGS)","The Cleveland Family Study (CFS) is one cohort involved in the WGS project. The CFS was designed to provide fundamental epidemiological data on genetic and non-genetic risk factors for  sleep disordered breathing (SDB). In brief, the CFS is a family-based study that enrolled a total of 2284 individuals from 361 families between 1990","Sleep Apnea Syndromes","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 19 variables, 2 documents, 2 molecular datasets,  SRA, 994 subjects, 994 samples","European (484), African (5), African American (492), Hispanic1 (9), Other Asian or Pacific Islander (1), Other (3)","NHLBI","DS-HLBS-IRB-NPU --- Disease-specific (heart, lung, blood, and sleep disorders, irb, npu)","2018-04-27","2018-04-27","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs000955.v1.p1","Genetic Components of Knee Osteoarthritis (GeCKO) Study: OAI","The Osteoarthritis Initiative (OAI) is a publicly and privately funded prospective longitudinal cohort with a primary objective of identifying risk factors for incidence and progression of tibiofemoral knee OA.  The OAI utilized a focused population-based recruitment to enroll 4,674 men and women between the ages of 45-79 years who either had radiographic","osteoarthritis","Prospective Longitudinal Cohort","HumanOmni2.5-4v1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 4129 subjects, 4129 samples","European (3341), African (15), African American (738), Hispanic1 (22), Hispanic2 (7), Other Asian or Pacific Islander (1), Other (5)","NIAMS","DS-OA-RD --- Disease-specific (osteoarthritis, rd)","2016-06-29","2016-06-29","Arthritides, Degenerative; Arthritis, Degenerative; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy; Degenerative joint disease"
"phs000956.v3.p1","NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish","The Amish Complex Disease Research Program includes a set of large community-based studies focused largely on cardiometabolic health carried out in the Old Order Amish (OOA) community of Lancaster,  Pennsylvania (http://medschool.umaryland.edu/endocrinology/amish/research-program.asp). The OOA population of Lancaster County, PA immigrated to the","Cardiovascular Diseases","Family/Twin/Trios","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 74 variables, 3 documents, 3 molecular datasets,  SRA, 1123 subjects, 1111 samples","European (1111)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds)","2018-05-17","2018-05-17","Not Provided"
"phs000957.v1.p1","Geisinger Health System - MyCode, eMERGE III Exome Chip","DNA samples were obtained from participants of the Geisinger MyCode biobank. Phenotype data to determine case or control status for abdominal aortic aneurysm or extreme obesity were derived from  Geisinger electronic medical record data through an enterprise data warehouse. Samples were genotyped using the Illumina Human CoreExome-12 v1.0","Aortic Aneurysm, Abdominal","Case-Control","HumanCoreExome-12v1-0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 84 variables, 1 molecular datasets, 9212 subjects, 9212 samples","European (9102), African (1), East Asian (11), African American (28), Hispanic1 (18), Hispanic2 (26), Other Asian or Pacific Islander (2), South Asian (13), Other (11)","NHGRI","GRU --- General research use","2015-11-16","2015-11-16","BMI; BMI - Body mass index; BODY MASS INDEX; Index, Body Mass; Index, Quetelet; Quetelet Index"
"phs000958.v1.p1","CSER-MedSeq","Whole genome sequencing (WGS) and whole exome sequencing (WES) services are currently available to and being utilized by physicians and their patients in both research and clinical settings, and  recently to anyone in the general public via direct-to-consumer companies. But the widespread availability and use of WGS and WES in the practice of","Cardiomyopathies","Case-Control","HumanOmni2.5-8v1_A, HumanOmni25-8v1","Not Applicable","SNP Genotypes (Array), WGS","4 phenotype datasets, 22 variables, 3 documents, 2 molecular datasets,  SRA, 100 subjects, 200 samples","","NHGRI","GRU --- General research use","2015-10-21","2015-10-21","Cardiomyopathies, Primary; Cardiomyopathy, Primary; Disease, Primary Myocardial; Diseases, Primary Myocardial; Myocardial Disease, Primary; Myocardial Diseases, Primary"
"phs000960.v1.p1","Biomarkers in Transplant Recipients","Biliary atresia causes jaundice and liver failure in newborn children. In this study, single nucleotide polymorphisms were characterized in children with biliary atresia and identified ARF6 as a susceptibility  gene for this disease. Knockdown of this gene in zebrafish embryos impaired formation of bile ducts and excretion of bile from the zebrafish liver","Biliary Atresia","Case-Control","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 14 variables, 1 molecular datasets, 63 subjects, 63 samples","European (63)","NIDDK","DS-BA-IRB-NPU-GSO --- Disease-specific (biliary atresia, irb, npu, gso)","2015-08-04","2015-08-04","Familial Extrahepatic Biliary Atresia"
"phs000961.v1.p1","eMERGE III: Columbia GENIE (Genomic Integration with EHR)","The Columbia GENIE study contributes and shares phenotype and genotype data for individuals who were treated with our healthcare facilities and consented to share their data with dbGaP for  scientific discovery. Some of these individuals have kidney or neurological problems and some are healthy volunteers from the Washington Height","Not Provided","Case-Control","Genome-Wide_Human_SNP_Array_6.0, MEGA_Consortium","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 33 variables, 1 molecular datasets, 3065 subjects, 2317 samples","European (895), African (30), East Asian (67), African American (570), Hispanic1 (457), Hispanic2 (140), Other Asian or Pacific Islander (25), South Asian (68), Other (65)","NHGRI","GRU-IRB-PUB --- General research use (irb, pub)","2016-06-07","2016-06-07","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Disease"
"phs000962.v1.p1","Exploring the Genetic Variants Associated with Brain Growth in Children","Understanding the genetic factors that control brain growth during childhood and adolescence is a priority for neuroscience. Its importance lies partly in the finding that disturbances in the course  of brain development characterizes many common childhood behavioral problems. Recent advances in neuroimaging such as the use of non-invasive","Cerebral Cortex","Case Set","1000G_ref_panel, HumanOmniExpressExome-8v1-2_A","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 34 variables, 2 molecular datasets, 377 subjects, 387 samples","European (330), African (2), East Asian (1), African American (21), Hispanic1 (6), Hispanic2 (1), Other Asian or Pacific Islander (7), South Asian (1), Other (8)","NHGRI","GRU-NPU --- General research use (npu)","2017-10-23","2017-10-23","Cerebral Cortices; Cerebral gray matter; Cerebri, Cortex; Cerebrus, Cortex; Cortex; Cortex Cerebri"
"phs000963.v1.p1","PGRN-RIKEN:Genetic Determinants of Cardiovascular Events while on Statins","Coronary heart disease (CHD) is an important public health problem in developed countries. Statins are effective in the prevention and treatment of CHD; nevertheless, many patients receiving statins still  suffer cardiovascular events (CV) such as heart attack. Identifying genetic variants responsible for differential clinical responses to statins will","Myocardial Revascularization","Case-Control","HumanOmniExpressExome-8v1-2_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 documents, 1 molecular datasets, 5890 subjects, 5890 samples","European (5816), African American (20), Hispanic1 (13), Hispanic2 (26), Other Asian or Pacific Islander (2), South Asian (1), Other (12)","NHLBI","HMB --- Health/medical/biomedical","2016-05-16","2017-05-16","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000964.v3.p1","NHLBI TOPMed: The Jackson Heart Study","Since there is a greater prevalence of cardiovascular disease among African Americans, the purpose of the Jackson Heart Study (JHS) is to explore the reasons for this disparity and  to uncover new approaches to reduce it. The JHS is a large, community-based, observational study whose 5306 participants were recruited from among","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 25 variables, 3 documents, 3 molecular datasets,  SRA, 3596 subjects, 3406 samples","African (75), East Asian (1), African American (3314), Hispanic1 (15), Other (1)","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2018-05-18","2018-05-18","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs000966.v1.p1","Family Study of Essential Tremor (FASET)","The Familial Study of Essential Tremor (FASET) was designed to identify susceptibility genes for Essential Tremor. ET is among the most common neurological diseases with a prevalence (age 40  years) estimated to be 4.0% and prevalence in advanced age (' 90 years) exceeding 20%. ET, often referred to as ""familial tremor"", is generally","Essential Tremor","Family/Twin/Trios","HumanOmniExpress","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 287 variables, 7 documents, 1 molecular datasets,  SRA, 242 subjects, 141 samples","","NINDS","DS-ETND-NPU-MDS-GSO-RD --- Disease-specific (essential tremor and neurodegenerative diseases, npu, mds, gso, rd)","2017-01-19","2017-01-19","Benign Essential Tremor; Benign Essential Tremors; Benign essential tremor syndrome; Essential Tremor, Benign; Essential Tremors; Essential Tremors, Benign"
"phs000967.v1.p1","Clear Cell Endometrial Cancer Exome Sequencing Study","The purpose of this study was to identify somatic (tumor-specific) mutations in clear cell endometrial tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center (NISC) and  NHGRI by next generation sequencing the exomes of 16 de-identified primary tumor DNAs and matched non-tumor DNAs.","Endometrial Neoplasms","Case Set","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 16 subjects, 32 samples","","NHGRI","DS-ECA-COL --- Disease-specific (endometrial cancer, col)","2016-03-10","2016-03-10","Endometrial Tumor; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium; Neoplasm, Endometrial"
"phs000968.v1.p1","The Cardiopulmonary Effects of Particulate Exposure","The study was initially designed as a longitudinal cohort study of cardiovascular effects of particulate exposure. Participants were boilermaker construction workers who were exposed to particulate matter (PM) component  (e.g. a focus on metal constituents) while performing welding, grinding or cutting work in the welding plants. Participants were followed up","Cardiovascular Disease","Prospective Longitudinal Cohort","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 22 variables, 1 molecular datasets, 75 subjects, 208 samples","","NIEHS","DS-CVD-NPU --- Health/medical/biomedical (irb)","2015-11-19","2016-05-19","Not Provided"
"phs000969.v1.p1","Whole Exome Sequence of Hearing Loss Family","Our goal is to find genes responsible for non-syndromic sensorineural hearing loss. Blood samples were collected from the JS6 family affected with hearing loss. The family is of Caribbean  Hispanic ethnicity. Family JS6 consisted of two deaf siblings, JS6.001 (Male) and JS6.002 (Female) and healthy parents, JS6.100 (mother) and JS6.200","Bilateral deafness","Family/Twin/Trios","exome_vcf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 4 subjects, 4 samples","","NIDCD","GRU-PUB --- General research use (pub)","2015-10-06","2015-11-06","Deafness, Prelingual; Prelingual Deafness"
"phs000970.v1.p1","Mercury and Gut Microbiota","There are few studies that have characterized maternal gut microbiota and fetal methylmercury exposure, yet microbes likely modulate this relationship. The primary objective of our pilot study was to  determine associations between gut microbial taxa and mercury concentrations in multiple biomarkers (stool, hair, and cord blood). Our secondary","Methylmercury Compounds","Cross-Sectional","Not Provided","Not Applicable","AMPLICON, WGS","4 phenotype datasets, 17 variables,  SRA, 17 subjects, 17 samples","","NIEHS","HMB --- Health/medical/biomedical","2015-12-11","2015-12-11","Compounds, Methyl Mercury; Compounds, Methylmercury; Mercury Compounds, Methyl; Methyl Mercury Compounds"
"phs000971.v1.p1","NHGRI ClinSeq","ClinSeq is a pilot project to investigate the use of whole-genome sequencing as a tool for clinical research. By piloting the acquisition of large amounts of DNA sequence data  from individual human subjects, we are fostering the development of hypothesis-generating approaches for performing research in genomic medicine","Atherosclerosis","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 177 variables, 1 molecular datasets,  SRA, 1001 subjects, 1001 samples","European (747), African (27), East Asian (4), African American (467), Hispanic1 (150), Hispanic2 (9), Other Asian or Pacific Islander (37), South Asian (18), Other (23)","NHGRI","GRU --- General research use","2015-11-09","2016-11-09","Atherogenesis"
"phs000972.v3.p1","NHLBI TOPMed: Genome-wide Association Study of Adiposity in Samoans","The individuals sequenced here represent a small subset of the parent study (described below) and were carefully selected for the purpose of creating a Samoan-specific reference panel for imputation  back into the parent study. The INFOSTIP algorithm of Gusev et. al. (2012) (PMID: 22135348) was used to optimally choose the individuals for","Obesity","Cross-Sectional","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 13 variables, 2 documents, 3 molecular datasets,  SRA, 1332 subjects, 1342 samples","East Asian (1), Other Asian or Pacific Islander (1193), Other (4)","NHLBI","GRU-IRB-PUB-COL-NPU-GSO --- General research use (irb, pub, col, npu, gso)","2018-11-19","2018-11-19","DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure; Diastolic arterial pressure; Pressure, Diastolic"
"phs000973.v1.p1","The Genomic Landscape of Juvenile Myelomonocytic Leukemia","This study analyzed samples from 29 patients with juvenile myelomonocytic leukemia (JMML) using whole exome sequencing. Each patient had a paired germline tissue along with a diagnostic leukemia sample.  Germline tissue types included buccal mucosa, cordblood, Epstein-Barr virus immortalized cell lines and fibroblasts from either skin or bone marrow","Leukemia, Myelomonocytic, Juvenile","Collection","WES_markerset_grc37","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 29 subjects, 65 samples","","NCI","DS-CA-NPU-MDS --- Disease-specific (cancer, npu, mds)","2016-12-21","2016-12-21","JCML; JCML - Juvenile chronic myeloid leukemia; JMML; Juvenile Chronic Myelogenous Leukemia; Juvenile Myelomonocytic Leukemias; Juvenile chronic myelomonocytic leukemia"
"phs000974.v3.p2","NHLBI TOPMed: Whole Genome Sequencing and Related Phenotypes in the    Framingham Heart Study","The Framingham Heart Study (FHS) is a prospective cohort study of 3 generations of subjects who have been followed up to 65 years to evaluate risk factors for cardiovascular  disease. Its large sample of 15,000 men and women who have been extensively phenotyped with repeated examinations make it ideal for the study of","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 13 variables, 2 documents, 3 molecular datasets,  SRA, 4154 subjects, 4166 samples","European (4145), Hispanic1 (2), Hispanic2 (1), Other Asian or Pacific Islander (2), Other (4)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-05-30","2018-05-30","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000975.v1.p1","Nurses' Health Study (NHS)","The Nurses' Health Study is an on-going prospective cohort study of women that was initiated in 1976. This specific study was part of a larger study to advance our  knowledge of breast cancer etiology, expand the current knowledge of mammographic density, and clarify the relationship between mammographic density","Mammographic density","Case-Control","HumanOmniExpress-12v1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 26 variables, 1 molecular datasets, 794 subjects, 794 samples","European (786), Hispanic1 (3), Hispanic2 (5)","NCI","GRU --- General research use","2015-12-02","2015-12-02","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs000976.v1.p1","COGA: African American Family GWAS","COGA is a family study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study  that includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Alcoholism","Family/Twin/Trios","HumanOmni2.5-8v1_C","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 68 variables, 1 molecular datasets, 4029 subjects, 3360 samples","European (58), African (59), African American (2882), Hispanic1 (153), Hispanic2 (11), Other (54)","NIAAA","DS-ALC-IRB-RD --- Disease-specific (alcoholism, irb, rd)","2016-08-30","2017-03-02","Alcohol Use Disorder; Alcohol Use Disorders; Use Disorder, Alcohol; Use Disorders, Alcohol"
"phs000977.v1.p1","Genetic Analysis of Desmoplastic Melanoma","Desmoplastic melanoma is an infrequent variant of melanoma with sarcomatous histology, distinct clinical behavior, and unknown pathogenesis. We performed low-coverage genome and high-coverage exome sequencing of 20 desmoplastic melanomas,  followed by targeted sequencing of 293 genes to validate candidate genes. A high mutation burden (median 62 mutations/Mb) ranked desmoplastic","Melanoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WGS, WXS","3 phenotype datasets, 12 variables,  SRA, 62 subjects, 140 samples","","NCI","GRU --- General research use , DS-M-MDS --- Disease-specific (melanoma, mds)","2015-10-01","2015-10-01","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs000978.v1.p1","WGS of a malignant GCT with metabolic response to pazopanib","We report one case study of a malignant granular cell tumor patient with metabolic response to pazopanib. In this study, we used whole-genome sequencing of the tumor with the  matched blood to characterize the somatic mutation profile in this tumor. This is the first reported whole-genome sequencing study of the rare","Granular Cell Tumor","Case-Control","Not Provided","Not Applicable","WGS","3 phenotype datasets, 22 variables,  SRA, 1 subjects, 2 samples","","NCI","GRU-PUB-NPU --- General research use (pub, npu)","2017-10-02","2017-10-02","Abrikossoff Tumor; Abrikossoff's Tumor; Cell Myoblastoma, Granular; Cell Myoblastomas, Granular; Cell Tumor, Granular; Cell Tumors, Granular"
"phs000979.v3.p2","HBCC Postmortem Psychiatric Molecular Studies","This postmortem study examines molecular, genetic and epigenetic signatures in the brains of hundreds of subjects with or without mental disorders conducted by the DIRP NIMH Human Brain Collection  Core (HBCC). The brain tissues are obtained under protocols approved by the CNS IRB (NCT00001260), with the permission of the next-of-kin (NOK","Schizophrenia","Case-Control","HumanHT-12_v4, HumanOmni5-Quad, HumanHap650Yv3, Human1M-Duov3_B, WGS_markerset_grc37","Not Applicable","SNP Genotypes (Array), mRNA Expression (Array), ChIP-Seq, RNA-Seq, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 31 variables, 3 molecular datasets, 970 subjects, 3788 samples","European (169), African (11), East Asian (5), African American (149), Hispanic1 (2), Hispanic2 (10), Other Asian or Pacific Islander (4), South Asian (2), Other (2)","NIMH","GRU --- General research use","","","Anxiety State, Neurotic; Anxiety States, Neurotic; Neurotic Anxiety State; Neurotic Anxiety States; State, Neurotic Anxiety; States, Neurotic Anxiety"
"phs000980.v1.p1","PD-1 Blockade in Non-Small Cell Lung Cancer","Patients with non-small cell lung cancer were treated with pembrolizumab. Their tumors and matched normal blood were sequenced.","Carcinoma, Non-Small-Cell Lung","Tumor vs. Matched-Normal","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 36 variables, 1 molecular datasets,  SRA, 34 subjects, 68 samples","","NCI","HMB-PUB-NPU --- Health/medical/biomedical (pub, npu)","2015-11-19","2015-11-19","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER"
"phs000982.v1.p1","Genetic Analysis of Psoriasis and Psoriatic Arthritis","This is a genome-wide study of genetic associations with psoriatic arthritis (PsA), an inflammatory musculoskeletal condition that develops in up to 30% of people who have chronic psoriasis skin  lesions. 1,526 cases affected with psoriatic arthritis and 1,508 unaffected controls were recruited and typed on the Illumina HumanOmni1-Quad","Arthritis, Psoriatic","Case-Control","HumanOmni1-Quad_v1-0_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 analyses, 1 molecular datasets, 2847 subjects, 2847 samples","European (2836), Hispanic2 (5), Other (6)","NIAMS","GRU --- General research use","2015-12-11","2015-12-11","Arthritic Psoriasis; Arthropathies, Psoriatic; Arthropathy, Psoriatic; PA (Psoriatic arthritis); PsA (Psoriatic arthritis); Psoriasis Arthropathica"
"phs000983.v1.p1","Pharmacogenomics of Rheumatoid Arthritis Therapy","Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis worldwide and affects 1.3 million adults in the USA. It has previously been studied using phenotype algorithms to identify  electronic health records (EHR) case cohorts. Early genetic studies of EHR-linked cohorts of RA patients have been replicated in known associations","Arthritis, Rheumatoid","Case Set","HumanExome-12v1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 512 subjects, 512 samples","","NIGMS","GRU --- General research use","2016-01-21","2017-01-21","Not Provided"
"phs000984.v1.p1","Pharmacogenomics of Metformin Dose Response in T2DM Patients","Type 2 Diabetes Mellitus (T2DM) is a chronic and sometimes debilitating disease that affects millions of adults in the USA. Metformin is commonly prescribed for T2DM; yet some T2DM  patients do not tolerate it or respond well. This pharmacogenomics study will examine response, as both change in T2DM patients' weight and","Diabetes Mellitus, Type 2","Case Set","HumanOmniExpressExome-8","Not Applicable","SNP Genotypes (Array)","7 phenotype datasets, 38 variables, 1 molecular datasets, 202 subjects, 208 samples","European (66), African (5), African American (123), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (1), Other (1)","NIGMS","GRU --- General research use","2016-09-23","2017-03-23","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000985.v1.p1","Functional Significance of Prostate Cancer Risk-SNPs","Prostate Cancer (PrCa), the most frequently diagnosed solid tumor in men in the U.S., results in 192,000 new cases and 27,000 deaths per year. Although the variation of PrCa  incidence is likely to be the result of several factors, there is a large body of literature that strongly implicates a genetic etiology. Genome-wide","Not Provided","Control Set","RNAseq_probe_set_grc37, HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array), RNA Seq expression levels","4 phenotype datasets, 30 variables, 5 documents, 2 molecular datasets,  SRA, 471 subjects, 942 samples","European (468), Hispanic1 (1), Other (2)","NCI","DS-PC-PUB-MDS --- Disease-specific (prostate cancer, pub, mds)","2016-07-26","2016-07-26",""
"phs000986.v1.p1","Genetic Basis of Cryptorchidism","Non-syndromic cryptorchidism is a common malformation, but the genetic loci that increase susceptibility to cryptorchidism remain unknown. A genome-wide association study (GWAS) was completed to determine whether common allelic  variants are associated with susceptibility to cryptorchidism. Two sets of discovery groups were genotyped. Group 1 (559 cases and 1772 controls) was","Cryptorchidism","Case-Control","Not Provided","Not Applicable","Not Provided","2 analyses","","NICHD","DS-CRYPT-PUB-COL-NPU-GSO --- Disease-specific (cryptorchidism, pub, col, npu, gso)","2016-07-05","2017-07-05","CRYPTORCHIDISM; Cryptorchidism (unilateral or bilateral); Cryptorchidism, Unilateral Or Bilateral; Cryptorchism; IDT - Imperfectly descended testis; Imperfectly descended testis"
"phs000987.v1.p1","Whole Exome Sequence of 184 Individuals with 22q11.2 Deletion Syndrome","Our goal is to find genetic modifiers of major phenotypes in patients with 22q11.2 deletion syndrome, also known as DiGeorge syndrome or velo-cardio-facial syndrome. Whole exome sequencing was performed  as part of a contract to the NHLBI, Resequencing and Genotyping Service. We have obtained cardiac phenotype information from the de-identified","DiGeorge Syndrome","Case Set","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 28 variables, 1 molecular datasets,  SRA, 184 subjects, 184 samples","","NHLBI","GRU-IRB --- General research use (irb)","2017-04-07","2017-10-07","22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome); 22q11.2 Deletion Syndrome; Autosomal Dominant Opitz G Bbb Syndrome; Autosomal Dominant Opitz G-Bbb Syndrome; CATCH22; CHROMOSOME 22q11.2 DELETION SYNDROME"
"phs000988.v3.p1","NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica","This administrative supplement to the project, ""The Genetic Epidemiology of Asthma in Costa Rica"" (R37 HL066289) is in response to NOT-HL-14-029 to perform whole genome sequencing (WGS) on existing  NHLBI populations. We focus on asthma because of its public health significance. Asthma affects 26 million U.S. children and adults, remains a major","Asthma","Family/Twin/Trios","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 38 variables, 2 documents, 3 molecular datasets,  SRA, 3478 subjects, 3224 samples","European (2), Hispanic2 (967), Other (72)","NHLBI","DS-ASTHMA-IRB-MDS-RD --- Disease-specific (asthma, irb, mds, rd)","2019-08-01","2019-08-01","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000989.v3.p1","Study of Human Developmental Neurogenesis","We sought to characterize cellular heterogeneity in the human cerebral cortex at a molecular level during cortical neurogenesis. We captured single cells and generated sequencing libraries using the C1TM  Single-Cell Auto Prep System (Fluidigm), the SMARTer Ultra Low RNA Kit (Clontech), and the Nextera XT DNA Sample Preparation Kit (Illumina). We","Stem cells, neural","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 12 variables,  SRA, 73 subjects, 6384 samples","","NIMH","HMB-IRB --- Health/medical/biomedical (irb)","2017-11-28","2016-01-12","Cerebral Cortex; Cerebral Cortices; Cerebral gray matter; Cerebri, Cortex; Cerebrus, Cortex; Cortex"
"phs000990.v1.p1","MIGen_ExS: University of Lubeck","MI cases were recruited from the German MI Family Study and the Angio-Lub study. Controls were recruited from the German MI Family Study and the Angio-Lub study. All exome  sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Illumina's ICE Capture reagent and","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1766 subjects, 1766 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2016-05-04","2016-05-04","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs000993.v3.p2","NHLBI TOPMed: Heart and Vascular Health Study (HVH)","Objectives The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation  (AF). The study setting is Group Health, an integrated health care delivery system in Washington State. Only VT cases and early-onset AF cases are","Cardiovascular Disease","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 14 variables, 2 documents, 3 molecular datasets,  SRA, 709 subjects, 711 samples","European (578), East Asian (5), African American (25), Hispanic1 (3), Hispanic2 (5), Other Asian or Pacific Islander (2), South Asian (1), Other (4)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, irb, mds)","2019-01-09","2019-01-09","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs000994.v1.p1","The Mutational Landscape of CTCL and Sezary Syndrome.","Sezary syndrome is a leukemic and aggressive form of cutaneous T-cell lymphoma (CTCL) resulting from the malignant transformation of skin-homing central memory CD4+ T cells. To identify new genetic  alterations involved in Sezary syndrome and CTCL transformation we performed whole-exome sequencing of tumor-normal sample pairs from 26 Sezary","Sezary Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 21 variables,  SRA, 84 subjects, 84 samples","","NCI","DS-CA-IRB-PUB --- Disease-specific (cancer, irb, pub)","2016-01-15","2016-01-15","Erythroderma, Sezary; Lymphoma, Sezary's; SEZARY SYNDROME, SOMATIC; Sezary Erythroderma; Sezary Lymphoma; Sezary's Disease"
"phs000996.v1.p1","Gene-Environment Interaction Effects in Neurodevelopment","Cognitive development is known to be highly heritable, but various genome wide association studies (GWAS) have failed to find common single nucleotide polymorphisms (SNPs) which can explain a large  proportion of the variance in cognitive ability. We hypothesized that an interaction between genes and exposure to potentially toxic metals may","Not Provided","Case Set","Human1M-Duov3, Human660W-Quad_v1_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 2 molecular datasets, 1385 subjects, 1385 samples","Hispanic2 (748), South Asian (612), Other (25)","NIEHS","GRU --- General research use","2017-02-15","2017-02-15",""
"phs000997.v3.p2","NHLBI TOPMed: The Vanderbilt AF Ablation Registry","The Vanderbilt Atrial Fibrillation Ablation Registry (VAFAR) was founded in 2011. Patients with AF referred for AF ablation are prospectively enrolled. A detailed clinical history is recorded, along with  imaging data (cardiac MRI or CT). Blood samples are obtained for DNA extraction at the time of ablation. Details of the ablation procedure are","Atrial Fibrillation","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 31 variables, 2 documents, 3 molecular datasets,  SRA, 173 subjects, 173 samples","European (116), Other (1)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb)","2018-05-29","2018-05-29","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs000998.v1.p1","Transcriptome Profile of Endothelial Cells in PAH Patients vs Controls","The transcriptome of pulmonary arterial endothelial cells from healthy lungs and from lungs of patients with idiopathic pulmonary arterial hypertension have been analyzed and specific differences in disease-relevant pathways  were identified. The genes identified as altered in these patients have direct effects on pulmonary arterial endothelial cell function. This finding","Familial Primary Pulmonary Hypertension","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 20 variables,  SRA, 13 subjects, 13 samples","","NHLBI","GRU --- General research use","2016-03-14","2016-03-14","FPAH; Familial pulmonary arterial hypertension; HPAH; Hereditary pulmonary arterial hypertension; Heritable Pulmonary Arterial Hypertension"
"phs000999.v2.p1","CSER: Clinical Sequencing in Cancer: Clinical, Ethical, and Technological    Studies","The Clinical Sequencing Exploratory Research (CSER) program supports multi-disciplinary projects that bring together clinicians, bioinformaticians, and ethicists to research the challenges of utilizing genomic sequence data in the clinic  in the routine practice of medicine. The challenges are many and not disease-specific. Important aims of the research include: development of","Colorectal Neoplasms","Prospective Longitudinal Cohort","HumanOmniExpressExome-8","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 158 subjects, 158 samples","","NHGRI","GRU --- General research use","2018-09-26","2018-09-26","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001000.v1.p1","MIGen_ExS: U. of Leicester","MI cases were ascertained from two studies: (i) the British Heart Foundation Family Heart Study and (ii) the BRICCS Study. Control subjects were ascertained from the control subjects being  recruited as part of the UK Aneurysm Growth Study (UKAGS). All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets, 2322 subjects, 2322 samples","","NHLBI","DS-CVD-NPU --- Disease-specific (cardiovascular disease, npu) , GRU-NPU --- General research use (npu)","2016-04-12","2016-04-12","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs001002.v1.p1","Metastatic Castration-resistant Prostate Cancer GWAS","The Cancer and Leukemia Group B (CALGB) 90401 trial compared docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer. A genome-wide association study using  clinical outcomes and toxicities was conducted on the basis of data from CALGB patients who provided consent for pharmacogenomic studies and usable","Prostatic Neoplasms","Prospective Longitudinal Cohort","Human610-Quadv1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 47 variables, 1 molecular datasets, 761 subjects, 761 samples","European (651), African (3), East Asian (4), African American (73), Hispanic1 (10), Hispanic2 (18), South Asian (2)","NIGMS","HMB --- Health/medical/biomedical","2016-01-06","2017-01-06","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001005.v1.p1","Antigen Discovery in Melanoma","This study of three metastatic melanoma patients utilized exome sequencing and RNA sequencing to help identify putative neoantigen peptides that could be further validated by standard immunological assays before  design of a personalized vaccine. For each set of neoantigens identified and verified by standard assays, we designed GMP peptides that correspond to","Not Provided","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 14 variables,  SRA, 3 subjects, 18 samples","","NHGRI","DS-MSC --- Disease-specific (melanoma and skin cancer research)","2015-10-29","2015-10-29",""
"phs001006.v1.p1","Intra-Lesion Heterogeneity and Clonality of Lobular Carcinomas In Situ","This study comprises prospectively accrued, microdissected fresh frozen samples of multifocal lobular carcinoma in situ (LCIS), ductal carcinoma in situ (DCIS), invasive lobular carcinoma and invasive ductal carcinoma from  patients undergoing prophylactic or therapeutic mastectomies after a diagnosis on LCIS diagnosed and managed at Memorial Sloan Kettering Cancer","Carcinoma, Lobular","Collection","Not Provided","Not Applicable","WXS","4 phenotype datasets, 26 variables,  SRA, 24 subjects, 94 samples","","NCI","GRU --- General research use","2018-09-13","2018-09-13","CIS; Cancer in situ; Carcinoma in situ morphology; Carcinoma in situ, no ICD-O subtype; Carcinoma in situ, no International Classification of Diseases for Oncology subtype; Carcinoma, Intraepithelial"
"phs001007.v1.p1","The Genetic Landscape of Metastasis and Recurrence in HNSCC","Recurrence and/or metastasis occur in more than half of patients with head and neck squamous cell carcinoma (HNSCC) and pose the greatest threats to long-term survival. The genetic alterations  underlying recurrent/metastatic HNSCC are unknown. This study represents the first whole exome sequencing (WES) cohort study of patient-matched tumor","Carcinoma, squamous cell of head and neck","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 26 variables, 23 subjects, 65 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2015-12-02","2015-12-02",""
"phs001008.v1.p1","GUARDIAN: IRAS FAMILY STUDY (IRASFS)","TThe IRAS Family Study was a family study designed to examine the genetic and epidemiologic basis of glucose homeostasis traits and abdominal adiposity. Briefly, self-reported Mexican pedigrees were recruited  in San Antonio, TX and San Luis Valley, CO. Probands with large families were recruited from the initial non-family-based IRAS Study, which was","Insulin Resistance","Family/Twin/Trios","HumanOmni1S-8v1_H, HumanOmniExpress-12v1_H","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 1024 subjects, 1024 samples","European (24), Hispanic2 (999), Other (1)","NHLBI","DS-DHD-IRB-NPU-MDS-RD --- Disease-specific (diabetes and heart disease, irb, npu, mds, rd)","2016-03-14","2017-03-14","Not Provided"
"phs001009.v1.p1","Determinants of Asthma Following RSV Bronchiolitis in Early Life","The goal of the RSV Bronchiolitis in Early Life (RBEL) study is to determine how specific genetic, biologic, and immunologic characteristics interact to predispose individuals to develop asthma. Participants  were carefully recruited by selecting a prospective cohort of 206 infants with severe respiratory syncytial virus (RSV) bronchiolitis who were at","Asthma","Prospective Longitudinal Cohort","GoldenGate_AsthmaRSV_Bronchiolitis","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 28 variables, 1 molecular datasets, 178 subjects, 178 samples","","NHLBI","DS-AAR-IRB --- Disease-specific (allergy, asthma, and respiratory, irb)","2016-04-07","2016-04-07","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001011.v1.p1","CCHMC-eMERGE-Phase IIIA","This submission includes genotyping or sequencing data from separate cohorts, each is described in separate paragraphs below. Extreme early onset obesity Obesity is a serious epidemic condition and on  the rise in the United States. Today, nearly one out of three children is overweight or obese in this country. According to the Center for Disease","Not Provided","Case-Control","CytoSNP-850Kv1-1, Human1M-Duov3_H, HumanExome-12v1-1_A, WES_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 2 molecular datasets,  SRA, 1568 subjects, 1571 samples","European (790), African (3), East Asian (12), African American (126), Hispanic1 (42), Hispanic2 (27), Other Asian or Pacific Islander (2), South Asian (4), Other (11)","NHGRI","GRU-IRB-COL --- General research use (irb, col)","2016-09-27","2016-09-27","Arthritis, Juvenile Systemic; Juvenile Onset Still Disease; Juvenile Onset Stills Disease; Juvenile Systemic Arthritis; Juvenile onset Still's disease; Juvenile-Onset Still's Disease"
"phs001012.v1.p1","The Diabetes Heart Study (DHS)","The Diabetes Heart Study is a family based study enriched for type 2 diabetes (T2D). The cohort included 1220 self-reported European Americans from 475 families (Bowden et al 2010  Review of Diabetic Studies 7:188-201: PMID: 21409311; Bowden et al 2008 Annals of Human Genetics 72:598-601 PMID: 18460048) and included siblings","Cardiovascular Diseases","Cross-Sectional","Genome-Wide_Human_SNP_Array_5.0","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 29 variables, 1 analyses, 1 molecular datasets, 1177 subjects, 1177 samples","European (1176), Hispanic1 (1)","NHLBI","DS-DRC-IRB --- Disease-specific (diabetes and related complications, irb)","2016-11-15","2017-11-15","Calcification, Vascular; Calcifications, Vascular; Calcinoses, Vascular; Calcinosis, Vascular; Vascular Calcification; Vascular Calcifications"
"phs001013.v3.p2","Heart and Vascular Health Study (HVH)","Objectives The Heart and Vascular Health Study (HVH) is a case-control study of risk factors for the development of myocardial infarction (MI), stroke, venous thrombosis (VT), and atrial fibrillation  (AF). The study setting is Group Health, an integrated health care delivery system in Washington State. Background The HVH originated in 1988 with","Cardiovascular Disease","Case-Control","HumanOmniExpress-12v1_H, HumanOmniExpressExome-8v1_A, HumanCNV370-Quadv3_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 38 variables, 5 documents, 1 molecular datasets, 1204 subjects, 1014 samples","European (943), African (1), East Asian (13), African American (24), Hispanic1 (3), Hispanic2 (12), Other Asian or Pacific Islander (8), South Asian (4), Other (6)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, irb, mds)","2018-01-16","2018-01-16","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001014.v1.p1","GUARDIAN: IRAS (IRAS Classic)","The Insulin Resistance Atherosclerosis Study (IRAS) was an epidemiologic cohort study designed to examine the relationship between insulin resistance and carotid atherosclerosis across a range of glucose tolerance. Individuals  of self-reported Mexican-American ethnicity were recruited in San Antonio, TX and San Luis Valley, CO. Recruitment was balanced across age and","Insulin Resistance","Prospective Longitudinal Cohort","HumanOmni1S-8v1_H, HumanOmniExpress-12v1_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 173 subjects, 173 samples","European (5), Hispanic2 (168)","NHLBI","DS-DHD-IRB-NPU-MDS-RD --- Disease-specific (diabetes and heart disease, irb, npu, mds, rd)","2016-03-01","2017-03-01","Not Provided"
"phs001015.v1.p1","Deciphering the Pathophysiology of Chronic Fatigue Syndrome","Myalgic encephalomyelitis, also known as chronic fatigue syndrome or ME/CFS, is a complex and heterogeneous disease that severely impacts the health and quality of life of those afflicted. Several  lines of evidence support the possibility that ME/CFS development may involve a heritable component. In this pilot study, 42 cases that meet the","Fatigue Syndrome, Chronic","Case-Control","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 80 subjects, 80 samples","","NIAID","DS-ME-CFS-IRB --- Disease-specific (myalgic encephalopathy - chronic fatigue syndrome, irb)","2016-10-04","2016-10-04","Benign myalgic encephalomyelitis; CFS - Chronic fatigue syndrome; Chronic Fatigue Disorder; Chronic Fatigue Disorders; Chronic Fatigue Fibromyalgia Syndrome; Chronic Fatigue Syndromes"
"phs001016.v1.p1","Fixed Single Cell Study (Radial Glia Cells)","The human neocortex is created from diverse intermixed progenitors in the prenatal germinal zones. These progenitors have been difficult to characterize since progenitors - particularly radial glia (RG) -  are rare, and are defined by a combination of intracellular markers, position and morphology. To circumvent these problems we developed a method","Neuroglia","Control Set","RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 3 subjects, 136 samples","","NINDS","GRU-NPU --- General research use (npu)","2015-11-06","2016-01-13","Cell, Glial; Cell, Neuroglial; Cells, Glial; Cells, Neuroglial; Glia; Glial Cells"
"phs001020.v1.p1","Genomic Psychiatry Cohort (GPC) Whole Genome Sequencing Pilot Study","The Center for Genomic Psychiatry at the University of Southern California (USC) and an extensive network of academic medical centers have created the Genomic Psychiatry Cohort (GPC). The GPC  consists of a large clinical cohort of patients with schizophrenia, bipolar disorder, and healthy controls. The pilot phase of whole genome","Not Provided","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 750 subjects, 750 samples","European (707), African American (9), Hispanic1 (5), Hispanic2 (23), Other Asian or Pacific Islander (2), Other (4)","NIMH","DS-SZRD --- Disease-specific (schizophrenia and related disorders) , DS-BPD --- Disease-specific (bipolar disorder)","2016-12-14","2016-12-14",""
"phs001021.v1.p1","Center for Health Discovery and Well Being (CHDWB)","In order to evaluate whether rare regulatory variants in the vicinity of promoters are likely to impact gene expression, we conducted a novel burden test for rare variants at  the extreme of expression. After targeted sequencing of 2kb promoter regions of 472 genes in 410 healthy adults, burden tests were performed by","Wellness Center","Prospective Longitudinal Cohort","Not Provided","Not Applicable","OTHER","4 phenotype datasets, 20 variables,  SRA, 410 subjects, 410 samples","","NIGMS","HMB --- Health/medical/biomedical","2016-02-02","2016-02-02","Aging, Biological; Biological Aging; Cardiovascular Syndrome, Metabolic; Cardiovascular Syndromes, Metabolic; Dysmetabolic Syndrome X; Insulin Resistance Syndrome X"
"phs001023.v1.p1","Male Infertility: Genetics of Spermatogenic Failure","Spermatogenesis is a complex biological process that requires the coordination of thousands of genes. Perhaps because of the large number of genes involved, spermatogenic failure occurs frequently and affects  approximately 1% of men. While environmental and genetic factors likely contribute to this disorder, it is thought that the majority of cases have an","Azoospermia","Case-Control","Not Provided","Not Applicable","WXS","4 phenotype datasets, 13 variables,  SRA, 601 subjects, 601 samples","","NHGRI","DS-RD --- Disease-specific (reproductive disorders)","2016-07-18","2016-07-18","Not Provided"
"phs001024.v3.p1","NHLBI TOPMed: Partners HealthCare Biobank","The Atrial Fibrillation Genetics Consortium (AFGen) was organized to identify common and rare genetic variation associated with atrial fibrillation risk. In the current study, we have performed whole genome  sequencing in cases with early-onset atrial fibrillation. Samples in this study were enrolled as a part of the Partners HealthCare Biobank. Cases","Atrial Fibrillation","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 32 variables, 2 documents, 3 molecular datasets,  SRA, 128 subjects, 128 samples","European (121), African (1), East Asian (1), African American (3), Hispanic1 (1), Other (1)","NHLBI","HMB --- Health/medical/biomedical","2018-05-18","2018-05-18","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001025.v1.p1","Hispanic Lupus GWAS_HISPSLEI Study","The study comprises SLE patients recruited from specialist rheumatology clinics from the United States, Mexico, Argentina, Chile and Peru. Two strategies were used to enrich samples for Native American  ancestry: a. previously genotyped Hispanic and Latin American and US Native American individuals were selected according to their ancestry based on","Lupus Erythematosus, Systemic","Case-Control","HumanOmni1-Quad_v1-0_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 analyses, 1 molecular datasets, 2279 subjects, 2279 samples","European (187), Hispanic1 (15), Hispanic2 (2053), Other (24)","NIAMS","DS-SLE-NPU-MDS-RD --- Disease-specific (systemic lupus erythematosus, npu, mds, rd)","2017-01-11","2017-01-11","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs001027.v2.p1","Epigenomics studies in Acute Myeloid Leukemia (AML)","Acute Myeloid Leukemia (AML) remains a clinical challenge since most patients diagnosed with AML will die from the disease. Some patients harbor treatment-refractory disease and others relapse with disease  that in many cases is resistant to treatments. Our study was designed to understand the molecular basis of disease progression in AML through","Acute Myeloid Leukemia","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Bisulfite-Seq, RNA-Seq, WGS, WXS","5 phenotype datasets, 32 variables,  SRA, 152 subjects, 574 samples","","NCI","GRU-PUB --- General research use (pub)","2016-08-31","2016-08-31","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs001032.v4.p2","NHLBI TOPMed: The Vanderbilt Atrial Fibrillation Registry","The Vanderbilt Atrial Fibrillation (AF) Registry was founded in 2001. Patients with AF and family members are prospectively enrolled. At enrollment a detailed past medical history is obtained along  with an AF symptom severity assessment. Blood samples are obtained for DNA extraction. Patients are followed longitudinally along with serial","Atrial Fibrillation","Case Set","TOPMed_WGS_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 38 variables, 2 documents, 2 molecular datasets,  SRA, 1134 subjects, 1134 samples","European (962), African (3), East Asian (1), African American (41), Hispanic1 (2), Hispanic2 (5), Other Asian or Pacific Islander (2), South Asian (2)","NHLBI","GRU-IRB --- General research use (irb)","2019-01-09","2019-01-09","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001033.v1.p1","PAGE: Global Reference Panel","Stanford contributed samples to the PAGE study that can act as a population reference dataset across the globe. Therefore this dataset includes reference individuals, without phenotypes, chosen to help  infer ancestry that will help us understand the diverse samples available in PAGE. The complete dataset comprises individuals of European, African","Population","Control Set","MEGA_Consortium_15063755_B2","Not Applicable","SNP Genotypes (Array), WGS","3 phenotype datasets, 15 variables, 1 molecular datasets,  SRA, 1517 subjects, 2065 samples","European (195), African (99), East Asian (141), African American (56), Hispanic1 (115), Hispanic2 (514), Other Asian or Pacific Islander (120), South Asian (138), Other (61)","NHGRI","GRU --- General research use","2016-12-27","2016-12-27","Populations"
"phs001034.v1.p1","New England-Based Case-Control Study of Ovarian Cancer (NECC)","The case-control data provided to dbGaP were collected under NCI grant number CA54419 which had 3 enrollment phases: I (1992-1997), II (1998-2002) and III (2003-2008). Altogether, CA54419 funded 15  years of data and specimen collection, resulting in one of the longest running population based case-control studies of ovarian cancer. The study","Ovarian Neoplasms","Case-Control","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 84 variables, 3 documents, 4141 subjects","","NCI","GRU-NPU --- General research use (npu)","2016-01-14","2016-01-14","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian"
"phs001036.v1.p1","Genomic Characterization of Acral Melanoma","In this study, we performed paired tumor/normal long insert whole genome and exome sequencing and tumor RNA sequencing on primary or metastatic acral melanoma tumors collected from 34 patients.  Patients were enrolled from either Vanderbilt University or the Memorial Sloan-Kettering Cancer Center. We report an integrated analysis of DNA and","Melanoma","Tumor vs. Matched-Normal","maf_grc37","Not Applicable","RNA-Seq, SNV Aggregate (.MAF), WGS, WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 34 subjects, 109 samples","","NCI","GRU-PUB-NPU --- General research use (pub, npu)","2017-03-01","2017-03-01","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001038.v1.p1","DNA Methylation Inhibitors in Immunotherapy","We show that DNA methyltransferase inhibitors (DNMTis) upregulate immune signaling in cancer through the viral defense pathway and re-expression of epigenetically silenced endogenous retrovirus. In melanoma patients treated with  an immune checkpoint therapy, high viral defense signature expression in tumors significantly associates with durable clinical response and DNMTi","Melanoma","Case Set","RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 38 variables, 1 molecular datasets,  SRA, 20 subjects, 20 samples","","NCI","HMB-PUB-NPU-MDS --- Health/medical/biomedical (pub, npu, mds)","2016-03-02","2016-03-02","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001039.v1.p1","International AMD Genomics Consortium - Exome Chip Experiment","Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with limited therapeutic options. To further our understanding of AMD genetics, we examined the contribution  of common and rare genetic variation in the International AMD Genomics Consortium that included 50,000 samples of 26 AMD case - control cohorts that","Macular Degeneration","Case-Control","HumanCoreExome-24v1-0_A, 1000G_ref_panel","Not Applicable","SNP/CNV Genotypes (imputed), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 14 variables, 2 molecular datasets, 35358 subjects, 35358 samples","European (32554), African (26), East Asian (1289), African American (398), Hispanic1 (144), Hispanic2 (158), Other Asian or Pacific Islander (492), South Asian (101), Other (196)","NEI","GRU --- General research use , DS-AMD --- Disease-specific (age-related macular degeneration)","2016-10-26","2017-04-26","Atrophies, Geographic; Atrophy, Geographic; Degeneration, Dry Macular; Degenerations, Dry Macular; Dry Macular Degeneration; Dry Macular Degenerations"
"phs001040.v3.p1","NHLBI TOPMed: Novel Risk Factors for the Development of Atrial    Fibrillation in Women","The Women's Genome Health Study (WGHS) is a prospective cohort comprised of over 25,000 initially healthy female health professionals enrolled in the Women's Health Study, which began in 1992-1994.  All participants in WGHS provided baseline blood samples and extensive survey data. Women who reported atrial fibrillation during the course of the","Atrial Fibrillation","Case Set","TOPMed_WGS_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 61 variables, 2 documents, 2 molecular datasets,  SRA, 118 subjects, 117 samples","European (114), Hispanic2 (1)","NHLBI","HMB --- Health/medical/biomedical","2018-07-19","2018-07-19","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001041.v1.p1","Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs  overall survival in patients with melanoma. CTLA-4 blockade activates T cells and enables them to destroy tumor cells. We obtained tumor tissue from","Melanoma","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 41 variables, 1 molecular datasets,  SRA, 64 subjects, 128 samples","","NCI","HMB-PUB-NPU-MDS --- Health/medical/biomedical (pub, npu, mds)","2016-06-10","2016-06-10","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001043.v1.p1","GWAS of Breast Events with Adjuvant Aromatase Inhibitors","Source of patients:The source of the patients for this genome-wide case-control study was MA.27, which was conducted as a multi-cooperative group effort under the auspices of the NCI Breast  Cancer Intergroup of North America. The NCIC Clinical Trials Group (CTG) serves as the coordinating group, with participation by the NCI-sponsored","Neoplasm","Case-Control","Human610-Quadv1_B, HumanOmniExpress-12v1_C, HumanOmniExpressExome-8v1-2_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 39 variables, 1 molecular datasets, 4658 subjects, 4658 samples","European (4316), African (4), East Asian (41), African American (138), Hispanic1 (47), Hispanic2 (67), Other Asian or Pacific Islander (12), South Asian (20), Other (13)","NIGMS","DS-CA --- Disease-specific (cancer)","2017-03-01","2017-09-01","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001044.v1.p1","Breast Cancer Risk Pathways","We sought to identify genomic variants that differed between individuals who developed familial breast cancer and individuals who had a family history of breast cancer but who had not  developed breast cancer. We aggregated these data at the pathway level to identify pathways that play a role in familial breast cancer development","Breast Neoplasms","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 35 subjects, 35 samples","","NCI","GRU --- General research use","2016-09-19","2016-09-19","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001046.v1.p1","Genomic Architecture of Progression and Treatment Response in AMD","Numerous studies have identified common and rare genetic variation associated with risk of advanced age-related macular degeneration (AMD). However, risk is just one facet of AMD disease architecture. Both  disease progression and response to treatment are two critical elements that may also be influenced by genetic variation. The primary aim of this","Macular Degeneration","Case-Control","HumanCoreExome-12v1-1_A, HumanCoreExome-24v1-0_A, WES_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), WXS","6 phenotype datasets, 28 variables, 1 molecular datasets,  SRA, 897 subjects, 915 samples","European (677), East Asian (1), African American (22), Hispanic1 (2), Hispanic2 (6), Other Asian or Pacific Islander (1), Other (2)","NEI","GRU-IRB --- General research use (irb) , DS-AMD-IRB --- Disease-specific (age-related macular degeneration, irb)","2018-06-06","2018-06-06","AAMD - Age related macular degeneration; AMD; AMD - Age-related macular degeneration; ARMD; ARMD - Age-related macular degeneration; Age Related Macular Degeneration"
"phs001048.v2.p1","The FUSION Tissue Biopsy Study","The Finland-United States Investigation of NIDDM Genetics (FUSION) study is a long-term effort to identify genetic variants that predispose to type 2 diabetes (T2D) or that impact the variability  of T2D-related quantitative traits (QTs). Skeletal muscle and adipose are major insulin target tissues and play key roles in insulin resistance. We","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37, MethylationEPIC_v-1-0_B4, HumanOmni2.5-4v1_H, InfiniumOmni2-5Exome-8v1-3_A1, HRC1_ref_panel","Not Applicable","ATAC-seq, Methylation (CpG), SNP Genotypes (Array), Bisulfite-Seq, SNP Genotypes (imputed), RNA-Seq, RNA Seq expression levels, WGS, miRNA-Seq","4 phenotype datasets, 34 variables, 1 documents, 4 molecular datasets,  SRA, 307 subjects, 2130 samples","European (304), Other (2)","NHGRI","GRU --- General research use","2019-05-06","2019-05-06","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001049.v1.p1","Genomics of Relapsed Small Cell Lung Cancer Progression","Small cell lung cancer (SCLC) accounts for nearly 15% of all patients with lung cancer. Though the response to initial therapy is favorable in many patients, a majority of  patients go on to develop recurrent disease which is very difficult to treat. The response rates to chemotherapy are very low and most patients","Small Cell Lung Carcinoma","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 18 variables,  SRA, 30 subjects, 105 samples","","NHGRI","DS-LC --- Disease-specific (lung cancer)","2018-12-18","2018-12-18","Recrudescence; Recrudescences; Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer"
"phs001050.v1.p1","Breast Cancer Genome Guided Therapy Study (BEAUTY)","The Breast Cancer Genome Guided Therapy Study (BEAUTY) is a prospective neoadjuvant clinical study enrolling 140 women with Stage I-III breast cancer. The goals of this study were to  1) perform comprehensive sequencing of germline and tumor tissues (exome and RNA seq), 2) identify genomic alterations and perturbed pathways","Breast Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 33 variables,  SRA, 118 subjects, 354 samples","","NIGMS","GRU --- General research use","2016-01-26","2017-01-26","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001053.v1.p1","NEI Exfoliation Genotyping Study","The overall goal of our research is to elucidate the pathogenesis of exfoliation syndrome and the associated glaucoma, making it possible to implement effective screening and prevention strategies and  to develop novel therapies. Cases genotyped for this project are from the Nurses Health Study (NHS), the Health Professionals Follow-up Study (HPFS","Glaucoma","Case Set","HumanOmniExpressExome-8v1-2_A","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 25 variables, 1 documents, 1 molecular datasets, 1506 subjects, 1572 samples","European (1435), African (1), East Asian (3), African American (23), Hispanic1 (20), Hispanic2 (14), Other Asian or Pacific Islander (2), Other (8)","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2018-02-20","2018-02-20","EXFOLIATION GLAUCOMA; Exfoliation Syndrome; Exfoliation Syndromes; Exfoliative Syndrome; Exfoliative Syndromes; Glaucoma Capsulare"
"phs001054.v1.p1","Genomic Characterization of Pediatric Low-Grade Gliomas","Pediatric low-grade gliomas (PLGGs) are the most common pediatric brain-tumor, with more than ten histologic subtypes recognized by the World Health Organization. We performed a genomic analysis of 230  PLGGs of which 73 had whole genome/RNA sequencing performed and show that MYB-QKI fusions define the seizure associated tumor, Angiocentric Glioma","Glioma","Case Set","Not Provided","Not Applicable","ChIP-Seq, RNA-Seq, WGS, WXS","4 phenotype datasets, 13 variables,  SRA, 80 subjects, 93 samples","","NCI","GRU --- General research use , DS-NTT --- Disease-specific (nervous tissue tumors)","2016-04-06","2016-04-06","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytic tumor; Astrocytoma, no ICD-O subtype"
"phs001055.v1.p1","Whole Genome Study for De Novo Mutation Rates","Germline mutations are the source of evolution and contribute substantially to many health-related processes. In this study, we use whole genome deep sequencing data from parents-offspring trios to examine  the de novo point mutations (DNMs) in the offspring. We studied correlation between parental ages with de novo mutation rates. This study is","Preterm Birth","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 2397 subjects, 817 samples","","NHGRI","GRU --- General research use","2017-08-25","2017-08-25","Age, Maternal; Ages, Maternal; Maternal Age; Maternal Ages; Age, Paternal; Ages, Paternal"
"phs001057.v1.p1","Population Genetics Analysis Program: Immunity to Vaccines/Infections    (NIAID/NIH)","The study examines the role of candidate human immune response gene polymorphisms (and their receptors, expression and function) and variations in immune response, among 1,000 active duty members of  the military who were recently vaccinated with ACAM2000 or Dryvax Smallpox vaccine. In addition to the phenotype and genotype data available through","Smallpox Vaccine","Prospective Longitudinal Cohort","HumanOmni2.5-8v1_C","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 17 variables, 1 molecular datasets, 993 subjects, 993 samples","European (656), African (1), East Asian (11), African American (105), Hispanic1 (39), Hispanic2 (142), Other Asian or Pacific Islander (17), South Asian (2), Other (20)","NIAID","GRU-IRB --- General research use (irb)","2016-04-22","2016-04-22","Not Provided"
"phs001058.v1.p1","MIGen_ExS: BioImage Study","The BioImage Study (BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population, NCT00738725), is a prospective, observational study aimed at characterizing subclinical atherosclerosis in  U.S. adults (55 to 80 years old) at risk for clinical atherosclerotic cardiovascular disease (PMID: 25790876). All exome sequencing was performed at","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 503 subjects, 503 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2016-02-19","2016-02-19","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs001059.v1.p1","Maternal folate and newborn DNA methylation meta-analysis","Folic acid is routinely recommended for women trying to conceive to ensure proper fetal development. Mechanisms whereby periconceptional folate influences normal development and disease are poorly understood: epigenetics may  be involved. This data represents meta-analysis results from a large epigenomics study to examine the association between maternal plasma folate","Embryonic and Fetal Development","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","1 molecular datasets","","NIEHS","GRU --- General research use","2016-02-10","2016-02-10","Embryo and Fetal Development; 2-[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]aminopentanedioic acid; B9, Vitamin; FA; FA - Folic acid; L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-"
"phs001062.v3.p2","NHLBI TOPMed: MGH Atrial Fibrillation Study","The Massachusetts General Hospital (MGH) Atrial Fibrillation Study was initiated in 2001. The study has enrolled serial probands, unaffected and affected family members with atrial fibrillation. At enrollment participants  undergo a structured interview to systematically capture their past medical history, AF treatments, and family history. An electrocardiogram is","Atrial Fibrillation","Case Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 3 molecular datasets,  SRA, 999 subjects, 999 samples","European (976), African American (1), Hispanic1 (2), Hispanic2 (4), Other (1)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-AF-IRB-RD --- Disease-specific (atrial fibrillation, irb, rd)","2018-05-29","2018-05-29","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001063.v1.p1","Genomic Characterization of PDX Models for Breast Cancer Brain Metastases","We have developed orthotopic patient-derived xenograft models of HER2 positive breast cancer metastasized into the brain of patients to test novel therapeutic strategies. In this study, we identified a  novel combinatorial therapeutic strategy that has resulted in a durable remission and markedly increased overall survival in majority of patient","Breast Neoplasms","Case Set","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NCI","GRU-IRB-PUB --- General research use (irb, pub)","2016-05-12","2016-05-12","BT - Brain tumor; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain"
"phs001064.v1.p1","Whole Exome Sequencing of Signet Ring/Plasmacytoid Variant Bladder Cancer","In this study, six plasmacytoid bladder cancers were analyzed by whole exome sequencing. The results show loss of the CDH1 gene in every sample and correlate with E-cadherin loss  of expression by immunohistochemistry. A separate validation cohort of plasmacytoid samples showed loss of E-cadherin expression by CDH1 mutation or","Carcinoma, Signet Ring Cell","Case Set","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets,  SRA, 6 subjects, 12 samples","","NCI","DS-BLADDERCA --- Disease-specific (bladder cancer)","2018-03-12","2018-03-12","Signet Ring Cell Adenocarcinoma; Signet Ring Cell Carcinoma; Signet ring carcinoma; Bladder Cancer; Bladder Cancers; CA - Bladder cancer"
"phs001065.v1.p1","Coenzyme Q10 (CoQ) in Huntington's Disease (HD) (2CARE)","This is a multi-center, randomized, double-blind, placebo-controlled trial of CoQ involving 609 ambulatory subjects with HD who are not requiring skilled care or institutionalization. Eligible subjects were randomized to  receive either CoQ 2400 mg/day or matching placebo. Subjects were followed prospectively and systematically for 60 months of double-blind observation","Huntington Disease","Clinical Trial","Not Provided","Not Applicable","Not Provided","46 phenotype datasets, 735 variables, 609 subjects","","NINDS","GRU --- General research use","2016-06-06","2016-06-06","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea"
"phs001066.v1.p1","DNA and RNA Sequence of an Acute Lymphoblastic Leukemia","We used massively parallel sequencing technology to profile the genomic DNA and RNA of tumor cells (leukemic bone marrow) and normal cells (skin biopsy) obtained from a single patient  with Acute Lymphoblastic Leukemia (ALL), referred to throughout this study as 'ALL1'. Included in this study are samples obtained from a primary","Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 13 variables,  SRA, 1 subjects, 23 samples","","NCI","HMB --- Health/medical/biomedical","2016-05-19","2016-05-19","Aleukemic leukemia [obs]; Blood (Leukemia); Blood cancer; Chronic leukemia [obs]; Leucocythaemia; Leucocythaemias"
"phs001067.v1.p1","Metagenomic Deep Sequencing in Meningitis and Encephalitis","This is a prospective observational study seeking to identify pathogens in cases of unexplained neurological disease, particularly those in which there is a presumed infectious cause. This next generation  analytical approach will hopefully allow for rapid identification of foreign genomic material, and through a sophisticated bioinformatics pipeline","Encephalitis","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 18 variables, 3 subjects, 6 samples","","NIAID","DS-NDR-IRB --- Disease-specific (neurological disorders research, irb)","2016-02-17","2016-02-17","Brain Inflammation; Brain Inflammations; Inflammation, Brain; Pachymeningitides; Pachymeningitis; Inflammation of spinal cord"
"phs001071.v1.p1","NINDS Family-Based Whole-Genome Sequencing to Find HD Modifiers","The goal of our studies is to identify genetic modifiers of neurodegeneration in Huntington's disease (HD). HD is caused by expansion of CAG repeats in the huntingtin (Htt) gene,  with longer stretches often leading to more rapid disease onset and progression. Yet, for a given number of repeats, the age of symptom onset can be","Huntington Disease","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 37 subjects, 39 samples","European (37)","NINDS","GRU --- General research use","2017-09-28","2017-09-28","Ataxia (loss of muscle coordination); Ataxias; Ataxy; Coordination Impairment; Coordination Impairments; Dyssynergia"
"phs001072.v1.p1","Genomic Analysis of Relapsed Pediatric Acute Lymphoblastic Leukemia","Although multi-agent combination chemotherapy is curative in a significant fraction of childhood acute lymphoblastic leukemia (ALL) patients, 20% of cases relapse and most die due to chemo-refractory disease. Here  we used whole-exome and whole-genome sequencing to analyze the mutational landscape and pattern of clonal evolution at relapse in pediatric ALL cases","Leukemia, Lymphoid","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WGS, WXS","4 phenotype datasets, 21 variables,  SRA, 57 subjects, 179 samples","","NCI","DS-CA-PUB-MDS-GSO --- Disease-specific (cancer, pub, mds, gso)","2016-10-11","2016-10-11","Aleukemic lymphatic leukemia [obs]; Aleukemic lymphocytic leukemia [obs]; Aleukemic lymphoid leukemia [obs]; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid"
"phs001073.v1.p1","Epigenetic Analysis of Malnutrition","The PROVIDE study (Dhaka, Bangladesh) is a randomized clinical trial platform which evaluated the efficacy of delayed-dose oral rotavirus vaccine as well as the benefit of an injectable polio  vaccine replacing one dose of oral polio vaccine. This rigorous infrastructure supported the additional examination of hypotheses of vaccine","Stunting","Clinical Trial","Not Provided","Not Applicable","ChIP-Seq, WCS","5 phenotype datasets, 45 variables, 14 documents,  SRA, 59 subjects, 98 samples","","NICHD","HMB-IRB --- Health/medical/biomedical (irb)","2018-11-13","2018-11-13","Digestive System Disease; Digestive System Diseases; Disease, Digestive System; Diseases, Digestive System; Gastrointestinal and digestive disorder; System Disease, Digestive"
"phs001074.v1.p1","GeneSTAR NextGen Functional Genomics of Platelet Aggregation","The causal mechanisms of common diseases and their therapies have been only marginally illuminated by genetic variants identified in genome wide association studies (GWAS) utilizing single nucleotide polymorphism (SNPs).  Platelet activation pathways reflecting hemostasis and thrombosis are the underlying substrate for many cardiovascular diseases and related acute","Platelet Aggregation","Prospective Longitudinal Cohort","MEGA_Consortium, HumanExome-12v1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 125 variables, 10 documents, 1 molecular datasets, 250 subjects, 440 samples","European (136), African (2), African American (108), Hispanic1 (3), Other (1)","NHLBI","DS-CVD-IRB-NPU-RD --- Disease-specific (cardiovascular disease, irb, npu, rd)","2016-08-23","2016-08-23","Blood Physiological Concept; Blood Physiological Concepts; Blood Physiological Phenomena; Blood Physiological Phenomenas; Blood Physiological Phenomenon; Blood Physiology"
"phs001075.v1.p1","Sequencing to Guide Cancer Care (CanSeq)","The overall goal of the CanSeq U01 project is to study the impact of whole-exome sequencing (WES) on the clinical care of cancer patients and oncology provider practices. The  aims of Project 1 are to implement and establish the feasibility of germline and somatic WES in patients with advanced solid tumors (lung and colon","Neoplasms","Case Set","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 166 subjects, 332 samples","","NHGRI","GRU --- General research use","2018-05-04","2018-05-04","Adenocarcinoma of lung; CA - Cancer of colon; COLON CANCER; Cancer of Colon; Cancer of the Colon; Cancer, Colon"
"phs001076.v1.p1","Inflammatory Bowel Disease Exome Sequencing Study","The Broad Institute and Massachusetts General Hospital (MGH) are launching a new initiative to perform large-scale exome sequencing in inflammatory bowel disease (Crohn's disease and ulcerative colitis). Given the  considerable unmet therapeutic need in inflammatory bowel disease (IBD), the recent emergence of rapid and efficient genome sequencing technologies","Inflammatory Bowel Diseases","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 4626 subjects, 4629 samples","","NHGRI","DS-IBD --- Disease-specific (inflammatory bowel disease) , GRU --- General research use","2017-05-04","2017-05-04","Colitis Gravis; Colitis ulcerosa; Colitis, Ulcerative; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis"
"phs001079.v2.p1","PD-1+ and PD-1- CD4+ Teff and Treg cells in Glioblastoma and Health","PD-1 is an important immune checkpoint inhibitor that shows great promise in the clinic, particularly for melanoma and lung cancers. Since PD-1 is also expressed on infiltrating CD4+ Treg  and Teffector cells in glioblastoma, we sought to better understand the role of PD-1 on these infiltrating CD4+ Treg and Teffector cells. To this end","Glioblastoma","Case-Control","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 11 variables,  SRA, 10 subjects, 66 samples","","NIAID","GRU-IRB --- General research use (irb)","2017-09-01","2016-05-20","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (Glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme"
"phs001080.v1.p1","Genome Studies in Hereditary Spastic Paraplegia","Next-generation sequencing technology is opening up new opportunities to rethink the way we identify disease causing genetic variation. An early application, whole exome sequencing, has now been established by  a small number of research labs, including ours. Exome sequencing allows obtaining a near complete set of protein coding genomic variation in single","Spastic Paraplegia, Hereditary","Case Set","Not Provided","Not Applicable","WXS","5 phenotype datasets, 18 variables,  SRA, 103 subjects, 103 samples","","NINDS","GRU --- General research use","2016-05-11","2016-05-11","Familial spastic paraparesis; Familial spastic paraplegia; Familial spastic paraplegia syndrome; HSP; HSP - Hereditary spastic paraplegia; Hereditary Spastic Paraplegia"
"phs001082.v1.p1","T Cell Responses to Varicella Zoster Virus","Diversity and size of the antigen-specific T cell receptor (TCR) repertoire are two critical determinants for successful control of chronic infection. Varicella zoster virus (VZV) that establishes latency during  childhood is able to escape control mechanisms, in particular with increasing age. We examined the TCR diversity of VZV-specific CD4 T cells in","Herpes Zoster","Prospective Longitudinal Cohort","Not Provided","Not Applicable","OTHER","5 phenotype datasets, 23 variables,  SRA, 9 subjects, 197 samples","","NIAID","GRU-IRB --- General research use (irb)","2017-02-14","2017-08-14","Herpes zoster infection; Shingles; Zona; Zoster; Alpha-Beta TCR; Alpha-Beta-TCR"
"phs001083.v1.p1","99 Cases of Small Cell Lung Cancer Study","Small cell lung cancer (SCLC) is an aggressive disease with poor survival. A few sequencing studies performed on limited number of samples have revealed potential disease-driving genes in SCLC,  however, much still remains unknown, particularly in the Asian patient population. Here we conducted whole exome sequencing (WES) and transcriptomic","Small Cell Lung Carcinoma","Case Set","Not Provided","Not Applicable","WXS","99 subjects, 99 samples","","NCI","","","","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL; SCLC"
"phs001084.v1.p1","Differential Mutations in Matched Primary and Metastatic Colorectal    Cancers","This study compares DNA mutations detected in matched primary and metastatic colorectal cancer samples from 18 individuals across 1,321 genes. We found many more mutations were shared between tumor  pairs (avg. 33.3 mutations/tumor) than were discordant (avg. 2.3 mutations / tumor). Nearly all tumors showed at least one discordance, and these","Colorectal Neoplasms","Case Set","Not Provided","Not Applicable","Targeted-Capture","4 phenotype datasets, 14 variables, 18 subjects, 38 samples","","NCI","GRU --- General research use","2018-02-20","2018-02-20","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001087.v2.p1","Clonal Evolution of Platinum-Resistant Metastatic Urothelial Cancer","Using whole-exome sequencing of urothelial carcinoma samples including matched sets of primary and locally recurrent or metastatic UC tumors collected over time and space and an in-depth analysis of  tumors from two rapid autopsies, we provide the first detailed analysis of the therapy-driven clonal evolution of platinum-resistant urothelial","Carcinoma, Transitional Cell","Case Set","target_markerset_grc37","Not Applicable","RNA-Seq, CNV (NGS), SNV (.MAF), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 62 subjects, 165 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2019-06-26","2018-04-09","Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize; Neoplasm Metastases; Tumor Cell Migration"
"phs001088.v1.p1","Shanghai Breast Cancer Genetics Study (SBCGS)","The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast  Cancer Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only","Breast Neoplasms","Case-Control","HumanExome-12v1-2_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 2392 subjects, 2392 samples","","NCI","HMB-PUB-NPU --- Health/medical/biomedical (pub, npu)","2017-11-14","2017-11-14","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001089.v3.p1","CSER: Genomic Diagnosis in Children with Developmental Delay    (CSER-HudsonAlpha)","The overarching goal of this project is to explore the ability for whole exome and genome sequencing technologies to identify the genetic causes of unexplained developmental delay, intellectual disability  (DD/ID), and related congenital anomalies in children. Such information may be useful as an endpoint to the otherwise fruitless ""diagnostic odyssey","Intellectual Disability","Family/Twin/Trios","Not Provided","Not Applicable","WGS, WXS","5 phenotype datasets, 45 variables,  SRA, 1275 subjects, 1275 samples","","NHGRI","GRU --- General research use","2018-04-19","2017-06-15","Ataxia (loss of muscle coordination); Ataxias; Ataxy; Coordination Impairment; Coordination Impairments; Dyssynergia"
"phs001090.v1.p1","GWAS for Non-syndromic Clefts in the African Population: CIDR","The focus of this project is to identify genetic variants that are associated with orofacial clefts in African populations in sub-Saharan Africa. Most genetic studies of CLP (including the  vast majority of GWAS) have been conducted in populations of European origin with only a few focused on Asian or African populations. We choose to","Cleft Lip","Family/Twin/Trios","MEGA_Consortium_v2_15070954_A2, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","5 phenotype datasets, 27 variables, 2 molecular datasets, 3179 subjects, 3327 samples","","NIDCR","DS-CFR --- Disease-specific (craniofacial research)","2019-05-28","2019-05-28","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip; Congenital fissure of lip"
"phs001091.v1.p1","Clonal Evolution in Patients with Chronic Lymphocytic Leukemia","We analyzed clonal evolution in serial samples from five CLL patients who became resistant to the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, using whole-exome and deep targeted sequencing. We  observe a BTK-C481S mutation in one of five patients, and multiple PLCG2 mutations in a second patient. The other patients had an expansion of clones","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","RNA-Seq, SNV (.MAF), WXS","4 phenotype datasets, 15 variables, 1 molecular datasets, 5 subjects, 19 samples","","NHGRI","GRU --- General research use","2018-02-07","2018-02-07","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs001093.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: UK South Asian","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D)  through multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a","Diabetes Mellitus, Type 2","Case-Control","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 36 variables, 1 molecular datasets,  SRA, 1068 subjects, 1068 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-08","2016-07-08","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001095.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Ashkenazi","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D)  through multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a","Diabetes Mellitus, Type 2","Case-Control","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 39 variables, 1 molecular datasets,  SRA, 858 subjects, 867 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-09-30","2016-09-30","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001096.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: KARE","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D)  through multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a","Diabetes Mellitus, Type 2","Case-Control","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 38 variables, 1 molecular datasets,  SRA, 1087 subjects, 1087 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-07","2016-07-07","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001097.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Singapore","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D)  through multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a","Diabetes Mellitus, Type 2","Case-Control","exome_vcf_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 39 variables, 1 molecular datasets,  SRA, 2226 subjects, 2226 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-08","2016-08-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001101.v1.p1","MIGen_ExS: MDC","The Malmo Diet and Cancer Study (MDCS) is a community-based prospective epidemiologic cohort of 28,449 subjects who were recruited for baseline examination between 1991 and 1996. From this cohort,  6103 subjects were randomly selected to participate in a cardiovascular cohort (MDCSCC), which seeks to investigate risk factors for cardiovascular","Myocardial Infarction","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 10 variables, 1 molecular datasets, 1081 subjects, 1081 samples","","NHLBI","HMB-MDS --- Health/medical/biomedical (mds)","2016-08-10","2016-08-10","Cardiac infarction; Cardiovascular Stroke; Cardiovascular Strokes; Heart Attack; Infarct, Myocardial; Infarction of heart"
"phs001105.v1.p1","NHGRI-Mayo Clinic Whole Genome Sequencing of Aggressive Prostate Tumors","We collected DNA from fresh frozen prostate tumor samples and matched peripheral blood from 10 subjects with aggressive, Gleason score 8 disease. Tumor and normal samples were sequenced on  the Illumina HiSeq 2000 to mean depths of 95.3X and 48.3X, respectively.","Prostatic Neoplasms","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 10 subjects, 20 samples","European (10)","NHGRI","GRU-IRB-PUB-GSO --- General research use (irb, pub, gso)","2017-09-12","2017-09-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001106.v1.p1","Genomics of Hepatocellular Carcinoma","Despite the growing incidence of hepatocellular carcinoma (HCC) due to increased hepatitis C virus infection and non-alcoholic steatohepatitis in Western populations, the genetic determinants of this cancer have yet  to be established. A minority (15-20%) of HCC occurs in livers without cirrhosis or other chronic disease. Because the liver is functionally","Not Provided","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 31 variables,  SRA, 120 subjects, 380 samples","","NHGRI","DS-CA --- Disease-specific (cancer)","2018-10-17","2018-10-17",""
"phs001107.v1.p1","Patient-Specific Factors Influence Somatic Variations in VHL Tumors","Patients affected with von Hippel-Lindau disease are at risk of developing multiple independent clear cell renal carcinomas. This study performed whole genome sequencing on 40 tumors from 6 VHL  patients to compare somatic variation patterns within and between patients. Although tumors from the same patient showed many differences, within","von Hippel-Lindau Disease","Tumor vs. Matched-Normal","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WGS","4 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 6 subjects, 51 samples","","NCI","DS-RCC-IRB --- Disease-specific (kidney cancer, irb)","2016-06-08","2016-06-08","Angiomatoses, Familial Cerebello-Retinal; Angiomatoses, Familial Cerebelloretinal; Angiomatosis Retinae; Angiomatosis, Familial Cerebello-Retinal; Angiomatosis, Familial Cerebelloretinal; Cerebello-Retinal Angiomatoses, Familial"
"phs001108.v1.p1","Assessing Neural Mechanisms using MRI and Magnetic Resonance Spectroscopy","Urea cycle disorders represent a group of rare inborn errors of metabolism that lead to accumulation of ammonia, a toxic product of protein metabolism. Individuals with urea cycle disorders  cannot metabolize the ammonia that accumulates due to enzyme deficiency. The symptoms of these disorders may present at birth, childhood or adulthood","Urea Cycle Disorders, Inborn","Case-Control","Not Provided","Not Applicable","Not Provided","9 phenotype datasets, 633 variables, 6 documents, 46 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-04-16","2018-04-16","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder"
"phs001109.v1.p1","Addictions: Genotypes and Genetic Correlates","Drug addiction continues to be a major medical and social problem. It is estimated that one million or more persons in the United States are currently addicted to heroin  or prescription opioids, with millions more worldwide. Cocaine addiction and alcohol dependence are frequent comorbid conditions in persons with","Substance-Related Disorders","Case-Control","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 35 variables, 1 documents, 1 molecular datasets, 1661 subjects, 1661 samples","European (697), African (32), East Asian (11), African American (693), Hispanic1 (187), Hispanic2 (76), Other Asian or Pacific Islander (11), South Asian (12), Other (75)","NIDA","DS-ADX-IRB-NPU --- Disease-specific (addictive disorders, irb, npu)","2016-08-29","2016-08-29","Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs001110.v1.p1","Kids First: Pediatric Research Project on the Genomic Analysis of    Congenital Diaphragmatic Hernia","The Gabriella Miller Kids First Pediatric Research Program (Gabriella Miller Kids First Pediatric Research Program) (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller  Kids First Research Act and supported by the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth","Hernias, Diaphragmatic, Congenital","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","CNV Genotypes, SNP Genotypes (NGS), WGS","5 phenotype datasets, 27 variables, 1 molecular datasets,  SRA, 594 subjects, 594 samples","","NICHD","DS-CDH-COL-GSO-RD --- Disease-specific (congenital diaphragmatic hernia, col, gso, rd)","2017-05-25","2017-05-25","Agenesis of Hemidiaphragm; CDH; CDH - Congenital diaphragmatic hernia; Congenital Diaphragmatic Defect; Congenital Diaphragmatic Defects; Congenital Diaphragmatic Hernias"
"phs001111.v1.p1","A Prognostic Role of APC in Colorectal Cancers","Colorectal cancer (CRC) is a highly heterogeneous disease, for which prognosis has been relegated to clinic-pathologic staging for decades. There is a need to molecularly stratify subpopulations of CRC  to better predict outcome and assign therapies. Here we report targeted exome sequencing of 1,321 cancer-related genes on 468 tumor specimens, which","Colorectal Neoplasms","Case Set","Not Provided","Not Applicable","Targeted-Capture","4 phenotype datasets, 29 variables,  SRA, 468 subjects, 468 samples","","NCI","GRU --- General research use","2016-09-21","2016-09-21","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001112.v1.p1","Chromosome X Mosaicism Methylation Study","This study investigates methylation patterns in promoter regions on the X chromosomes of females with X chromosome mosaicism in an effort to phase mosaic events to either the active  or inactive X chromosome.","Neoplasm","Case Set","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 14 variables, 1 molecular datasets, 33 subjects, 33 samples","","NCI","O-MDS_ONLY --- Methods only","2016-07-01","2016-07-01","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs001115.v1.p1","Tissue Specimens from Patients with Melanoma for Genetic Analysis","The purpose of this study was to obtain tissue specimens derived from patients with melanoma to generate research tools to advance our understanding of the genetics, pathogenesis, and therapeutics  of melanoma. Briefly, tissue was obtained from metastatic lesions and used to generate clonal primary cell lines from melanoma cells and fibroblasts","Melanoma, Cutaneous Malignant","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 20 variables, 1 documents,  SRA, 3 subjects, 6 samples","","NCI","GRU --- General research use","2016-06-27","2016-06-27","CMM; Cutaneous Malignant Melanoma; Dysplastic Nevus Syndrome, Hereditary; Familial Atypical Mole-Malignant Melanoma Syndrome; Fammm; MELANOMA, CUTANEOUS MALIGNANT"
"phs001121.v1.p1","Integrated Genetic and Pharmacologic Interrogation of Rare Cancers","Due to the paucity of patient derived models in rare cancers, identification of therapeutic targets remains challenging. We developed a patient derived model, CLF-PED-015-T, from a patient with an  undifferentiated sarcoma. From this model, we performed pooled RNAi and CRISPR-Cas9 negative selection screens and integrated that with a small","Sarcoma","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","RNA-Seq, SNV Aggregate (.MAF), WXS","4 phenotype datasets, 14 variables, 1 molecular datasets, 1 subjects, 3 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2017-03-21","2017-03-21","Sarcoma, Spindle Cell; Sarcomas, Spindle Cell; Spindle Cell Sarcomas"
"phs001123.v1.p1","Consortium on Asthma among African-ancestry Populations in the Americas","Asthma is a complex disease where the interplay between genetic factors and environmental exposures influences susceptibility and disease prognosis. Asthmatics of African descent tend to have more severe asthma  and more severe clinical symptoms than individuals of European ancestry. Advances in genetic and genomic technologies have revolutionized gene","Asthma","Case-Control","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WGS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 917 subjects, 917 samples","European (18), African (328), African American (6676), Hispanic1 (622), Hispanic2 (66), South Asian (1), Other (1302)","NHLBI","GRU-IRB --- General research use (irb) , HMB --- Health/medical/biomedical , DS-LD --- Disease-specific (lung disease) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2017-04-12","2017-04-12","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001124.v1.p1","Mechanisms of Risk for Sulfonamide Hypersensitivity","Hypersensitivity (HS) reactions to sulfonamide antibiotics occur uncommonly, but with potentially severe clinical manifestations. A familial predisposition to sulfonamide HS is suspected, but robust predictive genetic risk factors have  yet to be identified. Strongly linked genetic polymorphisms have been used clinically as screening tests for other HS reactions prior to","Drug Hypersensitivity Syndrome","Case-Control","HumanExome-12v1-1_A, Human660W-Quad_v1_A, HumanCore-12-v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 documents, 1 molecular datasets, 297 subjects, 333 samples","","NIGMS","GRU --- General research use","","","Anticonvulsant hypersensitivity syndrome; DHS; DRESS Syndrome; DRESS Syndromes; Drug Hypersensitivity Syndromes; Drug Reaction with Eosinophilia and Systemic Symptoms"
"phs001127.v1.p1","Genomic Analysis of Paired Endometrial Cancer Primaries and Metastases","Formation of metastases is the major cause of cancer related deaths. Recent studies have sequenced primary endometrial carcinomas yielding data for a single entity in the progression from the  birth of a progenitor tumor cell to metastatic disease. However, the progression of these tumors to metastases has not been characterized. We","Endometrial Neoplasms","Case Set","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets, 52 subjects, 143 samples","","NHGRI","DS-CA-MDS --- Disease-specific (cancer, mds)","2016-09-15","2016-09-15","Endometrial Tumor; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium; Neoplasm, Endometrial"
"phs001130.v1.p1","NIDDM-Atherosclerosis Study (NIDDM-Athero)","The NIDDM-Atherosclerosis Study, funded by NHLBI, was designed as a family study to examine the genetic basis of subclinical atherosclerosis and diabetes in Hispanic families. Family members of probands  with T2D were recruited in the Los Angeles area. The baseline examination of the cohort included the euglycemic hyperinsulinemic clamp test from","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","HumanOmni1S-8v1_H_HumanOmniExpress-12v1_H","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 247 subjects, 247 samples","European (8), Hispanic1 (6), Hispanic2 (231), Other (2)","NHLBI","DS-DHD-IRB-NPU-MDS-RD --- Disease-specific (diabetes and heart disease, irb, npu, mds, rd)","2018-09-28","2018-09-28","Diabetes Complications; Diabetes Mellitus Complication; Diabetes Mellitus Complications; Diabetes Related Complications; Diabetes-Related Complication; Diabetes-Related Complications"
"phs001135.v1.p1","Starting Treatment with Agonist Replacement Therapies (START)","The Starting Treatment with Agonist Replacement Therapy (START) study was a 24-week, open-label, randomized trial of methadone versus Suboxone (buprenorphine/naloxone) for the treatment of opioid dependence. Patients were over  the age of 18 and met DSM-IV qualifications for opioid dependence. The primary goal of the study was to determine if either medicine was associated","Opioid-Related Disorders","Prospective Longitudinal Cohort","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 41 variables, 1 documents, 1 molecular datasets, 979 subjects, 978 samples","European (692), East Asian (2), African American (128), Hispanic1 (41), Hispanic2 (75), Other Asian or Pacific Islander (11), Other (29)","NIDA","GRU --- General research use","2017-02-02","2017-02-02","Abuse, Narcotic; Abuses, Narcotic; Narcotic Abuse; Narcotic Abuses; Disorder, Drug Use; Drug Use Disorder"
"phs001138.v3.p2","GMKF: Kids First Pediatric Research Program in Congenital Heart Disease","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Heart Defects, Congenital","Family/Twin/Trios","Not Provided","Not Applicable","WGS","3 phenotype datasets, 10 variables,  SRA, 2208 subjects, 2229 samples","","NCI","HMB --- Health/medical/biomedical , DS-CHD --- Disease-specific (congenital heart disease)","2019-03-26","2018-09-14","Abnormalities, Heart; Abnormality, Heart; Cardiac abnormalities; Cardiac anomaly; Congenital Heart Defect; Congenital anomaly of heart"
"phs001139.v1.p1","NextGen/GENESiPS","Variability in induced pluripotent stem cell (iPSC) lines remains a roadblock for disease modeling and regenerative medicine. Through linear mixed models we have described different sources of gene expression  variability from RNA sequencing data in 317 human iPSC lines from 101 individuals. We found that 50% of genome-wide expression variability is","Insulin Resistance","Case-Control","1000G_ref_panel","Not Applicable","SNP Genotypes (imputed)","4 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 94 subjects, 94 samples","European (66), African (1), East Asian (8), African American (6), Hispanic2 (6), Other Asian or Pacific Islander (2), South Asian (4), Other (1)","NHLBI","GRU-IRB --- General research use (irb)","2017-02-27","2018-02-27","Not Provided"
"phs001141.v1.p1","PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)","The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer that may identify an individualized treatment approach for men with the disease. Understanding  the molecular biology behind castration-resistant prostate cancer has led to more treatment options, but there are still no definite conclusions","Prostatic Neoplasms, Castration-Resistant","Case Set","WES_markerset_grc37","Not Applicable","RNA-Seq, SNP Genotypes (NGS), WXS","4 phenotype datasets, 27 variables, 1 molecular datasets,  SRA, 88 subjects, 246 samples","","NCI","GRU --- General research use","2017-02-21","2017-02-21","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001143.v2.p1","NHLBI TOPMed: The Genetics and Epidemiology of Asthma in Barbados","Asthma is a complex disease where the interplay between genetic factors and environmental exposures influences susceptibility and disease prognosis. Asthmatics of African descent tend to have more severe asthma  and more severe clinical symptoms than individuals of European ancestry. The baseline prevalence of asthma in Barbados is high ( 20%), and from","Asthma","Family/Twin/Trios","TOPMed_WGS_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 54 variables, 3 documents, 2 molecular datasets,  SRA, 1527 subjects, 1022 samples","European (3), African (88), African American (845), Hispanic1 (4), Other (5)","NHLBI","GRU-IRB --- General research use (irb)","2019-01-14","2019-01-14","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001146.v1.p1","eQTL Mapping of Mid-Secretory Phase Endometrial Cells","We performed an unbiased genome-wide expression quantitative trait locus (eQTL) mapping study to identify common regulatory (expression) single nucleotide polymorphisms (eSNPs) in mid-secretory endometrium, corresponding to the luteal phase  of the ovarian cycle. Biopsies were collected from 58 women with two or more early pregnancy losses and 53 of these samples passed all quality","Fertility","Collection","Axiom_GW_EUR_1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 53 subjects, 53 samples","European (42), East Asian (2), African American (2), Hispanic1 (2), Hispanic2 (3), South Asian (2)","NICHD","GRU-IRB-NPU --- General research use (irb, npu)","2019-01-07","2019-01-07","Differential Fertility; Fertility, Differential; Postpartum Sterility; Sterility, Postpartum; Time to Pregnancy; Time-to-Pregnancies"
"phs001151.v1.p1","Region-specific Transcriptome Analysis of the Human Retina and    RPE/Choroid","Proper spatial differentiation of retinal cell types is necessary for normal human vision. Many retinal diseases, such as Best disease and male germ cell associated kinase (MAK)-associated retinitis pigmentosa,  preferentially affect distinct topographic regions of the retina. While much is known about the distribution of cell types in the retina, the","Not Provided","Control Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 24 variables,  SRA, 5 subjects, 29 samples","","NEI","GRU-NPU --- General research use (npu)","2016-08-15","2016-08-15",""
"phs001153.v1.p1","Somatic Mutational Analysis by Exome Sequencing Late-Stage Endometrioid    Endometrial Carcinoma","The purpose of this study was to identify somatic (tumor-specific) mutations in advanced stage endometrioid endometrial carcinoma tumor exomes. The dataset was generated at the NIH Intramural Sequencing Center  (NISC) and NHGRI by next generation sequencing the exomes of 19 de-identified primary tumor DNAs, from advanced stage tumors, and matched non-tumor","Endometrial Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 16 variables,  SRA, 19 subjects, 38 samples","","NHGRI","DS-ECA-COL --- Disease-specific (endometrial cancer, col)","2017-09-25","2017-09-25","Endometrial Tumor; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium; Neoplasm, Endometrial"
"phs001154.v1.p1","Indexing Genes Impacted by Copy Number Variation in Developmental    Disorders","A challenge in clinical genomics is to predict whether copy number variation (CNV) affecting a gene or multiple genes will manifest as disease. Increasing recognition of gene dosage effects  in neurodevelopmental disorders prompted us to develop a computational approach based on critical-exon (highly expressed in brain, highly conserved","Developmental Disabilities","Case-Control","Cytogenetic_Arrays","Not Applicable","CNV Genotypes","4 phenotype datasets, 12 variables, 1 molecular datasets, 10618 subjects, 10618 samples","","NICHD","HMB-IRB-PUB-NPU-GSO --- Health/medical/biomedical (irb, pub, npu, gso)","2018-09-25","2018-09-25","Child Development Disorder; Child Development Disorders; Development Disorder, Child; Development Disorders, Child; Developmental Disability; Disabilities, Developmental"
"phs001156.v2.p1","The EVE Asthma Genetics Consortium: Building Upon GWAS","The EVE Asthma Genetics Consortium comprises U.S. investigators who have conducted genome-wide association studies (GWAS) of asthma; the main objective is to combine results of individual studies to increase  the overall power to identify loci for asthma and asthma-associated traits. The consortium includes investigators at 9 U.S. institutions with GWAS","Asthma","Case-Control","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 19 variables, 4 analyses, 296 subjects, 296 samples","","NHLBI","GRU-NPU --- General research use (npu)","2018-05-08","2018-05-08","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001157.v1.p1","Wisconsin Longitudinal Study on Aging","The Wisconsin Longitudinal Study (WLS) is a long-term study of a random sample of men and women, who graduated from Wisconsin high schools in 1957, and their siblings. The  WLS panel started out with a panel of 10,317 members from the class of 1957. Over time a second panel of 8,734 randomly selected siblings of the","Not Provided","Prospective Longitudinal Cohort","HumanOmniExpress-24v1-1_A, 1000G_ref_panel","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (imputed)","4 phenotype datasets, 23 variables, 2 molecular datasets, 9027 subjects, 9429 samples","European (8971), East Asian (3), African American (14), Hispanic1 (6), Hispanic2 (31), Other (2)","NIA","GRU --- General research use","2017-06-14","2017-06-14",""
"phs001158.v2.p1","Human Dorsal Root Ganglion RNA Seq Profiling","RNA sequencing was performed on human DRGs and relative gene abundances were calculated. Various analyses were performed: 1. Human DRG gene expression profiles were contrasted with a panel of  gene expression profiles of relevant tissues in human and mouse ( integrating, among other sources, datasets from ENCODE and GTex ) in order to","Chronic Pain","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 36 variables,  SRA, 21 subjects, 27 samples","","NINDS","GRU --- General research use","2019-03-01","2017-07-28","Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Pains, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Pains, Widespread Chronic"
"phs001159.v1.p1","Genetic Analysis to Interrogate Tumor Heterogeneity in Lung    Adenocarcinoma","We employed next-generation sequencing to identify somatic alterations in multiple metastatic sites from an ""exceptional responder"" lung adenocarcinoma patient during his seven year course of ERBB2-directed therapies. The degree  of heterogeneity was unprecedented, with 1% similarity between somatic alterations of the lung and lymph nodes. One novel translocation, PLAG1-ACTA2","Adenocarcinoma of lung","Case Set","WGS_markerset_grc37, Somatic_Variant_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS, WXS","3 phenotype datasets, 22 variables, 2 molecular datasets,  SRA, 1 subjects, 4 samples","Other (1)","NCI","HMB-IRB-PUB --- Health/medical/biomedical (irb, pub)","2017-12-12","2017-12-12",""
"phs001165.v1.p1","eMERGE: Children's Hospital of Philadelphia - WGS","The Center for Applied Genomics (CAG) is a specialized Center of Emphasis at the Children's Hospital of Philadelphia (CHOP) with the primary goal of translating basic research findings to  medical innovations. The mission of CAG is to develop new and better ways to diagnose and treat children affected by rare and complex medical","Pediatrics","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WGS","4 phenotype datasets, 13 variables, 900 subjects, 900 samples","","NHGRI","GRU --- General research use","2018-05-25","2018-05-25","Not Provided"
"phs001168.v2.p2","Kids First: Genomic Studies of Orofacial Cleft Birth Defects","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Cleft Lip","Family/Twin/Trios","Not Provided","Not Applicable","WGS","5 phenotype datasets, 23 variables,  SRA, 1378 subjects, 1311 samples","","NCI","DS-OBDR-MDS --- Disease-specific (orofacial birth defects and related phenotypes, mds) , DS-OBD-MDS --- Disease-specific (orofacial birth defects, mds) , DS-OC-PUB-MDS --- Disease-specific (oral clefts, pub, mds) , HMB-MDS --- Health/medical/biomedical (mds) , GRU --- General research use","2019-04-05","2018-03-20","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip; Congenital fissure of lip"
"phs001169.v1.p1","Integrative Analysis of Lung Adenocarcinoma","We performed an integrative genomic analysis, incorporating whole exome sequence, DNA copy number, DNA methylation and transcriptome sequencing, for 101 LUAD samples from the Environment And Genetics in Lung  cancer Etiology (EAGLE) study.","Adenocarcinoma of lung","Case Set","HumanOmniExpress","Not Applicable","SNP Genotypes (Array), RNA-Seq, WXS","4 phenotype datasets, 15 variables, 1 molecular datasets,  SRA, 101 subjects, 382 samples","European (100)","NCI","DS-LDS-MDS --- Disease-specific (lung disease or smoking, mds)","2017-09-14","2017-09-14",""
"phs001173.v1.p1","Head and Neck Cancer Genome-wide Association Study","Head and neck cancers have well-documented associations with tobacco and alcohol exposure, but the disease develops in only a small fraction of users, which implies an important role for  genetic susceptibility. Therefore, head and neck cancers are an excellent model for studying genetic susceptibility to environmental carcinogens. The","Carcinoma, squamous cell of head and neck","Case-Control","HumanOmniExpress-12v1_C","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 3333 subjects, 3333 samples","European (3301), African American (1), Hispanic1 (3), Hispanic2 (22), Other Asian or Pacific Islander (3), Other (3)","NCI","GRU --- General research use","2017-09-27","2017-09-27",""
"phs001174.v1.p1","Female Infertility: Primary ovarian insufficiency","Premature ovarian failure, or primary ovarian insufficiency (POI) is a phenotype of diminished or absent ovarian function occurring in 1-2% of reproductive aged women. Most cases occur spontaneously. Evaluation  of the gametes in women with POI is difficult and invasive. Practitioners must often rely on indirect biomarkers of ovarian function and oocyte","Infertility, Female","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 13 variables,  SRA, 98 subjects, 98 samples","","NHGRI","HMB --- Health/medical/biomedical","2017-04-20","2017-04-20","Postpartum Sterility; Sterility, Postpartum"
"phs001176.v2.p1","GxE and Complex Traits","Functional variants associated with complex traits tend to fall in non-coding regions and affect regulatory mechanisms that are not yet well characterized. Furthermore, it is generally difficult to determine  in which tissues and conditions they may have a functional impact. This is because the effect of a genetic variant on a molecular pathway, and","Gene-Environment Interaction","Collection","Not Provided","Not Applicable","OTHER, RNA-Seq","4 phenotype datasets, 20 variables,  SRA, 15 subjects, 1388 samples","","NIGMS","GRU --- General research use","2018-02-02","2017-10-18","Environment Gene Interaction; Environment-Gene Interaction; Environment-Gene Interactions; Gene Environment Interaction; Gene-Environment Interactions; Interaction, Environment-Gene"
"phs001177.v1.p1","Rare Germline CNVs in Familial Melanoma","Mounting evidence suggests that copy number variations (CNVs) can contribute to cancer susceptibility. The main goal of this study was to evaluate the role of germline CNVs in melanoma  predisposition in high-risk melanoma families. We used genome-wide tiling comparative genomic hybridization and SNP arrays to characterize CNVs in","Melanoma","Family/Twin/Trios","HumanOmniExpress","Not Applicable","SNP Genotypes (Array), RNA-Seq","5 phenotype datasets, 22 variables, 1 molecular datasets,  SRA, 116 subjects, 166 samples","European (112), Hispanic2 (1)","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2017-03-30","2017-03-30","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001178.v1.p1","UCLA/Gabriella Miller Kids First Disorders of Sex Development Study","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Disorders of Sex Development","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 300 subjects, 300 samples","","NCI","GRU --- General research use","2019-03-19","2019-03-19","46, XX Testicular DSD; 46, XX Testicular Disorder of Sex Development; 46, XX Testicular Disorders of Sex Development; 46,XX testicular DSD; De la Chapelle syndrome; Reversal, XX Sex"
"phs001179.v1.p1","Foundation Medicine Adult Cancer Clinical Dataset (FM-AD)","The Foundation Medicine adult cancer clinical dataset consists of 18,004 unique solid tumor samples that underwent genomic profiling on a single uniform platform as part of standard clinical care.  The dataset is derived from the FoundationOne genomic profiling assay version 2 that interrogates exonic regions of 287 cancer-related genes and","Neoplasms","Case Set","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 4 variables,  SRA, 18004 subjects, 18004 samples","","NCI","HMB-PUB --- Health/medical/biomedical (pub)","2017-07-31","2017-07-31","Abdominal Neoplasm; Abdominal Neoplasms; Neoplasm, Abdominal; Neoplasms, Abdominal; Tumor of abdomen; BARD1-Related Susceptibility to Breast Cancer"
"phs001181.v1.p1","Single-Cell DNA and RNA Sequencing over A 29-Year Period of A CLL Patient","Chronic lymphocytic leukemia (CLL) is a frequent B-cell malignancy characterized by recurrent somatic chromosome alterations and a low level of point mutations. Here we present single nucleotide polymorphism (SNP)  microarray analyses of a single CLL patient over 29-years of observation and treatment, and transcriptome and whole genome sequencing at selected","Leukemia, Lymphocytic, Chronic, B-Cell","Case Set","HumanOmniExpress","Not Applicable","SNP Genotypes (Array), RNA-Seq, WGS","4 phenotype datasets, 15 variables, 1 molecular datasets,  SRA, 1 subjects, 16 samples","Other (1)","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2017-03-24","2017-03-24","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs001182.v1.p1","Somatic Mutation Load in Clones of Single Human Cells","Accumulation of genetic changes with time and proliferation of cells is inevitable. We report here the genome-wide magnitude and spectra of mutations accrued in skin fibroblasts over the lifetime  of healthy humans. We found that every cell contains at least one somatic chromosomal rearrangement and 600 - 13,000 base substitutions, similar to","Clonal Evolution","Control Set","Somatic_Mutations","Not Applicable","SNV (.MAF), WGS, WXS","4 phenotype datasets, 21 variables, 1 documents, 1 molecular datasets,  SRA, 2 subjects, 20 samples","","NIEHS","GRU --- General research use","2016-10-27","2016-10-27","Evolution, Clonal; Cell, Clone; Cells, Clone; Clone Cell; Clones; Corium"
"phs001185.v1.p1","Genome-Wide Scan of Early-onset Prostate Cancer","This is a genome-wide association scan of 931 early-onset prostate cancer cases of European ancestry. The samples were selected from prostate cancer studies at the University of Michigan. Controls  were previously genotyped individuals selected from the Cancer Genetics Markers of Susceptibility (CGEMS) and Illumina's iControlDB database.","Prostatic Neoplasms","Case-Control","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 931 subjects, 931 samples","European (930), Other (1)","NCI","DS-CA --- Disease-specific (cancer)","2016-11-03","2016-11-03","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001187.v1.p1","Epigenomics of Human CD8 T cell Differentiation and Aging","The efficacy of the adaptive immune response declines dramatically with age, but the cell-intrinsic mechanisms driving the changes characteristic of immune aging in humans remain poorly understood. One hallmark  of immune aging is the loss of self-renewing naive cells and the accumulation of differentiated but dysfunctional cells within the CD8 T cell","Aging","Case-Control","Not Provided","Not Applicable","ChIP-Seq, RNA-Seq, Tn-Seq","3 phenotype datasets, 16 variables,  SRA, 23 subjects, 75 samples","","NIAID","GRU-IRB --- General research use (irb)","2017-02-16","2017-10-16","Aging, Biological; Biological Aging; Antigens, Differentiation, T Lymphocyte; Antigens, Differentiation, T-Cell; Antigens, Differentiation, T-Lymphocyte; Antigens, T-Cell Differentiation"
"phs001188.v1.p1","The FUSION Study - Islet Expression and Regulation","We analyzed mRNA extracted from pancreatic islets obtained from 31 deceased donors, along with genome-wide genotypes, and open chromatin information obtained from ATAC-seq experiments on two additional islet samples.  2500-5000 islet equivalents (IEQ) from each islet distribution were harvested for RNA isolation. 500-1000 IEQ were cultured as in Gershengorn","Diabetes Mellitus, Type 2","Control Set","RNAseq_probe_set_grc37, 1000G_ref_panel, HumanOmni2.5-4v1_H","Not Applicable","ATAC-seq, SNP Genotypes (Array), SNP/CNV Genotypes (imputed), QTL Results, RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 28 variables, 1 documents, 2 molecular datasets,  SRA, 33 subjects, 64 samples","","NHGRI","GRU --- General research use","2017-08-09","2017-08-09","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001189.v2.p1","NHLBI TOPMed: Cleveland Clinic Atrial Fibrillation (CCAF) Study","The Cleveland Clinic Atrial Fibrillation Study consists of clinical and genetic data of patients with atrial fibrillation and control cohorts from the Cleveland Clinic CV/Arrhythmia Biobank, including the Cleveland  Clinic Lone Atrial Fibrillation GeneBank. The Cleveland Clinic Lone AF GeneBank Study has enrolled patients with lone AF, defined as AF in the","Atrial fibrillation","Case Set","TOPMed_WGS_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 39 variables, 2 documents, 2 molecular datasets,  SRA, 363 subjects, 364 samples","European (359)","NHLBI","GRU-IRB --- General research use (irb)","2019-01-25","2019-01-25","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001191.v1.p1","NUgene WGS","The NUgene Project is a biorepository with longitudinal medical information from participating patients at Northwestern Medicine affiliated hospitals and outpatient clinics. Participants' DNA samples are coupled with data from  a self-reported questionnaire (2 versions were used, 1 before and 1 after February 2006, both are included) and continuously updated data from our","Healthy Volunteers","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WGS","4 phenotype datasets, 18 variables, 3 documents,  SRA, 900 subjects, 900 samples","","NHGRI","GRU --- General research use","2017-10-03","2017-10-03","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human"
"phs001192.v1.p1","Thoracic Patient-Derived Xenografts","Targeted capture sequencing of 341 cancer associated genes in thoracic patient-derived xenografts.","Lung Neoplasms","Case Set","Not Provided","Not Applicable","Targeted-Capture","3 phenotype datasets, 19 variables,  SRA, 1 subjects, 4 samples","","NCI","DS-LC-PUB-NPU --- Disease-specific (lung cancer, pub, npu)","2017-04-11","2017-04-11","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs001193.v1.p1","Hispanic Colorectal Cancer Study","Genome-wide association studies (GWAS) of colorectal cancer (CRC) have been instrumental in identifying a number of common susceptibility loci in Non Hispanic (NH)-White populations, and a NCI priority is  to extend GWAS findings to other populations to address racial/ethnic disparities in cancer susceptibility. Currently, GWA studies of CRC in NH","Colorectal Neoplasms","Case-Control","HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 7 documents, 1 molecular datasets, 1597 subjects, 1597 samples","European (81), African (1), African American (6), Hispanic1 (20), Hispanic2 (1438), Other Asian or Pacific Islander (10), Other (41)","NCI","GRU --- General research use , DS-CA --- Disease-specific (cancer) , HMB-MDS --- Health/medical/biomedical (mds)","2018-12-27","2018-12-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001195.v1.p1","A Study to Assess the Cardiovascular, Cognitive, and Subjective Effects    of Atomoxetine in Combination with Intravenous Methamphetamine","The Study to Assess the Cardiovascular, Cognitive, and Subjective Effects of Atomoxetine in Combination with Intravenous Methamphetamine started in 2007 and ended in 2011. It was a small pilot  study that included methamphetamine abusing individuals and healthy control participants aged 18-50 years. Participants who qualified over the","Sex/Gender Identity","Case-Control","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 3 documents, 1 molecular datasets, 13 subjects, 13 samples","European (6), East Asian (1), African American (2), Hispanic1 (1), Hispanic2 (2), Other (1)","NIDA","GRU --- General research use","2018-03-29","2018-03-29","Age Groups; Group, Age; Groups, Age; Abuser, Drug; Abusers, Drug; Drug Abuser"
"phs001197.v1.p1","Neural Systems, Inhibitory Control, and Methamphetamine Dependence","The Neural Systems, Inhibitory Control, and Methamphetamine Dependence study started in 2011 and is currently finishing data collection for its last participants. The study included methamphetamine abusing individuals and  healthy control participants aged 18-55 years. Participants who qualified over the telephone were scheduled to visit the London Laboratory at the","Substance-Related Disorders","Case-Control","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 1 molecular datasets, 193 subjects, 188 samples","European (63), African (2), East Asian (3), African American (30), Hispanic1 (3), Hispanic2 (69), Other Asian or Pacific Islander (8), South Asian (1), Other (9)","NIDA","GRU --- General research use","2018-05-01","2018-05-01","Ethnic Groups; Ethnic Origin; Ethnic Origins; Ethnic category; Ethnicity; Benzeneethanamine, N,alpha-dimethyl-, (S)-"
"phs001198.v1.p1","Early Methamphetamine Abstinence: fMRI and Brain Function","This study included two groups of subjects, methamphetamine-dependent and healthy control participants, with the purpose of characterizing brain structure and cognition during the first month of abstinence from methamphetamine.  Participants were able to participate in one or both phases of the study. Methamphetamine abusers were held as inpatients and abstained from","Substance-Related Disorders","Case-Control","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 38 variables, 1 molecular datasets, 107 subjects, 93 samples","European (45), East Asian (2), African American (10), Hispanic1 (3), Hispanic2 (22), Other Asian or Pacific Islander (3), South Asian (1), Other (7)","NIDA","GRU --- General research use","2018-06-01","2018-06-01","Ethnic Groups; Ethnic Origin; Ethnic Origins; Ethnic category; Ethnicity; Benzeneethanamine, N,alpha-dimethyl-, (S)-"
"phs001199.v1.p1","TIGER-LC OncoVar Sequencing","Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We performed targeted sequencing of Thai ICC and HCC among the  Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC) cohort using the OncoVar platform.","Carcinoma, Hepatocellular","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 19 variables,  SRA, 197 subjects, 394 samples","","NCI","GRU --- General research use","2017-07-03","2017-07-03","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs001200.v1.p1","Neutralizing Antibodies against West Nile Virus from Human B Cells","West Nile virus (WNV) infection is a mosquito-borne disease that can cause severe neurological illness. We analyzed the humoral response to WNV of subjects infected with WNV at different  stages of the infection and at different levels of detail, from single cells to the repertoire level. We integrated single-cell analysis by","West Nile Fever","Case Set","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 18 variables,  SRA, 7 subjects, 26 samples","","NIAID","DS-IR-IRB --- Disease-specific (immunological research, irb)","2017-02-23","2017-02-23","Disease caused by West Nile virus; Infection, WNV; Infections, WNV; WNV Infection; WNV Infections; West Nile Virus Infection"
"phs001201.v2.p1","ASsessing and Predicting Infant RSV Effects and Severity (AsPIRES) Study","A prospective multi-year clinical translational study including three cohorts of term infants experiencing their first Respiratory Syncytial Virus (RSV) season. All infants are less than or equal to nine  months of age at study entry. The three subject cohorts represent the full spectrum of RSV disease severity and include a birth cohort, a cohort of","Respiratory Syncytial Virus Infections","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37","Not Applicable","AMPLICON, RNA-Seq, RNA Seq expression levels","8 phenotype datasets, 133 variables, 1 molecular datasets,  SRA, 186 subjects, 1460 samples","","NIAID","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2019-09-11","2019-09-11","Infections, Respiratory Syncytial Virus; RSV - Respiratory syncytial virus infection; Respiratory Syncytial Virus Infection"
"phs001202.v1.p1","OncoArray: Oral and Pharynx Cancer","Genetic factors play an important role in susceptibility to head and neck cancer and could also explain differences in response to treatment and outcome. The goal of this project  is to investigate genetic variation involved in oral and oropharyngeal cancer susceptibility by performing the largest GWAS on these diseases, using","Head and Neck Neoplasms","Case-Control","ConsortiumOncoArray","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets, 10096 subjects, 10219 samples","European (8148), African (21), African American (661), Hispanic1 (895), Hispanic2 (141), Other Asian or Pacific Islander (5), South Asian (4), Other (221)","NIDCR","HMB-PUB-MDS --- Health/medical/biomedical (pub, mds) , DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds)","2017-08-23","2017-08-23","Head Neoplasms; Neoplasms, Head; Hypopharyngeal Neoplasms; Hypopharyngeal Tumor; Neoplasm of Hypopharynx; Neoplasm of the Hypopharynx"
"phs001203.v1.p1","Stockholm-Tartu Atherosclerosis Reverse Network Engineering Task    (STARNET)","STARNET is a genetics of RNA expression study of multiple disease-relevant tissues obtained from living patients with cardiovascular disease. Tissue samples are obtained from blood, atherosclerotic-lesion-free internal mammary artery  (MAM) and atherosclerotic aortic root (AOR), subcutaneous fat (SF), visceral abdominal fat (VAF), skeletal muscle (SKLM), and liver (LIV) during open","Coronary Artery Disease","Case Set","RNAseq_gene_transcripts","Not Applicable","RNA Seq expression levels","3 phenotype datasets, 9 variables, 1 molecular datasets, 566 subjects, 3577 samples","","NHLBI","HMB --- Health/medical/biomedical","2016-12-14","2016-12-14","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs001204.v1.p1","Mayo Clinic - Fecal Microbiota and Colorectal Cancer Development","Background: Adenomatous polyps are the most common precursor to colorectal cancer (CRC), the second leading cause of cancer death in the United States. We sought to learn more about  early events of carcinogenesis by investigating shifts in the gut microbiota of patients with adenomas. Methods: We analyzed 16S rRNA gene sequences","Adenoma","Case-Control","Not Provided","Not Applicable","Not Provided","819 subjects, 819 samples","","NCI","","","","Adenoma, Microcystic; Adenomas, Microcystic; Microcystic Adenomas; CRC; Cancer of Large Bowel; Cancer of Large Intestine"
"phs001205.v1.p1","Cell types and lineages of hESC-derived brain cells","During development of the human brain, multiple cell types with diverse regional identities are generated. Here we report a system to generate early human brain forebrain and mid/hindbrain cell  types from human embryonic stem cells (hESCs), and infer and experimentally confirm a lineage tree for the generation of these types based on single","Neural Stem Cells","Control Set","RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 2 subjects, 472 samples","","NINDS","GRU-NPU --- General research use (npu)","2016-10-27","2016-10-27","Cell, Embryonic Stem; Cells, Embryonic Stem; Embryonic Stem Cells; Stem Cell, Embryonic; Stem Cells, Embryonic; Cell, Neural Stem"
"phs001206.v1.p1","Blepharospasm in a Multiplex African-American Pedigree","Blepharospasm (BSP) is a late-onset focal dystonia characterized by involuntary contractions of the orbicularis oculi muscles. Genetics plays an important role on the pathogenesis of BSP, especially in hereditary  BSP families. In this project, a large African-American pedigree with BSP was phenotypically characterized and its relationship with known common","Blepharospasm","Family/Twin/Trios","WES_markerset_grc37","Not Applicable","SNP Genotypes (PCR), SNP Genotypes (NGS)","6 phenotype datasets, 31 variables, 1 molecular datasets,  SRA, 12 subjects, 12 samples","","NINDS","GRU --- General research use","2018-03-01","2018-03-01","Dystonia, Muscle; Dystonic disease; Dystonic movements; Muscle Dystonia"
"phs001207.v1.p1","NHLBI TOPMed: African American Sarcoidosis Genetics Resource","This study aims to comprehensively interrogate the genomes of African American sarcoidosis families. Sarcoidosis is characterized by a hyperimmune response resulting in granuloma formation in multiple organs. It affects  African Americans (AAs) more frequently and more severely than whites. While previous linkage, admixture, candidate gene and genome-wide association","Sarcoidosis","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 51 variables, 2 documents, 1 molecular datasets,  SRA, 637 subjects, 634 samples","African (23), African American (579), Hispanic1 (4)","NHLBI","DS-SAR-IRB --- Disease-specific (sarcoidosis, irb)","2018-11-16","2018-11-16","Benign lymphogranulomatosis of Schaumann; Besnier Boeck Disease; Besnier Boeck Schaumann Syndrome; Besnier-Boeck Disease; Besnier-Boeck-Schaumann Syndrome; Besnier-Boeck-Schaumann disease"
"phs001208.v2.p1","COGA: Smokescreen GWAS","This is a family study of alcoholism, in which the subjects have been drawn from the Collaborative Study on the Genetics of Alcoholism (COGA), a large, ongoing family-based study  that includes subjects from seven sites around the US. COGA has gathered detailed, standardized data on study participants, including diagnostic and","Alcoholism","Family/Twin/Trios","Axiom_Smokesc1, WES_markerset_grc38","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS)","5 phenotype datasets, 65 variables, 2 molecular datasets, 7148 subjects, 5415 samples","European (4715), African (1), East Asian (12), African American (113), Hispanic1 (133), Hispanic2 (292), Other Asian or Pacific Islander (47), South Asian (18), Other (84)","NIDA","DS-ADX-IRB --- Disease-specific (addictive disorders, irb)","2019-09-04","2019-09-04","Alcohol Use Disorder; Alcohol Use Disorders; Use Disorder, Alcohol; Use Disorders, Alcohol"
"phs001209.v1.p1","MIDCIRS Reveals Antibody Diversification in Young Children with Malaria","This study describes a novel Immune Repertoire Sequencing technique, termed Molecular Identifier Clustering-based Immune Repertoire Sequencing (MIDCIRS), to reduce sequencing error while maintaining extremely high coverage and applies this  technique to investigate the differential immune response to malaria between infants and toddlers. Despite a lower somatic hypermutation load, we","Malaria","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 16 variables,  SRA, 22 subjects, 80 samples","","NIA","GRU --- General research use","2017-10-20","2017-10-20","Disease caused by Plasmodiidae; Fever, Marsh; Fever, Remittent; Infection, Plasmodium; Infections, Plasmodium; Marsh Fever"
"phs001210.v1.p1","NCI Lung Cancer and Smoking Phenotypes in African-American Subjects","This is a two-stage case-control study designed to evaluate the association between common genetic variants and the risk of lung cancer. The stage 1 studies included 1737 cases and  3602 controls from the following studies: MD Anderson Lung Cancer Epidemiology Study, The Multiethnic Cohort Study (MEC), NCI-MD Lung Cancer-Case","Lung Neoplasms","Case-Control","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 molecular datasets, 5339 subjects, 5644 samples","European (1), African (133), African American (5102), Hispanic1 (86), Other (17)","NCI","DS-CA --- Disease-specific (cancer) , GRU --- General research use , GRU-IRB --- General research use (irb) , DS-CA-PUB-NPU-RD --- Disease-specific (cancer, pub, npu, rd) , DS-CA-MDS --- Disease-specific (cancer, mds)","2017-04-07","2017-04-07","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs001211.v2.p2","NHLBI TOPMed: Trans-Omics for Precision Medicine Whole Genome Sequencing    Project: ARIC","Participants from the Atherosclerosis Risk in Communities (ARIC) Study, a large population-based longitudinal cohort study, have been included in this Project and whole genome sequencing will be performed to  contribute to analyses of early-onset atrial fibrillation and venous thromboembolism. Additional phenotype and genotype data are available for these","Cardiovascular Diseases","Case-Control","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 18 variables, 2 documents, 2 molecular datasets,  SRA, 13546 subjects, 13550 samples","European (3375), African (14), African American (224), Hispanic1 (3), Hispanic2 (3)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2019-02-14","2019-02-14","Arrhythmia; Arrhythmia, Cardiac; Arrhythmias, Cardiac; Arrythmia; Cardiac Arrhythmias; Cardiac Dysrhythmia"
"phs001212.v1.p1","NextGen Consortium: Globin Gene Expression in Sickle Cell    Genotype-Specific iPS Cells","1. Implement an efficient, highly reproducible and 'scalable' system for the production of large numbers of sickle cell anemia-specific iPS cells (iPSC). 2. Derive and characterize a novel, in  vitro system for the production of an unlimited supply of erythroid lineage cells from the directed differentiation of 'clinical grade' transgene","Anemia, Sickle Cell","Case Set","target_markerset_grc37","Not Applicable","SNP Genotypes (NGS), SNV Aggregate (.MAF)","4 phenotype datasets, 23 variables, 1 molecular datasets, 55 subjects, 91 samples","European (1), African (7), African American (28), Hispanic1 (17), Other (1)","NHLBI","GRU --- General research use","2017-12-11","2017-12-11","Anemias, Sickle Cell; Cell Disease, Sickle; Cell Diseases, Sickle; Cell Disorder, Sickle; Cell Disorders, Sickle; Disease, Hemoglobin S"
"phs001213.v1.p1","Molecular Genetics of Heroin Dependence in China","Our principal goal was to determine the chromosomal locations of genetic variations associated with increased vulnerability to heroin dependence. This goal was attained by identifying specific DNA markers that  are genetically linked to heroin dependence. We collected blood and diagnostic information (using a structured diagnostic interview) from 1230 people","Drug Dependence","Family/Twin/Trios","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 46 variables, 2 documents, 1 molecular datasets, 1711 subjects, 1043 samples","European (1), East Asian (636), African American (1), Hispanic1 (1), Other Asian or Pacific Islander (404)","NIDA","GRU --- General research use","2017-02-02","2017-02-02","Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs001214.v1.p1","DNA and RNA Profiling Using Simultaneous Sequencing (Simul-seq)","Paired DNA and RNA profiling is increasingly employed in genomics research to uncover molecular mechanisms of disease and to explore personal genotype and phenotype correlations. We developed a novel  simultaneous DNA and RNA sequencing approach (Simul-seq) that enables comprehensive genomic and transcriptomic profiles from small quantities of","Esophageal Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WGA, WGS","4 phenotype datasets, 22 variables,  SRA, 2 subjects, 13 samples","","NHGRI","GRU-IRB-PUB --- General research use (irb, pub)","2016-10-31","2016-10-31","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophagus Neoplasm; Esophagus Neoplasms; Esophagus Tumor"
"phs001215.v2.p2","NHLBI TOPMed: San Antonio Family Heart Study (SAFHS)","The San Antonio Family Heart Study (SAFHS) is a complex pedigree-based mixed longitudinal study designed to identify low frequency or rare variants influencing susceptibility to cardiovascular disease, using whole  genome sequence (WGS) information from 2,590 individuals in large Mexican American pedigrees from San Antonio, Texas. The major objectives of this","Cardiovascular Diseases","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 46 variables, 2 documents, 1 molecular datasets,  SRA, 2594 subjects, 2682 samples","European (10), Hispanic2 (1460), Other (9)","NHLBI","DS-DHD-IRB-PUB-MDS-RD --- Disease-specific (diabetes and heart disease, irb, pub, mds, rd)","","","Blood Sugar; Glucose, Blood; Sugar, Blood; DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure"
"phs001216.v1.p1","A Genome-Wide Association Study for Post-bronchodilator Lung Function in    Children with Asthma","In this study, we conducted a genome-wide association study (GWAS) of post-bronchodilator (BD) FEV1 (forced expiratory volume in 1 second) and FEV1/FVC (forced vital capacity) in Puerto Rican children  with asthma. From September 2003 to June 2010, we recruited 618 Puerto Rican children with asthma, which was defined as physician diagnosed asthma","Asthma","Prospective Longitudinal Cohort","HumanOmni25-8v1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 447 subjects, 447 samples","European (2), African American (38), Hispanic1 (362), Hispanic2 (8), Other (37)","NHLBI","DS-ASTHMA-IRB-PUB-NPU-MDS-GSO-RD --- Disease-specific (asthma, irb, pub, npu, mds, gso, rd)","2017-04-21","2017-04-21","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001217.v1.p1","NHLBI TOPMed: Genetic Epidemiology Network of Salt Sensitivity (GenSalt)","The GenSalt study aims to identify genes which interact with dietary sodium and potassium intake to influence blood pressure in Han Chinese participants from rural north China. Whole genome  sequencing will be conducted among 1,860 participants of the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) Study. We will work in","Arterial Pressure, Mean","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 28 variables, 2 documents, 1 molecular datasets,  SRA, 3142 subjects, 1908 samples","East Asian (1658), Other Asian or Pacific Islander (24)","NHLBI","GRU-IRB --- General research use (irb)","2019-03-15","2019-03-15","Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure; Mean Arterial Pressure; Mean Arterial Pressures; Pressure, Mean Arterial"
"phs001218.v1.p1","NHLBI TOPMed: GeneSTAR (Genetic Study of Atherosclerosis Risk)","GeneSTAR began in 1982 as the Johns Hopkins Sibling and Family Heart Study, a prospective longitudinal family-based study conducted originally in healthy adult siblings of people with documented early  onset coronary disease under 60 years of age. Commencing in 2003, the siblings, their offspring, and the coparent of the offspring participated in a","Platelet Aggregation","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 157 variables, 17 documents, 1 molecular datasets,  SRA, 1787 subjects, 1785 samples","European (892), African (8), African American (715), Hispanic1 (10), Other Asian or Pacific Islander (4), Other (7)","NHLBI","DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, irb, npu, mds)","2019-02-27","2019-02-27","Blood Physiological Concept; Blood Physiological Concepts; Blood Physiological Phenomena; Blood Physiological Phenomenas; Blood Physiological Phenomenon; Blood Physiology"
"phs001219.v1.p1","Detection of Genes Predisposing to Hematologic Malignancies","We have been conducting genetic studies on families at high risk of different hematologic malignancies, in order to define the related tumors in the families, define precursor and other  related conditions, and map and identify susceptibility genes. We have focused mainly on four types of lymphoid malignancies: chronic lymphocytic","Leukemia, Lymphocytic, Chronic, B-Cell","Family/Twin/Trios","Not Provided","Not Applicable","WXS","5 phenotype datasets, 26 variables,  SRA, 475 subjects, 475 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds)","2018-05-10","2018-05-10","CHL; Disease, Hodgkin; Disease, Hodgkin's; Disease, Hodgkins; Familial Hodgkin Disease; Granuloma, Hodgkin"
"phs001223.v1.p1","Analysis of AR Gene Rearrangements in Prostate Cancer","Molecularly-targeted therapies for advanced prostate cancer include castration modalities that suppress ligand-dependent transcriptional activity of the androgen receptor (AR). However, persistent AR signaling undermines therapeutic efficacy and promotes progression  to lethal castration-resistant prostate cancer (CRPC), even when patients are treated with potent second-generation AR-targeted therapies abiraterone","Prostatic Neoplasms","Case Set","Not Provided","Not Applicable","OTHER, RNA-Seq","42 subjects, 57 samples","","NCI","DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds)","2016-10-31","2016-10-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001224.v1.p1","Platinum Genomes","Improvement of variant calling in next-generation sequence data requires a comprehensive, genome-wide catalogue of high-confidence variants called in a set of genomes for use as a benchmark. We generated  deep, whole-genome sequence data of seventeen individuals in a three-generation pedigree and called variants in each genome using a range of","Computational Biology","Control Set","WGS_markerset_grc37, WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 17 subjects, 17 samples","European (13)","NHGRI","GRU --- General research use","2016-11-23","2016-11-23","Biology, Computational"
"phs001226.v1.p1","Regulatory Genomics of Human Embryonic Development","We used epigenetic profiling to map active enhancers in the developing human limb and cortex as described in two published studies: Cotney J, Leng J, Yin J, Reilly SK  et al. The evolution of lineage-specific regulatory activities in the human embryonic limb. Cell 2013;154(1):185-96. Reilly SK, Yin J, Ayoub AE","Embryonic Development","Control Set","Not Provided","Not Applicable","ChIP-Seq, RNA-Seq","3 phenotype datasets, 10 variables, 19 subjects, 64 samples","","NIGMS","HMB-NPU --- Health/medical/biomedical (npu)","2017-03-28","2017-03-28","Encephalon; Development, Embryo; Development, Embryonic; Embryo Development; Embryogenesis; Embryonal Development"
"phs001228.v1.p1","Kids First Pediatric Research Program in Susceptibility to Ewing Sarcoma    Based on Germline Risk and Familial History of Cancer","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Sarcoma, Ewing","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 4 variables,  SRA, 1112 subjects, 1112 samples","","NCI","GRU --- General research use","2018-06-18","2018-06-18","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs001229.v1.p1","Sequencing Follicular Lymphoma","We performed exome sequencing of tumor (lymph node) and normal (skin) frozen tissue pairs from 24 patients in a discovery cohort with untreated follicular lymphoma (FL), relapsed FL, or  transformed FL/iNHL (indolent non-Hodgkin lymphoma). From 24 patients, 28 tumor samples were exome sequenced including 1 patient with both untreated","Lymphoma, Follicular","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WXS","4 phenotype datasets, 26 variables,  SRA, 39 subjects, 128 samples","","NHGRI","DS-LYM --- Disease-specific (lymphoma)","2017-07-21","2017-07-21","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma"
"phs001231.v2.p1","NeuroLINCS","The NeuroLINCS Center is part of the NIH Common Fund's Library of Integrated Network-based Cellular Signatures (LINCS) program, which aims to characterize how a variety of human cells, tissues  and the entire organism respond to perturbations by drugs and other molecular factors. As Part of the LINCS program, the NeuroLINCS study","Amyotrophic Lateral Sclerosis","Case-Control","Not Provided","Not Applicable","OTHER, RNA-Seq, SNP Genotypes (NGS), WGS","4 phenotype datasets, 37 variables,  SRA, 20 subjects, 148 samples","European (17), African American (1), Hispanic2 (2)","NINDS","GRU --- General research use , DS-NNMC --- Disease-specific (neurologic and neuromuscular conditions)","2018-05-11","2017-04-24","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs001232.v1.p1","Undiagnosed Diseases Network (UDN)","The Undiagnosed Diseases Network (UDN) is an initiative to facilitate the diagnosis of conditions that have eluded diagnosis through the coordinated action of leading clinical and research centers. The  purpose of this cooperative research network is to establish a national network added to and building upon the NIH Undiagnosed Diseases Program (NIH","Rare Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS, WXS","6 phenotype datasets, 24 variables, 1 documents, 1 molecular datasets,  SRA, 462 subjects, 462 samples","","NHGRI","GRU --- General research use","2018-06-13","2018-06-13","Disease, Rare; Diseases, Rare; Rare Disease; Rare disorder"
"phs001233.v1.p1","Disease Severity in Familial Dysautonomia","Familial Dysautonomia (FD) is a developmental and degenerative genetic disease that manifests in the neural crest cells and peripheral nervous system (PNS). Despite all FD patients having the same  mutation in IKBKAP, patients present with varying disease severity, ranging from mild to severe. We used the human pluripotent stem cell technology","Dysautonomia, Familial","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 16 variables,  SRA, 6 subjects, 6 samples","","NINDS","DS-FDY-COL --- Disease-specific (familial dysautonomia, col)","2016-11-30","2016-11-30","DYS; DYSAUTONOMIA, FAMILIAL; Dominant Hereditary Sensory Neuropathy, Type III; FD; Familial Dysautonomia; HSAN (Hereditary Sensory and Autonomic Neuropathy) Type III"
"phs001234.v1.p1","Sequence of Primary ER+ Breast Tumors Treated with 5 Years of Tamoxifen","Targeted massively parallel sequencing analysis was conducted on DNA extracted from archived 22-28 year old, formalin-fixed primary breast tumors from 625 patents from British Columbia treated with five years  of adjuvant tamoxifen monotherapy and followed for over 10 years. Genes were selected for targeted sequencing by review of existing large-scale","Breast Neoplasms","Case Set","Not Provided","Not Applicable","WXS","3 phenotype datasets, 12 variables,  SRA, 625 subjects, 625 samples","","NCI","DS-CA-IRB --- Disease-specific (cancer, irb)","2018-10-16","2018-10-16","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001235.v1.p1","Rhinovirus Susceptibility in Human MDA5 Deficiency","We studied a child with life-threatening and recurrent respiratory tract infections, caused by multiple viruses including rhinovirus, influenza virus, and respiratory syncytial virus (RSV). We identified in her a  homozygous missense mutation in IFIH1 that encodes MDA5 by Whole Exome Sequencing. MDA5-deficiency is a novel inborn error of innate immunity that","Immunologic Deficiency Syndromes","Case-Control","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 5 subjects, 5 samples","","NIAID","GRU --- General research use","2019-03-21","2019-03-21","Antibody Deficiency Syndrome; Antibody Deficiency Syndromes; Deficiency Syndrome, Antibody; Deficiency Syndromes, Antibody; Syndrome, Antibody Deficiency; Syndromes, Antibody Deficiency"
"phs001236.v1.p1","Genetic Analysis of Tuberous Sclerosis Complex (TSC) Hypomelanotic    Macules","In this study we searched for mutations in the TSC1 and TSC2 genes in cultured melanocytes from individuals with the genetic disease Tuberous Sclerosis Complex.","Tuberous Sclerosis","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 14 variables,  SRA, 5 subjects, 5 samples","","NHLBI","DS-TSC-IRB-NPU-MDS-GSO --- Disease-specific (tuberous sclerosis complex, irb, npu, mds, gso)","2017-09-27","2017-09-27","Congenital hypomelanotic and hypermelanotic macules; Hereditary congenital hypopigmented and hyperpigmented macules; Hypo-and hypermelanotic cutaneous macules, retarded growth, intellectual disability syndrome; Macules hereditary congenital hypopigmented and hyperpigmented; Macules, Hereditary Congenital Hypopigmented and Hyperpigmented; Westerhof Beemer Cormane syndrome"
"phs001237.v1.p1","NHLBI TOPMed: Women's Health Initiative (WHI)","This is Whole Genome Sequencing data from the TOPMed participation of the Women's Health Initiative. Approximately 11,100 subjects were involved in this study: approximately 1,100 cases of VTE, 4,000  cases of ischemic stroke, 900 cases of hemorrhagic stroke, and 5,100 controls. Summary level phenotypes for the WHI Cohort study participants can be","Stroke","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 15 variables, 2 documents, 1 molecular datasets,  SRA, 11357 subjects, 11640 samples","European (8223), African (46), East Asian (147), African American (1255), Hispanic1 (78), Hispanic2 (193), Other Asian or Pacific Islander (41), Other (17)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2019-01-17","2019-01-17","Apoplexy; Apoplexy, Cerebrovascular; Brain Vascular Accident; Brain Vascular Accidents; CEREBROVASCULAR ACCIDENT; CVA (Cerebrovascular Accident)"
"phs001241.v1.p1","Clonal Architectures and Driver Mutations in Metastatic Melanomas","This study contains sequence data from 15 patients with stage IV melanoma, including the whole genome sequence of 15 metastatic tumors and corresponding normal blood samples from 13 cases,  and targeted capture sequence of four synchronous metastatic samples from two additional cases. These data provide a comprehensive survey of the","Melanoma","Case Set","Not Provided","Not Applicable","WGS, WXS","4 phenotype datasets, 14 variables, 15 subjects, 36 samples","","NCI","GRU-MDS --- General research use (mds)","2017-11-20","2017-11-20","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001242.v1.p1","Small genomic insertions form enhancers that misregulate oncogenes","ChIP-Seq data from 102 cell lines were processed to identify insertions relative to the human reference genome. To confirm the ability of a computational pipeline to identify insertions that  are actually present in these genomes, we PCR-amplified and deeply sequenced regions where insertions were predicted to exist in MOLT4 T-cell acute","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","Case Set","Not Provided","Not Applicable","AMPLICON","3 phenotype datasets, 13 variables,  SRA, 1 subjects, 1 samples","","NHGRI","GRU --- General research use","2017-01-19","2017-01-19","Acute T Cell Leukemia; Acute T Cell Lymphoblastic Leukemia; Acute T-Cell Leukemia; Acute T-Cell Leukemias; Acute T-Cell Lymphoblastic Leukemia; Acute T-Lymphocytic Leukemia"
"phs001243.v1.p1","Genetic Basis of Breast Cancer Resistance in BRCA1 Mutation Carrier","Our study addressed a specific question in NCI RFA-CA-12-022: ""What underlying causal events - e.g., genetic, epigenetic, biologic, behavioral, or environmental - allow certain individuals to survive beyond the  expected limits of otherwise highly lethal cancers?"". A germline mutation in BRCA1 (BRCA1+) is the most penetrant genetic predisposition for breast","Breast Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 14 variables, 54 subjects, 54 samples","","NCI","GRU-PUB --- General research use (pub)","2016-12-15","2017-06-15","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001244.v1.p1","Nasopharynx Cancer Whole Exome Sequencing","Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer characterized by Epstein-Barr virus (EBV) infection and dense lymphocyte infiltration. The scarcity of NPC genomic data hinders the understanding  of NPC biology, disease progression, and rational therapy design. Here, we performed whole-exome sequencing (WES) on 111 micro-dissected EBV-positive","Nasopharyngeal Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 22 variables, 108 subjects, 211 samples","","NHGRI","DS-CA-NPU-MDS --- Disease-specific (cancer, npu, mds)","2017-02-21","2017-02-21","Nasopharyngeal Tumor; Nasopharyngeal neoplasm; Nasopharynx Neoplasm; Nasopharynx Neoplasms; Neoplasm of Nasopharynx; Neoplasm of the Nasopharynx"
"phs001245.v1.p1","Autosomal Recessive CD70 Deficiency","We describe four patients from two unrelated families of different ethnicities who had primary immunodeficiency predominantly manifesting as susceptibility to EBV-related diseases. We performed whole exome sequencing (P1 and  P2 from family 1) or whole genome sequencing (P4 and both parents from family 2) in those two families and identified homozygous frameshift or in","Immunologic Deficiency Syndromes","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 24 variables, 1 molecular datasets, 5 subjects, 5 samples","","NIAID","GRU --- General research use (irb)","2018-02-02","2018-02-02","EBV Infections; Epstein Barr Virus Infection; Epstein Barr Virus Infections; Epstein-Barr Virus Infection; Epstein-Barr Virus Infections; Herpesvirus 4 Infections, Human"
"phs001246.v1.p1","Genetics of Arhinia","The goal of this project is to determine the genetic etiology of congenital arhinia and Bosma arhinia microphthalmia syndrome through a combination of whole-exome, whole-genome, and targeted sequencing followed  by in silico, in vitro, and in vivo functional modeling.","Arhinia, choanal atresia, and microphthalmia","Case-Control","Not Provided","Not Applicable","RNA-Seq, WXS","5 phenotype datasets, 20 variables,  SRA, 28 subjects, 26 samples","","NICHD","GRU --- General research use","2017-01-27","2017-01-27","ARHINIA, CHOANAL ATRESIA, MICROPHTHALMIA, AND HYPOGONADOTROPIC HYPOGONADISM; Arhinia, choanal atresia and microphthalmia; BAMS; BAMS - Bosma arhinia microphthalmia syndrome; Bosma Henkin Christiansen syndrome; Bosma arhinia microphthalmia syndrome"
"phs001247.v1.p1","GMKF: Congenital Cranial Dysinnervation Disorders (CCDD) and Related    Conditions","The Gabriella Miller Kids First Pediatric Research Program (Gabriella Miller Kids First Pediatric Research Program) (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller  Kids First Research Act and supported by the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth","Cranial Nerve Diseases","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","6 phenotype datasets, 41 variables, 1 molecular datasets,  SRA, 899 subjects, 899 samples","","NCI","DS-EMD --- Disease-specific (eye movement disorders) , DS-ELMD --- Disease-specific (eye and lid movement disorders) , DS-CCDD-RD --- Disease-specific (congenital cranial dysinnervation disorders, rd)","2018-08-24","2018-08-24","Abducens Nerve Disease; Abducens palsy; Cranial Nerve VI Diseases; Lateral rectus muscle innervation disorder; Sixth Cranial Nerve Diseases; Sixth Cranial Nerve Disorders"
"phs001248.v1.p1","Gene Array to Predict Bacterial Infection with in Respiratory Illness","Accurate tests for microbiologic diagnosis of lower respiratory tract infections (LRTI) are needed. Gene expression profiling of whole blood represents a powerful new approach for analysis of the host  response during respiratory infection that can be used to supplement pathogen detection testing. Using qPCR, we prospectively validated the","Respiratory Tract Infections","Case Set","RNAseq_gene_transcripts","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 37 variables, 1 molecular datasets,  SRA, 94 subjects, 94 samples","","NIAID","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-03-10","2017-09-10","Infection, Respiratory Tract; Infections, Respiratory; Infections, Respiratory Tract; RTI - Respiratory tract infection; Respiratory Infections; Respiratory Tract Infection"
"phs001249.v1.p1","Chemosensitive Relapse in Small Cell Lung Cancer Patient-Derived    Xenografts","Genetic and epigenetic analysis of patient-derived xenograft models of acquired chemoresistance in small cell lung cancer.","Lung Neoplasms","Case Set","Not Provided","Not Applicable","ChIP-Seq, RNA-Seq, WGS, WXS","3 phenotype datasets, 21 variables, 10 subjects, 110 samples","","NCI","HMB-PUB --- Health/medical/biomedical (pub)","2017-04-03","2017-04-03","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs001250.v1.p1","Sequencing of Coding and Non-coding Regions in Primary Breast Cancers and    Patient-matched Controls","Genomic analysis of tumor samples has led to the identification of hundreds of cancer genes based on the presence of mutations in protein-coding regions. By contrast, much less is  known about cancer-causing mutations in non-coding regions. Here, we performed deep sequencing in 360 primary breast cancers and developed","Breast Neoplasms","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","SNV Aggregate (.MAF), WXS","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 360 subjects, 720 samples","","NHGRI","GRU --- General research use , DS-CA-MDS --- Disease-specific (cancer, mds) , HMB-MDS --- Health/medical/biomedical (mds)","2017-06-27","2017-06-27","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001251.v1.p1","Family-Based Study on Ulcerative Colitis with Whole Exome Sequencing","Genetic risk factors for ulcerative colitis are not well understood. We performed a family-based whole exome sequencing analysis to identify potential causal mutations. In the proband, we found a  heterozygous de novo mutation in the gene HSPA1L. Our results indicate that the de novo mutation in HSPA1L is associated with ulcerative colitis.","Colitis, Ulcerative","Family/Twin/Trios","Not Provided","Not Applicable","WGS, WXS","5 phenotype datasets, 18 variables,  SRA, 4 subjects, 4 samples","","NHGRI","GRU --- General research use","2017-02-02","2017-02-02","Colitis Gravis; Colitis ulcerosa; Idiopathic Proctocolitis; Inflammatory Bowel Disease, Ulcerative Colitis Type; UC - Ulcerative colitis; ULCERATIVE COLITIS"
"phs001252.v1.p1","Evaluation of COPD Longitudinally to Identify Predictive Surrogate    Endpoints (ECLIPSE)","ECLIPSE was a longitudinal observational study of 2164 COPD subjects and a smaller number of smoking controls (337) and nonsmoking controls (245) followed regularly for three years, with three  chest CT scans (at baseline, one year, and three years) (Vestbo, European Respiratory Journal 2008; 31: 869). Inclusion criteria included age 40-75","Pulmonary Disease, Chronic Obstructive","Case-Control","HumanHap550_v3","Not Applicable","SNP Genotypes (Array)","41 phenotype datasets, 1182 variables, 1 molecular datasets, 2746 subjects, 2159 samples","European (2123), African American (5), Hispanic1 (5), Hispanic2 (14), Other Asian or Pacific Islander (1), Other (11)","NHLBI","DS-COPD-RD --- Disease-specific (chronic obstructive pulmonary disease, rd)","2017-07-25","2017-07-25","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease"
"phs001253.v1.p1","Pharmacogenetics of Efavirenz Discontinuation for Reported CNS Symptoms","This is an evaluation of genetic associations with efavirenz (EFV) discontinuation for central nervous system (CNS) symptoms within 12 months of treatment. Patients were treated at an HIV primary  care clinic in Nashville TN from 1998 to 2012. Previously known SNPs in CYP2B6 and CYP2A6 were used to define metabolizer genotypes (extensive","Central Nervous System Diseases","Case-Control","HumanCore-12-v1-0_B","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 563 subjects, 563 samples","European (334), African (8), East Asian (2), African American (188), Hispanic1 (2), Hispanic2 (21), Other Asian or Pacific Islander (4), Other (4)","NIAID","DS-HIV-IRB --- Disease-specific (human immunodeficiency virus, irb)","2017-03-01","2017-03-01","CNS Disease; CNS Diseases; Central Nervous System Disease; Central Nervous System Disorders; Central nervous system (CNS) disease; Encephalomyeloneuropathy"
"phs001255.v1.p1","Molecular Evolution of Cancer","Recently developed methods that utilize partitioning of long genomic DNA fragments, and barcoding of shorter fragments derived from them, have succeeded in retaining long-range information in short sequencing reads.  These so-called read cloud approaches represent a powerful, accurate, and cost-effective alternative to single-molecule long-read sequencing. We","Liposarcoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","WGS","3 phenotype datasets, 11 variables, 1 subjects, 8 samples","","NCI","DS-BRCA-MDS --- Disease-specific (breast cancer, mds)","2017-06-09","2017-06-09","DDLS; Dedifferentiated Liposarcomas; Liposarcoma, Dedifferentiated"
"phs001256.v2.p1","Hypoplastic Left Heart Syndrome Study","To understand the genetic etiology of hypoplastic left heart syndrome (HLHS), patients with HLHS were consented and recruited, with blood drawn for DNA extraction and exome sequencing. Using the  exome sequencing dataset obtained, rare coding sequence variants were recovered and enrichment analysis was carried out to identify genes and","Hypoplastic Left Heart Syndrome","Case-Control","Not Provided","Not Applicable","WXS","4 phenotype datasets, 18 variables,  SRA, 68 subjects, 163 samples","","NHLBI","GRU-IRB-NPU --- General research use (irb, npu)","2017-05-16","2017-04-26","HLH - Hypoplastic left heart syndrome; HLHS; HLHS - Hypoplastic left heart syndrome; Heart left ventricle hypoplasia; Hypoplastic left heart; Left Heart Hypoplasia Syndrome"
"phs001257.v2.p1","Genetic Analysis of Tumor Samples","Antibody blockade of the inhibitory CTLA-4 pathway has led to clinical benefit in a subset of patients with metastatic melanoma. Anti-CTLA-4 enhances T cell responses, including production of IFN-,  which is a critical cytokine for host immune responses. However, the role of IFN- signaling in tumor cells in the setting of anti-CTLA-4 therapy","Melanoma","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 21 variables,  SRA, 22 subjects, 44 samples","","NCI","DS-M-PUB-NPU --- Disease-specific (melanoma, pub, npu)","2017-04-12","2017-01-18","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001258.v1.p1","Total exRNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects","There are currently few datasets describing baseline expression levels for total cell-free circulating RNA from healthy control subjects. Total extracellular RNA was isolated from plasma, urine, and saliva samples  from healthy controls. We sequenced small RNAs from 183 plasma samples, 204 urine samples and 46 saliva samples from 55 college athletes ages 18-25","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","Not Applicable","miRNA-Seq","4 phenotype datasets, 19 variables, 57 subjects, 428 samples","","NHLBI","HMB --- Health/medical/biomedical","2017-07-25","2017-07-25","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; MIR; MIRN"
"phs001259.v1.p1","CCDG CVD: VIRGO - Variation in Recover-Role of Gender on Outcomes of    Young Acute Myocardial Infarction (AMI) Patients","The VIRGO study is a four year research project funded by the NHLBI to study young women and men with heart attacks. A total of 2,000 women who are  18 - 55 years of age and a smaller comparison group of 1,000 similarly aged men will be enrolled in this multi-site observational study from","Myocardial Infarction","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 2149 subjects, 2150 samples","European (1574), African (7), East Asian (20), African American (344), Hispanic1 (48), Hispanic2 (103), Other Asian or Pacific Islander (19), South Asian (19), Other (15)","NHGRI","DS-CARD-MDS-GSO --- Disease-specific (cardiology, mds, gso)","2019-07-03","2019-07-03","Anterolateral Myocardial Infarction; Anterolateral Myocardial Infarctions; Infarction, Anterolateral Myocardial; Infarctions, Anterolateral Myocardial; Myocardial Infarction, Anterolateral; Myocardial Infarctions, Anterolateral"
"phs001260.v1.p1","Metagenomic Epidemiology of Antibiotic Resistance in Infectious Diarrhea","The study of antimicrobial resistance (AMR) in infectious diarrhea has generally been limited to cultivation, antimicrobial susceptibility testing and targeted PCR assays. When individual strains of significance are identified,  whole genome shotgun (WGS) sequencing of important clones and clades is performed. Genes that encode resistance to antibiotics have been detected in","Diarrhea","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON, WGS","4 phenotype datasets, 41 variables,  SRA, 43 subjects, 43 samples","","NIAID","HMB-IRB --- Health/medical/biomedical (irb)","2017-03-13","2017-03-13","Adenoviridae; Adenovirus; Adenovirus group; Family Adenoviridae; Alkalescens-Dispar Group; Genus Norovirus"
"phs001261.v1.p1","DNA Inverted Repeat as an at-Risk Motif of Palindromic Gene Amplification","DNA Inverted Repeats as an At-risk Motif for Palindromic Gene Amplificatio defines oncogene amplification that is configured as a series of inverted duplications (palindromic gene amplification). There are several,  recurrently amplified oncogenes throughout the human genome. However, it remains unclear whether this recurrent amplification is solely a","Breast Neoplasms","Case Set","Genome-Wide_Human_SNP_Array_6.0","Not Applicable","SNP Genotypes (Array), OTHER, WGS","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 8 subjects, 17 samples","","NCI","DS-BRCA-NPU-MDS --- Disease-specific (breast cancer, npu, mds)","2017-09-13","2017-09-13","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001262.v1.p1","PROSET-HD (Profiling of Cell Subsets in Human Disease)","PROSET-HD aims to identify and study immune cell populations altered in patients with autoimmune and inflammatory diseases. We have identified a population of PD-1hi CXCR5- 'peripheral helper' T (Tph)  cells that are expanded in the joints and circulation of patients with seropositive rheumatoid arthritis. This T cell population uniquely combines","Arthritis, Rheumatoid","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 17 variables,  SRA, 4 subjects, 32 samples","","NIAMS","HMB --- Health/medical/biomedical","2017-02-01","2017-02-01","Not Provided"
"phs001263.v1.p1","DRIVE Breast Cancer GWAS Meta-Analysis","Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) was one of five projects funded in 2010 as part of the NCI's Genetic Associations and Mechanisms in  Oncology (GAME-ON) initiative (http://epi.grants.cancer.gov/gameon/). GAME-ON's overall goal was to foster an intra-disciplinary and collaborative","Breast Neoplasms","Case-Control","Not Provided","Not Applicable","Not Provided","1 documents, 2 analyses","","NCI","DS-BRCA-MDS --- Disease-specific (breast cancer, mds)","2017-03-09","2017-03-09","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001265.v1.p1","DRIVE Breast Cancer OncoArray Genotypes","Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) was one of five projects funded in 2010 as part of the NCI's Genetic Associations and Mechanisms in  Oncology (GAME-ON) initiative (http://epi.grants.cancer.gov/gameon/). GAME-ON's overall goal was to foster an intra-disciplinary and collaborative","Breast Neoplasms","Case-Control","ConsortiumOncoArray","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 27 variables, 1 molecular datasets, 60015 subjects, 60015 samples","European (58491), African (541), African American (812), Hispanic1 (54), Hispanic2 (53), South Asian (3), Other (61)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU --- Health/medical/biomedical (pub, npu) , DS-BROC --- Disease-specific (breast and ovarian cancer) , DS-BRCA-PUB --- Disease-specific (breast cancer, pub) , DS-BCEMOPCA-NPU-MDS --- Disease-specific (breast, colorectal, endometrial, melanoma, ovarian, and/or prostate cancer, npu, mds) , DS-BOED-MDS --- Disease-specific (breast, ovarian, or endometrial disease, mds) , DS-CA --- Disease-specific (cancer) , DS-CA-NPU-GSO --- Disease-specific (cancer, npu, gso) , GRU --- General research use , HMB-PUB --- Health/medical/biomedical (pub)","2017-06-12","2017-06-12","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001266.v1.p1","Genome-Wide Analysis for Addiction Susceptibility Genes","Genome wide analysis for addiction susceptibility genes is an affected sibling pair linkage study using subjects who were patients in methadone replacement treatment programs (MMTP). Such patients are highly  addicted to opioids and usually to other addicting substances as well. For entry into the programs, patients had to be at least 18 years of age and","Opioid-Related Disorders","Family/Twin/Trios","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 41 variables, 1 molecular datasets, 1331 subjects, 645 samples","European (64), African (4), African American (176), Hispanic1 (274), Hispanic2 (24), Other (103)","NIDA","GRU --- General research use","2018-03-15","2018-03-15","Abuse, Narcotic; Abuses, Narcotic; Narcotic Abuse; Narcotic Abuses; Disorder, Drug Use; Drug Use Disorder"
"phs001270.v1.p1","Sleep and Circadian Disorders Study (SACDS)","Sleep is essential for life. A good night's sleep is pleasurable and sleep deprivation is stressful. Prolonged sleep loss impairs temperature control, metabolism, immunity, and ultimately leads to death.  Extensive observational and epidemiological evidence indicates that optimal sleep duration of 8 hours is associated with the maintenance of good","Sleep Wake Disorders","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 documents, 1 molecular datasets, 10 subjects, 10 samples","","NINDS","DS-SLCD --- Disease-specific (sleep and circadian disorders)","2017-10-06","2017-10-06","CLOCK Protein; CLOCK Proteins; Circadian Locomotor Output Cycles Kaput Proteins; Circadian Clock; Circadian Clock System; Circadian Clock Systems"
"phs001271.v1.p1","Pooled Genome-Wide Analysis of Kidney Cancer Risk (KIDRISK)","Incidence rates of renal cell carcinoma (RCC) are rising and the latest estimates show that it accounts for over 300,000 cases and 120,000 deaths worldwide each year. Mechanisms underlying  RCC occurrence are not fully understood and a large part of the disease heritability remains unexplained. The study aimed at augmenting the size of","Carcinoma, Renal Cell","Case-Control","HumanOmni5-4v1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 5307 subjects, 5307 samples","European (5208), Hispanic1 (6), Hispanic2 (1), South Asian (3), Other (89)","NCI","HMB-PUB-NPU-MDS --- Health/medical/biomedical (pub, npu, mds) , DS-CA-NPU-GSO --- Disease-specific (cancer, npu, gso) , DS-RCC-MDS --- Disease-specific (kidney cancer, mds)","2017-02-28","2017-02-28","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs001272.v1.p1","Broad Institute Center for Mendelian Genomics","The Centers for Mendelian Genomics project uses next-generation sequencing and computational approaches to discover the genes and variants that underlie Mendelian conditions. By discovering genes that cause Mendelian conditions,  we will expand our understanding of their biology to facilitate diagnosis and new treatments.","Genetic Diseases, Inborn","Family/Twin/Trios","WES_markerset_grc37","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), WGS, WXS","5 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 1031 subjects, 1037 samples","European (35)","NHGRI","GRU --- General research use , DS-KRD-RD --- Disease-specific (kidney and related disorders, rd) , HMB-MDS --- Health/medical/biomedical (mds) , DS-NIC-EMP-LENF --- Disease-specific (no insurance companies, employers, or the police until required by court order or by law)","2018-11-20","2018-11-20","BBS; Bardet Biedl Syndrome; Biedl-Bardet syndrome; LMBB - Laurence-Moon-Bardet-Biedl syndrome; Laurence Moon Bardet Biedl Syndrome; Laurence-Moon-Bardet-Biedl Syndrome"
"phs001273.v2.p2","Oncoarray Consortium - Lung Cancer Studies","The study was conducted under the auspices of the Transdisciplinary Research In Cancer of the Lung (TRICL) Research Team, which is a part of the Genetic Associations and MEchanisms  in ONcology (GAME-ON) consortium, and associated with the International Lung Cancer Consortium (ILCCO). Ethics All participants provided written","Lung Neoplasms","Case-Control","ConsortiumOncoArray","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 20 variables, 1 documents, 2 molecular datasets, 36974 subjects, 36974 samples","European (31208), African (26), East Asian (3617), African American (939), Hispanic1 (282), Hispanic2 (384), Other Asian or Pacific Islander (301), South Asian (21), Other (196)","NCI","CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB --- Health/medical/biomedical , DS-CA --- Disease-specific (cancer) , DS-CA-GSO --- Disease-specific (cancer, gso) , DS-CA-COL-NPU-MDS --- Disease-specific (cancer, col, npu, mds) , HMB-MDS-GSO --- Health/medical/biomedical (mds, gso) , DS-CALD-PUB-NPU --- Disease-specific (cancer or lung diseases, pub, npu) , GRU --- General research use , LDS --- Lung disease and smoking , GRU-COL --- General research use (col) , DS-CA-MDS --- Disease-specific (cancer, mds) , LCEDOE --- Lung cancer, environmental, diet, occupational exposures , HMB-PUB --- Health/medical/biomedical (pub) , DS-CA-PUB-NPU --- Disease-specific (cancer, pub, npu)","2018-09-26","2018-09-26","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs001275.v1.p1","Differential Gene Expression in Cryptorchid Testes","Differential Gene Expression in Cryptorchid Testes Study uses whole-genome RNA profiling of testicular biopsies to determine a potential causative role of isolated congenital cryptorchidism in azoospermia and/or infertility in  the context of our previously published GeneChip data. Cryptorchid patients, aged 7 months to 5 years and otherwise healthy, were enrolled in this","Cryptorchidism","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 24 variables, 70 subjects, 70 samples","","NICHD","DS-CRYPT-IRB-PUB-NPU-GSO --- Disease-specific (cryptorchidism, irb, pub, npu, gso)","2017-06-20","2017-06-20","CRYPTORCHIDISM; Cryptorchidism (unilateral or bilateral); Cryptorchidism, Unilateral Or Bilateral; Cryptorchism; IDT - Imperfectly descended testis; Imperfectly descended testis"
"phs001276.v1.p1","Single-cell profiling of hESC-derived interneuron development","GABAergic interneurons are essential for neural circuit function and their loss or dysfunction is implicated in human neuropsychiatric disease. In vitro methods for interneuron generation hold promise for studying  human cellular and functional properties and ultimately therapeutic cell replacement. We used a protocol for generating cortical interneurons from","Growth and Development","Control Set","RNAseq_gene_transcripts","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 4 subjects, 104 samples","","NINDS","GRU-NPU --- General research use (npu)","2017-03-10","2017-03-10","Not Provided"
"phs001277.v1.p1","NHGRI Genome Integrity of iPSCs Study","The purpose of this study is to compare mutation load in induced pluripotent stem cells derived from skin fibroblasts.","Platelet Disorder, Familial, with Associated Myeloid Malignancy","Case-Control","HumanOmniExpressExome-8v1_B","Not Applicable","SNP Genotypes (Array), Targeted-Capture, WXS","3 phenotype datasets, 12 variables, 1 molecular datasets, 2 subjects, 75 samples","","NHGRI","DS-PF-RD --- Disease-specific (platelet function, rd)","2017-11-01","2017-11-01","FPD/AML; FPDAML; FPDMM; FPS/AML; Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia; Familial platelet disorder with associated myeloid malignancy"
"phs001278.v1.p1","Longitudinal Study of the Porphyrias","This is an observational, longitudinal study of approximately 800 individuals with various types of porphyria. Those participants will be evaluated annually for 5 years, or longer if they agree.  Participation in this project will include: Participating in annual visits or contacts. Providing samples, including blood, buccal cells (cells from","Porphyrias","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","21 phenotype datasets, 5272 variables, 30 documents, 198 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-06-26","2017-06-26","Disorder of porphyrin and heme metabolism; Disorder, Porphyrin; Disorders, Porphyrin; Porphyria; Porphyrin Disorder; Porphyrin Disorders"
"phs001279.v1.p1","Cross-Sectional Characterization of Idiopathic Bronchiectasis","This GDMCC protocol will study adult patients with non-CF, idiopathic bronchiectasis, whose genetic etiologies are not known. Idiopathic bronchiectasis is reportedly more common in females with certain tall, thin  body types and associated with environmental organisms, such as nontuberculous mycobacterium (NTM). The other susceptibility factors predisposing to","Bronchiectasis","Cross-Sectional","Not Provided","Not Applicable","Not Provided","17 phenotype datasets, 2284 variables, 14 documents, 39 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-02-09","2018-02-09","Bronchiectases; Permanent enlargement of the airways of the lungs; Mycobacterium terrae; Radish bacillus"
"phs001281.v2.p1","Establish Reliability for qEEG, Transcranial Doppler and OCT in SWS","Sturge-Weber syndrome (SWS) is a rare, congenital syndrome with vascular malformations of the brain, skin and eye. The underlying cause of SWS is unknown and the extent of involvement  varies greatly from patient to patient. Those with brain involvement present with seizures, stroke-like episodes and neurologic deficits, usually in","Sturge-Weber Syndrome","Cross-Sectional","Not Provided","Not Applicable","Not Provided","14 phenotype datasets, 867 variables, 11 documents, 40 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-08-15","2017-02-27","Angiomatosis Oculoorbital-Thalamic Syndrome; Angiomatosis oculo-orbital-thalamo-encephalic syndrome; Angiomatosis, Meningo-Oculo-Facial; Encephalocutaneous angiomatosis; Encephalofacial Hemangiomatosis Syndrome; Encephalofacial angiomatosis"
"phs001282.v1.p1","Genomics of Endemic Burkitt Lymphoma","This genomic landscape of Burkitt lymphoma represents a multimodal sequencing of tumors and control tissues and individuals to better understand the etiology, and molecular pathogenesis of Burkitt lymphoma including  the roles of the associated Plasmodium falciparum malaria and EBV infections. Comprehensive sequencing set includes genomic, transcriptomic, and","Burkitt Lymphoma","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 21 variables,  SRA, 30 subjects, 30 samples","","NCI","DS-BL-PUB-NPU --- Disease-specific (burkitt lymphoma, pub, npu)","2017-02-13","2017-02-13","BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt tumor [obs]; Burkitt's Lymphoma; Burkitt's Tumor"
"phs001284.v1.p1","NCI Waldenstrom Macroglobulinemia Genome-wide Association Study","A discovery GWAS is performed, consisting of genotyping 221 Waldenstrom macroglobulinemia (WM) cases on the Illumina Omni Express 12v1.1 platform and analyzing the genotypes together with those of 3798  previously genotyped controls in a model taking into account gender, age, and principal components of ancestry (i.e., significant eigenvectors","Waldenstrom Macroglobulinemia","Case-Control","HumanOmniExpress-12v1_K, HRC1_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 17 variables, 2 molecular datasets, 217 subjects, 217 samples","European (216), Other (1)","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , GRU --- General research use","2019-08-09","2019-08-09","Lymphoma, Lymphocytic, Plasmacytoid; Lymphoma, Lymphoplasmacytoid; Lymphomas, Lymphoplasmacytoid; Lymphoplasmacytoid Lymphoma; Lymphoplasmacytoid Lymphomas; Macroglobulinaemia, Waldenstrom's"
"phs001286.v1.p1","The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)","The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large population-based randomized trial designed and sponsored by the National Cancer Institute (NCI) to determine the effects  of screening on cancer-related mortality and secondary endpoints in over 150,000 men and women aged 55 to 74. The screening component of the trial","Neoplasms","Prospective Longitudinal Cohort","Human660W-Quad_v1_A, HumanHap550-2v3_B, Human610-Quadv1_B, Human1M-Duov3_B, HumanOmniExpress-12v1_A, HumanOmni2.5-4v1_B, HumanHap300_v1.1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 13 variables, 1 molecular datasets, 13155 subjects, 13154 samples","European (11880), African (36), East Asian (66), African American (1100), Hispanic1 (30), Hispanic2 (25), Other Asian or Pacific Islander (7), South Asian (2), Other (8)","NCI","CADM --- Research relating to adults diseases and methods","2019-04-01","2019-04-01","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs001287.v4.p3","CPTAC 3 study","Recently, significant progress has been made in characterizing and sequencing the genomic alterations in statistically robust numbers of samples from several types of cancer. For example, The Cancer Genome  Atlas (TCGA), International Cancer Genome Consortium (ICGC) and other similar efforts are identifying genomic alterations associated with specific","Neoplasms","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 27 variables,  SRA, 1301 subjects, 5178 samples","","NCI","GRU --- General research use","2019-08-05","2019-03-06","Adenocarcinoma of lung; Carcinoma, squamous cell of head and neck; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal"
"phs001288.v1.p1","Evaluating the Genetic Causes and Progression of Cholestatic Liver    Diseases (LOGIC)","This longitudinal observational study will investigate the natural history and progression of four genetic causes of intrahepatic cholestasis of childhood, including alpha-1 antitrypsin deficiency (1-AT), Alagille syndrome (AGS), progressive  familial intrahepatic cholestasis (PFIC), and bile acid synthesis defects (BAD). This study will be conducted as part of the Cholestatic Liver","alpha 1-Antitrypsin Deficiency","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","24 phenotype datasets, 2842 variables, 55 documents, 264 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-11-13","2017-11-13","AHD; ALAGILLE SYNDROME; ALAGILLE-WATSON SYNDROME; ALGS; ARTERIOHEPATIC DYSPLASIA; AWS"
"phs001289.v1.p1","Characteristics of Andersen-Tawil Syndrome","Andersen-Tawil Syndrome (ATS) is a rare, genetic disorder that causes episodes of muscle weakness, potentially life-threatening changes in heart rhythm, and developmental abnormalities. Disease symptoms can vary, the cause  of some ATS cases remains unknown, and no specific treatment has been identified. The purpose of this multi-site study is to better characterize ATS","Andersen Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","16 phenotype datasets, 1814 variables, 15 documents, 29 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-01","2018-05-01","ANDERSEN SYNDROME; ANDERSEN-TAWIL SYNDROME; ATS; Andersen Cardiodysrhythmic Periodic Paralysis; Andersen Cardiodysrythmic Periodic Paralysis; Andersen Tawil Syndrome"
"phs001291.v1.p1","Neoadjuvant Trastuzumab Response in Breast Cancer","HER2 (ERBB2) gene amplification and overexpression are present in 15-30% of invasive breast cancers. While HER2-targeted agents such as trastuzumab are effective treatments, therapeutic resistance remains a concern in  HER2-positive breast cancer with 40-50% of patients having residual disease after neoadjuvant treatment with chemotherapy and trastuzumab. To","Breast Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 13 variables, 48 subjects, 234 samples","","NHGRI","DS-CA --- Disease-specific (cancer)","2018-04-24","2018-04-24","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001292.v2.p1","Sleep in Rare Disease","This research study will investigate sleep behavior in the rare neurological disorders Angelman Syndrome (AS), Rett Syndrome (RTT), Prader-Willi Syndrome (PWS) and Early-onset Morbid Obesity (EMO). Sleep is very  important to proper health and plays a critical role in learning, memory, brain development and brain function. Sleep disturbances can have negative","Angelman Syndrome","Case-Control","Not Provided","Not Applicable","Not Provided","12 phenotype datasets, 278 variables, 6 documents, 808 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-07-18","2019-07-18","AS; Angelman syndrome-like; Angelman's syndrome; Children, Puppet; HAPPY PUPPET SYNDROME; HAPPY PUPPET SYNDROME, FORMERLY"
"phs001293.v1.p1","NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy","The Hypertension Genetic Epidemiology Network Study (HyperGEN) - Genetics of Left Ventricular (LV) Hypertrophy is a familial study aimed to understand genetic risk factors for LV hypertrophy by conducting  genetic studies of continuous traits from echocardiography exams. The originating HyperGEN study aimed to understand genetic risk factors for","Hypertrophy, Left Ventricular","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 164 variables, 2 documents, 1 molecular datasets,  SRA, 2104 subjects, 2104 samples","European (1), African (67), East Asian (1), African American (1701), Hispanic1 (3)","NHLBI","GRU-IRB --- General research use (irb) , DS-CVD-IRB-RD --- Disease-specific (cardiovascular disease, irb, rd)","2019-04-26","2019-04-26","DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure; Diastolic arterial pressure; Pressure, Diastolic; Cardiac US scan"
"phs001295.v2.p1","Development and Validation of a Disability Severity Index for    Charcot-Marie-Tooth Disease","In Charcot-Marie-Tooth Disease (CMT) or inherited neuropathy research studies, it is the researcher who has selected what they believe to be important markers of impairment in function in patients.  For example, it has been inferred that the wearing of ankle-foot-orthosis (AFOs), the use of walking aids such as canes, or the use of wheelchairs","Charcot-Marie-Tooth Disease","Cross-Sectional","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 71 variables, 1 documents, 293 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-05-06","2017-07-06","Atrophies, Peroneal Muscular; Atrophy, Muscular, Peroneal; Atrophy, Peroneal Muscular; CMT/HMSN; Charcot Marie Disease; Charcot Marie Tooth Disease"
"phs001296.v2.p1","UCD Imaging Study","This is a case controlled, observational study. This project studies cognitive and motor dysfunction in adult and pediatric patients who are female carriers of ornithine transcarbamylase deficiency (OTCD) or  are males with late onset presentation (outside of the newborn period) of OTCD, utilizing state of the art MRI (magnetic resonance imaging), a non","Urea Cycle Disorders, Inborn","Case-Control","Not Provided","Not Applicable","Not Provided","9 phenotype datasets, 421 variables, 41 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-08-19","2019-08-19","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder"
"phs001297.v1.p1","PROP Functional and Lymphocytic Markers of Respiratory Morbidity in    Hyperoxic Preemies","Approximately 550,000 babies born prematurely each year in the United States suffer from birth at a time in development when the respiratory tract and immune system would normally be  protected and maintained in a na ve state. This project is a component of the NIH Prematurity and Respiratory Outcomes Program (PROP) whose goals are","Premature Infant","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 46 variables,  SRA, 277 subjects, 721 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-16","2017-06-16","Flora, Intestinal; Gut Microbiome; Gut Microbiota; Intestinal Flora; Intestinal Microbiomes; Intestinal Microbiota"
"phs001298.v1.p1","Fine Mapping of Eight Psoriasis Susceptibility Loci","Psoriasis is a common immune-mediate disease identified through scaly patches of the skin. In this study we collected genotype information on 5,067 samples of European ancestry as a follow-up  study of our initial GWAS (Nair et al. 2009). We designed an Illumina iSelect custom genotyping array with 2,269 tagging SNPs in the eight known","Psoriasis","Case-Control","iSELECT_HG19","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 4806 subjects, 4806 samples","","NIAMS","GRU-PUB --- General research use (pub) , DS-PSO-PSA-PUB --- Disease-specific (psoriasis and psoriatic arthritis, pub)","2019-01-05","2019-01-05","Acropustulosis; Chronic palmoplantar pustular psoriasis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis"
"phs001299.v1.p1","Nicotine Addiction Genetics and Correlates","Ascertainment: Families were ascertained through panels of adult Australian twins, and a sample of spouses of Australian twins. Families with at least one offspring who was identified as a  current or former smoker in an earlier survey. Screening telephone interviews were conducted with index cases to provide confirmation of a history of","Behavior, Addictive","Family/Twin/Trios","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 42 variables, 1 molecular datasets, 3508 subjects, 2452 samples","European (2428), Hispanic2 (3), Other Asian or Pacific Islander (4), Other (17)","NIDA","GRU --- General research use","2018-04-26","2018-04-26","Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs001303.v1.p1","GWAS of Sporadic and Familial Testicular Germ Cell Tumors","Case-Control Study: Testicular germ cell cancer has been increasing among men during most of the 20th century. Despite this increase, the etiology of testicular cancer is poorly understood. To  better understand the molecular epidemiology of testicular cancer, the National Cancer Institute and the Department of Defense are conducting a case","Germinoma","Case-Control","HumanHap550_v1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 1509 subjects, 1556 samples","European (1354), East Asian (10), African American (40), Hispanic1 (24), Hispanic2 (64), Other Asian or Pacific Islander (10), South Asian (1), Other (6)","NCI","GRU --- General research use , DS-TGCT-COL-MDS --- Disease-specific (testicular cancer, col, mds)","2017-10-26","2017-10-26","Not Provided"
"phs001305.v1.p1","Buphenyl and Low-Dose Arginine Vs. High-Dose Arginine in Patients with    ASA","Individuals with Urea Cycle Disorders (UCD) cannot remove ammonia, a waste product, from the blood. At present there is little information on the use of sodium phenylbutyrate (Buphenyl )  in children with argininosuccinic aciduria (ASA). It is hoped that this drug may help lower ammonia and argininosuccinic acid levels in patients with","Urea Cycle Disorders, Inborn","Interventional","Not Provided","Not Applicable","Not Provided","12 phenotype datasets, 313 variables, 8 documents, 12 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-01-19","2018-01-19","Disorder of urea cycle; Disorder, Urea Cycle; Disorders, Urea Cycle; Inborn Urea Cycle Disorder; UCD; Urea Cycle Disorder"
"phs001306.v1.p1","Large Scale Meta-analysis Characterizes Genetic Architecture for Common    Psoriasis-associated Variants","The genotypes obtained from the Affymetrix Biobank Plus array constituted one of eight Caucasian datasets used in a large genome-wide meta-analysis of the association of psoriasis cases versus unaffected  controls. With a combined effective sample size of 39,000 individuals, this study identified 16 new psoriasis loci achieving genome-wide significance","Psoriasis","Case-Control","Axiom_PsorMich","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 23 variables, 1 analyses, 1 molecular datasets, 11675 subjects, 11675 samples","European (9664), Hispanic1 (18), Other (13)","NIAMS","GRU-PUB --- General research use (pub) , DS-PSO-PUB --- Disease-specific (psoriasis, pub)","2018-07-13","2018-07-13","Acropustulosis; Chronic palmoplantar pustular psoriasis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis"
"phs001309.v1.p1","MICEPAP Trial","The purpose of this study is to (1) compare a technically improved assay with an existing assay used to measure serum anti-GM-CSF antibodies in stored serum samples previously obtained  from patients diagnosed with either primary, secondary, congenital or idiopathic pulmonary alveolar proteinosis (PAP), other chronic diseases or","Pulmonary Alveolar Proteinosis","Clinical Trial","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 384 variables, 13 documents, 159 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-22","2018-05-22","Not Provided"
"phs001310.v1.p1","PCD Longitudinal Prior to 10","Primary Ciliary Dyskinesia (PCD) is a genetic defect in airway host-defense, and typically results in chronic infection of the airways. Patients with PCD have chronic lung, sinus and ear  infections. This longitudinal study is designed to define the rate of progression of PCD lung function in participants prior to 10 years of age using","Kartagener Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","12 phenotype datasets, 1268 variables, 13 documents, 56 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-10-23","2017-10-23","Bronchiectasis, chronic sinusitis AND dextrocardia syndrome; DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS; KARTAGENER SYNDROME; Kartagener Triad; Kartagener's Syndrome; Kartagener's Triad"
"phs001311.v1.p1","Mexiletine in Non-Dystrophic Myotonia","Non-dystrophic myotonias are a group of rare muscle disorders caused by abnormalities in different muscle cell membrane proteins. Patients experience delayed muscle relaxation that causes impaired physical activity, stiffness,  and pain. Mexiletine has been shown to be beneficial for symptoms of myotonia in case reports of patients with non-dystrophic myotonia, however","Myotonia","Case Set","Not Provided","Not Applicable","Not Provided","20 phenotype datasets, 647 variables, 15 documents, 62 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-22","2018-05-22","Delayed relaxation of muscle fibers after contraction; Myotonias"
"phs001313.v1.p1","Examining Genetic Differences Among People With 21-Hydroxylase Deficiency","CAH is a genetic steroidogenesis disorder. The most common form, 21OHD, leads to cortisol deficiency and, in turn, an excess of androgen, a hormone that promotes the development and  maintenance of male sex characteristics. As a result of this androgen excess, prepubescent males and newborn, prepubescent, and grown females exhibit","Adrenal Hyperplasia, Congenital","Clinical Trial","Not Provided","Not Applicable","Not Provided","8 phenotype datasets, 584 variables, 9 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-25","2018-05-25","Not Provided"
"phs001314.v1.p1","OPG in CAH","21-hydroxylase deficiency (21-OHD) is an inherited disorder that results from a mutation on the CYP21A2 gene. It affects the adrenal glands and is the most common cause of congenital  adrenal hyperplasia (CAH). 21-OHD CAH causes the body to produce an insufficient amount of cortisol and an excess of androgen, the type of hormone","Steroid 21-Hydroxylase","Case-Control","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 97 variables, 4 documents, 17 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-07-02","2018-07-02","21 Hydroxylase; 21-Hydroxylase; Cytochrome P 450 21 Hydroxylase; Cytochrome P 450 CYP21; Cytochrome P 450 c21; Cytochrome P-450 21-Hydroxylase"
"phs001315.v1.p1","GECCO: Detecting Common and Rare Genetic Loci and GxE Interactions in    Colorectal Cancer","COLON, Colorectal Cancer: Longitudinal Observational study on Nutritional and lifestyle factors that influence colorectal tumor recurrence, survival and quality of life: The COLON study is a multi-center prospective cohort  study to assess the role of diet and other lifestyle factors in cancer recurrence and survival among incident colorectal cancer patients in the","Colorectal Neoplasms","Case-Control","HumanOmniExpressExome-8v1-2_A, HRC1_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 24 variables, 2 molecular datasets, 8725 subjects, 9101 samples","European (8607), African (1), East Asian (17), African American (23), Hispanic1 (11), Hispanic2 (6), Other Asian or Pacific Islander (18), Other (42)","NCI","GRU --- General research use , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-PUB-NPU --- Disease-specific (colorectal cancer, pub, npu) , HMB-PUB --- Health/medical/biomedical (pub)","2018-05-23","2018-05-23","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001316.v1.p1","TAPP-ATS","Andersen-Tawil syndrome (ATS) is an ion channel disorder that causes episodes of muscle weakness and potentially life-threatening heart arrhythmias. The majority of ATS cases are caused by a mutation  in the KCNJ2 gene, which is linked to potassium channels in the heart, brain, and skeletal muscle; other cases are presumed to be caused by an","Andersen Syndrome","Clinical Trial","Not Provided","Not Applicable","Not Provided","15 phenotype datasets, 651 variables, 11 documents, 3 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-06-22","2018-06-22","ANDERSEN SYNDROME; ANDERSEN-TAWIL SYNDROME; ATS; Andersen Cardiodysrhythmic Periodic Paralysis; Andersen Cardiodysrythmic Periodic Paralysis; Andersen Tawil Syndrome"
"phs001317.v1.p1","Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated    Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing    to 21-Hydroxylase Deficiency","Summary The purpose of this study is to perform the first long-term follow up study both of adolescents and young adults with a history of prenatal treatment with dexamethasone  and of their mothers and to test for adverse medical or behavioral side effects. The emphasis will be on the outcome of this prenatal treatment in","Adrenal Hyperplasia, Congenital","Clinical Trial","Not Provided","Not Applicable","Not Provided","8 phenotype datasets, 458 variables, 8 documents, 166 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-06-13","2018-06-13","Not Provided"
"phs001318.v1.p1","Phase I/II Study of Revlimid/Azacitidine","This single-arm study design has been selected to investigate the safety of combination therapy with Vidaza (azacitidine) and Revlimid (lenalidomide) in a population of 18 participants with advanced MDS  for the Phase I portion, and 18 participants for the Phase II portion. The multi-center nature of the study should enhance the general applicability","Myelodysplastic Syndromes","Case Set","Not Provided","Not Applicable","Not Provided","24 phenotype datasets, 3105 variables, 17 documents, 50 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-06-22","2018-06-22","Hematopoetic Myelodysplasia; Hematopoetic Myelodysplasias; Myelodysplasia, Hematopoetic; Myelodysplasias, Hematopoetic"
"phs001319.v1.p1","Glioma International Case Control Study (GICC)","The main goals of the GICC Study were: 1) to identify novel genetic risk variants for glioma, as well as validate variants implicated by previous genome-wide association studies of  glioma; and 2) to explore biologically relevant gene-gene and gene-environment interactions in glioma susceptibility. The GICC Study includes","Glioma","Case-Control","ConsortiumOncoArray","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 7566 subjects, 7566 samples","European (7500), Hispanic1 (18), Hispanic2 (26), South Asian (1), Other (21)","NCI","GRU --- General research use , DS-BT --- Disease-specific (brain tumors) , DS-GL-PUB --- Disease-specific (glioma, pub) , DS-GL --- Disease-specific (glioma) , GRU-COL --- General research use (col) , DS-CA --- Disease-specific (cancer) , DS-GLRC --- Disease-specific (glioma and related conditions)","2017-03-31","2017-03-31","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia"
"phs001320.v1.p1","Investigating Human Placentation and Pregnancy Using First Trimester    Chorionic Villi","Chorionic villus sampling (CVS) is routinely used for prenatal diagnosis of cytogenetic disorders, but also possesses great potential for studying placentation. To better understand villi biology, human placentation, and  how these relate to pregnancy outcomes, we examined the morphology and transcriptomes of villi obtained via CVS from 10-14 weeks of pregnancy and","Pre-eclampsia","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 18 variables, 1 documents, 1 molecular datasets,  SRA, 59 subjects, 59 samples","","NICHD","GRU-IRB-PUB-COL --- General research use (irb, pub, col)","2017-05-24","2017-05-24","abnormalities; anomalies; Diabetes Mellitus, Gestational; Diabetes in Pregnancy; Diabetes mellitus arising in pregnancy; Diabetes, Gestational"
"phs001321.v1.p1","Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)","The data come from 40 studies participating in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). CIMBA recruits individuals with pathogenic mutations in BRCA1 or BRCA2. The majority  of carriers were recruited through cancer genetics clinics offering genetic testing, and were enrolled into national or regional studies. The","Breast Neoplasms","Prospective Longitudinal Cohort","ConsortiumOncoArray","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 19 variables, 1 molecular datasets, 11841 subjects, 11841 samples","European (11666), East Asian (125), Hispanic1 (13), Hispanic2 (8), South Asian (1), Other (28)","NCI","GRU --- General research use , GRU-IRB --- General research use (irb) , GRU-NPU --- General research use (npu) , CABNHD-MDS --- Cancer, benign neoplasms, or hematopoietic diseases (mds) , DS-BRCA-MDS --- Disease-specific (breast cancer, mds) , DS-BROC-MDS-GSO --- Disease-specific (breast and ovarian cancer, mds, gso) , DS-BROC-NPU --- Disease-specific (breast and ovarian cancer, npu) , DS-CA-MDS --- Disease-specific (cancer, mds) , DS-CA-MDS-GSO --- Disease-specific (cancer, mds, gso)","2017-09-11","2017-09-11","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001322.v2.p1","NINDS Inherited Forms of Motor Neuron Disease Study","Sequencing data from primary fibroblasts were obtained from individuals with a family history of an inherited form of motor neuron disease.","Amyotrophic Lateral Sclerosis 4, Juvenile","Family/Twin/Trios","Not Provided","Not Applicable","Bisulfite-Seq, OTHER, RNA-Seq","12 subjects, 26 samples","","NINDS","","","","ALS4; AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; Distal hereditary motor neuropathy with upper motor neuron signs; NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES; SETX-Related Amyotrophic Lateral Sclerosis; dHMN with upper motor neuron signs"
"phs001325.v2.p1","NextGen Consortium: The iPSCORE (iPSC Collection for Omic Research)    Resource - Whole Genome Sequence","The iPSCORE Resource of human induced pluripotent stem cells (hiPSCs) was created as part of the Next-Gen Consortium funded by the NHLBI. The overarching purpose of the iPSCORE Resource  is to provide a large collection of hiPSCs for use in studying the impact of genetic variation on molecular and physiological phenotypes. This","Heart Diseases","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 44 variables, 2 molecular datasets,  SRA, 273 subjects, 291 samples","European (187), African (1), East Asian (21), African American (5), Hispanic1 (4), Hispanic2 (12), Other Asian or Pacific Islander (21), South Asian (6), Other (16)","NHLBI","GRU-NPU --- General research use (npu) , DS-CMP-NPU-MDS --- Disease-specific (cardiomyopathy, npu, mds) , DS-CMP-MD-NPU-MDS --- Disease-specific (cardiomyopathy and mitochondrial disease, npu, mds)","2019-02-22","2019-02-22","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Cardiac Disease; Cardiac Diseases"
"phs001326.v1.p1","A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID    Since January 1, 1968","Individuals with a past diagnosis of severe combined immune deficiency (including many cases of ""leaky SCID"", Omenn syndrome, and reticular dysgenesis) who have undergone blood and marrow transplant, gene  therapy, or enzyme replacement in the past may be eligible for 6902. The purpose of 6902 is very similar to 6901, except 6902 is looking backwards at","Severe Combined Immunodeficiency","Cross-Sectional","Not Provided","Not Applicable","Not Provided","35 phenotype datasets, 2847 variables, 35 documents, 748 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-06-26","2018-06-26","Bubble boy disease; Combined Immunodeficiencies, Severe; Combined Immunodeficiency, Severe; Combined T-cell and B-cell immunodeficiency; Immunodeficiencies, Severe Combined; Immunodeficiency Syndrome, Severe Combined"
"phs001327.v1.p1","Childhood Cancer Survivor Study (CCSS)","Background and Rationale for the Childhood Cancer Survivor Study (CCSS) Over the last several decades, advances in treatments for childhood and adolescent cancer have substantially improved survival following diagnosis.  These improvements gave rise to the responsibility for investigating long-term treatment-associated morbidity and mortality. Early efforts to","Neoplasm","Prospective Longitudinal Cohort","1000G_ref_panel","Not Applicable","SNP/CNV Genotypes (imputed)","4 phenotype datasets, 18 variables, 1 molecular datasets, 5739 subjects, 5739 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2017-09-07","2017-09-07","Bone Diseases; Cognitive Decline; Cognitive Declines; Cognitive decline, progressive; Decline, Cognitive; Declines, Cognitive"
"phs001328.v1.p1","Longitudinal Studies of Brain Structure and Function in MPS Disorders","Mucopolysaccharidosis (MPS) types I, II, IV, VI and VII, are inherited diseases that result from the bodies inability to break down large sugar molecules that are by-products of metabolism.  MPS affects most organs of the body and causes abnormalities in the liver, spleen, bones, and brain. We are studying the central nervous system","Mucopolysaccharidoses","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","17 phenotype datasets, 2444 variables, 24 documents, 93 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-06-02","2017-06-02","Alpha-L-Iduronidase deficiency; Attenuated MPS I (subtype); Hurler syndrome (former subtype); Hurler-Scheie syndrome (former subtype); IDUA deficiency; L-iduronidase deficiency"
"phs001329.v2.p1","The Natural History of Mucolipidosis Type IV","Mucolipidosis type IV (MLIV) is an autosomal recessive disorder typically characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual  impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. The purpose of this research study is","Mucolipidosis IV","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","14 phenotype datasets, 2868 variables, 13 documents, 5 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-05-15","2019-05-15","I Cell Disease; I-CELL DISEASE; I-Cell Diseases; I-cell - Inclusion cell disease; ICD; Inclusion Cell Disease"
"phs001330.v1.p1","Characterizing Phenotype(s) in MPS III","Mucopolysaccharidosis III (MPSIII) syndrome is characterized by a severe cognitive decline ending in dementia and death. MPSIII is also associated with a range of abnormal and disruptive behaviors that  can include, but go well beyond, childhood noncompliance and oppositionality. The purpose of this study is to conduct a cross-sectional investigation","Mucopolysaccharidosis III","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","14 phenotype datasets, 962 variables, 11 documents, 27 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-18","2018-05-18","MPS3; MPSIII; Mucopoly-saccharidosis type 3; Mucopolysaccharidosis 3; Mucopolysaccharidosis IIIs; Mucopolysaccharidosis Type III"
"phs001331.v2.p1","Immune Mediated Disorders after Allo-HCG","Allogeneic hematopoietic cell transplantation (HCT) is the only known curative option for many hematologic disorders. After transplantation, many patients develop immune mediated disorders that may be life-threatening. Post-HCT immune  mediated disorders are rare relative to other diseases but the prototype of graft versus host disease (GVHD) develops in 30-70% of patients. The","Graft vs Host Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","21 phenotype datasets, 1251 variables, 21 documents, 1023 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-09-16","2019-09-16","Bronchiolitides, Exudative; Bronchiolitis, Exudative; Exudative Bronchiolitides; Exudative Bronchiolitis; Disease, Graft-Versus-Host; Disease, Graft-vs-Host"
"phs001332.v1.p1","Spinocerebellar Ataxias Natural History","Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of SCA and this study will focus on types 1,  2, 3, and 6 (SCA 1, SCA 2, SCA 3, also known as Machado-Joseph disease and SCA 6). The diseases are rare, slowly progressive, cause increasingly","Spinocerebellar Ataxias","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","20 phenotype datasets, 3288 variables, 18 documents, 301 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-02-16","2018-02-16","3s, Spinocerebellar Ataxia; AZOREAN NEUROLOGIC DISEASE; Ataxia 3, Spinocerebellar; Ataxia 3s, Spinocerebellar; Atrophy III, Spinocerebellar; Atrophy IIIs, Spinocerebellar"
"phs001333.v2.p1","Natural History in Fabry Renal Disease","Fabry disease is a rare genetic disease with deficient activity of an enzyme, which leads to accumulation of inclusions in different organs including kidney, heart and vessels. The purpose  of the study is to conduct a cross-sectional investigation of the natural history of Fabry renal disease and measure renal function and renal","Fabry Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","8 phenotype datasets, 561 variables, 8 documents, 21 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","","","ALPHA-GALACTOSIDASE A DEFICIENCY; ANDERSON-FABRY DISEASE; ANGIOKERATOMA CORPORIS DIFFUSUM; Anderson Fabry Disease; Angiokeratoma Diffuse; Angiokeratoma corporis diffusum universale"
"phs001336.v1.p1","ECLS Survival in Pediatric HCT Recipient with Presumed Cardiac GVHD","We report the case of a 15-year-old female with hypodiploid pre-B acute lymphoblastic leukemia status post allogeneic hematopoietic stem cell transplantation (HCT) from a matched unrelated male donor who  presented on transplant day +75 with cardiac arrest due to ventricular fibrillation associated with fulminant myocarditis. Using conventional","Bone Marrow Transplantation","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 19 variables, 1 documents,  SRA, 1 subjects, 1 samples","","NICHD","HMB-IRB-PUB-COL-MDS-GSO --- Health/medical/biomedical (irb, pub, col, mds, gso)","2017-05-23","2017-05-23","BMT - Bone marrow transplant; Bone Marrow Grafting; Bone Marrow Transplant; Bone marrow graft; Grafting, Bone Marrow; Marrow Transplantation"
"phs001338.v1.p1","Tibetan Population History and High Altitude Adaptation Study","Due to a unique adaptation to high altitude, the Tibetan Plateau population has been the subject of much research interest. In this study, we conducted whole genome sequencing of  27 Tibetan individuals. Through our analysis, we inferred a detailed history of demography and revealed the natural selection of Tibetan population","Not Provided","Control Set","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 12 variables, 1 documents, 1 molecular datasets, 27 subjects, 27 samples","East Asian (3), Other Asian or Pacific Islander (24)","NHLBI","GRU-IRB --- General research use (irb)","2017-07-03","2017-07-03",""
"phs001341.v1.p1","NextGen Consortium: iPS Derived Hepatocytes Study (PhLiPS Study)","The goal of the PhLiPS study is to create a library of induced pluripotent stem cell (iPSC) lines and iPSC-derived hepatocytes of diverse genotypes for use in metabolic profiling  and interrogating lipid phenotypes. These cell lines were created as a part of the Next Generation Genetic Association Studies (Next Gen) Program","Lipids","Prospective Longitudinal Cohort","HumanCoreExome-24v1-0_A","Not Applicable","SNP Genotypes (Array), RNA-Seq","5 phenotype datasets, 28 variables, 1 molecular datasets, 90 subjects, 264 samples","European (46), African (4), African American (35), Hispanic2 (2), South Asian (2)","NHLBI","GRU --- General research use","2018-05-04","2018-05-04","(3beta)-Cholest-5-en-3-ol; Cholest-5-en-3-ol (3beta)-; Cholesterol, HDL2; HDL cholesterol 2; HDL(2) Cholesterol; HDL2 Cholesterol"
"phs001342.v1.p1","Genetic Susceptibility to Statin-Induced Myopathy","Severe myopathic events occur in 0.1-0.5% of patients taking statins. Although genetic association studies have identified some possibly associated gene loci, these have not been reproducible in additional studies  with independent patient cohorts. A more reasonable explanation for susceptibility to statin-induced myopathy is the presence of rare pathogenic","Myopathy","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 46 subjects, 46 samples","","NHLBI","DS-MP-IRB-NPU-GSO --- Disease-specific (myopathy, irb, npu, gso)","2018-09-06","2018-09-06","CPT II Deficiency; CPT2; CPT2 - Carnitine palmitoyltransferase II deficiency; CPTII; CPTII - Carnitine palmitoyltransferase deficiency type II; Carnitine Palmitoyltransferase 2 Deficiency"
"phs001343.v1.p1","Biological Insights from the genome Sequences of Human Embryonic Stem    Cell Lines","Human embryonic stem cells (hESCs) are a powerful tool for the study of human development and can form the basis of cellular disease models or therapies. However, the genetic  make-up and stability of hESCs has not been systematically studied at a genome-wide level with single nucleotide resolution. We therefore sequenced","Human Embryonic Stem Cells","Control Set","Not Provided","Not Applicable","WXS","3 phenotype datasets, 13 variables,  SRA, 125 subjects, 125 samples","","NIGMS","GRU --- General research use , HMB --- Health/medical/biomedical","2017-05-11","2017-05-11","Cells, Human Embryonic Stem; Human Embryonic Stem Cell; Stem Cells, Human Embryonic; hESCs"
"phs001344.v1.p1","GnRH Agonist-Induced Ovarian Suppression and Ovarian Steroids in PMDD and    Controls","In this study, lymphoblastoid cell line cultures (LCLs) from women with premenstrual dysphoric disorder (PMDD) and asymptomatic controls were compared via whole-transcriptome sequencing (RNA-seq) during untreated (ovarian steroid-free) conditions  and after estradiol and progesterone treatment. In untreated LCLs, pathway analysis of the LCL transcriptome revealed, among others, over-expression","Premenstrual Dysphoric Disorder","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 18 variables,  SRA, 22 subjects, 52 samples","","NIMH","GRU --- General research use","2018-05-15","2018-05-15","Disorder, Premenstrual Dysphoric; Dysphoric Disorder, Premenstrual; Premenstrual Dysphoric Syndrome; Syndrome, Premenstrual Dysphoric"
"phs001345.v1.p1","NHLBI TOPMed: Genetic Epidemiology Network of Arteriopathy (GENOA)","The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of four networks in the NHLBI Family-Blood Pressure Program (FBPP). GENOA's long-term objective is to elucidate the genetics of target  organ complications of hypertension, including both atherosclerotic and arteriolosclerotic complications involving the heart, brain, kidneys, and","Hypertension","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 1 molecular datasets,  SRA, 1854 subjects, 1266 samples","African (42), African American (1095), Hispanic1 (4), Other (2)","NHLBI","DS-ASC-RF-NPU --- Disease-specific (arteriosclerosis and its risk factors, npu)","2019-03-08","2019-03-08","Aging, Biological; Biological Aging; Arterial Pressure, Mean; Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure"
"phs001346.v1.p1","Human Gene Expression Patterns Associated with Experimental P. falciparum    Infection","Description: Experimental exposure to malaria parasites can lead to development of protective immunity, providing a foothold for the development of a malaria vaccine. The goal of this study is  to investigate immune transcriptional profiles associated with malaria protective immune responses induced by experimental Chemo-Prophylaxis and","Malaria","Clinical Trial","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 21 variables, 15 subjects, 219 samples","","NIAID","DS-MALARIA-IRB --- Disease-specific (malaria, irb)","2019-04-01","2019-04-01","Analyses, Transcript Expression; Analyses, Transcriptome; Analysis, Transcript Expression; Analysis, Transcriptome; Gene Expression Monitoring; Gene Expression Monitorings"
"phs001347.v2.p1","Prematurity, Respiratory Outcomes, Immune System, and Microbiome Study    (PRISM)","Public health importance: Babies born preterm, approximately 1 out of every 9 live births in the United States, have significant respiratory morbidity over the first two years of life,  exacerbated by respiratory viral infections. Many ( 50%) return to pediatricians, emergency rooms and pulmonologists with symptoms of respiratory","Infant, Premature","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 33 variables,  SRA, 270 subjects, 2938 samples","","NIAID","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2018-01-11","2017-09-20","Flora, Intestinal; Gut Microbiome; Gut Microbiota; Intestinal Flora; Intestinal Microbiomes; Intestinal Microbiota"
"phs001348.v2.p1","Biesecker Lab (NHGRI) Whole Genome Medical Sequencing for Gene Discovery","We aim to use whole-genome medical sequencing (WGMS) to discover causative molecular lesions for a set of rare, severe phenotypes hypothesized to be caused by either somatic mutations, germline  de nova heterozygous mutations, germline inherited recessive, or germline inherited dominant mutations in currently unknown or uncharacterized genes","Not Provided","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS), Targeted-Capture, WXS","5 phenotype datasets, 22 variables, 2 molecular datasets,  SRA, 45 subjects, 45 samples","","NHGRI","HMB --- Health/medical/biomedical","2017-12-13","2017-12-13",""
"phs001349.v1.p1","Meta-Analysis of Five Genome-Wide Association Studies of TGCT","The international TEsticular CAncer Consortium (TECAC) combined information from five GWAS (3,558 TGCT cases and 13,970 controls) to identify novel susceptibility loci. Using observed and imputed data, we conducted  a fixed effects meta-analysis, including the first analysis of the X chromosome. Eight new loci mapping to 2q14.2, 3q26.2, 4q35.2, 7q36.3, 10q26.13","Testicular Germ Cell Tumor","Case-Control","Not Provided","Not Applicable","Not Provided","1 documents, 1 analyses","","NCI","DS-TGCT-PUB-MDS --- Disease-specific (testicular cancer, pub, mds)","2017-08-14","","Genetic Loci; Genetic Locus; Loci, Genetic; Locus, Genetic"
"phs001352.v1.p1","Metagenomics-Guided Pathogen Discovery in Travelers' Diarrhea","Traveler's diarrhea (TD) is caused by enterotoxigenic Escherichia coli (ETEC), other pathogenic gram-negative pathogens, norovirus and some parasites. Nevertheless, standard diagnostic methods fail to identify pathogens in more than  30% of TD patients, so it is predicted that new pathogens or groups of pathogens may be causative agents of disease. A comprehensive metagenomic","Diarrhea","Case-Control","Not Provided","Not Applicable","AMPLICON, WGS","4 phenotype datasets, 17 variables, 30 subjects, 30 samples","","NIDDK","GRU-IRB --- General research use (irb)","2017-10-27","2017-10-27","Adenoviridae; Adenovirus; Adenovirus group; Family Adenoviridae; Alkalescens-Dispar Group; Genus Norovirus"
"phs001357.v1.p1","The Genomic Landscape of Tuberous Sclerosis Complex (TSC)","In this study, we characterized the genomic landscape of tuberous sclerosis complex (TSC), a rare genetic disease causing multisystem growth of benign tumors and other hamartomatous lesions. We analyzed  127 human tissues, including 111 TSC-associated samples and 16 non-TSC negative controls, using multiple genomic platforms including whole exome","Tuberous Sclerosis","Case-Control","HumanOmni2.5-8v1_C, HumanMethylation450","Not Applicable","Methylation (CpG), SNP Genotypes (Array), RNA-Seq, Targeted-Capture, WXS","4 phenotype datasets, 22 variables, 1 documents, 1 molecular datasets,  SRA, 74 subjects, 424 samples","","NHGRI","GRU --- General research use","2017-10-13","2017-10-13","Adenoma sebaceum syndrome; Bourneville Disease; Bourneville Phacomatosis; Bourneville Phakomatosis; Bourneville Pringle Disease; Bourneville Pringle's Disease"
"phs001359.v1.p1","NHLBI TOPMed: Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)","The GOLDN study was initiated to assess how genetic factors interact with environmental (diet and drug) interventions to influence blood levels of triglycerides and other atherogenic lipid species and  inflammation markers (registered at clinicaltrials.gov, number NCT00083369). The study recruited Caucasian participants primarily from three","Lipids","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets,  SRA, 1069 subjects, 1064 samples","European (891), Hispanic1 (3), Other Asian or Pacific Islander (2), Other (2)","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2019-02-14","2019-02-14","Acute Phase Glycoproteins; Acute-Phase Glycoproteins; Glycoproteins, Acute-Phase; ACRP30 Protein; Adipocyte Complement Related Protein 30 kDa; Adipocyte Complement-Related Protein 30-kDa"
"phs001361.v2.p1","Genetics of Age-Related Macular Degeneration in the Amish","Identifying genetic risk loci for Age-Related Macular Degeneration is important. Most of the loci identified to date have been found through the interrogation of common variants. This study initiates  the identification of rare variants in a founder population, the Amish, and will use genotyping of known risk loci and ultimately use the whole exome","Macular Degeneration","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","1 documents, 2 analyses","","NEI","GRU-IRB --- General research use (irb)","2019-02-06","2019-02-06","AAMD - Age related macular degeneration; AMD; AMD - Age-related macular degeneration; ARMD; ARMD - Age-related macular degeneration; Age Related Macular Degeneration"
"phs001362.v1.p1","Linked Read Sequencing of Gastric Cancer Metastases","In this study, linked read sequencing was performed on two ovarian metastases and matched normal tissue, from a patient with primary diffuse gastric cancer. Linked read sequencing is a  DNA preparation technology whereby high molecular weight molecules of DNA are uniquely barcoded prior to fragmentation and sequencing, thus retaining","Stomach Neoplasms","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 16 variables,  SRA, 1 subjects, 3 samples","","NHGRI","HMB-PUB-NPU-MDS --- Health/medical/biomedical (pub, npu, mds)","2017-06-09","2017-06-09","Cancer metastatic to ovary; Carcinoma, Krukenberg; Krukenberg Carcinoma; Krukenberg Neoplasm; Krukenberg's Tumor; Krukenbergs Tumor"
"phs001363.v1.p1","The Pioneer 100 Wellness Project (P100)","108 individuals (age 21-89+ years; 59% males, 41% females; 89% Caucasian; not recruited based on any specific phenotype) participated in an IRB-approved study from April 2014 to January 2015.  Each individual had the genome sequenced in full. Blood was collected in clinics every three months. Additionally, participants completed at-home","Health","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 22 variables, 1 molecular datasets,  SRA, 108 subjects, 107 samples","European (92), East Asian (7), African American (2), Hispanic2 (1), Other Asian or Pacific Islander (2), South Asian (1), Other (2)","NIGMS","GRU-IRB-PUB-COL-NPU --- General research use (irb, pub, col, npu)","2017-08-30","2017-08-30","CF; Genetic Predisposition; Genetic Predisposition to Disease; Genetic Predispositions; Genetic Susceptibilities; Genetic Susceptibility"
"phs001364.v1.p1","Mapping the Human Connectome: Structure, Function, and Heritability","The Human Connectome Project (HCP) has acquired vast amounts of data about the pattern of long-distance connections (wiring) in the brains of large numbers of healthy participants aged 22-35  using cutting-edge MRI and MEG neuroimaging, and extensive behavioral testing. Types of MR data collected included diffusion MRI (dMRI), resting","Connectome","Control Set","1000G_ref_panel, MEGAEx_Immunov2_0_Psych, Neuro_Consortium_20013217_A2","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 22 variables, 4 molecular datasets, 1142 subjects, 1142 samples","European (781), African (3), East Asian (38), African American (183), Hispanic1 (12), Hispanic2 (72), Other Asian or Pacific Islander (23), South Asian (14), Other (15)","NIMH","GRU-IRB-PUB --- General research use (irb, pub)","2018-03-01","2018-03-01","Behavioral Research; Research, Behavioral; Connectomes; Human Volunteer; Human Volunteers; Volunteer, Human"
"phs001365.v1.p1","Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics","Neoadjuvant chemotherapy (NAC) for breast cancer is widely employed. We performed genome-wide association studies (GWAS) to determine if germline genetic variability was associated with benefits, in terms of pathological  complete response (pCR), disease-free survival (DFS), and overall survival (OS), in patients entered on the NSABP B-40 NAC (National Surgical","Breast Neoplasms","Case-Control","HumanOmniExpressExome-8v1-2_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 31 variables, 1 molecular datasets, 920 subjects, 920 samples","European (676), African (7), East Asian (6), African American (111), Hispanic1 (33), Hispanic2 (64), Other Asian or Pacific Islander (10), South Asian (3), Other (10)","NIGMS","GRU --- General research use","2018-05-01","2018-05-01","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001366.v1.p1","Pilot Study of Exome and mRNA Profiling in Small Cell Lung Cancer    Patients","In this prospective study, custom genome-wide exome and whole transcriptome sequencing (NGS) was used to identify genomic events and associated expression changes in advanced Small Cell Lung Cancer (SCLC)  and attempt to prescribe systemic therapy based on the results. Tumor/normal pairs were sequenced from 12 patients with advanced SCLC for this study.","Small Cell Lung Carcinoma","Case Set","WES_markerset_grc37","Not Applicable","RNA-Seq, CNV Genotypes, SNV (.MAF), WXS","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 12 subjects, 35 samples","","NHGRI","DS-LC-PUB-MDS --- Disease-specific (lung cancer, pub, mds)","2018-01-08","2018-01-08","Carcinoma, Small Cell Lung; Lung Small Cell Neuroendocrine Carcinoma; Oat Cell Carcinoma of Lung; Oat Cell Lung Cancer; SCCL; SCLC"
"phs001367.v1.p1","Add Health: The National Longitudinal Study of Adolescent to Adult Health    (Add Health)","The National Longitudinal Study of Adolescent to Adult Health [Add Health] is an ongoing longitudinal study of a nationally representative U.S. cohort of more than 20,000 adolescents in grades  7-12 (aged 12-19 years) in 1994 followed into adulthood with five interviews/surveys in 1995, 1996, 2001-02, 2008, and 2016-18. Add Health was","Adolescent Health","Prospective Longitudinal Cohort","HumanOmni1-Quad_v1-0_H, 1000G_ref_panel, HRC1_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","5 phenotype datasets, 24 variables, 1 documents, 2 molecular datasets, 9974 subjects, 19948 samples","European (6031), African (40), East Asian (221), African American (2049), Hispanic1 (280), Hispanic2 (873), Other Asian or Pacific Islander (292), South Asian (16), Other (172)","NICHD","GRU-IRB-PUB-GSO --- General research use (irb, pub, gso)","2018-09-12","2018-09-12","Health, Adolescent; Health, Teen; AI - Alcohol intake; Alcohol Consumption; Alcohol Drinking; Alcoholic drink intake"
"phs001368.v1.p1","NHLBI TOPMed: Cardiovascular Health Study","Participants from the Cardiovascular Health Study (CHS), a large population-based longitudinal cohort study (phs000287), have been included in the TOPMed project. Whole genome sequencing will be performed to contribute  to multiple analyses, including cardiovascular disease risk factors, subclinical disease measures, the occurrence of myocardial infarction (MI) and","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 17 variables, 2 documents, 1 molecular datasets,  SRA, 3622 subjects, 3622 samples","European (56), African (2), African American (10), Hispanic1 (1)","NHLBI","HMB-MDS --- Health/medical/biomedical (mds) , HMB-NPU-MDS --- Health/medical/biomedical (npu, mds) , DS-CVD-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2018-06-13","2018-06-13","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Hemorrhage, Posterior Fossa"
"phs001369.v1.p1","CARD11 Mutations in Atopic Disease","We describe five patients from four unrelated families who had severe atopic dermatitis and susceptibility to mild skin viral infections. Some patients also exhibit other allergic symptoms such as  asthma and food allergy. We performed targeted sequencing for affected patients A-I of family A and B-I of family B, whole exome sequencing for D-I","Allergy and Immunology","Case-Control","Not Provided","Not Applicable","Not Provided","7 subjects, 7 samples","","NIAID","","","","Allergy, Immunology; Immunology and Allergy; Immunology, Allergy; Airway hyperreactivity; Asthma, Bronchial; Asthmas"
"phs001370.v1.p1","Whole Exome Sequencing of Uveal Melanoma","Uveal melanoma is a rare form of melanoma that occurs in the eye and has no effective treatment once metastatic. To further characterize the genomic events driving uveal melanoma,  whole exome sequencing was performed on 61 primary tumors derived from enucleations, 3 liver metasases, and paired normal DNA. Recurrent somatic","Melanoma, Uveal","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WXS","89 subjects, 144 samples","","NHGRI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-UM-NPU --- Disease-specific (uveal melanoma, npu)","2019-07-30","2019-07-30","Intraocular Melanoma; Melanoma of Uvea; Melanoma of the Uvea; Uveal melanoma"
"phs001371.v1.p1","Inflammation-Induced Stabilization of mRNA in Rheumatoid Arthritis","During rheumatoid arthritis (RA), TNF activates fibroblast-like synoviocytes (FLS) inducing in a temporal order a constellation of genes, which perpetuate synovial inflammation. Although the molecular mechanisms regulating TNF-induced transcription  are well characterized, little is known about the impact of mRNA stability on gene expression and the impact of TNF on decay rates of mRNA","Arthritis, Rheumatoid","Case Set","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 11 variables,  SRA, 2 subjects, 20 samples","","NIAMS","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-27","2017-06-27","Not Provided"
"phs001372.v1.p1","Integrated Single-Cell Analysis in Chronic Lymphocytic Leukemia","Intratumoral genetic heterogeneity has been characterized across cancers by genome sequencing of bulk tumors, including chronic lymphocytic leukemia (CLL). In order to more accurately identify subclones, define phylogenetic relationships,  and probe genotype-phenotype relationships, we developed methods for targeted mutation detection in DNA and RNA isolated from thousands of single","Leukemia, Lymphoid","Case Set","target_markerset_grc37, RNAseq_probe_set_grc37","Not Applicable","SNP Genotypes (NGS), RNA Seq expression levels","4 phenotype datasets, 15 variables, 2 molecular datasets,  SRA, 5 subjects, 1567 samples","","NCI","GRU --- General research use","2018-10-18","2018-10-18","Aleukemic lymphatic leukemia [obs]; Aleukemic lymphocytic leukemia [obs]; Aleukemic lymphoid leukemia [obs]; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid"
"phs001373.v1.p1","Mechanisms Controlling Gene Expression of Human Microglia","This study marks the first comprehensive cataloging of the gene expression and epigenomic signatures of human microglia taken from living patients. It also enables comparisons with cultured microglia from  the same cohort and identification of the changes that occur when microglia are removed from the brain microenviromnent. In collaboration with the","Epilepsy","Case Set","Not Provided","Not Applicable","ATAC-seq, ChIP-Seq, OTHER, RNA-Seq","4 phenotype datasets, 22 variables,  SRA, 28 subjects, 33 samples","","NINDS","HMB --- Health/medical/biomedical","2017-09-15","2017-09-15","BT - Brain tumor; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain"
"phs001374.v1.p1","VA APOLLO Project - Research for Precision Oncology (RePOP)","The Research for Precision Oncology Program (RePOP) is a research activity that establishes a cohort of Veterans diagnosed with cancer and who have had genomic analyses performed on their  tumor tissue as part of standard of care. All data relevant to a patient's cancer and cancer care will be collected under RePOP, including patient","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 4 variables,  SRA, 7 subjects, 7 samples","","NCI","GRU --- General research use","2018-08-22","2018-08-22","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs001376.v1.p1","Autosomal Recessive CD55 Deficiency","We describe 11 patients from 8 families with homozygous LOF mutations in the complement regulatory protein CD55. Loss of CD55 is associated with increased complement activation, severe protein losing  enteropathy accompanying a primary intestinal lymphangiectasia, and deep vein thrombotic events. We have named this disease CHAPLE after the","Protein-Losing Enteropathies","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 25 variables, 1 molecular datasets, 9 subjects, 9 samples","","NIAID","GRU-IRB --- General research use (irb)","2017-06-30","2017-06-30","Intestinal Lymphangiectases; Intestinal Lymphangiectasis; Intestinal lymphangiectasia; Lymphangiectases, Intestinal; Lymphangiectasia, Intestinal; Hypercatabolic Hypoproteinemia, Idiopathic"
"phs001377.v1.p1","Epigenetics of Cocaine and Nicotine Addiction","This project characterizes DNA methylation and gene expression changes that occur in the human brain, specifically in neurons from the rostral striatum. Major advances from NIDA funded initiatives for  noninvasive neuroimaging studies have made it possible to study neuroanatomical, neurochemical and functional changes in the human brain that","Cocaine-Related Disorders","Case Set","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 53 variables, 1 molecular datasets, 380 subjects, 365 samples","European (147), African (5), East Asian (1), African American (152), Hispanic1 (26), Hispanic2 (22), Other Asian or Pacific Islander (2), South Asian (1), Other (9)","NIDA","GRU --- General research use","2017-10-02","2017-10-02","Abuse, Cocaine; Cocaine Abuse"
"phs001378.v1.p1","scRNA-Seq Reveals Lymphoma B Cell Diversity and T Cell Immune Checkpoint    Co-Expression","Follicular lymphoma (FL) is a generally incurable B-cell malignancy which has the potential to transform into highly aggressive lymphomas. Genomic studies indicate it is often a small subpopulation rather  than the dominant population in the FL that gives rise to the more aggressive subtype. To resolve the underlying transcriptional networks of","Lymphoma, Follicular","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 22 variables,  SRA, 10 subjects, 10 samples","","NHGRI","DS-FL-PUB-NPU --- Disease-specific (follicular lymphoma, pub, npu)","2019-05-07","2019-05-07","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma"
"phs001381.v1.p1","Gut Microbiome and Types of Colorectal Polyps","Colorectal cancer is a heterogeneous disease arising from at least two precursors-the conventional adenoma and the serrated polyp. This dataset was used to test the relationship of the gut  microbiota to specific colorectal polyp types. We included samples from two independent study populations based at colonoscopy clinics: the Centers","Colonic Polyps","Cross-Sectional","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 43 variables, 667 subjects, 667 samples","","NCI","GRU --- General research use","2018-06-15","2018-06-15","Not Provided"
"phs001382.v1.p1","Reproductive Health in Men and Women with Vasculitis","The purpose of this study is to learn about reproductive health, including fertility and pregnancies, in people with vasculitis. All patients enrolled in the Vasculitis Clinical Research Consortium's Contact  Registry will be invited via email to participate in this study. The Contact Registry includes people who self-identify as having one of 11","Vasculitis","Clinical Trial","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 2071 variables, 1 documents, 467 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-10-12","2017-10-12","Arterial Inflammation; Arteritides; Arteritis; Inflammation of artery; Inflammation, Arterial; Adamantiades Behcet Disease"
"phs001384.v1.p1","Time Lapse to Cancer-Defining the Transition from Polyp to Cancer","In the US, CRC incidence has declined with uptake in colonoscopy for early detection and removal of polyps, the precursor lesion, can stop a cancer from developing but in  spite of this, CRC remains the second leading cause of cancer death in the United States. One third of people who undergo screening colonoscopy will","Colorectal Neoplasms","Case Set","WGS_markerset_grc37","Not Applicable","Bisulfite-Seq, RNA-Seq, SNP Genotypes (NGS), WGS","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 31 subjects, 268 samples","European (29), African American (1), Hispanic1 (1)","NCI","HMB --- Health/medical/biomedical","2017-09-20","2017-09-20","Adenoma, Microcystic; Adenomas, Microcystic; Microcystic Adenomas; CRC; Cancer of Large Bowel; Cancer of Large Intestine"
"phs001385.v1.p1","Ancestry Admixture among Chileans","The purpose of this study is to investigate ancestry admixture among Chileans with and without gallbladder cancer.","Gallbladder Neoplasms","Case-Control","HumanOmniExpress-12v1_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 17 variables, 1 molecular datasets, 189 subjects, 204 samples","European (3), Hispanic2 (186)","NCI","GRU --- General research use","2017-12-28","2017-12-28","Bladder Cancer, Gall; Bladder Cancers, Gall; Cancer of Gallbladder; Cancer of the Gallbladder; Cancer, Gall Bladder; Cancer, Gallbladder"
"phs001386.v1.p1","Smoking and the Vaginal Microbiome","The focus of this study was to better understand the effects of cigarette smoking on the vaginal microbiome. There were two phases of the study, cross-sectional and longitudinal, conducted  at the Center for Health Behavior Research at the University of Maryland School of Public Health. In the cross-sectional phase, 20 smokers and 20 non","Smoking","Case-Control","Not Provided","Not Applicable","Not Provided","7 phenotype datasets, 739 variables,  SRA, 47 subjects, 195 samples","","NIAID","GRU-IRB --- General research use (irb)","2017-12-06","2017-12-06","Behavior, Smoking; Behaviors, Smoking; Smoking Behaviors; Smoking, Tobacco and Cancer-Behavior; Cessation, Smoking; Giving Up Smoking"
"phs001387.v1.p1","NHLBI TOPMed: Rare Variants for Hypertension in Taiwan Chinese (THRV)","The THRV-TOPMed study consists of three cohorts: The SAPPHIRe Family cohort (N 1,271), TSGH (Tri-Service General Hospital, a hospital-based cohort, N 160), and TCVGH (Taichung Veterans General Hospital, another  hospital-based cohort, N 922), all based in Taiwan. 1,271 subjects were previously recruited as part of the NHLBI-sponsored SAPPHIRe Network (which","Blood pressure","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 91 variables, 4 documents, 1 molecular datasets,  SRA, 2353 subjects, 2353 samples","East Asian (1496), Other Asian or Pacific Islander (6)","NHLBI","DS-CVD-IRB-COL-NPU-RD --- Disease-specific (cardiovascular disease, irb, col, npu, rd)","2019-05-06","2019-05-06","DAP - Diastolic arterial pressure; DBP - Diastolic blood pressure; Diastolic Pressure; Diastolic arterial pressure; Pressure, Diastolic; (3beta)-Cholest-5-en-3-ol"
"phs001388.v1.p1","SIGMA Exome Sequencing Study: Diabetes in Mexico Study","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type  2 diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Diabetes Mellitus, Type 2","Case-Control","ExomeChip, HumanOmni2.5-4v1_H, WES_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 22 variables, 2 molecular datasets,  SRA, 3296 subjects, 3296 samples","European (3), Hispanic2 (1143), Other (1)","NIDDK","GRU --- General research use","2019-01-31","2019-01-31","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001389.v1.p1","Gene Expression and Histone Modification Profiles in GBM Tumors","The primary goal of this study was to collect and analyze genomic data from primary glioblastoma multiforme tumors. Our collaborators at St David's Medical Center (SDMC) obtained informed consent  from patients undergoing surgery to remove a tumor in the brain. After consent was obtained, specimens were removed from the operating suite and","Glioblastoma","Case Set","Not Provided","Not Applicable","ChIP-Seq, RNA-Seq","4 phenotype datasets, 23 variables,  SRA, 13 subjects, 109 samples","","NCI","HMB --- Health/medical/biomedical","2018-03-06","2018-03-06","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytic tumor; Astrocytoma, no ICD-O subtype"
"phs001391.v1.p1","OncoArray: Prostate Cancer","Original description of the study: From ELLIPSE (linked to the PRACTICAL consortium), we contributed 78,000 SNPs to the OncoArray. A large fraction of the content was derived from the  GWAS meta-analyses in European ancestry populations (overall and aggressive disease; 27K SNPs). We also selected just over 10,000 SNPs from the meta","Prostatic Neoplasms","Case-Control","ConsortiumOncoArray","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 99622 subjects, 99622 samples","European (87794), African (1216), East Asian (390), African American (6686), Hispanic1 (361), Hispanic2 (2309), Other Asian or Pacific Islander (212), South Asian (276), Other (378)","NCI","GRU --- General research use , CADM --- Cancer in all age groups, other diseases in adults only, and methods , CHRONIC --- Chronic diseases (including cancer), methods , DS-BCEMOPCA-NPU-MDS --- Disease-specific (breast, colorectal, endometrial, melanoma, ovarian, and/or prostate cancer, npu, mds) , DS-CA --- Disease-specific (cancer) , DS-CA-MDS-GSO --- Disease-specific (cancer, mds, gso) , DS-CA-NPU --- Disease-specific (cancer, npu) , DS-CA-NPU-GSO --- Disease-specific (cancer, npu, gso) , DS-PC-MDS-GSO --- Disease-specific (prostate cancer, mds, gso) , DS-PCP --- Disease-specific (prostate cancer predisposition) , GRU-IRB --- General research use (irb) , DS-PC-PUB-MDS --- Disease-specific (prostate cancer, pub, mds) , GRU-NPU --- General research use (npu) , MHNSI-MDS --- Men's health and nutrition in serious illnesses (mds) , PC-RITPC --- Prostate cancer or radiation-induced toxicity in prostate cancer patients , HMB-PUB --- Health/medical/biomedical (pub) , DS-CA-PUB --- Disease-specific (cancer, pub) , DS-CA-MDS --- Disease-specific (cancer, mds) , EPIMEDCA --- Epidemiological and medical research on cancer, methods , DS-PC-MDS --- Disease-specific (prostate cancer, mds) , PC-MDS-NOCTRL --- Prostate cancer, methods, non-control , HMB-NPU --- Health/medical/biomedical (npu) , DS-CHDSAD-MDS --- Disease-specific (cancer, heart disease, stroke, alzheimer disease, and diabetes, mds) , HMB-PUB-NPU --- Health/medical/biomedical (pub, npu) , DS-PC --- Disease-specific (prostate cancer) , HMB --- Health/medical/biomedical","2018-03-21","2018-03-21","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001392.v1.p1","Natural History Study of SCID Disorders","Individuals, including infants who were identified by newborn screening, with a recent/new diagnosis of severe combined immune deficiency (SCID) may be eligible to be enrolled in the PIDTC research  study: A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders. To determine eligibility for this","Severe Combined Immunodeficiency","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","28 phenotype datasets, 2184 variables, 19 documents, 30 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-10-23","2017-10-23","Bubble boy disease; Combined Immunodeficiencies, Severe; Combined Immunodeficiency, Severe; Combined T-cell and B-cell immunodeficiency; Immunodeficiencies, Severe Combined; Immunodeficiency Syndrome, Severe Combined"
"phs001394.v1.p1","Hypertension-Insulin Resistance Family Study (HTN-IR)","The HTN-IR Study, funded by NHLBI, was designed to explore genetic contributions to hypertension and glucose homeostasis traits among Hispanics using a family-based design. The baseline examination of the  cohort included the euglycemic hyperinsulinemic clamp test from which the two key phenotypes were obtained: insulin sensitivity (M) and metabolic","Hypertension","Family/Twin/Trios","HumanOmni1S-8v1_H","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 765 subjects, 765 samples","European (14), Hispanic2 (695), Other Asian or Pacific Islander (1), Other (55)","NHLBI","DS-CMED-IRB-NPU-MDS-GSO --- Disease-specific (cardiovascular, metabolic, and endocrine diseases, irb, npu, mds, gso)","2018-01-03","2018-01-03","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs001396.v1.p1","Genetics of Pigmentation in Eastern and Southern African Populations    Study","The goal of this study was to identify genes and loci associated with pigmentation in African populations. It comprises 1,593 participants from Ethiopia, Tanzania, and Botswana. Sexes are evenly  represented (768 males and 825 females) and self reported ages ranged from 18 to 103. Mean age was used for individuals without ages. For each","Skin Pigmentation","Cross-Sectional","HumanOmni2.5-8v1.1, WGS_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS), WGS","4 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 1573 subjects, 1573 samples","African (472), African American (1096), Hispanic1 (2)","NCI","GRU-NPU --- General research use (npu)","2018-05-15","2018-05-15","Age Factor; Age Factors; Factor, Age; Factors, Age; Genotypic Sex; Sex, Genotypic"
"phs001397.v1.p1","Mexican-American Coronary Artery Disease Study (MACAD)","The MACAD Study, funded by NHLBI, was designed to explore genetic contributions to coronary artery disease and glucose homeostasis traits among Hispanics using a family-based design. The baseline examination  of the cohort included the euglycemic hyperinsulinemic clamp test from which the two key phenotypes were obtained: insulin sensitivity (M) and","Coronary Artery Disease","Family/Twin/Trios","HumanOmni1S-8v1_H","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 22 variables, 1 molecular datasets, 821 subjects, 821 samples","European (6), African American (2), Hispanic1 (2), Hispanic2 (780), Other (31)","NHLBI","DS-CMED-IRB-NPU-MDS-GSO --- Disease-specific (cardiovascular, metabolic, and endocrine diseases, irb, npu, mds, gso)","2018-01-03","2018-01-03","Arterioscleroses, Coronary; Arteriosclerosis, Coronary; Arteriosclerotic heart disease; Atheroscleroses, Coronary; Atherosclerosis of coronary artery; Atherosclerosis of native coronary artery"
"phs001398.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular: The    Bangladesh Risk of Acute Vascular Events (BRAVE) Study","The Bangladesh Risk of Acute Vascular Events (BRAVE) study is a hospital-based case-control study in Bangladesh which was established by the Cardiovascular Epidemiology Unit of Cambridge University in the  UK in partnership with the key local cardiology and research centres to examine environmental, genetic, lifestyle and biochemical determinants of","Not Provided","Prospective Longitudinal Cohort","WGS_markerset_grc38, WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 12 variables, 2 molecular datasets, 1991 subjects, 1991 samples","Other Asian or Pacific Islander (2), South Asian (481), Other (13)","NHGRI","GRU --- General research use","2018-08-09","2018-08-09",""
"phs001399.v1.p1","Development of Precision Neoadjuvant-Adjuvant Therapies","In clinical trials assessing neoadjuvant androgen deprivation therapy plus next-generation androgen receptor axis inhibitors, a subset of patients fail to demonstrate a complete pathologic response following treatment and radical  prostatectomy. We performed exome and transcriptome analyses on laser capture microdissected foci of residual tumor from these patients.","Prostatic Neoplasms","Case Set","Not Provided","Not Applicable","WXS","5 phenotype datasets, 23 variables,  SRA, 19 subjects, 69 samples","","NCI","DS-CA-NPU --- Disease-specific (cancer, npu)","2018-05-31","2018-05-31","17-(3-Pyridyl)-5,16-androstadien-3beta-acetate; Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, acetate (ester), (3beta)-; NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate"
"phs001400.v1.p1","Advanced Genomic Techniques in Sequencing of Colorectal Cancer","We developed a method that uses allelic imbalance information in combination with phased genomic sequencing to generate mega-haplotypes that can encompass entire chromosome arms. We applied this technique to  characterize aneuploidy and chromosomal alterations in colorectal cancers.","Cancer, Colorectal","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 15 variables, 4 subjects, 11 samples","","NHGRI","HMB-PUB-NPU-MDS --- Health/medical/biomedical (pub, npu, mds)","2017-11-13","2017-11-13","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancers, Colorectal"
"phs001402.v1.p1","NHLBI TOPMed: Whole Genome Sequencing of Venous Thromboembolism (WGS of    VTE)","This study consists of 338 VTE cases from an inception cohort of Olmsted County, MN residents (OC) with a first lifetime objectively-diagnosed idiopathic VTE during the 40-year study period,  1966-2005. All living study subjects were invited to provide a whole blood sample at the Mayo Clinical Research Unit for leukocyte genomic DNA and","Venous Thromboembolism","Case Set","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 59 variables, 2 documents, 1 molecular datasets,  SRA, 1534 subjects, 1534 samples","European (1226), African American (3), Hispanic1 (3), Hispanic2 (13), Other Asian or Pacific Islander (2), South Asian (1), Other (2)","NHLBI","GRU --- General research use","2018-09-10","2018-09-10","Phlebothromboses; Phlebothrombosis; Thromboses, Venous; Thrombosis, Venous; VENOUS THROMBOSIS; Venous Thromboses"
"phs001403.v1.p1","WES and CNV analysis of NF1-Associated Plexiform Neurofibromas","Neurofibromatosis type 1 (NF1) is a common tumor-predisposition disorder due to germline mutations in the tumor suppressor gene NF1. A virtually pathognomonic finding of NF1 is the plexiform neurofibroma  (PN), a benign, likely congenital tumor that arises from biallelic inactivation of NF1. PN can undergo transformation to a malignant peripheral nerve","Neurofibromatosis Type I","Case-Control","HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array), WXS","5 phenotype datasets, 26 variables, 1 molecular datasets, 21 subjects, 44 samples","European (18), African American (2), Other Asian or Pacific Islander (1)","NCI","GRU --- General research use","2017-11-30","2017-11-30","Molluscum Fibrosum; Multiple non-ossifying fibromatosis; NEUROFIBROMATOSIS TYPE 1; NEUROFIBROMATOSIS, PERIPHERAL TYPE; NEUROFIBROMATOSIS, TYPE I; NEUROFIBROMATOSIS, TYPE I, SOMATIC"
"phs001405.v1.p1","Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212","In this study the investigators looked at adaptive reprogramming impact on the kinome when a MEK inhibitor called GSK1120212 (trametinib) was administered in a ""window of opportunity"" trial. GSK1120212  is not yet approved by the FDA for use in breast cancer patients. The investigators gave GSK1120212 for a short period of time (one week) to examine","Triple Negative Breast Neoplasms","Clinical Trial","Not Provided","Not Applicable","RNA-Seq","5 phenotype datasets, 32 variables, 5 documents,  SRA, 12 subjects, 28 samples","","NCI","HMB-PUB-MDS --- Health/medical/biomedical (pub, mds)","2018-03-07","2018-03-07","Agents, Anticancer; Agents, Antineoplastic; Agents, Antitumor; Agents, Cancer Chemotherapy; Agents, Chemotherapeutic Anticancer; Anti-Cancer Agents"
"phs001407.v1.p1","HNPCC-Sys: Molecular Characterization of Lynch Syndromes","Lynch Syndrome (LS) tumors are characterized by constitutional mutations in DNA mismatch-repair genes. Colorectal cancers (CRCs) are the predominant tumor type in patients with LS. Here, we have used  whole-genome and transcriptome sequencing of LS- CRC to find similarities and differences of mutation and gene expression characteristics between LS","Lynch syndrome I","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq, WGS","4 phenotype datasets, 30 variables,  SRA, 11 subjects, 46 samples","","NCI","DS-LYN-PUB-NPU --- Disease-specific (lynch syndrome, pub, npu)","2017-09-18","2017-09-18","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001409.v1.p1","Genetic Risk Underlying Racial Disparities in Uterine Fibroids","Fibroids affect 77% of women by onset of menopause in the U.S. and account for $2.1 billion in healthcare costs each year. Fibroids negatively impact reproductive health causing heavy  and painful menses, pelvic pain and pressure, pregnancy complications, and interventions including myomectomy and hysterectomy. Until recently, tumor","Leiomyoma","Case-Control","Axiom_BioBank1, Axiom_GW_AFR_1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 1 molecular datasets, 4600 subjects, 4594 samples","European (3128), African (42), East Asian (1), African American (1326), Hispanic1 (46), Hispanic2 (13), Other Asian or Pacific Islander (7), South Asian (11), Other (20)","NICHD","DS-UF-PUB-COL --- Disease-specific (uterine fibroids, pub, col)","2019-05-08","2019-05-08","Fibroid; Fibroid Tumors; Fibromyoma; Fibromyomas; Leiomyomas; Leiomyomatous Tumor"
"phs001410.v1.p1","Kids First: Pediatric Research Project on Adolescent Idiopathic Scoliosis","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the2014 Gabriella Miller Kids First Research Act and supported by the  NIH Common Fund. This program focuses on gene discovery in childhood cancers and structural birth defects and the development of the Gabriella Miller","Scoliosis","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 26 variables,  SRA, 300 subjects, 300 samples","","NCI","HMB --- Health/medical/biomedical , DS-MUS-SKEL-IRB --- Disease-specific (musculoskeletal diseases, irb)","2018-10-12","2018-10-12","Abnormal curving of the spine; Curvature of spine; Curved spine; Scolioses"
"phs001411.v1.p1","Action to Control Cardiovascular Risk in Diabetes (ACCORD)","The Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial was a randomized, multicenter, double 2 x 2 factorial design study involving 10,251 middle-aged and older participants with  type-2 diabetes who are at high risk for CVD events because of existing CVD or additional risk factors. The purpose of ACCORD was to determine if","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","Axiom_BioBank1, HumanOmniExpressExome-8","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 10 variables, 2 molecular datasets, 6385 subjects, 6385 samples","European (4361), African (48), East Asian (181), African American (849), Hispanic1 (198), Hispanic2 (158), Other Asian or Pacific Islander (39), South Asian (95), Other (42)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CDKD-IRB --- Disease-specific (cardiovascular disease, diabetes and kidney disease, irb)","2018-04-12","2018-04-12","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001412.v1.p1","NHLBI TOPMed: Diabetes Heart Study (DHS) African American Coronary Artery    Calcification (AA CAC)","The Diabetes Heart Study (DHS) is a family-based study enriched for type 2 diabetes (T2D). The cohort included 1443 European American and African American participants from 564 families with  multiple cases of type 2 diabetes (Bowden et al., 2010. Review of Diabetic Studies 7:188-201. PMID: 21409311). The cohort was recruited between 1998","Cardiovascular Disease","Cross-Sectional","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 54 variables, 2 documents, 1 molecular datasets,  SRA, 405 subjects, 403 samples","African (11), African American (326)","NHLBI","HMB-IRB-COL-NPU --- Health/medical/biomedical (irb, col, npu) , DS-DHD-IRB-COL-NPU --- Disease-specific (diabetes and heart disease, irb, col, npu)","2019-02-14","2019-02-14","Calcification, Vascular; Calcifications, Vascular; Calcinoses, Vascular; Calcinosis, Vascular; Vascular Calcification; Vascular Calcifications"
"phs001415.v1.p1","Uncovering the Genetic Architecture of Colorectal Cancer with Focus of    Rare and Less Frequent Variants","The Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort comprised of a coordinating center and scientific researchers from well-characterized cohort and case-control studies conducted in  North America and Europe. This international consortium aims to accelerate the discovery of common and rare genetic risk variants for colorectal","Not Provided","Case-Control","Peters_Onco_Plus_Custom_20006640_A1, HRC1_ref_panel","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 29 variables, 3 molecular datasets, 29540 subjects, 30487 samples","European (25853), African (85), East Asian (762), African American (1990), Hispanic1 (98), Hispanic2 (107), Other Asian or Pacific Islander (410), South Asian (55), Other (180)","NCI","GRU --- General research use , DS-CA-IRB --- Disease-specific (cancer, irb) , RCV-CRC-MDS --- Rare and common variants associated with colorectal cancer risk, and methods , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-GSO --- Health/medical/biomedical (pub, npu, gso) , HMB-COL-GSO --- Health/medical/biomedical (col, gso) , HMB --- Health/medical/biomedical , HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , HMB-PUB --- Health/medical/biomedical (pub) , DS-BOCA --- Disease-specific (bowel cancer) , GRU-GSO --- General research use (gso) , DS-CEC-IRB --- Disease-specific (colorectal and endometrial cancer, irb)","2019-03-27","2019-03-27",""
"phs001416.v1.p1","NHLBI TOPMed: MESA and MESA Family AA-CAC","The Multi-Ethnic Study of Atherosclerosis (MESA) is a study of the characteristics of subclinical cardiovascular disease (disease detected non-invasively before it has produced clinical signs and symptoms) and the  risk factors that predict progression to clinically overt cardiovascular disease or progression of the subclinical disease. MESA researchers study a","Cardiovascular Diseases","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 16 variables, 2 documents, 1 molecular datasets,  SRA, 5383 subjects, 5418 samples","European (1716), African (85), East Asian (549), African American (1686), Hispanic1 (191), Hispanic2 (581), Other Asian or Pacific Islander (8), South Asian (1), Other (58)","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2019-06-20","2019-06-20","Cholesteronil"
"phs001417.v1.p1","Scalable WES of cfDNA Reveals High Concordance with Metastatic Tumors","We performed whole genome sequencing and whole-exome sequencing of cell-free DNA (cfDNA) and whole-exome sequencing of matched tumor biopsies and germline DNA from patients with metastatic cancer. Using ichorCNA,  a software tool that quantifies tumor content in ultra-low pass whole genome sequencing ( 0.1x) of cfDNA without prior genomic characterization of","Neoplasms","Case-Control","Not Provided","Not Applicable","WGS, WXS","4 phenotype datasets, 12 variables,  SRA, 545 subjects, 1673 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-BRCA-MDS --- Disease-specific (breast cancer, mds) , DS-PC-MDS --- Disease-specific (prostate cancer, mds)","2018-03-27","2018-03-27","Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize; Neoplasm Metastases; Tumor Cell Migration"
"phs001418.v1.p1","Molecular Role of DNA Variants Associated with Crohn's Disease","Crohn's disease (CD), one of the two major inflammatory bowel diseases (IBD), results from an inappropriately directed inflammatory response to the enteric microbiota in a genetically susceptible host. Genome  wide association studies (GWAS) have linked 200 specific single nucleotide polymorphisms (SNPs) to CD disease pathogenesis. Within these regions","Crohn Disease","Case-Control","1000G_ref_panel, InfiniumImmunoArray-24v2-0, InfiniumOmni2-5-8v1-3_A1-b37","Not Applicable","SNP Genotypes (Array), FAIRE-seq, SNP Genotypes (imputed), RNA-Seq","2 molecular datasets, 33 subjects, 33 samples","Other (1)","NIEHS","GRU --- General research use","2018-12-12","2018-12-12","CD - Crohn's disease; CROHN DISEASE; Crohn's Disease; Crohn's Enteritis; Crohn's regional enteritis; Crohns Disease"
"phs001419.v1.p1","Natural History Study of Charcot-Marie-Tooth Disease","Charcot Marie Tooth disease (CMT) is an umbrella term that covers any inherited peripheral neuropathy. People with CMT have a problem with the nerves that go to the feet  and hands that cause muscle and sensation loss, as well as difficulty with balance. There are at least forty genes that, when mutated, cause CMT. The","Charcot-Marie-Tooth Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","19 phenotype datasets, 2553 variables, 17 documents, 1002 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2017-12-11","2017-12-11","Atrophies, Peroneal Muscular; Atrophy, Muscular, Peroneal; Atrophy, Peroneal Muscular; CMT/HMSN; Charcot Marie Disease; Charcot Marie Tooth Disease"
"phs001420.v1.p1","Kids First: Genomics of Orofacial Cleft Birth Defects in Latin American    Families","The Gabriella Miller Kids First Pediatric Research Program) (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Cleft Lip","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 7 variables,  SRA, 828 subjects, 828 samples","","NCI","DS-OBDR-RD --- Disease-specific (orofacial birth defects and related phenotypes, rd)","2019-06-14","2019-06-14","CL - Cleft lip; Cheiloschisis; Cheiloschisis of upper lip; Cleft Lips; Cleft of upper lip; Congenital fissure of lip"
"phs001421.v1.p1","Whole Exome Sequencing and Methylation Profiling of Uveal Melanoma","Uveal melanoma (UM) is the most common primary cancer of the eye and frequently leads to metastatic death. Metastatic risk can be stratified into low, intermediate and high based  on the presence of mutually exclusive mutations in EIF1AX, SF3B1 and BAP1, respectively. The purpose of this study was to comprehensively profile the","Uveal melanoma","Prospective Longitudinal Cohort","HumanMethylation450","Not Applicable","Methylation (CpG), WXS","1 molecular datasets, 37 subjects, 64 samples","","NCI","HMB-PUB --- Health/medical/biomedical (pub)","2018-01-25","2018-01-25","Intraocular Melanoma; Melanoma of Uvea; Melanoma of the Uvea; Melanoma, Uveal"
"phs001422.v1.p1","GETHIN","The Genomics and Transcriptomics of Human Insulinoma The common forms of diabetes - Types 1 and 2 - ultimately result from a deficiency of insulin-producing pancreatic beta cells. The  Genomics and Transcriptomics of Human Insulinoma study was performed in order to identify novel approaches to inducing human pancreatic beta cells to","Insulinoma","Case-Control","WES_markerset_grc37, target_markerset_grc37","Not Applicable","RNA-Seq, Methylome sequencing, SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 24 subjects, 34 samples","","NIDDK","HMB-IRB --- Health/medical/biomedical (irb)","2019-02-06","2019-02-06","Adenoma, beta Cell; Adenoma, beta-Cell; Adenomas, beta-Cell; Beta Cell Tumor; Beta Cell Tumor of Pancreas; Beta Cell Tumor of the Pancreas"
"phs001423.v2.p2","Whole Exome Sequencing in Tourette Disorder in Simplex Trios-TIC Genetics","The Tourette International Collaborative Genetics (TIC Genetics) Study is an international collaboration of scientists and clinicians specialized in Tourette Disorder (TD) from more than 20 sites across the United  States, Europe, and South Korea. The study was established to further our understanding of the genetic architecture of tic disorders by developing a","Tourette Disorder","Family/Twin/Trios","HumanOmniExpressExome-8v1_C","Not Applicable","SNP Genotypes (Array), WXS","6 phenotype datasets, 106 variables, 3 documents, 1 molecular datasets,  SRA, 1449 subjects, 1449 samples","","NIMH","DS-TS-IRB-PUB-GSO-RD --- Disease-specific (tourette syndrome, irb, pub, gso, rd)","2018-12-28","2018-12-28","ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorder with Hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder"
"phs001424.v1.p1","Genomic Analysis of Pre-Treatment and Autopsy Glioblastoma Specimens","We performed whole exome sequencing data of pre-treatment glioblastoma specimens, matched to post-treatment recurrent intracranial autopsy samples and metastatic extracranial post-treatment autopsy samples. We identified early genetic events common  to the evolutionary ancestry of both pre-treatment glioblastoma and later recurrences. We demonstrated that there were no protein-coding mutations as","Glioblastoma","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 12 variables,  SRA, 12 subjects, 36 samples","","NCI","DS-NDC-MDS --- Disease-specific (neurological disorders and cancer, mds)","2017-10-13","2017-10-13","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (Glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme"
"phs001425.v1.p1","Melanoma Sequential Immune Checkpoint Blockade Treatment Sequencing Study","Blockade of T cell coinhibitory molecules such as CTLA-4 and PD-1, can activate T cell antitumor response. Although these immune checkpoint blockades (CTLA-4 blockade and PD-1 blockade) have shown  durable response, response rate is modest. Therefore, there is a need to find stable biomarkers predictive of response to immune checkpoint blockades","Melanoma","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 20 variables, 34 subjects, 85 samples","","NCI","GRU-PUB-NPU --- General research use (pub, npu)","2017-08-24","2017-08-24","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001426.v1.p1","Type 1 Diabetes Genetics Consortium (T1DGC): Case-only RNA-Seq Study","Peripheral blood mononuclear cells (PBMC) from 82 T1D cases from the T1DGC study were fractionated by positive selection on magnetic beads into CD4+ T cells, CD8+ T cells and  CD19+ B cells. RNA purification, library preparation and sequencing to an average of 50 million reads per sample were performed by the HudsonAlpha","Diabetes Mellitus, Type 1","Case Set","Not Provided","Not Applicable","RNA-Seq","5 phenotype datasets, 23 variables, 8 documents,  SRA, 82 subjects, 246 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2018-02-27","2018-02-27","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs001427.v1.p1","Resistance of Melanoma Tumors to Checkpoint Blockade Therapy","Although immune checkpoint blockade (CPB) leads to prolonged responses in 15-40% of patients with metastatic melanoma, treatment refractory disease and progression after initial response remain major causes of mortality.  While predictors of response have been reported, the common mechanisms of both primary and acquired resistance are poorly understood. To identify","Immunotherapy","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 21 variables, 17 subjects, 66 samples","","NHGRI","DS-MSC --- Disease-specific (melanoma and skin cancer research)","2018-02-21","2018-02-21","Antigens, Melanoma; Antigens, Melanoma-Specific; Melanoma Antigens; Melanoma Specific Antigens; Melanoma-Specific Antigens"
"phs001428.v1.p1","GWAS for Breast Cancer Chemotherapy Toxicities in S0221","When undergoing treatment for breast cancer, many women experience severe side effects, some of which result in treatment-related death and some that can persist for years. Little is understood  regarding factors that may predict drug toxicities. Pharmacogenetics, the investigation of variants in candidate genes in drug metabolism pathways","Peripheral Nervous System Diseases","Clinical Trial","HumanOmni1-Quad_v1-0_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 24 variables, 1 molecular datasets, 1847 subjects, 1847 samples","European (1465), African (5), East Asian (46), African American (161), Hispanic1 (24), Hispanic2 (106), Other Asian or Pacific Islander (29), South Asian (6), Other (5)","NCI","DS-BRCATOX-COL-MDS-GSO --- Disease-specific (breast cancer treatment toxicities, col, mds, gso)","2019-08-13","2019-08-13","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001430.v1.p1","STAIR SLOS Longitudinal Study of Patients Receiving Cholesterol","Smith-Lemli-Opitz syndrome (SLOS) is a disorder of cholesterol production by the body. It is caused by changes in the DHCR7 gene, which is the blueprint for an enzyme called  7-dehydrocholesterol- delta7-reductase. This enzyme is necessary for the production of cholesterol by all cells in the body. People with SLOS often","Smith-Lemli-Opitz Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","35 phenotype datasets, 2701 variables, 28 documents, 5 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-07-11","2018-07-11","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs001432.v1.p1","Rapid Autopsy in Thoracic Malignancy Cancer Patients to Investigate Tumor    Heterogeneity","Integrated proteo-genomics studies to characterize tumor heterogeneity of metastatic lung adenocarcinoma and thymic carcinoma are lacking. We carried out whole exome sequencing, RNA sequencing, copy number estimation and mass  spectrometry-based proteomics of 40 tumors from five rapid/warm autopsy patients. We found highly variable mutational heterogeneity that was largely","Adenocarcinoma of lung","Case Set","WES_markerset_grc37, RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, SNP/CNV Genotypes (NGS), RNA Seq expression levels, WXS","4 phenotype datasets, 31 variables, 1 molecular datasets,  SRA, 6 subjects, 86 samples","","NCI","HMB-PUB --- Health/medical/biomedical (pub)","2019-05-28","2019-05-28",""
"phs001436.v1.p1","Discovering the Genetic Basis of Human Neuroblastoma: A Kids First    Project","The Gabriella Miller Kids First Pediatric Research Program (Kids First) is a trans-NIH effort initiated in response to the 2014 Gabriella Miller Kids First Research Act and supported by  the NIH Common Fund. This program focuses on gene discovery in pediatric cancers and structural birth defects and the development of the Gabriella","Neuroblastoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 6 variables,  SRA, 1694 subjects, 2281 samples","","NCI","GRU --- General research use","","","Not Provided"
"phs001437.v1.p1","Pediatric Preclinical Testing Consortium (PPTC)","The Pediatric Preclinical Testing Consortium (PPTC) is addressing the unmet need of streamlining the development of new therapies for childhood cancers. The PPTC seeks to develop robust biomarkers of  anticancer drug activity, and the majority of these are predicted to be genetic mutations that can be detected in tumor DNA and/or RNA. In order to","Leukemia, Lymphoid","Xenograft","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 32 variables,  SRA, 244 subjects, 261 samples","","NCI","GRU --- General research use","","","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytic tumor; Astrocytoma, no ICD-O subtype"
"phs001438.v1.p1","Chromatin Accessibility in Developing Human Brain","Non-coding regions comprise most of the human genome and harbor a significant fraction of risk alleles for neuropsychiatric diseases, yet their functions remain poorly defined. We created a high-resolution  map of non-coding elements involved in human cortical neurogenesis by contrasting chromatin accessibility and gene expression in the germinal zone","Chromatin","Collection","Not Provided","Not Applicable","ATAC-seq, RNA-Seq","5 phenotype datasets, 28 variables,  SRA, 3 subjects, 37 samples","","NIMH","GRU --- General research use","2017-12-21","2017-12-21","Not Provided"
"phs001439.v1.p1","University of Utah Pelvic Organ Prolapse Disorder Study","The overall purpose of this University of Utah Pelvic Organ Prolapse Disorder Study was to identify and localize predisposition genes contributing to pelvic organ prolapse (POP). POP cases recruited  for this study were identified by one of three methods: high-risk POP pedigree cases, POP sister pairs, and surgically-treated POP cases reporting a","Pelvic Organ Prolapse","Case Set","HumanOmni25-8v1, HumanOmni1-Quad_v1-0_H, HumanOmniExpress-24v1-0_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 334 subjects, 335 samples","European (331), Hispanic1 (1), Hispanic2 (2)","NICHD","DS-PFD-RD --- Disease-specific (pelvic floor disorders, rd)","2019-01-22","2019-01-22","Bulge of the vaginal vault; Prolapse, Vaginal Vault; Prolapses, Vaginal Vault; Vaginal Vault Prolapse; Vaginal Vault Prolapses; Vault Prolapse, Vaginal"
"phs001440.v1.p1","AMP-AD/M OVE-AD Genomic Umbrella","The AMP-AD/M2OVE-AD Genomic Data Umbrella was created as part of the AMP-AD Knowledge Portal, funded by the National Institute on Aging (NIA). The overarching purpose of the Knowledge Portal  is to provide data, analysis results, analytical methodology and research tools to enable transparent and reproducible systems biology research on","Alzheimer Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","","","NIA","","","","AD; AD - Alzheimer's disease; ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE; Alzheimer Dementia; Alzheimer Dementias; Alzheimer Sclerosis"
"phs001441.v1.p1","Admixture Mapping of Staphylococcus Aureus Bacteremia","In this study, we used admixture mapping to test the hypothesis that genomic variations with different frequencies in European and African ancestral genomes influence susceptibility to Staphylococcus aureus bacteremia  (SAB) in a sample of African Americans. A total of 565 adult African Americans were genotyped for admixture mapping. Cases were unique African","Staphylococcus aureus","Case-Control","MEGA_Consortium","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 15 variables, 1 analyses, 1 molecular datasets, 565 subjects, 565 samples","African (16), African American (543), Hispanic1 (4), Other (2)","NIAID","DS-GNB-IRB --- Disease-specific (gram negative bacteremia, irb)","2017-12-15","2017-12-15","Comparative Genomic; Comparative Genomics; Genomic, Comparative; Genomics, Comparative; Nucleotide Polymorphism, Single; Nucleotide Polymorphisms, Single"
"phs001444.v1.p1","Genomic Variation in Diffuse Large B Cell Lymphomas","Integrative analysis of genetic lesions in 574 diffuse large B cell lymphomas (DLBCL). The study investigates genomic structural variation, genetic alteration and its effect on the development and biology  of lymphomas by using high throughput sequencing, gene expression, and methylation status.","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 7 variables, 489 subjects, 1916 samples","","NCI","DS-BCL-PUB-MDS --- Disease-specific (b cell lymphoma, pub, mds)","2018-04-11","","DLBCL; Diffuse Histiocytic Lymphoma; Diffuse Histiocytic Lymphomas; Diffuse Large Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse Large-Cell Lymphomas"
"phs001447.v1.p1","Metastatic Castrate-Resistant Prostate Cancer Study (MCRPCS)","We examined genetic resistance to second generation androgen targeting therapies (abiraterone acetate or enzalutamide) by analyzing whole exome sequencing of patient-matched pre-treatment and post-resistance tumors from a series of  castrate-resistant prostate cancer (CRPC) patients. Abiraterone resistant tumors harbored alterations in AR and MYC, whereas patients treated with","Prostatic Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 12 variables, 7 subjects, 21 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-PC-MDS --- Disease-specific (prostate cancer, mds)","2018-03-07","2018-03-07","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001448.v1.p1","Sub-Saharan Sophageal Squamous Cell Carcinoma Molecular Analysis","Esophageal squamous cell carcinoma (ESCC) occurs as much as 20x more frequently in sub-Saharan Africa than Western countries. Through the UNC-Malawi project collaboration we obtained whole-exome matched tumor/normal and  RNA sequencing of 59 ESCC from Malawi between 2011-2012. DNA analysis revealed similar mutations as other cohorts, while RNA analysis revealed three","Esophageal Neoplasm","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 35 variables,  SRA, 59 subjects, 177 samples","","NCI","DS-E-C --- Disease-specific (esophageal cancer)","2017-10-27","2017-10-27","Carcinoma, Epidermoid; Carcinoma, Planocellular; Carcinoma, Squamous; Carcinoma, Squamous Cell; Carcinomas, Epidermoid; Carcinomas, Planocellular"
"phs001451.v1.p1","A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma","Effective anti-tumor immunity in humans has been associated with presence of T cells targeting neoantigens that arise from non-silent tumor-specific mutations. Here we conducted whole-exome sequencing of tumor and  normal cells from individual patients to identify mutations. We assessed the expression of mutated alleles by RNA-sequencing of tumor. We","Melanoma","Clinical Trial","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 15 variables,  SRA, 10 subjects, 30 samples","","NCI","GRU --- General research use","2018-02-28","2018-02-28","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001454.v1.p1","Genomic Regions Associated with Susceptibility to Barrett's Esophagus and    Esophageal Adenocarcinoma in African Americans: The Cross BETRNet    Admixture Study","Differences in rates of diseases between different populations with similar environments are presumed to be secondary to variability in population frequencies of disease causing alleles. Recently admixed populations such  as African Americans (AAs) provide a natural opportunity to identify disease-causing variants by examining the ancestry of long chromosomal","Adenocarcinoma Of Esophagus","Case Set","HumanOmni2.5-8v1_A","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 11 variables, 1 molecular datasets, 28 subjects, 28 samples","","NCI","GRU-IRB --- General research use (irb)","2017-10-10","2017-10-10","ADENOCARCINOMA OF ESOPHAGUS; Adenocarcinoma of the Esophagus; Esophageal adenocarcinoma; Esophagus Adenocarcinoma; Oesophageal Adenocarcinoma NOS; BARRETT METAPLASIA"
"phs001457.v1.p1","Accelerating Medicines Partnership-Rheumatoid Arthritis (AMP-RA)","This project is analyzing tissue and blood samples from people with RA and lupus to pinpoint genes, proteins, chemical pathways, and networks involved at a single cell level. This  type of modular, molecular analysis will allow comparisons across the diseases and will provide insights into key aspects of the disease process. The","Arthritis, Rheumatoid","Case-Control","RNAseq_probe_set_grc37","Not Applicable","Legacy Genotypes, RNA-Seq","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 55 subjects, 10193 samples","","NIAMS","HMB --- Health/medical/biomedical","2018-07-30","2018-07-30","Arthritides, Degenerative; Arthritis, Degenerative; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy; Degenerative joint disease"
"phs001458.v1.p1","Deep Sequencing Studies for Cannabis and Stimulant Dependence","Cannabis and stimulants are among the most widely used illicit drug in the United States, and their use is associated with substantial physical and psychiatric sequelae. Twin studies have  shown a substantial genetic component to the etiology of cannabis and stimulant use disorders, but, genome-wide association studies using genotype","Marijuana Abuse","Family/Twin/Trios","Not Provided","Not Applicable","WGS","5 phenotype datasets, 62 variables, 2573 subjects, 1887 samples","","NIDA","DS-ADMH-IRB --- Disease-specific (addiction and mental health, irb)","2018-04-20","2018-04-20","Dependence, Cannabis; Dependence, Marijuana; Marijuana Dependence; Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs001463.v1.p1","Differential Transcription Start Site Usage in Brain-Related Samples","RNA-Seq is an effective method to study the transcriptome, but specialized methods are required to identify 5' ends of transcripts. Several published strategies exist for this specific purpose, but  their relative merits have not been systematically analyzed. Here, we directly compare the performance of six such methods - testing five with","Brain","Control Set","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 12 variables,  SRA, 8 subjects, 8 samples","","NIMH","GRU --- General research use","2018-04-02","2018-04-02","Astroglia; Astroglias; Encephalon; Cell, Endothelial; Cells, Endothelial; Endothelial Cells"
"phs001464.v1.p1","Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer","Mechanisms of acquired resistance to immune checkpoint inhibitors (ICIs) are poorly understood. The purpose of this study was to investigate whether alterations in genes encoding components of the HLA  Class I antigen processing and presentation machinery or interferon signaling pathways play a role in acquired resistance to PD-1 or PD-L1","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 24 variables, 14 subjects, 63 samples","","NCI","DS-LCTC-MDS --- Disease-specific (lung cancer and thoracic malignancies, mds)","2017-10-06","2017-10-06","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER"
"phs001469.v1.p1","High Response Rate to Anti PD-1 Therapy in Desmoplastic Melanoma","Desmoplastic melanoma (DM) is a rare subtype of melanoma characterized by dense fibrous stroma, resistance to chemotherapy and a lack of actionable driver mutations, but is highly associated with  ultraviolet light DNA damage. We analysed 60 patients with advanced DM treated with programmed cell death 1 (PD-1) or PD-1 ligand (PD-L1) blocking","Immunotherapy","Case-Control","WES_markerset_grc37","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 17 subjects, 34 samples","","NCI","HMB-PUB-NPU-MDS --- Health/medical/biomedical (pub, npu, mds)","2018-03-01","2018-03-01","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001479.v1.p1","Heterozygous Missense Mutation in the Coiled-Coil Domain of STAT5B","We describe one patient with a heterozygous missense mutation in the coiled-coil domain of STAT5B. This patient presented with leukocytosis, lymphadenopathy, splenomegaly, necrotizing granulomas, hyper-IgM and autoimmune thrombocytopenia. Mutant  STAT5B protein was shown to dominantly-interfere with IL2-induced transcriptional activity resulting in global downregulation of STAT5-regulated","Lymphadenopathy","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 27 variables, 1 molecular datasets, 2 subjects, 3 samples","","NIAID","GRU-IRB --- General research use (irb)","2018-06-13","2018-06-13","Hyper IgM Immunodeficiency Syndrome; Hyper IgM Syndrome; Hyper-IgM Immunodeficiency Syndrome; Hyper-IgM Immunodeficiency Syndromes; Hyper-IgM Syndrome; Hyper-IgM Syndromes"
"phs001481.v1.p1","Inherited Bone Marrow Failure Syndromes Study","Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Mutations in IBMFS genes are relevant  to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients","Bone Marrow Failure Syndromes","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","5 phenotype datasets, 19 variables, 456 subjects, 456 samples","","NCI","GRU --- General research use","2018-09-06","2018-09-06","Anemia, Fanconi; Anemia, Fanconi's; Anemias, Fanconi; FA; Fanconi Anemias; Fanconi Hypoplastic Anemia"
"phs001482.v1.p1","Genetic Ancestry and Self-reported Ethnicity in Carrier Screening","Current professional society guidelines recommend genetic carrier screening be offered on the basis of ethnicity, or when using expanded carrier screening panels, they recommend to compute residual risk based  on ethnicity. We investigated the reliability of self-reported ethnicity in 9125 subjects referred to carrier screening. We identified several","Infertility","Cross-Sectional","custom_markerset","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 9125 subjects, 9125 samples","","NICHD","GRU --- General research use","2017-12-01","2017-12-01","ethnology; Sub-Fertility; Subfertility"
"phs001483.v1.p1","DRIVE Breast Cancer Whole Genome Sequencing","This study consists of whole genome sequencing (target: average 30x coverage) of 110 European-ancestry (EA), early-onset, family-history-positive breast cancer cases, 21 Asian cases, 25 African-American cases, and 24 controls  from six studies participating in the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) consortium, part of the NCI's","Breast Neoplasms","Case Set","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 180 subjects, 180 samples","","NCI","DS-CA-PUB --- Disease-specific (cancer, pub) , GRU --- General research use , DS-BRD-MDS --- Disease-specific (breast diseases, mds) , DS-BRD --- Disease-specific (breast diseases) , DS-COBC-NPU-MDS --- Disease-specific (colorectal, ovarian, and/or breast cancer, npu, mds) , HMB-PUB-NPU --- Health/medical/biomedical (pub, npu) , HMB-PUB --- Health/medical/biomedical (pub)","2019-05-01","2019-05-01","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001484.v1.p1","Pharmacogenomics of HIV Therapy - Atazanavir Bilirubin-related Side    Effects","This is an evaluation of genetic associations with atazanavir (ATV) discontinuation for bilirubin-related causes within 12 months of treatment. Patients were treated at an HIV primary care clinic in  Nashville TN from 1998 to 2012. A previously known SNP in UGT1A1 (rs887829) was used to define metabolizer genotypes (extensive, intermediate, slow","Drug-Related Side Effects and Adverse Reactions","Case-Control","HumanCoreExome-12v1-0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 54 variables, 1 molecular datasets, 321 subjects, 321 samples","","NIAID","DS-HIV-IRB --- Disease-specific (human immunodeficiency virus, irb)","2018-05-18","2018-05-18","ADR; ADR - Adverse drug reaction; Adverse Drug Event; Adverse Drug Events; Adverse Drug Experience; Adverse Drug Reaction"
"phs001485.v1.p1","Somatic Mutations and Cell Lineage in the Human Brain","Genetic mutations causing human disease are conventionally thought to be inherited from one's parents and present in all somatic (body) cells. Increasingly however, somatic mutations are implicated in neurological  diseases. Somatic mutations that arise during the cell divisions of prenatal brain development are inherited in clonal fashion and can cause","Cockayne Syndrome","Case-Control","Not Provided","Not Applicable","WGA, WGS","5 phenotype datasets, 30 variables,  SRA, 24 subjects, 185 samples","","NINDS","DS-NEURO-PUB-GSO --- Disease-specific (neurological diseases, pub, gso)","2018-02-02","2018-02-02","Cockayne's syndrome; Dwarfism-Retinal Atrophy-Deafness Syndrome; Progeria Like Syndrome; Progeria-Like Syndrome; Progeria-Like Syndromes; Progeroid Nanism"
"phs001486.v2.p2","NCI Cancer Model Development for the Human Cancer Model Initiative","The Cancer Model Development Center (CMDC) project is part of the Human Cancer Model Initiative (HCMI) and is managed by the Office of Cancer Genomics within the Center for  Cancer Genomics at the National Cancer Institute (NCI). The goal of the HCMI is to generate approximately 1000 novel human ""next generation"" tumor","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 5 variables, 451 subjects, 451 samples","","NCI","GRU --- General research use","2019-06-05","2019-02-07","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001487.v1.p1","Center Common Disease Genomics [CCDG] - CVD - TAICHI","The TaiChi consortium consists of 6 studies that collaborated initially in a large scale metabochip study, and became an ongoing consortium for studies of cardiometabolic disease in the Chinese  population in Taiwan. The six studies included the following: 1) SAPPHIRe (Stanford-Asian Pacific Program in Hypertension and Insulin Resistance), a","Not Provided","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets,  SRA, 770 subjects, 770 samples","East Asian (770)","NHGRI","DS-MULTIPLE_DISEASES-IRB-COL-NPU-RD --- Disease-specific (cardiovascular, metabolic disease and associated risk factors, irb, col, npu, rd)","2018-08-15","2018-08-15",""
"phs001488.v1.p1","Creatine in Huntington's Disease (HD) (CREST-E)","This is a multi-center, randomized, double-blind, placebo-controlled trial of creatine monohydrate involving 553 ambulatory subjects with HD who are not requiring skilled care or institutionalization. Eligible subjects were randomized  to receive up to 40 grams daily of creatine monohydrate or matching placebo. Randomization will be followed by a Titration Phase, a Maintenance Phase","Huntington Disease","Clinical Trial","Not Provided","Not Applicable","Not Provided","61 phenotype datasets, 767 variables, 50 documents, 553 subjects","","NINDS","DS-NDR-COL --- Disease-specific (neurological disorders research, col)","2018-03-26","2018-03-26","Chorea, Chronic Progressive Hereditary (Huntington); Chorea, Huntington; Chorea, Huntington's; Chronic Progressive Hereditary Chorea (Huntington); Chronic progressive chorea; Chronic progressive hereditary chorea"
"phs001489.v1.p1","CCDG NP Epilepsy: Epi25 Consortium","Epilepsy genetics research is at an exciting stage where it is now feasible, with the power of a large cohort, to understand the more complex genetic components of epilepsy.  The driving principle behind the Epi25 Consortium is collaboration and synergy - it is only possible to achieve this type of research by working","Epilepsy","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 5859 subjects, 5859 samples","","NHGRI","EPIL_BRAIN_AB_INTEL_DIS_MDS --- Epilepsy, structural brain abnormalities, intellectual dis, mds , DS-EP --- Disease-specific (epilepsy) , HMB-MDS --- Health/medical/biomedical (mds) , GRU-IRB --- General research use (irb) , GRU --- General research use , CARDIO_NEURO --- Cardiology and neurology research , DS-SEIZD --- Disease-specific (seizure disorders) , DS-EP-MDS --- Disease-specific (epilepsy, mds) , DS-EP-NPU --- Disease-specific (epilepsy, npu) , EPILEPSY_MULTIPLE_CONDITIONS_MDS --- Epilepsy, multiple conditions , HMB --- Health/medical/biomedical , EPIL_BRAIN_AB_MDS --- Epilepsy, structural brain abnormalities, mds , DS-EPI-ADULT-NPU-MDS --- Disease-specific (epilepsy - adults, npu, mds) , GRU-NPU --- General research use (npu) , EPIL_BRAINAB_CONVUL_INTELCT_DIS_MDS --- Epilepsy, structural brain abnormalities, convulsions, intellect dis, mds , EPIL_CO_MORBIDI_MDS --- Epilepsy and epilepsy comorbidities, mds , EPIL_BRAINCONVULS_INTELLECT_DIS_MDS --- Epilepsy, structural brain abnormalities, convulsions, intellect dis, npu, mds , EPIL_MULTIPLE_CONDTIONS_MDS --- Epilepsy, multiple conditions, mds , EPIL_ANTI_SEIZURE_MEDS_MDS --- Epilepsy, antiseizure meds, mds , HMB-NPU-MDS --- Health/medical/biomedical (npu, mds) , EPIL_ETIOLOGY_ANTI_SEIZURE_MEDS_MDS --- Epilepsy, etiology, and antiseizure drugs, mds","2018-12-21","2018-12-21","EP - Epilepsy; Epilepsies; Epileptic; Epileptic disorder; Seizure Disorder; Seizure Disorders"
"phs001490.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: BioMe Biobank Program","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Diabetes Mellitus, Type 2","Case-Control","ExomeChip, WES_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 21 variables, 2 molecular datasets,  SRA, 2587 subjects, 2587 samples","European (9), African (245), African American (2297), Hispanic1 (18), Hispanic2 (1), South Asian (4), Other (18)","NIDDK","HMB-MDS --- Health/medical/biomedical (mds)","2018-07-09","2018-07-09","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001491.v1.p1","Proteomics and Genetics of Enamel and Dentin","The long-term objective of this research project is to discover the complete spectrum of genes that contribute to the etiologies of genetic disorders of the dentition. Inherited tooth defects  can be isolated (the only symptom) or syndromic (having additional symptoms) and can be caused by mutations in many different genes. Clinically, it","Amelogenesis Imperfecta","Case-Control","Not Provided","Not Applicable","WXS","5 phenotype datasets, 22 variables,  SRA, 100 subjects, 100 samples","","NIDCR","NTUH-HMB-IRB-PUB-COL-NPU-MDS-GSO --- Ntuh taiwan health/medical/biomedical (irb, pub, col, npu, mds, gso) , TURKEY-HMB-IRB-PUB-COL-NPU-MDS-GSO --- Turkey health/medical/biomedical (irb, pub, col, npu, mds, gso) , HMB --- Health/medical/biomedical","2018-03-12","","AI; AI - Amelogenesis imperfecta; Congenital Enamel Hypoplasia; DGI; DGI without OI; DI"
"phs001492.v1.p1","GWAS on Calcific Aortic Valve Stenosis in Quebec (QUEBEC-CAVS)","Calcific aortic valve stenosis (CAVS) is a common and life-threatening heart disease with no drug that can stop or delay its progression. A genome-wide association study (GWAS) on 1,009  cases and 1,017 ethnically-matched controls was performed to identify susceptibility genes for CAVS.","Aortic Valve Stenosis","Case-Control","Not Provided","Not Applicable","Not Provided","1 analyses","","NHLBI","GRU --- General research use","2018-03-13","2018-03-13","AORTIC VALVE STENOSIS; Aortic Stenosis; Aortic Valve Stenoses; Narrowing of aortic valve; Stenosed aortic valve; Stenoses, Aortic"
"phs001493.v1.p1","Whole Exome Predictors Immune Checkpoint Therapy Response in Renal Cell    Carcinoma","Immune checkpoint therapies, including monoclonal antibodies to programmed cell death-1 (PD-1) and cytotoxic % lymphocyte associated protein-4 (CTLA-4), yield durable clinical responses across many tumor types, including metastatic melanoma,  non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC). However, predictors of response to these therapies in RCC are still unknown","Carcinoma, Renal Cell","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 17 variables, 71 subjects, 143 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , GRU --- General research use","2018-02-02","2018-02-02","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs001494.v1.p1","AIDS Linked to the Intravenous Experience (ALIVE) Cohort","The AIDS Linked to the Intravenous Experience (ALIVE) Study is a long-standing community based research effort that includes past and current injection drug users (IDUs). ALIVE has been ongoing  since 1988 and is one of the longest-running community-based cohorts of IDUs in existence. The primary objectives when the study started were to","Substance-Related Disorders","Prospective Longitudinal Cohort","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 35 variables, 1 molecular datasets, 1145 subjects, 1140 samples","European (163), African (18), African American (944), Hispanic1 (7), Hispanic2 (1), Other Asian or Pacific Islander (1), Other (6)","NIDA","GRU --- General research use","2018-03-14","2018-03-14","Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs001495.v2.p1","DAXX Suppression of ALT","Many tumors maintain chromosome ends through a telomerase-independent, homologous recombination based mechanism called alternative lengthening of telomeres (ALT). While ALT occurs in only a subset of tumors, it is  strongly associated with mutations in the genes encoding components of the histone H3.3 chaperone complex, ATRX and DAXX. To date the mechanistic","Osteosarcoma","Case Set","Not Provided","Not Applicable","OTHER, RNA-Seq","4 phenotype datasets, 20 variables,  SRA, 5 subjects, 14 samples","","NCI","GRU --- General research use","2019-03-06","2018-02-02","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteochondrosarcoma; Osteogenic Sarcoma; Osteogenic Sarcomas"
"phs001496.v1.p1","A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean    Hispanics","Warfarin is an oral anticoagulant and one of the most used drugs in the world accounting for up to 1.5% of prescriptions globally. Warfarin inhibits vitamin K epoxide reductase  complex 1 (VKORC1), an enzyme responsible for the vitamin K recycling that is required for the activation of clotting factors. Warfarin is prescribed","Warfarin Sensitivity","Case-Control","target_markerset_grc37, custom_array","Not Applicable","SNP Genotypes (Array), SNP Genotypes (NGS)","4 phenotype datasets, 45 variables, 8 documents, 2 analyses, 1 molecular datasets,  SRA, 115 subjects, 212 samples","","NHLBI","GRU-IRB-NPU --- General research use (irb, npu)","2018-12-07","2018-12-07","WARFARIN SENSITIVITY"
"phs001497.v1.p1","UCSF Adult Glioma Study","The UCSF Adult Glioma Study is a case-control study conducted at the University of California, San Francisco. The goals of the study were to discover inherited (genetic), developmental, immunologic  and other risk factors for glioma and to determine molecular level tumor markers that would be helpful in classifying glioma into more homogeneous","Not Provided","Case-Control","ConsortiumOncoArray, HumanCNV370-Duo_v1, HumanMethylation450","Not Applicable","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 2247 subjects, 2247 samples","European (1842), African (1), East Asian (60), African American (69), Hispanic1 (20), Hispanic2 (93), Other Asian or Pacific Islander (41), South Asian (17), Other (32)","NCI","GRU --- General research use , DS-BT-CA-MDS --- Disease-specific (brain tumors and all cancer, mds)","2018-01-10","2018-01-10",""
"phs001498.v1.p1","INSIGHT Microbiome Study","This is a study of the oral and gut microbiome of 226 mother-child dyads enrolled in the INSIGHT (Intervention Nurses Start Infants Growing on Healthy Trajectories) study. INSIGHT is  a randomized, controlled trial comparing a responsive parenting intervention designed for the primary prevention of childhood obesity against a","Pediatric Obesity","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 55 variables, 452 subjects","","NIDDK","GRU-IRB-GSO --- General research use (irb, gso)","2018-03-29","2018-03-29","Child Obesity; Childhood Obesity; Childhood Onset Obesity; Childhood obesity BMI 95-100 percentile; Obesity in Childhood; Obesity, Child"
"phs001500.v1.p1","NCI Primary Human Melanocyte QTL Study","In order to create a melanocyte-specific eQTL resource, we obtained primary human melanocyte cultures isolated from foreskin of 106 healthy newborn males predominantly of European descent. Melanocytes were cultured  in lot-matched culture medium in randomized batches to minimize variability that could be introduced by culturing conditions. RNA sequencing and","Melanocytes","Methods","RNAseq_probe_set_grc37, HumanOmniExpress-24v1-0_A","Not Applicable","SNP Genotypes (Array), RNA-Seq, RNA Seq expression levels","5 phenotype datasets, 24 variables, 2 molecular datasets, 106 subjects, 106 samples","","NCI","GRU --- General research use","2018-08-02","2018-08-02","Not Provided"
"phs001502.v1.p1","CCDG-Cardiovascular: University of Pennsylvania Cohort","The National Human Genome Research Institute (NHGRI) has funded the Centers for Common Disease Genomics (CCDG), a collaborative large-scale genome sequencing effort to comprehensively identify rare risk and protective  variants contributing to multiple common disease phenotypes and to better understand the general principles of genomic architecture underlying common","Cardiovascular Diseases","Case-Control","custom_markerset, WGS_markerset_grc37","Not Applicable","Legacy Genotypes, SNP Genotypes (NGS)","4 phenotype datasets, 13 variables, 1 molecular datasets, 1373 subjects, 95 samples","","NHLBI","HMB-IRB-PUB --- Health/medical/biomedical (irb, pub)","2019-09-12","2019-09-12","Not Provided"
"phs001503.v1.p1","Women's Interagency HIV Study (WIHS)","The Women's Interagency HIV Study (WIHS), a multicenter, prospective study, was established in August 1993 to carry out comprehensive investigations of the impact of HIV infection and its clinical,  laboratory, and psychosocial effects in women. The purpose of this study is to collect and evaluate these data from HIV infected and at-risk women to","HIV","Prospective Longitudinal Cohort","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 26 variables, 3 documents, 1 molecular datasets, 864 subjects, 864 samples","European (95), African (26), African American (693), Hispanic1 (17), Hispanic2 (18), Other Asian or Pacific Islander (3), South Asian (1), Other (11)","NIDA","HMB-IRB --- Health/medical/biomedical (irb)","2018-05-14","2018-05-14","AIDS Virus; AIDS Viruses; Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; HIV - Human immunodeficiency virus; HTLV-III"
"phs001504.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Hong Kong","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Diabetes Mellitus, Type 2","Case-Control","WGS_markerset_grc37, custom_array","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 976 subjects, 976 samples","East Asian (963), Other Asian or Pacific Islander (24)","NIDDK","DS-ENDO-IRB-NPU-MDS --- Disease-specific (endocrine diseases, irb, npu, mds)","2018-05-29","2018-05-29","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001505.v1.p1","Host Genetic Determinants of the Outcome of SAB by WES","In this case-control study, Complicated Staphylococcus aureus (case) is defined as bacteremia plus endocarditis or bone/joint infection, and Uncomplicated Staphylococcus aureus (control) has no such complications and was cured  at follow-up. We used whole exome sequencing to examine the cumulative effect of coding variants in each gene on risk of complicated SAB in a","Staphylococcus aureus","Case-Control","WES_markerset_grc37, target_markerset_grc37","Not Applicable","SNP Genotypes (NGS), Targeted-Capture, WXS","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 408 subjects, 408 samples","","NIAID","DS-GNB-IRB --- Disease-specific (gram negative bacteremia, irb)","2018-09-12","2018-09-12","Not Provided"
"phs001512.v1.p1","Platform for Assessing Immune Response Signatures in Healthy Human    Subjects","RNA sequencing (RNAseq) of peripheral blood lymphocytes was used to develop a means to assess immune function in a way that can be used in discovery science and applied  to patients individually in clinical settings. The premise is that profiles of RNA present in immune cells is reflective of the combined influence of","Immune System Phenomena","Methods","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 18 variables,  SRA, 17 subjects, 68 samples","","NIAID","GRU-IRB --- General research use (irb)","2018-04-05","2018-04-05","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Immune Function; Immune Function, Multicellular"
"phs001513.v1.p1","Mechanisms of Chemotherapy Resistance in T-ALL","The goals of this study are to unravel the molecular mechanisms underlying leukemic transformation and chemotherapy resistance in T-cell acute lymphoblastic leukemia (T-ALL). Towards this end, a cohort of  T-ALL lymphoblast specimens was collected at the time of initial T-ALL diagnosis (prior to the start of therapy) from children enrolled on","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, Targeted-Capture","4 phenotype datasets, 17 variables,  SRA, 109 subjects, 109 samples","","NCI","DS-LEU --- Disease-specific (leukemia)","2018-08-02","2018-08-02","Acute T Cell Leukemia; Acute T Cell Lymphoblastic Leukemia; Acute T-Cell Leukemia; Acute T-Cell Leukemias; Acute T-Cell Lymphoblastic Leukemia; Acute T-Lymphocytic Leukemia"
"phs001516.v1.p1","Phenotype Risk Score Study of Rare Variants","This study was designed to assess the phenotypic effects of rare variants. Rare variants are difficult to study in a high-throughput manner because most cohorts are underpowered to detect  associations. In order to gain power to test rare variants, we use Phenotype Risk Scores (PheRS) based on features of Mendelian diseases. PheRS is","Genetic Diseases, Inborn","Case-Control","HumanExome","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 1217 variables, 1 documents, 1 analyses, 1 molecular datasets,  SRA, 21701 subjects, 21701 samples","","OD","GRU-NPU --- General research use (npu)","2018-03-16","2018-03-16","Disease, Genetic; Disease, Hereditary; Diseases, Genetic; Diseases, Hereditary; Disorder, Genetic; Disorders, Genetic"
"phs001517.v1.p1","Genetics of Human Inherited Retinal Diseases (GHIRD)","The goal of this project is to identify novel mutations and genes involved in human retinal disorders, a stated priority of the National Eye Institute. To accomplish this, additional  genes whose mutations cause inherited retinal diseases (IRD) will be identified by combining targeted and whole exome sequencing. We have collected","Retinitis Pigmentosa","Case Set","target_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 877 subjects, 877 samples","","NEI","DS-ED-NPU-GSO --- Disease-specific (eye disease, npu, gso)","2018-02-22","2018-02-22","CONE-ROD DYSTROPHY; Cone Rod Degenerations; Cone Rod Dystrophies; Cone Rod Dystrophy; Cone Rod Retinal Dystrophy; Cone-Rod Degeneration"
"phs001519.v1.p1","Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme","Neoantigens, which are derived from tumour-specific protein-coding mutations, are exempt from central tolerance, can generate robust immune responses and can function as bona fide antigens that facilitate tumour rejection.  We demonstrated that a strategy that uses multi-epitope, personalized neoantigen vaccination, which has previously been tested in patients with high","Glioblastoma","Clinical Trial","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 15 variables,  SRA, 10 subjects, 31 samples","","NCI","GRU --- General research use","2018-12-14","2018-12-14","Astrocytoma, Grade IV; Astrocytomas, Grade IV; GBM; GBM (Glioblastoma); Giant cell glioblastoma (histologic variant); Glioblastoma multiforme"
"phs001521.v1.p1","Immunoprotective Mechanisms and Microbiota Interplay in Salmonella Typhi    Infection","Vaccine development against Salmonella enterica serovar Typhi (S. Typhi) requires a better understanding of interaction between human host and the resident microbial consortia in gastrointestinal tract. Healthy adult volunteers  received either Ty21a, M01ZH09 or placebo, and underwent challenges with wt S. Typhi. Stool samples were collected at the screening interview","Microbiota","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 18 variables,  SRA, 99 subjects, 297 samples","","NIAID","GRU-IRB --- General research use (irb)","2018-12-12","2018-12-12","Human Microbiome; Human Microbiomes; Microbiome, Human"
"phs001522.v1.p1","Germline De Novo Mutations with Parent of Origin in WGS Trios","This study is part of the 'First 1,000 Days of Life and Beyond' study at the Inova Translational Medicine Institute. Whole-genome sequencing data from 1,291 parent-offspring trios was used  to study the properties of clustered de novo mutations. The maternal clusters were found to be enriched in regions with accelerated maternal mutation","Not Provided","Family/Twin/Trios","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","5 phenotype datasets, 19 variables, 1 molecular datasets,  SRA, 3813 subjects, 1291 samples","","NICHD","GRU-IRB --- General research use (irb)","2018-04-19","2018-04-19",""
"phs001523.v1.p1","Multi-Omic Microbiome Study-Pregnancy Initiative (MOMS-PI)","The Vaginal Microbiome Consortium team at Virginia Commonwealth University has conducted the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) in collaboration with the Global Alliance to Prevent Prematurity and Stillbirth  (GAPPS) to better understand how microbiome and host profiles change throughout pregnancy and influence the establishment of the nascent microbiome","Pregnancy","Prospective Longitudinal Cohort","Not Provided","Not Applicable","OTHER","9 phenotype datasets, 263 variables,  SRA, 597 subjects, 10580 samples","","NICHD","DS-PREG-COM-IRB-PUB-MDS --- Disease-specific (pregnancy complications, irb, pub, mds)","2019-05-02","2019-05-02","Gestation; Pregnancy, function; Birth, Premature; Birth, Preterm; Births, Premature; Births, Preterm"
"phs001525.v1.p1","Genome and Transcriptome Analysis of X-Linked Dystonia Parkinsonism    Cohort","X-linked Dystonia-Parkinsonism (XDP) is a long-standing quandary in human disease genetics. XDP is predominantly observed on Panay island in the Philippines. This study is one of the first of  its kind to interrogate an unsolved Mendelian disorder by integrating genome and transcriptome assembly methods using Illumina, 10X Genomics, Pacific","X-Linked Dystonia Parkinsonism","Mendelian","Not Provided","Not Applicable","RNA-Seq, Targeted-Capture, WGS","6 phenotype datasets, 40 variables,  SRA, 62 subjects, 180 samples","","NINDS","HMB --- Health/medical/biomedical","2018-03-12","2018-03-12","TAF(II)250-interacting factor B; TATA-binding protein associated factor 250 kDa; TFIID 250 kDa subunit; DYSTONIA-PARKINSONISM, X-LINKED; DYT3; Lubag"
"phs001526.v1.p1","Next Generation Sequencing of Diffuse Intrinsic Pontine Glioma Samples","Diffuse intrinsic pontine glioma (DIPG) is an extremely rare ( 350 cases/year) and universally fatal childhood brain cancer. Standard clinical strategies such as chemotherapy and radiotherapy show only transient  improvement in patient condition and result in negligible change in survival, DIPG remains at below 1% survival after 5 years. Prioritization of","Glioma","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels, WXS","4 phenotype datasets, 27 variables, 1 molecular datasets,  SRA, 14 subjects, 52 samples","","NCI","GRU --- General research use , GRU-COL --- General research use (col) , GRU-COL-NPU --- General research use (col)","2019-05-06","2019-05-06","Glial Cell Tumor; Glial Cell Tumors; Glial Neoplasm; Glial Tumor; Neoplasm of Neuroglia; Neoplasm of the Neuroglia"
"phs001527.v1.p1","Oral Microbiome in Esophageal Adenocarcinoma","The purpose of our study was to assess the influence of oral microbiota on the development of esophageal cancer. Our preliminary case-control studies reported a global alteration of foregut  microbiome in esophageal adenocarcinoma with the strongest changes found in the oral microbiome. We hypothesise that commensal oral bacteria are","Esophageal Neoplasms","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 18 variables,  SRA, 219 subjects, 219 samples","","NCI","HMB-IRB-PUB-COL --- Health/medical/biomedical (irb, pub, col)","2018-09-28","2018-09-28","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophagus Neoplasm; Esophagus Neoplasms; Esophagus Tumor"
"phs001528.v1.p1","Gene Expression of Small Cell Carcinoma of the Ovary-Hypercalcemic Type","Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) is a rare and aggressive form of ovarian cancer afflicting young women at a median age of 24 years. SCCOHTs are  characterized by loss of protein expression of SWI/SNF chromatin remodeling ATPases SMARCA4 and SMARCA2 through mutation and epigenetic silencing","Ovarian Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq","5 phenotype datasets, 22 variables, 2 subjects, 2 samples","","NCI","HMB --- Health/medical/biomedical","2018-02-22","2018-02-22","Neoplasm of Ovary; Neoplasm of the Ovary; Neoplasm of the ovaries; Neoplasm, Ovarian; Neoplasm, Ovary; Neoplasms, Ovarian"
"phs001529.v1.p1","Single-Cell RNA-Seq of Rheumatoid Arthritis Synovial Tissue","Droplet-based single-cell RNA-seq has emerged as a powerful technique for massively parallel cellular profiling. While these approaches offer the exciting promise to deconvolute cellular heterogeneity in diseased tissues, the  lack of cost-effective, reliable, and user-friendly instrumentation has hindered widespread adoption of droplet microfluidic techniques. To address","Arthritis, Rheumatoid","Methods","RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels","3 phenotype datasets, 13 variables, 1 molecular datasets, 6 subjects, 20287 samples","","NIAMS","HMB-MDS --- Health/medical/biomedical (mds)","2018-04-16","2018-04-16","Not Provided"
"phs001531.v1.p1","Genetic Variation Associated with Bicuspid Aortic Valve in Turner    Syndrome","Turner syndrome is a disorder affecting only girls and women, which is caused by a complete or partial loss of the second sex chromosome. Girls and women with Turner  syndrome have a variety of phenotypes. Of interest to this study is aortopathy, including bicuspid aortic valve (BAV) and thoracic aortic dilation","Turner Syndrome","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 22 variables, 1 documents, 1 molecular datasets,  SRA, 188 subjects, 188 samples","","NHLBI","DS-TS-X-IRB-NPU-MDS --- Disease-specific (turner syndrome, irb, npu, mds)","2018-10-11","2018-10-11","45, X Syndrome; 45,X syndrome; 45,X/46,XX syndrome; Bonnevie-Ulrich syndrome; Chromosome X Monosomy X; Gonadal Dysgenesis"
"phs001532.v1.p1","Nicotine Dependence GWAS Meta-Analysis","Nicotine dependence reduces the likelihood of quitting smoking and predicts withdrawal severity, treatment response, and smoking-related health outcomes. Nicotine dependence is a heritable trait (heritability estimates up to 75%),  and prior genome-wide association study (GWAS) analyses have firmly established associations with DNA sequence variants in nicotine acetylcholine","Tobacco Use Disorder","Cross-Sectional","Not Provided","Not Applicable","Not Provided","3 analyses","","NIDA","GRU-IRB-NPU --- General research use (irb, npu)","2018-04-18","2018-04-18","Dependence, Nicotine; Nicotine Addiction; Nicotine Dependence"
"phs001534.v1.p1","Pathways Study","The Pathways Study (NCI R01 CA105274, PI: Kushi), is a prospective cohort study of a diverse population of recently diagnosed breast cancer survivors in KPNC. The aims are to  examine the effect on recurrence and survival of 1) lifestyle factors such as diet, physical activity, and use of complementary and alternative","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4383 subjects, 4576 samples","European (2993), African (11), East Asian (334), African American (324), Hispanic1 (32), Hispanic2 (384), Other Asian or Pacific Islander (196), South Asian (49), Other (53)","NCI","","","","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001535.v1.p1","Offspring Sex Affects Placental DNA Methylation and Gene Expression in    Diabetics","Exposure to diabetes in utero is known to increase the offspring's likelihood of developing metabolic disease in adulthood, but the mechanisms involved are unknown. It has been proposed that  early exposure to hyperglycemia and elevated insulin levels may lead to malprogramming of the fetus leading to the subsequent development of diabetes","Diabetes, Gestational","Case-Control","HumanMethylation450","Not Applicable","Methylation (CpG)","4 phenotype datasets, 15 variables, 1 molecular datasets, 34 subjects, 34 samples","","NIDDK","DS-T2D_GDM-IRB-COL --- Disease-specific (type 2 diabetes or gestational diabetes mellitus, irb, col)","2018-08-22","2018-08-22","Diabetes Mellitus, Gestational; Diabetes in Pregnancy; Diabetes mellitus arising in pregnancy; Diabetes, Pregnancy Induced; Diabetes, Pregnancy-Induced; GDM"
"phs001538.v1.p1","NAMDC Patient Registry and Biorepository","Mitochondrial diseases are caused by dysfunction of the mitochondria, which are specialized compartments that are present in every cell of the body except red blood cells. Mitochondria generate more  than 90% of the energy that the body needs to sustain life and support growth. When they fail, less and less energy is generated within the cell","Mitochondrial Diseases","Methods","Not Provided","Not Applicable","Not Provided","12 phenotype datasets, 610 variables, 1 documents, 541 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-06-25","2018-06-25","Miras; Mitochondrial Recessive Ataxia Syndrome; Sando; Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia; 3 Methylglutaconic Aciduria, Type II; 3 Methylglutaconicaciduria Type 2"
"phs001539.v1.p1","MAGNet Study","The MAGNet repository includes samples from normal donors at the time of cardiac transplantation. The study protocol was approved by the Institutional Review Board at the University of Pennsylvania,  and all patients provided written informed consent to participate.","Atrial Fibrillation","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 14 variables,  SRA, 101 subjects, 101 samples","","NHLBI","HMB-MDS --- Health/medical/biomedical (mds)","2018-09-04","2018-09-04","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001548.v1.p1","TCR Repertoire of CD4+ T Cells in Human Lymph Nodes","The TCR repertoire of CD4+ T cells in human lymph nodes is a case-based analysis of the TCR repertoire of CD4+ T cells in human lymph nodes. The study  aims to determine how HIV infection alters the repertoire complexity of follicular helper T cells (TFH) in relationship to other T cell subsets in","HIV","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 23 variables,  SRA, 8 subjects, 24 samples","","NIAID","DS-HIV-PUB-NPU --- Disease-specific (human immunodeficiency virus, pub, npu)","2018-03-14","2018-03-14","AIDS Virus; AIDS Viruses; Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; HIV - Human immunodeficiency virus; HTLV-III"
"phs001549.v1.p1","Genome-wide Association Study and Meta-Analysis of Ewing Sarcoma","We combined a set of 122 French Ewing sarcoma (EWS) cases from the Institut Curie, 19 EWS cases from the National Cancer Institute (NCI) Center for Cancer Research (CCR),  and 29 EWS cases from the NCI Bone Disease and Injury Study. All EWS cases were confirmed by medical record review and the presence of a specific","Sarcoma, Ewing","Case-Control","1000G_ref_panel, HumanOmniExpress","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 13 variables, 2 molecular datasets, 170 subjects, 170 samples","European (165), Hispanic1 (4), Other (1)","NCI","DS-BONE --- Disease-specific (bone cancers) , DS-ES --- Disease-specific (ewing's sarcoma) , GRU --- General research use","2018-08-31","2018-08-31","ES; Ewing Sarcoma; Ewing Tumor; Ewing's Sarcoma; Ewing's Tumor; Ewings Sarcoma"
"phs001550.v2.p1","The Genetic and Transcriptomic Evolution of Melanoma","The overarching goal of the study was to better understand the evolution of melanoma. To do this, we collected archival tissue of melanomas adjacent to their intact, remnant precursor  lesions. We also collected archival tissue of primary melanomas and their matching metastases. From the formalin-fixed paraffin-embedded (FFPE","Melanoma","Tumor vs. Matched-Normal","Not Provided","Not Applicable","RNA-Seq, Targeted-Capture, WXS, miRNA-Seq","4 phenotype datasets, 21 variables,  SRA, 82 subjects, 348 samples","","NCI","DS-M-NPU --- Disease-specific (melanoma, npu)","2019-01-10","2018-03-19","Clonal Evolution; Evolution, Clonal; Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas"
"phs001551.v1.p1","Epilepsy Genetics Initiative","The Epilepsy Genetics Initiative (EGI) was created in 2014 with the goal of amassing a database of clinically-generated exome sequence data for patients with epilepsy who have had diagnostic  whole exome sequencing. Most of the subjects enrolled in the study did not receive a secure genetic diagnosis from their initial sequencing","Epilepsy","Family/Twin/Trios","Not Provided","Not Applicable","WXS","5 phenotype datasets, 22 variables,  SRA, 101 subjects, 101 samples","","NINDS","GRU-PUB --- General research use (pub)","2018-09-11","2018-09-11","EP - Epilepsy; Epilepsies; Epileptic; Epileptic disorder; Seizure Disorder; Seizure Disorders"
"phs001552.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: PGR","The 52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2  diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by","Diabetes Mellitus, Type 2","Case-Control","ExomeChip, WES_markerset_grc37","Not Applicable","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 2 molecular datasets,  SRA, 1826 subjects, 1826 samples","African American (2), Hispanic1 (7), Other Asian or Pacific Islander (1), South Asian (1783), Other (33)","NIDDK","GRU-IRB --- General research use (irb)","2018-09-24","2018-09-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001553.v1.p1","Charcot-Marie-Tooth Disease Pediatric Scale","Information about how different forms of CMT affect children is not readily available because there are not good methods to measure impairment of children with CMT. The purpose of  this project is to develop and test such a method and to then test this scale to ensure that it is an effective measurement of impairment of CMT in","Charcot-Marie-Tooth Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 21 variables, 1 documents, 208 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-04-10","2018-04-10","Atrophies, Peroneal Muscular; Atrophy, Muscular, Peroneal; Atrophy, Peroneal Muscular; CMT/HMSN; Charcot Marie Disease; Charcot Marie Tooth Disease"
"phs001554.v1.p1","Detection of Colorectal Cancer Susceptibility Loci Using Genome-Wide    Sequencing","The Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) is a collaborative effort comprised of a coordinating center and scientific researchers from well-characterized cohort and case-control studies. This international  consortium aims to accelerate the discovery of common and rare genetic risk variants for colorectal cancer by conducting large-scale meta-analyses of","Colorectal Neoplasms","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","4 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 2892 subjects, 2892 samples","European (2889), Hispanic1 (1), Hispanic2 (1), Other (1)","NCI","GRU --- Disease-specific (colorectal cancer, npu, gso) , HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , CADM --- Disease-specific (colorectal cancer, npu, gso)","2018-08-06","2018-08-06","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001555.v1.p1","CRIM Status and Follow-up of Individuals with Pompe Disease","Infantile-onset Pompe disease is an inherited disorder that is normally diagnosed within the first months of life. It is caused by lack of or defect in an enzyme (a  special protein that carries out normal chemical reactions within the body) called acid alpha-glucosidase (GAA). GAA normally breaks down glycogen","Pompe Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 91 variables, 3 documents, 144 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-05-08","2018-05-08","ACID ALPHA-GLUCOSIDASE DEFICIENCY; ACID MALTASE DEFICIENCY; ALPHA-1,4-GLUCOSIDASE DEFICIENCY; AMD; Acid Alpha Glucosidase Deficiency; Acid Alpha-Glucosidase Deficiencies"
"phs001556.v1.p1","BRAINcode","BRAINCODE: How Does the Human Genome Function in Specific Brain Neurons? The human brain comprises about 86 billion neurons whose function is central to human biology. How does the  human genome program high performing neurons and neural networks in response to experience? What subprograms does the genome express in","Parkinson Disease","Control Set","HumanOmniExpressExome-8v1_A","Not Applicable","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 100 subjects, 211 samples","European (91)","NINDS","HMB-COL --- Health/medical/biomedical (col)","2018-07-19","2018-07-19","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease"
"phs001557.v1.p1","Mosaic Chromosomal Aneuploidy","Mosaic chromosomal aneuploidy occurs when only a subset of cells carries an abnormal number of chromosomes. Mosaic aneuploidy has been reported in multiple types of diseases. Here we have  developed a new sequencing-based approach to identify, characterize and quantify mosaic aneuploidy events in human tissue samples. This ongoing study","Hemihyperplasia","Case-Control","target_markerset_grc37, WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), Targeted-Capture, WXS","4 phenotype datasets, 19 variables, 1 molecular datasets, 2 subjects, 3 samples","","NICHD","GRU-PUB --- General research use (pub)","2018-05-16","2018-05-16","Child Development Disorders, Pervasive; Pervasive Child Development Disorders; HEMI-3 SYNDROME; HEMIHYPERPLASIA; HEMIHYPERTROPHY, ISOLATED; HHP"
"phs001559.v1.p1","Contribution of Genetic Polymorphisms to the Abuse Liability of Oxycodone","The proposed study examined the prevalence of various genetic polymorphisms thought to be involved in opioid abuse among current heroin users. In addition to providing blood samples for genetics  analysis, participants completed a number of questionnaires that allowed us to learn detailed information about their current and history of opioid","Heroin Dependence","Case Set","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 37 variables, 2 documents, 1 molecular datasets, 190 subjects, 183 samples","European (44), African (2), African American (82), Hispanic1 (40), Hispanic2 (2), Other (13)","NIDA","GRU-IRB --- General research use (irb)","2018-08-23","2018-08-23","Addiction, Heroin; Dependence, Heroin; Heroin Addiction"
"phs001563.v1.p1","Blood Handling and Leukocyte Isolation Methods Impact the Global    Transcriptome of Immune Cells","In order to characterize the effects of upstream sample handling on the transcriptome of isolated leukocyte populations, we simulated various sample handling methods on whole blood prior to leukocyte  isolation for low-input RNA-sequencing.","Cerebral Hemorrhage","Control Set","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 12 variables, 9 subjects, 87 samples","","NINDS","HMB --- Health/medical/biomedical","2018-10-22","2018-10-22","Bleeding in brain; Brain Hemorrhage, Cerebral; Brain Hemorrhages, Cerebral; Cerebral Brain Hemorrhage; Cerebral Brain Hemorrhages; Cerebral Hemorrhages"
"phs001564.v1.p1","Sequencing of Urinary Cell-Free DNA From Renal Transplant Recipients","The risk of acquiring urinary tract infection (UTI) is very high for patients who have received kidney transplants; nearly half will develop bacteruria and an eighth viruria via BK  polyomavirus in the first three years following transplantation. Current methodology for diagnosing viral and bacterial infections, while well","Bacteriuria","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 24 variables,  SRA, 82 subjects, 141 samples","","NIAID","GRU-IRB-PUB-COL --- General research use (irb, pub, col)","2018-06-22","2018-06-22","BK Polyomavirus; BK Virus; BKV; Human Polyomavirus BK; Human polyomavirus type BK; Papovavirus BKV"
"phs001565.v1.p1","Pre-treatment Molecular Characterizations of Tumors from Patients Who    Receive Immune Checkpoint Therapies","Immune checkpoint inhibitors yield clinical benefit in many cancer types, but molecular predictors of response have not yet been robustly characterized. In this study, we pursued whole exome sequencing  (WES) of pre-treatment tumors from patients treated with immune checkpoint therapies - including monoclonal antibodies targeting programmed cell","Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 14 variables, 71 subjects, 142 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-BLADDERCA-MDS --- Disease-specific (bladder cancer, mds) , DS-CATHLU-MDS --- Disease-specific (cancer -thoracic and lung, mds) , GRU --- General research use","2018-07-03","2018-07-03","Carcinoma, squamous cell of head and neck; Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung"
"phs001566.v1.p1","Mutations in Breast Cancer Patient with Neurofibromatosis","Targeted genetic sequencing was performed on a 41-year-old female with metaplastic breast cancer (MBC) and neurofibromatosis type I (NF1). A custom panel capturing 279 cancer related genes was used  to identify a germline pathogenic SNV in NF1, as well several other somatic alterations.","Neurofibromatosis 1","Case Set","target_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 24 variables, 1 molecular datasets, 1 subjects, 2 samples","","NCI","GRU --- General research use","2018-07-25","2018-07-25","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001568.v1.p1","Genetic Epidemiology of CLL","Chronic lymphocytic leukemia (CLL) is a subtype of B-cell lymphoproliferative disorders (LPD), and is the most common form of adult leukemia in Caucasians in the United States. Small lymphocytic  lymphoma (SLL) is also a B-cell LPD and is typically considered to be the same disease as CLL, based on pathology. We consider CLL and SLL as the","Leukemia, Lymphoid","Case-Control","HumanOmni1-Quad_v1-0_H","Not Applicable","SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 715 subjects, 715 samples","European (701), East Asian (3), African American (2), Hispanic2 (8), Other Asian or Pacific Islander (1)","NCI","DS-HM-GSO --- Disease-specific (hematological malignancies, gso)","2019-08-12","2019-08-12","Aleukemic lymphatic leukemia [obs]; Aleukemic lymphocytic leukemia [obs]; Aleukemic lymphoid leukemia [obs]; Leukemia, Lymphocytic; Leukemias, Lymphocytic; Leukemias, Lymphoid"
"phs001570.v1.p1","Randomized Phase III Trial of Neoadjuvant HER2 Therapy in Breast Cancer","This randomized phase III trial studies paclitaxel and trastuzumab with or without lapatinib to see how well they work in treating patients with stage II or stage III breast  cancer that can be removed by surgery. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells","Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 36 variables,  SRA, 277 subjects, 682 samples","","NCI","HMB-IRB-COL --- Health/medical/biomedical (irb, col)","2018-09-06","2018-09-06","lapatinib; Mitosis Modulators; ABI 007; ABI-007; ABI007; Agents, Antimitotic"
"phs001572.v1.p1","Pan-Tumor Genomic Biomarkers for PD-1 Based Immunotherapy","Tumor mutation burden (TMB) and a T-cell-inflamed gene expression profile (GEP) independently predict clinical outcome in pembrolizumab-treated patients in 22 indications and stratify distinct targets of resistance biology.","Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 15 variables,  SRA, 312 subjects, 624 samples","","NCI","DS-CA-IRB --- NULL","2018-10-11","2018-10-11","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs001575.v1.p1","Assessment of Neurological Deterioration in Subjects with LINCL","Late infantile ceroid lipofuscinosis (LINCL) is a rare, rapidly progressing lysosomal storage disease resulting from mutations in the CLN2 gene that lead to deficiency in the lysosomal protease tripeptidyl  peptidase I (TPP-I). The symptoms are largely neurological with onset at 2-4 years age with progression to death at age 8-12 yrs. The rareness of the","Late Infantile Neuronal Ceroid Lipofuscinosis","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 19 variables, 13 documents, 42 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-09-13","2018-09-13","Amaurotic idiocy early juvenile type; Amaurotic idiocy late infantile type; Amaurotic idiocy, early juvenile type; Amaurotic idiocy, late infantile type; Bielschowsky-Jansky disease; Bielschowsky-Jansky type neuronal ceroid lipofuscinosis"
"phs001576.v1.p1","Longitudinal Study of Bone and Endocrine Disease","Mucopolysaccharidoses (MPS) I, II, and VI are a group of rare, lysosomal storage diseases in which certain enzymes are missing that are normally required for breaking down specific complex  carbohydrates. Deficiencies in these enzymes result in the build-up of toxic substances in various tissues and cause damage to the body's organs. In","Mucopolysaccharidoses","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","12 phenotype datasets, 433 variables, 10 documents, 55 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-08-14","2018-08-14","Alpha-L-Iduronidase deficiency; Attenuated MPS I (subtype); Hurler syndrome (former subtype); Hurler-Scheie syndrome (former subtype); IDUA deficiency; L-iduronidase deficiency"
"phs001577.v1.p1","Structural Alterations in Castration-Resistant Prostate Cancer","Adapted from manuscript in review: Nearly all prostate cancer deaths are from metastatic castration-resistant prostate cancer (mCRPC) but there have been few whole genome sequencing (WGS) studies of this  disease state. We performed linked-read WGS on 23 mCRPC biopsy specimens and analyzed cell-free DNA sequencing data from 86 patients with mCRPC. In","Prostatic Neoplasms, Castration-Resistant","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WGS","4 phenotype datasets, 11 variables,  SRA, 20 subjects, 43 samples","","NCI","DS-MDS --- Disease-specific (cancer, mds) , DS-PC-MDS --- Disease-specific (prostate cancer, mds)","2018-09-12","2018-09-12","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001578.v1.p1","The Preterm Infant Microbiome: Biological, Behavioral and Health Outcomes    at 2 and 4 Years of Age","This project follows a cohort of 78 Very Low Birth Weight (VLBW) previously enrolled infants in a R21 grant plus additional 25 infants through their Neonatal Intensive Care Unit  (NICU) stay until they reach the age of 4 years. The data, gathered over 6 weeks of the NICU stay, includes multiple factors, such as prenatal and","Microbiota","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","82 subjects, 368 samples","","NINR","HMB --- Health/medical/biomedical","2019-02-15","2019-02-15","Acceptance Process; Acceptance Processes; Process, Acceptance; Processes, Acceptance; Child Development; Development, Child"
"phs001581.v1.p1","Genomic Characterization of Head and Neck Cancer Cell Lines","Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer by incidence worldwide(1). Various chemical carcinogens (tobacco, alcohol and betel nut), human papillomavirus (HPV) infection, and genetic  predisposition contribute to the etiology of HNSCC, and to the complex genetic alterations in tumor subsets that differ in prognosis and response to","Head and Neck Neoplasms","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 25 variables,  SRA, 25 subjects, 37 samples","","NIDCD","GRU-PUB-NPU --- General research use (pub, npu) , DS-HNSC-PUB-NPU --- Disease-specific (head and neck squamous cell carcinoma, pub, npu)","2018-11-05","2018-11-05","Carcinoma, squamous cell of head and neck; Head Neoplasms; Neoplasms, Head; HPV Infection; HPV Infections; Human Papilloma Virus Infection"
"phs001584.v1.p1","eMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants","The Electronic Medical Records and Genomics (eMERGE) Network is a National Institutes of Health (NIH)-organized and funded consortium of U.S. medical research institutions. The primary goal of the eMERGE  Network is to develop, disseminate, and apply approaches to research that combine biorepositories with electronic medical record (EMR) systems for","Not Provided","Case-Control","HRC1_ref_panel","Not Applicable","SNP Genotypes (imputed)","6 phenotype datasets, 68 variables, 39 documents, 1 molecular datasets, 83717 subjects, 83592 samples","European (62164), African (222), East Asian (478), African American (15386), Hispanic1 (2218), Hispanic2 (1886), Other Asian or Pacific Islander (295), South Asian (327), Other (616)","NHGRI","GRU --- General research use , HMB-GSO --- Health/medical/biomedical (gso) , GRU-IRB-PUB-GSO --- General research use (irb, pub, gso) , GRU-IRB-COL-NPU --- General research use (irb, col, npu) , HMB --- Health/medical/biomedical , HMB-MDS --- Health/medical/biomedical (mds) , DS-CHILDD --- Disease-specific (childhood diseases) , DS-DEM --- Disease-specific (dementia) , HMB-PUB-GSO --- Health/medical/biomedical (pub, gso) , GRU-IRB-PUB --- General research use (irb, pub)","2019-07-11","2019-07-11","ACE Inhibitors; Angiotensin Converting Enzyme Antagonists; Angiotensin Converting Enzyme Inhibitors; Angiotensin I Converting Enzyme Inhibitors; Angiotensin I-Converting Enzyme Inhibitors; Angiotensin-Converting Enzyme Antagonists"
"phs001586.v1.p1","Rhode Island Child Health Study (RICHS)","Mother and infant pairs were enrolled in the Rhode Island Child Health Study (RICHS) at the Woman and Infant's Hospital from 2009 through 2014. This population consists of singleton,  term infants ( 37 weeks gestation) born without serious pregnancy complications or congenital or chromosomal abnormalities. Given a priority interest","Child Health","Prospective Longitudinal Cohort","MEGA_Consortium","Not Applicable","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 199 subjects, 348 samples","European (99), African (2), East Asian (2), African American (17), Hispanic1 (9), Hispanic2 (11), Other Asian or Pacific Islander (6), South Asian (1), Other (2)","NIEHS","GRU --- General research use","2019-07-23","2019-07-23","Child care; Children's Health; Childrens Health; Health, Child; Health, Children's; Health, Childrens"
"phs001587.v1.p1","Establishment and Characterization of Prostate Cancer Organoids","Using 20 models from the LuCaP mCRPC PDX cohort, including adenocarcinoma and neuroendocrine lineages, the purpose of this study was the systematic testing of 20 modifications to prostate organoid  conditions. 4 of the organoid cell lines were comprehensively evaluated for genomic and phenotypic stability and continued reliance on the AR","Prostatic Neoplasms","Case Set","HumanOmniExpress-24v1-1_A","Not Applicable","SNP Genotypes (Array), RNA-Seq, WXS","5 phenotype datasets, 21 variables, 1 molecular datasets, 4 subjects, 31 samples","European (2)","NCI","GRU --- General research use","2018-06-25","2018-06-25","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001588.v1.p1","Low LDL Cholesterol and Increased Risk of Type 2 Diabetes","Lipid lowering therapy using HMG-CoA reductase inhibitors (statins) is associated with an approximately 9-12% increase in the risk of new-onset type 2 diabetes (T2DM). The risk of diabetes could  be increased by statins directly; however, genetic approaches have also implicated low LDL cholesterol (LDL-C) concentrations as a risk factor for","Diabetes Mellitus, Type 2","Cross-Sectional","Not Provided","Not Applicable","Not Provided","80286 subjects","","NIGMS","HMB-IRB-PUB-COL-NPU --- Health/medical/biomedical (irb, pub, col, npu)","2018-07-24","2018-07-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001589.v1.p1","Breast Cancer Family Registry Early-onset Breast Cancer GWAS","In order to enhance our understanding of the genetic etiology of breast cancer, this study analyzed 1,265,548 Hapmap3 single-nucleotide polymorphisms (SNP) among a discovery set of 3,523 EOBC incident  cases and 2,702 age-matched population control women, all of whom were age 50 or younger at enrollment. Subjects were recruited from the eight sites","Breast Neoplasms","Case-Control","Not Provided","Not Applicable","Not Provided","2 analyses","","NCI","GRU --- General research use","2019-03-07","2019-03-07","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001591.v1.p1","Genomic Studies of Oral Health and Disease","The purpose of this project is to identify the genetic factors contributing to dental caries in children and adults. The datasets come from the Center for Oral Health Research  in Appalachia (COHRA), which has the long-term goal of determining the sources of oral health disparities in a high risk, Northern Appalachian","Dental Caries","Family/Twin/Trios","Not Provided","Not Applicable","Not Provided","2282 samples","","NIDCR","","","","Caries; Caries, Dental; Cariosity of teeth; Carious lesion; Decay, Dental; Dental Decay"
"phs001592.v1.p1","Center for Common Disease Genomics [CCDG] - Cardiovascular ATVB:    Atherosclerosis Thrombosis and Vascular Biology","Italian Atherosclerosis Thrombosis and Vascular Biology study is a prospective, nationwide, case-control study involving 125 coronary care units in Italy. The cases were patients who were hospitalised for a  first MI before the age of 45 years and underwent coronary angiography. Acute MI was defined as resting chest pain lasting more than 30 minutes","Atherosclerosis","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 9 variables, 1 molecular datasets,  SRA, 58 subjects, 58 samples","","NHLBI","DS-CVD --- Disease-specific (cardiovascular disease)","2019-04-08","2019-04-08","Atherogenesis; Blood Clot; Blood Clots; Clot, Blood; Clots, Blood; Thrombi"
"phs001594.v1.p1","Mucosal Melanoma Targeted Sequencing Study (UCSF)","Mucosal melanoma is a deadly disease that carries the worst prognosis amongst subtypes of melanoma. Like all melanomas, mucosal melanomas are frequently driven by activating mutations in the MAPK  and/or PI3K pathways; however, unlike melanomas that arise on sun-exposed skin, mucosal melanomas harbor few point mutations. Instead, most somatic","Melanoma","Case Set","Not Provided","Not Applicable","Targeted-Capture","4 phenotype datasets, 15 variables, 4 documents,  SRA, 38 subjects, 43 samples","","NCI","DS-M-NPU --- Disease-specific (melanoma, npu)","2019-03-19","2019-03-19","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001595.v1.p1","Norepinephrine Transporter Blockade in Neurogenic Orthostatic Hypotension","The clinical picture of autonomic failure is dominated by disabling orthostatic hypotension. Recent developments in the understanding of the underlying pathophysiology of the discrete clinical forms of autonomic failure  have revealed that participants with multiple system atrophy (MSA) are characterized by impairment of central autonomic pathways crucial for","Hypotension, Orthostatic","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 878 variables, 22 documents, 50 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2018-07-12","2018-07-12","Decrease in blood pressure upon standing up; HYPOTENSION, ORTHOSTATIC; Hypotension, Postural; Orthostatic Hypotension; Postural Hypotension; Atrophies, Multisystem"
"phs001596.v1.p1","Acral Melanoma Targeted Sequencing Study (UCSF)","Acral melanoma affects world populations irrespective of skin color. It has comparatively few single nucleotide mutations, but exhibits genomic instability characterized by structural rearrangements and amplifications. As acral melanoma  harbors BRAF (GeneID:673) mutations at low frequencies, we searched for alternative therapeutic targets. We performed targeted deep sequencing of","Melanoma","Case Set","Not Provided","Not Applicable","Targeted-Capture","4 phenotype datasets, 14 variables,  SRA, 37 subjects, 37 samples","","NCI","DS-M-NPU --- Disease-specific (melanoma, npu)","2019-05-22","2019-05-22","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001609.v1.p1","Genetic Contributions of Lupus Nephritis in A Multi-Ethnic Cohort","Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) and it occurs at a much higher rate in patients that are not of European descent. The  purpose of this study is to identify genetic variants contributing to the risk of LN in a multi-ethnic cohort of SLE patients. We used a","Lupus Erythematosus, Systemic","Case-Control","Axiom","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 964 subjects, 964 samples","European (364), African (4), East Asian (165), African American (217), Hispanic1 (6), Hispanic2 (123), Other Asian or Pacific Islander (59), South Asian (14), Other (12)","NIAMS","DS-ADO --- Disease-specific (autoimmune diseases) , DS-SLE-IRB-PUB-NPU-MDS --- Disease-specific (systemic lupus erythematosus, irb, pub, npu, mds) , DS-SLE-PUB --- Disease-specific (systemic lupus erythematosus, pub) , DS-SLE-GSO --- Disease-specific (systemic lupus erythematosus, gso)","2019-01-10","2019-01-10","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs001611.v1.p1","Pancreas Cancer Organoid Profiling","We generated a collection of patient-derived pancreatic normal and cancer organoids. We performed whole genome sequencing, targeted exome sequencing, and RNA sequencing on organoids as well as matched tumor  and normal tissue if available. This dataset is a valuable resource for pancreas cancer researchers, and those looking to compare primary tissue to","Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 16 variables, 1 documents,  SRA, 71 subjects, 188 samples","","NCI","GRU --- General research use","2019-06-21","2019-06-21","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinoma, Pancreatic Ductal; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas"
"phs001615.v1.p1","Comprehensive Epigenetic Landscape of Rheumatoid Arthritis FLS","We characterized the epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes (FLS) compared with osteoarthritis FLS. Multiple technologies were used, including ChIP-seq to assay H3K27ac, H3K4me1, H3K4me3, H3K36me3, H3K27me3, and  H3K9me3, ATAC-seq for chromatin accessibility, the transcriptome by RNA-seq and whole genomic bisulfite sequencing for DNA methylation. Integrative","Arthritis, Rheumatoid","Case-Control","Not Provided","Not Applicable","ATAC-seq, Bisulfite-Seq, ChIP-Seq, RNA-Seq","4 phenotype datasets, 14 variables,  SRA, 22 subjects, 213 samples","","NIAMS","HMB --- Health/medical/biomedical","2018-09-27","2018-09-27","Arthritides, Degenerative; Arthritis, Degenerative; Degenerative Arthritides; Degenerative Arthritis; Degenerative arthropathy; Degenerative joint disease"
"phs001616.v1.p1","eMERGE Network Phase III Clinical Sequencing: eMERGEseq Panel","The Electronic Medical Records and Genomics (eMERGE) Network is a National Institutes of Health (NIH)-organized and funded consortium of U.S. medical research institutions. The primary goal of the eMERGE  Network is to develop, disseminate, and apply approaches to research that combine biorepositories with electronic medical record (EMR) systems for","Precision Medicine","Prospective Longitudinal Cohort","target_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), Targeted-Capture","8 phenotype datasets, 53 variables, 1 documents, 1 molecular datasets,  SRA, 15700 subjects, 15700 samples","","NHGRI","GRU --- General research use , GRU-COL-NPU --- General research use (col, npu) , GRU-IRB --- General research use (irb) , GRU-IRB-NPU --- General research use (irb, npu) , GRU-IRB-PUB-NPU --- General research use (irb, pub, npu) , HMB --- Health/medical/biomedical , HMB-GSO --- Health/medical/biomedical (gso) , HMB-NPU --- Health/medical/biomedical (npu) , GRU-NPU --- General research use (npu)","2019-05-01","2019-05-01","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001618.v1.p1","Dormant TILs and Sensitivity to Immune Checkpoint Blockers in Lung Cancer","The biological determinants of sensitivity and resistance to immune checkpoint inhibitors are not completely understood. To elucidate the role of intratumoral T-cells and its association with the tumor genomic  landscape, we perform paired whole exome DNA sequencing and multiplexed quantitative immunofluorescence (QIF) in pre-treatment samples from non-small","Neoplasms","Prospective Longitudinal Cohort","WES_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 49 subjects, 84 samples","","NCI","GRU --- General research use , DS-LCTC-MDS --- Disease-specific (lung cancer and thoracic malignancies, mds)","2018-08-03","2018-08-03","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinoma, Non-Small-Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell"
"phs001619.v1.p1","Genetic Analysis of Patients with Inherited Retinal Dystrophies (IRDs)","Genetic analysis of patients with Inherited Retinal Dystrophies (IRDs) was carried out by performing Whole Genome Sequencing (WGS). The main purpose of this study is to identify simple and  complex mutations responsible for IRD in patients. WGS was performed on selected affected and unaffected individuals using the Illumina HiSeqX10. The","Retinal Degeneration","Case-Control","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WGS","5 phenotype datasets, 28 variables, 1 molecular datasets, 9 subjects, 9 samples","European (139), East Asian (1), African American (4), Hispanic1 (2), Hispanic2 (101), Other Asian or Pacific Islander (2), South Asian (64)","NEI","DS-HED-NPU-GSO --- Disease-specific (hereditary eye diseases, npu, gso)","2018-09-19","2018-09-19","Degeneration, Retinal; Degenerations, Retinal; Retina degeneration; Retinal Degenerations"
"phs001621.v1.p1","The Platinum Study","The Platinum Study is an R01-funded, multicenter study of testicular cancer survivors that characterizes both long-term cisplatin-induced peripheral neuropathy (CisIPN) and cisplatin-associated ototoxicity, i.e., permanent, bilateral hearing loss. We  collected data abstracted from medical records (e.g., cumulative cisplatin dose), conducted audiometric examinations, and administered self-report","Not Provided","Cross-Sectional","1000G_ref_panel, HumanOmniExpress","Not Applicable","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 28 variables, 2 molecular datasets, 680 subjects, 680 samples","European (680)","NCI","GRU --- NULL","2018-12-21","2018-12-21",""
"phs001623.v1.p1","Genomic Analysis of Head and Neck Cancers","These aggregate studies focus on specimens from head and neck squamous cell carcinoma (HNSCC) patients who were treated with standard of care or window of opportunity clinical trial approaches.  Specimens were interrogated with exome and RNA-Seq analysis. Patient derived xenografts (PDXs) represent a robust platform for performing co-clinical","Carcinoma, squamous cell of head and neck","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 19 variables,  SRA, 15 subjects, 116 samples","","NIDCR","GRU --- General research use , DS-CA --- Disease-specific (cancer)","2018-10-23","2018-10-23",""
"phs001625.v1.p1","Whole Genome Sequencing in Psychotic Major Depression","The goal of this case-control study, ""Whole Genome Sequencing in Psychotic Major Depression"", is to identify genes that contribute to the psychotic major depression phenotype. The samples herein were  used as controls and were obtained from the NIMH Repository Study #29, ""Molecular Genetics of Schizophrenia"".","Control Groups","Control Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 19 variables,  SRA, 252 subjects, 252 samples","","NIMH","GRU-PUB --- General research use (pub)","2019-03-27","2019-03-27","Not Provided"
"phs001627.v1.p1","Single-Cell DNA Sequencing of AML with Droplet Microfluidics","We developed a novel microfluidic platform to automatically barcode genomic DNA from individual cancer cells. Using this approach, we sequenced acute myeloid leukemia (AML) tumors targeting up to 62  loci relevant for the disease from thousands of cells. We predict that our platform will enable analysis of heterogeneity in AML and improve","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 14 variables,  SRA, 1 subjects, 3 samples","","NHGRI","GRU --- General research use","2018-07-24","2018-07-24","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs001628.v1.p1","Clinical Crenolanib Resistance in AML","FLT3 mutations are commonly detected in Acute Myeloid Leukemia (AML) patients and are associated with poor prognosis. Crenolanib, a potent type I pan-FLT3 (GeneID:2322) inhibitor, is effective against both  internal tandem duplications (ITD) and resistance-conferring tyrosine kinase domain (TKD) mutations. While crenolanib monotherapy has demonstrated","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","2 phenotype datasets, 6 variables,  SRA, 56 subjects, 119 samples","","NCI","DS-LEU --- Disease-specific (leukemia)","2019-03-29","2019-03-29","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs001629.v1.p1","Single Patient BRAF Mutant Brain Tumor, Pre- and Post-dabrafenib WES.","A single adolescent patient with a BRAF V600E mutated brain tumor was treated with dabrafenib and had a complete response, followed by progression. The pre-treatment and post-progression tumors were  both sequenced in order to identify potential drivers of resistance.","Ganglioglioma","Case Set","Somatic_Mutations","Not Applicable","SNV (.MAF), WXS","4 phenotype datasets, 25 variables, 1 molecular datasets,  SRA, 1 subjects, 2 samples","","NCI","GRU-IRB-PUB --- General research use (irb, pub)","2018-11-08","2018-11-08","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytic tumor; Astrocytoma, no ICD-O subtype"
"phs001632.v1.p1","African American Multiple Myeloma GWAS","The case set is from a case-control study designed to identify common genetic risk factors for multiple myeloma in African Americans, the population with the highest risk for this  cancer. We conducted two GWAS and combined each of these with convenience controls consisting of unaffected African American participants in cohorts","Multiple Myeloma","Case Set","HumanCoreExome-12v1-0, MEGA_Consortium_15063755_B2","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 14 variables, 1 molecular datasets, 1408 subjects, 1408 samples","European (2), African (43), African American (1348), Hispanic1 (8), Other (7)","NCI","GRU --- General research use , DS-CA --- Disease-specific (cancer) , GRU-NPU --- General research use (npu) , GRU-PUB-NPU --- General research use (pub, npu) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-MM-MDS --- Disease-specific (multiple myeloma, mds) , DS-CA-IRB-GSO --- Disease-specific (cancer, irb, gso)","2019-09-06","2019-09-06","Cell Myeloma, Plasma; Cell Myelomas, Plasma; Disease, Kahler; Familial Myeloma; Kahler Disease; Kahler's disease"
"phs001643.v1.p1","Chordoma Genomics","In this study, we performed paired tumor/normal whole exome and shallow long insert whole genome sequencing, as well as tumor RNAseq, from archival chordoma specimens collected from four patients  at the Barrow Neurological Institute in Phoenix, AZ. The purpose of this analysis was to identify potential therapeutic targets. In three patients","Chordoma","Case Set","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","4 phenotype datasets, 15 variables,  SRA, 4 subjects, 8 samples","","NCI","HMB-PUB --- Health/medical/biomedical (pub)","2018-09-25","2018-09-25","CHDM; CHORDOMA, SUSCEPTIBILITY TO; Chordomas; Notochordal sarcoma; Analysis using pyrosequencing technique; Pyrosequencing"
"phs001645.v1.p1","Genomic Landscape of Cutaneous Diffuse Large B Cell Lymphoma","Cutaneous diffuse large B cell lymphomas (DLBCL) are aggressive lymphomas with a poor prognosis. To elucidate their genetic bases, we performed whole exome capture and massively parallel sequencing on  19 tumor samples of diffuse large B cell lymphoma, leg type (DLBCL-LT) and 6 samples of secondary cutaneous diffuse large B cell lymphoma, not","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 22 variables, 25 subjects, 25 samples","","NCI","HMB-NPU --- Health/medical/biomedical (npu)","2019-02-19","2019-02-19","DLBCL; Diffuse Histiocytic Lymphoma; Diffuse Histiocytic Lymphomas; Diffuse Large Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse Large-Cell Lymphomas"
"phs001646.v1.p1","Regulatory Changes in Glioblastoma Brain Tumors and Xenografts","Non-coding elements in our genomes that play critical roles in complex disease are frequently marked by highly unstable RNA species. Sequencing nascent RNAs attached to an actively transcribing RNA  polymerase complex can identify unstable RNAs, including those templated from gene-distal enhancers (eRNAs). However, nascent RNA sequencing","Glioblastoma","Case Set","custom_array","Not Applicable","Legacy Genotypes, OTHER","3 phenotype datasets, 16 variables, 1 molecular datasets, 23 subjects, 30 samples","","NHGRI","DS-BT-IRB --- Disease-specific (brain tumors, irb)","2018-10-26","2018-10-26","BT - Brain tumor; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain"
"phs001647.v1.p1","Varieties of Impulsivity in Opiate and Stimulant Users","The overall aim of this study is to investigate the role of impulsivity as an endophenotype for drug addiction. Although impulsivity is considered one of the strongest candidate endophenotypes  for addiction, progress in the field is hampered by the heterogeneity of impulsivity, characterized by multiple personality, psychiatric, and","Impulsive Behavior","Case-Control","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 80 variables, 1 molecular datasets, 383 subjects, 383 samples","European (367), Hispanic1 (2), South Asian (2), Other (12)","NIDA","DS-SUD-IRB --- Disease-specific (substance use disorders, irb)","2018-09-27","2018-09-27","Amphetamine Related Disorders; Amphetamine induced mental disorder; Amphetamine-Related Disorders; Amphetamine-related disorder; Disorder, Amphetamine-Related; Disorders, Amphetamine-Related"
"phs001648.v1.p1","Genomic Characterization of Metastatic Castration Resistant Prostate    Cancer","Biopsies of castration resistant prostate cancer metastases were subjected to whole genome sequencing (WGS), along with RNA-sequencing (RNA-Seq). The overarching goal of the study is to illuminate molecular mechanisms  of acquired resistance to therapeutic agents, and particularly androgen signaling inhibitors, in the treatment of metastatic castration resistant","Prostatic Neoplasms, Castration-Resistant","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","101 subjects, 301 samples","","NCI","GRU --- General research use","2019-05-02","2019-05-02","Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize; Neoplasm Metastases; Tumor Cell Migration"
"phs001649.v1.p1","Center for Education and Drug Abuse Research (CEDAR)","Under its programmatic name, the Center for Education and Drug Abuse research (CEDAR), this Center of Excellence project was completed in 2015. The CEDAR sample consists of 775 nuclear  families comprising an adult male (proband), his spouse/mate, and their biological child who is 10-12 years of age at recruitment. This child is","Substance-Related Disorders","Prospective Longitudinal Cohort","Human660W-Quad_v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 37 variables, 1 molecular datasets, 469 subjects, 469 samples","European (329), African American (131), Hispanic1 (7), Hispanic2 (2)","NIDA","DS-ADX-IRB-GSO-RD --- Disease-specific (addictive disorders, irb, gso, rd)","2019-02-27","2019-02-27","Disorder, Drug Use; Drug Use Disorder; Drug Use Disorders"
"phs001651.v1.p1","Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky","This is a pilot study of squamous cell lung cancer and matched normal tissue pairs collected (convenience sample) from patients from Central Appalachia, in Southeastern Kentucky. This study performed  whole exome sequencing on tumor and matched normal DNA samples from 51 lung squamous cell carcinoma (SQCC) subjects from Appalachian Kentucky (AppKY","Lung Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 24 variables,  SRA, 51 subjects, 102 samples","","NCATS","HMB-IRB --- Health/medical/biomedical (irb)","2018-09-19","2018-09-19","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs001653.v1.p1","Coding and Non-coding Elements Implicated in Holoprosencephaly","We applied targeted capture to examine 153 genes representative of all the major vertebrate developmental pathways among 340 probands and 285 of their unaffected parents to rank their relative  significance as causes for holoprosencephaly (HPE).","Holoprosencephaly","Cross-Sectional","target_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 625 subjects, 625 samples","","NHGRI","DS-BDIS-IRB-PUB --- Disease-specific (brain disorders, irb, pub)","2019-04-15","2019-04-15","Cingulosynapsis; Holoprosencephalies, Lobar; Holoprosencephaly, Lobar; Lobar Holoprosencephalies; Lobar Holoprosencephaly; Olfactory aplasia"
"phs001654.v1.p1","NSAIDS and Somatic Mutations in Barrett's Esophagus","Background: Use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to protect against tetraploidy, aneuploidy, and chromosomal alterations in the metaplastic condition Barrett's esophagus (BE) and  to lower the incidence and mortality of esophageal adenocarcinoma (EA). The esophagus is exposed to both intrinsic and extrinsic mutagens resulting","Barrett Esophagus","Case-Control","target_markerset_grc37","Not Applicable","OTHER, SNP/CNV Genotypes (NGS)","4 phenotype datasets, 20 variables, 1 molecular datasets,  SRA, 82 subjects, 164 samples","","NCI","DS-BE --- Disease-specific (barrett's esophagus)","2018-11-28","2018-11-28","BARRETT METAPLASIA; BE; Barret syndrome; Barrett Metaplasias; Barrett Syndrome; Barrett esophagus"
"phs001655.v1.p1","Human Skin Metagenome Associated with Acne","Studies have emphasized the importance of disease-associated microorganisms in perturbed communities, however, the protective roles of commensals are largely under recognized and poorly understood. Using acne as a model  disease, we investigated the determinants of the overall virulence property of the skin microbiota when disease- and health-associated organisms","Acne Vulgaris","Case-Control","Not Provided","Not Applicable","WGS","4 phenotype datasets, 16 variables, 82 subjects, 82 samples","","NIAMS","DS-HMP --- Disease-specific (human microbiome research)","2019-01-31","2019-01-31","Not Provided"
"phs001657.v1.p1","Functional Genomic Landscape of Acute Myeloid Leukemia","The implementation of targeted therapies for acute myeloid leukemia has been challenged by complex mutational patterns within and across patients as well as a dearth of pharmacologic agents for  most mutational events. Here, we report initial findings from the Beat AML program on a cohort of 672 tumor specimens collected from 562 patients. We","Leukemia, Myeloid, Acute","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 9 variables,  SRA, 583 subjects, 1478 samples","","NCI","DS-LEU --- Disease-specific (leukemia)","2019-08-26","2019-08-26","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs001658.v1.p1","Tumor Heterogeneity in Metastatic Adrenocortical Tumors","We have analyzed 33 human metastatic adrenocortical tumors from 14 patients with advanced metastases and performed whole exome sequencing to identify novel signatures in these tumors. We observed tumor  heterogeneity in these tumors coming from the same metastatic tissue site across different patients while the different metastatic tumor sites coming","Adrenocortical Carcinoma","Prospective Longitudinal Cohort","maf_grc37","Not Applicable","SNV (.MAF), WXS","3 phenotype datasets, 22 variables, 1 molecular datasets,  SRA, 14 subjects, 33 samples","","NCI","GRU --- General research use","2018-12-04","2018-12-04","Adrenal Cortex Adenocarcinoma; Adrenal Cortex Cancer; Adrenal Cortical Adenocarcinoma; Adrenal Cortical Carcinoma; Adrenal Cortical Carcinomas; Adrenal carcinoma"
"phs001659.v1.p1","Bayesian-Based Noninvasive Prenatal Diagnosis of Single-Gene Disorders","In the last decade, non-invasive prenatal diagnosis (NIPD) has emerged as an effective procedure for early detection of inherited diseases during pregnancy. This technique is based on using cell-free  DNA (cfDNA) and fetal cfDNA (cffDNA) in maternal blood, and hence, has minimal risk for the mother and fetus compared with invasive techniques. NIPD","Not Provided","Family/Twin/Trios","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS, WXS","3 phenotype datasets, 10 variables, 1 molecular datasets,  SRA, 9 subjects, 12 samples","Hispanic1 (5), Other (1)","NICHD","GRU-IRB-NPU --- General research use (irb, npu)","2019-01-24","2019-01-24",""
"phs001660.v1.p1","Lung Cancer Pharmacogenomics (LUPG)","Lung cancer is frequently treated with paclitaxel in combination with several other agents; however, paclitaxel treatment is often ineffective or limited by treatment-related toxicities. Heritable variants in genes associated  with absorption, distribution, metabolism, and elimination may predict paclitaxel clinical outcome and toxicity. We designed a prospective multi","Paclitaxel","Case Set","DMET_Plus","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 274 variables, 1 molecular datasets, 103 subjects, 103 samples","","NCI","GRU-IRB --- General research use (irb) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-IRB --- Disease-specific (cancer, irb)","2019-02-22","2019-02-22","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs001664.v1.p1","Parkinson's Disease Cognitive Genetics Consortium (PDCGC)","Cognitive impairment is a common and disabling problem in Parkinson's disease (PD). Identification of genetic variants that influence the presence or severity of cognitive deficits in PD might provide  a clearer understanding of the pathophysiology underlying this important nonmotor feature. We are presently undertaking a large-scale, two-stage","Parkinson Disease","Case Set","target_markerset_grc37","Not Applicable","SNP Genotypes (NGS)","4 phenotype datasets, 32 variables, 1 molecular datasets, 1219 subjects, 1219 samples","","NINDS","DS-NDR-IRB-NPU --- Disease-specific (neurological disorders research, irb, npu) , DS-PDND-PUB-MDS-GSO --- Disease-specific (parkinson's disease or other neurodegenerative disorders, pub, mds, gso) , DS-PDND-MDS --- Disease-specific (parkinson's disease or other neurodegenerative disorders, mds) , GRU --- General research use","2018-10-11","2018-10-11","Cognitive Decline; Cognitive Declines; Cognitive decline, progressive; Decline, Cognitive; Declines, Cognitive; Deterioration, Mental"
"phs001666.v1.p1","Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Castration    Resistant and Neuroendocrine Prostate Cancer","Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that may develop de novo or as a mechanism of treatment resistance. N-myc is capable of driving NEPC  progression. Alisertib inhibits the interaction between N-myc and its stabilizing factor Aurora-A, inhibiting N-myc signaling, and suppressing tumor","Adenocarcinoma","Case Set","Not Provided","Not Applicable","RNA-Seq, WXS","4 phenotype datasets, 14 variables,  SRA, 49 subjects, 64 samples","","NCI","HMB-PUB --- Health/medical/biomedical (pub)","2019-04-25","2019-04-25","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs001670.v1.p1","Genetic Variants Associated with Tacrolimus Metabolism in Kidney    Transplant Recipients","An extreme phenotype sampling (EPS) model with targeted next-generation sequencing (NGS) identified genetic variants associated with tacrolimus (Tac) metabolism in subjects from the Deterioration of Kidney Allograft Function (DeKAF)  Genomics cohort which included 1,442 European Americans (EA) and 345 African Americans (AA). This study included 48 subjects separated into 4 groups","Tacrolimus","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 61 variables,  SRA, 48 subjects, 48 samples","","NIAID","DS-KTO-IRB-PUB-COL-NPU-MDS --- Disease-specific (kidney transplant outcomes, irb, pub, col, npu, mds)","2019-04-10","2019-04-10","15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-, monohydrate, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*))-; Hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone"
"phs001672.v3.p1","VA Million Veteran Program (MVP)","MVP is an ongoing prospective cohort study and mega-biobank in the Department of Veterans Affairs Healthcare System designed to study genetic influences on health and disease among veterans.","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","34 analyses","","NHLBI","HMB-MDS --- Health/medical/biomedical (mds)","2019-08-13","2019-08-13","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001673.v1.p1","ADAGESIII: Contribution of Genotype to Glaucoma Phenotype in African    Americans","Glaucoma results in vision loss due to damage of the optic nerve that is irreversible if undetected or untreated. The most common form of glaucoma is primary open angle  glaucoma (POAG). While glaucoma affects all races, persons of African descent are disproportionately affected; studies show African-Americans (AAs","Glaucoma","Case-Control","MEGA_Consortium_v1-1_15071648_A1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 23 variables, 1 molecular datasets, 2058 subjects, 2058 samples","European (4), African (224), African American (1755), Hispanic1 (39), Hispanic2 (2), South Asian (2), Other (32)","NEI","DS-G-PUB-GSO --- Disease-specific (glaucoma, pub, gso)","2019-05-14","2019-05-14","Not Provided"
"phs001674.v1.p1","The Genomic Landscape of Endocrine Resistant Advanced Breast Cancers.","The genomic evolution of breast cancers exposed to systemic therapy and its effects on clinical outcome have not been broadly characterized. We integrated the genomic sequencing of 1918 breast  cancers, including 1501 hormone receptor-positive tumors, with detailed clinical information and treatment outcomes. Functional mutations in ERBB2","Breast Neoplasms","Case Set","Not Provided","Not Applicable","WXS","3 phenotype datasets, 17 variables,  SRA, 30 subjects, 95 samples","","NCI","HMB --- Health/medical/biomedical","2018-11-05","2018-11-05","Agents, Antineoplastic Hormonal; Antineoplastic Agents, Hormonal; Antineoplastic Drugs, Hormonal; Antineoplastic Endocrinal Agent; Antineoplastic Hormonal Agent; Antineoplastic Hormonal Agents"
"phs001677.v1.p1","Adolescent Idiopathic Scoliosis (AIS) 1000 Exomes Study","Adolescent idiopathic scoliosis (AIS) is the most common pediatric spinal deformity. Although the Bracing in AIS Trial (BrAIST) recently demonstrated the effectiveness of bracing for preventing scoliosis progression in  some patients, more than 20,000 children undergo major spinal fusion surgery at an annual cost of $3 billion. Spinal fusion surgery is a major","Scoliosis","Case Set","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","4 phenotype datasets, 20 variables, 1 molecular datasets, 1093 subjects, 1093 samples","","NIAMS","DS-IMD-IRB --- Disease-specific (inherited musculoskeletal disorders, irb) , DS-SCOID-IRB --- Disease-specific (scoliosis, idiopathic, irb)","2019-02-21","2019-02-21","Abnormal curving of the spine; Curvature of spine; Curved spine; Scolioses"
"phs001678.v1.p1","High-Throughput Determination of the Antigen Specificities of T cell    Receptors in Single Cells","High-throughput linking of T cell receptor (TCR) sequences to their binding antigens is vital for immune profiling, yet challenging. We present Tetramer associated TCR Sequencing (TetTCR-Seq) to address this  challenge. Binding is determined using a library of DNA-barcoded antigen tetramers that are rapidly and inexpensively generated using an in vitro","Humans","Methods","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 15 variables,  SRA, 10 subjects, 144 samples","","NCI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2018-11-23","2018-11-23","Not Provided"
"phs001680.v1.p1","T Cell States Associated with Response to Checkpoint Blockade in Melanoma","Checkpoint blockade therapy using antibodies targeting CTLA4, PD1 or PDL1 have changed the way cancer patients with advanced disease are being treated, as evident by their FDA approval in  a wide variety of malignancies, and their ability to induce high response rates when compared to conventional therapies (e.g. chemotherapy). However","Immunotherapy","Prospective Longitudinal Cohort","Not Provided","Not Applicable","ATAC-seq, RNA-Seq, WXS","5 phenotype datasets, 19 variables, 32 subjects, 98 samples","","NCI","DS-MSC-MDS --- Disease-specific (melanoma and skin cancer research, mds) , DS-CA-IRB-PUB --- Disease-specific (cancer, irb, pub)","2019-07-23","2019-07-23","Cancer of skin pigment cells; MM - Malignant melanoma; Malignant Melanoma; Malignant Melanomas; Malignant melanoma, no ICD-O subtype; Malignant melanoma, no International Classification of Diseases for Oncology subtype"
"phs001684.v1.p1","mNGS of Pulmonary Fluid in Immunocompromised Children","Despite improved diagnostics, pulmonary pathogens in immunocompromised children frequently evade detection, leading to significant mortality. In this study, we performed RNA and DNA-based metagenomic next generation sequencing (mNGS) on  41 lower respiratory samples collected from 34 children. We identified a rich cross-domain pulmonary microbiome containing bacteria, fungi, RNA","Immunocompromised Host","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 14 variables,  SRA, 34 subjects, 41 samples","","NICHD","HMB-IRB-COL-MDS --- Health/medical/biomedical (irb, col, mds)","2018-10-18","2018-10-18","Host, Immunocompromised; Host, Immunosuppressed; Hosts, Immunocompromised; Hosts, Immunosuppressed; Immunocompromised Hosts; Immunocompromised Patient"
"phs001685.v1.p1","DNA Repair Profiling of HGSC Organoids","In this study, 34 ovarian tumor organoids generated from 23 patients underwent paired DNA damage repair defect functional analyses and whole exome sequencing analysis to compare genetic mutational status  to DNA repair functional capacity. 22 of the patients had high grade serous cancer and 1 of the patients had low grade serous cancer. A normal","Ovarian Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 22 variables,  SRA, 23 subjects, 91 samples","","NHLBI","HMB --- Health/medical/biomedical , DS-GC --- Disease-specific (gynecological cancer)","2019-04-30","2019-04-30","Cancer of Fallopian Tube; Cancer of the Fallopian Tube; Cancer, Fallopian Tube; Cancers, Fallopian Tube; Carcinoma of Fallopian Tube; Carcinoma of the Fallopian Tube"
"phs001686.v1.p1","IL-17 Signaling in Midbrain Neurons in Parkinson's Disease","To determine IL-17-induced global transcriptome changes in midbrain neurons derived from induced pluripotent stem cells (iPSC) from three sporadic Parkinson's disease (PD) patients and three age- and sex-machted controls,  deep RNA sequencing (RNA-Seq) of IL-17-treated and untreated PD and control iPSC-dderived midbrain neurons was performed. Total RNA was isolated from","Parkinson Disease","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 29 variables,  SRA, 6 subjects, 24 samples","","NINDS","HMB-COL-NPU --- Health/medical/biomedical (col, npu)","2019-03-14","2019-03-14","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs001687.v1.p1","West Africa Breast Cancer Study (WABCS)","Differences in breast cancer incidence and mortality rates between North American Caucasian and African American women are well-described and transcend socioeconomic issues. Black women are diagnosed with breast cancer  at a younger median age; have more clinically aggressive disease and stage-for-stage; and have higher mortality rates than age-matched Caucasian","Breast Neoplasms","Case-Control","Not Provided","Not Applicable","Not Provided","4 phenotype datasets, 63 variables,  SRA, 294 subjects, 722 samples","","NCI","GRU-PUB --- General research use (pub)","2019-08-29","2019-08-29","Black; Blacks; Negro; Negroes; BARD1-Related Susceptibility to Breast Cancer; Breast Cancer"
"phs001688.v1.p1","Microarray Gene Expression Data from Early Skin Biopsies of a Secukinumab    Clinical Trial in Psoriasis","The phase II clinical study CAIN457A2223 (NCT01537432) was designed to evaluate the proportion of patients achieving reversal of chronic plaque psoriasis at weeks 4 and 12 following multiple doses  of secukinumab, administered subcutaneously, compared to placebo. 36 patients were enrolled in this study, with 24 being randomly assigned to the","Psoriasis","Clinical Trial","Affy_expression_Human_Genome_U133_Plus2_0","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 42 variables, 1 molecular datasets, 35 subjects, 183 samples","","NIAMS","DS-PSO-RD-NPU --- Disease-specific (psoriasis and related diseases, npu)","2019-06-19","2019-06-19","Acropustulosis; Chronic palmoplantar pustular psoriasis; LPP; Localized pustular psoriasis; PPP; PPP - Palmoplantar pustulosis"
"phs001690.v1.p1","Endometrial Carcinoma Somatic Copy Number Analysis Study","Endometrial cancer (EC) is the most commonly diagnosed gynecologic malignancy in the United States and is the sixth leading cause of cancer death amongst American women. The purpose of  this study was to identify somatic (tumor-specific) copy number alterations in 7 clear cell ECs, 31 serous ECs, 17 endometrioid ECs, and the clear","Endometrial Neoplasms","Case Set","Human660W-Quad_v1_A, HumanHap650Yv3","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 16 variables, 1 molecular datasets, 57 subjects, 114 samples","European (24), African (1), African American (3)","NHGRI","DS-ECA-COL-NPU-GSO --- Disease-specific (endometrial cancer, col, npu, gso)","2018-11-06","2018-11-06","Endometrial Tumor; Endometrium Neoplasm; Endometrium Tumor; Neoplasm of Endometrium; Neoplasm of the Endometrium; Neoplasm, Endometrial"
"phs001692.v1.p1","Lifestyle, Infertility, Fertility, and Evaluation (LIFE) Study","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a  different purpose. The purpose of the original study was to establish a data and biological specimen repository to advance future research into male","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","Not Applicable","miRNA-Seq","4 phenotype datasets, 20 variables,  SRA, 8 subjects, 8 samples","","NHLBI","DS-MRUH --- Disease-specific (male reproductive and urologic health)","2018-10-30","2018-10-30","MIR; MIRN; Micro RNA; MicroRNA; RNA, Micro; miRNA"
"phs001693.v1.p1","Maternal-Fetal Immune Responses in Preterm Labor and Congenital Anomalies","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a  different purpose. The purpose of the original study was to learn and understand more about the causes of preterm labor, how to prevent it, and how","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","Not Applicable","miRNA-Seq","4 phenotype datasets, 20 variables,  SRA, 20 subjects, 20 samples","","NHLBI","DS-PTL --- Disease-specific (pre-term labor)","2018-10-30","2018-10-30","MIR; MIRN; Micro RNA; MicroRNA; RNA, Micro; miRNA"
"phs001694.v1.p1","CSF Analysis in HIV-1 Infected Subjects: Response to Antiretroviral    Therapy","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a  different purpose. The purpose of the original study was to collect information on the changes in cerebrospinal fluid (CSF) related to HIV infection","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","Not Applicable","miRNA-Seq","4 phenotype datasets, 21 variables,  SRA, 8 subjects, 8 samples","","NHLBI","DS-MHIV --- Disease-specific (markers of hiv infection)","2018-10-30","2018-10-30","AIDS Virus; AIDS Viruses; Acquired Immune Deficiency Syndrome Virus; Acquired Immunodeficiency Syndrome Virus; HIV - Human immunodeficiency virus; HTLV-III"
"phs001695.v1.p1","UCSF Center for Reproductive Health (CRH) Research Bank","The purpose of this study is to provide a reference profile of small extracellular RNAs in body fluids. These samples were originally obtained in a study that had a  different purpose. The purpose of the original study was to add excess biological materials during the course of IVF treatment to a tissue bank","MicroRNAs","Prospective Longitudinal Cohort","Not Provided","Not Applicable","miRNA-Seq","4 phenotype datasets, 20 variables,  SRA, 10 subjects, 10 samples","","NHLBI","DS-INF --- Disease-specific (infertility and infertility treatments)","2018-10-30","2018-10-30","Sub-Fertility; Subfertility; MIR; MIRN; Micro RNA; MicroRNA"
"phs001696.v1.p1","Genomic Studies for Understanding Etiology of Esophageal Adenocarcinoma    (EsophagealAdenocarcinoma_Chinese)","While the incidence of esophageal adenocarcinoma (EAC) has risen drastically in Western countries over the last 40 years, a similar trend has not been observed for EAC in China.  Here we analyzed mutational spectrum, copy number alterations, and structural variants from whole-genome sequencing of ten Chinese EAC tumor samples","Esophageal Neoplasms","Case Set","WGS_markerset_grc37","Not Applicable","SNP Genotypes (NGS), WGS","4 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 10 subjects, 20 samples","","NCI","DS-E-C-NPU --- Disease-specific (esophageal cancer, npu)","2018-11-27","2018-11-27","Esophageal Neoplasms, Benign and Malignant; Esophageal Tumor; Esophageal Tumors; Esophagus Neoplasm; Esophagus Neoplasms; Esophagus Tumor"
"phs001699.v1.p1","Germline DNA Methylation Associated with Breast Cancer Predisposition","Understanding and explaining hereditary predisposition to cancer has focused on the genetic etiology of the disease. However, mutations in known genes associated with breast cancer such as BRCA1 and  BRCA2 account for less than 25% of familial cases of breast cancer. Heritable epigenetic modifications, in the form of hypermethylated MLH1 promoter","Not Provided","Case-Control","Not Provided","Not Applicable","Bisulfite-Seq","4 phenotype datasets, 18 variables, 155 subjects, 155 samples","","NHGRI","GRU --- General research use","2019-03-29","2019-03-29",""
"phs001701.v1.p1","INGENIOUS","The INGenious trial planed to enroll a total of 6,000 patients, with 2,000 patients assigned to a pharmacogenetic testing arm and 4,000 to a control arm who will be  followed, but not tested. It is randomized between an intervention arm and one that receives no intervention in order that the genotyped group can be","Metabolism","Prospective Longitudinal Cohort","SNP-PCR","Not Applicable","CNV Genotypes","4 phenotype datasets, 13 variables, 1 molecular datasets, 1309 subjects, 1309 samples","","NHGRI","HMB --- Health/medical/biomedical","","","Not Provided"
"phs001702.v1.p1","eQTL Interactions in Lupus Patients","The purpose of this study is to discover in vivo cytokine expression quantitative trait locus (eQTL) interactions from a cohort of patients with systemic lupus erythematosus. 157 lupus patients  were enrolled in a clinical trial to test the efficacy and safety of an anti-IL-6 monoclonal antibody. At three time points, we measured interferon","Lupus Erythematosus, Systemic","Prospective Longitudinal Cohort","HumanOmniExpressExome-8v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 160 subjects, 160 samples","European (89), African (1), African American (20), Hispanic1 (2), Hispanic2 (39), Other Asian or Pacific Islander (1), Other (8)","NIAMS","HMB --- Health/medical/biomedical","2018-10-25","2018-10-25","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs001703.v2.p1","Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression","While many genetic variants have been associated with risk for human diseases, how these variants affect gene expression in various cell types remains largely unknown. To address this gap,  the DICE (Database of Immune Cell Expression, Expression quantitative trait loci (eQTLs) and Epigenomics) project was established. Considering all","Not Provided","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37, MEGA_Consortium","Not Applicable","SNP Genotypes (Array), RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 14 variables, 2 molecular datasets,  SRA, 91 subjects, 1635 samples","European (40), East Asian (18), African American (5), Hispanic1 (5), Hispanic2 (14), Other Asian or Pacific Islander (2), South Asian (4), Other (3)","NIAID","GRU --- General research use","2019-01-15","2018-11-15",""
"phs001704.v1.p1","Enhancer Mapping in Chronic Lymphocytic Leukemia","In this study we profile the epigenomic enhancer landscapes of CLL B cells (CD19+/CD5+) harvested from peripheral blood of patients from our Center. Included are results of ChIPseq profiling  using chromatin immunoprecipitation of the enhancer histone mark H3K27ac (acetylated lysine 27 on histone H3), and open chromatin profiles using ATAC","Leukemia, Lymphocytic, Chronic, B-Cell","Case-Control","Not Provided","Not Applicable","ATAC-seq, ChIP-Seq, RNA-Seq","4 phenotype datasets, 19 variables,  SRA, 28 subjects, 66 samples","","NCI","DS-CLL --- Disease-specific (chronic lymphocytic leukemia)","2018-12-18","2018-12-18","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs001705.v1.p1","NCI-Epidemiology of Burkitt Lymphoma in East African Children and Minors    (EMBLEM)","A genome-wide analysis of genetic structure, gene flow, and natural selection was conducted in populations in the endemic Burkitt lymphoma (eBL) belt in Ghana and Northern Uganda, both subject  to a high incidence of falciparum malaria and eBL. These populations have different ethnolinguistic ancestries and are located 2400 miles apart in","Burkitt Lymphoma","Case-Control","HumanOmni5Exome-4v1_A","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 15 variables, 1 molecular datasets, 568 subjects, 568 samples","African (143), African American (425)","NCI","GRU-IRB --- General research use (irb)","2019-08-15","2019-08-15","BL; BL - Burkitt's lymphoma; Burkitt Tumor; Burkitt tumor [obs]; Burkitt's Lymphoma; Burkitt's Tumor"
"phs001706.v1.p1","Castleman Genome Project","Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder driven by excessive production of inflammatory cytokines. Patients can exhibit a wide range of clinical features from mild flu-like symptoms  to multiple organ failure and death. Human herpesvirus-8 (HHV-8) is a well-established cause of MCD in individuals who are immunosuppressed due to","Castleman Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WGS","4 phenotype datasets, 16 variables,  SRA, 32 subjects, 32 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2019-03-26","2019-03-26","AFLH; Angiofollicular Lymph Hyperplasia; Angiofollicular Lymph Hyperplasias; Angiofollicular Lymph Node Hyperplasia; Angiofollicular Lymphoid Hyperplasia; Angiofollicular Lymphoid Hyperplasias"
"phs001707.v1.p1","UPenn CAR T cell Responders and Non-responders","The adoptive transfer of autologous T cells genetically modified to express a CD19-specific, 4-1BB/CD3zeta-signaling chimeric antigen receptor (CAR; CTL019) has shown remarkable activity in patients with B acute lymphoblastic  leukemia. Similar therapy can induce long-term remissions for relapsed/refractory chronic lymphocytic leukemia (CLL) patients, but in only a small","Leukemia, Lymphocytic, Chronic, B-Cell","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 17 variables,  SRA, 34 subjects, 82 samples","","NCI","GRU-IRB-NPU --- General research use (irb, npu)","2019-02-28","2019-02-28","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs001709.v1.p1","Count Me In: Metastatic Breast Cancer Project (CMI-MBCproject)","Count Me In - The Metastatic Breast Cancer Project: A Patient-Driven Research Initiative to Accelerate Metastatic Breast Cancer Research The Metastatic Breast Cancer Project (MBCproject; mbcproject.org) is a research  study that directly engages patients with metastatic breast cancer via social media and advocacy groups and empowers them to accelerate cancer","Breast Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WXS","200 subjects, 478 samples","","NCI","","","","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001712.v1.p1","VCRC One-Time DNA Study","The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Better methods  are needed to recruit patients with these rare diseases into cohorts of adequate size for high-quality genetics studies, and the existing","Vasculitis","Case-Control","Not Provided","Not Applicable","Not Provided","12 phenotype datasets, 2586 variables, 7 documents, 152 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-02-11","2019-02-11","Allergic Angiitides; Allergic Angiitides, Granulomatous; Allergic Angiitis; Allergic Angiitis and Granulomatosis; Allergic Angiitis, Granulomatous; Allergic Granulomatoses"
"phs001715.v1.p1","Protocol for Imaging in Takayasu's Arteritis","Takayasu's arteritis is a rare disease that affects the blood vessels. Takayasu's arteritis can cause swelling of large and medium-sized blood vessels. The blood vessels that are commonly affected  are the branches of the aorta (the main blood vessel that leaves the heart). The purpose of this study is to help doctors learn more about this","Vasculitis","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","8 phenotype datasets, 146 variables, 9 documents, 19 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-03-26","2019-03-26","Aortic Disease; Aortic Diseases; Disease of the aorta; Disease, Aortic; Diseases, Aortic; Cutaneous Disorder"
"phs001717.v1.p1","Genetic Variants Influence on the Placenta Regulatory Landscape","This study of the regulatory landscape of the placenta relies on the identification of associations between genetic variant and gene expression changes (eQTLs); genetic variant and DNA methylation changes  (mQTLs); and, gene expression change and DNA methylation change (eQTMs). It involves the analysis of DNA sequence variation (n 303), DNA methylation","Control Groups","Control Set","InfiniumOmni2-5-8v1-3_A1-b37, divers_arrays","Not Applicable","SNP Genotypes (Array), Methylome sequencing, RNA Seq expression levels","4 phenotype datasets, 25 variables, 1 molecular datasets,  SRA, 302 subjects, 302 samples","European (72), African (7), East Asian (27), African American (82), Hispanic1 (30), Hispanic2 (46), Other Asian or Pacific Islander (14), South Asian (11), Other (13)","NICHD","HMB-IRB-PUB-COL-MDS --- Health/medical/biomedical (irb, pub, col, mds)","2019-05-01","2019-05-01","Not Provided"
"phs001718.v1.p1","C9ORF72 Hexanucleotide Repeat Sequence Genotyping Project","This study reports long-range and high-resolution repeat sizing of the C9orf72 repeat region for 2095 samples from the National Institute of Neurological Disorders and Stroke (NINDS) repository's ALS collection.  Genomic DNA samples were analyzed with a PCR assay (AmplideX PCR/CE C9orf72 Kit) and resolved on capillary electrophoresis. Expanded samples were","Amyotrophic Lateral Sclerosis","Prospective Longitudinal Cohort","target_markerset_grc37","Not Applicable","CNV Genotypes","4 phenotype datasets, 15 variables, 1 molecular datasets, 2095 subjects, 2095 samples","","NINDS","GRU --- General research use","","","ALS; ALS (Amyotrophic Lateral Sclerosis); ALS - Amyotrophic lateral sclerosis; Amytrophic lateral sclerosis; Bulbar motor neuron disease; Charcot Disease"
"phs001719.v1.p1","Longitudinal Multi-Omics Profiling of Prediabetes","Type 2 diabetes mellitus (T2D) is a significant health problem. Close to 20 million individuals in the United States have T2D, and 79 million aged 20 years or older  are clinically pre-diabetic, with a 5-year conversion rate of 10% to 23% from prediabetes to T2D. In a collaborative effort to systematically","Prediabetic State","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","4 phenotype datasets, 15 variables,  SRA, 111 subjects, 111 samples","","NIDDK","GRU-IRB-PUB --- General research use (irb, pub)","2019-05-10","2019-05-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001720.v1.p1","Kidney on a Chip","We generated primary cultures from mechanically isolated kidney glomeruli (filtration unit of the nephron) which are composed of podocytes and mesangial cells. In parallel, we generated primary kidney cortex  tubule cell cultures, which are composed primarily of proximal tubule cells. Early passage cultures of these two cell types were subjected to","Podocytes","Collection","target_markerset_grc37, RNAseq_probe_set_grc37","Not Applicable","DNase-Hypersensitivity, RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 17 variables, 1 molecular datasets,  SRA, 2 subjects, 10 samples","","NHGRI","KF --- Kidney function","2019-03-04","2019-03-04","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs001724.v1.p1","Genomics and Modification of Pain","We have capitalized on inherited erythromelalgia (IEM) as a well-characterized genetic model of chronic pain, and studied IEM patients carrying Nav1.7 mutations which affect channel activation and often produce  hyperexcitability of DRG neurons. Whole exome sequencing was used to discover multiple gene variants that might contribute to neuronal excitability","Erythromelalgia","Family/Twin/Trios","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS), WXS","5 phenotype datasets, 24 variables, 1 molecular datasets,  SRA, 3 subjects, 3 samples","","NINDS","DS-EM-COL --- Disease-specific (erythromelalgia, col)","2019-03-15","2019-03-15","Erythermalgia; Erythermalgias; Erythralgia; Erythromelalgias; Weir Mitchell's disease"
"phs001733.v1.p1","Molecular Etiology of Early-Onset Dystonia","Primary torsin dystonias (PTD) are a group of movement disorders characterized by twisting muscle contractures, where dystonia is the only clinical sign (except for tremor) and there is no  evidence of neuronal degeneration or an acquired cause. Eleven genes have been mapped for primary dystonia including DYT1 (TOR1A), DYT2, DYT4 (TUBB4A","Dystonia","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","5 phenotype datasets, 25 variables,  SRA, 17 subjects, 17 samples","","NINDS","DS-MDP --- Disease-specific (movement disorders phenotypes)","2019-02-05","2019-02-05","Dystonia, Muscle; Dystonic disease; Dystonic movements; Muscle Dystonia; Dystonia 1, Torsion, Autosomal Dominant; Dystonia Musculorum Deformans 1"
"phs001734.v1.p1","Youth Drug Abuse, ADHD and Related Disorders","There are two major aims with this study. 1. To describe the developmental trajectory of (a) a community-based sample of youth with a childhood diagnosis of ADHD that has  been prospectively followed from childhood into adulthood (approximately a 17-year span), and (b) a clinical sample of youth that received drug abuse","Attention Deficit Disorder with Hyperactivity","Prospective Longitudinal Cohort","HumanOmni25-8v1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 66 variables, 1 molecular datasets,  SRA, 607 subjects, 607 samples","European (516), African (2), East Asian (5), African American (47), Hispanic1 (9), Hispanic2 (22), Other Asian or Pacific Islander (3), South Asian (1), Other (2)","NIDA","HMB --- Health/medical/biomedical","2019-04-03","2019-04-03","ADDH; ADHD; ADHD - Attention deficit disorder with hyperactivity; Attention Deficit Disorders with Hyperactivity; Attention Deficit Hyperactivity Disorder; Attention Deficit Hyperactivity Disorders"
"phs001736.v1.p1","NCI Expanded Genome-Wide Association Study of Renal Cell Carcinoma","The National Cancer Institute (NCI) expanded genome-wide association study (GWAS) of renal cell carcinoma (RCC) was a 2nd GWAS of this cancer performed by NCI to further investigate common  genetic variants associated with RCC risk. The GWAS includes 2,781 cases and 2,940 controls of European background from 13 studies conducted in the","Carcinoma, Renal Cell","Case Set","HumanOmniExpress, HumanOmni2.5-4v1_B","Not Applicable","SNP/CNV Genotypes (imputed), SNP/CNV Genotypes (NGS)","4 phenotype datasets, 19 variables, 2 molecular datasets, 2385 subjects, 2385 samples","European (2377), Hispanic1 (4), Hispanic2 (2), Other (2)","NCI","GRU --- General research use , GRU-IRB-NPU --- General research use (irb, npu) , DS-RCC --- Disease-specific (kidney cancer) , CADM --- Cancer in all age groups, other diseases in adults, and methods","","","Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell; Adenocarcinomas, Renal"
"phs001737.v2.p1","Ectrodactyly Ectodermal Dysplasia Cleft Lip/Palate (EEC) Syndrome Study","Transcription factor p63 is a key regulator of epidermal keratinocyte proliferation and differentiation. Heterozygous mutations of TP63 encoding p63 cause a spectrum of developmental disorders. EEC syndrome is caused  by point mutations in the p63 DNA-binding domain, and manifests ectodermal dysplasia with defects in the epidermis and epidermal related appendages","Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3","Case-Control","Not Provided","Not Applicable","ChIP-Seq, RNA-Seq, RNA Seq expression levels","5 phenotype datasets, 22 variables, 2 documents,  SRA, 14 subjects, 86 samples","","NIAMS","GRU-IRB-PUB-NPU --- General research use (irb, pub, npu)","","","EEC SYNDROME 3; EEC3; Ectrodactyly, Ectodermal Dysplasia, Cleft Lip/Palate Syndrome 3 (EEC3); Ectrodactyly, Ectodermal Dysplasia, Clefting Syndrome; Ectrodactyly, Ectodermal Dysplasia, Clefting Syndrome Type 3 (EEC3); TP63-Related Disorders"
"phs001739.v1.p1","Role of the Cervico-Vaginal Microbiome in Spontaneous Preterm Birth","Preterm birth is the leading cause of neonatal morbidity and mortality. A failure to predict and understand the causes of preterm birth have limited effective interventions and therapeutics. From  a cohort of 2,000 pregnant women, we performed a nested case control study on 107 well-phenotyped cases of spontaneous preterm birth (sPTB) and 432","Premature Birth","Case-Control","Not Provided","Not Applicable","AMPLICON","4 phenotype datasets, 25 variables,  SRA, 539 subjects, 1505 samples","","NINR","GRU --- General research use","2019-03-26","2019-03-26","Age, Fetal; Age, Gestational; Ages, Fetal; Ages, Gestational; Chronologic Fetal Maturity; Fetal Age"
"phs001740.v1.p1","CCDG- Neuropsychiatric: Autism- Study of Autism Genetics Exploration    (SAGE)","In this study, we address the enormous challenges common complex diseases pose for genomic analysis and the enormous opportunities surmounting them offers for advancing healthcare. The common genetic disorders  proposed for study here are believed to have extreme locus heterogeneity, requiring the analysis of large numbers of samples to comprehensively","Autism Spectrum Disorder","Prospective Longitudinal Cohort","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 26 variables, 1 molecular datasets,  SRA, 580 subjects, 580 samples","","NHGRI","DS-ASD-RD-IRB --- Disease-specific (autism spectrum disorder and related diseases, irb)","2019-08-02","2019-08-02","Child Development Disorders, Pervasive; Pervasive Child Development Disorders"
"phs001742.v1.p1","Clonal Mapping of Multi-Organ Metastasis in Triple Negative Breast cancer","Clonal dynamics during metastasis were studied in two patient-derived xenograft (PDX) models established from treatment-naive primary breast tumors from TNBC patients diagnosed with concurrent metastatic disease. Genomic sequencing and  barcode-mediated clonal tracking revealed robust alterations in clonal architecture between primary tumors and metastases. Polyclonal seeding and","Triple Negative Breast Neoplasms","Case-Control","Not Provided","Not Applicable","RNA-Seq, Targeted-Capture, WXS","3 phenotype datasets, 16 variables,  SRA, 1 subjects, 67 samples","","NCI","GRU --- General research use","2019-01-11","2019-01-11","Metastases, Neoplasm; Metastasis; Metastasis, Neoplasm; Metastasize; Neoplasm Metastases; Tumor Cell Migration"
"phs001745.v1.p1","Human Lung Tissue eQTL Study","Genetic risks underlying respiratory diseases (e.g. COPD and asthma) are carefully studied by large genome-wide association studies (GWAS), where many loci were identified. In the post-GWAS era, the main  challenge is to find the causal genes and pathways in GWAS-nominated chromosomal regions and to characterize etiology mechanism. The Lung eQTL","Smoking","Prospective Longitudinal Cohort","Human1M-Duov3_B","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 1103 subjects, 1103 samples","European (1087), Hispanic1 (2), Hispanic2 (8), South Asian (2), Other (4)","NHLBI","DS-LD-IRB-COL-NPU-GSO --- Disease-specific (lung disease, irb, col, npu, gso)","2019-03-19","2019-03-19","Age Groups; Group, Age; Groups, Age; Gender Role; Role, Sex; Roles, Gender"
"phs001746.v1.p1","A Genomic Atlas of Systemic Interindividual Epigenetic Variation in    Humans (GTEx)","Methylation of cytosines in CpG dinucleotides is an epigenetic mechanism with essential roles in mammalian development. To explore its functions in cellular differentiation, unbiased analysis of CpG methylation by  whole genome bisulfite sequencing (WGBS) has been used to characterize epigenetic differences among different human tissues and cell types. Meanwhile","Reference Values","Cross-Sectional","Not Provided","Not Applicable","Bisulfite-Seq","3 phenotype datasets, 9 variables,  SRA, 10 subjects, 30 samples","","NHGRI","GRU --- General research use","2019-05-06","2019-05-06","Normal Value; Normal Values; Range, Normal; Range, Reference; Ranges, Normal; Ranges, Reference"
"phs001747.v1.p1","Caregiving as a Natural Stressor in Coronary Heart Disease (CAREGIVER)","The burden of caregiving for an ill relative has been shown to interact with existing comorbidities to increase risk of several health outcomes including metabolic syndrome and blood pressure  reactivity. The CAREGIVER study was developed to compare cardiometabolic risk factors in caregivers and controls. These risk factors include","Coronary Disease","Case-Control","target_markerset_grc38, HumanMethylation450","Not Applicable","Methylation (CpG), SNP Genotypes (PCR)","4 phenotype datasets, 40 variables, 1 molecular datasets, 342 subjects, 342 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb)","2019-07-05","2019-07-05","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs001749.v1.p1","Genetics of CAKUT","The Genetics of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) contributes data from unrelated individuals who were recruited at the Columbia University Medical Center, NY; the Polish  Registry of Congenital Malformations, Poland; the Universities of Parma, Bari and Brescia and the Gaslini Insitute, in Italy; the University of","Congenital Anomalies Of Kidney And Urinary Tract","Prospective Longitudinal Cohort","MEGA_Consortium_15063755_B2","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 11 variables, 1 molecular datasets, 1058 subjects, 1058 samples","","NIDDK","GRU-IRB --- General research use (irb)","2019-08-22","2019-08-22","CAKUT; Congenital anomalies of the kidney and urinary tract (CAKUT)"
"phs001750.v1.p1","Single Cell Analysis of Pulmonary Fibrosis","Pulmonary fibrosis is a heterogenous syndrome in which fibrotic scar replaces normal lung tissue. We performed massively parallel single-cell RNA-Seq on lung tissue from eight lung transplant donors and  eight patients with pulmonary fibrosis. Combined with in situ RNA hybridization, with amplification, these data provide a molecular atlas of disease","Pulmonary Fibrosis","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 18 variables, 1 molecular datasets,  SRA, 39 subjects, 83 samples","","NHLBI","GRU --- General research use","2019-01-14","2019-01-14","Alveolitides, Fibrosing; Fibrosing Alveolitides; Fibrosing Alveolitis; Hamman Rich Syndrome; Hamman-Rich Syndrome; Syndrome, Hamman-Rich"
"phs001754.v1.p1","Spit for Science","Spit for Science is a university-wide research opportunity with the scientific goal of understanding how genetic and environmental factors come together to influence substance use and emotional health across  the college years and beyond. To address this goal, we have comprehensively and longitudinally studied eligible incoming freshmen (18 years or older","Not Provided","Prospective Longitudinal Cohort","Axiom_BioBank1_na35, Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets, 8040 subjects, 8040 samples","European (3980), African (113), East Asian (475), African American (1553), Hispanic1 (269), Hispanic2 (370), Other Asian or Pacific Islander (471), South Asian (507), Other (302)","NIDA","DS-ADX-IRB --- Disease-specific (addictive disorders, irb)","2019-06-06","2019-06-06",""
"phs001757.v1.p1","Sequencing of the olfactory receptor subgenome","The goal of this study was to explore the relationship between genetic variation in the olfactory receptor family and odor perception. 332 subjects rated the intensity and pleasantness of  66 odors at 2 concentrations and 2 solvents. Detection thresholds of 3 odors were also measured. Targeted sequencing was performed on 413 olfactory","Smell","Collection","Not Provided","Not Applicable","Targeted-Capture","4 phenotype datasets, 15 variables,  SRA, 332 subjects, 345 samples","","NIDCD","HMB-NPU --- Health/medical/biomedical (npu)","2019-04-15","2019-04-15","Not Provided"
"phs001759.v1.p1","Profiles of exRNA in CSF and Plasma from Subarachnoid Hemorrhage Patients","Brain injury resulting from hemorrhagic stroke is clinically challenging to manage and results in high rates of morbidity and mortality. The pathophysiology of brain damage resulting from aneurysmal subarachnoid  hemorrhage (aSAH) is largely unknown, and methods to treat and monitor patients are variable with no meaningful correlations to patient outcome","Circulating MicroRNA","Case Set","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 23 variables,  SRA, 7 subjects, 126 samples","","NHLBI","HMB --- Health/medical/biomedical","2019-03-25","2019-03-25","Hemorrhage, Subarachnoid; Hemorrhages, Subarachnoid; SAH (Subarachnoid Hemorrhage); SAH - Subarachnoid hemorrhage; SAHs (Subarachnoid Hemorrhage); Subarachnoid Hemorrhage"
"phs001765.v1.p1","Genomic Characterization of Parathyroid Cancer","Here we performed genomic characterization of twenty-nine sporadic parathyroid cancers using next generation whole exome sequencing. Thirty-three novel candidate driver genes for sporadic parathyroid cancer were proposed, in addition  to previously known driver genes CDC73 and MEN1.","Parathyroid Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","WXS","41 subjects, 41 samples","","NCI","GRU --- General research use","2019-02-27","2019-02-27","Neoplasm of Parathyroid; Neoplasm of Parathyroid Gland; Neoplasm of the Parathyroid; Neoplasm of the Parathyroid Gland; Neoplasm, Parathyroid; Neoplasms, Parathyroid"
"phs001767.v1.p1","Identifying Novel Small RNA Biomarkers for Patients with Gastric Cancer","The biomarker development study consisted of two parts: discovery and validation. The first part was the discovery and verification phase of biomarkers using two different platforms: transcriptomic and miRNA.  The salivary transcriptomes of 63 GC samples and 31 non-GC controls were profiled using Affymetrix HG U133+2.0 microarrays (Affymetrix, Santa Clara","Circulating MicroRNA","Case-Control","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 22 variables,  SRA, 198 subjects, 198 samples","","NHLBI","HMB-IRB-PUB-NPU --- Health/medical/biomedical (irb, pub, npu)","2019-03-20","2019-03-20","CA - Cancer of stomach; Cancer of Stomach; Cancer of the Stomach; Cancer, Gastric; Cancer, Stomach; Cancers, Gastric"
"phs001768.v1.p1","Longitudinal Assessment of Methylmercury and Gut Microbes During    Pregnancy","Methylmercury is a potent neurotoxin, and the fetal period is the most vulnerable exposure period. There is significant variability in methylmercury metabolism, which has been attributed to differences in  the structure and function of the gut microbiome. Our main objective was to better understand the interplay between gut microorganisms and","Not Provided","Prospective Longitudinal Cohort","Not Provided","Not Applicable","OTHER","4 phenotype datasets, 38 variables,  SRA, 29 subjects, 53 samples","","NIEHS","DS-MERCURY --- Disease-specific (mercury and other environmental exposures)","2019-05-09","2019-05-09",""
"phs001769.v1.p1","Intravenous Norepinephrine for Orthostatic Hypotension","Patients with chronic autonomic failure (CAF) often have disabling orthostatic hypotension (OH). OH in CAF patients is often associated with supine hypertension (hypertension while lying down), which can be  severe. Drugs to treat OH worsen supine hypertension. Therefore, the combination of OH with supine hypertension poses a difficult therapeutic","Pure Autonomic Failure","Interventional","Not Provided","Not Applicable","Not Provided","3 phenotype datasets, 164 variables, 6 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-03-05","2019-03-05","Decrease in blood pressure upon standing up; HYPOTENSION, ORTHOSTATIC; Hypotension, Postural; Orthostatic Hypotension; Postural Hypotension; Idiopathic Parkinson Disease"
"phs001770.v1.p1","Assessment of Health-related Quality of Life in Rare Kidney Stones","The purpose of this study is to learn about Health-related Quality Of Life (HRQoL) in patients enrolled in the Rare Kidney Stone Consortium (RKSC) registries. Quality of life studies  look at different aspects of both physical and mental components of people's lives. HRQoL data for people affected by kidney stones are not currently","Dent Disease","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","5 phenotype datasets, 91 variables, 1 documents, 356 subjects","","NCATS","GRU-IRB-PUB --- General research use (irb, pub)","2019-03-06","2019-03-06","2,8-dihydroxyadenine urolithiasis; APRT DEFICIENCY; APRTD; Adenine phosphoribosyl transferase deficiency; Dihydroxyadeninuria; NEPHROLITHIASIS, DHA"
"phs001773.v1.p1","Linked-Read Sequencing to Resolve Complex Structural Variants","Large structural variants (SVs) are important contributors to disease yet remain one of the most difficult types of variation to accurately ascertain, in part because they cluster in duplicated/repetitive  regions, but also because the signals for these events can be challenging to detect with short reads. Clinically, array comparative genome","Genomic Structural Variation","Case Set","Not Provided","Not Applicable","Not Provided","23 subjects, 23 samples","","NHGRI","","","","Not Provided"
"phs001776.v1.p1","NCI LTG Human Pancreas QTL Study","We created a human histologically normal pancreas eQTL resource using 91 fresh frozen tissue samples from patients diagnosed with pancreatic cancer (Mayo Clinic and Memorial Sloan Kettering Cancer Center)  or from organ donors without a history of pancreatic cancer (Penn State University) by RNA-Sequencing. Genome wide genotyping was done using blood","Pancreas","Case-Control","HumanOmni1-Quad_v1-0_B, HumanOmniExpress-12v1_A, HumanOmniExpress-12v1_B, HumanOmniExpress-24v1-0_A","Not Applicable","SNP Genotypes (Array), RNA-Seq","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 91 subjects, 182 samples","European (89), Hispanic1 (1), Other (1)","NCI","DS-PACA-IRB-MDS --- Disease-specific (pancreatic cancer, irb, mds) , GRU-IRB-PUB-NPU --- General research use (irb, pub, npu)","2019-07-12","2019-07-12","Not Provided"
"phs001777.v1.p1","Sertoli Cell-Only Syndrome Human Transcriptome Profiling Study","Sertoli cell-only syndrome is severe form of human male infertility in which most seminiferous tubules appear to lack all spermatogenic cells, including spermatogonial stem cells (SSCs). However, a few  small tubule segments of some patients have active spermatogenesis and, thus, functional stem cell niches and SSCs. Normally SSCs replicate, migrate","Sertoli Cell-Only Syndrome","Case-Control","Not Provided","Not Applicable","RNA-Seq","3 phenotype datasets, 13 variables, 11 subjects, 11 samples","","NICHD","DS-MINF-IRB-PUB-COL --- Disease-specific (male infertility, irb, pub, col)","2019-04-04","2019-04-04","AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS; AZOOSPERMIA WITH MATURATION ARREST; Arrest of spermatogenesis; Aspermatogenesis; PREGNANCY LOSS 4; SPERMATOGENESIS ARREST"
"phs001780.v1.p1","African Demographic History Study Using Illumina 1M Array Data","These data were used as part of a study to characterize genomic diversity in Africa, population substructure, and evolutionary history.","Not Provided","Cross-Sectional","Human1M-Duov3_H","Not Applicable","SNP Genotypes (Array)","4 phenotype datasets, 12 variables, 1 molecular datasets, 697 subjects, 697 samples","African (179), African American (517), Hispanic1 (1)","NIGMS","GRU-PUB-NPU --- General research use (pub, npu)","2019-03-18","2019-03-18",""
"phs001781.v1.p1","Proteogenomic Landscape of Squamous Cell Lung Cancer","To provide a detailed analysis on how genomic and transcriptomic alterations related to proteome level changes in squamous cell lung cancer (SCC), we performed an integrated analysis incorporating DNA  copy number, somatic mutations, expression RNA-sequencing, and expression proteomics in 108 SCC nested within clinical outcome, tumor pathology, and","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, Targeted-Capture","4 phenotype datasets, 18 variables,  SRA, 108 subjects, 108 samples","","NCI","HMB-MDS --- Health/medical/biomedical (mds)","2019-08-14","2019-08-14","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER"
"phs001782.v1.p1","Placental Transcriptome and Stunting","Therian mammals and angiosperms evolved genomic imprinting in nutritive tissues, the placenta and endosperm, where maternal and paternal genomes are in conflict with respect to resource allocation. In imprinted  genes, transcription is repressed from either the paternal or the maternal allele, resulting in allele specific expression (ASE). We studied","Growth","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38, target_markerset_grc38","Not Applicable","Allele-Specific Expression, RNA-Seq, SNP/CNV Genotypes (NGS), Targeted-Capture","5 phenotype datasets, 21 variables, 2 molecular datasets,  SRA, 112 subjects, 233 samples","","NICHD","GRU-IRB-PUB-COL --- General research use (irb, pub, col)","2019-08-16","2019-08-16","Not Provided"
"phs001783.v1.p1","Exome Sequencing of Prospectively Characterized Clinical Specimens","The study cohort comprises samples from patients whose tumors have been prospectively characterized as part of their care at Memorial Sloan Kettering Cancer Center. This includes a variety of  distinct tumor type and molecular subtypes.","Neoplasms","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 14 variables,  SRA, 794 subjects, 1610 samples","","NCI","DS-CA-PUB-MDS --- Disease-specific (cancer, pub, mds)","2019-07-10","2019-07-10","Comparative Genomic; Comparative Genomics; Genomic, Comparative; Genomics, Comparative; CA; CA - Cancer"
"phs001784.v1.p1","Functional Genomics and Molecular Imaging of Liver Disease and Cancer","Molecular imaging with 18F-fluorocholine PET/CT reveals two distinct imaging phenotypes for hepatocellular carcinoma (HCC) as a potential source of non-invasive insight into its molecular heterogeneity. Using gene set enrichment  analyses, we found 18F-fluorocholine-avid tumors to be significantly enriched by genes comprising a subset of previously published HCC-related gene","Carcinoma, Hepatocellular","Case Set","HumanHT-12_v4","Not Applicable","mRNA Expression (Array)","4 phenotype datasets, 21 variables, 1 molecular datasets,  SRA, 41 subjects, 41 samples","","NCI","DS-LCCLD-COL --- Disease-specific (liver cancer and chronic liver disease, col)","2019-07-15","2019-07-15","Adult Liver Cancer; Adult Liver Cancers; Cancer, Adult Liver; Cancers, Adult Liver; Carcinoma of Liver Cells; Carcinoma of the Liver Cells"
"phs001788.v1.p1","CFAR Network of Integrated Clinical Systems (CNICS)","Advances in antiretroviral therapies (ART) and patient management have improved survival of people living with HIV (PLWH). However, with exposure to ART and associated side effects and toxicities as  well as to the virus itself, PLWH are at an increased risk of several chronic diseases. The Centers for AIDS Research (CFAR) Network of Integrated","HIV Infections","Case-Control","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 24 variables, 1 molecular datasets, 4761 subjects, 4761 samples","European (2180), African (40), East Asian (17), African American (1809), Hispanic1 (83), Hispanic2 (510), Other Asian or Pacific Islander (48), South Asian (5), Other (69)","NIDA","GRU-IRB --- General research use (irb)","2019-04-16","2019-04-16","HIV - Human immunodeficiency virus infection; HIV infection; HTLV III Infections; HTLV III LAV Infections; HTLV-III Infection; HTLV-III Infections"
"phs001790.v1.p1","NIMH Human Middle Temporal Gyrus (MTG) Cell Types","Elucidating the cellular architecture of the human neocortex is central to understanding our cognitive abilities and susceptibility to disease. In this study, we applied single nucleus RNA sequencing to  perform a comprehensive analysis of cell types in the middle temporal gyrus of human cerebral cortex. We identify a highly diverse set of excitatory","Cerebral Cortex","Cross-Sectional","Not Provided","Not Applicable","Not Provided","8 subjects, 15928 samples","","NIMH","NHD --- Neuroscience, health and disease","2019-03-21","2019-03-21","Cerebral Cortices; Cerebral gray matter; Cerebri, Cortex; Cerebrus, Cortex; Cortex; Cortex Cerebri"
"phs001791.v1.p1","A Multimodal Atlas of Human Brain Cell Types","""A multimodal atlas of human brain cell types"" includes sample data targeting two cell types that show species differences between mouse and human. First, it includes a detailed transcriptomic,  morphological, and electrophysiological characterization of cell types in layer 1 of human middle temporal gyrus, focusing primarily on different","Cerebral Cortex","Cross-Sectional","Not Provided","Not Applicable","Not Provided","2 subjects, 2472 samples","","NIMH","NHD --- Neuroscience, health and disease","2019-03-21","2019-03-21","Cerebral Cortices; Cerebral gray matter; Cerebri, Cortex; Cerebrus, Cortex; Cortex; Cortex Cerebri"
"phs001795.v1.p1","Genetic Analysis of the Chiari I Malformation","This study used whole exome sequencing (WES) on families affected with Chiari I Malformation (CM1). Individuals were recruited from the Republic of Tartarstan in the Russian Federation, where CM1  has a high prevalence (approximately 413 out of 100,000). At least one-third of these affected individuals have an affected relative. In","Arnold-Chiari Malformation","Case-Control","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 20 variables, 1 analyses, 1 molecular datasets,  SRA, 62 subjects, 62 samples","European (10), Hispanic2 (4), Other Asian or Pacific Islander (1), South Asian (1), Other (46)","NINDS","GRU --- General research use","2019-06-28","2019-06-28","ARNOLD-CHIARI MALFORMATION; Arnola-Chiari malformation; Arnold Chiari Deformity; Arnold Chiari Syndrome; Arnold-Chiari Deformity; Arnold-Chiari Syndrome"
"phs001796.v1.p1","Molecular and Cellular Correlates of Nerve Repair in Humans","This is a longitudinal prospective cohort study in patients with carpal tunnel syndrome undergoing decompression surgery. Phenotypic data and skin biopsies were collected before and 6 months after surgery  to determine molecular and cellular correlates associated with neural regeneration and neuropathic pain. RNA sequencing was performed in the skin","Carpal Tunnel Syndrome","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 46 variables, 78 subjects, 92 samples","","NINDS","GRU --- General research use","2019-05-24","2019-05-24","AMYOTROPHY, THENAR, OF CARPAL ORIGIN; CTS; CTS - Carpal tunnel syndrome; CTS1; Carpal Tunnel Syndromes; Carpal canal"
"phs001798.v1.p1","A New Reference Panel to Boost African American Genotype Imputation","Modern genetic studies have been conducted predominantly in cohorts of individuals of European ancestry. By 2010, there were approximately ten times as many published genome wide association studies (GWAS)  in people of European ancestry than studies in people of all other ancestries combined. This research disparity has led to an uneven understanding of","Not Provided","Cross-Sectional","WGS_markerset_grc38","Not Applicable","SNP/CNV Genotypes (NGS), WGS","3 phenotype datasets, 6 variables, 1 molecular datasets, 2328 subjects, 2328 samples","African (96), African American (2202), Hispanic1 (1), Other (4)","NHGRI","HGV --- Human genetic variation research","","",""
"phs001799.v1.p1","Genomic landscape of Neutrophilic Leukemias of Ambiguous Diagnosis","Chronic neutrophilic leukemia (CNL), atypical chronic myeloid leukemia (aCML), and unclassified myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN-U) are a group of rare, heterogeneous myeloid disorders. There is strong morphologic resemblance amongst  these distinct diagnostic entities as well as lack of specific molecular markers and limited understanding of disease pathogenesis, which has made","Leukemia","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","176 subjects, 238 samples","","NCI","","","","Aleukemic leukemia [obs]; Blood (Leukemia); Blood cancer; Chronic leukemia [obs]; Leucocythaemia; Leucocythaemias"
"phs001800.v1.p1","Genomics of Pediatric Renal Medullary Carcinomas","We derived faithful cancer cell lines from patients with a diagnosis of renal medullary carcinomas (RMC). These models have been sequenced with whole genome, exome and transcriptome technologies along  with the patient's primary germline and tumor samples. We took these faithful models and performed loss-of-function genetic perturbation screens (e.g","SMARCB1 Protein","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq, WGS, WXS","2 subjects, 7 samples","","NCI","HMB --- Health/medical/biomedical , DS-CA-MDS --- Disease-specific (cancer, mds) , GRU --- General research use","2019-06-14","2019-06-14","Black; Blacks; Negro; Negroes; Kidney Neoplasms; Kidney Tumor"
"phs001802.v1.p1","Genetics of Lymphatic Anomalies from CAG","Lymphatic anomaly, a rare and devastating disease spectrum of mostly unknown etiologies, is characterized by diffuse or multicentric proliferation of dilated lymphatic vessels, and includes a variety of diagnoses:  lymphangiectasia, central conducting lymphatic anomaly, generalized lymphatic anomaly, kaposiform lymphangiomatosis, and Gorham Stout disease","Lymphatic Diseases","Case Set","Not Provided","Not Applicable","WXS","4 phenotype datasets, 17 variables,  SRA, 5 subjects, 5 samples","","NCI","GRU --- General research use","2019-05-23","2019-05-23","Lymphatism"
"phs001804.v1.p1","Genetic Epidemiology of Opioid Dependence in Bulgaria (GEODB)","The study was conducted in Bulgaria as a collaboration between the Molecular Medicine Center (Medical University, Sofia), the Bulgarian Addictions Institute (Sofia), the Initiative for Health Foundation (Sofia) and  Washington University School of Medicine (Saint Louis, MO, USA). This is a case-population control study. Participants (N 2,499 interviews; N 1,995","Opioid-Related Disorders","Case-Control","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 370 variables, 1 molecular datasets, 3001 subjects, 3001 samples","European (2593), Hispanic1 (26), Hispanic2 (1), Other Asian or Pacific Islander (1), South Asian (162), Other (218)","NIDA","DS-SUD --- Disease-specific (substance use disorders)","2019-06-28","2019-06-28","Abuse, Narcotic; Abuses, Narcotic; Narcotic Abuse; Narcotic Abuses"
"phs001807.v1.p1","InTEAM Consortium - Alcoholic Hepatitis","Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound hepatocellular dysfunction for which targeted treatments are urgently needed. Identification of molecular drivers is hampered by the lack of  suitable animal models. By performing RNA sequencing in livers from patients with different phenotypes of alcohol-related liver disease (ALD), we","Hepatitis, Alcoholic","Case Set","MethylationEPIC_v-1-0_B4","Not Applicable","Methylation (CpG), RNA-Seq","1 molecular datasets, 90 subjects, 90 samples","","NIAAA","DS-ALC-IRB-NPU-RD --- Disease-specific (alcoholism, irb, npu, rd)","2019-06-13","2019-06-13","Alcoholic Fatty Liver; Alcoholic fatty liver disease; Fatty Liver, Alcoholic; AH - Alcoholic hepatitis; Alcoholic Hepatitis; Alcoholic Cirrhosis"
"phs001810.v1.p1","Gene-Environment Interactions in COCCaINE Use Disorder (COCCaINE)","Drug addiction is a phenotype that has high heritability estimates. In recent years, association studies of candidate genes and some genome-wide association studies (GWAS) have identified a large number  of SNPs associated with substance use, abuse or dependence, particularly in phenotypes related to alcohol and nicotine use. Regarding snorted or","Cocaine","Prospective Longitudinal Cohort","Axiom_Smokesc1","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 45 variables, 1 molecular datasets, 1547 subjects, 1547 samples","European (591), African American (142), Hispanic1 (303), Hispanic2 (215), Other (296)","NIDA","GRU --- General research use","2019-08-01","2019-08-01","Cocaine HCl; HCl, Cocaine; Hydrochloride, Cocaine; Methyl 3-beta-hydroxy-1-alpha-H,5-alpha-H-tropan-2-beta-carboxylate, benzoate (ester) HCl; AIDS Virus; AIDS Viruses"
"phs001813.v1.p1","Integrative Tissue Analysis of Men with Prostate Cancer","The goal of this research is to assess the molecular alterations that contribute to prostate cancer development, and whether the clonality of these alterations influence their detection in plasma.","Prostatic Neoplasms","Case Set","Not Provided","Not Applicable","AMPLICON, RNA-Seq, WGS, WXS","5 phenotype datasets, 17 variables,  SRA, 121 subjects, 383 samples","","NCI","GRU --- General research use","2019-09-09","2019-09-09","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001823.v1.p1","Genome and Transcriptome Analysis of Lung Cancer Cell Lines","We have used a ""chemistry first"" approach to discover druggable acquired vulnerabilities that arised in the pathogenesis of non-small cell lung cancer (NSCLC). We screened chemical libraries ( 200,000  compounds) for chemical toxins that killed subsets of NSCLC but not normal human lung epithelial cells (HBECs). We first screened a panel of 12 NSCLC","Carcinoma, Non-Small-Cell Lung","Prospective Longitudinal Cohort","RNAseq_probe_set_grc38, WES_markerset_grc38","Not Applicable","RNA-Seq, SNV (.MAF), RNA Seq expression levels, WXS","4 phenotype datasets, 19 variables, 2 molecular datasets, 279 subjects, 813 samples","","NCI","DS-LC-IRB --- Disease-specific (lung cancer, irb)","2019-08-09","2019-08-09","Carcinoma, Non Small Cell Lung; Carcinoma, Non-Small Cell Lung; Carcinomas, Non-Small-Cell Lung; Lung Carcinoma, Non-Small-Cell; Lung Carcinomas, Non-Small-Cell; NONSMALL CELL LUNG CANCER"
"phs001824.v1.p1","RNASeq of Plasmacytoid Dendritic Cells in Head and Neck Squamous Cell    Cancer","Plasmacytoid dendritic cells (pDC) are a subset of dendritic cells with unique immunophenotypic properties and functions. While their role in antiviral immunity through production of type I interferons is  well-established, their contributions to anti-tumor immunity are less clear. While some evidence demonstrates that pDC in the tumor microenvironment","Dendritic Cells","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 14 variables,  SRA, 7 subjects, 19 samples","","NCI","GRU --- General research use","2019-06-28","2019-06-28","Not Provided"
"phs001830.v1.p1","Tumor Heterogeneity and Drug Resistance in FGFR2-Fusion    Cholangiocarcinoma","Whole exome sequencing was performed on blood and tumor specimens (collected from biopsy or rapid research autopsy) from a patient with FGFR2 fusion positive cholangiocarcinoma.","Cholangiocarcinoma","Case Set","WES_markerset_grc37","Not Applicable","CNV Genotypes, WXS","4 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 1 subjects, 12 samples","","NCI","DS-CA --- Disease-specific (cancer)","2019-08-06","2019-08-06","Bile duct cancer; CC; CCA; Carcinoma, Cholangiocellular; Carcinomas, Cholangiocellular; Cholangiocarcinomas"
"phs001833.v1.p1","Genetic Model of MS Severity","The goal of ""Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the CNS"" is to define the pathophysiological mechanisms underlying the development of disability in immune-mediated disorders of the central  nervous system (CNS) and to distinguish these from physiological (and often beneficial) responses of the human immune system to CNS injury. The long","Multiple Sclerosis","Prospective Longitudinal Cohort","WGS_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","4 phenotype datasets, 16 variables, 1 molecular datasets, 299 subjects, 299 samples","","NIAID","GRU-IRB-PUB-NPU --- General research use (irb, pub, npu)","2019-07-23","2019-07-23","DS - Disseminated sclerosis; Disseminated Sclerosis; MS (Multiple Sclerosis); MS - Multiple sclerosis; Sclerosis, Disseminated; Sclerosis, Multiple"
"phs001836.v1.p1","A Single Cell Transcriptomic Analysis of Human Neocortical Development","Defining the number, proportion, or lineage of distinct cell types in the developing human brain is an important goal of modern brain research. We produced single cell transcriptomic profiles  for 40,000 cells at mid-gestation to define deep expression profiles corresponding to all known major cell types at this developmental period and","Autism Spectrum Disorder","Prospective Longitudinal Cohort","Not Provided","Not Applicable","RNA-Seq","4 phenotype datasets, 19 variables,  SRA, 4 subjects, 76 samples","","NIMH","GRU --- General research use","2019-07-18","2019-07-18","Child Development Disorders, Pervasive; Pervasive Child Development Disorders; EP - Epilepsy; Epilepsies; Epileptic; Epileptic disorder"
"phs001839.v1.p1","Deep Sequencing of 3 Cancer Cell Lines on 2 Sequencing Platforms","To test the performance of a new sequencing platform, develop an updated somatic calling pipeline and establish a reference for future benchmarking experiments, we performed whole-genome sequencing of 3  common cancer cell lines (COLO-829, HCC-1143 and HCC-1187) along with their matched normal cell lines to great sequencing depths (up to 278X coverage","Neoplasms","Case Set","Not Provided","Not Applicable","WGS","4 phenotype datasets, 19 variables, 3 subjects, 12 samples","","NCI","GRU --- General research use","","","BARD1-Related Susceptibility to Breast Cancer; Breast Cancer; Breast Malignant Neoplasm; Breast Malignant Neoplasms; Breast Malignant Tumor; Breast Malignant Tumors"
"phs001840.v1.p1","Single-Cell Analysis of Human Pancreatic Ductal Adenocarcinoma","Cancer-associated fibroblasts (CAFs) are major players in the progression and drug resistance of pancreatic ductal adenocarcinoma (PDAC). CAFs constitute a diverse cell population consisting of several recently described subtypes,  although the extent of CAF heterogeneity has remained undefined. Here we employ single-cell RNA-sequencing to thoroughly characterize the neoplastic","Carcinoma, Pancreatic Ductal","Prospective Longitudinal Cohort","RNAseq_probe_set_grc37","Not Applicable","RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 15 variables, 1 molecular datasets, 6 subjects, 9 samples","","NCI","GRU --- General research use","2019-07-17","2019-07-17","Carcinoma, Ductal, Pancreatic; Carcinoma, Pancreas Duct-Cell; Carcinomas, Pancreas Duct-Cell; Carcinomas, Pancreatic Ductal; Duct Cell Carcinoma of the Pancreas; Duct Cell Carcinoma, Pancreas"
"phs001848.v1.p1","Human PI3K Deficiency with Immunodeficiency and Tissue Immunopathology","Whole exome sequencing of a trio (parents and offspring) reveals PIK3CG mutations that result in loss of protein in the child with immunodeficiency and immunopathology.","Immune System Diseases","Family/Twin/Trios","WES_markerset_grc37","Not Applicable","SNP/CNV Genotypes (NGS)","5 phenotype datasets, 23 variables, 1 molecular datasets,  SRA, 3 subjects, 3 samples","","NIAID","HMB-IRB --- Health/medical/biomedical (irb)","2019-07-26","2019-07-26","Disease, Immune; Disease, Immune System; Disease, Immunologic; Disease, Immunological; Diseases of Immune System; Diseases, Immune"
"phs001850.v1.p1","Systemic Lupus Erythematosus Subtypes in a Multi-Ethnic Cohort","Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects multiple organ systems and varies in severity across different populations. To examine the clinical heterogeneity of SLE, we  sought to identify different lupus subtypes within our multi-ethnic cohort using a clustering approach. Additionally, with genome-wide methylation","Lupus Erythematosus, Systemic","Prospective Longitudinal Cohort","MethylationEPIC_v-1-0_B4, Axiom","Not Applicable","Methylation (CpG), SNP Genotypes (Array)","4 phenotype datasets, 22 variables, 1 molecular datasets, 333 subjects, 310 samples","European (89), African (1), East Asian (76), African American (32), Hispanic1 (2), Hispanic2 (46), Other Asian or Pacific Islander (23), South Asian (3), Other (10)","NIAMS","HMB --- Health/medical/biomedical","2019-07-24","2019-07-24","DNASE1-Related Susceptibility to Systemic Lupus Erythematosus; Disseminated lupus erythematosus; Lupus Erythematosus Disseminatus; SLE; SLE - Lupus Erythematosus, Systemic; SLE - Systemic lupus erythematosus"
"phs001852.v1.p1","Analysis of the Genetic Basis of Height in Large Jewish Nuclear Families","This is a family based study of the genetic basis of height, which focused on very large nuclear families (10 siblings or more, average of 12), all from a  founder (Jewish) population. All participants have completed their growth. This study design increases the frequency of some genetic variants that","Body Height","Family/Twin/Trios","Axiom","Not Applicable","SNP Genotypes (Array)","5 phenotype datasets, 34 variables, 1 molecular datasets, 404 subjects, 399 samples","European (347), Hispanic1 (22), Other (30)","NICHD","HMB-IRB --- Health/medical/biomedical (irb) , LHMB --- Limited health/medical/biomedical","2019-08-28","2019-08-28","Not Provided"
"phs001853.v1.p1","MGH Gastrointestinal Malignancies Resistance Initiative","Tumor heterogeneity can drive the evolution of multiple tumor subclones harboring unique molecular resistance alterations in different metastatic lesions in an individual patient, under the selective pressure of therapy1-3.  Studies have suggested that liquid biopsy may better capture the heterogeneity of acquired resistance, but systematic, direct comparisons of post","Colorectal Neoplasms","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","","","NCI","","","","Bile duct cancer; CC; CCA; Carcinoma, Cholangiocellular; Carcinomas, Cholangiocellular; Cholangiocarcinomas"
"phs001854.v1.p1","Human Pilocytic Astrocytoma Single Cell RNA Sequencing","Pilocytic astrocytoma (PA), the most common childhood brain tumor, is a low-grade glioma with a single driver BRAF rearrangement. Here, we perform scRNAseq in six PAs using methods that  enabled detection of the rearrangement. When compared to higher-grade gliomas, a strikingly higher proportion of the PA cancer cells exhibit a","Astrocytoma","Case Set","Not Provided","Not Applicable","Not Provided","6 subjects, 931 samples","","NCI","","","","ASTROCYTOMA; Astrocytic Glioma; Astrocytic Gliomas; Astrocytic Neoplasm; Astrocytic tumor; Astrocytoma, no ICD-O subtype"
"phs001858.v1.p1","Germline Variants of Clinical Cancer Specimens","These clinical specimens were collected were collected as part of patients' routine care at Memorial Sloan Kettering Cancer Center. They were sequenced on the targeted platform MSK-IMPACT. Here, we  anonymized germline variant calling on these specimens for comprehensive exploration of the landscape of pathogenic germline variants in patients","Neoplasms","Tumor vs. Matched-Normal","Not Provided","Not Applicable","SNV (.MAF)","17152 subjects, 34304 samples","","NCI","","","","Comparative Genomic; Comparative Genomics; Genomic, Comparative; Genomics, Comparative; CA; CA - Cancer"
"phs001867.v1.p1","Detection of Somatic Mutations In Vitro Aging Cells","Deep sequencing was performed to analyze the prevalence of somatic mutations during in vitro cell aging. Primary dermal fibroblasts from healthy subjects of young and advanced age, from Hutchinson-Gilford  progeria syndrome, and from Xeroderma Pigmentosum complementation group A (XPA) and C (XPC), were first restricted in number and then expanded in","Hutchinson-Gilford Progeria Syndrome","Cross-Sectional","HumanOmniExpress-12v1_H","Not Applicable","SNP Genotypes (Array), Targeted-Capture","5 phenotype datasets, 26 variables, 1 molecular datasets, 13 subjects, 25 samples","Other (1)","NHGRI","GRU --- General research use","2019-08-06","2019-08-06","Aging, Biological; Biological Aging; Atypical Werner Syndrome; HGPS; Hutchinson Gilford Progeria Syndrome; Hutchinson Gilford Syndrome"
"phs001877.v1.p1","Genetics of Cutaneous T-Cell Lymphoma","Mycosis fungoides (MF) is a common extranodal T-cell lymphoma primarily arising in the skin. In early disease stages, MF presents as skin patches and plaques that in some cases  may progress to tumor and disperse to lymph nodes and other internal organs. The 10-year overall survival is 50% in advanced stages. Early diagnosis","Mycosis Fungoides","Case-Control","Not Provided","Not Applicable","Not Provided","31 subjects, 82 samples","","NCI","","","","Granulomatous Slack Skin; Slack Skin, Granulomatous"
"phs001884.v1.p1","Cognitive Ability and Homozygosity Study","Recent studies of genetic foundations of cognitive ability rely on large samples (hundreds of thousands) of individuals from relatively outbred populations of mostly European ancestry. Hypothesizing that the genetic  foundation of cognitive ability depends on the broader population-specific genetic context, we performed a genome-wide association study and","Intelligence","Prospective Longitudinal Cohort","Not Provided","Not Applicable","Not Provided","","","NICHD","","","","Consanguinities; Consanguinity"
"phs000089.v4.p2","NINDS- Genome-Wide Genotyping in Parkinson's Disease","This sub-study phs000089 PD GWAS contains genotype and selected phenotype of subjects available from the phs001172 study. Summary level phenotypes for the NINDS Parkinson's Disease Cohort study participants can  be viewed at the top-level study page phs001172 NINDS Parkinson's Disease Cohor. Individual level phenotype data and molecular data for all NINDS","Parkinson Disease","Prospective Longitudinal Cohort","Not Provided","National Institute of Neurological Disorders and Stroke (NINDS) Parkinson&#39;s Disease (phs001172.v1.p2)","Not Provided","3 phenotype datasets, 113 variables, 3 documents, 3 analyses, 1 molecular datasets, 1741 subjects, 1741 samples","European (1697), Hispanic1 (9), Hispanic2 (13), Other Asian or Pacific Islander (1), Other (21)","NINDS","GRU --- General research use","2016-12-22","2016-12-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs000090.v5.p1","GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study","This sub-study phs000090 GENEVA ARIC contains genotype data and selected phenotype of subjects available from the phs000090 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can  be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study","Cardiovascular Diseases","Case-Control","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (Array), SNP Genotypes (imputed)","2 phenotype datasets, 366 variables, 166 documents, 3 molecular datasets,  SRA, 12771 subjects, 13249 samples","European (9590), African (112), East Asian (1), African American (3003), Hispanic1 (34), Hispanic2 (20), Other Asian or Pacific Islander (1), South Asian (2), Other (8)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","Atherogenesis; Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System"
"phs000100.v4.p1","The Finland-United States Investigation of NIDDM Genetics (FUSION) - GWAS    Study","The Finland-United States Investigation of NIDDM Genetics (FUSION) study is a long-term effort to identify genetic variants that predispose to type 2 diabetes (T2D) or that impact the variability  of T2D-related quantitative traits. The initial effort involved linkage analysis of affected-sibling-pair (ASP) families based on over 5,000","Diabetes Mellitus, Type 2","Case-Control","Not Provided","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study (phs000867.v1.p1)","SNP Genotypes (Array)","2 phenotype datasets, 6 variables, 1 analyses, 1 molecular datasets, 1706 subjects, 1706 samples","European (1701), South Asian (1), Other (4)","NIDDK","GRU-IRB --- General research use (irb)","2015-04-24","2015-04-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000140.v2.p1","A Whole Genome Association Search for Type 2 Diabetes Genes in African    Americans","This sub-study phs000140 CIDR T2D Bowden contains genotype data and selected phenotype of subjects available from the phs000140 study. Summary level phenotypes for the NIDDK T2D Seq GWAS AA  Cohort study participants can be viewed at the top-level study page phs001167 T2D Seq GWAS AA Cohort. Individual level phenotype data and molecular","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Type 2 Diabetes in African Americans, GWAS and Exome Sequencing (phs001167.v1.p1)","SNP Genotypes (Array)","4 phenotype datasets, 52 variables, 2 documents, 1 molecular datasets, 2004 subjects, 2142 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000143.v2.p1","Starr County Health Studies' Genetics of Diabetes Study","This sub-study phs000143 CIDR T2D Hanis contains genotype data and selected phenotype of subjects available from the phs000143 study. Summary level phenotypes for the NIDDK T2D Seq GWAS Starr  County Cohort study participants can be viewed at the top-level study page phs001166 T2D Seq GWAS Starr County Cohort. Individual level phenotype","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Type 2 Diabetes Starr County GWAS and Exome Sequencing (phs001166.v1.p1)","SNP Genotypes (Array)","2 phenotype datasets, 28 variables, 1 molecular datasets, 1980 subjects, 2121 samples","African American (1887), Hispanic1 (3)","NIDDK","GRU-IRB --- General research use (irb)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000182.v3.p1","AMD-MMAP Cohort Study: A Joint Genome Wide Association Study","Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves  interaction of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis","Macular Degeneration","Case-Control","Not Provided","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","SNP Genotypes (Array)","4 phenotype datasets, 18 variables, 2 analyses, 1 molecular datasets, 3340 subjects, 3577 samples","European (3291), African American (5), Hispanic1 (3), Hispanic2 (8), Other (2)","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2014-05-08","2015-05-08",""
"phs000223.v5.p1","PAGE: CALiCo: Atherosclerosis Risk in Communities (ARIC)","This sub-study phs000223 PAGE CALiCo ARIC contains genotype data and selected phenotype of subjects available from the phs000223. Summary level phenotypes for the NHLBI ARIC Cohort study participants can  be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 6 variables, 4 analyses, 1 molecular datasets, 3743 subjects, 3425 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","C Reactive Protein; C-Reactive Protein; CRP - C-reactive protein; Protein, C-Reactive; Proteins, specific or class, C-reactive; Cholesterol, HDL2"
"phs000226.v6.p1","STAMPEED: Cardiovascular Health Study (CHS)","Note: This substudy phs000226 STAMPEED Cardiovascular Health Study contains GWAS data of the subset of the CHS cohort selected for the NHLBI's SNP Typing for Association with Multiple Phenotypes  from Existing Epidemiologic Data (STAMPEED) project. Summary level phenotypes for the Cardiovascular Health Study Cohort study participants can be","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 5 variables, 2 documents, 6 analyses, 2 molecular datasets, 4211 subjects, 4792 samples","European (3345), African (48), East Asian (2), African American (763), Hispanic1 (26), Hispanic2 (19), Other (7)","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Aging, Biological; Biological Aging; Brain Vascular Disorder; Brain Vascular Disorders; CVD - Cerebrovascular disease; Cerebrovascular Disease"
"phs000227.v4.p3","PAGE: Women's Health Initiative (WHI)","This substudy phs000227 PAGE WHI contains genotypes generated using BeadXpress and Metabochip, produced as part of NHGRI's PAGE project. Summary level phenotypes for the WHI Cohort study participants can  be viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and","Women's Health","Prospective Longitudinal Cohort","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (Array), SNP Genotypes (PCR), WGS","1 phenotype datasets, 6 variables, 9 analyses, 4 molecular datasets, 45707 subjects, 56001 samples","European (1014), African (233), East Asian (366), African American (6584), Hispanic1 (625), Hispanic2 (3296), Other Asian or Pacific Islander (69), South Asian (5), Other (276)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Cholesterol, HDL2; HDL cholesterol 2; HDL(2) Cholesterol; HDL2 Cholesterol; High density lipoprotein cholesterol subfraction 2; High density lipoprotein cholesterol, sub-fraction II"
"phs000236.v2.p2","PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA)","This sub-study phs000236 PAGE CALiCo CARDIA contains genotype derived from sequence data and selected phenotype of subjects available from the phs000236 study. Summary level phenotypes for the NHLBI CARDIA  Cohort study participants can be viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (PCR)","1 phenotype datasets, 3 variables, 83 documents, 4 analyses, 1 molecular datasets, 3595 subjects, 3595 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","C Reactive Protein; C-Reactive Protein; CRP - C-reactive protein; Protein, C-Reactive; Proteins, specific or class, C-reactive; Cholesterol, HDL2"
"phs000246.v2.p1","Fuchs' Corneal Dystrophy GWAS","We sought to identify biological pathways contributing to Fuchs corneal dystrophy (FCD) by performing a genome wide association study (GWAS). We re-coded the ocular phenotypes for a previous GWAS  on age-related macular degeneration that employed an unrelated case-control study design. The recoded cases with FCD were matched to two controls","Fuchs' Endothelial Dystrophy","Case-Control","Not Provided","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","Not Provided","1 phenotype datasets, 3 variables, 389 subjects","","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2014-05-08","2015-05-08","Dystrophy, Fuch's Endothelial; Dystrophy, Fuchs' Endothelial; Endothelial Dystrophy, Fuch's; Endothelial Dystrophy, Fuchs'; Fuch Endothelial Dystrophy; Fuch's Endothelial Dystrophy"
"phs000249.v3.p1","NABEC: Genome-Wide Genotyping","This sub-study contains genotypes for 382 neurologically healthy control samples deposited from the North American Brain Expression Consortium (NABEC). Here, we release the raw genotype data of these control  individuals where the genotypes were assayed on Illumina genome-wide genotyping arrays. Previous Study Name: Abundant Quantitative Trait Loci Exist","Healthy Volunteers","Control Set","Not Provided","NABEC: North American Brain Expression Consortium (phs001300.v1.p1)","SNP Genotypes (Array), SNP/CNV Genotypes (NGS), WXS","3 phenotype datasets, 12 variables, 4 molecular datasets,  SRA, 382 subjects, 1013 samples","","NIA","GRU --- General research use","2018-03-21","2018-03-21","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Loci, Quantitative Trait; Locus, Quantitative Trait"
"phs000281.v7.p3","NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) -    WHISP","This substudy phs000281 WHISP contains exome sequencing, produced as part of NHLBI's GO-ESP project. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level  study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are available by","Women's Health","Prospective Longitudinal Cohort","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 79 variables, 1 documents, 5 molecular datasets,  SRA, 2150 subjects, 2206 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","BMI; BMI - Body mass index; BODY MASS INDEX; Index, Body Mass; Index, Quetelet; Quetelet Index"
"phs000282.v19.p11","NHLBI Framingham Candidate Gene Association Resource (CARe)","This substudy phs000282 Framingham CARe contains 50K genotypes from 2,100 candidate genes across a range of cardiovascular, metabolic, and inflammatory syndromes, produced as part of NHLBI's Candidate Gene Association  Resource (CARe) project. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page phs000007","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (Array)","1 molecular datasets, 8556 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000283.v7.p3","NHLBI MESA Candidate Gene Association Resource (CARe)","This substudy phs000283 MESA CARe contains 50k genotypes from 2,100 candidate genes across a range of cardiovascular, metabolic, and inflammatory syndromes, produced as part of NHLBI's Candidate Gene Association  Resource (CARe) project. Summary level phenotypes for the MESA Cohort study participants can be viewed at the top-level study page phs000209 MESA","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 6354 subjects, 6420 samples","","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Atherogenesis"
"phs000296.v5.p2","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (COPDGene)","This sub-study phs000296 ESP LungGO COPDGene contains genotype derived from sequence data and selected phenotype of subjects available from the phs000179 COPDGene_v6 study. Summary level phenotypes for the NHLBI  COPDGene Cohort study participants can be viewed at the top-level study page eric.austin@Vanderbilt.Edu COPDGene Cohort. Individual level phenotype","Pulmonary Disease, Chronic Obstructive","Case-Control","Not Provided","Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute (phs000179.v6.p2)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 20 variables, 2 molecular datasets,  SRA, 289 subjects, 289 samples","","NHLBI","HMB --- Health/medical/biomedical , DS-CS --- Disease-specific (copd and smoking)","2019-05-03","2015-09-19","Emphysema; CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD"
"phs000301.v5.p1","PAGE: CALiCo: Cardiovascular Health Study (CHS)","Note: This substudy phs000301 PAGE Cardiovascular Health Study contains genotypes on selected SNP loci of the subset of the CHS cohort selected for the NHGRI's Population Architecture using Genomics  and Epidemiology (PAGE) project. Summary level phenotypes for the Cardiovascular Health Study Cohort study participants can be viewed at the top","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array), SNP Genotypes (PCR)","2 phenotype datasets, 8 variables, 4 analyses, 2 molecular datasets, 5346 subjects, 5346 samples","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","AP - Angina pectoris; Angina; Anginal syndrome; Angor Pectoris; Cardiac angina; Ischemic heart disease - angina"
"phs000307.v15.p11","NHLBI Framingham Heart Study Allelic Spectrum Project","This substudy phs000307 Framingham Allelic Spectrum Project includes the generation of deep coverage targeted re-sequencing and variant identification for 216 genes in the Framingham Heart Study (FHS) sample collection,  produced as part of NHLBI's Medical Resequencing projects. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP/CNV Genotypes (NGS), WXS","1 phenotype datasets, 4 variables, 1 molecular datasets,  SRA, 1634 subjects, 1634 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12",""
"phs000309.v3.p2","The CARDIA-GENEVA Study","This sub-study phs000309 GENEVA CARDIA contains genotype and selected phenotype of subjects available from the phs000309 study. Summary level phenotypes for the NHLBI CARDIA Cohort study participants can be  viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all CARDIA Cohort top-level study","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (Array), SNP Genotypes (imputed), SNP Genotypes (Array), SNP Genotypes (imputed)","2 phenotype datasets, 155 variables, 59 documents, 2 molecular datasets, 1926 subjects, 4991 samples","European (1644), East Asian (1), African American (1), Hispanic1 (5), Hispanic2 (12), Other Asian or Pacific Islander (7), Other (5)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Atherogenesis; Caloric Intake; Energy intake; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High"
"phs000315.v7.p3","WHI GARNET","This substudy phs000315 WHI GARNET contains genotypes generated using Illumina array, produced as part of NHGRI's GARNET project. Summary level phenotypes for the WHI Cohort study participants can be  viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and","Cardiovascular Diseases","Case-Control","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 4983 samples","European (4338), African (13), East Asian (64), African American (273), Hispanic1 (45), Hispanic2 (105), Other Asian or Pacific Islander (36), Other (20)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000334.v1.p1","NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Acute Lung Injury)","This sub-study phs000334 LungGO ALI contains genotype and selected phenotype of subjects available from the phs000631 study. Summary level phenotypes for the ""ARDSnet and the iSPAAR Consortium: Genetic Studies""  study participants can be viewed at the top-level study page phs000631 ARDSNet iSPAAR cohort. Individual level phenotype data and molecular data for","Acute Lung Injury","Case-Control","Not Provided","ARDSnet and the iSPAAR Consortium: Genomic Basis of Susceptibility and Outcomes in Patients with the Acute Respiratory Distress Syndrome (ARDS) (phs000631.v1.p1)","SNP Genotypes (Array), SNP Genotypes (NGS), WXS, SNP Genotypes (Array), SNP Genotypes (NGS), WXS","1 phenotype datasets, 5 variables, 3 molecular datasets,  SRA, 1536 subjects, 1536 samples","","NHLBI","HMB --- Health/medical/biomedical","2014-01-15","2015-01-15","ALI; ALI - Acute lung injury; Acute Lung Injuries; Lung Injuries, Acute; Lung Injury, Acute; Gram-positive septic shock"
"phs000342.v18.p11","NHLBI Framingham SNP Health Association Resource (SHARe)","This substudy phs000342 Framingham SHARe contains 100K and 550K genotypes, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. It also contains 4.3 million genotypes produced under  Illumina's Fast Track Genotyping Service. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (Array), SNP Genotypes (imputed), Legacy Genotypes, SNP Genotypes (PCR)","2 phenotype datasets, 8 variables, 2812 analyses, 11 molecular datasets, 10315 subjects, 31682 samples","European (4616), African (3), East Asian (105), African American (269), Hispanic1 (134), Hispanic2 (158), Other Asian or Pacific Islander (22), South Asian (84), Other (62)","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000363.v17.p11","NHLBI Framingham SABRe CVD","This substudy phs000363 Framingham SABRe contains immunoassays, gene expression profiling, and microRNA data. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study  page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all Framingham top-level study and substudies are available","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","miRNA Expression (Array), mRNA Expression (Array)","21 phenotype datasets, 1404 variables, 73 documents, 2 molecular datasets, 7558 subjects, 11329 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System; Cardiovascular Systems"
"phs000377.v5.p1","NHLBI Cardiovascular Health Study (CHS) Candidate Gene Association    Resource (CARe)","Note: This substudy phs000377 CARe Cardiovascular Health Study contains 50K genotypes from 2,100 candidate genes produced as part of NHLBI's Candidate-Gene Association Resource (CARe) project. Summary level phenotypes for  the Cardiovascular Health Study Cohort study participants can be viewed at the top-level study page phs000287 Cardiovascular Health Study (CHS","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array)","2 phenotype datasets, 7 variables, 1 molecular datasets, 5279 subjects, 5282 samples","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","AP - Angina pectoris; Angina; Anginal syndrome; Angor Pectoris; Cardiac angina; Ischemic heart disease - angina"
"phs000386.v7.p3","NHLBI WHI SHARe","This substudy phs000386 WHI SHARe contains genotypes generated using Affymetrix array, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. Summary level phenotypes for the WHI Cohort  study participants can be viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top","Women's Health","Prospective Longitudinal Cohort","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 12007 subjects, 12262 samples","European (598), African (283), East Asian (1), African American (7983), Hispanic1 (541), Hispanic2 (2406), Other Asian or Pacific Islander (19), Other (176)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Health, Woman's; Health, Women's; Health, Womens; Woman's Health; Womens Health"
"phs000398.v5.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)","This sub-study phs000398 HeartGO_ARIC contains genotype derived from sequence data and selected phenotype of subjects available from the phs000398 study. Summary level phenotypes for the NHLBI ARIC Cohort study  participants can be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort","Cardiovascular Diseases","Case-Control","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (NGS), WXS, SNP Genotypes (NGS), WXS","2 phenotype datasets, 127 variables, 3 molecular datasets,  SRA, 843 subjects, 843 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Cardiac infarction"
"phs000399.v1.p2","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)","This sub-study phs000399 GO-ESP HeartGO_CARDIA contains genotype derived from sequence data and selected phenotype of subjects available from the phs000399 study. Summary level phenotypes for the NHLBI CARDIA Cohort  study participants can be viewed at the top-level study page phs000285 CARDIA Cohort. Individual level phenotype data and molecular data for all","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 86 variables, 2 molecular datasets,  SRA, 199 subjects, 199 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Cardiac infarction"
"phs000400.v5.p1","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)","Note: This substudy phs000400 GO-ESP Cardiovascular Health Study contains harmonized phenotype data, whole exome sequencing and .vcf data of the subset of the CHS cohort selected for NHLBI's GO-ESP  Exome Sequencing Project. Summary level phenotypes of the Cardiovascular Health Cohort study participants may be viewed at the top-level study page","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (NGS), WXS","3 phenotype datasets, 123 variables, 3 molecular datasets,  SRA, 210 subjects, 211 samples","","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Cardiac infarction"
"phs000401.v13.p11","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (FHS)","This substudy phs000401 Framingham ESP Heart-GO contains exome sequence data and harmonized phenotype variables, produced as part of NHLBI's GO-ESP project. Summary level phenotypes for the Framingham Cohort study  participants can be viewed at the top-level study page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 110 variables, 2 molecular datasets,  SRA, 462 subjects, 720 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Cardiac infarction"
"phs000402.v4.p2","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (JHS)","This sub-study phs000402 HeartGO JHS contains genotype derived from sequence data and selected phenotype of subjects available from the phs000402 study. Summary level phenotypes for the NHLBI JHS Cohort  study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS","Cardiovascular Diseases","Case-Control","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v6.p2)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 92 variables, 3 molecular datasets,  SRA, 402 subjects, 403 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Cardiac infarction"
"phs000403.v3.p3","NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)","The NHLBI ""Grand Opportunity"" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery Act investment, was designed to identify genetic variants in coding regions (exons) of the  human genome (the ""exome"") that are associated with heart, lung and blood diseases. These and related diseases that are of high impact to public","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 97 variables, 2 molecular datasets,  SRA, 404 subjects, 404 samples","","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Brain Ischemias; Encephalopathy, Ischemic; Ischemia, Brain; Ischemic Encephalopathies; Ischemic Encephalopathy; Cardiac infarction"
"phs000406.v3.p1","Spatiotemporal Transcriptome of the Human Brain","Comprehensive knowledge about the spatiotemporal dynamics of the brain transcriptome is essential for a better understanding of neurodevelopment, sexual dimorphism, and evolution, as well as our increased susceptibility to  certain brain disorders. We generated and analyzed genome-wide exon-level transcriptome data from 16 brain regions of 57 postmortem human brains","Aging","Control Set","Not Provided","BrainSpan Atlas of the Human Brain (phs000755.v2.p1)","SNP Genotypes (Array)","2 phenotype datasets, 8 variables, 1 molecular datasets, 57 subjects, 57 samples","European (30), African American (15), Hispanic1 (4), Hispanic2 (2), Other Asian or Pacific Islander (2), South Asian (1), Other (3)","NIMH","GRU --- General research use","2019-01-08","2018-05-23","Aging, Biological; Biological Aging"
"phs000420.v6.p3","NHLBI MESA SHARe","This substudy phs000420 MESA SHARe contains Affy 6.0 genotypes and Infinium HumanExome BeadChip data, produced as part of NHLBI's SNP Health Association Resource (SHARe) project. Summary level phenotypes for  the MESA Cohort study participants can be viewed at the top-level study page phs000209 MESA Cohort. Individual level phenotype data and molecular","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Multi-Ethnic Study of Atherosclerosis (MESA) Cohort (phs000209.v13.p3)","CNV Genotypes, SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 2 molecular datasets, 8388 subjects, 17098 samples","European (2737), African (122), East Asian (773), African American (2648), Hispanic1 (457), Hispanic2 (1354), Other Asian or Pacific Islander (14), South Asian (2), Other (117)","NHLBI","HMB --- Health/medical/biomedical , HMB-NPU --- Health/medical/biomedical (npu)","2014-11-18","2015-11-18","Atherogenesis"
"phs000429.v1.p1","NEI Age-Related Eye Disease Study (AREDS) - Genetic Variation in    Refractive Error Substudy","A genome-wide association study of refractive error using the Illumina 2.5M chip was performed using a subset of the control group from the original AREDS study. These control individuals  are all Caucasian, do not have age-related macular degeneration (AMD) and were further screened to also exclude individuals with cataracts, retinitis","Refractive Error","Case-Control","Not Provided","National Eye Institute (NEI) Age-Related Eye Disease Study (AREDS) (phs000001.v3.p1)","SNP Genotypes (Array)","1 phenotype datasets, 15 variables, 1 molecular datasets, 2000 subjects, 3877 samples","European (1874), Hispanic2 (2), Other (1)","NEI","EDO --- Eye disease research only , GRU --- General research purposes","2012-04-05","2016-02-11","Abnormal curving of the cornea or lens of the eye; Astigmatism; Farsightedness; Hypermetropia; Hypermetropia (farsightedness); Hyperopia"
"phs000457.v1.p1","MMAP-Methylation in AMD","This is a case-control study of Age-related Macular Degeneration (AMD). AMD is a progressive disease which results in loss of vision in the central field. In the U.S., AMD  affects over 1.7 million people now, and due to the aging population, that number is predicted to reach 3 million by 2015. Gene expression changes in","Macular Degeneration","Case-Control","Not Provided","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 7 variables, 1 molecular datasets, 300 subjects, 300 samples","","NEI","DS-ED --- Disease-specific (eye disease)","2014-05-08","2015-05-08","AAMD - Age related macular degeneration; AMD; AMD - Age-related macular degeneration; ARMD; ARMD - Age-related macular degeneration; Age Related Macular Degeneration"
"phs000462.v2.p1","T2D-GENES Project 2: San Antonio Mexican American Family Studies    (SAMAFS), Substudy 2: Whole genome sequencing in pedigrees","The Type 2 Diabetes (T2D) Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Consortium is a collaborative international effort to identify genes influencing susceptibility to type 2 diabetes  in multiple ethnic groups using next generation sequencing. T2D-GENES Project 2 (San Antonio Mexican American Family Studies [SAMAFS], Substudy 2) is","Diabetes Mellitus, Type 2","Family/Twin/Trios","Not Provided","T2D-GENES Consortium: San Antonio Mexican American Family Studies (SAMAFS) (phs000847.v2.p1)","SNP Genotypes (Array), mRNA Expression (Array), SNP Genotypes (NGS), WGS, SNP Genotypes (Array), mRNA Expression (Array), SNP Genotypes (NGS), WGS","3 phenotype datasets, 272 variables, 2 molecular datasets, 1048 subjects, 1651 samples","European (6), East Asian (1), Hispanic1 (2), Hispanic2 (1016), Other Asian or Pacific Islander (4), Other (6)","NIDDK","DS-DIAB-IRB-RD --- Disease-specific (diabetes, irb, rd)","2016-12-13","2016-12-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000463.v19.p8","TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1","There are 189 fully characterized patient cases that make up the pilot phase (Phase I) of the TARGET ALL dataset, each with gene expression, tumor and paired normal copy  number analyses, and at least one type of sequencing (Sanger and/or next-generation) data available. There are 230 cases with partial molecular","Acute Lymphoblastic Leukemia","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","Not Provided","2 phenotype datasets, 8 variables,  SRA, 289 subjects, 65 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000464.v19.p8","TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2","There are 175 fully characterized patient cases with relapsed precursor B-cell ALL (all tumor/normal pairs, 85 with relapse sample as well) that will make up Phase II of the  TARGET ALL dataset, each with gene expression, tumor and paired normal copy number analyses, and comprehensive next-generation sequencing to include","Acute Lymphoblastic Leukemia","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","RNA-Seq, WGS, WXS, miRNA-Seq","2 phenotype datasets, 24 variables,  SRA, 1199 subjects, 3461 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","ALL, Childhood; Childhood ALL; Childhood Acute Lymphoid Leukemia; Childhood Precursor Lymphoblastic Leukemia; L1 Lymphocytic Leukemia; Leukemia, L1 Lymphocytic"
"phs000465.v19.p8","TARGET: Acute Myeloid Leukemia (AML)","There are 200+ fully characterized patient cases with AML (all tumor/normal pairs, 100 with relapse sample as well) that make up the TARGET AML dataset, each with gene expression,  tumor and paired normal copy number analyses, methylation and comprehensive next-generation sequencing to include whole genome sequencing, mRNA-seq","Leukemia, Myeloid, Acute","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 8 variables,  SRA, 2119 subjects, 4249 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","AML; AML - Acute Myeloid Leukemia; AML - Acute myeloblastic leukemia; AML adult; AML, NOS; AMegL"
"phs000466.v19.p8","TARGET: Kidney, Clear Cell Sarcoma of the Kidney (CCSK)","To further explore some more aggressive subtypes in pediatric cancer already under study in OCG, CGCI is partnering with TARGET initiative to support extensive sequencing analysis of three hard  to treat childhood cancers: refractory to treatment cases of acute myeloid leukemia and two rare kidney tumors; clear cell sarcoma of the kidney","Clear Cell Sarcomas","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","RNA-Seq, WGS","2 phenotype datasets, 8 variables,  SRA, 14 subjects, 45 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","Chordoid Sarcoma; Clear Cell Sarcoma; Clear Cell Sarcoma of Soft Parts; Clear cell sarcoma of the tendons and aponeuroses; Malignant Melanoma of Soft Parts; Malignant Melanoma of the Soft Parts"
"phs000467.v19.p8","TARGET: Neuroblastoma (NBL)","There are 214 fully characterized patient cases with neuroblastoma (all tumor/normal pairs, 10 with relapse sample as well) that will make up the TARGET NBL dataset, along with some  cell lines and xenografts. The dataset includes 24 4S cases as well. Each fully characterized case has gene expression, tumor and paired normal copy","Neuroblastoma","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 29 variables,  SRA, 1195 subjects, 1950 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","Not Provided"
"phs000468.v19.p8","TARGET: Osteosarcoma (OS)","There are 93 fully characterized patient cases that make up the TARGET OS dataset, each with gene expression, tumor and paired normal copy number analyses, methylation, miRNA profiles, along  with comprehensive next-generation sequencing to include mRNA-seq and exome sequencing (whole genome sequencing where available). There are","Osteosarcoma","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","RNA-Seq, WGS, WXS","2 phenotype datasets, 8 variables,  SRA, 310 subjects, 744 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","Bone cell cancer; OSRC; OSTEOSARCOMA; Osteochondrosarcoma; Osteogenic Sarcoma; Osteogenic Sarcomas"
"phs000469.v19.p8","TARGET: Cancer Model Systems (MDLS): Cell Lines and Xenografts (including    PPTP)","As part of the TARGET initiative, some disease projects characterized tumor cell lines or xenografts, with or without matched normal comparators, as well as some normal non-involved tissues. These  reagents will be available for in vitro validation experiments and their molecular characteristics will be available through the TARGET Data Matrix","Antitumor Assay, Xenograft","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","Bisulfite-Seq, ChIP-Seq, RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 8 variables,  SRA, 132 subjects, 183 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","Antitumor Assays, Xenograft; Antitumor Assays, Xenograft Model; Assay, Xenograft Antitumor; Assays, Xenograft Antitumor; Tumor Xenograft Assay; Xenograft Antitumor Assay"
"phs000470.v19.p8","TARGET: Kidney, Rhabdoid Tumor (RT)","To further explore some more aggressive subtypes in pediatric cancer already under study in OCG, CGCI is partnering with TARGET initiative to support extensive sequencing analysis of three hard  to treat childhood cancers: refractory to treatment cases of acute myeloid leukemia and two rare kidney tumors; clear cell sarcoma of the kidney and","Rhabdoid Tumor","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","Bisulfite-Seq, ChIP-Seq, RNA-Seq, WGS, miRNA-Seq","2 phenotype datasets, 8 variables,  SRA, 70 subjects, 236 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","Not Provided"
"phs000471.v19.p8","TARGET: Kidney, Wilms Tumor (WT)","There are 130 fully characterized patient cases with high risk Wilms tumor (all tumor/normal pairs; 8 with additional samples for analysis 3 with tumor adjacent normal, 5 with relapse  sample) that will make up the TARGET WT dataset. Each case will have gene expression, tumor and paired normal copy number analyses, methylation and","Wilms Tumor","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments (phs000218.v22.p8)","RNA-Seq, Targeted-Capture, WGS, WXS, miRNA-Seq","2 phenotype datasets, 8 variables,  SRA, 653 subjects, 1018 samples","","NCI","PCR --- Pediatric cancer research","2019-09-13","2012-04-10","Embryonal adenosarcoma; Embryonal nephroma; NEPHROBLASTOMA; Nephroblastoma (Wilms tumor); Nephroblastomas; Nephroma"
"phs000498.v4.p2","Jackson Heart Study Allelic Spectrum Project","This sub-study phs000498 JHS Allelic Spectrum Seq contains genotype derived from sequence data and selected phenotype of subjects available from the phs000498 study. Summary level phenotypes for the NHLBI  JHS Cohort study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v6.p2)","SNP Genotypes (NGS), WXS","2 phenotype datasets, 5 variables, 1 molecular datasets,  SRA, 1983 subjects, 1983 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","Not Provided"
"phs000499.v4.p2","NHLBI Jackson Heart Study Candidate Gene Association Resource (CARe)","This sub-study phs000499 JHS CARe contains genotype data of subjects available from the phs000499 study. Summary level phenotypes for the NHLBI JHS Cohort study participants can be viewed at  the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and sub-study","Longitudinal Studies","Prospective Longitudinal Cohort","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v6.p2)","SNP Genotypes (Array)","2 phenotype datasets, 72 variables, 3 molecular datasets, 3352 subjects, 5460 samples","African (31), East Asian (1), African American (2150), Hispanic1 (6)","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","Studies, Longitudinal; Study, Longitudinal"
"phs000503.v5.p3","Women's Health Initiative Sight Examination (WHISE)","This substudy phs000503 WHISE contains phenotypes only for the Sight Examination study. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page  phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are available by requesting","Macular Degeneration","Clinical Trial","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","Not Provided","1 phenotype datasets, 192 variables, 1 documents, 3031 subjects","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Atrophies, Geographic; Atrophy, Geographic; Degeneration, Dry Macular; Degenerations, Dry Macular; Dry Macular Degeneration; Dry Macular Degenerations"
"phs000527.v10.p2","CGCI: Burkitt Lymphoma Genome Sequencing Project (BLGSP)","The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging  sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric","Lymphoma, Non-Hodgkin","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v13.p2)","Not Provided","230 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma; Reticulum-Cell Sarcomas"
"phs000528.v10.p2","CGCI: HIV+ Tumor Molecular Characterization Project - Cervical Cancer    (HTMCP - CC)","The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging  sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric","Lymphoma, AIDS-Related","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v13.p2)","Not Provided","214 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","AIDS Associated Lymphoma; AIDS Lymphoma; AIDS Related Lymphoma; AIDS-Associated Lymphoma; AIDS-Associated Lymphomas; AIDS-Related Lymphoma"
"phs000529.v10.p2","CGCI: HIV+ Tumor Molecular Characterization Project - Diffuse Large    B-Cell Lymphoma (HTMCP - DLBCL)","The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging  sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric","Lymphoma, AIDS-Related","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v13.p2)","RNA-Seq, WGS, miRNA-Seq","2 phenotype datasets, 8 variables,  SRA, 23 subjects, 30 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","AIDS Associated Lymphoma; AIDS Lymphoma; AIDS Related Lymphoma; AIDS-Associated Lymphoma; AIDS-Associated Lymphomas; AIDS-Related Lymphoma"
"phs000530.v10.p2","CGCI: HIV+ Tumor Molecular Characterization Project - Lung Cancer (HTMCP    - LC)","The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging  sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric","Lymphoma, AIDS-Related","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v13.p2)","RNA-Seq, WGS, miRNA-Seq","2 phenotype datasets, 8 variables,  SRA, 16 subjects, 42 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","Lung Tumor; Lung cancer; Neoplasm of Lung; Neoplasm of the Lung; Neoplasm, Lung; Neoplasm, Pulmonary"
"phs000531.v10.p2","CGCI: Medulloblastoma","The Office of Cancer Genomics (OCG) at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel  emerging sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different","Medulloblastoma","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v13.p2)","Not Provided","","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","Arachnoidal Cerebellar Sarcoma, Circumscribed; Circumscribed arachnoidal cerebellar sarcoma; Desmoplastic Medulloblastomas; Desmoplastic Nodular Medulloblastoma; MEDULLOBLASTOMA, DESMOPLASTIC; Medulloblastoma, desmoplastic, somatic"
"phs000532.v10.p2","CGCI: Non-Hodgkin Lymphoma","The Office of Cancer Genomics (OCG) at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel  emerging sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different","Lymphoma, Non-Hodgkin","Tumor vs. Matched-Normal","Not Provided","National Cancer Institute Cancer Genome Characterization Initiative (CGCI) (phs000235.v13.p2)","RNA-Seq, WGS, WXS","2 phenotype datasets, 33 variables,  SRA, 118 subjects, 207 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , PCR --- Pediatric cancer research","2018-11-16","2013-06-20","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma"
"phs000555.v1.p1","PAGE: CALiCo: Hispanic Community Health Study / Study of Latinos    (HCHS/SOL)","This sub-study phs000555 PAGE CALiCo SOL contains genotype data and selected phenotype of subjects available from the phs000555. Summary level phenotypes for the NHLBI HCHS SOL Cohort study participants  can be viewed at the top-level study page phs000810 HCHS SOL Cohort. Individual level phenotype data and molecular data for all HCHS SOL Cohort top","Diabetes Mellitus, Type 2","Prospective Longitudinal Cohort","Not Provided","Hispanic Community Health Study /Study of Latinos (HCHS/SOL) (phs000810.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 6 variables, 1 molecular datasets, 12089 subjects, 12341 samples","","NHLBI","HMB-NPU --- Health/medical/biomedical (npu) , HMB --- Health/medical/biomedical","2015-12-07","2016-12-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000557.v4.p1","NHLBI ARIC Candidate Gene Association Resource (CARe)","This sub-study phs000557 ARIC_CARe contains genotype derived from sequence data and selected phenotype of subjects available from the phs000557 study. Summary level phenotypes for the NHLBI ARIC Cohort study  participants can be viewed at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort","Atherosclerosis","Case-Control","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (Array)","2 phenotype datasets, 97 variables, 1 molecular datasets, 14502 subjects, 14560 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","Atherogenesis; Body System, Cardiovascular; Cardiovascular; Cardiovascular Body System; Cardiovascular Organ System; Cardiovascular System"
"phs000571.v5.p2","PCGC: Congenital Heart Disease Genetic Network Study","This substudy phs000571 PCGC contains whole exome sequences, targeted sequences, and SNP array data. Summary level phenotypes for the PCGC Cohort study participants can be viewed at the top-level  study page phs001194 PCGC Cohort. Individual level phenotype data and molecular data for all PCGC top-level study and substudies are available by","Heart Defects, Congenital","Prospective Longitudinal Cohort","Not Provided","National Heart, Lung, and Blood Institute (NHLBI) Bench to Bassinet Program: The Pediatric Cardiac Genetics Consortium (PCGC) Study (phs001194.v2.p2)","AMPLICON, SNP Genotypes (Array), RNA-Seq, WGS, WXS","2 phenotype datasets, 14 variables, 2 molecular datasets,  SRA, 9444 subjects, 11829 samples","European (1443), African (6), East Asian (22), African American (145), Hispanic1 (121), Hispanic2 (135), Other Asian or Pacific Islander (29), South Asian (70), Other (48)","NHLBI","HMB --- Health/medical/biomedical , DS-CHD --- Disease-specific (congenital heart disease)","2018-09-14","2017-11-09","Abnormalities, Heart; Abnormality, Heart; Cardiac abnormalities; Cardiac anomaly; Congenital Heart Defect; Congenital anomaly of heart"
"phs000610.v1.p1","RM Epigenomics Program - Broad_Alz_and_Age-Related","This sub-study phs000610 RM_Epigenomics_Broad_Alz contains molecular data of subjects available from the phs000610 study. Summary level phenotypes for the NADI Roadmap Epigenomics Broad cohort study participants can be viewed  at the top-level study page phs000700 Roadmap Epigenomics Broad cohort. Individual level phenotype data and molecular data for all Roadmap","Nervous System Diseases","Cross-Sectional","Not Provided","NIH Roadmap Epigenomics Program - Broad Institute (phs000700.v1.p1)","Bisulfite-Seq, ChIP-Seq, RNA-Seq, Bisulfite-Seq, ChIP-Seq, RNA-Seq","3 phenotype datasets, 11 variables,  SRA, 3 subjects, 19 samples","","NIDA","AARC --- Alzheimer's and age related conditions","2014-07-23","2015-04-23","Disease, Nervous System; Diseases, Nervous System; Disorder, Nervous System; Disorder, Neurologic; Disorder, Neurological; Disorders, Nervous System"
"phs000613.v1.p2","NHLBI CARDIA Candidate Gene Association Resource (CARe)","This sub-study phs000613 CARDIA_CARe contains genotype of subjects available from the phs000613 study. Summary level phenotypes for the NHLBI CARDIA Cohort study participants can be viewed at the top-level  study page phs000285 CARDIA_v3 Cohort. Individual level phenotype data and molecular data for all CARDIA Cohort top-level study and sub-study are","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Coronary Artery Risk Development in Young Adults (CARDIA) Study - Cohort (phs000285.v3.p2)","SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 2 molecular datasets, 3299 subjects, 4754 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2013-08-22","2014-08-22","Atherogenesis; Caloric Intake; Energy intake; BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High"
"phs000635.v1.p1","Adult Influenza Vaccine Genetics","This study includes two cohorts composed of healthy adults immunized with seasonal influenza vaccine. The first cohort was composed exclusively of males and second of females. Enrollment was restricted  to individuals of European heritage to simplify the genetic analysis. Serum samples were collected prior to immunization and at 14 days and 28 days","Influenza, Human","Prospective Longitudinal Cohort","Not Provided","Viral Respiratory Pathogens Genetics (phs001030.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","3 phenotype datasets, 30 variables, 246 subjects, 246 samples","European (238), Hispanic1 (1), Hispanic2 (7)","NIAID","GRU-IRB --- General research use (irb)","2017-06-02","2017-06-02","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas"
"phs000642.v7.p1","The Haplotype-Resolved Genome and Epigenome of The HeLa Cancer Cell Line","The genomic architecture of HeLa remains largely unexplored beyond its karyotype, partly because like many cancers, its extensive aneuploidy renders such analyses challenging. We carried out haplotype-resolved whole-genome sequencing  of the HeLa CCL-2 strain, examined point- and indel-mutation variations, mapped copy-number variations and loss of heterozygosity regions, and phased","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","CLONEEND, OTHER, POOLCLONE, RNA-Seq, SNP Genotypes (NGS), WGS, CLONEEND, OTHER, POOLCLONE, RNA-Seq, SNP Genotypes (NGS), WGS","1 phenotype datasets, 3 variables, 1 molecular datasets,  SRA, 1 subjects, 12 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs000643.v7.p1","The Genomic and Transcriptomic Landscape of a HeLa Cell Line","HeLa is the most widely used model cell line for studying human cellular and molecular biology. To date, no genomic reference for this cell line has been released, and  experiments have relied on the human reference genome. Effective design and interpretation of molecular genetic studies performed using HeLa cells","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","RNA-Seq, SNP Genotypes (NGS), WGS, RNA-Seq, SNP Genotypes (NGS), WGS","1 phenotype datasets, 3 variables, 1 molecular datasets,  SRA, 1 subjects, 1 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs000650.v3.p1","PediGFR-CKiD","This sub-study phs000650 CKiD contains genotype and selected phenotype of subjects available from the phs000650 study. Summary level phenotypes for the NIDDK PediGFR_v2 Cohort study participants can be viewed  at the top-level study page phs000842 PediGFR_v2 Cohort. Individual level phenotype data and molecular data for all PediGFR_v2 Cohort top-level study","Kidney Diseases","Prospective Longitudinal Cohort","Not Provided","Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) (phs000842.v2.p1)","SNP Genotypes (Array)","2 phenotype datasets, 28 variables, 2 molecular datasets, 842 subjects, 624 samples","European (430), East Asian (5), African American (42), Hispanic1 (5), Hispanic2 (42), Other Asian or Pacific Islander (4), Other (6)","NIDDK","DS-CKD-COMP-IRB --- Disease-specific (chronic kidney disease and related complications, irb)","2019-03-29","2019-03-29","Failure, Kidney; Failures, Kidney; Failures, Renal; Kidney Failures; RF - Renal failure; Renal Failure"
"phs000651.v10.p11","Building on GWAS: the U.S. CHARGE consortium - Sequencing (CHARGE-S): FHS","This substudy phs000651 Framingham CHARGE-S contains whole genome, whole exome, and targeted sequence data, produced as part of NHLBI's CHARGE-S project. Summary level phenotypes for the Framingham Cohort study  participants can be viewed at the top-level study page phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","5 phenotype datasets, 40 variables, 7 molecular datasets,  SRA, 2532 subjects, 2532 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000654.v3.p1","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in    Epileptic Encephalopathies","Project 1 of the Epi4K: Gene Discovery in 4,000 Epilepsy Genomes project is designed to study the genetics of sporadic epileptic encephalopathies, which are a group of severe childhood  epilepsy disorders for which the cause is often unknown. The study focuses on two of the more common types: infantile spasms (IS) and Lennox-Gastaut","Epileptic encephalopathy, Lennox-Gastaut type","Family/Twin/Trios","Not Provided","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes (phs000653.v3.p1)","SNP Genotypes (NGS), WXS, SNP Genotypes (NGS), WXS","2 phenotype datasets, 12 variables, 2 molecular datasets,  SRA, 1011 subjects, 1011 samples","European (168), East Asian (2), African American (9), Hispanic1 (12), Hispanic2 (7), Other Asian or Pacific Islander (5), South Asian (6), Other (10)","NINDS","GRU --- General research use , DS-ESD-GSO --- Disease-specific (epilepsy and seizure disorders, gso)","2018-09-19","2018-09-19","Childhood Epileptic Encephalopathy with Diffuse Slow Spikes and Waves; Attack, Lightning; Attacks, Lightning; EIEE1; Infantile Spasm; Infantile Spasms"
"phs000665.v6.p1","HeLa S3 (CCL-2.2) HiC Sequencing","HiC chromatin conformation sequencing was performed for the purpose of chromosome fusion and structural rearrangement identification.","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","OTHER","3 phenotype datasets, 12 variables,  SRA, 1 subjects, 1 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs000667.v3.p1","Building on GWAS for NHLBI-Diseases: The U.S. CHARGE Consortium -    Sequencing (CHARGE-S): CHS","Note: This substudy phs000667 CHARGE-S Cardiovascular Health Study contains harmonized phenotype data, whole genome, exome, targeted sequencing data and exome chip data of a subset of the CHS cohort  selected for NHLBI's CHARGE-S CONSORTIUM Project. Summary level phenotypes of the Cardiovascular Health Cohort study participants may be viewed at","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older (phs000287.v6.p1)","SNP Genotypes (Array), SNP Genotypes (NGS), WGS, WXS","5 phenotype datasets, 40 variables, 3 molecular datasets,  SRA, 5114 subjects, 7743 samples","European (236), Hispanic2 (1)","NHLBI","HMB-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , HMB-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-MDS --- Disease-specific (cardiovascular disease, npu, mds) , DS-CVD-IRB-NPU-MDS --- Disease-specific (cardiovascular disease, npu, mds)","2017-01-13","2018-01-13","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000668.v3.p1","Building on GWAS: the U.S. CHARGE consortium - Sequencing (CHARGE-S):    ARIC","This sub-study phs000668 CHARGE-S Atherosclerosis Risk in Communities (ARIC) contains whole genome, whole exome, and targeted sequencing data, and exome SNP array data, produced as part of NHLBI's CHARGE-S  project for subjects available from the phs000668 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be viewed at the","Atherosclerosis","Case Set","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","SNP Genotypes (Array), SNP Genotypes (NGS), SNP/CNV Genotypes (NGS), WGS, WXS","6 phenotype datasets, 72 variables, 6 molecular datasets,  SRA, 14858 subjects, 14858 samples","European (1696), African (57), African American (1806), Hispanic1 (14), Hispanic2 (4), Other (3)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","Atherogenesis; AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations"
"phs000674.v3.p3","Resource for Genetic Epidemiology Research on Aging (GERA)","The Resource for Genetic Epidemiology Research on Aging (GERA) Cohort was created by a RC2 ""Grand Opportunity"" grant that was awarded to the Kaiser Permanente Research Program on Genes,  Environment, and Health (RPGEH) and the UCSF Institute of Human Genetics (AG036607; Schaefer/Risch, PIs). The RC2 project enabled a genome-wide SNP","Aging","Prospective Longitudinal Cohort","Not Provided","Research Program on Genes, Environment and Health (RPGEH) (phs000788.v2.p3)","SNP Genotypes (Array), SNP Genotypes (imputed)","4 phenotype datasets, 79 variables, 6 documents, 2 molecular datasets, 78419 subjects, 78419 samples","European (66620), African (42), East Asian (3751), African American (1913), Hispanic1 (390), Hispanic2 (3462), Other Asian or Pacific Islander (1330), South Asian (365), Other (546)","NIA","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2018-05-15","2018-05-15","Aging, Biological; Biological Aging; Anxiety State, Neurotic; Anxiety States, Neurotic; Neurotic Anxiety State; Neurotic Anxiety States"
"phs000675.v3.p3","WHIMS+ GWAS: GWAS on Selected WHI Hormone Trial European Americans","WHI WHIMS+ GWAS This substudy contains genotypes generated using Illumina Omni Express on additional WHI European American (EA) participants. When these participants are combined with the GARNET participants, they  form a population that is representative of the entire WHI EA HT population. Also, all Women's Health Initiative Memory Study (WHIMS) participants","Memory","Prospective Longitudinal Cohort","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (Array)","1 phenotype datasets, 6 variables, 1 molecular datasets, 5740 subjects, 5740 samples","European (5709), East Asian (1), African American (4), Hispanic1 (11), Hispanic2 (10), Other Asian or Pacific Islander (1), Other (4)","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Adrenal Gland Tumor; Adrenal Neoplasm; Adrenal Neoplasms; Adrenal Tumor; Adrenal neoplasia; Neoplasm of Adrenal Gland"
"phs000685.v1.p1","Age-related Macular Degeneration (AMD) Targeted Sequencing Study","Age-related Macular Degeneration (AMD) is a leading cause of incurable blindness in people over the age of 65. AMD is a late-onset multi-factorial neurodegenerative disease and its pathogenesis involves  interaction of genetic and environmental factors. Several chromosomal regions have been associated with AMD susceptibility through linkage analysis","Macular Degeneration","Case-Control","Not Provided","Age related Macular Degeneration (AMD) - Michigan, Mayo, AREDS, Pennsylvania (MMAP) Cohort Study: Association and Sequencing Studies (phs000684.v1.p1)","WXS, WXS","2 phenotype datasets, 7 variables,  SRA, 3337 subjects, 3352 samples","","NEI","GRU --- General research use , DS-ED --- Disease-specific (eye disease)","2014-05-08","2015-05-08","AAMD - Age related macular degeneration; AMD; AMD - Age-related macular degeneration; ARMD; ARMD - Age-related macular degeneration; Age Related Macular Degeneration"
"phs000686.v1.p1","Genetic Risks for ALI in ARDSNet and the iSPAAR Consortium","This GWAS sub-study phs000686 contains genotype and selected phenotype of subjects available from the phs000631 study. Summary level phenotypes for the ""ARDSnet and the iSPAAR Consortium: Genetic Studies"" study  participants can be viewed at the top-level study page phs000631 ARDSNet iSPAAR cohort. Individual level phenotype data and molecular data for all","Acute Lung Injury","Case-Control","Not Provided","ARDSnet and the iSPAAR Consortium: Genomic Basis of Susceptibility and Outcomes in Patients with the Acute Respiratory Distress Syndrome (ARDS) (phs000631.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 2236 subjects, 2236 samples","European (2233), East Asian (1), Hispanic1 (1), Other (1)","NHLBI","HMB --- Health/medical/biomedical","2014-01-15","2015-01-15","ALI; ALI - Acute lung injury; Acute Lung Injuries; Lung Injuries, Acute; Lung Injury, Acute; Pyaemia"
"phs000702.v1.p1","Sequence Data From Participants in the FUSION Study","This study is part of a re-sequencing project to identify variants associated with metabolic syndrome traits in a Finnish cohort. Metabolic syndrome (MetS) increases the risk of cardiovascular disease  and diabetes, and prevalence is estimated to be as high as 25% in the United States. MetS is characterized via measure of triglycerides (TG), high","Diabetes Mellitus, Type 2","Case-Control","Not Provided","The Finland-United States Investigation of NIDDM Genetics (FUSION) Study (phs000867.v1.p1)","WXS, WXS","2 phenotype datasets, 6 variables,  SRA, 1825 subjects, 2222 samples","","NIDDK","GRU-IRB --- General research use (irb)","2015-04-24","2015-04-24","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000704.v1.p1","CATHGEN: Identification of Novel Genetic and Metabolomic CV Phenotypes","The CATHGEN biorepository consists of biological samples collected on sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board  informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization","Coronary Disease","Cross-Sectional","Not Provided","CATHeterization GENetics (CATHGEN) (phs000703.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 20 variables, 2 documents, 1 molecular datasets, 1327 subjects, 1327 samples","European (944), African (11), East Asian (2), African American (268), Hispanic1 (86), Hispanic2 (6), Other Asian or Pacific Islander (1), South Asian (6), Other (3)","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2014-07-30","2014-07-30","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000705.v1.p1","CATHGEN: Genetic Mediators of Metabolic Cardiovascular Disease Risk","The CATHGEN biorepository consists of biological samples collected on sequential consenting individuals undergoing cardiac catheterization at Duke University Medical Center between 2001 and 2010 inclusive. The Institutional Review Board  informed consent allowed for 50 mL of blood to be collected from fasting patients through the femoral arterial sheath during the catheterization","Coronary Disease","Cross-Sectional","Not Provided","CATHeterization GENetics (CATHGEN) (phs000703.v1.p1)","SNP Genotypes (Array), mRNA Expression (Array), SNP Genotypes (Array), mRNA Expression (Array)","2 phenotype datasets, 19 variables, 2 documents, 2 molecular datasets, 1977 subjects, 1979 samples","European (1391), African (18), East Asian (4), African American (398), Hispanic1 (94), Hispanic2 (11), Other Asian or Pacific Islander (3), South Asian (10), Other (2)","NHLBI","DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2014-07-30","2014-07-30","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000724.v7.p11","Framingham Offspring Exam 8 DNA Methylation Study","This substudy phs000724 Framingham DNA Methylation contains DNA methylation raw data only. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page  phs000007 Framingham Cohort. Individual level phenotype data and molecular data for all Framingham top-level study and substudies are available by","Epigenomics","Prospective Longitudinal Cohort","Not Provided","Framingham Cohort (phs000007.v30.p11)","Methylation (CpG)","2 phenotype datasets, 38 variables, 2 molecular datasets, 4243 subjects, 6885 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Epigenetic; Epigenetics; Cardiac Disease; Cardiac Diseases; Cardiac disorder; Cardiopathy"
"phs000731.v2.p1","BrainSpan Atlas of the Developing and Adult Human Brain","The NIH-funded BrainSpan (www.brainspan.org) and PsychENCODE (www.psychencode.org). Consortia sought to generate and analyze multi-dimensional genomics data from the developing and adult human brain in healthy and disease states. One  of the main goals has been to perform large-scale and integrated analysis of the genome, transcriptome, and epigenome of the human brain to broaden","Brain Diseases","Control Set","Not Provided","BrainSpan Atlas of the Human Brain (phs000755.v2.p1)","Methylation (CpG), ChIP-Seq, RNA-Seq, WGS, miRNA-Seq, Methylation (CpG), ChIP-Seq, RNA-Seq, WGS, miRNA-Seq","1 phenotype datasets, 3 variables, 1 molecular datasets,  SRA, 48 subjects, 1222 samples","","NIMH","GRU --- General research use","2019-01-08","2018-05-23","Brain Disease; Brain Disorders; CNS Disorder, Intracranial; CNS Disorders, Intracranial; Central Nervous System Disorders, Intracranial; Central Nervous System Intracranial Disorders"
"phs000746.v2.p3","WHI Harmonized and Imputed GWAS Data","This substudy phs000746 WHI Imputation is the effort of a joint imputation and harmonization effort for many of the Genome Wide Association Studies (GWAS) within the Women's Health Initiative  (WHI) Clinical Trials and Observational Studies. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study","Women's Health","Prospective Longitudinal Cohort","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","SNP Genotypes (imputed)","1 phenotype datasets, 19 variables, 2 documents, 1 molecular datasets, 29814 subjects, 31806 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Health, Woman's; Health, Women's; Health, Womens; Woman's Health; Womens Health"
"phs000754.v1.p1","HGSC-BCM Whole-exome Sequencing of Intracranial Germ Cell Tumors (IGCTs)","This sub-study phs000754 Intracranial Germ Cell Tumors molecular and phenotype data of subjects available from the phs000754 study. Summary level phenotypes for the NHGRI Rare Cancer Tumors study participants  can be viewed at the top-level study page phs000725 Rare Cancer Tumors Cohort. Individual level phenotype data and molecular data for all Rare Cancer","Neoplasms","Case Set","Not Provided","Rare Cancer Tumors Project (phs000725.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 8 variables, 1 molecular datasets,  SRA, 28 subjects, 56 samples","East Asian (5), Other Asian or Pacific Islander (3), Other (2)","NHGRI","GRU --- General research use","2016-01-20","2016-01-20","BT - Brain tumor; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain"
"phs000762.v1.p1","OPPERA baseline case-control study of chronic TMJD","The OPPERA project investigates effects of genetic, physiological, psychological and clinical factors on risk of developing painful temporomandibular disorder. The baseline case-control study evaluated factors associated with chronic temporomandibular  disorder among OPPERA participants who enrolled in the study between May 2006 and November 2008.","Temporomandibular Joint Disorders","Case-Control","Not Provided","Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) (phs000761.v1.p1)","SNP Genotypes (NGS), SNP Genotypes (NGS)","24 phenotype datasets, 1079 variables, 20 documents, 1 molecular datasets, 1818 subjects, 1608 samples","","NIDCR","DS-TMJD-RD --- Disease-specific (temporomandibular joint disorder, rd)","2015-03-27","2015-03-27","Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Pains, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Pains, Widespread Chronic"
"phs000765.v3.p2","Genetic Epidemiology of COPD (COPDGene) Genetic Analysis","This sub-study phs000765 COPDGene_Geno contains genotype of subjects available from the phs000765 study. Summary level phenotypes for the NHLBI COPDGene Cohort study participants can be viewed at the top-level  study page phs000179 COPDGene_v5 Cohort. Individual level phenotype data and molecular data for all COPDGene Cohort top-level study and sub-study are","Pulmonary Disease, Chronic Obstructive","Case-Control","Not Provided","Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute (phs000179.v6.p2)","SNP Genotypes (Array), RNA-Seq, SNP Genotypes (NGS)","1 phenotype datasets, 7 variables, 2 analyses, 3 molecular datasets,  SRA, 9991 subjects, 11951 samples","European (6641), African (96), African American (3176), Hispanic1 (36), Hispanic2 (15), Other Asian or Pacific Islander (2), Other (18)","NHLBI","HMB --- Health/medical/biomedical , DS-CS --- Disease-specific (copd and smoking)","2019-05-03","2015-09-19","CAFL - Chronic airflow limitation; CAL - Chronic airflow limitation; COAD; COAD - Chronic obstructive airways disease; COLD; COLD - Chronic obstructive lung disease"
"phs000786.v2.p3","RPGEH WGS Pilot Study","The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) is a resource developed to facilitate research on genetic and environmental factors on common diseases and healthy aging.  The RPGEH resource links biospecimens, health surveys, and comprehensive electronic medical records on broadly consented adult members of Kaiser","Not Provided","Prospective Longitudinal Cohort","Not Provided","Research Program on Genes, Environment and Health (RPGEH) (phs000788.v2.p3)","SNP Genotypes (NGS), SNP Genotypes (NGS)","1 phenotype datasets, 3 variables, 1 molecular datasets,  SRA, 4 subjects, 4 samples","","NIA","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2018-05-15","2018-05-15",""
"phs000802.v2.p1","NCI Non-Hodgkin Lymphoma GWAS: CLL","This sub-study phs000802 NCI Non-Hodgkin Lymphoma GWAS: CLL contains genotype and subject and sample phenotype data from subjects available from the phs000802 study. Summary level phenotypes for the NCI  Non-Hodgkin Lymphoma GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Individual level","Lymphoma, Non-Hodgkin","Prospective Longitudinal Cohort","Not Provided","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2178 subjects, 2225 samples","European (2173), Hispanic1 (1), Hispanic2 (2), Other (2)","NCI","DS-CA-IRB-NPU-GSO --- Disease-specific (cancer, irb, npu, gso) , DS-NHL-NPU-GSO --- Disease-specific (non-hodgkin lymphoma, npu, gso) , GRU-NPU-MDS --- General research use (npu, mds)","2016-09-22","2016-09-22","B Cell CLL; B Cell Chronic Lymphocytic Leukemia; B Cell Leukemia, Chronic; B Cell Lymphocytic Leukemia; B Lymphocytic Leukemia, Chronic; B-CLL"
"phs000818.v2.p1","NCI Non-Hodgkin Lymphoma GWAS: Controls","This sub-study phs000818 NCI Non-Hodgkin Lymphoma GWAS: Controls contains genotype and subject and sample phenotype of subjects available from the phs000818 study. Summary level phenotypes for the NCI Non-Hodgkin  Lymphoma GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Within the framework of the","Lymphoma, Non-Hodgkin","Prospective Longitudinal Cohort","Not Provided","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2685 subjects, 2835 samples","European (2680), Hispanic1 (1), Other (4)","NCI","DS-CA-IRB-NPU-GSO --- Disease-specific (cancer, irb, npu, gso) , DS-NHL-NPU-GSO --- Disease-specific (non-hodgkin lymphoma, npu, gso) , GRU-NPU-MDS --- General research use (npu, mds)","2016-09-22","2016-09-22","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma; Reticulum-Cell Sarcomas"
"phs000834.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T) (UCSD)","A comprehensive characterization of transcriptional diversity and heterogeneity of the human cortex is crucial to understand its functions in healthy and disease conditions. The diversity and cellular states of  the densely packed cellular network in the cortex can be accurately captured by the transcriptional activities of individual cells. An overarching","Prefrontal Cortex","Case Set","Not Provided","Single Cell Analysis Program - Transcriptome (SCAP-T) (phs000833.v7.p1)","RNA-Seq, RNA Seq expression levels, RNA-Seq, RNA Seq expression levels","2 phenotype datasets, 123 variables, 2 documents, 5 molecular datasets,  SRA, 6 subjects, 5161 samples","","NIMH","GRU --- General research use , GRU-NPU --- General research use (npu)","2017-11-27","2017-11-27","Cerebral Cortex; Cerebral Cortices; Cerebral gray matter; Cerebri, Cortex; Cerebrus, Cortex; Cortex"
"phs000835.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T) (U. Penn)","The goal of this study is to characterize and understand the variability in the expressed transcriptome of human excitable cells. There are two predominant types of excitable cell in  the human body, neurons and muscle cells, including cardiac cells. Many human CNS diseases result from modulation of the electrical responsiveness of","Brain","Case Set","Not Provided","Single Cell Analysis Program - Transcriptome (SCAP-T) (phs000833.v7.p1)","RNA-Seq, RNA Seq expression levels, WGS, RNA-Seq, RNA Seq expression levels, WGS","3 phenotype datasets, 128 variables, 330 documents, 6 molecular datasets,  SRA, 38 subjects, 1069 samples","","NIMH","GRU --- General research use , GRU-NPU --- General research use (npu)","2017-11-27","2017-11-27","Astroglia; Astroglias; Encephalon; Cell, Endothelial; Cells, Endothelial; Endothelial Cells"
"phs000836.v7.p1","Single Cell Analysis Program - Transcriptome (SCAP-T) (USC)","This study aims to assess the technical and biological noise in measured RNA levels in single cells in a number of human tissue types, and to develop analytical tools  to address the complexity observed at the single-cell level. Understanding the sources and relative sizes of technical and biological noise has","Neurons","Case Set","Not Provided","Single Cell Analysis Program - Transcriptome (SCAP-T) (phs000833.v7.p1)","RNA-Seq, RNA Seq expression levels, RNA-Seq, RNA Seq expression levels","4 phenotype datasets, 137 variables, 1037 documents, 5 molecular datasets,  SRA, 170 subjects, 3039 samples","","NIMH","GRU --- General research use , GRU-NPU --- General research use (npu)","2017-11-27","2017-11-27","Cell, Nerve; Cells, Nerve; Nerve Cell; Nerve Cells; Neural Cell; Neurocyte"
"phs000843.v2.p1","PediGFR - 4C Study Cohort","This sub-study phs000843 4C contains genotype and selected phenotype of subjects available from the phs000843 study. Summary level phenotypes for the NIDDK PediGFR_v2 Cohort study participants can be viewed  at the top-level study page phs000842 PediGFR_v2 Cohort. Individual level phenotype data and molecular data for all PediGFR_v2 Cohort top-level study","Kidney Diseases","Prospective Longitudinal Cohort","Not Provided","Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) (phs000842.v2.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 23 variables, 1 molecular datasets, 677 subjects, 663 samples","European (423), African (5), African American (1), Hispanic1 (41), Hispanic2 (2), South Asian (13), Other (178)","NIDDK","DS-CKD-COMP-IRB --- Disease-specific (chronic kidney disease and related complications, irb)","2019-03-29","2019-03-29","Failure, Kidney; Failures, Kidney; Failures, Renal; Kidney Failures; RF - Renal failure; Renal Failure"
"phs000844.v2.p1","PediGFR - ESCAPE Trial Cohort","This sub-study phs000844 ESCAPE contains genotype and selected phenotype of subjects available from the phs000844 study. Summary level phenotypes for the NIDDK PediGFR_v2 Cohort study participants can be viewed  at the top-level study page phs000842 PediGFR_v2 Cohort. Individual level phenotype data and molecular data for all PediGFR_v2 Cohort top-level study","Kidney Diseases","Prospective Longitudinal Cohort","Not Provided","Pediatric Investigation for Genetic Factors Linked with Renal Progression (PediGFR) (phs000842.v2.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 21 variables, 1 molecular datasets, 309 subjects, 293 samples","European (247), African American (2), Hispanic1 (2), Other Asian or Pacific Islander (1), Other (41)","NIDDK","DS-CKD-COMP-IRB --- Disease-specific (chronic kidney disease and related complications, irb)","2019-03-29","2019-03-29","Failure, Kidney; Failures, Kidney; Failures, Renal; Kidney Failures; RF - Renal failure; Renal Failure"
"phs000849.v2.p1","T2D-GENES Project 1: San Antonio Mexican American Family Studies    (SAMAFS), Substudy 1: Whole exome sequencing","The Type 2 Diabetes (T2D) Genetic Exploration by Next-generation sequencing in Ethnic Samples (T2D-GENES) Consortium is a collaborative international effort to identify genes influencing susceptibility to type 2 diabetes  in multiple ethnic groups using next generation sequencing. T2D-GENES Project 1 uses whole exome sequencing to identify low frequency or rare","Diabetes Mellitus, Type 2","Case-Control","Not Provided","T2D-GENES Consortium: San Antonio Mexican American Family Studies (SAMAFS) (phs000847.v2.p1)","SNP Genotypes (NGS), WXS, SNP Genotypes (NGS), WXS","3 phenotype datasets, 40 variables, 1 molecular datasets,  SRA, 491 subjects, 491 samples","","NIDDK","DS-DIAB-IRB-RD --- Disease-specific (diabetes, irb, rd)","2016-12-13","2016-12-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs000850.v1.p1","OPPERA prospective cohort study of first-onset TMJD","The OPPERA project investigates effects of genetic, physiological, psychological and clinical factors on risk of developing painful temporomandibular disorder. The prospective cohort study evaluated factors at enrollment that predicted  subsequent risk of developing first-onset temporomandibular disorder (TMD). Between May 2006 and November 2008, 3,263 study participants with no","Temporomandibular Joint Disorders","Prospective Longitudinal Cohort","Not Provided","Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) (phs000761.v1.p1)","SNP Genotypes (NGS), SNP Genotypes (NGS)","23 phenotype datasets, 1061 variables, 19 documents, 1 molecular datasets, 3258 subjects, 2866 samples","","NIDCR","DS-TMJD-RD --- Disease-specific (temporomandibular joint disorder, rd)","2015-03-27","2015-03-27","Amplified Musculoskeletal Pain Syndrome; Chronic Pain, Widespread; Chronic Pains, Widespread; Chronic Widespread Pain; Pain, Widespread Chronic; Pains, Widespread Chronic"
"phs000854.v2.p8","Genome-wide Analysis of Noncoding Regulatory Mutations in Cancer","Large-scale sequencing of human tumor samples has transformed the identification of somatic genetic alterations that drive the cancer phenotype. However, most efforts have focused on the protein-coding exome, which  comprises less than 2% of the human genome. Here, we analyzed whole genome sequences from The Cancer Genome Atlas with a focus on recurrently mutated","Neoplasms","Tumor vs. Matched-Normal","Not Provided","National Institutes of Health The Cancer Genome Atlas (TCGA) (phs000178.v10.p8)","SNV Aggregate (.MAF)","2 phenotype datasets, 4 variables, 1 molecular datasets, 356 subjects, 356 samples","","NCI","GRU --- General research use","2018-08-17","2018-08-17","CA; CA - Cancer; Cancer; Malignancies; Malignancy; Malignant Tumor"
"phs000859.v1.p1","Integrated Genomic Analysis of Sezary Syndrome","This sub-study phs000859 Sezary Syndrome Genomic Analysis molecular and phenotype data of subjects available from the phs000859 study. Summary level phenotypes for the NHGRI Rare Cancer Tumors study participants  can be viewed at the top-level study page phs000725 Rare Cancer Tumors Cohort. Individual level phenotype data and molecular data for all Rare Cancer","Sezary Syndrome","Prospective Longitudinal Cohort","Not Provided","Rare Cancer Tumors Project (phs000725.v1.p1)","RNA-Seq, WXS, RNA-Seq, WXS","2 phenotype datasets, 10 variables,  SRA, 42 subjects, 134 samples","","NHGRI","GRU --- General research use","2016-01-20","2016-01-20","Interdigitating cell sarcoma; Reticulosarcomas; Reticulum Cell Sarcoma; Reticulum cell sarcoma morphology; Reticulum-Cell Sarcoma; Reticulum-Cell Sarcomas"
"phs000860.v3.p1","MIchigan-CORnell-TEXas (MICORTEX)","This sub-study phs000860 MICORTEX contains genotype and selected phenotype of subjects available from the phs000860 study. Summary level phenotypes for the NHLBI ARIC Cohort study participants can be viewed  at the top-level study page phs000280 ARIC Cohort. Individual level phenotype data and molecular data for all ARIC Cohort top-level study and sub","Coronary Disease","Prospective Longitudinal Cohort","Not Provided","Atherosclerosis Risk in Communities (ARIC) Cohort (phs000280.v5.p1)","Legacy Genotypes","1 phenotype datasets, 4 variables, 1 molecular datasets, 7218 subjects, 7218 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-CVD-IRB --- Disease-specific (cardiovascular disease, irb)","2018-12-11","2018-12-11","CHD - Coronary heart disease; Coronary Diseases; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs000861.v1.p1","Whole Exome Sequencing of Craniopharyngioma Tumors","This sub-study phs000861 Craniopharyngioma Tumors molecular and phenotype data of subjects available from the phs000861 study. Summary level phenotypes for the NHGRI Rare Cancer Tumors study participants can be  viewed at the top-level study page phs000725 Rare Cancer Tumors Cohort. Individual level phenotype data and molecular data for all Rare Cancer Tumors","Craniopharyngioma","Prospective Longitudinal Cohort","Not Provided","Rare Cancer Tumors Project (phs000725.v1.p1)","WXS, WXS","2 phenotype datasets, 10 variables,  SRA, 29 subjects, 58 samples","","NHGRI","GRU --- General research use","2016-01-20","2016-01-20","BT - Brain tumor; Brain Tumor; Brain Tumors; Brain neoplasm; Brain tumour; Neoplasm of Brain"
"phs000872.v2.p1","PsychENCODE Consortium: Autism Post-Mortem Brain RNA-Sequencing - SRRM4    Splicing Study","Purpose: The goal of this study was to assess the status of splicing changes in microexons in the cortex of individuals with autism. Methods: We performed RiboZero Gold (rRNA  depleted) 50bp PE RNA-seq in a larger set of case and control samples to define 12 autism and 12 control samples showing the greatest global","Autistic Disorder","Case-Control","Not Provided","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","RNA-Seq","3 phenotype datasets, 17 variables,  SRA, 24 subjects, 24 samples","","NIMH","GRU --- General research use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs000877.v1.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Meta    Analysis","This sub-study phs000877 Meta Analysis contains genotype, sequence data, and selected phenotype of subjects available from the phs000877 study. Summary level phenotypes for the NCI Lung Cancer Transdisciplinary Research  Cohort study participants can be viewed at the top-level study page phs000876 Lung Cancer Transdisciplinary Research Cohort. Individual level","Lung Neoplasms","Case-Control","Not Provided","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing (phs000876.v1.p1)","Not Provided","3 analyses","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-CA --- Disease-specific (cancer) , HMB-MDS --- Health/medical/biomedical (mds) , LCRF --- Lung cancer risk factors , DS-LCS-RD --- Disease-specific (lung cancer or smoking, rd)","2017-02-07","2017-02-07","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000878.v1.p1","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Exome Plus    Targeted Sequencing","This sub-study phs000878 CIDR Lung Cancer contains genotype, sequence data, and selected phenotype of subjects available from the phs000878 study. Summary level phenotypes for the NCI Lung Cancer Transdisciplinary  Research Cohort study participants can be viewed at the top-level study page phs000878 Lung Cancer Transdisciplinary Research Cohort. Individual","Lung Neoplasms","Case-Control","Not Provided","Transdisciplinary Research Into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing (phs000876.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 1942 subjects, 2030 samples","","NCI","DS-CA-MDS --- Disease-specific (cancer, mds) , DS-CA --- Disease-specific (cancer) , HMB-MDS --- Health/medical/biomedical (mds) , LCRF --- Lung cancer risk factors , DS-LCS-RD --- Disease-specific (lung cancer or smoking, rd)","2017-02-07","2017-02-07","Adenocarcinoma, no subtype; Adenocarcinomas; Adenoma, Malignant; Adenomas, Malignant; Malignant Adenoma; Malignant Adenomas"
"phs000880.v1.p1","Omics in Latinos (Ola) - Genetic Analysis of HCHS/SOL","This sub-study phs000880 HCHS SOL Hispanic Community Health Study contains genotype data and selected phenotype of subjects available from the phs000880. Summary level phenotypes for the NHLBI HCHS SOL  Cohort study participants can be viewed at the top-level study page phs000810 HCHS SOL Cohort. Individual level phenotype data and molecular data for","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Hispanic Community Health Study /Study of Latinos (HCHS/SOL) (phs000810.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 12437 subjects, 13405 samples","European (1284), African (2), East Asian (1), African American (1092), Hispanic1 (2776), Hispanic2 (6284), Other Asian or Pacific Islander (11), Other (987)","NHLBI","HMB-NPU --- Health/medical/biomedical (npu) , HMB --- Health/medical/biomedical","2015-12-07","2016-12-17","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs000889.v1.p1","NCI Non-Hodgkin Lymphoma GWAS: DLBCL","This sub-study phs000889 NCI Non-Hodgkin Lymphoma GWAS: DLBCL contain genotype and subject and sample phenotype of subjects available from the phs000889 study. Summary level phenotypes for the NCI Non-Hodgkin  Lymphoma GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Diffuse large B-cell lymphoma","Lymphoma, Non-Hodgkin","Case-Control","Not Provided","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2661 subjects, 2706 samples","European (2651), Hispanic1 (2), Hispanic2 (3), Other (5)","NCI","DS-CA-IRB-NPU-GSO --- Disease-specific (cancer, irb, npu, gso) , DS-NHL-NPU-GSO --- Disease-specific (non-hodgkin lymphoma, npu, gso) , GRU-NPU-MDS --- General research use (npu, mds)","2016-09-22","2016-09-22","DLBCL; Diffuse Histiocytic Lymphoma; Diffuse Histiocytic Lymphomas; Diffuse Large Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse Large-Cell Lymphomas"
"phs000890.v1.p1","NCI Non-Hodgkin Lymphoma GWAS: FL","This sub-study phs000890 NCI Non-Hodgkin Lymphoma GWAS: FL contains genotype and subject and sample phenotype of subjects available from the phs000890 study. Summary level phenotypes for the NCI Non-Hodgkin  Lymphoma GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Genome-wide association studies","non-Hodgkin lymphoma","Case-Control","Not Provided","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 2142 subjects, 2186 samples","European (2139), Hispanic1 (3)","NCI","DS-CA-IRB-NPU-GSO --- Disease-specific (cancer, irb, npu, gso) , DS-NHL-NPU-GSO --- Disease-specific (non-hodgkin lymphoma, npu, gso) , GRU-NPU-MDS --- General research use (npu, mds)","2016-09-22","2016-09-22","Brill - Symmers' disease; Brill Symmers Disease; Brill-Symmers Disease; Disease, Brill-Symmers; FOLLICULAR LYMPHOMA, SOMATIC; Follicle Center Lymphoma"
"phs000891.v1.p1","NCI Non-Hodgkin Lymphoma GWAS: MZL","This sub-study phs000891 NCI Non-Hodgkin Lymphoma GWAS: MZL contains genotype and subject and sample phenotype of subjects available from the phs000891 study. Summary level phenotypes for the NCI Non-Hodgkin  Lymphoma GWAS study participants can be viewed at the top-level study page phs000801 NCI Non-Hodgkin Lymphoma GWAS. Marginal zone lymphoma (MZL","Lymphoma, Non-Hodgkin","Case Set","Not Provided","National Cancer Institute (NCI) Non-Hodgkin Lymphoma Genome-wide Association Study (GWAS) (phs000801.v2.p1)","SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 1 molecular datasets, 825 subjects, 839 samples","European (823), Hispanic1 (2)","NCI","DS-CA-IRB-NPU-GSO --- Disease-specific (cancer, irb, npu, gso) , DS-NHL-NPU-GSO --- Disease-specific (non-hodgkin lymphoma, npu, gso) , GRU-NPU-MDS --- General research use (npu, mds)","2016-09-22","2016-09-22","Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue; Extranodal marginal zone B-cell lymphoma; Lymphoma of Mucosa Associated Lymphoid Tissue; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, B-Cell, Marginal Zone; Lymphoma, MALT"
"phs000894.v2.p1","VESPA: Genome Wide Study of Vancomycin","The goal of this study was to identify genetic variants associated with risk for acute kidney injury (AKI) in patients being treated with vancomycin and genetic variants associated with  variability in vancomycin pharmacokinetics. AKI is a common adverse drug event and known complication of vancomycin therapy. Known risk factors fail","Acute Kidney Injury","Prospective Longitudinal Cohort","Not Provided","VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment (phs000991.v1.p1)","SNP Genotypes (Array)","3 phenotype datasets, 12 variables, 1 molecular datasets, 555 subjects, 555 samples","European (554), Hispanic1 (1)","NIGMS","HMB --- Health/medical/biomedical","2016-10-26","2017-10-26","AKI; ARF - Acute renal failure; Acute Kidney Failure; Acute Kidney Failures; Acute Renal Failure; Acute Renal Failures"
"phs000965.v1.p1","VITamins And Lifestyle (VITAL)","This study phs000965 VITAL contains genotype and phenotype of subjects available from the phs000965 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 607 subjects, 637 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs000992.v1.p1","VESPA: Genome Wide Study of Ace Inhibitor Cough","The goal of this study was to identify single nucleotide polymorphisms (SNPs) associated with the adverse reaction of cough due to an ace inhibitor. Subjects were identified through the  Electronic Medical Records and Genomics (eMERGE) network, a consortium of medical centers that utilize electronic medical records (EMR) as a tool for","Cough","Case-Control","Not Provided","VESPA: Vanderbilt Electronic Systems for Pharmacogenomic Assessment (phs000991.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","3 phenotype datasets, 20 variables, 1 molecular datasets, 1697 subjects, 1697 samples","European (1447), African (5), East Asian (10), African American (189), Hispanic1 (11), Hispanic2 (19), Other Asian or Pacific Islander (4), South Asian (8), Other (4)","NIGMS","HMB --- Health/medical/biomedical","2016-10-26","2017-10-26","ACE Inhibitors; Angiotensin Converting Enzyme Antagonists; Angiotensin Converting Enzyme Inhibitors; Angiotensin I Converting Enzyme Inhibitors; Angiotensin I-Converting Enzyme Inhibitors; Angiotensin-Converting Enzyme Antagonists"
"phs001010.v4.p1","High Resolution Maps of the HeLa 3D Genome Using Hi-C","We use in situ Hi-C to probe the three-dimensional architecture of genomes, constructing haploid and diploid maps of nine cell types (including HeLa). The densest, in human lymphoblastoid cells,  contains 4.9 billion contacts, achieving 1-kilobase resolution. We find that genomes are partitioned into contact domains (median length, 185kb","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","OTHER","1 phenotype datasets, 7 variables,  SRA, 1 subjects, 4 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs001026.v2.p1","BCM Advancing Sequencing in Childhood Cancer Care Study (BASIC3)","This sub-study phs001026 BASIC3 contains sequence data, and selected phenotype of subjects available from the phs001026 study. Summary level phenotypes for the NCI Clinical Sequencing Exploratory Research Consortium Cohort  study participants can be viewed at the top-level study page phs001683 Clinical Sequencing Exploratory Research Consortium Cohort. Individual level","Genes, Neoplasm","Prospective Longitudinal Cohort","Not Provided","Clinical Sequencing Exploratory Research Consortium: Incorporation of Genomic Sequencing into Pediatric Cancer Care (phs001683.v1.p1)","RNA-Seq, WXS","2 phenotype datasets, 13 variables,  SRA, 252 subjects, 482 samples","","NCI","GRU-PUB --- General research use (pub)","2019-08-20","2019-08-20","Bone Cancer; Cancer of Bone; Cancer of the Bone; Malignant Bone Tumor; Malignant Neoplasm of Bone; Malignant Neoplasm of the Bone"
"phs001029.v5.p1","Full-Length Single-Cell RNA-seq Applied to HeLa S3 Cells","In this study, we produced full-length RNA-seq data of 45 single HeLa S3 cells, 8 replicates of 10 pg total RNA and one 5 ng total RNA from HeLa  S3 cell population. Using this data, we investigated the heterogeneity of HeLa S3 cells in gene expression, alternative splicing, fusion and HPV-host","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","RNA-Seq","1 phenotype datasets, 8 variables, 1 subjects, 60 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","HPV Infection; HPV Infections; Human Papilloma Virus Infection; Human Papillomavirus Infection; Human Papillomavirus Infections; Papillomavirus Infection"
"phs001031.v1.p1","Acute Viral Respiratory Infection Genetics","This study was conducted at Texas A M University, College Station. Healthy adults at the college and in the community were invited to enroll to be followed for acute  respiratory illness (ARI) through two consecutive influenza seasons 2009-2010 and 2010-2011. After subjects provided consent, a medical history was","Influenza","Prospective Longitudinal Cohort","Not Provided","Viral Respiratory Pathogens Genetics (phs001030.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","3 phenotype datasets, 25 variables, 142 subjects, 272 samples","European (98), African (1), East Asian (3), African American (3), Hispanic1 (1), Hispanic2 (13), Other Asian or Pacific Islander (3), South Asian (18), Other (2)","NIAID","GRU-IRB --- General research use (irb)","2017-06-02","2017-06-02","Flu; Flu, Human; Grippe; Human Flu; Human Influenza; Human Influenzas"
"phs001037.v2.p1","The Environmental Determinants of Diabetes in the Young (TEDDY) SNP Study","The Environmental Determinants of Diabetes in the Young (TEDDY) Study investigates genetic and genetic-environmental interactions, including gestational events, childhood infections, dietary exposures, and other environmental factors after birth, in  relation to the development of islet autoimmunity and type 1 diabetes (T1D). A consortium of six clinical centers assembled to participate in the","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","Not Provided","The Environmental Determinants of Diabetes in the Young Study (TEDDY) Project (phs001442.v1.p1)","SNP Genotypes (Array)","2 phenotype datasets, 7 variables, 1 molecular datasets, 7012 subjects, 7012 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2018-08-31","2018-08-31","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs001056.v1.p1","Diet, Activity, and Lifestyle Study (DALS)","This study phs001056 DALS contains genotype and phenotype of subjects available from the phs001056 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 880 subjects, 916 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001061.v1.p1","PsychENCODE Consortium: Autism Post-Mortem Brain RNA-Sequencing - Global    Changes in Patterning, Splicing and lncRNAs","Autism spectrum disorder (ASD) is a neurodevelopmental syndrome characterized by deficits in social communication and mental flexibility. Genetic risk factors contribute substantially to ASD risk, and recent studies support  the potential contribution of more than a thousand genes to ASD risk. However, given the shared cognitive and behavioral features across the autism","Autistic Disorder","Case-Control","Not Provided","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","RNA-Seq, RNA-Seq","2 phenotype datasets, 13 variables,  SRA, 78 subjects, 181 samples","","NIMH","GRU --- General research use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs001069.v1.p2","MIGen_ExS: JHS","This sub-study phs001069 MIGen JHS contains sample phenotype and sequence data of subjects available from the phs001069 study. Summary level phenotypes for the NHLBI JHS Cohort study participants can  be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and","Cardiovascular Diseases","Control Set","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v6.p2)","WXS","2 phenotype datasets, 5 variables,  SRA, 1065 subjects, 1065 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","Not Provided"
"phs001077.v1.p1","Women's Health Initiative (WHI)","This study phs001077 WHI Colorectal Cancer contains genotype and phenotype of subjects available from the phs001077 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be  viewed at the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 2191 subjects, 2191 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001081.v1.p1","ELLIPSE Prostate Cancer Meta-Analysis","The Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium is an international effort to discover risk loci for prostate cancer. It includes the meta-analysis of existing GWAS data.  The GWAS meta-analysis includes the following cases and controls from studies of European ancestry: UK GWAS stage 1 (Illumina Infinium HumanHap 550","Prostatic Neoplasms","Case-Control","Not Provided","ELLIPSE Prostate Cancer Meta-Analysis and Genotyping (phs001120.v1.p1)","Not Provided","2 analyses","","NCI","DS-PC-MDS --- Disease-specific (prostate cancer, mds) , DS-CA --- Disease-specific (cancer) , GRU-MDS --- General research use (mds) , DS-PC --- Disease-specific (prostate cancer)","2017-03-31","2017-03-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001092.v1.p1","Postmenopausal Hormones Supplementary Study to the Colon Cancer Family    Registry (PMH-CCFR)","This study phs001092 PMH CCFR contains genotype and phenotype of subjects available from the phs001092 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed  at the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 450 subjects, 463 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001094.v1.p1","Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)","This study phs001094 PLCO contains genotype and phenotype of subjects available from the phs001094 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Prospective Longitudinal Cohort","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1123 subjects, 1189 samples","European (917), African (3), East Asian (58), African American (108), Hispanic1 (5), Hispanic2 (15), Other Asian or Pacific Islander (14), South Asian (1), Other (2)","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001098.v2.p2","T2D-GENES Multi-Ethnic Exome Sequencing Study: Jackson Heart Study","This sub-study phs001098 T2D GENES Exome Seq contains genotype derived from sequence data and selected phenotype of subjects available from the phs001098 study. Summary level phenotypes for the NHLBI  JHS Cohort study participants can be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v6.p2)","SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 33 variables, 1 molecular datasets,  SRA, 1029 subjects, 1030 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001099.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Starr County","This sub-study phs001099 T2D GENES Starr County contains genotype data and selected phenotype of subjects available from the phs001099 study. Summary level phenotypes for the NIDDK T2D Seq GWAS  Starr County Cohort study participants can be viewed at the top-level study page phs001166 T2D Seq GWAS Starr County Cohort. Individual level","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Type 2 Diabetes Starr County GWAS and Exome Sequencing (phs001166.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 29 variables, 1 molecular datasets,  SRA, 1474 subjects, 1457 samples","","NIDDK","GRU-IRB --- General research use (irb)","2016-07-13","2016-07-13","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001100.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: METSIM","T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) is a NIDDK-funded international research consortium which seeks to identify genetic variants for type 2 diabetes (T2D)  through multiethnic sequencing studies. T2D-GENES Project 1 is a multi-ethnic sequencing study designed to assess whether less common variants play a","Diabetes Mellitus, Type 2","Case-Control","Not Provided","METSIM (<u>MET</u>abolic <u>S</u>yndrome <u>I</u>n <u>M</u>en) Study (phs000743.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 8 variables, 1 molecular datasets,  SRA, 982 subjects, 982 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-08","2017-01-19","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001102.v1.p1","T2D-GENES Multi-Ethnic Exome Sequencing Study: Wake Forest African    American","This sub-study phs001102 T2D GENES AA contains genotype data and selected phenotype of subjects available from the phs001102 study. Summary level phenotypes for the NIDDK T2D Seq GWAS AA  Cohort study participants can be viewed at the top-level study page phs001167 T2D Seq GWAS AA Cohort. Individual level phenotype data and molecular","Bacterial Infections and Mycoses","Case-Control","Not Provided","Type 2 Diabetes in African Americans, GWAS and Exome Sequencing (phs001167.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 16 variables, 1 molecular datasets,  SRA, 1050 subjects, 1050 samples","","NIDDK","DS-T2D-IRB-RD --- Disease-specific (type 2 diabetes, irb, rd)","2016-07-13","2016-07-13",""
"phs001103.v1.p2","NINDS-Exome Sequencing in Parkinson's Disease","This sub-study phs001103 PD Exome contains whole exome sequence data and selected phenotype of subjects available from the phs001103 study. Summary level phenotypes for the NINDS Parkinson's Disease Cohort  participants can be viewed at the top-level study page phs001172 NINDS Parkinson's Disease Cohort. Individual level phenotype data and molecular data","Parkinson Disease","Case Set","Not Provided","National Institute of Neurological Disorders and Stroke (NINDS) Parkinson&#39;s Disease (phs001172.v1.p2)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 11 variables, 1 molecular datasets,  SRA, 618 subjects, 1841 samples","","NINDS","GRU --- General research use","2016-12-22","2016-12-22","Idiopathic Parkinson Disease; Idiopathic Parkinson's Disease; Idiopathic Parkinsonism; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; PARKINSON DISEASE"
"phs001104.v1.p1","French Association STudy Evaluating RISK for Sporadic Colorectal Cancer    (ASTERISK)","This study phs001104 ASTERISK contains genotype and phenotype of subjects available from the phs001104 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortioum. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1937 subjects, 2005 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001113.v1.p1","Darmkrebs: Chancen der Verhutung durch Screening (DACHS)","This study phs001113 DACHS contains genotype and phenotype of subjects available from the phs001113 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 4686 subjects, 5125 samples","European (3496), African (1), East Asian (3), African American (1), Hispanic1 (4), South Asian (2), Other (4)","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC --- Health/medical/biomedical (pub) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001114.v1.p1","Health Professionals Follow-up Study (HPFS)","This study phs001114 HPFS contains genotype and phenotype of subjects available from the phs001114 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 1497 subjects, 1539 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001116.v1.p1","CHARGE-S: MGH AF Study","This substudy phs001116 CHARGE-S: Massachusetts General Hospital (MGH) AF Study includes targeted capture sequencing produced as part of NHLBI's CHARGE-S project. Summary level phenotypes for the Massachusetts General Hospital  (MGH) Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page phs001001 MGH AF Study. Individual level phenotype data","Atrial Fibrillation","Case Set","Not Provided","Massachusetts General Hospital (MGH) Atrial Fibrillation Study (phs001001.v1.p1)","SNP/CNV Genotypes (NGS), Targeted-Capture, SNP/CNV Genotypes (NGS), Targeted-Capture","1 phenotype datasets, 4 variables, 1 molecular datasets, 200 subjects, 200 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-AF-IRB-RD --- Disease-specific (atrial fibrillation, irb, rd)","2018-03-06","2018-03-06","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001117.v1.p1","MGH AF Study: Exome Sequencing in Early-Onset Atrial Fibrillation","This substudy phs001117 Massachusetts General Hospital (MGH) AF Study: Exome Sequencing Study includes exome sequencing for subjects with early-onset atrial fibrillation. Summary level phenotypes for the Massachusetts General Hospital  (MGH) Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page phs001001 MGH AF Study. Individual level phenotype data","Atrial Fibrillation","Case Set","Not Provided","Massachusetts General Hospital (MGH) Atrial Fibrillation Study (phs001001.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","1 phenotype datasets, 4 variables, 1 molecular datasets, 287 subjects, 287 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-AF-IRB-RD --- Disease-specific (atrial fibrillation, irb, rd)","2018-03-06","2018-03-06","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001118.v1.p1","MGH AF Study: Resequencing Five GWAS Loci for Atrial Fibrillation","This substudy phs001118 Massachusetts General Hospital (MGH) AF Study: Resequencing includes deep coverage targeted re-sequencing and variant identification for 5 GWAS loci in the MGH AF sample collection. Summary  level phenotypes for the Massachusetts General Hospital (MGH) Atrial Fibrillation (AF) Study participants can be viewed at the top-level study page","Atrial Fibrillation","Case Set","Not Provided","Massachusetts General Hospital (MGH) Atrial Fibrillation Study (phs001001.v1.p1)","SNP/CNV Genotypes (NGS), Targeted-Capture, SNP/CNV Genotypes (NGS), Targeted-Capture","1 phenotype datasets, 4 variables, 1 molecular datasets, 462 subjects, 462 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , DS-AF-IRB-RD --- Disease-specific (atrial fibrillation, irb, rd)","2018-03-06","2018-03-06","AF; AF - Atrial fibrillation; Atrial Fibrillations; Auricular Fibrillation; Auricular Fibrillations; Fibrillation, Atrial"
"phs001125.v1.p1","ELLIPSE Prostate Cancer Genotyping","The Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium is an international effort to discover risk loci for prostate cancer. The following de novo genotyping was performed. The  OMNI 2.5M genotyping was conducted for 977 prostate cancer cases from UKGPCS. The Exome SNP array genotyping was conducted for 4741 subjects from","Prostatic Neoplasms","Case-Control","Not Provided","ELLIPSE Prostate Cancer Meta-Analysis and Genotyping (phs001120.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 10 variables, 3 molecular datasets, 12947 subjects, 12947 samples","European (11012), African (4), East Asian (1), African American (12), Hispanic1 (13), Hispanic2 (2), South Asian (12), Other (16)","NCI","DS-PC-MDS --- Disease-specific (prostate cancer, mds) , DS-CA --- Disease-specific (cancer) , GRU-MDS --- General research use (mds) , DS-PC --- Disease-specific (prostate cancer)","2017-03-31","2017-03-31","NGP - New growth of prostate; Neoplasm of Prostate; Neoplasm of the Prostate; Neoplasm, Prostate; Neoplasm, Prostatic; Neoplasms, Prostate"
"phs001128.v1.p1","Physicians' Health Study (PHS)","This study phs001128 PHS contains genotype and phenotype of subjects available from the phs001128 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Prospective Longitudinal Cohort","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 806 subjects, 817 samples","European (775), East Asian (12), African American (4), Hispanic1 (1), Hispanic2 (4), Other Asian or Pacific Islander (5), South Asian (3), Other (2)","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001129.v1.p1","Nurses' Health Study (NHS)","This study phs001129 NHS contains genotype and phenotype of subjects available from the phs001129 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortium. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 2606 subjects, 2660 samples","","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001170.v1.p1","Hawai'i Colorectal Cancer Studies 2 3 (Colo2 3)","This study phs001170 Colo2and3 contains genotype and phenotype of subjects available from the phs001170 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be viewed at  the top-level study page phs001078 GECCO Consortioum. Individual level phenotype data and molecular data for all GECCO Consortium top-level study and","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 225 subjects, 232 samples","European (214), East Asian (1), Hispanic1 (3), Hispanic2 (3), Other Asian or Pacific Islander (4)","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC-MDS --- Disease-specific (colorectal cancer, mds) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001171.v1.p1","Multiethnic Cohort Study (MEC)","This study phs001171 MEC Colorectal Cancer contains genotype and phenotype of subjects available from the phs001171 study. Summary level phenotypes for the NCI GECCO Consortium study participants can be  viewed at the top-level study page phs001078 GECCO Consortioum. Individual level phenotype data and molecular data for all GECCO Consortium top-level","Colorectal Neoplasms","Case-Control","Not Provided","Common Variant GWAS, Genetics &amp; Epidemiology of Colorectal Cancer Consortium (GECCO) (phs001078.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","2 phenotype datasets, 11 variables, 1 molecular datasets, 722 subjects, 735 samples","European (674), African (1), East Asian (1), African American (2), Hispanic1 (7), Hispanic2 (15), Other Asian or Pacific Islander (13), Other (6)","NCI","GRU --- General research use , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , CADM --- Cancer in all age groups, other diseases in adults only, and methods , HMB-PUB-NPU-MDS-GSO --- Health/medical/biomedical (pub, npu, mds, gso) , DS-CC-NPU-GSO --- Disease-specific (colorectal cancer, npu, gso) , DS-CC --- Health/medical/biomedical (pub) , HMB-IRB --- Health/medical/biomedical (irb) , DS-CA-PUB --- Disease-specific (cancer, pub) , HMB-PUB --- Health/medical/biomedical (pub)","2018-11-27","2018-11-27","CRC; Cancer of Large Bowel; Cancer of Large Intestine; Cancer of the Large Bowel; Cancer of the Large Intestine; Cancer, Colorectal"
"phs001183.v1.p1","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in    Periventricular Nodular Heterotopia","Project 1 of the Epi4K: Gene Discovery in 4,000 Epilepsy Genomes project is designed to study the genetics of severe sporadic epilepsies. For this arm of the study we  focused the analysis on patients with periventricular nodular heterotopia (PVNH), a disorders whereby neurons fail to migrate properly during brain","Periventricular Nodular Heterotopia","Family/Twin/Trios","Not Provided","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes (phs000653.v3.p1)","WXS","2 phenotype datasets, 10 variables,  SRA, 3 subjects, 3 samples","","NINDS","GRU --- General research use , DS-ESD-GSO --- Disease-specific (epilepsy and seizure disorders, gso)","2018-09-19","2018-09-19","FLNA-Related Disorders; HETEROTOPIA, PERIVENTRICULAR NODULAR, 1; HETEROTOPIA, PERIVENTRICULAR, 1; HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT; Heterotopia familial nodular; Heterotopia periventricular X-linked dominant"
"phs001184.v2.p2","CTSP Diffuse Large B-Cell Lymphoma (DLBCL) CALGB 50303","For the CTSP-DLBCL sub-project, National Cancer Institute (NCI) will utilize whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing to try to identify recurrent genetic alterations  (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures that would be important to the hypothesis(es) submitted by","Lymphoma, Large B-Cell, Diffuse","Case Set","Not Provided","CTSP: Clinical Trial Sequencing Project (phs001175.v2.p2)","Not Provided","366 samples","","NCI","GRU --- General research use","2019-01-29","2018-04-11","DLBCL; Diffuse Histiocytic Lymphoma; Diffuse Histiocytic Lymphomas; Diffuse Large Cell Lymphoma; Diffuse Large-Cell Lymphoma; Diffuse Large-Cell Lymphomas"
"phs001190.v1.p1","PsychENCODE Consortium: Chromatin contact map in human brain development","Chromosome conformation capture experiments demonstrate that chromatin is organized into hierarchical structures, which include compartments, topological associating domains (TADs), and loops. These structures are thought to play a role  in gene regulation and biological function by defining functional genomic units and mediating the effects of cis-regulatory elements via both short","Brain","Control Set","Not Provided","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","OTHER, OTHER","4 phenotype datasets, 15 variables,  SRA, 3 subjects, 6 samples","","NIMH","GRU --- General research use","2017-08-18","2017-08-18","Encephalon; Cerebral Cortex; Cerebral Cortices; Cerebral gray matter; Cerebri, Cortex; Cerebrus, Cortex"
"phs001220.v1.p1","PsychENCODE Consortium: Epigenetic Dysregulation in Autism Spectrum    Disorder","Autism spectrum disorder (ASD) is a collection of neuro-developmental disorders characterized by deficits in social interaction and social communication, along with restricted and repetitive behaviour patterns. The etiology of  ASD is complex and multifactorial, including both genetic and environmental components. Large scale gene expression studies on ASD postmortem brain","Autistic Disorder","Case-Control","Not Provided","PsychENCODE Consortium: Epigenetic and Transcriptional Dysregulation in Autism Spectrum (phs001022.v1.p1)","ChIP-Seq, ChIP-Seq","2 phenotype datasets, 13 variables,  SRA, 117 subjects, 288 samples","","NIMH","GRU --- General research use","2017-08-18","2017-08-18","AUTISTIC DISORDER; AUTS; Autism; Autism (209850); Autism disorder; Autism, Early Infantile"
"phs001268.v3.p1","Sequencing Thousands of Single Cell Genomes with Combinatorial Indexing","Single-cell genome sequencing has proven valuable for the detection of somatic variation, particularly in the context of tumor evolution. Current technologies suffer from high library construction costs which restrict  the number of cells that can be assessed and thus impose limitations on the ability to measure heterogeneity within a tissue. Here, we present Single","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","WGS","1 phenotype datasets, 12 variables,  SRA, 1 subjects, 1 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs001269.v3.p1","Massively Multiplex Single-Cell Hi-C","In this study, we developed a massively multiplexed, single-cell Hi-C protocol to study the chromosomal architecture of single HeLa cells.","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","OTHER","1 phenotype datasets, 12 variables,  SRA, 1 subjects, 6 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs001274.v1.p1","Genes-environments and Admixture in Latino Asthmatics (GALA II) GWAS    Study","This study contains Genome Wide Association sequence data and phenotype variables. A case-control pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. The overall goal  is to identify genetic factors which are predictive of drug response in children with asthma. The principal tools include a questionnaire and","Asthma","Case-Control","Not Provided","Genes-Environments and Admixture in Latino Asthmatics (GALA II) Study (phs001180.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 5 variables, 1 molecular datasets, 4427 subjects, 4427 samples","European (27), African American (210), Hispanic1 (1735), Hispanic2 (1978), Other (477)","NHLBI","DS-LD-RD --- Disease-specific (lung disease, rd)","2017-12-20","2017-12-20","Airway hyperreactivity; Asthma, Bronchial; Asthmas; Asthmatic; Bronchial Asthma; Reactive airway disease"
"phs001301.v1.p1","NABEC Exome Sequencing of Human Cerebral Frontal Cortex","Genome wide exome DNA sequencing was done in 343 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from cerebral frontal cortex. The  exome sequencing data was generated and provided by the laboratory of Neurogenetics, NIA, NIH.","Not Provided","Control Set","Not Provided","NABEC: North American Brain Expression Consortium (phs001300.v1.p1)","SNP/CNV Genotypes (NGS), WXS, SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 7 variables, 1 molecular datasets,  SRA, 343 subjects, 835 samples","","NIA","GRU --- General research use","2018-03-21","2018-03-21",""
"phs001302.v1.p1","NABEC CAGE Sequencing of Human Cerebral Frontal Cortex","In this paper (Blauwendraat et al., 2016, PMID: 27287230) we describe a comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe. Correlations are made between  common genetic variability across the human genome and gene expression values obtained from neurologically normal human frontal cortex brain","Not Provided","Control Set","Not Provided","NABEC: North American Brain Expression Consortium (phs001300.v1.p1)","RNA-Seq, RNA-Seq","2 phenotype datasets, 7 variables,  SRA, 142 subjects, 142 samples","","NIA","GRU --- General research use","2018-03-21","2018-03-21",""
"phs001334.v1.p3","Metabolomics of Coronary Heart Disease (CHD) in the WHI","The primary goal of this substudy phs001334 Metabolomics of CHD in WHI study was to analyze the relationship between metabolite profiles and incident coronary heart disease (CHD) in women  using a nested case-control design. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page","Coronary Heart Disease","Case-Control","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","Not Provided","3 phenotype datasets, 746 variables, 1 documents, 2151 subjects","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","CHD - Coronary heart disease; Coronary Disease; Coronary Diseases; Coronary Heart Diseases; Disease, Coronary; Disease, Coronary Heart"
"phs001335.v1.p3","NHLBI's BA23 in WHI","This substudy phs001335 Integrative genomics and risk of CHD and related phenotypes in WHI study was to analyze epigenetic markers in blood and to associate these markers with phenotypes  related to coronary heart disease. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200","Coronary Artery Disease","Case-Control","Not Provided","Women&#39;s Health Initiative Clinical Trial and Observational Study (phs000200.v11.p3)","Methylation (CpG), miRNA Expression (Array)","2 phenotype datasets, 23 variables, 2 documents, 1 molecular datasets, 2129 subjects, 4256 samples","","NHLBI","HMB-IRB --- Health/medical/biomedical (irb) , HMB-IRB-NPU --- Health/medical/biomedical (irb, npu)","2017-06-23","2017-11-02","Aging, Biological; Biological Aging; Blood Sugar; Glucose, Blood; Sugar, Blood; DAP - Diastolic arterial pressure"
"phs001353.v1.p1","NABEC mRNA Sequencing of Human Cerebral Frontal Cortex","mRNA Sequencing was performed in 69 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from cerebral frontal cortex. The mRNA sequencing data  was generated and provided by the laboratory of Neurogenetics, NIA, NIH.","Healthy Volunteers","Control Set","Not Provided","NABEC: North American Brain Expression Consortium (phs001300.v1.p1)","RNA-Seq, RNA-Seq","2 phenotype datasets, 7 variables,  SRA, 69 subjects, 69 samples","","NIA","GRU --- General research use","2018-03-21","2018-03-21","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human"
"phs001354.v1.p1","NABEC Total RNA Sequencing of Human Cerebral Frontal Cortex","TotalRNA Sequencing was performed in 276 neurologically normal control samples deposited in North American Brain Expression Consortium (NABEC). The DNA comes from cerebral frontal cortex. The total RNA sequencing  data was generated and provided by the laboratory of Neurogenetics, NIA, NIH.","Healthy Volunteers","Control Set","Not Provided","NABEC: North American Brain Expression Consortium (phs001300.v1.p1)","RNA-Seq, RNA-Seq","2 phenotype datasets, 7 variables,  SRA, 276 subjects, 483 samples","","NIA","GRU --- General research use","2018-03-21","2018-03-21","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human"
"phs001356.v1.p2","Exome Chip Genotyping: The Jackson Heart Study","This sub-study phs001356 Exome Chip contains sequence data and selected phenotype of subjects available from the phs001356 study. Summary level phenotypes for the NHLBI JHS Cohort study participants can  be viewed at the top-level study page phs000286 JHS Cohort. Individual level phenotype data and molecular data for all JHS Cohort top-level study and","Cardiovascular Diseases","Prospective Longitudinal Cohort","Not Provided","Jackson Heart Study (JHS) Cohort (phs000286.v6.p2)","SNP Genotypes (Array)","1 phenotype datasets, 8 variables, 1 molecular datasets, 2788 subjects, 2788 samples","","NHLBI","HMB-IRB-NPU --- Health/medical/biomedical (irb, npu) , DS-FDO-IRB-NPU --- Disease-specific (focused disease only, irb, npu) , HMB-IRB --- Health/medical/biomedical (irb) , DS-FDO-IRB --- Disease-specific (focused disease only, irb)","2019-05-10","2019-05-10","BP - High blood pressure; BP+ - Hypertension; Blood Pressure, High; Blood Pressures, High; Elevated blood pressure; HBP - High blood pressure"
"phs001401.v2.p1","Genetic Epidemiology Network of Arteriopathy (GENOA): GWAS Studies","This substudy phs001401 GENOA GWAS Studies, contains genome-wide genetic variants on a subset of participants in the GENOA Cohorts. A total of 1385 European American and 1263 African American  participants from GENOA were genotyped on the Affymetrix Genome-Wide Human SNP Array 6.0 array using the protocol outlined by Affymetrix (Affymetrix","Hypertension","Prospective Longitudinal Cohort","Not Provided","Genetic Epidemiology Network of Arteriopathy (GENOA) (phs001238.v2.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 phenotype datasets, 4 variables, 1 molecular datasets, 3039 subjects, 3039 samples","European (1507), African (48), African American (1478), Hispanic1 (4), Other (2)","NHLBI","DS-ASC-RF-NPU --- Disease-specific (arteriosclerosis and its risk factors, npu)","2018-08-08","2017-09-08","Aging, Biological; Biological Aging; Arterial Pressure, Mean; Arterial Pressures, Mean; MAP - Mean arterial pressure; MBP - Mean blood pressure"
"phs001443.v1.p1","The Environmental Determinants of Diabetes in the Young (TEDDY)    Microbiome Study","The Environmental Determinants of Diabetes in the Young (TEDDY) Study investigates genetic and genetic-environmental interactions, including gestational events, childhood infections, dietary exposures, and other environmental factors after birth, in  relation to the development of islet autoimmunity and type 1 diabetes (T1D). A consortium of six clinical centers assembled to participate in the","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","Not Provided","The Environmental Determinants of Diabetes in the Young Study (TEDDY) Project (phs001442.v1.p1)","OTHER, WGS, OTHER, WGS","2 phenotype datasets, 8 variables,  SRA, 912 subjects, 13046 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2018-08-31","2018-08-31","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs001450.v2.p1","G-quadruplex Clusters Identification","G-quadruplex (G4) is a non-canonical DNA structure that has been found in the genome. To identify clusters of G4-forming sequences in the genome, we performed whole genome amplification (WGA)  in the presence or absence of a G4 ligand that inhibits DNA polymerase activity on the G4 forming regions, followed by high-throughput sequencing of","Uterine Cervical Neoplasms","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","WGA","1 phenotype datasets, 5 variables,  SRA, 1 subjects, 2 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26","Cervical Neoplasm, Uterine; Cervical Neoplasms; Cervical Neoplasms, Uterine; Cervical Tumor; Cervix Neoplasm; Cervix Neoplasms"
"phs001462.v1.p1","NABEC NeuroChip Genotyping","This study describes the design, application and implementation of the NeuroChip genotyping platform. The NeuroChip (Illumina) is an affordable, high-throughput genotyping array that contains a tagging variant backbone (n  300,000 variants) as well as manually curated custom variant content. These custom variants have been previously reported in diverse neurological","Molecular Probe Techniques","Control Set","Not Provided","NABEC: North American Brain Expression Consortium (phs001300.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","1 molecular datasets, 270 subjects, 270 samples","European (270)","NIA","GRU --- General research use","2018-03-21","2018-03-21","Human Volunteer; Human Volunteers; Volunteer, Human; Volunteers, Human; Molecular Probe Technic; Molecular Probe Technics"
"phs001476.v1.p1","Field Studies of Human Immunity to Amebiasis in Bangladesh","This sub-study phs001476 Amebiasis Immunity contains genotype data and selected phenotype of subjects available from the phs001476. Summary level phenotypes for the NIAID Infection Malnutrition Bangladesh Cohort study participants  can be viewed at the top-level study page phs001475 Infection Malnutrition Bangladesh Cohort. Individual level phenotype data and molecular data for","Intestinal Diseases","Prospective Longitudinal Cohort","Not Provided","Field Studies of Human Immunity to Amebiasis in Bangladesh (NIH Birth Cohort) and Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh (PROVIDE) (phs001475.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","11 phenotype datasets, 178 variables, 1 molecular datasets, 447 subjects, 447 samples","South Asian (439), Other (8)","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-specific (tropical enteropathy, irb, pub, npu, mds, gso, rd)","2018-11-13","2018-11-13","Child Development; Development, Child; Communicable Disease; Disease due to infection; Disease, Communicable; Disease, Infectious"
"phs001478.v1.p1","Exploration of the Biologic Basis for Underperformance of Oral Polio and    Rotavirus Vaccines in Bangladesh","This sub-study phs001478 Polio Rotavirus Vaccines contains genotype data and selected phenotype of subjects available from the phs001478. Summary level phenotypes for the NIAID Infection Malnutrition Bangladesh Cohort study  participants can be viewed at the top-level study page phs001475 Infection Malnutrition Bangladesh Cohort. Individual level phenotype data and","Intestinal Diseases","Prospective Longitudinal Cohort","Not Provided","Field Studies of Human Immunity to Amebiasis in Bangladesh (NIH Birth Cohort) and Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh (PROVIDE) (phs001475.v1.p1)","SNP Genotypes (Array), SNP Genotypes (Array)","10 phenotype datasets, 163 variables, 1 molecular datasets, 640 subjects, 640 samples","South Asian (516), Other (25)","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-specific (tropical enteropathy, irb, pub, npu, mds, gso, rd)","2018-11-13","2018-11-13","Child Development; Development, Child; Communicable Disease; Disease due to infection; Disease, Communicable; Disease, Infectious"
"phs001520.v1.p1","Using Extrachromosomal Vector to Study Replication Timing and Subnuclear    Compartment","The role of DNA sequence in determining replication timing (RT) and chromatin higher order organization remains elusive. To address this question, we have developed an extra-chromosomal replication system consisting  of 200kb human bacteria artificial chromosomes (BACs) modified with Epstein-Barr virus (EBV) replication origin elements (E-BACs). E-BACs were stably","Not Provided","Methods","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","ChIP-Seq, OTHER","2 phenotype datasets, 7 variables,  SRA, 1 subjects, 38 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26",""
"phs001558.v1.p1","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes: Genetic Analyses in    Multiplex Families and Sibling Pairs","Project 2 of the Epi4K: Gene Discovery in 4,000 Epilepsy Genomes project is designed to study the genetic bases of familial epilepsies, in particular genetic generalized and non-acquried (non-lesional)  focal epilepsy. This exome-sequencing study consists of two parts: (1) a co-segregation analyses to identify genetic epilepsy syndromes within and","Epilepsy","Family/Twin/Trios","Not Provided","Epi4K: Gene Discovery in 4,000 Epilepsy Genomes (phs000653.v3.p1)","WXS","2 phenotype datasets, 9 variables,  SRA, 1172 subjects, 1172 samples","","NINDS","GRU --- General research use , DS-ESD-GSO --- Disease-specific (epilepsy and seizure disorders, gso)","2018-09-19","2018-09-19","Disorders, Focal Seizure; Disorders, Partial Seizure; Epilepsies, Focal; Epilepsies, Localization-Related; Epilepsy, Focal; Epilepsy, Localization-Related"
"phs001562.v1.p1","The Environmental Determinants of Diabetes in the Young (TEDDY) Gene    Expression Study","The Environmental Determinants of Diabetes in the Young (TEDDY) Study investigates genetic and genetic-environmental interactions, including gestational events, childhood infections, dietary exposures, and other environmental factors after birth, in  relation to the development of islet autoimmunity and type 1 diabetes (T1D). A consortium of six clinical centers assembled to participate in the","Diabetes Mellitus, Type 1","Prospective Longitudinal Cohort","Not Provided","The Environmental Determinants of Diabetes in the Young Study (TEDDY) Project (phs001442.v1.p1)","mRNA Expression (Array), mRNA Expression (Array)","2 phenotype datasets, 8 variables, 1 molecular datasets, 401 subjects, 2013 samples","","NIDDK","DS-T1DR-IRB-RD --- Disease-specific (type 1 diabetes, its complications and other autoimmune diseases, irb, rd)","2018-08-31","2018-08-31","DIABETES MELLITUS, INSULIN-DEPENDENT, 1; DIABETES MELLITUS, TYPE I; Diabetes Mellitus, Insulin Dependent; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Juvenile-Onset; Diabetes mellitus Type I"
"phs001610.v1.p11","T2D-GENES Multi-Ethnic Exome Sequencing Study: Framingham Heart Study","This substudy phs001610 Framingham T2D-GENES contains next-generation sequencing in multi-ethnic samples. Summary level phenotypes for the Framingham Cohort study participants can be viewed at the top-level study page phs000007  Framingham Cohort. Individual level phenotype data and molecular data for all Framingham top-level study and substudies are available by requesting","Diabetes Mellitus, Type 2","Case-Control","Not Provided","Framingham Cohort (phs000007.v30.p11)","SNP/CNV Genotypes (NGS), WXS","2 phenotype datasets, 14 variables, 1 molecular datasets,  SRA, 992 subjects, 992 samples","","NHLBI","HMB-IRB-MDS --- Health/medical/biomedical (irb, mds) , HMB-IRB-NPU-MDS --- Health/medical/biomedical (irb, npu, mds)","2018-10-12","2018-10-12","Adult-Onset Diabetes; Adult-Onset Diabetes Mellitus; DIABETES MELLITUS, TYPE 2; DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; DIABETES MELLITUS, TYPE II; DIABETES MELLITUS, TYPE II, SUSCEPTIBILITY TO"
"phs001634.v1.p1","CIT_mRNA","This study phs001634 CIT mRNA contains molecular data and phenotype of subjects available from the phs001634 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can  be viewed at the top-level study page phs001304 Biospecimen PV study. Individual level phenotype data and molecular data for all Biospecimen PV","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 131 variables, 1 molecular datasets,  SRA, 40 subjects, 209 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001635.v1.p1","CNV_aCGH","This study phs001635 CNV aCGH contains molecular data and phenotype of subjects available from the phs001635 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can  be viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 168 variables, 1 molecular datasets,  SRA, 38 subjects, 229 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001636.v1.p1","FixationDelay","This study phs001636 Fixation Delay contains molecular data and phenotype of subjects available from the phs001636 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can  be viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 116 variables, 1 molecular datasets,  SRA, 20 subjects, 95 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001637.v1.p1","GlobalMetaboliteProfiling","This study phs001637 Global Metabolite Profiling contains molecular data and phenotype of subjects available from the phs001637 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants  can be viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 49 variables, 1 molecular datasets,  SRA, 40 subjects, 240 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001638.v1.p1","mRNA_TaqMan","This study phs001638 mRNA TaqMan contains molecular data and phenotype of subjects available from the phs001638 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can  be viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 124 variables, 1 molecular datasets,  SRA, 20 subjects, 100 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001639.v1.p1","NGS","This study phs001639 NGS contains molecular data and phenotype of subjects available from the phs001639 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can be  viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV cohort","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","RNA-Seq, WXS, miRNA-Seq, RNA-Seq, WXS, miRNA-Seq","1 phenotype datasets, 129 variables,  SRA, 35 subjects, 341 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001640.v1.p1","TumorStorage","This study phs001640 Tumor Storage contains molecular data and phenotype of subjects available from the phs001640 study. Summary level phenotypes for the NCI Biospecimen PV cohort study participants can  be viewed at the top-level study page phs001304 Biospecimen PV cohort. Individual level phenotype data and molecular data for all Biospecimen PV","Carcinoma, Renal Cell","Case Set","Not Provided","National Cancer Institute (NCI) Biospecimen Pre-analytical Variables (BPV) Analysis (phs001304.v1.p1)","Legacy Genotypes, Legacy Genotypes","1 phenotype datasets, 156 variables, 1 molecular datasets,  SRA, 53 subjects, 340 samples","","NCI","GRU-PUB --- General research use (pub)","2018-10-12","2018-10-12","Adenocarcinoma of lung; Adenocarcinoma Of Kidney; Adenocarcinoma Of Kidneys; Adenocarcinoma of the Kidney; Adenocarcinoma, Renal; Adenocarcinoma, Renal Cell"
"phs001665.v1.p1","Field studies of Cryptosporidiosis and Enteropathogens in Bangladesh","This sub-study phs001665 Cryptosporidiosis Enteropathogens contains genotype data, sequence data, and selected phenotype of subjects available from the phs001665. Summary level phenotypes for the NIAID Infection Malnutrition Bangladesh Cohort  study participants can be viewed at the top-level study page phs001475 Infection Malnutrition Bangladesh Cohort. Individual level phenotype data and","Environment","Clinical Trial","Not Provided","Field Studies of Human Immunity to Amebiasis in Bangladesh (NIH Birth Cohort) and Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh (PROVIDE) (phs001475.v1.p1)","RNA-Seq, RNA-Seq","2 phenotype datasets, 16 variables,  SRA, 6 subjects, 6 samples","","NIAID","DS-TENT-IRB-PUB-NPU-MDS-GSO-RD --- Disease-specific (tropical enteropathy, irb, pub, npu, mds, gso, rd)","2018-11-13","2018-11-13","Communicable Disease; Disease due to infection; Disease, Communicable; Disease, Infectious; Diseases, Communicable; Diseases, Infectious"
"phs001669.v1.p1","Examination of Engineered LINE-1 Integration Events in HeLa Cells","Long Interspsesed Element-1 (LINE1 or L1) encodes two proteins (ORF1p and ORF2p) required for its mobilization (i.e. retrotransposition) in the human genome. Human ORF2p, a 150kDa protein, has endonuclease  (EN) and reverse transcriptase (RT) activities. L1 EN is classified as apurinic/apyrimidin-like endonuclease (APE) and is responsible for initiating","Not Provided","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","OTHER, Tn-Seq","1 phenotype datasets, 6 variables,  SRA, 1 subjects, 9 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26",""
"phs001671.v1.p1","RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition","Long Interspersed Element-1 (L1) retrotransposons make up approximately 17% of the human genome. L1 moves throughout the genome via a copy-and-paste mechanism termed retrotransposition. L1 retrotransposition also mobilizes other  cellular RNAs such as SINES, U6 snRNA and, mRNA, which for the latter results in the formation of processed pseudogenes. In this study we demonstrate","Not Provided","Case Set","Not Provided","HeLa Cell Genome Sequencing Studies (phs000640.v7.p1)","RNA-Seq","1 phenotype datasets, 5 variables,  SRA, 1 subjects, 3 samples","","OD","HMB --- Health/medical/biomedical","2018-10-26","2018-10-26",""
"phs001878.v1.p1","Kids First: Novel Cancer Susceptibility in Families (from BASIC3)","This sub-study phs001878 GMKF BASIC3 contains sequence data, and selected phenotype of subjects available from the phs001878 study. Summary level phenotypes for the NCI Clinical Sequencing Exploratory Research Consortium  Cohort study participants can be viewed at the top-level study page phs001683 Clinical Sequencing Exploratory Research Consortium Cohort. Individual","Genes, Neoplasm","Prospective Longitudinal Cohort","Not Provided","Clinical Sequencing Exploratory Research Consortium: Incorporation of Genomic Sequencing into Pediatric Cancer Care (phs001683.v1.p1)","Not Provided","","","NCI","GRU-PUB --- General research use (pub)","2019-08-20","2019-08-20","Bone Cancer; Cancer of Bone; Cancer of the Bone; Malignant Bone Tumor; Malignant Neoplasm of Bone; Malignant Neoplasm of the Bone"

